archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,PID INTEGRIN4 PATHWAY,9.2696e-08,1.5122,1.4388,1,1
1,CYTOPLASM ORGANIZATION AND BIOGENESIS,8.0176e-08,1.2803,1.1731,1,1
1,PID INTEGRIN5 PATHWAY,5.2837e-06,1.2107,1.0512,1,1
1,REACTOME SMOOTH MUSCLE CONTRACTION,3.6563e-08,1.1933,1.3371,1,1
1,BIOCARTA PLATELETAPP PATHWAY,2.9301e-06,1.1574,0.96445,1,1
1,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,7.2756e-08,1.122,1.1364,1,1
1,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,8.628e-07,1.111,1.0566,1,1
1,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,7.2756e-08,0.99584,0.91805,1,1
1,SA MMP CYTOKINE CONNECTION,1.5331e-06,0.96233,0.97717,1,1
1,PID UPA UPAR PATHWAY,7.2756e-08,0.95392,1.1326,1,1
1,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,2.0033e-05,0.93894,1.01,1,1
1,BIOCARTA FIBRINOLYSIS PATHWAY,1.6729e-06,0.90828,0.84052,1,1
1,PID INTEGRIN3 PATHWAY,6.2985e-07,0.90301,0.90249,1,1
1,PID INTEGRIN1 PATHWAY,7.2756e-08,0.90005,1.0014,1,1
1,PID A6B1 A6B4 INTEGRIN PATHWAY,7.889e-07,0.89452,0.76235,1,1
1,REACTOME METABOLISM OF PORPHYRINS,9.8628e-07,0.86,0.83976,1,1
1,BIOCARTA TOB1 PATHWAY,1.2962e-05,0.85389,0.72085,1,1
1,REACTOME SIGNALING BY HIPPO,1.349e-05,0.83835,0.79199,1,1
1,BIOCARTA AMI PATHWAY,4.6597e-05,0.82992,0.60213,1,1
1,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,7.5427e-07,0.82553,0.77934,1,1
1,KEGG ECM RECEPTOR INTERACTION,5.6999e-08,0.79525,0.88968,1,1
1,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,2.0784e-06,0.78602,0.68044,1,1
1,PID INTEGRIN CS PATHWAY,4.1802e-07,0.77053,0.85518,1,1
1,POSITIVE REGULATION OF CELL CYCLE,4.1617e-05,0.76957,0.58491,1,1
1,PID SYNDECAN 4 PATHWAY,3.7791e-06,0.76572,0.75796,1,1
1,REACTOME HYALURONAN METABOLISM,8.628e-07,0.76547,0.71295,1,1
1,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,5.6999e-08,0.76536,0.86582,1,1
1,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,1.4674e-06,0.76107,0.71312,1,1
1,PID PDGFRAPATHWAY,0.00032948,0.75628,0.52413,1,1
1,BIOCARTA RELA PATHWAY,1.3605e-07,0.75593,0.74878,1,1
1,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,5.0194e-07,0.7541,0.70433,1,1
1,BIOCARTA SODD PATHWAY,5.508e-06,0.75037,0.87006,1,1
1,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,4.8379e-05,0.74205,0.66419,1,1
1,REGULATION OF CELL MIGRATION,1.8084e-07,0.73801,0.80759,1,1
1,BIOCARTA CBL PATHWAY,3.1888e-05,0.73322,0.63753,1,1
1,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,4.6623e-06,0.73074,0.77347,1,1
1,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,3.0264e-07,0.73072,0.70722,1,1
1,REACTOME COLLAGEN FORMATION,2.3654e-06,0.72732,0.71173,1,1
1,COLLAGEN,1.349e-05,0.72298,0.85927,1,1
1,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,1.6729e-06,0.71722,0.64999,1,1
1,POSITIVE REGULATION OF PHOSPHORYLATION,3.0264e-07,0.71442,0.73857,1,1
1,LIPID HOMEOSTASIS,4.6623e-06,0.71198,0.71266,1,1
1,REACTOME MUSCLE CONTRACTION,7.6379e-08,0.71063,0.77032,1,1
1,FOCAL ADHESION,0.00018427,0.70516,0.65818,1,1
1,BIOCARTA PML PATHWAY,4.4712e-06,0.70116,0.62537,1,1
1,I KAPPAB KINASE NF KAPPAB CASCADE,7.2111e-07,0.69778,0.65482,1,1
1,BIOCARTA CASPASE PATHWAY,1.8521e-05,0.69315,0.69825,1,1
1,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,4.7955e-07,0.69099,0.6811,1,1
1,REACTOME ER PHAGOSOME PATHWAY,1.4039e-05,0.68884,0.53965,1,1
1,PID SYNDECAN 1 PATHWAY,5.4977e-07,0.68849,0.78563,1,1
1,PROTEASE INHIBITOR ACTIVITY,0.00012074,0.67967,0.53941,1,1
1,PID NFKAPPABCANONICALPATHWAY,4.8612e-06,0.67727,0.63322,1,1
1,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,6.7728e-06,0.67721,0.53688,1,1
1,SARCOMERE,3.3287e-06,0.66343,0.62145,1,1
1,BIOCARTA INTRINSIC PATHWAY,0.00023468,0.66227,0.54484,1,1
1,PID FRA PATHWAY,1.2366e-07,0.65986,0.92269,1,1
1,POSITIVE REGULATION OF TRANSLATION,4.7955e-07,0.6584,0.69889,1,1
1,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,6.0198e-07,0.65038,0.69614,1,1
1,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,1.1267e-06,0.64894,0.6637,1,1
1,LIPID TRANSPORT,6.7728e-06,0.64639,0.54072,1,1
1,BIOCARTA EXTRINSIC PATHWAY,7.547e-05,0.64162,0.56245,1,1
1,KEGG OTHER GLYCAN DEGRADATION,6.2786e-05,0.63854,0.60432,1,1
1,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,1.3441e-06,0.63476,0.55217,1,1
1,LIPID RAFT,2.1663e-05,0.63376,0.63128,1,1
1,REGULATION OF INTRACELLULAR TRANSPORT,3.8583e-05,0.6335,0.54673,1,1
1,PID ERBB NETWORK PATHWAY,5.7413e-06,0.62901,0.58514,1,1
1,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,9.4334e-07,0.62242,0.67728,1,1
1,BIOCARTA INFLAM PATHWAY,3.6414e-07,0.62225,0.86479,1,1
1,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,1.4674e-06,0.62144,0.65738,1,1
1,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,1.2454e-05,0.6208,0.6123,1,1
1,BIOCARTA SPRY PATHWAY,0.00057693,0.61871,0.48226,1,1
1,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,7.2111e-07,0.61281,0.60562,1,1
1,KEGG PROTEASOME,7.547e-05,0.61203,0.48648,1,1
1,EXTRACELLULAR MATRIX PART,1.4044e-06,0.60656,0.67207,1,1
1,BIOCARTA IL10 PATHWAY,8.3127e-06,0.60594,0.66485,1,1
1,BIOCARTA P53HYPOXIA PATHWAY,9.389e-05,0.6042,0.45088,1,1
1,REACTOME SHC1 EVENTS IN EGFR SIGNALING,9.7346e-05,0.60331,0.46492,1,1
1,BIOCARTA NFKB PATHWAY,1.7474e-06,0.59999,0.61391,1,1
1,PID AP1 PATHWAY,5.6174e-05,0.59971,0.53911,1,1
1,KEGG GLYCOSAMINOGLYCAN DEGRADATION,1.5201e-05,0.59822,0.49615,1,1
1,PID MYC REPRESSPATHWAY,1.4268e-07,0.58802,0.54932,1,1
1,CELL MATRIX JUNCTION,1.4609e-05,0.58778,0.63479,1,1
1,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.5759e-05,0.58597,0.51451,1,1
1,REACTOME CALNEXIN CALRETICULIN CYCLE,1.104e-05,0.58226,0.51865,1,1
1,PID TRAIL PATHWAY,1.8251e-06,0.58047,0.51113,1,1
1,BIOCARTA NTHI PATHWAY,3.4421e-05,0.57989,0.52383,1,1
1,CELL SUBSTRATE ADHERENS JUNCTION,3.4421e-05,0.57863,0.61542,1,1
1,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,1.6455e-05,0.5783,0.49579,1,1
1,PID TGFBRPATHWAY,1.1237e-07,0.5759,0.56249,1,1
1,BIOCARTA CARDIACEGF PATHWAY,0.0001547,0.5749,0.54905,1,1
1,PID IL27PATHWAY,1.5331e-06,0.57471,0.67821,1,1
1,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,1.1493e-05,0.574,0.52097,1,1
1,BIOCARTA TEL PATHWAY,2.7343e-05,0.57159,0.55261,1,1
1,REGULATION OF PROTEIN MODIFICATION PROCESS,3.4772e-07,0.57152,0.59646,1,1
1,PID CASPASE PATHWAY,6.4994e-06,0.57003,0.5076,1,1
1,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,1.6729e-06,0.56841,0.56511,1,1
1,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,5.6174e-05,0.56739,0.53378,1,1
1,PID AVB3 INTEGRIN PATHWAY,8.8325e-08,0.56454,0.6813,1,1
1,BIOCARTA LAIR PATHWAY,3.7791e-06,0.56279,0.74527,1,1
1,SULFUR COMPOUND BIOSYNTHETIC PROCESS,2.0829e-07,0.55963,0.64991,1,1
1,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,8.6584e-06,0.55905,0.50986,1,1
1,PROTEINACEOUS EXTRACELLULAR MATRIX,2.0829e-07,0.55868,0.70609,1,1
1,EXTRACELLULAR MATRIX,2.0829e-07,0.55868,0.70609,1,1
1,BIOCARTA TID PATHWAY,3.7791e-06,0.55718,0.46564,1,1
1,REACTOME COMPLEMENT CASCADE,2.5774e-06,0.55483,0.58927,1,1
1,PID HIF2PATHWAY,0.00042998,0.55211,0.49227,1,1
1,PID LYMPHANGIOGENESIS PATHWAY,2.2524e-05,0.54846,0.62044,1,1
1,PID IL23PATHWAY,0.0099891,0.5465,0.46043,1,1
1,BIOCARTA DEATH PATHWAY,1.0184e-05,0.54376,0.56483,1,1
1,REACTOME HDL MEDIATED LIPID TRANSPORT,9.7346e-05,0.54346,0.54529,1,1
1,KEGG FOCAL ADHESION,2.1077e-08,0.54073,0.65314,1,1
1,REACTOME STRIATED MUSCLE CONTRACTION,3.4728e-06,0.53793,0.4846,1,1
1,BASEMENT MEMBRANE,3.6228e-06,0.5376,0.56306,1,1
1,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,1.0604e-05,0.53639,0.44327,1,1
1,SA CASPASE CASCADE,8.2505e-07,0.53539,0.54792,1,1
1,REACTOME INTERFERON ALPHA BETA SIGNALING,0.00012074,0.53355,0.74838,1,1
1,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,8.6584e-06,0.53332,0.50434,1,1
1,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,3.0689e-05,0.53256,0.44848,1,1
1,PID AVB3 OPN PATHWAY,0.0023671,0.53224,0.42896,1,1
1,PID TOLL ENDOGENOUS PATHWAY,0.013465,0.532,0.3795,1,1
1,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,2.1702e-06,0.53144,0.58763,1,1
1,KEGG BLADDER CANCER,3.1904e-06,0.53098,0.43901,1,1
1,AMINE BIOSYNTHETIC PROCESS,0.00084609,0.52801,0.42308,1,1
1,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,8.2505e-07,0.52677,0.66774,1,1
1,KEGG SMALL CELL LUNG CANCER,3.4772e-07,0.52591,0.47171,1,1
1,BIOCARTA GSK3 PATHWAY,8.3127e-06,0.52544,0.44622,1,1
1,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,0.00032948,0.52281,0.389,1,1
1,BIOCARTA CELL2CELL PATHWAY,2.8418e-05,0.52277,0.52045,1,1
1,JAK STAT CASCADE,0.00019079,0.52055,0.47451,1,1
1,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.007729,0.51936,0.39984,1,1
1,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,4.1617e-05,0.51582,0.38503,1,1
1,INTERLEUKIN RECEPTOR ACTIVITY,2.4346e-05,0.51271,0.65628,1,1
1,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,3.5759e-05,0.51247,0.38653,1,1
1,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,0.0020453,0.51189,0.39433,1,1
1,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,2.2879e-07,0.50962,0.52312,1,1
1,PID ILK PATHWAY,7.2111e-07,0.50817,0.6188,1,1
1,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,2.6307e-05,0.50558,0.47963,1,1
1,COLLAGEN BINDING,0.018836,0.50374,0.56193,1,1
1,ST TUMOR NECROSIS FACTOR PATHWAY,3.6228e-06,0.5034,0.5939,1,1
1,REACTOME GAP JUNCTION ASSEMBLY,0.00055855,0.50236,0.42706,1,1
1,PID TNFPATHWAY,4.7955e-07,0.50122,0.55703,1,1
1,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,2.4346e-05,0.49945,0.48039,1,1
1,REGULATION OF CELL SHAPE,1.4609e-05,0.49937,0.44866,1,1
1,BIOCARTA GCR PATHWAY,8.7323e-05,0.49916,0.43259,1,1
1,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,2.5308e-05,0.49852,0.43818,1,1
1,BASAL LAMINA,0.00017796,0.49738,0.50059,1,1
1,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,7.8282e-05,0.49731,0.53476,1,1
1,KEGG COMPLEMENT AND COAGULATION CASCADES,1.6729e-06,0.49637,0.58069,1,1
1,INTEGRIN COMPLEX,9.7346e-05,0.49376,0.63562,1,1
1,PID ECADHERIN STABILIZATION PATHWAY,1.5331e-06,0.4933,0.50751,1,1
1,CONTRACTILE FIBER PART,3.3202e-07,0.49196,0.53258,1,1
1,BASOLATERAL PLASMA MEMBRANE,4.1617e-05,0.49182,0.38906,1,1
1,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,1.2454e-05,0.49077,0.55766,1,1
1,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,7.3528e-06,0.49038,0.45694,1,1
1,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.00026003,0.48988,0.36532,1,1
1,CELLULAR DEFENSE RESPONSE,0.00014418,0.4892,0.49996,1,1
1,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,0.00010462,0.48906,0.48276,1,1
1,STEROID BINDING,0.0015653,0.4868,0.49448,1,1
1,PID FAK PATHWAY,2.2879e-07,0.4867,0.52458,1,1
1,PID SYNDECAN 2 PATHWAY,2.5774e-06,0.48528,0.53449,1,1
1,PID TCPTP PATHWAY,1.2862e-06,0.48509,0.50834,1,1
1,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,9.0221e-07,0.48457,0.53086,1,1
1,REGULATION OF CELL MORPHOGENESIS,1.0604e-05,0.48417,0.43911,1,1
1,REACTOME INTERFERON SIGNALING,0.00010462,0.48237,0.46125,1,1
1,KEGG RENIN ANGIOTENSIN SYSTEM,0.00037661,0.48061,0.50958,1,1
1,FATTY ACID OXIDATION,0.00013433,0.48052,0.43254,1,1
1,INTERLEUKIN BINDING,5.2837e-06,0.48026,0.59266,1,1
1,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,9.7801e-06,0.4802,0.57863,1,1
1,PID DELTANP63PATHWAY,0.00019753,0.4788,0.57254,1,1
1,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.042857,0.47609,0.27083,1,1
1,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,3.8583e-05,0.47536,0.4859,1,1
1,REACTOME HS GAG DEGRADATION,0.001228,0.47525,0.44128,1,1
1,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,4.8612e-06,0.47442,0.446,1,1
1,CYTOKINE BINDING,2.8418e-05,0.47442,0.4133,1,1
1,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.02068,0.47379,0.30447,1,1
1,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,1.8958e-07,0.47288,0.52923,1,1
1,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.00010845,0.47277,0.3561,1,1
1,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.00011241,0.47269,0.40904,1,1
1,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.00019753,0.47054,0.49745,1,1
1,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,2.9532e-05,0.47037,0.49917,1,1
1,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.2658e-06,0.47035,0.48571,1,1
1,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,7.8282e-05,0.46977,0.40292,1,1
1,REACTOME LIPOPROTEIN METABOLISM,3.4421e-05,0.46918,0.44938,1,1
1,PID INTEGRIN A9B1 PATHWAY,1.1964e-05,0.46838,0.65022,1,1
1,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.025994,0.46636,0.52875,1,1
1,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,1.1964e-05,0.4659,0.4615,1,1
1,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,6.4994e-06,0.46337,0.49582,1,1
1,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,3.0576e-06,0.46306,0.50311,1,1
1,REGULATION OF MUSCLE CONTRACTION,0.00014418,0.46253,0.4602,1,1
1,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,1.1964e-05,0.46165,0.42831,1,1
1,MEMBRANE COAT,1.906e-06,0.46118,0.42201,1,1
1,COATED MEMBRANE,1.906e-06,0.46118,0.42201,1,1
1,KEGG LYSOSOME,1.4039e-05,0.46088,0.38871,1,1
1,BIOCARTA VEGF PATHWAY,0.0001165,0.45585,0.41555,1,1
1,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,1.349e-05,0.45566,0.50194,1,1
1,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,4.4878e-05,0.45407,0.40197,1,1
1,BIOCARTA IL22BP PATHWAY,0.0019282,0.45334,0.41016,1,1
1,PEPTIDYL TYROSINE PHOSPHORYLATION,7.9801e-06,0.45243,0.44795,1,1
1,REACTOME SIGNALING BY WNT,9.0179e-06,0.45214,0.37183,1,1
1,BIOCARTA ARAP PATHWAY,5.0683e-06,0.44898,0.45879,1,1
1,GOLGI MEMBRANE,1.4044e-06,0.44705,0.43965,1,1
1,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,8.7323e-05,0.44464,0.3501,1,1
1,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,2.2658e-06,0.44298,0.47164,1,1
1,BIOCARTA FAS PATHWAY,1.4609e-05,0.44213,0.43414,1,1
1,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.0012662,0.44154,0.39113,1,1
1,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,8.3127e-06,0.43993,0.60381,1,1
1,PID P53DOWNSTREAMPATHWAY,0.0022992,0.43834,0.31288,1,1
1,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00038934,0.43629,0.45702,1,1
1,PEPTIDYL TYROSINE MODIFICATION,2.6902e-06,0.43588,0.45995,1,1
1,PID INTEGRIN A4B1 PATHWAY,0.0011199,0.43465,0.34532,1,1
1,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,1.2308e-06,0.43459,0.52066,1,1
1,PID WNT CANONICAL PATHWAY,3.3132e-05,0.43186,0.3927,1,1
1,BIOCARTA HIVNEF PATHWAY,1.5201e-05,0.43186,0.40586,1,1
1,PID ARF 3PATHWAY,1.1493e-05,0.43171,0.38746,1,1
1,REGULATION OF ANGIOGENESIS,0.00024286,0.43138,0.36713,1,1
1,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00017186,0.43136,0.38179,1,1
1,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.00092958,0.43127,0.33355,1,1
1,BIOCARTA HER2 PATHWAY,0.00098941,0.43107,0.31656,1,1
1,REGULATION OF DNA REPLICATION,0.00022676,0.42973,0.47506,1,1
1,PID RAS PATHWAY,1.2308e-06,0.42932,0.50379,1,1
1,KEGG APOPTOSIS,3.3287e-06,0.42925,0.40207,1,1
1,HEPARIN BINDING,0.016734,0.42865,0.32052,1,1
1,INFLAMMATORY RESPONSE,0.00034072,0.42747,0.40169,1,1
1,PROTEIN TYROSINE KINASE ACTIVITY,5.8301e-05,0.42742,0.33653,1,1
1,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,7.547e-05,0.42659,0.33956,1,1
1,VESICLE COAT,9.0179e-06,0.42521,0.40111,1,1
1,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,3.4421e-05,0.42487,0.35657,1,1
1,BIOCARTA TNFR2 PATHWAY,5.2139e-05,0.4238,0.49329,1,1
1,BIOCARTA UCALPAIN PATHWAY,1.8521e-05,0.42353,0.51409,1,1
1,PROTEOGLYCAN METABOLIC PROCESS,7.547e-05,0.4229,0.39549,1,1
1,REGULATION OF PHOSPHORYLATION,3.8583e-05,0.4191,0.37915,1,1
1,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.030383,0.41875,0.25048,1,1
1,BIOCARTA TFF PATHWAY,1.5331e-06,0.41867,0.48085,1,1
1,KEGG SELENOAMINO ACID METABOLISM,6.7596e-05,0.41816,0.40131,1,1
1,BIOCARTA PROTEASOME PATHWAY,6.5149e-05,0.41753,0.38006,1,1
1,BIOCARTA RHO PATHWAY,1.6729e-06,0.4142,0.47751,1,1
1,RESPONSE TO DRUG,0.0029794,0.4139,0.32417,1,1
1,REACTOME TRANSLATION,0.031748,0.41152,0.22278,1,1
1,PROTEIN IMPORT INTO NUCLEUS,2.6307e-05,0.41092,0.35747,1,1
1,LYSOSOMAL TRANSPORT,7.5427e-07,0.4108,0.48138,1,1
1,KEGG PRIMARY IMMUNODEFICIENCY,0.00035231,0.41001,0.29858,1,1
1,PID IL12 STAT4PATHWAY,0.0042883,0.40942,0.38332,1,1
1,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,1.5331e-06,0.40866,0.40216,1,1
1,INTERACTION WITH HOST,6.5149e-05,0.40678,0.44086,1,1
1,BIOCARTA TGFB PATHWAY,0.029068,0.40659,0.36955,1,1
1,PROTEASOME COMPLEX,0.00021167,0.40502,0.35484,1,1
1,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.00079435,0.4045,0.42178,1,1
1,MITOCHONDRIAL MATRIX,0.00072223,0.40411,0.29408,1,1
1,MITOCHONDRIAL LUMEN,0.00072223,0.40411,0.29408,1,1
1,REACTOME SULFUR AMINO ACID METABOLISM,2.7343e-05,0.40398,0.40017,1,1
1,PID TAP63PATHWAY,4.3218e-05,0.40388,0.46614,1,1
1,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,1.4044e-06,0.40258,0.44865,1,1
1,REACTOME GLYCOSPHINGOLIPID METABOLISM,0.00087311,0.40128,0.27991,1,1
1,NEGATIVE REGULATION OF TRANSPORT,0.0015189,0.401,0.31194,1,1
1,AMINO SUGAR METABOLIC PROCESS,2.2524e-05,0.40075,0.43067,1,1
1,COATED VESICLE MEMBRANE,1.349e-05,0.40041,0.39605,1,1
1,RHO GTPASE ACTIVATOR ACTIVITY,0.00038934,0.39754,0.38773,1,1
1,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,6.5149e-05,0.3968,0.33392,1,1
1,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,1.349e-05,0.39669,0.43516,1,1
1,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,8.3127e-06,0.39581,0.55704,1,1
1,METALLOENDOPEPTIDASE ACTIVITY,0.00074557,0.39579,0.36262,1,1
1,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,7.2754e-05,0.39575,0.33999,1,1
1,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,5.9841e-06,0.39513,0.40451,1,1
1,PID INTEGRIN2 PATHWAY,1.2454e-05,0.39123,0.55359,1,1
1,KEGG HEMATOPOIETIC CELL LINEAGE,5.2837e-06,0.39063,0.58475,1,1
1,KEGG RETINOL METABOLISM,0.001662,0.38928,0.30745,1,1
1,PID GLYPICAN 1PATHWAY,1.4609e-05,0.3878,0.40717,1,1
1,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,2.7578e-07,0.38775,0.44962,1,1
1,CALCIUM MEDIATED SIGNALING,1.4039e-05,0.38759,0.50502,1,1
1,PID FOXM1PATHWAY,2.1663e-05,0.38593,0.38161,1,1
1,PID IL6 7PATHWAY,0.00013917,0.38547,0.43458,1,1
1,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.00016023,0.38515,0.40235,1,1
1,VIRAL REPRODUCTIVE PROCESS,7.889e-07,0.38465,0.44254,1,1
1,REACTOME CS DS DEGRADATION,0.0006154,0.38363,0.63801,1,1
1,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,4.8379e-05,0.38348,0.31545,1,1
1,VIRAL GENOME REPLICATION,1.349e-05,0.38268,0.35699,1,1
1,NUCLEAR IMPORT,0.00017186,0.38255,0.32346,1,1
1,SULFUR METABOLIC PROCESS,2.0833e-05,0.38053,0.35354,1,1
1,BIOCARTA IL1R PATHWAY,0.0025817,0.3798,0.42523,1,1
1,RUFFLE,0.0028957,0.37979,0.35702,1,1
1,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,3.3287e-06,0.37886,0.44157,1,1
1,BIOCARTA LONGEVITY PATHWAY,0.0011199,0.37885,0.29233,1,1
1,KERATINOCYTE DIFFERENTIATION,0.0081404,0.37876,0.34725,1,1
1,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,1.2454e-05,0.37818,0.34354,1,1
1,BIOCARTA WNT PATHWAY,0.00027832,0.37616,0.33448,1,1
1,ANTI APOPTOSIS,7.5427e-07,0.37578,0.3974,1,1
1,BIOCARTA CERAMIDE PATHWAY,0.0033369,0.37491,0.28811,1,1
1,CORNIFIED ENVELOPE,0.017137,0.37345,0.32974,1,1
1,REACTOME COMMON PATHWAY,0.0023671,0.37326,0.2728,1,1
1,PID RXR VDR PATHWAY,3.4728e-06,0.37313,0.40607,1,1
1,PID WNT SIGNALING PATHWAY,0.00031859,0.37148,0.42024,1,1
1,PID HIVNEFPATHWAY,0.00019079,0.37131,0.36956,1,1
1,RESPONSE TO WOUNDING,3.8583e-05,0.37077,0.38466,1,1
1,REACTOME NUCLEAR SIGNALING BY ERBB4,1.3441e-06,0.37006,0.36596,1,1
1,VACUOLE ORGANIZATION AND BIOGENESIS,0.0087944,0.36533,0.24881,1,1
1,DRUG BINDING,8.7323e-05,0.36337,0.35089,1,1
1,PID AURORA B PATHWAY,0.00017796,0.36236,0.37365,1,1
1,HETEROCYCLE METABOLIC PROCESS,8.3127e-06,0.35963,0.41089,1,1
1,ER TO GOLGI VESICLE MEDIATED TRANSPORT,3.0689e-05,0.35935,0.35269,1,1
1,COFACTOR BIOSYNTHETIC PROCESS,0.00054072,0.3592,0.34134,1,1
1,NEGATIVE REGULATION OF CELL MIGRATION,0.00084609,0.35821,0.47112,1,1
1,COFACTOR METABOLIC PROCESS,0.0010206,0.35734,0.26257,1,1
1,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.9418e-06,0.35727,0.42161,1,1
1,RAS GTPASE ACTIVATOR ACTIVITY,0.00020448,0.35614,0.34724,1,1
1,REACTOME PEROXISOMAL LIPID METABOLISM,0.004408,0.35611,0.26473,1,1
1,REACTOME GLYCOSAMINOGLYCAN METABOLISM,2.6307e-05,0.35513,0.34991,1,1
1,KEGG P53 SIGNALING PATHWAY,0.00030804,0.35423,0.31491,1,1
1,REGULATION OF CELL GROWTH,4.1112e-06,0.35334,0.37332,1,1
1,BIOCARTA MCALPAIN PATHWAY,9.0179e-06,0.35235,0.46649,1,1
1,NEGATIVE REGULATION OF CELL ADHESION,0.0016129,0.34878,0.40033,1,1
1,REGULATION OF MITOTIC CELL CYCLE,5.2533e-07,0.3485,0.38035,1,1
1,CYTOKINE BIOSYNTHETIC PROCESS,0.00017186,0.34835,0.39239,1,1
1,PID AR PATHWAY,7.9801e-06,0.34713,0.35487,1,1
1,PID ARF6 PATHWAY,1.6015e-06,0.34578,0.45699,1,1
1,ENDOSOME TRANSPORT,0.00013433,0.34556,0.32211,1,1
1,REACTOME EGFR DOWNREGULATION,0.00016595,0.34518,0.32195,1,1
1,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,0.022165,0.34431,0.26465,1,1
1,REACTOME REGULATION OF APOPTOSIS,4.4878e-05,0.34411,0.29307,1,1
1,REGULATION OF ACTIN FILAMENT LENGTH,0.0059384,0.34369,0.32979,1,1
1,SKELETAL DEVELOPMENT,5.8301e-05,0.34251,0.39259,1,1
1,BIOCARTA IL6 PATHWAY,0.0037331,0.342,0.42644,1,1
1,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,6.8936e-07,0.34135,0.47012,1,1
1,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.0039469,0.34096,0.34282,1,1
1,BIOCARTA G1 PATHWAY,0.0034322,0.3408,0.26905,1,1
1,AMINOPEPTIDASE ACTIVITY,1.2962e-05,0.34076,0.44194,1,1
1,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.0007696,0.3395,0.33465,1,1
1,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00037661,0.33708,0.34672,1,1
1,PROTEOLYSIS,4.0073e-05,0.33647,0.282,1,1
1,REACTOME PPARA ACTIVATES GENE EXPRESSION,2.0033e-05,0.33606,0.31344,1,1
1,PID ANGIOPOIETINRECEPTOR PATHWAY,4.2876e-06,0.33508,0.37254,1,1
1,RECEPTOR COMPLEX,0.001872,0.33506,0.32143,1,1
1,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.0020453,0.33266,0.33137,1,1
1,POSITIVE REGULATION OF CELL PROLIFERATION,5.753e-07,0.33205,0.44338,1,1
1,NEGATIVE REGULATION OF APOPTOSIS,3.3287e-06,0.33117,0.34217,1,1
1,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.00057693,0.33091,0.29027,1,1
1,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.00014935,0.33082,0.42749,1,1
1,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,1.7118e-05,0.33066,0.42185,1,1
1,PID SHP2 PATHWAY,0.0001547,0.33028,0.33378,1,1
1,REGULATION OF SIGNAL TRANSDUCTION,3.9418e-06,0.32922,0.32907,1,1
1,PID SMAD2 3PATHWAY,0.036164,0.32907,0.19112,1,1
1,REGULATION OF DNA METABOLIC PROCESS,3.3132e-05,0.32825,0.3995,1,1
1,BIOCARTA EGFR SMRTE PATHWAY,0.011904,0.32791,0.42411,1,1
1,MITOTIC CELL CYCLE CHECKPOINT,7.2754e-05,0.32784,0.33631,1,1
1,ST GAQ PATHWAY,3.7145e-05,0.32686,0.3467,1,1
1,PID TELOMERASEPATHWAY,2.6307e-05,0.32575,0.32863,1,1
1,REACTOME UNFOLDED PROTEIN RESPONSE,0.00019753,0.32439,0.27317,1,1
1,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,4.8379e-05,0.3243,0.33827,1,1
1,BIOCARTA PTDINS PATHWAY,9.7801e-06,0.3242,0.36696,1,1
1,REACTOME KERATAN SULFATE KERATIN METABOLISM,0.00013433,0.32418,0.3359,1,1
1,PID PTP1BPATHWAY,0.0015189,0.322,0.25919,1,1
1,PID ALK1PATHWAY,0.00074557,0.32195,0.3635,1,1
1,REACTOME PYRIMIDINE METABOLISM,0.00095906,0.32161,0.53499,1,1
1,BIOCARTA TNFR1 PATHWAY,0.001228,0.32054,0.2678,1,1
1,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.0049174,0.31963,0.3423,1,1
1,BIOCARTA ALK PATHWAY,5.6174e-05,0.3196,0.41083,1,1
1,ADHERENS JUNCTION,0.0064317,0.31936,0.34727,1,1
1,KEGG PANCREATIC CANCER,1.0604e-05,0.31813,0.29747,1,1
1,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.0046564,0.31757,0.23104,1,1
1,ACID AMINO ACID LIGASE ACTIVITY,2.3654e-06,0.31689,0.27404,1,1
1,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,7.3528e-06,0.3163,0.34301,1,1
1,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,5.7413e-06,0.31565,0.34549,1,1
1,PID NFAT TFPATHWAY,3.7145e-05,0.31529,0.41094,1,1
1,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,9.389e-05,0.31506,0.32945,1,1
1,CYTOKINE METABOLIC PROCESS,0.00044439,0.31437,0.36744,1,1
1,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.00023468,0.31432,0.28074,1,1
1,KEGG PROSTATE CANCER,3.4728e-06,0.31367,0.30832,1,1
1,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.0013457,0.31333,0.21668,1,1
1,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.030383,0.31324,0.25045,1,1
1,BIOCARTA RARRXR PATHWAY,8.4205e-05,0.31283,0.30179,1,1
1,KEGG VIRAL MYOCARDITIS,8.2505e-07,0.3127,0.4147,1,1
1,PID P73PATHWAY,1.7806e-05,0.31259,0.31077,1,1
1,B CELL ACTIVATION,0.027803,0.31153,0.24797,1,1
1,TRANSLATION,0.00052342,0.31126,0.26349,1,1
1,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.007729,0.31092,0.2891,1,1
1,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.038561,0.30958,0.1805,1,1
1,PID PS1PATHWAY,4.1617e-05,0.30925,0.29487,1,1
1,BIOCARTA ERK PATHWAY,2.2524e-05,0.30911,0.34617,1,1
1,REGULATION OF CELLULAR COMPONENT SIZE,0.0051916,0.30855,0.31809,1,1
1,BIOCARTA INTEGRIN PATHWAY,1.5331e-06,0.30816,0.47466,1,1
1,REACTOME SIGNALING BY BMP,0.025414,0.30813,0.24882,1,1
1,MUSCLE CELL DIFFERENTIATION,0.025994,0.30779,0.30075,1,1
1,REGULATION OF PROTEIN METABOLIC PROCESS,5.0683e-06,0.30743,0.30072,1,1
1,KEGG JAK STAT SIGNALING PATHWAY,7.013e-05,0.3057,0.32246,1,1
1,ST INTERLEUKIN 4 PATHWAY,0.00054072,0.30554,0.33192,1,1
1,CYTOKINESIS,0.0020453,0.30508,0.26252,1,1
1,STRUCTURAL MOLECULE ACTIVITY,4.2876e-06,0.30502,0.30222,1,1
1,CYTOKINE ACTIVITY,0.00012512,0.3037,0.38025,1,1
1,BIOCARTA EIF4 PATHWAY,6.0504e-05,0.30275,0.31521,1,1
1,PID RETINOIC ACID PATHWAY,0.00012512,0.30074,0.2581,1,1
1,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,3.9418e-06,0.29971,0.33152,1,1
1,MUSCLE DEVELOPMENT,0.0001547,0.2997,0.27754,1,1
1,REACTOME METABOLISM OF MRNA,0.00084609,0.2992,0.26658,1,1
1,REACTOME METABOLISM OF RNA,0.00084609,0.29866,0.25065,1,1
1,PROTEIN FOLDING,2.8418e-05,0.29794,0.27673,1,1
1,REACTOME SHC MEDIATED CASCADE,0.00098941,0.29779,0.22911,1,1
1,GROWTH,2.8077e-06,0.29775,0.30198,1,1
1,CONTRACTILE FIBER,5.508e-06,0.29775,0.36512,1,1
1,KEGG REGULATION OF ACTIN CYTOSKELETON,2.8891e-07,0.29774,0.30598,1,1
1,KEGG BASAL CELL CARCINOMA,0.0085714,0.29596,0.20666,1,1
1,BIOCARTA AKAP13 PATHWAY,0.0057817,0.2948,0.2534,1,1
1,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.0036303,0.29415,0.45577,1,1
1,PROTEIN IMPORT,2.4692e-06,0.29394,0.28888,1,1
1,BIOCARTA IGF1MTOR PATHWAY,0.0011199,0.2935,0.26524,1,1
1,BIOCARTA EGF PATHWAY,0.0060989,0.29295,0.27441,1,1
1,KEGG LEISHMANIA INFECTION,0.0057817,0.2929,0.25667,1,1
1,KEGG PATHWAYS IN CANCER,7.3528e-06,0.29226,0.26353,1,1
1,ANGIOGENESIS,0.021165,0.29223,0.26054,1,1
1,REGULATION OF CELL ADHESION,0.011612,0.29129,0.37975,1,1
1,KEGG GALACTOSE METABOLISM,0.0031536,0.29116,0.2674,1,1
1,BIOCARTA NKT PATHWAY,0.027803,0.29054,0.29325,1,1
1,STRIATED MUSCLE DEVELOPMENT,0.014486,0.29051,0.21462,1,1
1,BIOCARTA AGR PATHWAY,0.027188,0.29049,0.18482,1,1
1,KEGG FATTY ACID METABOLISM,0.001662,0.29042,0.3054,1,1
1,PID VEGFR1 2 PATHWAY,1.349e-05,0.28987,0.3033,1,1
1,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,0.00035231,0.28987,0.35306,1,1
1,RHO PROTEIN SIGNAL TRANSDUCTION,2.7343e-05,0.28944,0.28878,1,1
1,PID NECTIN PATHWAY,0.010245,0.28906,0.28122,1,1
1,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.001662,0.28682,0.23534,1,1
1,CELL DIVISION,0.0017641,0.28594,0.30564,1,1
1,KEGG TGF BETA SIGNALING PATHWAY,0.00052342,0.28473,0.26772,1,1
1,REACTOME GAP JUNCTION TRAFFICKING,0.0014738,0.28448,0.23254,1,1
1,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.0037331,0.28448,0.25774,1,1
1,REACTOME REGULATION OF MITOTIC CELL CYCLE,9.389e-05,0.28308,0.26515,1,1
1,MYOFIBRIL,1.5816e-05,0.28227,0.42059,1,1
1,ST B CELL ANTIGEN RECEPTOR,1.1964e-05,0.282,0.27037,1,1
1,BIOCARTA BCELLSURVIVAL PATHWAY,0.0037331,0.28149,0.32225,1,1
1,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,1.4039e-05,0.28087,0.30115,1,1
1,POSITIVE REGULATION OF CELLULAR PROCESS,6.7728e-06,0.27939,0.26142,1,1
1,MEMBRANE FUSION,0.00035231,0.27908,0.25288,1,1
1,MYOSIN COMPLEX,0.00014418,0.27731,0.34488,1,1
1,NUCLEAR TRANSPORT,0.00054072,0.27702,0.1965,1,1
1,RAS PROTEIN SIGNAL TRANSDUCTION,9.4334e-07,0.27686,0.30663,1,1
1,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.00084609,0.27626,0.23749,1,1
1,NUCLEOCYTOPLASMIC TRANSPORT,0.00055855,0.27588,0.20119,1,1
1,BLOOD COAGULATION,0.0001547,0.27544,0.35209,1,1
1,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,7.6603e-06,0.27426,0.24959,1,1
1,MITOCHONDRIAL PART,0.0069616,0.27204,0.16575,1,1
1,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,0.0022992,0.27194,0.27397,1,1
1,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,5.0194e-07,0.27181,0.25658,1,1
1,REGULATION OF DNA BINDING,1.2308e-06,0.27153,0.2786,1,1
1,GROWTH FACTOR BINDING,7.8282e-05,0.27098,0.3112,1,1
1,METALLOPEPTIDASE ACTIVITY,5.6174e-05,0.27058,0.35482,1,1
1,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.043763,0.27016,0.22779,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,0.00017186,0.26993,0.22004,1,1
1,PID IL1PATHWAY,0.0025817,0.26993,0.31442,1,1
1,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.00018427,0.26913,0.26146,1,1
1,UBIQUITIN PROTEIN LIGASE ACTIVITY,1.0779e-06,0.26913,0.26416,1,1
1,NEGATIVE REGULATION OF BINDING,0.00040247,0.26912,0.30356,1,1
1,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,2.1702e-06,0.26881,0.25539,1,1
1,PIGMENT METABOLIC PROCESS,0.010245,0.26879,0.22779,1,1
1,PIGMENT BIOSYNTHETIC PROCESS,0.0094949,0.26848,0.2129,1,1
1,DEFENSE RESPONSE,0.0060989,0.26822,0.24553,1,1
1,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,1.1267e-06,0.26804,0.28596,1,1
1,PID IFNGPATHWAY,0.02068,0.26784,0.18158,1,1
1,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.0057817,0.26776,0.19981,1,1
1,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0097392,0.26721,0.38012,1,1
1,BIOCARTA MTOR PATHWAY,0.00087311,0.26714,0.22098,1,1
1,VASCULATURE DEVELOPMENT,0.00059588,0.26578,0.314,1,1
1,CHEMOKINE RECEPTOR BINDING,0.00065623,0.26531,0.56309,1,1
1,CHEMOKINE ACTIVITY,0.00065623,0.26531,0.56309,1,1
1,POSITIVE REGULATION OF BIOLOGICAL PROCESS,1.2962e-05,0.26504,0.24983,1,1
1,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,2.3418e-05,0.26496,0.27675,1,1
1,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.00353,0.26407,0.26666,1,1
1,KEGG ADHERENS JUNCTION,0.00067758,0.26372,0.24735,1,1
1,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,5.2837e-06,0.26248,0.27944,1,1
1,TRANSLATION INITIATION FACTOR ACTIVITY,0.012203,0.26246,0.27289,1,1
1,GOLGI VESICLE TRANSPORT,0.00013433,0.26217,0.24718,1,1
1,OXIDOREDUCTASE ACTIVITY,0.00030804,0.26201,0.2214,1,1
1,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,9.389e-05,0.26169,0.30123,1,1
1,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.0011199,0.26137,0.24844,1,1
1,PID CERAMIDE PATHWAY,0.00020448,0.26126,0.2412,1,1
1,NEGATIVE REGULATION OF DNA BINDING,0.0030654,0.26091,0.27346,1,1
1,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.00087311,0.26066,0.2049,1,1
1,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00052342,0.26066,0.22702,1,1
1,POSITIVE REGULATION OF METABOLIC PROCESS,5.2533e-07,0.26011,0.24723,1,1
1,TRNA METABOLIC PROCESS,0.0069616,0.25943,0.23137,1,1
1,PROTEIN TARGETING,7.5427e-07,0.25939,0.262,1,1
1,KEGG DILATED CARDIOMYOPATHY,0.00017186,0.25851,0.26831,1,1
1,BIOCARTA CHEMICAL PATHWAY,0.0022332,0.2583,0.22252,1,1
1,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.0014299,0.25803,0.27105,1,1
1,PID CD40 PATHWAY,0.001872,0.25802,0.35657,1,1
1,CYTOKINE PRODUCTION,0.025994,0.25791,0.25115,1,1
1,EXTRACELLULAR REGION PART,0.00028792,0.25779,0.32107,1,1
1,REGULATION OF TRANSLATION,0.00040247,0.2568,0.27207,1,1
1,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,1.0779e-06,0.25677,0.24998,1,1
1,NEGATIVE REGULATION OF CELL CYCLE,1.104e-05,0.25675,0.29887,1,1
1,VACUOLAR TRANSPORT,3.0689e-05,0.25672,0.33703,1,1
1,INTEGRIN BINDING,0.0017123,0.25664,0.298,1,1
1,REACTOME M G1 TRANSITION,0.0027346,0.25651,0.15861,1,1
1,KEGG PYRUVATE METABOLISM,0.017969,0.25607,0.1825,1,1
1,SEQUENCE SPECIFIC DNA BINDING,0.00087311,0.25603,0.23735,1,1
1,REACTOME INNATE IMMUNE SYSTEM,0.00072223,0.25589,0.23694,1,1
1,REACTOME IMMUNE SYSTEM,5.2139e-05,0.25578,0.22647,1,1
1,VIRAL REPRODUCTION,8.7323e-05,0.25562,0.291,1,1
1,REACTOME NOD1 2 SIGNALING PATHWAY,0.0042883,0.25555,0.3513,1,1
1,REGULATION OF BINDING,2.5774e-06,0.25547,0.25246,1,1
1,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.0066042,0.25327,0.2882,1,1
1,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0030654,0.25015,0.17227,1,1
1,REACTOME METABOLISM OF NUCLEOTIDES,0.0011199,0.24988,0.32446,1,1
1,PROTEIN KINASE CASCADE,0.00030804,0.24986,0.22646,1,1
1,ST ERK1 ERK2 MAPK PATHWAY,3.7145e-05,0.24858,0.28685,1,1
1,ENDOSOME,0.00012074,0.24815,0.21391,1,1
1,RESPONSE TO EXTERNAL STIMULUS,0.00045924,0.24732,0.25241,1,1
1,BIOCARTA PTEN PATHWAY,0.00022676,0.24713,0.35291,1,1
1,EPIDERMIS DEVELOPMENT,0.0017641,0.24683,0.33976,1,1
1,PID SMAD2 3NUCLEARPATHWAY,0.0036303,0.24578,0.24003,1,1
1,REACTOME IL1 SIGNALING,0.0030654,0.24528,0.27299,1,1
1,REACTOME DOWNSTREAM TCR SIGNALING,0.0050528,0.24435,0.19775,1,1
1,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00074557,0.2442,0.27645,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,0.0051916,0.2439,0.23363,1,1
1,BIOCARTA AKT PATHWAY,0.0066042,0.24378,0.18831,1,1
1,PROTEIN COMPLEX BINDING,0.0014299,0.24249,0.21302,1,1
1,TRANSITION METAL ION BINDING,3.9418e-06,0.24169,0.25079,1,1
1,KEGG DORSO VENTRAL AXIS FORMATION,0.011904,0.24135,0.25462,1,1
1,BIOCARTA RACCYCD PATHWAY,0.0019282,0.24125,0.25345,1,1
1,BIOCARTA P38MAPK PATHWAY,0.00041602,0.24122,0.28269,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,0.00019079,0.24048,0.25603,1,1
1,CELLULAR PROTEIN CATABOLIC PROCESS,0.00042998,0.24014,0.22629,1,1
1,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,0.01282,0.24004,0.30742,1,1
1,REGULATION OF GROWTH,5.2139e-05,0.23938,0.23371,1,1
1,BIOCARTA TALL1 PATHWAY,0.00059588,0.23807,0.22078,1,1
1,KEGG CYSTEINE AND METHIONINE METABOLISM,0.0022992,0.23787,0.24354,1,1
1,HOMEOSTASIS OF NUMBER OF CELLS,0.004408,0.23787,0.21143,1,1
1,NEGATIVE REGULATION OF GROWTH,5.4121e-05,0.2377,0.2137,1,1
1,SECONDARY METABOLIC PROCESS,0.0018173,0.2362,0.244,1,1
1,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.0037331,0.236,0.20485,1,1
1,WNT SIGNALING,7.547e-05,0.23587,0.21043,1,1
1,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.0037331,0.23587,0.19458,1,1
1,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0060989,0.23587,0.15906,1,1
1,PID ERBB4 PATHWAY,6.7728e-06,0.23374,0.28379,1,1
1,DNA DEPENDENT DNA REPLICATION,0.0050528,0.23359,0.15441,1,1
1,PID MYC ACTIVPATHWAY,0.0081404,0.23317,0.22619,1,1
1,PEPTIDYL AMINO ACID MODIFICATION,6.7728e-06,0.23316,0.25525,1,1
1,REACTOME IL 7 SIGNALING,0.0051916,0.23272,0.25739,1,1
1,ORGANELLAR RIBOSOME,0.0060989,0.2317,0.27595,1,1
1,MITOCHONDRIAL RIBOSOME,0.0060989,0.2317,0.27595,1,1
1,REGULATION OF PROGRAMMED CELL DEATH,2.3418e-05,0.23135,0.24415,1,1
1,ELECTRON CARRIER ACTIVITY,0.001662,0.23131,0.16312,1,1
1,REACTOME BASIGIN INTERACTIONS,0.0031536,0.23129,0.39719,1,1
1,VIRAL INFECTIOUS CYCLE,0.00084609,0.23119,0.23074,1,1
1,PID EPHA2 FWDPATHWAY,0.00074557,0.23024,0.28828,1,1
1,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.011612,0.22987,0.12041,1,1
1,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.00019753,0.22967,0.19265,1,1
1,IMMUNE RESPONSE,0.0049174,0.2294,0.23563,1,1
1,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,0.0017641,0.22939,0.26051,1,1
1,COAGULATION,0.00042998,0.22921,0.32135,1,1
1,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,8.6584e-06,0.22903,0.21605,1,1
1,REACTOME CIRCADIAN CLOCK,0.00049035,0.22897,0.28518,1,1
1,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0010859,0.22826,0.21167,1,1
1,ZINC ION BINDING,0.00010092,0.228,0.23108,1,1
1,PROTEIN COMPLEX ASSEMBLY,5.0226e-05,0.22692,0.18703,1,1
1,CELL PROLIFERATION GO 0008283,6.5149e-05,0.2267,0.20311,1,1
1,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.0039469,0.22531,0.27434,1,1
1,PID CIRCADIANPATHWAY,0.0059384,0.22455,0.27801,1,1
1,CELL SUBSTRATE ADHESION,0.0022992,0.22368,0.24808,1,1
1,CELL MATRIX ADHESION,0.0022992,0.22368,0.24808,1,1
1,REGULATION OF APOPTOSIS,2.1663e-05,0.22348,0.24232,1,1
1,PID ERBB1 DOWNSTREAM PATHWAY,0.0025817,0.22318,0.16872,1,1
1,KEGG DRUG METABOLISM OTHER ENZYMES,0.0047853,0.22286,0.30492,1,1
1,KEGG PENTOSE PHOSPHATE PATHWAY,0.013465,0.22265,0.20646,1,1
1,REACTOME TCR SIGNALING,0.011326,0.22177,0.14429,1,1
1,BIOCARTA STRESS PATHWAY,0.027803,0.22123,0.20199,1,1
1,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00090094,0.2209,0.1982,1,1
1,REACTOME APOPTOSIS,0.00081984,0.22072,0.18996,1,1
1,PROGRAMMED CELL DEATH,4.1617e-05,0.22013,0.21606,1,1
1,ST STAT3 PATHWAY,0.0059384,0.21966,0.29294,1,1
1,RIBOSOME,0.040234,0.21965,0.17151,1,1
1,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.022165,0.21846,0.16828,1,1
1,CARBOHYDRATE CATABOLIC PROCESS,0.022165,0.21846,0.16828,1,1
1,PID AMB2 NEUTROPHILS PATHWAY,0.00079435,0.21738,0.31701,1,1
1,APOPTOSIS GO,3.8583e-05,0.21642,0.21451,1,1
1,PID ARF6 TRAFFICKINGPATHWAY,5.4121e-05,0.21616,0.3019,1,1
1,BIOCARTA EDG1 PATHWAY,0.0014299,0.21595,0.22541,1,1
1,POSITIVE REGULATION OF TRANSCRIPTION,1.1964e-05,0.21509,0.2165,1,1
1,BIOCARTA ECM PATHWAY,0.00057693,0.21474,0.34267,1,1
1,REACTOME SPHINGOLIPID METABOLISM,0.0031536,0.21462,0.16111,1,1
1,REGULATION OF CELL PROLIFERATION,6.0504e-05,0.21416,0.22207,1,1
1,KEGG CIRCADIAN RHYTHM MAMMAL,0.019739,0.21372,0.25062,1,1
1,KEGG PEROXISOME,0.02166,0.21362,0.13583,1,1
1,MAINTENANCE OF PROTEIN LOCALIZATION,0.011326,0.21318,0.23285,1,1
1,CELLULAR PROTEIN COMPLEX ASSEMBLY,1.2962e-05,0.21284,0.23271,1,1
1,REACTOME S PHASE,0.010245,0.21246,0.12793,1,1
1,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.0022332,0.21182,0.18239,1,1
1,BIOCARTA MET PATHWAY,0.0006154,0.2108,0.27343,1,1
1,INTRACELLULAR PROTEIN TRANSPORT,1.349e-05,0.21077,0.19962,1,1
1,PID S1P META PATHWAY,0.0057817,0.20981,0.23536,1,1
1,BIOCARTA HCMV PATHWAY,0.0099891,0.20939,0.18594,1,1
1,REGULATION OF DEVELOPMENTAL PROCESS,0.00011241,0.20794,0.19414,1,1
1,REGULATION OF CELL CYCLE,3.5759e-05,0.20628,0.17947,1,1
1,DOUBLE STRANDED DNA BINDING,0.035393,0.20602,0.20918,1,1
1,MITOCHONDRIAL TRANSPORT,0.026586,0.20543,0.14485,1,1
1,CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.00055855,0.20494,0.1852,1,1
1,EXTRACELLULAR REGION,0.0011199,0.20471,0.25328,1,1
1,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,3.4421e-05,0.20452,0.22665,1,1
1,POSITIVE REGULATION OF RNA METABOLIC PROCESS,3.4421e-05,0.20452,0.22665,1,1
1,TRANSLATION REGULATOR ACTIVITY,0.02268,0.2045,0.18508,1,1
1,SULFOTRANSFERASE ACTIVITY,0.0028957,0.20341,0.21887,1,1
1,SIGNAL SEQUENCE BINDING,0.00079435,0.20333,0.23882,1,1
1,KEGG ONE CARBON POOL BY FOLATE,0.026586,0.20272,0.13949,1,1
1,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0053338,0.20168,0.1879,1,1
1,CELLULAR BIOSYNTHETIC PROCESS,8.7323e-05,0.20146,0.23288,1,1
1,ST INTEGRIN SIGNALING PATHWAY,0.0047853,0.20105,0.20067,1,1
1,REACTOME IRON UPTAKE AND TRANSPORT,0.004408,0.20059,0.18413,1,1
1,ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0001165,0.20033,0.15287,1,1
1,PROTEIN CATABOLIC PROCESS,0.00026003,0.20015,0.18328,1,1
1,KEGG ENDOMETRIAL CANCER,0.00010845,0.19862,0.21314,1,1
1,REGULATION OF LYMPHOCYTE ACTIVATION,0.025994,0.19788,0.24762,1,1
1,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,7.2754e-05,0.19774,0.19396,1,1
1,KEGG NON SMALL CELL LUNG CANCER,2.8418e-05,0.19746,0.1968,1,1
1,REACTOME HEMOSTASIS,0.00029782,0.19735,0.16852,1,1
1,VACUOLE,0.015203,0.19693,0.14422,1,1
1,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.0075304,0.19634,0.19377,1,1
1,REACTOME SIGNALING BY PDGF,7.8282e-05,0.19627,0.21581,1,1
1,CELL CYCLE ARREST GO 0007050,0.00042998,0.19541,0.23457,1,1
1,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,6.7596e-05,0.1952,0.25958,1,1
1,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,1.349e-05,0.19495,0.19003,1,1
1,RESPONSE TO STRESS,0.0060989,0.19491,0.15052,1,1
1,REACTOME SIGNALING BY ERBB4,1.7474e-06,0.19386,0.20746,1,1
1,CIRCADIAN RHYTHM,0.014138,0.19365,0.17203,1,1
1,REGULATION OF MITOSIS,0.00024286,0.19319,0.2444,1,1
1,KEGG COLORECTAL CANCER,0.0039469,0.19199,0.15097,1,1
1,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.0047853,0.19159,0.16259,1,1
1,REACTOME MITOTIC M M G1 PHASES,0.001872,0.19051,0.15003,1,1
1,ORGAN MORPHOGENESIS,0.0022332,0.19017,0.19238,1,1
1,REACTOME METABOLISM OF CARBOHYDRATES,4.0073e-05,0.19008,0.21806,1,1
1,PROTEIN TRANSPORT,2.2524e-05,0.18983,0.17787,1,1
1,ENDOPLASMIC RETICULUM,6.0504e-05,0.18785,0.19078,1,1
1,ELECTRON TRANSPORT GO 0006118,0.00069957,0.18713,0.22676,1,1
1,NEGATIVE REGULATION OF CELLULAR PROCESS,2.6307e-05,0.18698,0.18506,1,1
1,ECTODERM DEVELOPMENT,0.012508,0.18698,0.26628,1,1
1,REACTOME G1 S TRANSITION,0.0051916,0.18693,0.12542,1,1
1,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.018398,0.1863,0.12769,1,1
1,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0047853,0.18602,0.18146,1,1
1,REACTOME PROTEIN FOLDING,0.00079435,0.18574,0.21822,1,1
1,REACTOME ADAPTIVE IMMUNE SYSTEM,2.0833e-05,0.18572,0.16917,1,1
1,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.00067758,0.18536,0.17541,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.0015189,0.18504,0.22339,1,1
1,PID INSULIN PATHWAY,0.00057693,0.18496,0.20165,1,1
1,CELL PROJECTION BIOGENESIS,0.038561,0.18493,0.12621,1,1
1,BIOCARTA HSP27 PATHWAY,0.036164,0.18422,0.18157,1,1
1,LIGASE ACTIVITY,0.00038934,0.18421,0.16653,1,1
1,REACTOME ERKS ARE INACTIVATED,0.020205,0.18391,0.19341,1,1
1,MITOSIS,0.015203,0.18374,0.12811,1,1
1,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0039469,0.18243,0.21253,1,1
1,STRUCTURAL CONSTITUENT OF MUSCLE,0.0012662,0.18185,0.25371,1,1
1,HEMOSTASIS,0.0050528,0.18161,0.26111,1,1
1,GOLGI APPARATUS PART,0.00055855,0.17998,0.15104,1,1
1,REACTOME FRS2 MEDIATED CASCADE,0.0097392,0.17951,0.14237,1,1
1,PID TCRRASPATHWAY,0.012508,0.17938,0.23236,1,1
1,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.0019282,0.17909,0.17634,1,1
1,SPINDLE,0.0064317,0.1771,0.18626,1,1
1,M PHASE OF MITOTIC CELL CYCLE,0.021165,0.17677,0.11765,1,1
1,PID CD8TCRPATHWAY,0.0097392,0.17659,0.13778,1,1
1,PROTEIN UBIQUITINATION,0.017137,0.17654,0.14244,1,1
1,KEGG MELANOMA,0.00072223,0.17558,0.16708,1,1
1,REACTOME MEMBRANE TRAFFICKING,0.0039469,0.17414,0.14375,1,1
1,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,7.547e-05,0.17377,0.15714,1,1
1,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.00092958,0.1737,0.22876,1,1
1,PID RHOA PATHWAY,0.00017796,0.17353,0.21066,1,1
1,PEPTIDASE ACTIVITY,0.0032441,0.17106,0.14287,1,1
1,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.010773,0.17054,0.17971,1,1
1,NUCLEAR HORMONE RECEPTOR BINDING,0.011326,0.17048,0.20817,1,1
1,HORMONE RECEPTOR BINDING,0.011326,0.17048,0.20817,1,1
1,MITOCHONDRIAL ENVELOPE,0.042857,0.16683,0.11006,1,1
1,PROTEIN HETERODIMERIZATION ACTIVITY,0.007729,0.16574,0.12826,1,1
1,ST ADRENERGIC,0.026586,0.16572,0.1697,1,1
1,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.0013872,0.16493,0.17826,1,1
1,BIOCARTA PPARA PATHWAY,0.017969,0.16419,0.15253,1,1
1,ANATOMICAL STRUCTURE FORMATION,0.035393,0.16188,0.19741,1,1
1,PROTEIN LOCALIZATION,0.00016595,0.16147,0.13046,1,1
1,BIOCARTA MAPK PATHWAY,0.0017641,0.16044,0.15416,1,1
1,RIBONUCLEASE ACTIVITY,0.038561,0.16034,0.16093,1,1
1,PID FCER1PATHWAY,0.013798,0.16027,0.15317,1,1
1,KEGG PYRIMIDINE METABOLISM,0.00063551,0.16017,0.20172,1,1
1,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.0064317,0.15993,0.13656,1,1
1,INTRACELLULAR TRANSPORT,0.00017186,0.1599,0.14065,1,1
1,KEGG GLIOMA,0.00055855,0.15882,0.13702,1,1
1,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.0090226,0.15801,0.12076,1,1
1,CELL SURFACE,0.0032441,0.15791,0.18056,1,1
1,PROTEIN DIMERIZATION ACTIVITY,0.0067808,0.15789,0.11535,1,1
1,PID PLK1 PATHWAY,0.0056288,0.15695,0.19756,1,1
1,KEGG GLYCOLYSIS GLUCONEOGENESIS,0.012203,0.15653,0.20989,1,1
1,PID S1P S1P1 PATHWAY,0.017137,0.15618,0.27151,1,1
1,REGULATION OF CELLULAR METABOLIC PROCESS,0.00037661,0.15469,0.1146,1,1
1,LYTIC VACUOLE,0.02166,0.15463,0.13277,1,1
1,LYSOSOME,0.02166,0.15463,0.13277,1,1
1,BIOCARTA PDGF PATHWAY,0.0032441,0.15414,0.23176,1,1
1,PID PDGFRBPATHWAY,0.0015189,0.15407,0.17916,1,1
1,GOLGI APPARATUS,5.4121e-05,0.15298,0.13395,1,1
1,PID HDAC CLASSI PATHWAY,0.00081984,0.15248,0.13527,1,1
1,KEGG ENDOCYTOSIS,0.00059588,0.15174,0.13345,1,1
1,CATION BINDING,0.0049174,0.15143,0.12204,1,1
1,REACTOME CELL CYCLE CHECKPOINTS,0.0053338,0.15121,0.12234,1,1
1,ST FAS SIGNALING PATHWAY,0.004408,0.15029,0.16552,1,1
1,REACTOME METABOLISM OF PROTEINS,0.0073363,0.14894,0.1284,1,1
1,REGULATION OF METABOLIC PROCESS,0.00040247,0.14887,0.11338,1,1
1,PID INSULIN GLUCOSE PATHWAY,0.0014738,0.14805,0.24741,1,1
1,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.0020453,0.14722,0.1223,1,1
1,PID RB 1PATHWAY,0.014486,0.14711,0.12593,1,1
1,REGULATION OF BODY FLUID LEVELS,0.012508,0.14684,0.23011,1,1
1,PID IL4 2PATHWAY,0.027803,0.14658,0.18644,1,1
1,MITOCHONDRION,0.010245,0.14641,0.11403,1,1
1,RNA BINDING,0.021165,0.14554,0.10033,1,1
1,PID MTOR 4PATHWAY,0.0019282,0.14511,0.14077,1,1
1,REACTOME MITOTIC G1 G1 S PHASES,0.0064317,0.14438,0.1168,1,1
1,PID TXA2PATHWAY,0.033166,0.14392,0.12524,1,1
1,UNFOLDED PROTEIN BINDING,0.035393,0.14312,0.1356,1,1
1,LEADING EDGE,0.043763,0.14105,0.16303,1,1
1,UBIQUITIN CYCLE,0.0025083,0.141,0.1841,1,1
1,ORGANELLE MEMBRANE,7.013e-05,0.14011,0.1344,1,1
1,REACTOME SIGNALING BY ILS,0.0024367,0.13947,0.21758,1,1
1,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.0038387,0.13544,0.12679,1,1
1,MACROMOLECULE LOCALIZATION,0.001986,0.13484,0.098597,1,1
1,PROTEIN N TERMINUS BINDING,0.020205,0.13444,0.10565,1,1
1,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.00074557,0.13406,0.14935,1,1
1,ST T CELL SIGNAL TRANSDUCTION,0.0042883,0.13357,0.14846,1,1
1,MACROMOLECULAR COMPLEX ASSEMBLY,0.00032948,0.13309,0.12004,1,1
1,SPINDLE POLE,0.013139,0.13019,0.23872,1,1
1,MICROBODY,0.036948,0.12931,0.1236,1,1
1,PEROXISOME,0.036948,0.12931,0.1236,1,1
1,PID IGF1 PATHWAY,0.0090226,0.12919,0.14829,1,1
1,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.0079323,0.12773,0.11811,1,1
1,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0087944,0.12696,0.1079,1,1
1,CELL CYCLE GO 0007049,0.016339,0.12339,0.082371,1,1
1,PROTEIN METABOLIC PROCESS,0.00013917,0.12337,0.12354,1,1
1,REACTOME TOLL RECEPTOR CASCADES,0.015574,0.12288,0.11842,1,1
1,CYTOSOL,0.00081984,0.12168,0.12644,1,1
1,DNA REPLICATION,0.022165,0.12054,0.11782,1,1
1,INTRACELLULAR SIGNALING CASCADE,0.017549,0.11737,0.10091,1,1
1,ENZYME ACTIVATOR ACTIVITY,0.0081404,0.11714,0.13546,1,1
1,CELL DEVELOPMENT,0.0041716,0.11684,0.10841,1,1
1,REACTOME G1 PHASE,0.029719,0.11681,0.1172,1,1
1,ENDOPEPTIDASE ACTIVITY,0.0032441,0.11638,0.15766,1,1
1,PID CD8TCRDOWNSTREAMPATHWAY,0.0062634,0.11451,0.24856,1,1
1,MACROMOLECULE CATABOLIC PROCESS,0.0016129,0.11408,0.11431,1,1
1,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.0027346,0.1118,0.13099,1,1
1,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0033369,0.11179,0.15465,1,1
1,REACTOME MRNA CAPPING,0.03939,0.11154,0.12416,1,1
1,LIPID BINDING,0.042857,0.11045,0.11477,1,1
1,POSITIVE REGULATION OF CASPASE ACTIVITY,0.013465,0.10677,0.168,1,1
1,GTP BINDING,0.029719,0.10663,0.14606,1,1
1,CELLULAR PROTEIN METABOLIC PROCESS,0.00026003,0.10565,0.11031,1,1
1,CELLULAR MACROMOLECULE METABOLIC PROCESS,0.00034072,0.10533,0.10598,1,1
1,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0054795,0.10343,0.085626,1,1
1,REGULATION OF HYDROLASE ACTIVITY,0.0099891,0.10236,0.11622,1,1
1,CELLULAR COMPONENT ASSEMBLY,0.0024367,0.10074,0.10051,1,1
1,POSITIVE REGULATION OF BINDING,0.036948,0.097724,0.10669,1,1
1,CYTOPLASMIC PART,0.00081984,0.096511,0.089397,1,1
1,DNA POLYMERASE ACTIVITY,0.040234,0.096339,0.14992,1,1
1,REGULATION OF GENE EXPRESSION,0.0046564,0.092984,0.08997,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.013465,0.090886,0.073039,1,1
1,ACTIVATION OF MAPK ACTIVITY,0.02268,0.089507,0.11011,1,1
1,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.012203,0.089467,0.11636,1,1
1,BIOPOLYMER CATABOLIC PROCESS,0.011612,0.089317,0.095695,1,1
1,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0028141,0.088365,0.071004,1,1
1,MACROMOLECULE BIOSYNTHETIC PROCESS,0.0099891,0.086482,0.10019,1,1
1,REGULATION OF MOLECULAR FUNCTION,0.0026572,0.085572,0.10188,1,1
1,PROTEIN AMINO ACID PHOSPHORYLATION,0.0083534,0.0849,0.090581,1,1
1,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.02268,0.084688,0.075687,1,1
1,REGULATION OF RNA METABOLIC PROCESS,0.033166,0.084245,0.071031,1,1
1,REACTOME HIV INFECTION,0.040234,0.08413,0.082739,1,1
1,KEGG HUNTINGTONS DISEASE,0.023741,0.082568,0.076358,1,1
1,CYTOPLASM,0.0028957,0.077484,0.076094,1,1
1,PID DNAPK PATHWAY,0.017549,0.071188,0.13605,1,1
1,MITOTIC CELL CYCLE,0.038561,0.069804,0.081121,1,1
1,RNA METABOLIC PROCESS,0.0094949,0.067874,0.067511,1,1
1,GUANYL NUCLEOTIDE BINDING,0.040234,0.067053,0.13962,1,1
1,PHOSPHORYLATION,0.0073363,0.066754,0.080092,1,1
1,BIOPOLYMER METABOLIC PROCESS,0.013465,0.058595,0.052161,1,1
1,REACTOME THE ACTIVATION OF ARYLSULFATASES,0.00014935,0.54558,0.46699,1,0
1,REACTOME P75NTR SIGNALS VIA NFKB,0.00016595,0.47825,0.49055,1,0
1,ARYLSULFATASE ACTIVITY,0.00079435,0.40163,0.45642,1,0
1,ER GOLGI INTERMEDIATE COMPARTMENT,0.0001547,0.35109,0.45808,1,0
1,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.0073363,0.33488,0.28338,1,0
1,SULFURIC ESTER HYDROLASE ACTIVITY,0.0019282,0.33319,0.36812,1,0
1,REACTOME DESTABILIZATION OF MRNA BY BRF1,5.6174e-05,0.33116,0.33626,1,0
1,MYOBLAST DIFFERENTIATION,0.03245,0.3274,0.3213,1,0
1,AGING,0.0017123,0.32452,0.34454,1,0
1,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.0011549,0.32195,0.29712,1,0
1,REACTOME PHASE II CONJUGATION,0.0014299,0.31985,0.25916,1,0
1,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,0.0011199,0.31602,0.30752,1,0
1,ISOPRENOID METABOLIC PROCESS,0.011326,0.28938,0.23407,1,0
1,GROWTH FACTOR ACTIVITY,0.00034072,0.28437,0.33176,1,0
1,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.015574,0.28135,0.22488,1,0
1,REACTOME ZINC TRANSPORTERS,0.0062634,0.27439,0.18069,1,0
1,KEGG THYROID CANCER,0.00067758,0.27193,0.29937,1,0
1,BIOCARTA ARF PATHWAY,0.0056288,0.27175,0.31364,1,0
1,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.019283,0.2685,0.27887,1,0
1,REGULATION OF ENDOCYTOSIS,0.010245,0.2682,0.24558,1,0
1,OXYGEN BINDING,0.042857,0.267,0.17179,1,0
1,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011326,0.26193,0.21061,1,0
1,REACTOME METAL ION SLC TRANSPORTERS,0.00055855,0.25899,0.25366,1,0
1,RESPONSE TO OXIDATIVE STRESS,0.001191,0.25872,0.23611,1,0
1,BIOCARTA CTCF PATHWAY,0.00014935,0.25782,0.34178,1,0
1,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.0010859,0.25205,0.3381,1,0
1,PID HEDGEHOG 2PATHWAY,0.011047,0.25199,0.24322,1,0
1,PID MYC PATHWAY,0.0042883,0.23761,0.20164,1,0
1,VESICLE MEMBRANE,0.00012964,0.23537,0.22759,1,0
1,FATTY ACID METABOLIC PROCESS,0.0069616,0.23339,0.19981,1,0
1,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.0015653,0.23261,0.17815,1,0
1,ENDOCYTIC VESICLE,0.027188,0.23238,0.23162,1,0
1,KEGG DRUG METABOLISM CYTOCHROME P450,0.023741,0.2318,0.21373,1,0
1,CYTOPLASMIC VESICLE MEMBRANE,0.00019753,0.23123,0.22173,1,0
1,CYTOPLASMIC VESICLE PART,0.00019753,0.23123,0.22173,1,0
1,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.001191,0.22796,0.29147,1,0
1,PID VEGFR1 PATHWAY,0.013798,0.22324,0.21588,1,0
1,BONE REMODELING,0.010773,0.22292,0.28135,1,0
1,PHAGOCYTOSIS,0.0028957,0.21754,0.24872,1,0
1,OXIDOREDUCTASE ACTIVITY GO 0016616,0.0073363,0.21725,0.19056,1,0
1,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.031059,0.21517,0.20693,1,0
1,REACTOME BIOLOGICAL OXIDATIONS,0.0034322,0.21239,0.18289,1,0
1,EARLY ENDOSOME,0.031748,0.20537,0.24541,1,0
1,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,0.041093,0.20332,0.22804,1,0
1,KEGG STARCH AND SUCROSE METABOLISM,0.012203,0.20218,0.18604,1,0
1,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.010773,0.20209,0.17833,1,0
1,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0024367,0.20092,0.1921,1,0
1,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.0053338,0.19934,0.32509,1,0
1,NUCLEOLAR PART,0.027803,0.19816,0.23273,1,0
1,MONOCARBOXYLIC ACID METABOLIC PROCESS,0.033894,0.19712,0.12027,1,0
1,PROTEIN AMINO ACID LIPIDATION,0.001191,0.19689,0.20227,1,0
1,RECEPTOR MEDIATED ENDOCYTOSIS,0.0013872,0.19058,0.1598,1,0
1,NITROGEN COMPOUND METABOLIC PROCESS,0.00052342,0.1854,0.16377,1,0
1,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.0049174,0.18528,0.31644,1,0
1,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.013798,0.18394,0.32131,1,0
1,SUGAR BINDING,0.013798,0.18326,0.24991,1,0
1,METALLOEXOPEPTIDASE ACTIVITY,0.02843,0.18326,0.2086,1,0
1,WOUND HEALING,4.1617e-05,0.18143,0.35588,1,0
1,ST MYOCYTE AD PATHWAY,0.0062634,0.18039,0.25456,1,0
1,REACTOME PURINE METABOLISM,0.021165,0.17706,0.25752,1,0
1,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,0.004408,0.17622,0.20816,1,0
1,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,0.00055855,0.17322,0.17887,1,0
1,RHYTHMIC PROCESS,0.017549,0.17162,0.16019,1,0
1,AROMATIC COMPOUND METABOLIC PROCESS,0.017137,0.16701,0.13104,1,0
1,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,0.0051916,0.166,0.18399,1,0
1,ENDOPLASMIC RETICULUM PART,0.0066042,0.16593,0.15178,1,0
1,VITAMIN METABOLIC PROCESS,0.0019282,0.16063,0.25708,1,0
1,RESPONSE TO HORMONE STIMULUS,0.019739,0.15973,0.21933,1,0
1,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.02068,0.15641,0.15779,1,0
1,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.0036303,0.15641,0.15245,1,0
1,CARBOXYLIC ACID METABOLIC PROCESS,0.015203,0.15614,0.10476,1,0
1,PID ARF6DOWNSTREAMPATHWAY,0.041093,0.15529,0.13101,1,0
1,PID IL12 2PATHWAY,0.0069616,0.15504,0.24851,1,0
1,COENZYME METABOLIC PROCESS,0.041967,0.15406,0.16711,1,0
1,RESPONSE TO BIOTIC STIMULUS,0.012508,0.15054,0.13598,1,0
1,ENDOMEMBRANE SYSTEM,0.0014738,0.15024,0.11856,1,0
1,AMINE METABOLIC PROCESS,0.001662,0.14509,0.13519,1,0
1,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.025414,0.14393,0.17387,1,0
1,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.016339,0.14295,0.15211,1,0
1,ORGANIC ACID METABOLIC PROCESS,0.010245,0.14241,0.10985,1,0
1,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.031748,0.14137,0.1639,1,0
1,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.033894,0.14008,0.15726,1,0
1,AMINO ACID METABOLIC PROCESS,0.034637,0.13781,0.094903,1,0
1,ANION TRANSPORT,0.043763,0.13696,0.19344,1,0
1,LIPID METABOLIC PROCESS,0.010773,0.13575,0.085725,1,0
1,TISSUE DEVELOPMENT,0.03245,0.13472,0.20808,1,0
1,ST GA13 PATHWAY,0.00036427,0.13225,0.19813,1,0
1,PID PRLSIGNALINGEVENTSPATHWAY,0.027803,0.13184,0.21771,1,0
1,MEMBRANE FRACTION,0.0054795,0.13178,0.1209,1,0
1,PID FGF PATHWAY,0.041967,0.13147,0.11821,1,0
1,MEMBRANE ORGANIZATION AND BIOGENESIS,0.0039469,0.13114,0.11048,1,0
1,BIOCARTA MEF2D PATHWAY,0.010506,0.13068,0.21831,1,0
1,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.017137,0.12741,0.17951,1,0
1,COPPER ION BINDING,0.036948,0.12718,0.20851,1,0
1,REACTOME DNA REPLICATION,0.033894,0.12383,0.085004,1,0
1,SYMPORTER ACTIVITY,0.038561,0.12347,0.15351,1,0
1,NEGATIVE REGULATION OF TRANSCRIPTION,0.022165,0.11365,0.0901,1,0
1,RESPONSE TO BACTERIUM,0.041093,0.11171,0.08657,1,0
1,CELL FRACTION,0.014138,0.11,0.10263,1,0
1,ENDOPLASMIC RETICULUM MEMBRANE,0.041967,0.10841,0.10414,1,0
1,LIPOPROTEIN METABOLIC PROCESS,0.033166,0.10766,0.11193,1,0
1,BIOCARTA VIP PATHWAY,0.02166,0.10653,0.16066,1,0
1,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.0036303,0.10599,0.17909,1,0
1,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.024846,0.099921,0.12382,1,0
1,CATABOLIC PROCESS,0.0045306,0.098089,0.083666,1,0
1,PID P75NTRPATHWAY,0.038561,0.095913,0.10669,1,0
1,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,0.03939,0.095516,0.086433,1,0
1,ION BINDING,0.036164,0.09542,0.07923,1,0
1,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,0.014486,0.091521,0.14688,1,0
1,CELLULAR CATABOLIC PROCESS,0.0040578,0.090764,0.088005,1,0
1,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.031748,0.090685,0.10147,1,0
1,BIOSYNTHETIC PROCESS,0.025414,0.089514,0.09091,1,0
1,CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.087268,0.093239,1,0
1,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.012203,0.087238,0.11799,1,0
1,KEGG CHRONIC MYELOID LEUKEMIA,0.042857,0.084862,0.1257,1,0
1,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.010506,0.08462,0.12603,1,0
1,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.022165,0.081252,0.076821,1,0
1,LIPID KINASE ACTIVITY,0.024846,0.080723,0.1704,1,0
1,REGULATION OF PROTEIN KINASE ACTIVITY,0.02068,0.078571,0.094456,1,0
1,REGULATION OF KINASE ACTIVITY,0.015574,0.077734,0.096139,1,0
1,REGULATION OF TRANSCRIPTION,0.0067808,0.07766,0.085481,1,0
1,REGULATION OF TRANSFERASE ACTIVITY,0.018836,0.076367,0.092906,1,0
1,PROTEIN KINASE ACTIVITY,0.041967,0.075287,0.077834,1,0
1,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,0.024288,0.073594,0.079841,1,0
1,TRANSCRIPTION,0.013798,0.066645,0.069587,1,0
1,RNA BIOSYNTHETIC PROCESS,0.036948,0.064466,0.059418,1,0
1,TRANSCRIPTION DNA DEPENDENT,0.036948,0.06441,0.059077,1,0
1,PHOSPHOINOSITIDE METABOLIC PROCESS,0.043763,0.056371,0.11712,1,0
1,POST TRANSLATIONAL PROTEIN MODIFICATION,0.029068,0.05424,0.065381,1,0
1,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.035393,0.053617,0.075264,1,0
1,NEGATIVE REGULATION OF METABOLIC PROCESS,0.033894,0.053007,0.076462,1,0
1,NUCLEUS,0.038561,0.050331,0.036693,1,0
1,REACTOME TRIF MEDIATED TLR3 SIGNALING,0.024846,0.042593,0.13506,1,0
1,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.038561,-0.049229,-0.097521,1,0
1,MEMBRANE BOUND VESICLE,0.033166,-0.066513,-0.088691,1,0
1,TRANSPORT,0.030383,-0.081201,-0.065791,1,0
1,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.025414,-0.081541,-0.093673,1,0
1,REACTOME SIGNALLING TO ERKS,0.038561,-0.08635,-0.084348,1,0
1,REACTOME PI3K AKT ACTIVATION,0.030383,-0.089113,-0.097943,1,0
1,HISTONE MODIFICATION,0.034637,-0.092874,-0.11734,1,0
1,COVALENT CHROMATIN MODIFICATION,0.034637,-0.092874,-0.11734,1,0
1,VESICLE,0.024846,-0.093389,-0.090585,1,0
1,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.015574,-0.093818,-0.11501,1,0
1,NEURITE DEVELOPMENT,0.041967,-0.099268,-0.26846,1,0
1,CELL CELL ADHESION,0.035393,-0.10002,-0.17844,1,0
1,PROTEIN PROCESSING,0.02068,-0.10241,-0.10651,1,0
1,MAGNESIUM ION BINDING,0.022165,-0.10306,-0.11228,1,0
1,CYTOPLASMIC VESICLE,0.018398,-0.10616,-0.10013,1,0
1,REACTOME BASE EXCISION REPAIR,0.019283,-0.10713,-0.12127,1,0
1,DNA PACKAGING,0.040234,-0.10768,-0.105,1,0
1,PROTEIN DNA COMPLEX ASSEMBLY,0.013465,-0.10814,-0.11891,1,0
1,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.010506,-0.11086,-0.12872,1,0
1,MRNA METABOLIC PROCESS,0.023741,-0.11342,-0.072514,1,0
1,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.0087944,-0.11467,-0.10782,1,0
1,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.0073363,-0.11482,-0.17074,1,0
1,MICROTUBULE ORGANIZING CENTER,0.023741,-0.11544,-0.088618,1,0
1,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.016339,-0.11629,-0.14597,1,0
1,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.033894,-0.11658,-0.1085,1,0
1,MAPKKK CASCADE GO 0000165,0.016734,-0.11869,-0.11035,1,0
1,LIPID BIOSYNTHETIC PROCESS,0.031059,-0.12221,-0.13033,1,0
1,KEGG OOCYTE MEIOSIS,0.013798,-0.12296,-0.10668,1,0
1,RESPONSE TO NUTRIENT LEVELS,0.043763,-0.12417,-0.14951,1,0
1,PID RHODOPSIN PATHWAY,0.040234,-0.12678,-0.15318,1,0
1,JNK CASCADE,0.018836,-0.12837,-0.12016,1,0
1,KEGG MTOR SIGNALING PATHWAY,0.0099891,-0.12914,-0.099599,1,0
1,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.0020453,-0.13017,-0.17769,1,0
1,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.019283,-0.1304,-0.11604,1,0
1,REGULATION OF PROTEIN STABILITY,0.024288,-0.13201,-0.16192,1,0
1,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.0069616,-0.13662,-0.10941,1,0
1,CENTROSOME,0.0079323,-0.13771,-0.1289,1,0
1,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.033166,-0.14094,-0.11844,1,0
1,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.010245,-0.14252,-0.14638,1,0
1,MRNA PROCESSING GO 0006397,0.015203,-0.14377,-0.10019,1,0
1,CHROMOSOME,0.036948,-0.14585,-0.10052,1,0
1,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0041716,-0.14604,-0.12987,1,0
1,REACTOME DARPP 32 EVENTS,0.042857,-0.14644,-0.13944,1,0
1,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0021689,-0.14702,-0.13195,1,0
1,CHROMATIN MODIFICATION,0.0059384,-0.15042,-0.13751,1,0
1,BIOGENIC AMINE METABOLIC PROCESS,0.031059,-0.15258,-0.15528,1,0
1,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.012508,-0.15355,-0.11504,1,0
1,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.015574,-0.1537,-0.20656,1,0
1,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,0.0046564,-0.15453,-0.15129,1,0
1,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.001191,-0.15463,-0.12787,1,0
1,PROTEIN AUTOPROCESSING,0.026586,-0.15497,-0.11625,1,0
1,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.007729,-0.15572,-0.14971,1,0
1,REACTOME PI METABOLISM,0.013139,-0.15724,-0.13036,1,0
1,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.0059384,-0.15759,-0.17536,1,0
1,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.015203,-0.15806,-0.13998,1,0
1,REACTOME SIGNALLING TO RAS,0.027188,-0.15997,-0.1161,1,0
1,RNA EXPORT FROM NUCLEUS,0.00047456,-0.16116,-0.21229,1,0
1,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.02843,-0.16403,-0.16711,1,0
1,NEUROGENESIS,0.0087944,-0.16655,-0.27771,1,0
1,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,0.017137,-0.16728,-0.32784,1,0
1,APOPTOTIC NUCLEAR CHANGES,0.017969,-0.16866,-0.19044,1,0
1,ST JNK MAPK PATHWAY,0.0032441,-0.17077,-0.2029,1,0
1,KEGG ARACHIDONIC ACID METABOLISM,0.026586,-0.17145,-0.26257,1,0
1,PROTEIN DOMAIN SPECIFIC BINDING,5.2139e-05,-0.17482,-0.22316,1,0
1,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.0038387,-0.17543,-0.16457,1,0
1,GLUCOSE METABOLIC PROCESS,0.025414,-0.17598,-0.16254,1,0
1,AXONOGENESIS,0.022165,-0.17667,-0.36703,1,0
1,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.0047853,-0.18066,-0.20765,1,0
1,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,0.0094949,-0.1808,-0.16283,1,0
1,CAMP MEDIATED SIGNALING,0.0094949,-0.1808,-0.16283,1,0
1,CLATHRIN COATED VESICLE,0.00055855,-0.18266,-0.21216,1,0
1,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.0046564,-0.18277,-0.22796,1,0
1,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,0.00037661,-0.18328,-0.17544,1,0
1,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0059384,-0.18355,-0.15797,1,0
1,MOLECULAR ADAPTOR ACTIVITY,0.024288,-0.18427,-0.18732,1,0
1,PID NETRIN PATHWAY,0.017969,-0.18465,-0.18202,1,0
1,REACTOME DAG AND IP3 SIGNALING,0.02068,-0.18577,-0.1446,1,0
1,REACTOME SHC RELATED EVENTS,0.016339,-0.18925,-0.14101,1,0
1,NEURON DIFFERENTIATION,0.0051916,-0.18929,-0.35406,1,0
1,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.029719,-0.18962,-0.20265,1,0
1,SYSTEM PROCESS,0.00012512,-0.19156,-0.17564,1,0
1,REGULATION OF GENE EXPRESSION EPIGENETIC,0.020205,-0.19172,-0.15945,1,0
1,CARBOXYLESTERASE ACTIVITY,0.029719,-0.19197,-0.16748,1,0
1,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.0083534,-0.1923,-0.25858,1,0
1,BIOCARTA MCM PATHWAY,0.013798,-0.19259,-0.19357,1,0
1,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.013798,-0.19527,-0.16554,1,0
1,SECRETION BY CELL,0.00017186,-0.19569,-0.22127,1,0
1,MICROTUBULE ORGANIZING CENTER PART,0.017969,-0.19574,-0.14078,1,0
1,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.017969,-0.19702,-0.25268,1,0
1,MICROTUBULE CYTOSKELETON,0.00026903,-0.19963,-0.20018,1,0
1,KEGG RIBOFLAVIN METABOLISM,0.023741,-0.20311,-0.24209,1,0
1,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.019739,-0.20377,-0.26384,1,0
1,G PROTEIN COUPLED RECEPTOR ACTIVITY,1.5816e-05,-0.20379,-0.20194,1,0
1,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.0026572,-0.20428,-0.2013,1,0
1,TUBULIN BINDING,0.00029782,-0.2048,-0.24185,1,0
1,KEGG MATURITY ONSET DIABETES OF THE YOUNG,0.0062634,-0.20487,-0.32392,1,0
1,REACTOME MEIOTIC RECOMBINATION,0.03245,-0.20515,-0.18783,1,0
1,BIOCARTA G2 PATHWAY,0.0085714,-0.20592,-0.1916,1,0
1,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.00081984,-0.20598,-0.17262,1,0
1,LYMPHOCYTE DIFFERENTIATION,0.022165,-0.206,-0.18998,1,0
1,REGULATION OF ACTION POTENTIAL,0.041967,-0.2095,-0.17848,1,0
1,GLYCOPROTEIN METABOLIC PROCESS,0.00074557,-0.20954,-0.22305,1,0
1,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,0.016339,-0.21074,-0.20327,1,0
1,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.016734,-0.21173,-0.1838,1,0
1,CHROMATIN,0.0037331,-0.21173,-0.21627,1,0
1,AMINE RECEPTOR ACTIVITY,0.011047,-0.21186,-0.17461,1,0
1,REACTOME OPIOID SIGNALLING,0.00013917,-0.21243,-0.23667,1,0
1,REACTOME DNA STRAND ELONGATION,0.0047853,-0.21296,-0.22973,1,0
1,POSITIVE REGULATION OF IMMUNE RESPONSE,0.027803,-0.21409,-0.21416,1,0
1,MEIOTIC RECOMBINATION,0.041967,-0.21411,-0.17538,1,0
1,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.0026572,-0.2143,-0.25405,1,0
1,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.015574,-0.21517,-0.19166,1,0
1,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015574,-0.21517,-0.19166,1,0
1,GENERATION OF NEURONS,0.0037331,-0.21601,-0.31799,1,0
1,SEXUAL REPRODUCTION,0.00013433,-0.21701,-0.25028,1,0
1,REACTOME CD28 CO STIMULATION,0.0066042,-0.21701,-0.17613,1,0
1,MONOOXYGENASE ACTIVITY,0.011612,-0.21841,-0.18242,1,0
1,REACTOME G ALPHA S SIGNALLING EVENTS,0.00042998,-0.22056,-0.21076,1,0
1,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.00069957,-0.22083,-0.24116,1,0
1,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.00065623,-0.223,-0.23309,1,0
1,REACTOME AMINE LIGAND BINDING RECEPTORS,0.011047,-0.22406,-0.17807,1,0
1,PID THROMBIN PAR4 PATHWAY,0.0050528,-0.22531,-0.23702,1,0
1,KEGG LONG TERM POTENTIATION,0.00021167,-0.22827,-0.23698,1,0
1,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.0010528,-0.22839,-0.2187,1,0
1,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.018836,-0.23039,-0.19211,1,0
1,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.036164,-0.23134,-0.16396,1,0
1,APICAL JUNCTION COMPLEX,0.026586,-0.23251,-0.22377,1,0
1,APICOLATERAL PLASMA MEMBRANE,0.026586,-0.23251,-0.22377,1,0
1,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.0069616,-0.23322,-0.23272,1,0
1,TIGHT JUNCTION,0.011904,-0.23583,-0.25412,1,0
1,DENDRITE,0.0020453,-0.23732,-0.296,1,0
1,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.001662,-0.23739,-0.27113,1,0
1,MICROTUBULE BINDING,0.00021167,-0.23755,-0.278,1,0
1,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00030804,-0.23801,-0.20476,1,0
1,PID EPHRINBREVPATHWAY,0.0024367,-0.24158,-0.27079,1,0
1,PID CXCR3PATHWAY,0.001986,-0.24185,-0.17434,1,0
1,KEGG LINOLEIC ACID METABOLISM,0.0064317,-0.24223,-0.31226,1,0
1,REGULATION OF NEURON APOPTOSIS,0.014486,-0.24277,-0.19659,1,0
1,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.0047853,-0.24349,-0.21924,1,0
1,REACTOME L1CAM INTERACTIONS,0.0021062,-0.24478,-0.2338,1,0
1,BRAIN DEVELOPMENT,0.0031536,-0.24572,-0.3205,1,0
1,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0030654,-0.24584,-0.20646,1,0
1,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.0013457,-0.24651,-0.28288,1,0
1,ION TRANSPORT,9.0551e-05,-0.24801,-0.23417,1,0
1,PID P38ALPHABETAPATHWAY,0.0017641,-0.24861,-0.18341,1,0
1,REACTOME TELOMERE MAINTENANCE,0.026586,-0.24861,-0.19817,1,0
1,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.0034322,-0.24935,-0.23059,1,0
1,PID RAC1 REG PATHWAY,0.0013872,-0.24972,-0.28508,1,0
1,KEGG LONG TERM DEPRESSION,5.0683e-06,-0.25229,-0.27194,1,0
1,MICROTUBULE,0.00029782,-0.25261,-0.22884,1,0
1,KEGG GLYCEROLIPID METABOLISM,0.0067808,-0.25269,-0.17439,1,0
1,COATED VESICLE,0.00016023,-0.25367,-0.23658,1,0
1,REACTOME PLC BETA MEDIATED EVENTS,4.1617e-05,-0.25399,-0.24869,1,0
1,REACTOME CTLA4 INHIBITORY SIGNALING,0.011326,-0.25757,-0.27977,1,0
1,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00021909,-0.25767,-0.2089,1,0
1,REACTOME IL 2 SIGNALING,0.011326,-0.25775,-0.21186,1,0
1,T CELL ACTIVATION,0.031748,-0.25776,-0.1767,1,0
1,PID NEPHRIN NEPH1 PATHWAY,0.00020448,-0.25827,-0.24108,1,0
1,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.029068,-0.25982,-0.21647,1,0
1,CHROMATIN ASSEMBLY,0.0062634,-0.26119,-0.22383,1,0
1,GAMETE GENERATION,2.1663e-05,-0.26144,-0.26748,1,0
1,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,9.7346e-05,-0.26159,-0.27548,1,0
1,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.021165,-0.26287,-0.21707,1,0
1,REACTOME CA DEPENDENT EVENTS,0.0030654,-0.26383,-0.18766,1,0
1,REACTOME RNA POL I PROMOTER OPENING,0.040234,-0.26391,-0.25037,1,0
1,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.027188,-0.26551,-0.32815,1,0
1,STEROID BIOSYNTHETIC PROCESS,0.011612,-0.266,-0.30678,1,0
1,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.023741,-0.267,-0.18335,1,0
1,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.0053338,-0.26861,-0.23501,1,0
1,REACTOME GABA B RECEPTOR ACTIVATION,0.00041602,-0.2724,-0.28818,1,0
1,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.0094949,-0.27262,-0.29186,1,0
1,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.011904,-0.27292,-0.20586,1,0
1,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,6.7596e-05,-0.27403,-0.2444,1,0
1,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.010245,-0.27409,-0.27632,1,0
1,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.013465,-0.27428,-0.22224,1,0
1,REACTOME SIGNALING BY SCF KIT,0.00025131,-0.27659,-0.24418,1,0
1,LIGAND GATED CHANNEL ACTIVITY,3.5759e-05,-0.27696,-0.31436,1,0
1,NEUROLOGICAL SYSTEM PROCESS,7.3528e-06,-0.27883,-0.25342,1,0
1,CELL CELL SIGNALING,0.00010845,-0.28254,-0.26037,1,0
1,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.0012662,-0.2832,-0.33207,1,0
1,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,1.104e-05,-0.28337,-0.33248,1,0
1,PID AR NONGENOMIC PATHWAY,0.00017186,-0.28564,-0.269,1,0
1,REACTOME RECYCLING PATHWAY OF L1,0.0045306,-0.28693,-0.25183,1,0
1,REACTOME PACKAGING OF TELOMERE ENDS,0.03939,-0.28765,-0.2742,1,0
1,NUCLEAR CHROMOSOME PART,0.016734,-0.2884,-0.18566,1,0
1,EMBRYONIC DEVELOPMENT,0.0081404,-0.28896,-0.23009,1,0
1,KEGG STEROID BIOSYNTHESIS,0.0060989,-0.28933,-0.41705,1,0
1,NUCLEAR CHROMOSOME,0.00028792,-0.2905,-0.24498,1,0
1,SECRETION,7.3528e-06,-0.29115,-0.27665,1,0
1,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.00055855,-0.29142,-0.27557,1,0
1,SPLICEOSOME ASSEMBLY,0.00055855,-0.29391,-0.24429,1,0
1,REGULATION OF JNK CASCADE,0.0056288,-0.29527,-0.25325,1,0
1,REACTOME SYNTHESIS OF PC,0.011612,-0.29646,-0.24417,1,0
1,MEIOSIS I,0.022165,-0.29667,-0.1867,1,0
1,SYNAPSE,0.00013917,-0.29884,-0.27968,1,0
1,PID LIS1PATHWAY,0.00025131,-0.30154,-0.29059,1,0
1,TUBE DEVELOPMENT,0.029719,-0.30237,-0.26528,1,0
1,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.0057817,-0.30345,-0.23954,1,0
1,AMINE BINDING,0.00028792,-0.30402,-0.34101,1,0
1,REACTOME G0 AND EARLY G1,0.00063551,-0.30476,-0.31266,1,0
1,REGULATION OF MYELOID CELL DIFFERENTIATION,0.024288,-0.3057,-0.2811,1,0
1,BIOCARTA IL2 PATHWAY,0.017137,-0.30671,-0.22951,1,0
1,MEIOTIC CELL CYCLE,0.00059588,-0.30779,-0.2808,1,0
1,KEGG FC EPSILON RI SIGNALING PATHWAY,0.00074557,-0.30983,-0.22402,1,0
1,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00041602,-0.31139,-0.27557,1,0
1,BIOCARTA BARR MAPK PATHWAY,0.0014738,-0.31336,-0.28888,1,0
1,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,4.5813e-07,-0.31355,-0.34273,1,0
1,REACTOME DSCAM INTERACTIONS,0.0007696,-0.31363,-0.34494,1,0
1,SECRETORY PATHWAY,3.6414e-07,-0.31389,-0.343,1,0
1,REACTOME PLATELET HOMEOSTASIS,7.3528e-06,-0.31467,-0.29474,1,0
1,CHROMATIN REMODELING,0.00095906,-0.31626,-0.28913,1,0
1,CELL FATE COMMITMENT,0.0036303,-0.31824,-0.27411,1,0
1,BIOCARTA MTA3 PATHWAY,0.0017641,-0.31846,-0.43804,1,0
1,REACTOME ION TRANSPORT BY P TYPE ATPASES,1.0184e-05,-0.31926,-0.37077,1,0
1,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0054795,-0.31949,-0.27508,1,0
1,KEGG TYPE II DIABETES MELLITUS,0.00012512,-0.32046,-0.29039,1,0
1,FEEDING BEHAVIOR,4.1112e-06,-0.32168,-0.37923,1,0
1,CELL PROJECTION PART,0.0046564,-0.323,-0.27131,1,0
1,BIOCARTA CSK PATHWAY,0.00036427,-0.32812,-0.31062,1,0
1,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02843,-0.32826,-0.2872,1,0
1,SA REG CASCADE OF CYCLIN EXPR,0.0049174,-0.32837,-0.28847,1,0
1,BIOCARTA CREB PATHWAY,0.0007696,-0.33,-0.2984,1,0
1,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.0094949,-0.33039,-0.24399,1,0
1,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.4039e-05,-0.33054,-0.29978,1,0
1,REACTOME BILE ACID AND BILE SALT METABOLISM,0.014841,-0.33355,-0.25154,1,0
1,CALCIUM ION TRANSPORT,0.00025131,-0.33394,-0.33808,1,0
1,NEUROPEPTIDE BINDING,0.0007696,-0.33554,-0.28654,1,0
1,NEUROPEPTIDE RECEPTOR ACTIVITY,0.0007696,-0.33554,-0.28654,1,0
1,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,5.7413e-06,-0.33839,-0.36629,1,0
1,CATION TRANSPORT,7.9801e-06,-0.34012,-0.32876,1,0
1,REACTOME SIGNALING BY NOTCH4,0.0056288,-0.34138,-0.27756,1,0
1,PID ALPHASYNUCLEIN PATHWAY,0.00024286,-0.35667,-0.34432,1,0
1,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.00049035,-0.35717,-0.39434,1,0
1,NERVOUS SYSTEM DEVELOPMENT,1.7118e-05,-0.35778,-0.35045,1,0
1,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.00052342,-0.36081,-0.40047,1,0
1,BIOCARTA PGC1A PATHWAY,0.0094949,-0.36179,-0.24604,1,0
1,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0064317,-0.36204,-0.27468,1,0
1,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,9.0551e-05,-0.36305,-0.36858,1,0
1,BIOCARTA CACAM PATHWAY,0.00040247,-0.36447,-0.36117,1,0
1,PID REELINPATHWAY,7.2754e-05,-0.36555,-0.37737,1,0
1,KINASE REGULATOR ACTIVITY,0.00087311,-0.36598,-0.33764,1,0
1,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.012508,-0.36679,-0.26189,1,0
1,KEGG OLFACTORY TRANSDUCTION,3.8583e-05,-0.36915,-0.30689,1,0
1,KEGG CELL ADHESION MOLECULES CAMS,0.00013917,-0.36957,-0.3231,1,0
1,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,2.3418e-05,-0.3702,-0.38109,1,0
1,KINESIN COMPLEX,0.0050528,-0.37067,-0.25468,1,0
1,BIOCARTA BARRESTIN SRC PATHWAY,0.00036427,-0.37127,-0.31895,1,0
1,SODIUM ION TRANSPORT,0.023205,-0.37301,-0.29231,1,0
1,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,9.0551e-05,-0.37539,-0.41863,1,0
1,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,3.4728e-06,-0.37594,-0.34978,1,0
1,KINASE ACTIVATOR ACTIVITY,0.00012512,-0.3772,-0.40508,1,0
1,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.00018427,-0.38175,-0.43158,1,0
1,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.0006154,-0.38449,-0.31493,1,0
1,REACTOME G PROTEIN ACTIVATION,0.00012512,-0.3845,-0.35184,1,0
1,NUCLEOTIDE KINASE ACTIVITY,0.0056288,-0.38649,-0.29447,1,0
1,KEGG NITROGEN METABOLISM,0.00029782,-0.39038,-0.37612,1,0
1,MICROTUBULE MOTOR ACTIVITY,0.00034072,-0.3909,-0.39553,1,0
1,TUBE MORPHOGENESIS,0.016734,-0.3921,-0.30506,1,0
1,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.00098941,-0.39866,-0.30139,1,0
1,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,4.2876e-06,-0.39928,-0.39776,1,0
1,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,2.1702e-06,-0.40256,-0.39823,1,0
1,REACTOME GABA RECEPTOR ACTIVATION,8.3127e-06,-0.40595,-0.40152,1,0
1,REGULATION OF MEMBRANE POTENTIAL,5.0226e-05,-0.408,-0.40164,1,0
1,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,2.0033e-05,-0.40976,-0.33687,1,0
1,METAL ION TRANSPORT,7.9801e-06,-0.41458,-0.3972,1,0
1,CALCIUM INDEPENDENT CELL CELL ADHESION,0.0067808,-0.4147,-0.36552,1,0
1,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.9301e-06,-0.42525,-0.41504,1,0
1,PID HNF3BPATHWAY,2.8418e-05,-0.42574,-0.42603,1,0
1,AXON,0.00034072,-0.42684,-0.51055,1,0
1,MICROTUBULE ASSOCIATED COMPLEX,7.0571e-06,-0.42916,-0.46991,1,0
1,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,6.5896e-07,-0.42933,-0.40177,1,0
1,MOTOR ACTIVITY,0.00092958,-0.43573,-0.30355,1,0
1,REACTOME ION CHANNEL TRANSPORT,1.1788e-07,-0.4372,-0.47091,1,0
1,DETECTION OF STIMULUS,2.3654e-06,-0.43799,-0.39228,1,0
1,MESODERM DEVELOPMENT,0.0019282,-0.43988,-0.38022,1,0
1,HOMOPHILIC CELL ADHESION,0.0032441,-0.44357,-0.39191,1,0
1,ION CHANNEL ACTIVITY,2.1702e-06,-0.4462,-0.44644,1,0
1,MAP KINASE ACTIVITY,3.3132e-05,-0.44698,-0.43486,1,0
1,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,1.9904e-06,-0.44727,-0.43557,1,0
1,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,4.4878e-05,-0.45023,-0.46017,1,0
1,NEUROTRANSMITTER BINDING,9.4334e-07,-0.45151,-0.43065,1,0
1,ACETYLCHOLINE BINDING,3.6228e-06,-0.45416,-0.5747,1,0
1,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.00012512,-0.45692,-0.56575,1,0
1,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,9.7801e-06,-0.46486,-0.4449,1,0
1,TRANSMISSION OF NERVE IMPULSE,4.5813e-07,-0.46548,-0.44934,1,0
1,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.009256,-0.46647,-0.35802,1,0
1,REACTOME INTEGRATION OF ENERGY METABOLISM,7.889e-07,-0.47092,-0.4059,1,0
1,REACTOME TIGHT JUNCTION INTERACTIONS,0.0099891,-0.47222,-0.36137,1,0
1,CALCIUM CHANNEL ACTIVITY,5.7413e-06,-0.47343,-0.5334,1,0
1,KEGG BUTANOATE METABOLISM,0.015574,-0.47744,-0.3127,1,0
1,PROTEIN KINASE REGULATOR ACTIVITY,0.00063551,-0.48063,-0.39216,1,0
1,BIOCARTA STATHMIN PATHWAY,0.00067758,-0.48215,-0.42205,1,0
1,CARBONATE DEHYDRATASE ACTIVITY,0.0069616,-0.48565,-0.39931,1,0
1,REACTOME INWARDLY RECTIFYING K CHANNELS,5.7413e-06,-0.48584,-0.50149,1,0
1,NEUROTRANSMITTER RECEPTOR ACTIVITY,5.0194e-07,-0.4886,-0.47393,1,0
1,REACTOME BOTULINUM NEUROTOXICITY,6.7728e-06,-0.48864,-0.52506,1,0
1,AXON GUIDANCE,0.00072223,-0.48929,-0.51017,1,0
1,GATED CHANNEL ACTIVITY,1.4674e-06,-0.49127,-0.48669,1,0
1,SECRETORY GRANULE,0.00092958,-0.49156,-0.39953,1,0
1,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,7.9801e-06,-0.49223,-0.49609,1,0
1,SYNAPTIC TRANSMISSION,3.6414e-07,-0.49716,-0.48664,1,0
1,REACTOME CGMP EFFECTS,1.0779e-06,-0.49867,-0.48124,1,0
1,BIOCARTA BAD PATHWAY,0.00044439,-0.50095,-0.37662,1,0
1,NEURON APOPTOSIS,0.00016023,-0.50138,-0.41029,1,0
1,HORMONE ACTIVITY,1.104e-05,-0.50328,-0.52086,1,0
1,RESPONSE TO ORGANIC SUBSTANCE,2.9301e-06,-0.50475,-0.51259,1,0
1,REACTOME N GLYCAN ANTENNAE ELONGATION,0.0025083,-0.50627,-0.4319,1,0
1,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.00012964,-0.50745,-0.44694,1,0
1,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,0.013798,-0.50773,-0.32366,1,0
1,PID ERB GENOMIC PATHWAY,0.024846,-0.50952,-0.24385,1,0
1,CENTRAL NERVOUS SYSTEM DEVELOPMENT,1.7474e-06,-0.50994,-0.45603,1,0
1,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,5.7413e-06,-0.5139,-0.46929,1,0
1,REACTOME AMINE COMPOUND SLC TRANSPORTERS,2.3418e-05,-0.52012,-0.43653,1,0
1,NEURON PROJECTION,2.5308e-05,-0.52092,-0.50249,1,0
1,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.0001165,-0.52166,-0.43485,1,0
1,REACTOME REGULATION OF BETA CELL DEVELOPMENT,1.3441e-06,-0.52357,-0.56714,1,0
1,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,0.00019079,-0.53535,-0.52516,1,0
1,GLYCOLIPID METABOLIC PROCESS,0.00074557,-0.53566,-0.47981,1,0
1,CHROMATIN REMODELING COMPLEX,9.0221e-07,-0.53737,-0.53232,1,0
1,REACTOME REGULATION OF KIT SIGNALING,0.00098941,-0.54403,-0.50057,1,0
1,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,7.547e-05,-0.54416,-0.47682,1,0
1,POSITIVE REGULATION OF SECRETION,2.2524e-05,-0.54627,-0.53419,1,0
1,CATION CHANNEL ACTIVITY,1.8251e-06,-0.5504,-0.50835,1,0
1,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.00023468,-0.55179,-0.39705,1,0
1,REACTOME REGULATION OF INSULIN SECRETION,6.2985e-07,-0.55205,-0.49394,1,0
1,MONOVALENT INORGANIC CATION TRANSPORT,3.0576e-06,-0.55708,-0.51037,1,0
1,KINASE INHIBITOR ACTIVITY,0.0087944,-0.55739,-0.36488,1,0
1,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,1.9873e-07,-0.5597,-0.50779,1,0
1,PROTEIN KINASE INHIBITOR ACTIVITY,0.0087944,-0.56586,-0.38327,1,0
1,MICROTUBULE BASED MOVEMENT,0.00013917,-0.56869,-0.56707,1,0
1,SH3 DOMAIN BINDING,1.7474e-06,-0.57317,-0.5773,1,0
1,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,2.6902e-06,-0.59072,-0.55917,1,0
1,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,5.2837e-06,-0.59335,-0.64186,1,0
1,REACTOME ADHERENS JUNCTIONS INTERACTIONS,3.3132e-05,-0.59833,-0.57678,1,0
1,VOLTAGE GATED CHANNEL ACTIVITY,2.3654e-06,-0.60127,-0.59795,1,0
1,REACTOME NEURONAL SYSTEM,1.4268e-07,-0.60283,-0.54198,1,0
1,REACTOME CELL CELL JUNCTION ORGANIZATION,6.2786e-05,-0.61036,-0.47147,1,0
1,REGULATION OF SECRETION,2.3418e-05,-0.61091,-0.49737,1,0
1,SYNAPSE ORGANIZATION AND BIOGENESIS,0.00036427,-0.6161,-0.55536,1,0
1,GLUTAMATE SIGNALING PATHWAY,5.9841e-06,-0.61894,-0.65116,1,0
1,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,1.4609e-05,-0.62134,-0.59875,1,0
1,REACTOME CHOLESTEROL BIOSYNTHESIS,0.00050664,-0.62227,-0.69874,1,0
1,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,3.1904e-06,-0.62634,-0.69319,1,0
1,POTASSIUM ION TRANSPORT,8.2505e-07,-0.63439,-0.62531,1,0
1,VOLTAGE GATED CATION CHANNEL ACTIVITY,2.5774e-06,-0.64656,-0.62157,1,0
1,CHANNEL REGULATOR ACTIVITY,2.8418e-05,-0.66088,-0.48971,1,0
1,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,1.0311e-06,-0.66377,-0.65868,1,0
1,DIGESTION,0.00032948,-0.67217,-0.59064,1,0
1,REGULATION OF BLOOD PRESSURE,6.5896e-07,-0.67617,-0.71672,1,0
1,CELL RECOGNITION,0.00036427,-0.68367,-0.58834,1,0
1,POTASSIUM CHANNEL ACTIVITY,2.0784e-06,-0.68401,-0.62952,1,0
1,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,2.0033e-05,-0.69225,-0.68371,1,0
1,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,1.0311e-06,-0.69266,-0.65283,1,0
1,POTASSIUM CHANNEL REGULATOR ACTIVITY,7.6603e-06,-0.70615,-0.57403,1,0
1,KEGG TASTE TRANSDUCTION,4.3763e-07,-0.7151,-0.65938,1,0
1,REACTOME POTASSIUM CHANNELS,2.2879e-07,-0.73084,-0.67289,1,0
1,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,9.4334e-07,-0.73564,-0.75644,1,0
1,REACTOME GABA A RECEPTOR ACTIVATION,6.0198e-07,-0.74867,-0.83441,1,0
1,DETECTION OF CHEMICAL STIMULUS,1.7474e-06,-0.7667,-0.66457,1,0
1,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,3.0689e-05,-0.80982,-0.74738,1,0
1,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.4728e-06,-0.81752,-0.85704,1,0
1,BIOCARTA CK1 PATHWAY,7.6603e-06,-0.82125,-0.70931,1,0
1,REACTOME AMINE DERIVED HORMONES,1.4039e-05,-0.82944,-0.68871,1,0
1,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,1.1776e-06,-0.91715,-0.86728,1,0
1,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,2.3654e-06,-0.91852,-0.8726,1,0
1,REACTOME NEUROTRANSMITTER RELEASE CYCLE,1.2366e-07,-0.93501,-0.84095,1,0
1,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,2.8418e-05,-0.9381,-0.71853,1,0
1,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,6.5896e-07,-0.95921,-0.86598,1,0
1,REGULATION OF NEUROTRANSMITTER LEVELS,7.889e-07,-0.97326,-0.86669,1,0
1,GLUTAMATE RECEPTOR ACTIVITY,1.4674e-06,-1.0666,-1.0341,1,0
1,EXOCYTOSIS,1.1237e-07,-1.0772,-0.98327,1,0
1,KEGG TYPE I DIABETES MELLITUS,1.2454e-05,-1.0972,-0.87464,1,0
1,SYNAPTIC VESICLE,1.5691e-07,-1.1086,-0.99508,1,0
1,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,3.4728e-06,-1.1262,-0.96707,1,0
1,REGULATED SECRETORY PATHWAY,1.725e-07,-1.1524,-1.0803,1,0
1,REACTOME CRMPS IN SEMA3A SIGNALING,2.5774e-06,-1.1613,-1.0517,1,0
1,REGULATION OF HORMONE SECRETION,5.8301e-05,-1.1687,-0.84874,1,0
1,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,2.0829e-07,-1.1763,-1.1303,1,0
1,HORMONE SECRETION,2.5308e-05,-1.2877,-0.94243,1,0
1,REACTOME INSULIN SYNTHESIS AND PROCESSING,7.889e-07,-1.2992,-1.0408,1,0
1,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,2.3975e-07,-1.4151,-1.1595,1,0
1,NEUROTRANSMITTER SECRETION,1.2366e-07,-1.4664,-1.3711,1,0
1,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,1.2971e-07,-1.5221,-1.3705,1,0
1,MYELOID LEUKOCYTE DIFFERENTIATION,0.05824,0.54831,0.32524,0,1
1,STRUCTURAL CONSTITUENT OF RIBOSOME,0.049546,0.48645,0.29131,0,1
1,REACTOME PEPTIDE CHAIN ELONGATION,0.063042,0.45839,0.28122,0,1
1,REACTOME INTERFERON GAMMA SIGNALING,0.14769,0.44929,0.27896,0,1
1,KEGG RIBOSOME,0.05824,0.43048,0.26548,0,1
1,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.064293,0.38904,0.21714,0,1
1,BIOCARTA EIF PATHWAY,0.087232,0.38424,0.16984,0,1
1,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.073629,0.37705,0.20663,0,1
1,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.0695,0.36052,0.22873,0,1
1,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.10465,0.35584,0.19668,0,1
1,PID ANTHRAXPATHWAY,0.16294,0.34588,0.24337,0,1
1,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.14769,0.33213,0.25533,0,1
1,REACTOME INFLUENZA LIFE CYCLE,0.049546,0.2978,0.2069,0,1
1,RESPONSE TO VIRUS,0.13814,0.28412,0.12942,0,1
1,RIBOSOME BIOGENESIS AND ASSEMBLY,0.060602,0.27453,0.23058,0,1
1,BIOCARTA KERATINOCYTE PATHWAY,0.05824,0.27314,0.20938,0,1
1,BIOCARTA D4GDI PATHWAY,0.12473,0.26636,0.33918,0,1
1,PID ATF2 PATHWAY,0.12473,0.26078,0.17452,0,1
1,REACTOME ENOS ACTIVATION AND REGULATION,0.055956,0.2405,0.20427,0,1
1,SKELETAL MUSCLE DEVELOPMENT,0.15264,0.23543,0.14846,0,1
1,BIOCARTA SHH PATHWAY,0.095625,0.23249,0.1567,0,1
1,REACTOME DIABETES PATHWAYS,0.16032,0.22937,0.11098,0,1
1,BIOCARTA 41BB PATHWAY,0.38888,0.22845,0.067091,0,1
1,BIOCARTA NUCLEARRS PATHWAY,0.14285,0.22385,0.1049,0,1
1,MONOCARBOXYLIC ACID TRANSPORT,0.18219,0.22059,0.17917,0,1
1,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.064293,0.21994,0.23151,0,1
1,KINETOCHORE,0.047551,0.21763,0.14687,0,1
1,RESPONSE TO OTHER ORGANISM,0.066855,0.2173,0.10692,0,1
1,RRNA PROCESSING,0.10845,0.21559,0.2081,0,1
1,RRNA METABOLIC PROCESS,0.10845,0.21559,0.2081,0,1
1,PID ECADHERIN KERATINOCYTE PATHWAY,0.04854,0.21089,0.21004,0,1
1,BILE ACID METABOLIC PROCESS,0.099158,0.21052,0.10853,0,1
1,LEUKOCYTE DIFFERENTIATION,0.5726,0.2077,0.043774,0,1
1,REGULATION OF TRANSLATIONAL INITIATION,0.065563,0.20613,0.13686,0,1
1,SENSORY ORGAN DEVELOPMENT,0.13355,0.20229,0.092246,0,1
1,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.15015,0.20118,0.20191,0,1
1,CARBOHYDRATE BINDING,0.13814,0.19955,0.15063,0,1
1,MITOCHONDRIAL MEMBRANE,0.065563,0.19361,0.082927,0,1
1,ST P38 MAPK PATHWAY,0.11841,0.19299,0.093306,0,1
1,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.060602,0.19183,0.18826,0,1
1,KEGG PROPANOATE METABOLISM,0.053746,0.19005,0.17555,0,1
1,DOUBLE STRANDED RNA BINDING,0.063042,0.18875,0.12831,0,1
1,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.05161,0.18856,0.15408,0,1
1,SMALL CONJUGATING PROTEIN BINDING,0.076492,0.18825,0.10801,0,1
1,PID TCRCALCIUMPATHWAY,0.27611,0.18773,0.14299,0,1
1,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.052669,0.18749,0.21001,0,1
1,KEGG N GLYCAN BIOSYNTHESIS,0.044685,0.18373,0.10723,0,1
1,ENDONUCLEASE ACTIVITY,0.04854,0.18047,0.11469,0,1
1,IMMUNE SYSTEM PROCESS,0.075049,0.17841,0.13448,0,1
1,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,0.063042,0.17687,0.19842,0,1
1,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.17934,0.17683,0.12561,0,1
1,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.17934,0.17596,0.078065,0,1
1,PID NCADHERINPATHWAY,0.095625,0.17331,0.129,0,1
1,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.25001,0.16966,0.061806,0,1
1,SIG IL4RECEPTOR IN B LYPHOCYTES,0.095625,0.16915,0.10583,0,1
1,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.092194,0.16749,0.10235,0,1
1,ENZYME INHIBITOR ACTIVITY,0.093897,0.16179,0.12763,0,1
1,NUCLEOLUS,0.12689,0.16,0.07536,0,1
1,KEGG RENAL CELL CARCINOMA,0.16559,0.15675,0.084722,0,1
1,LIPID TRANSPORTER ACTIVITY,0.088862,0.15489,0.22449,0,1
1,RNA CATABOLIC PROCESS,0.27227,0.15339,0.083916,0,1
1,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.42347,0.15033,0.071266,0,1
1,CHROMOSOMEPERICENTRIC REGION,0.087232,0.14538,0.11119,0,1
1,BIOPOLYMER BIOSYNTHETIC PROCESS,0.080955,0.14474,0.15385,0,1
1,PID IL2 STAT5PATHWAY,0.4598,0.1433,0.064212,0,1
1,ST G ALPHA I PATHWAY,0.15773,0.14118,0.093631,0,1
1,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.60883,0.14015,0.034068,0,1
1,REACTOME SIGNALING BY RHO GTPASES,0.04854,0.13823,0.098385,0,1
1,ACTIN FILAMENT BUNDLE FORMATION,0.082489,0.13692,0.15557,0,1
1,ISOMERASE ACTIVITY,0.1028,0.13676,0.097859,0,1
1,PID ECADHERIN NASCENTAJ PATHWAY,0.066855,0.1367,0.14685,0,1
1,TRANSLATIONAL INITIATION,0.087232,0.13603,0.11984,0,1
1,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.15264,0.136,0.10432,0,1
1,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.05824,0.13497,0.11064,0,1
1,PID IL2 PI3KPATHWAY,0.17934,0.13194,0.084621,0,1
1,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.16294,0.13081,0.086822,0,1
1,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.072231,0.12751,0.058572,0,1
1,METHYLTRANSFERASE ACTIVITY,0.052669,0.12718,0.097684,0,1
1,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.10465,0.1254,0.087053,0,1
1,REACTOME SYNTHESIS OF DNA,0.065563,0.12302,0.066355,0,1
1,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.10096,0.12256,0.10916,0,1
1,KEGG HISTIDINE METABOLISM,0.25363,0.12217,0.10884,0,1
1,REACTOME PHOSPHORYLATION OF THE APC C,0.087232,0.1212,0.12615,0,1
1,PEROXISOME ORGANIZATION AND BIOGENESIS,0.38408,0.11999,0.03815,0,1
1,ONE CARBON COMPOUND METABOLIC PROCESS,0.0695,0.1176,0.080989,0,1
1,DEOXYRIBONUCLEASE ACTIVITY,0.059411,0.11712,0.11126,0,1
1,BIOCARTA IL2RB PATHWAY,0.29992,0.11581,0.081008,0,1
1,SA PTEN PATHWAY,0.10096,0.1158,0.12245,0,1
1,KEGG TYROSINE METABOLISM,0.53167,0.1156,0.025818,0,1
1,RECEPTOR BINDING,0.10654,0.11559,0.073194,0,1
1,ATP DEPENDENT RNA HELICASE ACTIVITY,0.69707,0.11388,0.036923,0,1
1,PID TCR PATHWAY,0.04854,0.113,0.087342,0,1
1,KEGG SPLICEOSOME,0.2,0.11268,0.059783,0,1
1,DNA DIRECTED RNA POLYMERASE COMPLEX,0.093897,0.1125,0.079527,0,1
1,RNA POLYMERASE COMPLEX,0.093897,0.1125,0.079527,0,1
1,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.093897,0.1125,0.079527,0,1
1,PID PI3KPLCTRKPATHWAY,0.14526,0.11106,0.094375,0,1
1,REACTOME MITOTIC PROMETAPHASE,0.047551,0.11088,0.10332,0,1
1,BIOCARTA NFAT PATHWAY,0.1028,0.10724,0.07912,0,1
1,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,0.50337,0.10674,0.04908,0,1
1,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.16559,0.10581,0.098548,0,1
1,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.14285,0.10205,0.12073,0,1
1,IDENTICAL PROTEIN BINDING,0.16559,0.10191,0.061192,0,1
1,KEGG CELL CYCLE,0.10845,0.099762,0.073628,0,1
1,PID REG GR PATHWAY,0.31232,0.097613,0.09325,0,1
1,REACTOME GLUCOSE METABOLISM,0.095625,0.097155,0.078143,0,1
1,KINASE BINDING,0.25001,0.096417,0.052086,0,1
1,PID CMYB PATHWAY,0.44924,0.096285,0.036831,0,1
1,REACTOME ACTIVATION OF GENES BY ATF4,0.15517,0.092333,0.098927,0,1
1,REACTOME PERK REGULATED GENE EXPRESSION,0.12473,0.091341,0.097876,0,1
1,ENZYME BINDING,0.12473,0.090462,0.044842,0,1
1,ACTIN BINDING,0.3746,0.087371,0.039704,0,1
1,PID AURORA A PATHWAY,0.33373,0.086493,0.06247,0,1
1,SIGNAL TRANSDUCTION,0.15264,0.082981,0.057571,0,1
1,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.068167,0.082725,0.087176,0,1
1,RNA PROCESSING,0.18508,0.082543,0.071985,0,1
1,KEGG VIBRIO CHOLERAE INFECTION,0.17374,0.08116,0.056277,0,1
1,BIOCARTA CARM ER PATHWAY,0.42347,0.080711,0.048319,0,1
1,KEGG ACUTE MYELOID LEUKEMIA,0.21579,0.077043,0.046189,0,1
1,DNA METABOLIC PROCESS,0.076492,0.076997,0.069498,0,1
1,NUCLEAR BODY,0.56075,0.075384,0.051478,0,1
1,DNA INTEGRITY CHECKPOINT,0.62732,0.073061,0.022431,0,1
1,ORGANELLE LUMEN,0.066855,0.071685,0.051069,0,1
1,MEMBRANE ENCLOSED LUMEN,0.066855,0.071685,0.051069,0,1
1,BIOCARTA ATRBRCA PATHWAY,0.26098,0.071561,0.064776,0,1
1,KEGG BASE EXCISION REPAIR,0.11434,0.070439,0.057548,0,1
1,REACTOME SIGNALING BY EGFR IN CANCER,0.39858,0.069889,0.026731,0,1
1,REACTOME DNA REPAIR,0.26847,0.067457,0.041306,0,1
1,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.057089,0.06519,0.089277,0,1
1,KEGG GAP JUNCTION,0.15015,0.063765,0.072088,0,1
1,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.054842,0.063173,0.082167,0,1
1,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.29586,0.061121,0.048153,0,1
1,NUCLEOTIDE EXCISION REPAIR,0.10096,0.059233,0.10455,0,1
1,PURINE NUCLEOTIDE BINDING,0.27227,0.050804,0.034274,0,1
1,GTPASE BINDING,0.51459,0.050674,0.02833,0,1
1,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.188,0.050182,0.13945,0,1
1,RESPONSE TO RADIATION,0.15773,0.045389,0.037823,0,1
1,NUCLEOTIDE BINDING,0.34702,0.042723,0.030393,0,1
1,PURINE RIBONUCLEOTIDE BINDING,0.50896,0.038981,0.020833,0,1
1,PHOSPHOLIPASE C ACTIVATION,0.47588,0.22092,0.035978,0,0
1,POSITIVE REGULATION OF CELL DIFFERENTIATION,0.41341,0.20899,0.11223,0,0
1,BIOCARTA MITOCHONDRIA PATHWAY,0.092194,0.20362,0.21093,0,0
1,REACTOME HS GAG BIOSYNTHESIS,0.066855,0.20357,0.19635,0,0
1,EMBRYONIC MORPHOGENESIS,0.42347,0.20252,0.039786,0,0
1,PROTEIN TETRAMERIZATION,0.090515,0.19313,0.15613,0,0
1,ACTIN FILAMENT POLYMERIZATION,0.1313,0.19295,0.13301,0,0
1,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.072231,0.19235,0.097791,0,0
1,MYELOID CELL DIFFERENTIATION,0.33812,0.18689,0.087299,0,0
1,REACTOME GLUTATHIONE CONJUGATION,0.072231,0.1794,0.17446,0,0
1,REACTOME NCAM1 INTERACTIONS,0.065563,0.1782,0.20027,0,0
1,DEAMINASE ACTIVITY,0.27999,0.17792,0.098756,0,0
1,ICOSANOID METABOLIC PROCESS,0.17099,0.17528,0.1327,0,0
1,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.049546,0.17324,0.14789,0,0
1,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.24288,0.17215,0.1123,0,0
1,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.35153,0.16627,0.14831,0,0
1,KEGG GLUTATHIONE METABOLISM,0.52594,0.16464,0.039893,0,0
1,BIOCARTA GATA3 PATHWAY,0.05824,0.16273,0.12343,0,0
1,EXTRACELLULAR SPACE,0.070855,0.16076,0.16164,0,0
1,BIOCARTA ACTINY PATHWAY,0.082489,0.15915,0.1347,0,0
1,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,0.057089,0.15639,0.2244,0,0
1,PATTERN BINDING,0.29992,0.15302,0.10699,0,0
1,INORGANIC ANION TRANSPORT,0.24288,0.14932,0.12277,0,0
1,KEGG TIGHT JUNCTION,0.077957,0.1488,0.078558,0,0
1,MULTI ORGANISM PROCESS,0.29992,0.14678,0.060955,0,0
1,ANTIGEN BINDING,0.052669,0.14642,0.12225,0,0
1,PID HIF1 TFPATHWAY,0.075049,0.1429,0.26057,0,0
1,REACTOME METABOLISM OF NON CODING RNA,0.10845,0.14193,0.094939,0,0
1,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.088862,0.14146,0.10417,0,0
1,BIOCARTA TOLL PATHWAY,0.34256,0.1414,0.085197,0,0
1,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.13814,0.14018,0.24601,0,0
1,PID BMPPATHWAY,0.36526,0.14011,0.10852,0,0
1,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,0.044685,0.13957,0.13017,0,0
1,REGULATION OF CYTOKINE PRODUCTION,0.53742,0.13597,0.12015,0,0
1,TISSUE REMODELING,0.17374,0.1339,0.17913,0,0
1,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.080955,0.13347,0.087491,0,0
1,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.13583,0.1291,0.1159,0,0
1,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,0.14526,0.12827,0.081604,0,0
1,NOTCH SIGNALING PATHWAY,0.1313,0.12788,0.11441,0,0
1,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.16294,0.12663,0.2146,0,0
1,PID IL8CXCR1 PATHWAY,0.26098,0.12318,0.081845,0,0
1,ORGANELLE OUTER MEMBRANE,0.20309,0.12245,0.073784,0,0
1,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.10096,0.12089,0.31336,0,0
1,REGULATION OF MAP KINASE ACTIVITY,0.057089,0.12043,0.1056,0,0
1,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,0.049546,0.1203,0.077672,0,0
1,EXONUCLEASE ACTIVITY,0.28785,0.12013,0.11499,0,0
1,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.045624,0.12002,0.13934,0,0
1,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.054842,0.11834,0.14055,0,0
1,PID BETACATENIN NUC PATHWAY,0.075049,0.11797,0.13877,0,0
1,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.1028,0.11746,0.11727,0,0
1,EXTRINSIC TO MEMBRANE,0.32938,0.11702,0.083355,0,0
1,REGULATION OF GTPASE ACTIVITY,0.0695,0.11642,0.19591,0,0
1,CYTOSOLIC PART,0.21256,0.11613,0.085658,0,0
1,COENZYME BINDING,0.48678,0.11578,0.021057,0,0
1,DEACETYLASE ACTIVITY,0.16294,0.11502,0.087526,0,0
1,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.67137,0.11433,0.03324,0,0
1,OXIDOREDUCTASE ACTIVITY GO 0016705,0.36526,0.11403,0.054662,0,0
1,INTRINSIC TO ORGANELLE MEMBRANE,0.059411,0.11288,0.099547,0,0
1,POLYSACCHARIDE BINDING,0.43883,0.11219,0.095306,0,0
1,GLYCOSAMINOGLYCAN BINDING,0.43883,0.11219,0.095306,0,0
1,SA TRKA RECEPTOR,0.26847,0.11187,0.1052,0,0
1,HEART DEVELOPMENT,0.12259,0.11096,0.067272,0,0
1,REGULATION OF RAS GTPASE ACTIVITY,0.11434,0.10998,0.085525,0,0
1,PID THROMBIN PAR1 PATHWAY,0.063042,0.10927,0.12036,0,0
1,RIBONUCLEOPROTEIN COMPLEX,0.12473,0.10912,0.071181,0,0
1,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.18508,0.10744,0.11628,0,0
1,REGIONALIZATION,0.79636,0.10652,-0.0071607,0,0
1,BIOCARTA NO1 PATHWAY,0.36064,0.10638,0.053217,0,0
1,REACTOME SIGNALING BY NOTCH3,0.95466,0.10607,-0.025636,0,0
1,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.188,0.10498,0.073738,0,0
1,CELL CORTEX PART,0.16828,0.10478,0.076412,0,0
1,ATP DEPENDENT HELICASE ACTIVITY,0.38888,0.10439,0.061908,0,0
1,KEGG SPHINGOLIPID METABOLISM,0.22905,0.10341,0.049792,0,0
1,SPHINGOLIPID METABOLIC PROCESS,0.4598,0.10267,0.032751,0,0
1,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,0.079444,0.10229,0.1202,0,0
1,REACTOME DOUBLE STRAND BREAK REPAIR,0.1313,0.10215,0.12109,0,0
1,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.62113,0.10116,0.06769,0,0
1,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.36991,0.10063,0.032359,0,0
1,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.14048,0.10037,0.084788,0,0
1,REACTOME PYRUVATE METABOLISM,0.13814,0.10033,0.12469,0,0
1,PID BETACATENIN DEG PATHWAY,0.11235,0.099593,0.080947,0,0
1,PORE COMPLEX,0.073629,0.098888,0.093512,0,0
1,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.22235,0.098304,0.04948,0,0
1,RESPONSE TO UV,0.42347,0.098289,0.042591,0,0
1,KEGG CITRATE CYCLE TCA CYCLE,0.44402,0.096942,0.025657,0,0
1,PML BODY,0.17653,0.096519,0.12918,0,0
1,BIOCARTA P53 PATHWAY,0.18219,0.095883,0.1681,0,0
1,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.075049,0.095662,0.15079,0,0
1,ENVELOPE,0.087232,0.095495,0.049904,0,0
1,ORGANELLE ENVELOPE,0.087232,0.095495,0.049904,0,0
1,REACTOME ACYL CHAIN REMODELLING OF PE,0.71658,0.09521,0.026725,0,0
1,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.29992,0.094727,0.14114,0,0
1,PROTEIN HOMODIMERIZATION ACTIVITY,0.39371,0.094227,0.043052,0,0
1,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.12908,0.094204,0.1136,0,0
1,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.17934,0.094145,0.073029,0,0
1,KEGG TRYPTOPHAN METABOLISM,0.32938,0.093687,0.086139,0,0
1,MAINTENANCE OF LOCALIZATION,0.3746,0.093452,0.078402,0,0
1,GTPASE ACTIVATOR ACTIVITY,0.068167,0.093418,0.12138,0,0
1,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.40843,0.093091,0.041038,0,0
1,MITOCHONDRIAL INNER MEMBRANE,0.53742,0.092977,0.02593,0,0
1,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.088862,0.092428,0.12026,0,0
1,REGULATION OF CELL DIFFERENTIATION,0.50896,0.091815,0.050047,0,0
1,POSITIVE REGULATION OF JNK ACTIVITY,0.32077,0.091787,0.063397,0,0
1,REACTOME ACTIVATED TLR4 SIGNALLING,0.17099,0.091784,0.077061,0,0
1,REACTOME SIGNALING BY FGFR3 MUTANTS,0.34256,0.090695,0.08924,0,0
1,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.17374,0.090323,0.069478,0,0
1,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.56075,0.089693,0.031367,0,0
1,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.40843,0.088725,0.077639,0,0
1,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.44924,0.088709,0.029739,0,0
1,NUCLEAR PORE,0.10654,0.088613,0.099694,0,0
1,PID IL2 1PATHWAY,0.89907,0.088459,-0.024957,0,0
1,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.67776,0.087296,0.013589,0,0
1,INTEGRAL TO ORGANELLE MEMBRANE,0.10096,0.086246,0.094258,0,0
1,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,0.29992,0.086134,0.050976,0,0
1,KEGG INOSITOL PHOSPHATE METABOLISM,0.079444,0.085969,0.087854,0,0
1,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.69707,0.085885,0.029845,0,0
1,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,0.066855,0.085599,0.14163,0,0
1,REGULATION OF JNK ACTIVITY,0.16559,0.085255,0.077354,0,0
1,RNA HELICASE ACTIVITY,0.4598,0.08505,0.068641,0,0
1,KEGG HEDGEHOG SIGNALING PATHWAY,0.29184,0.08473,0.07216,0,0
1,KEGG RNA DEGRADATION,0.50896,0.084284,0.01995,0,0
1,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,0.36526,0.084252,0.06104,0,0
1,N ACYLTRANSFERASE ACTIVITY,0.085627,0.083912,0.088728,0,0
1,N ACETYLTRANSFERASE ACTIVITY,0.085627,0.083912,0.088728,0,0
1,BIOCARTA IGF1 PATHWAY,0.20309,0.083755,0.14394,0,0
1,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.28785,0.083303,0.1022,0,0
1,DEFENSE RESPONSE TO BACTERIUM,0.12473,0.082337,0.059817,0,0
1,ENZYME REGULATOR ACTIVITY,0.11841,0.081818,0.073763,0,0
1,ACTIN CYTOSKELETON,0.25363,0.081644,0.075009,0,0
1,REACTOME APOPTOTIC EXECUTION PHASE,0.14526,0.081357,0.11409,0,0
1,REGULATION OF RHO GTPASE ACTIVITY,0.17374,0.081168,0.062242,0,0
1,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,0.50896,0.080512,0.032542,0,0
1,BIOCARTA IL12 PATHWAY,0.48131,0.079053,0.064754,0,0
1,ST WNT BETA CATENIN PATHWAY,0.22568,0.077945,0.099941,0,0
1,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.23245,0.077695,0.10382,0,0
1,COFACTOR TRANSPORT,0.98255,0.077645,0.00069712,0,0
1,DAMAGED DNA BINDING,0.084046,0.077366,0.12369,0,0
1,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.64605,0.07722,0.03437,0,0
1,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.053746,0.076559,0.066155,0,0
1,REACTOME CELL CYCLE MITOTIC,0.10654,0.076548,0.054848,0,0
1,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.22235,0.076052,0.11587,0,0
1,CELL MIGRATION,0.18219,0.075751,0.097937,0,0
1,NUCLEOTIDE METABOLIC PROCESS,0.10465,0.075241,0.15716,0,0
1,BIOCARTA TPO PATHWAY,0.62732,0.074896,0.060126,0,0
1,CELL JUNCTION,0.13583,0.074558,0.10451,0,0
1,VESICULAR FRACTION,0.39858,0.073774,0.081001,0,0
1,ST GA12 PATHWAY,0.36064,0.073624,0.05066,0,0
1,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,0.84397,0.073047,-0.030804,0,0
1,CELLULAR LIPID METABOLIC PROCESS,0.17653,0.073027,0.02591,0,0
1,KEGG ETHER LIPID METABOLISM,0.77618,0.072746,0.027854,0,0
1,BIOCARTA ETS PATHWAY,0.98953,0.072641,-0.039908,0,0
1,PID LYSOPHOSPHOLIPID PATHWAY,0.16294,0.072244,0.096683,0,0
1,PROTEIN OLIGOMERIZATION,0.32506,0.07208,0.026527,0,0
1,BIOCARTA MAL PATHWAY,0.05824,0.071737,0.08819,0,0
1,GTPASE ACTIVITY,0.17934,0.071625,0.062492,0,0
1,PID ER NONGENOMIC PATHWAY,0.12689,0.071503,0.10386,0,0
1,TRANSCRIPTION REPRESSOR ACTIVITY,0.080955,0.071373,0.079332,0,0
1,REACTOME PI3K CASCADE,0.095625,0.071095,0.074316,0,0
1,BIOCARTA FMLP PATHWAY,0.62732,0.070847,0.018466,0,0
1,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.47588,0.070214,0.018554,0,0
1,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.32506,0.069749,0.051376,0,0
1,CELLULAR LIPID CATABOLIC PROCESS,0.11039,0.06956,0.12628,0,0
1,POSITIVE REGULATION OF TRANSPORT,0.40843,0.06873,0.069507,0,0
1,REACTOME PI 3K CASCADE,0.29184,0.06835,0.023835,0,0
1,SOLUBLE FRACTION,0.0695,0.068302,0.10874,0,0
1,MITOCHONDRIAL MEMBRANE PART,0.78962,0.068203,0.0019309,0,0
1,IMMUNE SYSTEM DEVELOPMENT,0.43367,0.067307,0.048236,0,0
1,REACTOME SYNTHESIS OF PA,0.44924,0.066823,0.075916,0,0
1,LIPOPROTEIN BINDING,0.5726,0.065601,0.037615,0,0
1,PID ENDOTHELINPATHWAY,0.29184,0.064978,0.080581,0,0
1,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,0.34256,0.064725,0.014647,0,0
1,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.050569,0.064431,0.12385,0,0
1,PROTEIN RNA COMPLEX ASSEMBLY,0.71006,0.064377,0.020607,0,0
1,PID NOTCH PATHWAY,0.67137,0.064126,0.03268,0,0
1,THIOLESTER HYDROLASE ACTIVITY,0.50896,0.064092,-0.00057804,0,0
1,LIPID CATABOLIC PROCESS,0.12473,0.063631,0.11919,0,0
1,POSITIVE REGULATION OF DNA BINDING,0.12908,0.063625,0.084052,0,0
1,KINASE ACTIVITY,0.097379,0.063036,0.056094,0,0
1,RNA DEPENDENT ATPASE ACTIVITY,0.67776,0.062999,0.035719,0,0
1,PID HDAC CLASSIII PATHWAY,0.51459,0.062964,0.030099,0,0
1,GABA RECEPTOR ACTIVITY,0.69061,0.062049,-0.11493,0,0
1,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.063042,0.061868,0.073221,0,0
1,REACTOME GLOBAL GENOMIC NER GG NER,0.22235,0.061779,0.057585,0,0
1,TRANSPORT VESICLE,0.33373,0.061443,0.11541,0,0
1,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.26471,0.061248,0.084562,0,0
1,KEGG WNT SIGNALING PATHWAY,0.082489,0.0609,0.085271,0,0
1,REACTOME IL RECEPTOR SHC SIGNALING,0.95466,0.060174,0.010648,0,0
1,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.32938,0.060037,0.045837,0,0
1,REGULATION OF CATALYTIC ACTIVITY,0.04854,0.058016,0.06947,0,0
1,KEGG HOMOLOGOUS RECOMBINATION,0.62732,0.057691,0.028944,0,0
1,PEPTIDE BINDING,0.4598,0.057228,0.0207,0,0
1,ACTIVATION OF JNK ACTIVITY,0.21905,0.057126,0.071821,0,0
1,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.14285,0.056692,0.086835,0,0
1,STRUCTURE SPECIFIC DNA BINDING,0.35607,0.056332,0.09432,0,0
1,MITOCHONDRIAL RESPIRATORY CHAIN,0.53742,0.056313,0.049333,0,0
1,ACTIN FILAMENT BASED PROCESS,0.47049,0.056308,0.034984,0,0
1,ORGAN DEVELOPMENT,0.12689,0.056091,0.11338,0,0
1,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.19393,0.055518,0.059842,0,0
1,KEGG ABC TRANSPORTERS,0.41341,0.055097,0.03968,0,0
1,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.41341,0.055004,0.066092,0,0
1,BIOCARTA MYOSIN PATHWAY,0.80989,0.0547,-0.0061744,0,0
1,REGULATION OF DEFENSE RESPONSE,0.65866,0.053898,0.063496,0,0
1,BIOCARTA CCR3 PATHWAY,0.59664,0.053777,0.043203,0,0
1,REACTOME NUCLEOTIDE EXCISION REPAIR,0.38408,0.05264,0.050368,0,0
1,SIG CHEMOTAXIS,0.62113,0.050976,0.019712,0,0
1,EXTRINSIC TO PLASMA MEMBRANE,0.69707,0.050382,0.036691,0,0
1,PROTEIN BINDING BRIDGING,0.74288,0.049686,0.020281,0,0
1,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.25001,0.049575,0.05172,0,0
1,STEROID METABOLIC PROCESS,0.86455,0.049325,-0.03765,0,0
1,ACETYLTRANSFERASE ACTIVITY,0.075049,0.049292,0.12735,0,0
1,SMALL GTPASE REGULATOR ACTIVITY,0.42347,0.049188,0.046381,0,0
1,KEGG PPAR SIGNALING PATHWAY,0.62113,0.048854,0.017496,0,0
1,OUTER MEMBRANE,0.59059,0.048237,-0.064836,0,0
1,KEGG RNA POLYMERASE,0.69061,0.048193,0.014998,0,0
1,ANATOMICAL STRUCTURE MORPHOGENESIS,0.22235,0.047441,0.063822,0,0
1,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.51459,0.047438,0.011879,0,0
1,REACTOME LYSOSOME VESICLE BIOGENESIS,0.83713,0.047436,-0.057886,0,0
1,BIOCARTA CDMAC PATHWAY,0.24643,0.047431,0.22675,0,0
1,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.87833,0.047417,-0.00488,0,0
1,RESPONSE TO CHEMICAL STIMULUS,0.50896,0.047319,0.054852,0,0
1,REACTOME SIGNALING BY FGFR MUTANTS,0.62732,0.047276,0.029728,0,0
1,APOPTOTIC PROGRAM,0.71658,0.047173,0.026653,0,0
1,BIOPOLYMER MODIFICATION,0.10465,0.047083,0.047928,0,0
1,KEGG ARGININE AND PROLINE METABOLISM,0.50896,0.047046,0.035864,0,0
1,ACTIN FILAMENT ORGANIZATION,0.4545,0.046695,0.047975,0,0
1,CYTOSKELETON,0.54321,0.045886,0.027404,0,0
1,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.57857,0.045621,0.056226,0,0
1,PROTEIN SECRETION,0.2839,0.04551,0.099671,0,0
1,ORGANELLE INNER MEMBRANE,0.85768,0.045418,-0.0021105,0,0
1,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.26098,0.045343,0.038203,0,0
1,PID E2F PATHWAY,0.23245,0.045317,0.063426,0,0
1,PID FOXOPATHWAY,0.8303,0.045147,0.0041035,0,0
1,PROTEIN MODIFICATION PROCESS,0.12473,0.044333,0.044104,0,0
1,PID CXCR4 PATHWAY,0.31232,0.044229,0.054811,0,0
1,ADAPTIVE IMMUNE RESPONSE,0.27611,0.04406,0.20075,0,0
1,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.46512,0.043795,0.032735,0,0
1,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,0.50896,0.043693,0.018326,0,0
1,PID GMCSF PATHWAY,0.87833,0.043452,0.023143,0,0
1,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,0.56666,0.042846,-0.064537,0,0
1,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.94073,0.042711,-0.0095826,0,0
1,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.52025,0.042408,0.054223,0,0
1,REGULATION OF BIOLOGICAL QUALITY,0.35153,0.042143,0.03606,0,0
1,KEGG BASAL TRANSCRIPTION FACTORS,0.22905,0.041484,0.10325,0,0
1,NUCLEAR LUMEN,0.2839,0.040714,0.02047,0,0
1,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.19695,0.040564,0.082268,0,0
1,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.21579,0.040483,0.05728,0,0
1,PID P38ALPHABETADOWNSTREAMPATHWAY,0.79636,0.039884,0.0071483,0,0
1,CELL CYCLE CHECKPOINT GO 0000075,0.29586,0.039853,0.066994,0,0
1,PID WNT NONCANONICAL PATHWAY,0.80312,0.039726,0.019018,0,0
1,BIOCARTA PAR1 PATHWAY,0.98953,0.039455,-0.0087303,0,0
1,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.29992,0.039072,0.085444,0,0
1,REACTOME CELL CYCLE,0.24288,0.038606,0.04078,0,0
1,KEGG CHEMOKINE SIGNALING PATHWAY,0.49227,0.038579,0.047696,0,0
1,PID RAC1 PATHWAY,0.59059,0.038546,0.031388,0,0
1,PID RHOA REG PATHWAY,0.60272,0.03854,0.03161,0,0
1,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.20937,0.038373,0.083596,0,0
1,CASPASE ACTIVATION,0.46512,0.03797,0.060944,0,0
1,INTERPHASE OF MITOTIC CELL CYCLE,0.50337,0.037204,-0.058589,0,0
1,BIOCARTA GH PATHWAY,0.64605,0.036984,0.020126,0,0
1,REACTOME AMYLOIDS,0.65866,0.036564,0.041912,0,0
1,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.90599,0.036532,-0.013719,0,0
1,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.29586,0.036472,0.054802,0,0
1,M PHASE,0.40349,0.035536,0.031524,0,0
1,REPRODUCTIVE PROCESS,0.41842,0.035293,0.04025,0,0
1,REACTOME MICRORNA MIRNA BIOGENESIS,0.52594,0.035251,0.048794,0,0
1,DNA BINDING,0.29586,0.034726,0.031088,0,0
1,POLYSACCHARIDE METABOLIC PROCESS,0.76948,0.034546,0.026858,0,0
1,BIOCARTA NKCELLS PATHWAY,0.63354,0.034205,-0.069159,0,0
1,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.60272,0.03367,0.041474,0,0
1,INTRACELLULAR ORGANELLE PART,0.097379,0.033483,0.033743,0,0
1,HEMOPOIESIS,0.90599,0.033452,-0.009102,0,0
1,HORMONE METABOLIC PROCESS,0.92682,0.03319,-8.4237e-05,0,0
1,BIOCARTA RAS PATHWAY,0.17934,0.032895,0.059482,0,0
1,RNA POLYMERASE ACTIVITY,0.83713,0.032125,0.0083166,0,0
1,ORGANELLE PART,0.10654,0.032105,0.033664,0,0
1,KEGG O GLYCAN BIOSYNTHESIS,0.80989,0.031252,-0.017967,0,0
1,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.16294,0.030258,0.043764,0,0
1,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.88523,0.029555,-0.0078359,0,0
1,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.71658,0.029387,0.027442,0,0
1,MICROSOME,0.8303,0.029335,0.043595,0,0
1,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.75615,0.029006,0.048779,0,0
1,BIOCARTA ERK5 PATHWAY,0.4598,0.028892,0.049736,0,0
1,PHOSPHOLIPID BINDING,0.77618,0.028424,0.0035243,0,0
1,DNA DAMAGE CHECKPOINT,0.54903,0.028255,0.056539,0,0
1,TRANSCRIPTION FACTOR BINDING,0.29992,0.027671,0.031884,0,0
1,REACTOME SIGNALING BY NOTCH2,0.74288,0.027578,0.024617,0,0
1,PHOSPHOLIPID TRANSPORTER ACTIVITY,0.31653,0.027333,0.13395,0,0
1,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.88523,0.027277,0.02743,0,0
1,NON MEMBRANE BOUND ORGANELLE,0.72969,0.026984,0.010492,0,0
1,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.72969,0.026984,0.010492,0,0
1,PID ATM PATHWAY,0.76948,0.026511,-0.019809,0,0
1,REACTOME PKB MEDIATED EVENTS,0.42855,0.026426,0.051179,0,0
1,BIOCARTA INSULIN PATHWAY,0.5726,0.026354,0.056752,0,0
1,UBIQUITIN LIGASE COMPLEX,0.62113,0.025668,0.050695,0,0
1,REACTOME SIGNALING BY ROBO RECEPTOR,0.53167,0.02558,0.060654,0,0
1,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.84397,0.025555,-0.021405,0,0
1,KEGG NUCLEOTIDE EXCISION REPAIR,0.38888,0.02534,0.044721,0,0
1,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,0.47049,0.024528,0.024792,0,0
1,HOMEOSTATIC PROCESS,0.43367,0.024441,0.025271,0,0
1,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.47588,0.024252,0.053061,0,0
1,GOLGI ASSOCIATED VESICLE,0.47049,0.024212,0.047973,0,0
1,SMALL GTPASE BINDING,0.69707,0.023675,0.015221,0,0
1,LOCOMOTORY BEHAVIOR,0.82348,0.023659,0.17994,0,0
1,REACTOME HIV LIFE CYCLE,0.50337,0.023387,0.037101,0,0
1,NITROGEN COMPOUND CATABOLIC PROCESS,0.64605,0.022868,0.036139,0,0
1,TRANSCRIPTION FACTOR COMPLEX,0.95466,0.021836,0.0014586,0,0
1,ACTIN FILAMENT BINDING,0.96163,0.021722,-0.017473,0,0
1,REACTOME SIGNALING BY INSULIN RECEPTOR,0.33812,0.021627,0.024214,0,0
1,PID TRKRPATHWAY,0.51459,0.021256,0.041584,0,0
1,ORGANIC ACID TRANSPORT,0.44402,0.02114,0.063294,0,0
1,CARBOXYLIC ACID TRANSPORT,0.44402,0.02114,0.063294,0,0
1,PID CDC42 PATHWAY,0.29184,0.020836,0.060967,0,0
1,EXTERNAL SIDE OF PLASMA MEMBRANE,0.57857,0.02057,0.055613,0,0
1,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,0.5726,0.020407,0.03221,0,0
1,BIOCARTA ACH PATHWAY,0.97557,0.020267,-0.004953,0,0
1,ESTABLISHMENT OF CELLULAR LOCALIZATION,0.72969,0.020062,0.0032745,0,0
1,KEGG ALZHEIMERS DISEASE,0.54321,0.020015,0.030848,0,0
1,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.9686,0.019457,-0.014957,0,0
1,PERINUCLEAR REGION OF CYTOPLASM,0.80312,0.01935,0.02953,0,0
1,REACTOME TRNA AMINOACYLATION,0.24288,0.019134,0.1129,0,0
1,PLASMA MEMBRANE PART,0.8303,0.019093,0.0083372,0,0
1,NUCLEAR EXPORT,0.62113,0.01865,-0.057961,0,0
1,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.62113,0.018364,0.020588,0,0
1,BIOCARTA CXCR4 PATHWAY,0.87144,0.018287,-0.010043,0,0
1,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.67776,0.018096,0.015309,0,0
1,BASE EXCISION REPAIR,0.85082,0.017911,0.0012595,0,0
1,ADENYL NUCLEOTIDE BINDING,0.69707,0.01765,0.0095602,0,0
1,TRANSCRIPTION ACTIVATOR ACTIVITY,0.54321,0.017382,0.022406,0,0
1,INTEGRAL TO PLASMA MEMBRANE,0.63978,0.017185,0.019417,0,0
1,REACTOME CELL JUNCTION ORGANIZATION,0.93377,0.017149,-0.0041902,0,0
1,CELLULAR LOCALIZATION,0.73628,0.016921,0.0022085,0,0
1,MEMBRANE,0.54903,0.016679,0.017418,0,0
1,PID P53REGULATIONPATHWAY,0.83713,0.016376,0.011393,0,0
1,REACTOME STEROID HORMONES,0.61497,0.016205,0.020578,0,0
1,VITAMIN TRANSPORT,0.67776,0.015995,0.033837,0,0
1,KEGG MAPK SIGNALING PATHWAY,0.34256,0.015971,0.043461,0,0
1,INTRINSIC TO PLASMA MEMBRANE,0.74288,0.015902,0.016214,0,0
1,CARBOHYDRATE KINASE ACTIVITY,0.51459,0.015206,-0.070484,0,0
1,ST WNT CA2 CYCLIC GMP PATHWAY,0.64605,0.014378,0.014743,0,0
1,LAMELLIPODIUM,1,0.014317,0.014421,0,0
1,TRANSCRIPTION COREPRESSOR ACTIVITY,0.31653,0.013836,0.061359,0,0
1,MEMBRANE PART,0.62113,0.013639,0.01572,0,0
1,PLASMA MEMBRANE,0.94073,0.013486,0.00055518,0,0
1,CELL CORTEX,0.84397,0.013234,0.021382,0,0
1,RESPONSE TO ENDOGENOUS STIMULUS,0.76948,0.012719,-0.011129,0,0
1,SERINE HYDROLASE ACTIVITY,0.59059,0.012425,0.015703,0,0
1,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.76948,0.012342,0.049818,0,0
1,DNA HELICASE ACTIVITY,0.71006,0.012023,0.025433,0,0
1,FEMALE PREGNANCY,0.90599,0.011897,-0.016059,0,0
1,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.98255,0.011727,0.039661,0,0
1,BIOCARTA CALCINEURIN PATHWAY,0.98255,0.011655,-0.010373,0,0
1,BIOCARTA CELLCYCLE PATHWAY,0.36526,0.011497,0.05068,0,0
1,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.97557,0.010552,-0.0094978,0,0
1,REACTOME RNA POL II TRANSCRIPTION,0.19695,0.010496,0.079439,0,0
1,REACTOME INFLAMMASOMES,0.76948,0.01028,-0.014366,0,0
1,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.81668,0.0097164,0.064324,0,0
1,KEGG NOTCH SIGNALING PATHWAY,0.74288,0.0095793,-0.019749,0,0
1,ATP BINDING,0.59059,0.0088486,0.019551,0,0
1,NUCLEAR PART,0.85082,0.0086394,0.0018123,0,0
1,KEGG PRION DISEASES,0.58456,0.0085297,0.098882,0,0
1,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.82348,0.0083625,0.028398,0,0
1,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.91293,0.0080877,-0.0082385,0,0
1,BIOCARTA IGF1R PATHWAY,0.96163,0.0077213,-0.0033542,0,0
1,NUCLEOPLASM,0.69707,0.0075483,0.0021554,0,0
1,RESPONSE TO ABIOTIC STIMULUS,0.84397,0.0068915,-0.013161,0,0
1,REACTOME SPRY REGULATION OF FGF SIGNALING,0.4598,0.0066362,0.06585,0,0
1,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.54321,0.0062202,0.087326,0,0
1,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.33812,0.0058474,0.071134,0,0
1,INTERPHASE,0.50337,0.0057371,-0.056498,0,0
1,PID P38 MK2PATHWAY,0.68418,0.0055984,0.026815,0,0
1,CELLULAR RESPONSE TO STIMULUS,0.87833,0.0054742,-0.012946,0,0
1,KEGG INSULIN SIGNALING PATHWAY,0.93377,0.004932,0.0016439,0,0
1,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.89215,0.0047848,0.0039644,0,0
1,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,0.73628,0.0047163,0.018879,0,0
1,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.8303,0.0040708,0.010149,0,0
1,PID EPOPATHWAY,0.54321,0.003993,0.037627,0,0
1,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,0.81668,0.0036875,-0.021343,0,0
1,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.96163,0.0034791,0.0048315,0,0
1,TRANSCRIPTION COFACTOR ACTIVITY,0.95466,0.0033162,-0.0059781,0,0
1,CHROMOSOME CONDENSATION,0.98953,0.0032202,-0.011536,0,0
1,BIOCARTA ATM PATHWAY,0.4545,0.0020132,0.032187,0,0
1,REACTOME SIGNALING BY FGFR,0.94769,0.0019839,-0.0017877,0,0
1,PYROPHOSPHATASE ACTIVITY,0.87833,0.0019687,0.0073544,0,0
1,REACTOME RAP1 SIGNALLING,0.70355,0.0019107,-0.033606,0,0
1,SINGLE STRANDED DNA BINDING,0.38888,0.0018633,0.10158,0,0
1,ALCOHOL METABOLIC PROCESS,0.57857,0.00181,0.0090911,0,0
1,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.63978,0.0014818,0.027714,0,0
1,PID CDC42 REG PATHWAY,0.69707,0.0011834,0.022625,0,0
1,BIOCARTA AT1R PATHWAY,0.80989,0.00064519,0.063168,0,0
1,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,0.92682,0.0005183,0.010186,0,0
1,REACTOME ACYL CHAIN REMODELLING OF PC,0.61497,0.00049369,0.034953,0,0
1,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.85082,0.00038616,-0.012619,0,0
1,VESICLE MEDIATED TRANSPORT,0.82348,0.0003673,0.00090214,0,0
1,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.8303,0.00025977,0.04068,0,0
1,POSITIVE REGULATION OF T CELL ACTIVATION,0.53742,7.2567e-05,0.12936,0,0
1,KEGG PURINE METABOLISM,0.69707,-0.00045228,0.014239,0,0
1,REACTOME SIGNALING BY NOTCH1,0.63978,-0.00063566,-0.028768,0,0
1,BIOCARTA RAC1 PATHWAY,0.39858,-0.00070491,0.044969,0,0
1,SPLICEOSOME,0.98255,-0.0011216,0.0072523,0,0
1,CYTOKINE SECRETION,0.53742,-0.0013137,0.10451,0,0
1,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.83713,-0.0015977,-0.024696,0,0
1,MACROMOLECULAR COMPLEX,0.83713,-0.0016979,0.0062396,0,0
1,RECEPTOR ACTIVITY,0.83713,-0.0018078,0.0039627,0,0
1,PID IL8CXCR2 PATHWAY,0.83713,-0.001881,-0.0085518,0,0
1,PID MET PATHWAY,0.4978,-0.0020513,0.04715,0,0
1,REACTOME PHOSPHOLIPID METABOLISM,0.85082,-0.0028055,-0.0034635,0,0
1,REGULATION OF IMMUNE SYSTEM PROCESS,0.80989,-0.0030693,0.032454,0,0
1,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.96163,-0.0031679,-0.0037075,0,0
1,NEGATIVE REGULATION OF CELL PROLIFERATION,0.35153,-0.0037958,0.053667,0,0
1,ORGANELLE LOCALIZATION,0.86455,-0.0044942,-0.034554,0,0
1,REACTOME SIGNALING BY ERBB2,0.65866,-0.0048513,0.01502,0,0
1,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.85082,-0.0049723,0.011421,0,0
1,BIOCARTA CHREBP2 PATHWAY,0.4598,-0.0050253,-0.052064,0,0
1,CHEMICAL HOMEOSTASIS,0.9686,-0.0052054,0.00056794,0,0
1,RAS GTPASE BINDING,0.56075,-0.00584,0.030371,0,0
1,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.92682,-0.0058728,0.00096994,0,0
1,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.82348,-0.0058954,0.03547,0,0
1,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.7495,-0.0059048,-0.014704,0,0
1,BIOCARTA FCER1 PATHWAY,0.40843,-0.0062046,-0.072211,0,0
1,INTEGRAL TO MEMBRANE,0.67776,-0.0065069,0.016513,0,0
1,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.36991,-0.0070983,0.042186,0,0
1,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.47588,-0.0079164,0.061838,0,0
1,PROTEIN KINASE BINDING,0.69061,-0.007943,-0.015549,0,0
1,HISTONE DEACETYLASE COMPLEX,0.86455,-0.0079532,-0.019392,0,0
1,LEUKOCYTE ACTIVATION,0.76281,-0.0079563,-0.02322,0,0
1,INTRINSIC TO MEMBRANE,0.75615,-0.007999,0.01496,0,0
1,REACTOME G ALPHA Q SIGNALLING EVENTS,0.63978,-0.0083738,-0.033047,0,0
1,KEGG VEGF SIGNALING PATHWAY,0.98953,-0.0087732,-0.0012013,0,0
1,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.91293,-0.0092115,0.0074637,0,0
1,G1 PHASE OF MITOTIC CELL CYCLE,0.90599,-0.0092509,0.0044913,0,0
1,PROTEIN COMPLEX,0.88523,-0.0095165,-0.0019742,0,0
1,AMINO ACID CATABOLIC PROCESS,0.64605,-0.0101,0.046543,0,0
1,PID NFAT 3PATHWAY,0.78289,-0.01017,-0.023228,0,0
1,NUCLEAR MEMBRANE PART,0.60883,-0.010207,0.029597,0,0
1,SERINE TYPE PEPTIDASE ACTIVITY,0.80989,-0.010207,0.00047755,0,0
1,PID EPHBFWDPATHWAY,0.67776,-0.010654,0.040241,0,0
1,REACTOME MRNA PROCESSING,0.54903,-0.010675,0.036586,0,0
1,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.65866,-0.010847,-0.0097715,0,0
1,RESPONSE TO LIGHT STIMULUS,0.96163,-0.010936,0.0081278,0,0
1,PID BCR 5PATHWAY,0.92682,-0.011893,0.01325,0,0
1,REACTOME MRNA SPLICING MINOR PATHWAY,0.76948,-0.012323,0.03165,0,0
1,DNA RECOMBINATION,0.78962,-0.012981,0.037175,0,0
1,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.72969,-0.013066,0.16047,0,0
1,NEGATIVE REGULATION OF ANGIOGENESIS,0.76948,-0.013196,0.06434,0,0
1,PID HEDGEHOG GLIPATHWAY,0.31653,-0.013272,-0.067115,0,0
1,NUCLEOPLASM PART,0.65866,-0.013353,-0.021859,0,0
1,REGULATION OF T CELL ACTIVATION,0.64605,-0.014086,0.059916,0,0
1,SIG CD40PATHWAYMAP,0.89907,-0.014545,-0.00041009,0,0
1,REACTOME KINESINS,0.59059,-0.014754,-0.043757,0,0
1,REACTOME GAB1 SIGNALOSOME,0.87833,-0.014793,0.01292,0,0
1,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.76281,-0.015006,0.01252,0,0
1,REACTOME RNA POL III TRANSCRIPTION,0.96163,-0.015182,0.0081636,0,0
1,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.89215,-0.015278,0.036093,0,0
1,MITOTIC SISTER CHROMATID SEGREGATION,0.81668,-0.016323,-0.020384,0,0
1,CYTOSKELETAL PROTEIN BINDING,0.64605,-0.016529,-0.024912,0,0
1,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.94769,-0.016657,0.020012,0,0
1,REACTOME SEMAPHORIN INTERACTIONS,0.98953,-0.016773,0.0075223,0,0
1,SISTER CHROMATID SEGREGATION,0.68418,-0.016929,-0.028555,0,0
1,PID P38 MKK3 6PATHWAY,0.9686,-0.017515,0.025412,0,0
1,REACTOME G2 M CHECKPOINTS,0.61497,-0.017583,-0.051523,0,0
1,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.22905,-0.017649,-0.076326,0,0
1,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.82348,-0.017693,-0.017409,0,0
1,PID PI3KCIPATHWAY,0.62732,-0.018399,-0.040379,0,0
1,TRANSCRIPTION COACTIVATOR ACTIVITY,0.4598,-0.018493,-0.044648,0,0
1,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,0.74288,-0.018675,-0.049291,0,0
1,REACTOME AXON GUIDANCE,0.94769,-0.020246,-0.0065754,0,0
1,REACTOME ELONGATION ARREST AND RECOVERY,0.97557,-0.021472,0.048885,0,0
1,CYTOSKELETAL PART,0.49227,-0.021574,-0.022013,0,0
1,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.91293,-0.022211,-0.00036703,0,0
1,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.92682,-0.02222,0.021253,0,0
1,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.23937,-0.022264,-0.099081,0,0
1,PROTEIN C TERMINUS BINDING,0.92682,-0.022344,-0.0029674,0,0
1,ORGANELLE ORGANIZATION AND BIOGENESIS,0.95466,-0.022831,0.0024221,0,0
1,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.93377,-0.023166,0.0058356,0,0
1,NUCLEASE ACTIVITY,0.4978,-0.023186,0.03493,0,0
1,BIOCARTA CCR5 PATHWAY,0.68418,-0.023213,-0.081066,0,0
1,PID FASPATHWAY,0.78289,-0.023374,0.045346,0,0
1,BIOCARTA PLCE PATHWAY,0.85768,-0.023491,0.030299,0,0
1,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,0.52025,-0.023693,-0.068151,0,0
1,REACTOME FANCONI ANEMIA PATHWAY,0.72313,-0.023765,-0.033768,0,0
1,GALACTOSYLTRANSFERASE ACTIVITY,0.26471,-0.024276,-0.11429,0,0
1,REACTOME MRNA SPLICING,0.89907,-0.024547,0.0021864,0,0
1,GTPASE REGULATOR ACTIVITY,0.71658,-0.024599,-0.013677,0,0
1,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.56075,-0.02499,-0.04078,0,0
1,REACTOME REGULATORY RNA PATHWAYS,0.94073,-0.025051,-0.0004317,0,0
1,THYROID HORMONE RECEPTOR BINDING,0.76281,-0.025134,0.051916,0,0
1,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.47049,-0.025403,-0.061984,0,0
1,ADENYL RIBONUCLEOTIDE BINDING,0.72313,-0.02546,-0.0087727,0,0
1,PID ERBB2ERBB3PATHWAY,0.63978,-0.026079,-0.024854,0,0
1,INTERCELLULAR JUNCTION,0.99651,-0.026306,-0.0003491,0,0
1,KEGG STEROID HORMONE BIOSYNTHESIS,0.84397,-0.026331,-0.046847,0,0
1,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.40843,-0.02653,-0.046065,0,0
1,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.5726,-0.027647,-0.013092,0,0
1,IMMUNE EFFECTOR PROCESS,0.65866,-0.027952,-0.038865,0,0
1,S PHASE,0.76281,-0.028401,-0.03844,0,0
1,PID KITPATHWAY,0.85082,-0.028455,-0.0062043,0,0
1,REACTOME SIGNAL AMPLIFICATION,0.37932,-0.029079,-0.056331,0,0
1,KEGG LYSINE DEGRADATION,0.91987,-0.029547,0.028274,0,0
1,ACTIN FILAMENT BASED MOVEMENT,0.63354,-0.029727,0.075301,0,0
1,PID LKB1 PATHWAY,0.4598,-0.029787,-0.035125,0,0
1,CALCIUM ION BINDING,0.90599,-0.030147,0.0068204,0,0
1,BIOCARTA TCR PATHWAY,0.67137,-0.030853,-0.039696,0,0
1,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.39371,-0.031026,-0.085821,0,0
1,REACTOME SIGNALING BY FGFR IN DISEASE,0.34256,-0.031377,-0.027443,0,0
1,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.89215,-0.031537,0.0010889,0,0
1,RESPONSE TO DNA DAMAGE STIMULUS,0.27999,-0.032382,-0.04591,0,0
1,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.69707,-0.033042,-0.023256,0,0
1,CELL CYCLE PHASE,0.73628,-0.033731,-0.010782,0,0
1,CARBOHYDRATE METABOLIC PROCESS,0.41341,-0.033927,-0.043293,0,0
1,REACTOME SIGNALING BY NOTCH,0.94769,-0.034401,0.0072887,0,0
1,G PROTEIN COUPLED RECEPTOR BINDING,0.42347,-0.035838,0.22335,0,0
1,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.64605,-0.036012,-0.013471,0,0
1,REACTOME CHROMOSOME MAINTENANCE,0.4598,-0.036737,-0.050461,0,0
1,PHOSPHOLIPASE ACTIVITY,0.31232,-0.037018,-0.066339,0,0
1,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.98953,-0.037408,-0.007648,0,0
1,CELL CYCLE PROCESS,0.85768,-0.037719,-0.006933,0,0
1,BIOCARTA NGF PATHWAY,0.9686,-0.038612,0.015073,0,0
1,PID RET PATHWAY,0.68418,-0.038853,-0.022474,0,0
1,RESPONSE TO EXTRACELLULAR STIMULUS,0.15264,-0.03933,-0.10581,0,0
1,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.71006,-0.039493,-0.0048623,0,0
1,PID HIF1APATHWAY,0.66501,-0.039618,-0.068729,0,0
1,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.65234,-0.039781,-0.044972,0,0
1,KEGG CALCIUM SIGNALING PATHWAY,0.15517,-0.040184,-0.062525,0,0
1,PID BARD1PATHWAY,0.87144,-0.040319,0.020147,0,0
1,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,0.59059,-0.040354,-0.030689,0,0
1,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.98953,-0.040379,0.0037388,0,0
1,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.87144,-0.040443,-0.010772,0,0
1,KEGG OXIDATIVE PHOSPHORYLATION,0.71006,-0.040686,-0.023666,0,0
1,SENSORY PERCEPTION,0.38408,-0.040869,-0.048713,0,0
1,NUCLEAR MEMBRANE,0.98953,-0.041068,0.0099251,0,0
1,ST G ALPHA S PATHWAY,0.36064,-0.041358,-0.037872,0,0
1,PID ERBB1 INTERNALIZATION PATHWAY,0.56666,-0.041641,-0.035935,0,0
1,KEGG CARDIAC MUSCLE CONTRACTION,0.58456,-0.041908,-0.041538,0,0
1,REACTOME GLYCOLYSIS,0.94769,-0.042811,0.0054878,0,0
1,MEMBRANE LIPID METABOLIC PROCESS,0.20937,-0.043026,-0.073987,0,0
1,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.21579,-0.043112,-0.0882,0,0
1,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.48678,-0.043946,-0.022385,0,0
1,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.11039,-0.044094,-0.10249,0,0
1,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.82348,-0.044287,-0.0040124,0,0
1,REACTOME SIGNALING BY NODAL,0.43883,-0.044583,-0.059011,0,0
1,BIOCARTA HDAC PATHWAY,0.79636,-0.045603,0.0014071,0,0
1,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.21579,-0.045611,-0.19579,0,0
1,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.38408,-0.04579,-0.059638,0,0
1,REACTOME GLUCOSE TRANSPORT,0.26471,-0.045826,-0.089794,0,0
1,REACTOME NEPHRIN INTERACTIONS,0.40349,-0.046144,-0.041702,0,0
1,AMINE CATABOLIC PROCESS,0.89907,-0.04631,-0.0061253,0,0
1,CELL ACTIVATION,0.44402,-0.046376,-0.051034,0,0
1,PID AJDISS 2PATHWAY,0.56666,-0.046527,-0.046864,0,0
1,REACTOME TRANSCRIPTION,0.73628,-0.047041,-0.0031323,0,0
1,REACTOME SIGNAL TRANSDUCTION BY L1,0.40349,-0.047268,-0.052444,0,0
1,LYMPHOCYTE ACTIVATION,0.4978,-0.047294,-0.040181,0,0
1,AMINO ACID TRANSPORT,0.93377,-0.047342,0.021858,0,0
1,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.79636,-0.047638,-0.0125,0,0
1,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.2839,-0.048315,-0.053931,0,0
1,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.11039,-0.048405,-0.12373,0,0
1,CHROMOSOME SEGREGATION,0.33812,-0.048415,-0.051521,0,0
1,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.66501,-0.049474,-0.021206,0,0
1,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.69061,-0.049786,-0.02437,0,0
1,DEPHOSPHORYLATION,0.18219,-0.049859,-0.063782,0,0
1,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.72969,-0.05006,-0.033173,0,0
1,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.95466,-0.050278,0.056125,0,0
1,KEGG MELANOGENESIS,0.59664,-0.0503,-0.027737,0,0
1,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.60272,-0.050332,-0.056012,0,0
1,MEDIATOR COMPLEX,0.40843,-0.050409,-0.085831,0,0
1,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.59664,-0.050499,-0.01614,0,0
1,CARBOHYDRATE TRANSPORT,0.97557,-0.05051,-0.0063436,0,0
1,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.14769,-0.050703,-0.11859,0,0
1,DNA CATABOLIC PROCESS,0.42855,-0.051111,-0.066615,0,0
1,REPRODUCTION,0.087232,-0.051401,-0.078236,0,0
1,KEGG REGULATION OF AUTOPHAGY,0.94073,-0.05165,-0.00029104,0,0
1,TRANSCRIPTION FACTOR ACTIVITY,0.65234,-0.052168,-0.018299,0,0
1,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.30402,-0.052931,-0.039891,0,0
1,BIOCARTA BIOPEPTIDES PATHWAY,0.32077,-0.053355,-0.044308,0,0
1,REACTOME DEVELOPMENTAL BIOLOGY,0.62113,-0.053633,-0.025631,0,0
1,INACTIVATION OF MAPK ACTIVITY,0.47049,-0.053891,-0.080136,0,0
1,PID MAPKTRKPATHWAY,0.82348,-0.054108,-0.021023,0,0
1,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.52025,-0.054286,-0.041229,0,0
1,AEROBIC RESPIRATION,0.31653,-0.055245,-0.068644,0,0
1,ADENYLATE CYCLASE ACTIVATION,0.94073,-0.055271,-0.017489,0,0
1,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.56666,-0.05579,-0.041884,0,0
1,CELLULAR RESPIRATION,0.1028,-0.055819,-0.12306,0,0
1,KEGG ERBB SIGNALING PATHWAY,0.39858,-0.056646,-0.034237,0,0
1,REACTOME GLUCONEOGENESIS,0.18219,-0.056705,-0.10979,0,0
1,PID ATR PATHWAY,0.4598,-0.05744,-0.10029,0,0
1,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.43367,-0.057659,-0.060298,0,0
1,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.88523,-0.057684,-0.0029518,0,0
1,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.24288,-0.058153,-0.1282,0,0
1,DETECTION OF EXTERNAL STIMULUS,0.23937,-0.058703,-0.074788,0,0
1,KEGG GNRH SIGNALING PATHWAY,0.16559,-0.061292,-0.080436,0,0
1,CELLULAR HOMEOSTASIS,0.15773,-0.06213,-0.08167,0,0
1,BIOCARTA CFTR PATHWAY,0.39371,-0.0628,-0.087786,0,0
1,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.1028,-0.062897,-0.10152,0,0
1,TRANSMEMBRANE RECEPTOR ACTIVITY,0.19695,-0.063296,-0.051551,0,0
1,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.72969,-0.06337,-0.025155,0,0
1,ESTABLISHMENT OF LOCALIZATION,0.046579,-0.063795,-0.058315,0,0
1,REACTOME MITOTIC G2 G2 M PHASES,0.05824,-0.063814,-0.094234,0,0
1,PATTERN SPECIFICATION PROCESS,0.65866,-0.064239,-0.019808,0,0
1,INSOLUBLE FRACTION,0.41341,-0.064516,-0.031636,0,0
1,PID S1P S1P4 PATHWAY,0.4978,-0.065447,-0.041132,0,0
1,N METHYLTRANSFERASE ACTIVITY,0.68418,-0.065554,0.043543,0,0
1,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.63354,-0.067223,-0.023486,0,0
1,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.1028,-0.067543,-0.092574,0,0
1,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.41842,-0.067722,-0.085869,0,0
1,CENTROSOME ORGANIZATION AND BIOGENESIS,0.85082,-0.067825,-0.011983,0,0
1,SIG BCR SIGNALING PATHWAY,0.34256,-0.06783,-0.076719,0,0
1,CATION HOMEOSTASIS,0.27227,-0.068213,-0.065473,0,0
1,CHROMATIN BINDING,0.35607,-0.06846,-0.070801,0,0
1,COFACTOR BINDING,0.088862,-0.068569,-0.16659,0,0
1,SA G1 AND S PHASES,0.25729,-0.068578,-0.066996,0,0
1,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.30815,-0.069039,-0.11664,0,0
1,CELLULAR CATION HOMEOSTASIS,0.21905,-0.069162,-0.073855,0,0
1,REGULATION OF PROTEIN SECRETION,0.90599,-0.069566,0.050138,0,0
1,PID TCRJNKPATHWAY,0.14048,-0.069654,-0.1203,0,0
1,EXOPEPTIDASE ACTIVITY,0.40349,-0.070157,-0.063473,0,0
1,KEGG DNA REPLICATION,0.16559,-0.070222,-0.11657,0,0
1,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.74288,-0.070806,-0.027273,0,0
1,PID CONE PATHWAY,0.093897,-0.071406,-0.10599,0,0
1,REACTOME G ALPHA Z SIGNALLING EVENTS,0.27227,-0.071722,-0.078225,0,0
1,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.27611,-0.071954,-0.079575,0,0
1,REACTOME MRNA 3 END PROCESSING,0.44402,-0.072059,-0.027399,0,0
1,PID FANCONI PATHWAY,0.27999,-0.072877,-0.091598,0,0
1,REACTOME GPCR LIGAND BINDING,0.21579,-0.073072,-0.051287,0,0
1,NUCLEAR ENVELOPE,0.17374,-0.073098,-0.05521,0,0
1,PHOSPHOLIPASE C ACTIVITY,0.44402,-0.073245,-0.069604,0,0
1,TRANS GOLGI NETWORK,0.25363,-0.07325,-0.062347,0,0
1,GLAND DEVELOPMENT,0.67776,-0.073342,-0.076695,0,0
1,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.95466,-0.073404,0.029183,0,0
1,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.43883,-0.073456,-0.10448,0,0
1,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.83713,-0.073691,0.00086437,0,0
1,ATPASE ACTIVITY,0.082489,-0.073735,-0.057922,0,0
1,DNA REPAIR,0.17374,-0.073923,-0.056734,0,0
1,NUCLEAR ORGANIZATION AND BIOGENESIS,0.054842,-0.073945,-0.1232,0,0
1,CORTICAL CYTOSKELETON,0.57857,-0.074238,-0.042483,0,0
1,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.2,-0.07486,-0.070579,0,0
1,HUMORAL IMMUNE RESPONSE,0.92682,-0.074886,0.053103,0,0
1,DNA DEPENDENT ATPASE ACTIVITY,0.52025,-0.075017,-0.030118,0,0
1,REGULATION OF TRANSPORT,0.40843,-0.075055,-0.058421,0,0
1,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.53742,-0.076568,0.0053352,0,0
1,CELL PROJECTION,0.16294,-0.076569,-0.078014,0,0
1,SECOND MESSENGER MEDIATED SIGNALING,0.16559,-0.077006,-0.067462,0,0
1,PID IL3 PATHWAY,0.36991,-0.07756,-0.10452,0,0
1,HELICASE ACTIVITY,0.28785,-0.077762,-0.03953,0,0
1,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,0.24288,-0.078196,-0.05097,0,0
1,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.068167,-0.078401,-0.092362,0,0
1,BIOCARTA AGPCR PATHWAY,0.37932,-0.079274,-0.069439,0,0
1,REACTOME SIGNALING BY GPCR,0.049546,-0.079343,-0.080819,0,0
1,MRNA BINDING,0.14048,-0.079562,-0.10889,0,0
1,REACTOME ERK MAPK TARGETS,0.59664,-0.080124,-0.036361,0,0
1,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.052669,-0.080364,-0.09544,0,0
1,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.18508,-0.08062,-0.16119,0,0
1,TRANSCRIPTION INITIATION,0.085627,-0.080655,-0.071079,0,0
1,INNATE IMMUNE RESPONSE,0.24643,-0.081482,-0.11945,0,0
1,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.1313,-0.08188,-0.11793,0,0
1,CHROMOSOMAL PART,0.075049,-0.083179,-0.083492,0,0
1,LIPASE ACTIVITY,0.15773,-0.083183,-0.076447,0,0
1,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.12473,-0.084013,-0.13424,0,0
1,INSULIN RECEPTOR SIGNALING PATHWAY,0.14048,-0.084191,-0.12922,0,0
1,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.68418,-0.0843,-0.045747,0,0
1,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.68418,-0.0843,-0.045747,0,0
1,RNA SPLICING,0.13583,-0.084558,-0.049114,0,0
1,REACTOME TIE2 SIGNALING,0.55487,-0.084831,0.028768,0,0
1,REGULATION OF HEART CONTRACTION,0.32077,-0.085131,-0.067113,0,0
1,ION HOMEOSTASIS,0.12908,-0.085235,-0.085529,0,0
1,DEVELOPMENTAL MATURATION,0.52594,-0.085246,-0.065117,0,0
1,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.12473,-0.085398,-0.073833,0,0
1,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.21579,-0.0855,-0.063925,0,0
1,REACTOME G ALPHA I SIGNALLING EVENTS,0.20309,-0.086443,-0.035958,0,0
1,REACTOME SIGNALLING BY NGF,0.04854,-0.087193,-0.062746,0,0
1,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.16828,-0.08782,-0.080018,0,0
1,REACTOME INSULIN RECEPTOR RECYCLING,0.23245,-0.088529,-0.12174,0,0
1,BIOCARTA PYK2 PATHWAY,0.74288,-0.088975,0.013851,0,0
1,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.33812,-0.089605,-0.037785,0,0
1,BIOCARTA GLEEVEC PATHWAY,0.52025,-0.090651,-0.06022,0,0
1,PHOSPHATASE REGULATOR ACTIVITY,0.37932,-0.091101,-0.034449,0,0
1,ATPASE ACTIVITY COUPLED,0.049546,-0.091873,-0.079959,0,0
1,BIOCARTA BCR PATHWAY,0.38408,-0.093622,-0.069764,0,0
1,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.44402,-0.093835,-0.057747,0,0
1,REACTOME GPCR DOWNSTREAM SIGNALING,0.053746,-0.093891,-0.079944,0,0
1,PID AR TF PATHWAY,0.20309,-0.094848,-0.062445,0,0
1,BEHAVIOR,0.4545,-0.095081,0.0034322,0,0
1,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.23937,-0.095373,-0.087633,0,0
1,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.12473,-0.096587,-0.069801,0,0
1,REACTOME EXTENSION OF TELOMERES,0.25001,-0.097365,-0.10585,0,0
1,SH2 DOMAIN BINDING,0.32938,-0.097501,-0.12668,0,0
1,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.093897,-0.097963,-0.22161,0,0
1,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,0.35607,-0.0981,-0.073637,0,0
1,CONDENSED CHROMOSOME,0.35607,-0.098814,-0.066857,0,0
1,REGULATION OF NEUROGENESIS,0.59664,-0.10025,-0.088854,0,0
1,SYNAPSE PART,0.087232,-0.10097,-0.13322,0,0
1,BIOCARTA SPPA PATHWAY,0.33812,-0.10172,-0.045561,0,0
1,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.11235,-0.10173,-0.12307,0,0
1,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.51459,-0.10179,-0.034087,0,0
1,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.51459,-0.10179,-0.034087,0,0
1,ER NUCLEAR SIGNALING PATHWAY,0.14526,-0.10209,-0.093489,0,0
1,PID PI3KCIAKTPATHWAY,0.087232,-0.1023,-0.12019,0,0
1,KEGG PARKINSONS DISEASE,0.12689,-0.1026,-0.081744,0,0
1,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.27227,-0.10346,-0.1016,0,0
1,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.27227,-0.10346,-0.1016,0,0
1,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.11636,-0.10367,-0.052122,0,0
1,CELLULAR COMPONENT DISASSEMBLY,0.059411,-0.10399,-0.14667,0,0
1,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.35607,-0.10402,-0.053555,0,0
1,PID ERA GENOMIC PATHWAY,0.12259,-0.10435,-0.1216,0,0
1,REACTOME O LINKED GLYCOSYLATION OF MUCINS,0.064293,-0.10462,-0.14112,0,0
1,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.093897,-0.10488,-0.076268,0,0
1,LEARNING AND OR MEMORY,0.50337,-0.10574,-0.050462,0,0
1,BIOCARTA IL7 PATHWAY,0.19393,-0.10622,-0.14116,0,0
1,REGULATION OF CYTOKINE SECRETION,0.98255,-0.10655,0.043425,0,0
1,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.48131,-0.10718,-0.036662,0,0
1,REACTOME MEIOSIS,0.11636,-0.10726,-0.096128,0,0
1,ANATOMICAL STRUCTURE DEVELOPMENT,0.48678,-0.10765,-0.038172,0,0
1,PID HDAC CLASSII PATHWAY,0.093897,-0.10845,-0.08808,0,0
1,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,1,-0.10858,0.035314,0,0
1,PID S1P S1P2 PATHWAY,0.19095,-0.11017,-0.1288,0,0
1,LYASE ACTIVITY,0.060602,-0.11093,-0.12326,0,0
1,MICROTUBULE BASED PROCESS,0.093897,-0.11126,-0.11131,0,0
1,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.050569,-0.11296,-0.12347,0,0
1,REACTOME MEIOTIC SYNAPSIS,0.2839,-0.11325,-0.075455,0,0
1,PHOSPHOLIPID METABOLIC PROCESS,0.076492,-0.11431,-0.083102,0,0
1,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.088862,-0.11447,-0.096353,0,0
1,RESPONSE TO NUTRIENT,0.25001,-0.11498,-0.10009,0,0
1,REACTOME NETRIN1 SIGNALING,0.50337,-0.11532,-0.039283,0,0
1,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.34256,-0.11546,-0.12659,0,0
1,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.26471,-0.11635,-0.13977,0,0
1,DETECTION OF ABIOTIC STIMULUS,0.32077,-0.11738,-0.075523,0,0
1,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.057089,-0.1183,-0.23946,0,0
1,CALMODULIN BINDING,0.2839,-0.11842,-0.091492,0,0
1,REACTOME CELL CELL COMMUNICATION,0.27999,-0.11866,-0.068514,0,0
1,SA B CELL RECEPTOR COMPLEXES,0.43883,-0.11877,-0.095659,0,0
1,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.075049,-0.11881,-0.1247,0,0
1,NEGATIVE REGULATION OF TRANSLATION,0.78962,-0.11927,-0.034933,0,0
1,HYDRO LYASE ACTIVITY,0.077957,-0.12004,-0.15519,0,0
1,INTERMEDIATE FILAMENT CYTOSKELETON,0.53742,-0.12194,0.079893,0,0
1,INTERMEDIATE FILAMENT,0.53742,-0.12194,0.079893,0,0
1,EXCRETION,0.14048,-0.1221,-0.10558,0,0
1,BIOCARTA MPR PATHWAY,0.072231,-0.12283,-0.11496,0,0
1,REACTOME SHC MEDIATED SIGNALLING,0.22235,-0.12294,-0.05872,0,0
1,CARBON OXYGEN LYASE ACTIVITY,0.072231,-0.1233,-0.14671,0,0
1,REACTOME ARMS MEDIATED ACTIVATION,0.3746,-0.1238,-0.058883,0,0
1,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.11841,-0.12391,-0.13461,0,0
1,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.05824,-0.12448,-0.14014,0,0
1,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.14769,-0.12454,-0.04399,0,0
1,APICAL PLASMA MEMBRANE,0.42347,-0.12492,-0.12811,0,0
1,SIG PIP3 SIGNALING IN B LYMPHOCYTES,0.21905,-0.12496,-0.078457,0,0
1,ANION CHANNEL ACTIVITY,0.10654,-0.12581,-0.10375,0,0
1,CHLORIDE CHANNEL ACTIVITY,0.10654,-0.12581,-0.10375,0,0
1,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.10654,-0.12597,-0.095206,0,0
1,REACTOME RNA POL I TRANSCRIPTION,0.25001,-0.12821,-0.061725,0,0
1,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.087232,-0.12893,-0.084813,0,0
1,REACTOME SIGNALING BY FGFR1 MUTANTS,0.17653,-0.12919,-0.091278,0,0
1,PID NFKAPPABATYPICALPATHWAY,0.092194,-0.13085,-0.16613,0,0
1,PEPTIDE RECEPTOR ACTIVITY,0.10845,-0.13103,-0.1037,0,0
1,PID P38GAMMADELTAPATHWAY,0.23245,-0.13154,-0.1523,0,0
1,NEURON DEVELOPMENT,0.055956,-0.13295,-0.24157,0,0
1,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.0695,-0.13398,-0.1091,0,0
1,KEGG AXON GUIDANCE,0.24643,-0.13509,-0.081206,0,0
1,REGULATION OF RESPONSE TO STIMULUS,0.095625,-0.13904,-0.10403,0,0
1,RIBONUCLEOTIDE METABOLIC PROCESS,0.34256,-0.13984,-0.060843,0,0
1,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.044685,-0.14022,-0.10398,0,0
1,SYSTEM DEVELOPMENT,0.25363,-0.14044,-0.065786,0,0
1,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.12473,-0.14404,-0.29835,0,0
1,KEGG MISMATCH REPAIR,0.070855,-0.14522,-0.17918,0,0
1,UDP GLYCOSYLTRANSFERASE ACTIVITY,0.12259,-0.14564,-0.15318,0,0
1,BIOCARTA GPCR PATHWAY,0.12908,-0.14598,-0.12417,0,0
1,MORPHOGENESIS OF AN EPITHELIUM,0.48678,-0.14727,-0.060203,0,0
1,BIOCARTA ARENRF2 PATHWAY,0.70355,-0.14743,0.048099,0,0
1,AMINE TRANSPORT,0.188,-0.14777,-0.10811,0,0
1,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.26098,-0.14826,-0.086599,0,0
1,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.093897,-0.14851,-0.10265,0,0
1,PID EPHA FWDPATHWAY,0.39858,-0.14903,-0.074692,0,0
1,PID LPA4 PATHWAY,0.061812,-0.14921,-0.15181,0,0
1,BIOCARTA NDKDYNAMIN PATHWAY,0.049546,-0.15125,-0.17765,0,0
1,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.18219,-0.15142,-0.083713,0,0
1,PID HNF3APATHWAY,0.063042,-0.15245,-0.14804,0,0
1,REACTOME ADP SIGNALLING THROUGH P2RY12,0.26098,-0.15246,-0.088292,0,0
1,BIOCARTA AKAPCENTROSOME PATHWAY,0.082489,-0.15649,-0.182,0,0
1,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.17934,-0.15651,-0.13874,0,0
1,ACTIN FILAMENT,0.097379,-0.15819,-0.15672,0,0
1,KEGG BETA ALANINE METABOLISM,0.054842,-0.15929,-0.1776,0,0
1,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.082489,-0.1596,-0.18936,0,0
1,SH3 SH2 ADAPTOR ACTIVITY,0.049546,-0.15971,-0.16884,0,0
1,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,0.16032,-0.1618,-0.099679,0,0
1,CONDENSED NUCLEAR CHROMOSOME,0.17099,-0.16315,-0.11532,0,0
1,APICAL PART OF CELL,0.16032,-0.1637,-0.19389,0,0
1,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.13355,-0.16492,-0.10007,0,0
1,REACTOME REGULATION OF SIGNALING BY CBL,0.084046,-0.16497,-0.15058,0,0
1,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.20621,-0.16637,-0.079502,0,0
1,G1 PHASE,0.28785,-0.1664,-0.081848,0,0
1,REGULATION OF IMMUNE RESPONSE,0.065563,-0.17033,-0.19266,0,0
1,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.17099,-0.17244,-0.083517,0,0
1,REACTOME MYOGENESIS,0.092194,-0.17365,-0.12787,0,0
1,PHOSPHATASE BINDING,0.076492,-0.17444,-0.11688,0,0
1,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.44402,-0.176,-0.1034,0,0
1,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.14048,-0.17604,-0.11718,0,0
1,REACTOME ADP SIGNALLING THROUGH P2RY1,0.045624,-0.1774,-0.17873,0,0
1,ACTIVATION OF IMMUNE RESPONSE,0.070855,-0.17792,-0.14801,0,0
1,APOPTOTIC MITOCHONDRIAL CHANGES,0.41842,-0.17799,-0.12788,0,0
1,CELL MATURATION,0.24643,-0.17939,-0.12824,0,0
1,BIOCARTA DREAM PATHWAY,0.063042,-0.18003,-0.19949,0,0
1,KEGG PHENYLALANINE METABOLISM,0.27611,-0.18021,-0.17083,0,0
1,PID S1P S1P3 PATHWAY,0.1028,-0.18203,-0.09261,0,0
1,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.11434,-0.18462,-0.13654,0,0
1,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.12049,-0.18606,-0.13425,0,0
1,REACTOME P38MAPK EVENTS,0.065563,-0.18679,-0.14654,0,0
1,PROTEIN POLYMERIZATION,0.097379,-0.18748,-0.17625,0,0
1,SIALYLTRANSFERASE ACTIVITY,0.11434,-0.1885,-0.17294,0,0
1,REGULATION OF MAPKKK CASCADE,0.064293,-0.18915,-0.14866,0,0
1,PROTEIN HOMOOLIGOMERIZATION,0.18508,-0.18935,-0.11896,0,0
1,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.14285,-0.19145,-0.18895,0,0
1,SPINDLE MICROTUBULE,0.13814,-0.19281,-0.12197,0,0
1,TISSUE MORPHOGENESIS,0.12473,-0.19304,-0.13851,0,0
1,BIOCARTA EPO PATHWAY,0.1313,-0.19436,-0.12814,0,0
1,KEGG PROTEIN EXPORT,0.060602,-0.19565,-0.15749,0,0
1,BIOCARTA NOS1 PATHWAY,0.065563,-0.1984,-0.16635,0,0
1,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.057089,-0.19932,-0.21149,0,0
1,REACTOME RNA POL III CHAIN ELONGATION,0.11434,-0.20101,-0.11996,0,0
1,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,0.084046,-0.20219,-0.22276,0,0
1,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.16828,-0.20528,-0.13994,0,0
1,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.52594,-0.20622,-0.096453,0,0
1,PHOSPHOINOSITIDE BINDING,0.15517,-0.20813,-0.1015,0,0
1,ANTIOXIDANT ACTIVITY,0.25001,-0.20859,-0.19763,0,0
1,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,0.10096,-0.21099,-0.15178,0,0
1,REACTOME IL 3 5 AND GM CSF SIGNALING,0.10465,-0.21113,-0.12742,0,0
1,CORTICAL ACTIN CYTOSKELETON,0.088862,-0.21458,-0.20236,0,0
1,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.0695,-0.21482,-0.19288,0,0
1,SODIUM CHANNEL ACTIVITY,0.13583,-0.21635,-0.19029,0,0
1,BIOCARTA RB PATHWAY,0.14048,-0.221,-0.16322,0,0
1,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.11841,-0.22652,-0.15682,0,0
1,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.046579,-0.22782,-0.15404,0,0
1,BIOCARTA CDK5 PATHWAY,0.33373,-0.22885,-0.037789,0,0
1,ST GRANULE CELL SURVIVAL PATHWAY,0.059411,-0.23104,-0.14598,0,0
1,RESPONSE TO HYPOXIA,0.05161,-0.23804,-0.24928,0,0
1,RESPIRATORY GASEOUS EXCHANGE,0.19095,-0.24764,-0.026981,0,0
1,PID HES HEYPATHWAY,0.20621,-0.2632,-0.096971,0,0
1,VESICLE LOCALIZATION,0.04854,-0.27006,-0.21851,0,0
1,REGULATION OF HOMEOSTATIC PROCESS,0.064293,-0.27433,-0.27263,0,0
1,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.053746,-0.28093,-0.08707,0,0
1,SA PROGRAMMED CELL DEATH,0.070855,-0.29885,-0.18069,0,0
1,PID SYNDECAN 3 PATHWAY,0.077957,-0.33179,-0.2084,0,0
1,LEUKOCYTE MIGRATION,0.20937,-0.34413,-0.21435,0,0
2,VESICLE LOCALIZATION,1.4039e-05,0.73664,0.69778,1,1
2,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.00022676,0.71634,0.64741,1,1
2,MORPHOGENESIS OF AN EPITHELIUM,9.389e-05,0.71428,0.62744,1,1
2,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,1.4039e-05,0.68678,0.5584,1,1
2,MESODERM DEVELOPMENT,0.00059588,0.6564,0.50016,1,1
2,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,5.2837e-06,0.65327,0.6602,1,1
2,KEGG LINOLEIC ACID METABOLISM,0.0001547,0.65254,0.50059,1,1
2,PID INTEGRIN4 PATHWAY,0.0017641,0.63961,0.68373,1,1
2,G1 PHASE OF MITOTIC CELL CYCLE,1.906e-06,0.63684,0.58816,1,1
2,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.00037661,0.62802,0.56844,1,1
2,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,9.0551e-05,0.61785,0.47304,1,1
2,REACTOME ACYL CHAIN REMODELLING OF PE,4.5813e-07,0.61037,0.57536,1,1
2,CYTOPLASM ORGANIZATION AND BIOGENESIS,0.00017186,0.60366,0.5833,1,1
2,GLAND DEVELOPMENT,0.0036303,0.5608,0.44263,1,1
2,REACTOME METABOLISM OF PORPHYRINS,0.001872,0.55312,0.39162,1,1
2,KEGG ETHER LIPID METABOLISM,7.6603e-06,0.54736,0.51624,1,1
2,CORNIFIED ENVELOPE,0.00021909,0.54067,0.49945,1,1
2,REACTOME GLUTATHIONE CONJUGATION,0.00013433,0.54005,0.56684,1,1
2,COFACTOR BIOSYNTHETIC PROCESS,6.2786e-05,0.5294,0.41931,1,1
2,COENZYME METABOLIC PROCESS,1.4609e-05,0.51666,0.43827,1,1
2,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.00017796,0.51425,0.36834,1,1
2,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,0.00040247,0.5081,0.46317,1,1
2,POSITIVE REGULATION OF PHOSPHORYLATION,0.00017796,0.49125,0.36472,1,1
2,PID ERBB NETWORK PATHWAY,0.00028792,0.4859,0.3904,1,1
2,BIOCARTA ARF PATHWAY,0.0010206,0.48482,0.34786,1,1
2,ANTIOXIDANT ACTIVITY,0.011612,0.48141,0.32108,1,1
2,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,0.00045924,0.47524,0.40987,1,1
2,FATTY ACID METABOLIC PROCESS,0.00012964,0.47484,0.36116,1,1
2,KERATINOCYTE DIFFERENTIATION,0.00012512,0.46967,0.4784,1,1
2,REACTOME ACYL CHAIN REMODELLING OF PC,2.5774e-06,0.46657,0.45062,1,1
2,COFACTOR METABOLIC PROCESS,2.0033e-05,0.46597,0.3792,1,1
2,REACTOME APOPTOTIC EXECUTION PHASE,4.6623e-06,0.46494,0.40784,1,1
2,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00019079,0.46468,0.39945,1,1
2,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.0075304,0.46253,0.33452,1,1
2,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00065623,0.45736,0.38849,1,1
2,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.00065623,0.44973,0.32386,1,1
2,STEROID BINDING,0.00050664,0.44949,0.48578,1,1
2,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,0.0010859,0.4466,0.35948,1,1
2,PID WNT CANONICAL PATHWAY,1.0779e-06,0.44646,0.47266,1,1
2,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00032948,0.44369,0.31954,1,1
2,PID IL2 STAT5PATHWAY,0.00012074,0.44017,0.3883,1,1
2,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.00034072,0.43576,0.34726,1,1
2,TRANSLATION REGULATOR ACTIVITY,0.00087311,0.43507,0.30578,1,1
2,KEGG FATTY ACID METABOLISM,1.349e-05,0.43183,0.41911,1,1
2,PID EPHA FWDPATHWAY,3.0689e-05,0.42995,0.38104,1,1
2,ISOPRENOID METABOLIC PROCESS,0.00019753,0.42459,0.37829,1,1
2,BIOCARTA SPPA PATHWAY,4.4712e-06,0.4227,0.39636,1,1
2,SA MMP CYTOKINE CONNECTION,0.00037661,0.40986,0.39742,1,1
2,TRANSLATION INITIATION FACTOR ACTIVITY,0.00018427,0.40855,0.40343,1,1
2,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,0.0054795,0.40564,0.26125,1,1
2,RIBOSOME BIOGENESIS AND ASSEMBLY,0.00037661,0.40331,0.35791,1,1
2,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,0.0039469,0.40099,0.28364,1,1
2,PID RHOA REG PATHWAY,0.00029782,0.3992,0.32749,1,1
2,DEAMINASE ACTIVITY,0.00021909,0.3979,0.40478,1,1
2,RRNA PROCESSING,0.00038934,0.38849,0.35705,1,1
2,RRNA METABOLIC PROCESS,0.00038934,0.38849,0.35705,1,1
2,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.0014299,0.38757,0.40214,1,1
2,BIOCARTA P53 PATHWAY,0.0053338,0.38552,0.26614,1,1
2,BIOCARTA MITOCHONDRIA PATHWAY,0.029719,0.38291,0.25847,1,1
2,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,0.0032441,0.38141,0.31366,1,1
2,KEGG RETINOL METABOLISM,0.00028792,0.38122,0.39711,1,1
2,PID MYC PATHWAY,0.00010092,0.37968,0.40102,1,1
2,BIOCARTA TEL PATHWAY,0.0027346,0.37965,0.34717,1,1
2,REGULATION OF CELL SHAPE,0.00067758,0.37947,0.29087,1,1
2,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.027803,0.37917,0.22696,1,1
2,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,0.0038387,0.3786,0.23909,1,1
2,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,0.00087311,0.37348,0.30452,1,1
2,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.00030804,0.37229,0.27712,1,1
2,FATTY ACID OXIDATION,0.0049174,0.37195,0.30171,1,1
2,PROTEIN BINDING BRIDGING,2.5774e-06,0.37184,0.3887,1,1
2,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,6.2786e-05,0.37061,0.36006,1,1
2,REACTOME SYNTHESIS OF PA,0.00029782,0.37036,0.35318,1,1
2,KEGG SELENOAMINO ACID METABOLISM,0.00092958,0.36792,0.2979,1,1
2,REACTOME PEROXISOMAL LIPID METABOLISM,0.00063551,0.36756,0.3115,1,1
2,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.010773,0.36697,0.28513,1,1
2,ACTIN FILAMENT POLYMERIZATION,0.030383,0.36566,0.34314,1,1
2,MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00030804,0.36277,0.27431,1,1
2,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,0.00027832,0.36212,0.31738,1,1
2,BIOCARTA WNT PATHWAY,0.00026003,0.36056,0.35045,1,1
2,KEGG GLUTATHIONE METABOLISM,0.001228,0.36054,0.31317,1,1
2,COENZYME BINDING,0.010245,0.36006,0.31434,1,1
2,REGULATION OF CELL MORPHOGENESIS,0.00098941,0.35815,0.25932,1,1
2,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.0056288,0.35752,0.31629,1,1
2,KEGG PROPANOATE METABOLISM,0.030383,0.35504,0.25816,1,1
2,REACTOME LYSOSOME VESICLE BIOGENESIS,0.016339,0.35286,0.2457,1,1
2,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,0.0016129,0.35059,0.27491,1,1
2,PHOSPHOLIPASE C ACTIVITY,0.00029782,0.35018,0.30477,1,1
2,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.00045924,0.34448,0.28116,1,1
2,BIOCARTA LONGEVITY PATHWAY,3.3132e-05,0.34263,0.41728,1,1
2,PIGMENT BIOSYNTHETIC PROCESS,0.00026903,0.3405,0.31313,1,1
2,PID EPOPATHWAY,0.00024286,0.33986,0.29695,1,1
2,KEGG PROTEASOME,0.0039469,0.3366,0.29289,1,1
2,KEGG PYRUVATE METABOLISM,0.024288,0.33619,0.27824,1,1
2,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,0.00054072,0.33574,0.2464,1,1
2,REACTOME SULFUR AMINO ACID METABOLISM,0.00014418,0.33334,0.35144,1,1
2,ORGANELLE OUTER MEMBRANE,5.8301e-05,0.33317,0.31204,1,1
2,BIOCARTA EIF PATHWAY,0.00036427,0.33243,0.3063,1,1
2,KEGG THYROID CANCER,0.00020448,0.33169,0.31997,1,1
2,REGULATION OF PROTEIN MODIFICATION PROCESS,0.0041716,0.33072,0.22864,1,1
2,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,0.0034322,0.32841,0.26726,1,1
2,REACTOME PHASE II CONJUGATION,0.00092958,0.32733,0.31218,1,1
2,ORGANELLE LOCALIZATION,0.0001547,0.32647,0.29583,1,1
2,PID IL2 PI3KPATHWAY,0.00022676,0.32346,0.29411,1,1
2,SIG PIP3 SIGNALING IN B LYMPHOCYTES,0.00040247,0.32329,0.26243,1,1
2,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.0015189,0.32305,0.29229,1,1
2,BIOCARTA PML PATHWAY,0.034637,0.32208,0.16389,1,1
2,PIGMENT METABOLIC PROCESS,0.00016023,0.31808,0.33291,1,1
2,EMBRYONIC MORPHOGENESIS,0.015574,0.31801,0.21673,1,1
2,NEGATIVE REGULATION OF ANGIOGENESIS,0.02166,0.31624,0.28485,1,1
2,KEGG GLYCOLYSIS GLUCONEOGENESIS,0.0073363,0.31574,0.23485,1,1
2,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,0.0032441,0.31537,0.25689,1,1
2,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0046564,0.31486,0.25942,1,1
2,TRANSLATIONAL INITIATION,0.00012074,0.31472,0.30404,1,1
2,ST T CELL SIGNAL TRANSDUCTION,0.00042998,0.31386,0.23427,1,1
2,MITOCHONDRIAL MATRIX,0.026586,0.31255,0.19595,1,1
2,MITOCHONDRIAL LUMEN,0.026586,0.31255,0.19595,1,1
2,BIOCARTA FCER1 PATHWAY,0.0022992,0.31118,0.23631,1,1
2,REACTOME BIOLOGICAL OXIDATIONS,0.00014935,0.31114,0.2979,1,1
2,KEGG ONE CARBON POOL BY FOLATE,0.00028792,0.30914,0.49319,1,1
2,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.0040578,0.30714,0.24661,1,1
2,REACTOME APOPTOSIS,0.00017796,0.30545,0.23736,1,1
2,REGULATION OF TRANSLATIONAL INITIATION,0.00087311,0.30519,0.25993,1,1
2,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.00059588,0.30358,0.27246,1,1
2,DRUG BINDING,6.5149e-05,0.30313,0.29339,1,1
2,SIG BCR SIGNALING PATHWAY,0.004408,0.3027,0.24408,1,1
2,HETEROCYCLE METABOLIC PROCESS,0.00021909,0.30226,0.35309,1,1
2,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.0001165,0.3007,0.33455,1,1
2,CELL CYCLE ARREST GO 0007050,1.9263e-05,0.30038,0.24937,1,1
2,PID CD8TCRPATHWAY,0.0042883,0.29982,0.22157,1,1
2,G1 PHASE,0.00024286,0.29872,0.36612,1,1
2,VITAMIN METABOLIC PROCESS,0.0010528,0.29843,0.29461,1,1
2,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.00029782,0.2984,0.24656,1,1
2,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0019282,0.2945,0.30419,1,1
2,KEGG ARACHIDONIC ACID METABOLISM,0.0014738,0.29381,0.31393,1,1
2,PROTEASOME COMPLEX,0.0031536,0.29378,0.2413,1,1
2,KEGG DRUG METABOLISM CYTOCHROME P450,0.0006154,0.29342,0.3502,1,1
2,TISSUE DEVELOPMENT,0.00052342,0.29291,0.2447,1,1
2,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,0.030383,0.2921,0.22201,1,1
2,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,0.0040578,0.29143,0.25595,1,1
2,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,5.2139e-05,0.29127,0.28639,1,1
2,REGULATION OF TRANSLATION,6.2786e-05,0.29112,0.24785,1,1
2,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,0.0010206,0.28952,0.26486,1,1
2,RAS GTPASE ACTIVATOR ACTIVITY,0.0054795,0.28948,0.2373,1,1
2,REACTOME SIGNALING BY HIPPO,0.0083534,0.28943,0.45668,1,1
2,PID NECTIN PATHWAY,0.015574,0.28921,0.23543,1,1
2,OXIDOREDUCTASE ACTIVITY GO 0016616,0.0025817,0.28868,0.26558,1,1
2,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00028792,0.28859,0.25681,1,1
2,PROTEIN IMPORT INTO NUCLEUS,0.00067758,0.28851,0.25349,1,1
2,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,0.0073363,0.28627,0.19158,1,1
2,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.00037661,0.28532,0.24961,1,1
2,BIOCARTA PAR1 PATHWAY,0.00090094,0.28484,0.23469,1,1
2,OXYGEN BINDING,0.014841,0.28446,0.24344,1,1
2,REGULATION OF MUSCLE CONTRACTION,0.0036303,0.28292,0.20545,1,1
2,REACTOME ZINC TRANSPORTERS,0.015203,0.28212,0.19713,1,1
2,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.0013872,0.28151,0.29565,1,1
2,REACTOME TCR SIGNALING,0.00052342,0.28092,0.21235,1,1
2,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.00081984,0.2804,0.2794,1,1
2,BIOCARTA RHO PATHWAY,0.00057693,0.27942,0.27207,1,1
2,KEGG INOSITOL PHOSPHATE METABOLISM,4.3763e-07,0.27919,0.27169,1,1
2,BIOCARTA CTCF PATHWAY,0.0013054,0.27877,0.2695,1,1
2,SECONDARY METABOLIC PROCESS,6.7596e-05,0.27754,0.33855,1,1
2,CELL PROJECTION BIOGENESIS,1.1493e-05,0.27732,0.26607,1,1
2,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.00024286,0.27515,0.28561,1,1
2,REACTOME IL1 SIGNALING,0.00026003,0.27503,0.22662,1,1
2,MEIOSIS I,0.043763,0.27471,0.16988,1,1
2,OXIDOREDUCTASE ACTIVITY,0.00019753,0.27463,0.24837,1,1
2,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,0.00020448,0.27337,0.22595,1,1
2,POSITIVE REGULATION OF CELL CYCLE,0.0047853,0.27286,0.28739,1,1
2,ADHERENS JUNCTION,0.00065623,0.27247,0.33688,1,1
2,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,4.6623e-06,0.27228,0.31499,1,1
2,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,0.00040247,0.27134,0.26805,1,1
2,RESPONSE TO HORMONE STIMULUS,0.00044439,0.27015,0.44566,1,1
2,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,0.0019282,0.26883,0.22608,1,1
2,ANTI APOPTOSIS,0.00029782,0.26868,0.22353,1,1
2,PID TCR PATHWAY,0.0011549,0.266,0.28657,1,1
2,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,0.004408,0.26577,0.2802,1,1
2,PID TCRJNKPATHWAY,0.02268,0.26566,0.18961,1,1
2,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,0.0032441,0.26322,0.21827,1,1
2,RNA HELICASE ACTIVITY,0.0024367,0.26256,0.19771,1,1
2,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.038561,0.26243,0.18347,1,1
2,PID HIF2PATHWAY,0.0021062,0.262,0.25777,1,1
2,PID ECADHERIN STABILIZATION PATHWAY,0.0022992,0.26199,0.23429,1,1
2,KEGG PRIMARY IMMUNODEFICIENCY,0.023741,0.26131,0.16089,1,1
2,SH3 SH2 ADAPTOR ACTIVITY,0.00041602,0.2601,0.25644,1,1
2,NUCLEOTIDE KINASE ACTIVITY,0.031748,0.25805,0.27927,1,1
2,KEGG FC EPSILON RI SIGNALING PATHWAY,0.0021062,0.25511,0.27181,1,1
2,REACTOME METABOLISM OF NON CODING RNA,7.547e-05,0.25451,0.27576,1,1
2,BIOCARTA ARAP PATHWAY,0.020205,0.25182,0.13938,1,1
2,REGULATION OF LYMPHOCYTE ACTIVATION,0.01282,0.25139,0.1951,1,1
2,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.0015189,0.25005,0.2331,1,1
2,INTERPHASE OF MITOTIC CELL CYCLE,0.00057693,0.24993,0.18378,1,1
2,SUGAR BINDING,0.00030804,0.24911,0.31725,1,1
2,REACTOME SMOOTH MUSCLE CONTRACTION,0.017969,0.24906,0.27593,1,1
2,BIOCARTA PTDINS PATHWAY,0.02268,0.24887,0.16757,1,1
2,PROTEIN RNA COMPLEX ASSEMBLY,0.0022332,0.24818,0.20718,1,1
2,BIOCARTA RARRXR PATHWAY,0.00045924,0.24688,0.25951,1,1
2,BIOCARTA RACCYCD PATHWAY,0.0056288,0.24681,0.21281,1,1
2,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.024846,0.24609,0.19574,1,1
2,RESPONSE TO OXIDATIVE STRESS,0.0021062,0.24583,0.20869,1,1
2,REACTOME PPARA ACTIVATES GENE EXPRESSION,0.00029782,0.24356,0.21739,1,1
2,BIOCARTA RAC1 PATHWAY,0.010506,0.2425,0.21132,1,1
2,KEGG SMALL CELL LUNG CANCER,0.0073363,0.24053,0.22302,1,1
2,KEGG LYSINE DEGRADATION,0.00018427,0.2403,0.26962,1,1
2,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.00353,0.24004,0.24173,1,1
2,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.00057693,0.23939,0.17519,1,1
2,NUCLEAR MEMBRANE,7.2754e-05,0.23907,0.21951,1,1
2,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,2.1663e-05,0.23893,0.26002,1,1
2,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,0.0006154,0.2386,0.2461,1,1
2,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,0.0049174,0.23751,0.18924,1,1
2,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,1.0604e-05,0.23736,0.24678,1,1
2,NUCLEAR IMPORT,0.0013872,0.23657,0.22218,1,1
2,REACTOME METABOLISM OF NUCLEOTIDES,0.0036303,0.23596,0.2152,1,1
2,MEMBRANE FUSION,0.00067758,0.23482,0.26979,1,1
2,BIOCARTA P38MAPK PATHWAY,0.00067758,0.23367,0.2475,1,1
2,NEGATIVE REGULATION OF CELL CYCLE,3.1888e-05,0.23328,0.23287,1,1
2,REACTOME PKB MEDIATED EVENTS,0.00072223,0.23295,0.20818,1,1
2,REACTOME PURINE METABOLISM,0.0014299,0.23277,0.317,1,1
2,BIOCARTA GCR PATHWAY,0.011326,0.23162,0.20453,1,1
2,AROMATIC COMPOUND METABOLIC PROCESS,0.0057817,0.22936,0.1931,1,1
2,PID FOXM1PATHWAY,0.017549,0.22931,0.17332,1,1
2,PROTEIN N TERMINUS BINDING,2.5774e-06,0.22921,0.26324,1,1
2,KEGG RIBOFLAVIN METABOLISM,0.0067808,0.22893,0.16986,1,1
2,RESPONSE TO BACTERIUM,0.00059588,0.2289,0.19003,1,1
2,PROTEIN IMPORT,0.00019079,0.22839,0.21855,1,1
2,DEFENSE RESPONSE TO BACTERIUM,0.00072223,0.22749,0.21217,1,1
2,SPLICEOSOME,0.00087311,0.22609,0.20329,1,1
2,PEPTIDYL TYROSINE PHOSPHORYLATION,0.0028141,0.22565,0.21961,1,1
2,PID FAK PATHWAY,0.0022332,0.2256,0.16972,1,1
2,PID P38ALPHABETADOWNSTREAMPATHWAY,0.00016595,0.22503,0.24946,1,1
2,PID ECADHERIN NASCENTAJ PATHWAY,0.007729,0.22422,0.2024,1,1
2,NUCLEAR TRANSPORT,0.00019079,0.22393,0.20041,1,1
2,KEGG BLADDER CANCER,0.0027346,0.22392,0.21566,1,1
2,PID KITPATHWAY,0.0021689,0.2239,0.18977,1,1
2,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.0030654,0.22375,0.21725,1,1
2,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.0053338,0.22371,0.15878,1,1
2,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.00098941,0.22357,0.22701,1,1
2,REGULATION OF CELL ADHESION,0.00020448,0.2232,0.29164,1,1
2,BIOCARTA PROTEASOME PATHWAY,0.011904,0.22316,0.19499,1,1
2,TRANSLATION,0.0034322,0.22302,0.20204,1,1
2,REACTOME METABOLISM OF RNA,0.0012662,0.22273,0.21418,1,1
2,BIOCARTA CHEMICAL PATHWAY,0.017549,0.22272,0.14041,1,1
2,REGULATION OF PROTEIN METABOLIC PROCESS,0.00090094,0.22067,0.15815,1,1
2,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,0.00035231,0.21865,0.2065,1,1
2,OUTER MEMBRANE,0.00057693,0.21829,0.24873,1,1
2,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.00084609,0.21702,0.25412,1,1
2,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,0.0022992,0.21647,0.18448,1,1
2,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0069616,0.21635,0.16734,1,1
2,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.0045306,0.21621,0.20155,1,1
2,CELL CORTEX,0.0015653,0.21606,0.1619,1,1
2,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,6.0504e-05,0.21533,0.24175,1,1
2,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.00057693,0.21337,0.24526,1,1
2,CARBOXYLIC ACID METABOLIC PROCESS,0.00049035,0.21308,0.22566,1,1
2,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.0057817,0.21249,0.27657,1,1
2,REACTOME SPRY REGULATION OF FGF SIGNALING,0.0011549,0.2114,0.2201,1,1
2,ORGANIC ACID METABOLIC PROCESS,0.00038934,0.2102,0.23066,1,1
2,PID NFKAPPABCANONICALPATHWAY,0.012508,0.20864,0.18425,1,1
2,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.0025083,0.20857,0.18373,1,1
2,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,0.023205,0.2085,0.13725,1,1
2,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,0.01282,0.20848,0.11969,1,1
2,INTERACTION WITH HOST,0.018836,0.20803,0.2179,1,1
2,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0041716,0.2079,0.15216,1,1
2,NUCLEOCYTOPLASMIC TRANSPORT,0.00021909,0.2078,0.19959,1,1
2,DNA RECOMBINATION,0.0036303,0.20766,0.16617,1,1
2,PID AVB3 INTEGRIN PATHWAY,0.021165,0.20665,0.16896,1,1
2,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.00074557,0.20574,0.16962,1,1
2,PEPTIDYL TYROSINE MODIFICATION,0.0040578,0.20509,0.19542,1,1
2,BIOCARTA HCMV PATHWAY,0.0018173,0.20499,0.20503,1,1
2,MOLECULAR ADAPTOR ACTIVITY,0.0028141,0.20479,0.21727,1,1
2,BASAL LAMINA,0.041093,0.20417,0.23994,1,1
2,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,2.8418e-05,0.20299,0.18542,1,1
2,REACTOME SIGNALING BY WNT,0.0047853,0.20248,0.19589,1,1
2,LIGASE ACTIVITY,8.6584e-06,0.20095,0.22856,1,1
2,REACTOME MEMBRANE TRAFFICKING,0.00026003,0.19996,0.19908,1,1
2,MEDIATOR COMPLEX,0.0031536,0.19934,0.17108,1,1
2,NUCLEAR MEMBRANE PART,0.00074557,0.19922,0.18752,1,1
2,KEGG RNA DEGRADATION,0.00049035,0.1988,0.17924,1,1
2,PROTEIN HETERODIMERIZATION ACTIVITY,0.00072223,0.19865,0.14858,1,1
2,PID VEGFR1 2 PATHWAY,0.0022992,0.19808,0.15691,1,1
2,KEGG CITRATE CYCLE TCA CYCLE,0.001662,0.19803,0.29923,1,1
2,REACTOME METABOLISM OF MRNA,0.004408,0.19783,0.19921,1,1
2,JAK STAT CASCADE,0.038561,0.19777,0.14672,1,1
2,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,0.022165,0.1965,0.1859,1,1
2,ACETYLTRANSFERASE ACTIVITY,0.00023468,0.19557,0.22665,1,1
2,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.02068,0.19549,0.27618,1,1
2,KEGG NON SMALL CELL LUNG CANCER,0.00016023,0.19487,0.18945,1,1
2,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.00049035,0.19414,0.262,1,1
2,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,0.027188,0.19396,0.19545,1,1
2,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.00016023,0.19316,0.17691,1,1
2,PID AR PATHWAY,0.014486,0.19261,0.20792,1,1
2,KEGG CYSTEINE AND METHIONINE METABOLISM,0.033894,0.19118,0.18539,1,1
2,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,0.00011241,0.19111,0.25133,1,1
2,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0014299,0.19076,0.16372,1,1
2,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.00019079,0.19068,0.20281,1,1
2,PEPTIDYL AMINO ACID MODIFICATION,0.00019753,0.18919,0.17229,1,1
2,ELECTRON CARRIER ACTIVITY,0.007729,0.18835,0.19097,1,1
2,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.0085714,0.18797,0.1551,1,1
2,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.0045306,0.18783,0.22489,1,1
2,MITOCHONDRIAL MEMBRANE,0.0047853,0.18714,0.16414,1,1
2,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.001986,0.187,0.14562,1,1
2,REACTOME BILE ACID AND BILE SALT METABOLISM,0.016734,0.18479,0.20509,1,1
2,PID IL8CXCR2 PATHWAY,0.011326,0.18422,0.24984,1,1
2,BIOCARTA FMLP PATHWAY,0.0027346,0.18367,0.1403,1,1
2,HOMEOSTASIS OF NUMBER OF CELLS,0.015574,0.18354,0.16983,1,1
2,PID S1P S1P1 PATHWAY,0.035393,0.18318,0.16342,1,1
2,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,0.010245,0.18273,0.1614,1,1
2,PID INSULIN GLUCOSE PATHWAY,0.036164,0.18048,0.14545,1,1
2,KEGG VEGF SIGNALING PATHWAY,0.00038934,0.18044,0.21754,1,1
2,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,0.00050664,0.17806,0.15875,1,1
2,VIRAL REPRODUCTIVE PROCESS,0.0081404,0.17739,0.14108,1,1
2,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0034322,0.17729,0.156,1,1
2,MITOCHONDRIAL PART,0.0053338,0.17724,0.17301,1,1
2,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.03245,0.1753,0.14693,1,1
2,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.001228,0.17505,0.18946,1,1
2,CELLULAR BIOSYNTHETIC PROCESS,0.00095906,0.17498,0.18441,1,1
2,ST B CELL ANTIGEN RECEPTOR,0.0022332,0.17362,0.19799,1,1
2,BIOCARTA BARR MAPK PATHWAY,0.017969,0.17346,0.1854,1,1
2,KEGG ENDOMETRIAL CANCER,0.0083534,0.1728,0.16144,1,1
2,PID RXR VDR PATHWAY,0.027188,0.17206,0.14399,1,1
2,BIOCARTA VIP PATHWAY,0.031059,0.17173,0.135,1,1
2,BIOCARTA UCALPAIN PATHWAY,0.030383,0.1713,0.12725,1,1
2,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.018836,0.17075,0.14324,1,1
2,ENVELOPE,0.00019079,0.17069,0.14453,1,1
2,ORGANELLE ENVELOPE,0.00019079,0.17069,0.14453,1,1
2,DNA HELICASE ACTIVITY,0.0014738,0.17053,0.18024,1,1
2,REACTOME SIGNALING BY RHO GTPASES,0.011047,0.16938,0.11901,1,1
2,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.0064317,0.16923,0.12848,1,1
2,KEGG ENDOCYTOSIS,0.00045924,0.16919,0.14956,1,1
2,TRANSCRIPTION FACTOR COMPLEX,0.00042998,0.16887,0.13566,1,1
2,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.030383,0.16858,0.11804,1,1
2,REACTOME SYNTHESIS OF PC,0.02068,0.16857,0.17009,1,1
2,NUCLEAR ENVELOPE,0.0033369,0.16756,0.13954,1,1
2,KEGG PEROXISOME,0.0030654,0.16537,0.17193,1,1
2,BIOCARTA CELL2CELL PATHWAY,0.009256,0.16495,0.22217,1,1
2,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.00074557,0.16478,0.15412,1,1
2,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,0.023205,0.16446,0.15151,1,1
2,ORGANELLE MEMBRANE,5.4121e-05,0.16427,0.14264,1,1
2,PID FCER1PATHWAY,0.0038387,0.16382,0.16305,1,1
2,ACID AMINO ACID LIGASE ACTIVITY,0.001191,0.16317,0.15311,1,1
2,RNA SPLICING,0.00059588,0.16289,0.16375,1,1
2,REACTOME MRNA PROCESSING,0.00026903,0.16276,0.17365,1,1
2,NUCLEAR PORE,0.0038387,0.1624,0.17673,1,1
2,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.036164,0.16131,0.15991,1,1
2,PID ANGIOPOIETINRECEPTOR PATHWAY,0.0029794,0.16046,0.19316,1,1
2,REACTOME REGULATION OF MITOTIC CELL CYCLE,0.0099891,0.16025,0.16807,1,1
2,RIBONUCLEOTIDE METABOLIC PROCESS,0.030383,0.15988,0.17994,1,1
2,REGULATION OF RAS GTPASE ACTIVITY,0.0007696,0.15943,0.16352,1,1
2,BIOCARTA BARRESTIN SRC PATHWAY,0.00065623,0.1557,0.2743,1,1
2,REACTOME PHOSPHOLIPID METABOLISM,0.0033369,0.15522,0.12049,1,1
2,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.00017186,0.15388,0.22561,1,1
2,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,0.03245,0.15329,0.12875,1,1
2,INTERPHASE,0.0021062,0.15313,0.14129,1,1
2,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.0064317,0.15215,0.13586,1,1
2,REACTOME DOWNSTREAM TCR SIGNALING,0.0090226,0.15055,0.17442,1,1
2,BIOCARTA EDG1 PATHWAY,0.0054795,0.14972,0.15867,1,1
2,CALMODULIN BINDING,0.029068,0.14946,0.13328,1,1
2,REGULATION OF CELL CYCLE,7.8282e-05,0.14892,0.14139,1,1
2,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,0.038561,0.14866,0.14989,1,1
2,BIOCARTA MAL PATHWAY,0.030383,0.14861,0.090082,1,1
2,RAS PROTEIN SIGNAL TRANSDUCTION,0.013798,0.14695,0.13912,1,1
2,KEGG VIBRIO CHOLERAE INFECTION,0.027188,0.14691,0.14319,1,1
2,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.0032441,0.14622,0.15529,1,1
2,KEGG SPLICEOSOME,0.0099891,0.14502,0.14473,1,1
2,NUCLEOTIDE EXCISION REPAIR,0.011047,0.14409,0.13476,1,1
2,REACTOME HIV LIFE CYCLE,0.012203,0.14403,0.10627,1,1
2,REACTOME PI METABOLISM,0.00027832,0.14363,0.1719,1,1
2,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.0071468,0.14318,0.14561,1,1
2,SMALL GTPASE BINDING,0.019283,0.14258,0.10991,1,1
2,PROTEIN TARGETING,0.0027346,0.14196,0.14156,1,1
2,PID INSULIN PATHWAY,0.022165,0.14133,0.11627,1,1
2,REACTOME MRNA SPLICING,0.0062634,0.14099,0.13803,1,1
2,BIOCARTA EIF4 PATHWAY,0.024288,0.14001,0.11531,1,1
2,KEGG ERBB SIGNALING PATHWAY,0.0017641,0.1397,0.13993,1,1
2,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,1.7118e-05,0.13883,0.15849,1,1
2,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,0.011326,0.13686,0.14688,1,1
2,DOUBLE STRANDED RNA BINDING,0.00353,0.1359,0.15333,1,1
2,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.015574,0.1357,0.13425,1,1
2,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.030383,0.13555,0.1321,1,1
2,RIBONUCLEOPROTEIN COMPLEX,0.0031536,0.13454,0.13458,1,1
2,MITOCHONDRIAL INNER MEMBRANE,0.042857,0.13338,0.12288,1,1
2,GTPASE BINDING,0.02068,0.13328,0.10508,1,1
2,RAS GTPASE BINDING,0.015953,0.13185,0.12239,1,1
2,RIBONUCLEASE ACTIVITY,0.0083534,0.13074,0.25697,1,1
2,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.0016129,0.13033,0.15676,1,1
2,PID PS1PATHWAY,0.0060989,0.12887,0.14023,1,1
2,REACTOME RNA POL II TRANSCRIPTION,0.018398,0.1279,0.11307,1,1
2,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.01282,0.1266,0.11079,1,1
2,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.017137,0.12499,0.11773,1,1
2,REGULATION OF RHO GTPASE ACTIVITY,0.0046564,0.12497,0.13371,1,1
2,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,0.011326,0.12475,0.11651,1,1
2,PID TELOMERASEPATHWAY,0.0047853,0.12441,0.13997,1,1
2,RNA PROCESSING,0.0054795,0.12391,0.1317,1,1
2,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.030383,0.12342,0.097084,1,1
2,ORGANELLE INNER MEMBRANE,0.018398,0.12154,0.12276,1,1
2,PORE COMPLEX,0.0069616,0.12095,0.16006,1,1
2,PID PDGFRBPATHWAY,0.018836,0.12071,0.092707,1,1
2,MITOCHONDRIAL ENVELOPE,0.0025083,0.1207,0.16306,1,1
2,REACTOME SIGNALING BY FGFR MUTANTS,0.0053338,0.11653,0.17038,1,1
2,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.0033369,0.11606,0.16376,1,1
2,POSITIVE REGULATION OF RNA METABOLIC PROCESS,0.0033369,0.11606,0.16376,1,1
2,CELLULAR PROTEIN CATABOLIC PROCESS,0.027188,0.11405,0.11551,1,1
2,HISTONE DEACETYLASE COMPLEX,0.036164,0.11401,0.099804,1,1
2,GOLGI ASSOCIATED VESICLE,0.029068,0.11388,0.10894,1,1
2,REACTOME MICRORNA MIRNA BIOGENESIS,0.02843,0.11379,0.15116,1,1
2,REACTOME MRNA SPLICING MINOR PATHWAY,0.015203,0.11275,0.15235,1,1
2,PID MET PATHWAY,0.021165,0.11217,0.11121,1,1
2,CELL CYCLE GO 0007049,0.0014299,0.11011,0.10068,1,1
2,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.041093,0.10997,0.084503,1,1
2,REGULATION OF GENE EXPRESSION,0.0029794,0.10995,0.095608,1,1
2,ENZYME ACTIVATOR ACTIVITY,0.00353,0.10951,0.15326,1,1
2,REGULATION OF RNA METABOLIC PROCESS,0.001662,0.10918,0.10408,1,1
2,PID ARF 3PATHWAY,0.034637,0.10901,0.12656,1,1
2,INTRACELLULAR PROTEIN TRANSPORT,0.0040578,0.10797,0.11251,1,1
2,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.0050528,0.10795,0.15797,1,1
2,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.0021689,0.10681,0.10247,1,1
2,ORGANELLE LUMEN,0.00037661,0.10679,0.11214,1,1
2,MEMBRANE ENCLOSED LUMEN,0.00037661,0.10679,0.11214,1,1
2,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,0.021165,0.10573,0.096466,1,1
2,PERINUCLEAR REGION OF CYTOPLASM,0.0026572,0.10545,0.13688,1,1
2,PID HDAC CLASSI PATHWAY,0.0027346,0.10513,0.096041,1,1
2,REACTOME SIGNALING BY ERBB4,0.018398,0.10307,0.091974,1,1
2,BIOCARTA PTEN PATHWAY,0.042857,0.1023,0.1095,1,1
2,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.012203,0.1016,0.11217,1,1
2,UBIQUITIN PROTEIN LIGASE ACTIVITY,0.024846,0.1013,0.091686,1,1
2,PID P53REGULATIONPATHWAY,0.0028957,0.098485,0.10668,1,1
2,REACTOME PI3K CASCADE,0.0021689,0.096936,0.125,1,1
2,KEGG CHRONIC MYELOID LEUKEMIA,0.038561,0.095776,0.1193,1,1
2,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.010506,0.095723,0.091873,1,1
2,POSITIVE REGULATION OF METABOLIC PROCESS,0.0073363,0.095172,0.11671,1,1
2,RNA BINDING,0.015574,0.094021,0.099035,1,1
2,BIOCARTA INTEGRIN PATHWAY,0.013465,0.0939,0.10064,1,1
2,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.0062634,0.09301,0.12149,1,1
2,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.03939,0.092319,0.15576,1,1
2,NUCLEAR EXPORT,0.0071468,0.09181,0.10869,1,1
2,NUCLEAR PART,0.00090094,0.091162,0.09712,1,1
2,PROTEIN CATABOLIC PROCESS,0.033166,0.090694,0.10961,1,1
2,REGULATION OF TRANSCRIPTION,0.015953,0.089773,0.082917,1,1
2,MACROMOLECULAR COMPLEX ASSEMBLY,0.010245,0.089318,0.082327,1,1
2,RECEPTOR MEDIATED ENDOCYTOSIS,0.021165,0.088576,0.11328,1,1
2,NUCLEOPLASM PART,0.00031859,0.085839,0.091019,1,1
2,INTRACELLULAR TRANSPORT,0.001228,0.085603,0.10225,1,1
2,NUCLEAR LUMEN,0.00035231,0.085124,0.10039,1,1
2,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.017549,0.084905,0.077145,1,1
2,NUCLEOPLASM,0.00035231,0.084065,0.093669,1,1
2,PID RB 1PATHWAY,0.041967,0.083887,0.09125,1,1
2,MITOTIC CELL CYCLE,0.0050528,0.08224,0.10052,1,1
2,RNA BIOSYNTHETIC PROCESS,0.011612,0.081047,0.078017,1,1
2,RNA METABOLIC PROCESS,0.00081984,0.080992,0.088599,1,1
2,ADENYL RIBONUCLEOTIDE BINDING,0.027803,0.080792,0.077997,1,1
2,TRANSCRIPTION DNA DEPENDENT,0.011904,0.080542,0.077702,1,1
2,RNA EXPORT FROM NUCLEUS,0.015203,0.080536,0.11028,1,1
2,PROTEIN TRANSPORT,0.01282,0.080001,0.091053,1,1
2,REACTOME HIV INFECTION,0.0050528,0.079501,0.12548,1,1
2,CELLULAR COMPONENT ASSEMBLY,0.010773,0.076781,0.084064,1,1
2,ADENYL NUCLEOTIDE BINDING,0.025994,0.075548,0.07875,1,1
2,CYTOPLASM,0.029719,0.070158,0.057933,1,1
2,KEGG HUNTINGTONS DISEASE,0.017549,0.067761,0.079734,1,1
2,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0081404,0.055475,0.067905,1,1
2,BIOPOLYMER METABOLIC PROCESS,0.013139,0.044296,0.058237,1,1
2,NUCLEUS,0.012203,0.039438,0.059028,1,1
2,ICOSANOID METABOLIC PROCESS,0.016734,0.53615,0.35932,1,0
2,BIOCARTA DEATH PATHWAY,0.019739,0.39844,0.28348,1,0
2,REACTOME ER PHAGOSOME PATHWAY,0.011047,0.34721,0.21959,1,0
2,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,0.025414,0.34384,0.26683,1,0
2,REACTOME CALNEXIN CALRETICULIN CYCLE,0.0038387,0.32075,0.25814,1,0
2,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,0.0069616,0.31885,0.24591,1,0
2,BIOCARTA IL10 PATHWAY,0.017137,0.30911,0.25727,1,0
2,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.015203,0.30748,0.23639,1,0
2,SA CASPASE CASCADE,0.02068,0.30366,0.24879,1,0
2,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.0022332,0.30006,0.35808,1,0
2,PID IL8CXCR1 PATHWAY,0.0045306,0.26053,0.35432,1,0
2,PID MYC ACTIVPATHWAY,0.0051916,0.25629,0.20569,1,0
2,MITOCHONDRIAL TRANSPORT,0.0013054,0.25541,0.2666,1,0
2,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,0.0047853,0.25397,0.2344,1,0
2,PID A6B1 A6B4 INTEGRIN PATHWAY,0.0030654,0.25185,0.37575,1,0
2,CYTOKINE BIOSYNTHETIC PROCESS,0.0064317,0.23999,0.18315,1,0
2,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.013139,0.23867,0.16299,1,0
2,RNA CATABOLIC PROCESS,0.036164,0.22569,0.18766,1,0
2,IMMUNE SYSTEM DEVELOPMENT,0.0014299,0.22429,0.1961,1,0
2,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,0.0041716,0.22018,0.16887,1,0
2,KEGG APOPTOSIS,0.025994,0.21773,0.16215,1,0
2,ENDOPLASMIC RETICULUM PART,0.001986,0.21458,0.16442,1,0
2,REGULATION OF INTRACELLULAR TRANSPORT,0.036948,0.21271,0.19562,1,0
2,CYTOKINE METABOLIC PROCESS,0.014841,0.21261,0.15351,1,0
2,PROTEIN TETRAMERIZATION,0.015203,0.21136,0.24725,1,0
2,PROTEIN TYROSINE KINASE ACTIVITY,0.036164,0.21068,0.152,1,0
2,MICROBODY,0.0030654,0.2065,0.19079,1,0
2,PEROXISOME,0.0030654,0.2065,0.19079,1,0
2,PID HDAC CLASSIII PATHWAY,0.029068,0.20564,0.1438,1,0
2,FOCAL ADHESION,0.022165,0.20233,0.26712,1,0
2,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.014138,0.20136,0.19781,1,0
2,ENDOPLASMIC RETICULUM MEMBRANE,0.0025083,0.19917,0.15778,1,0
2,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,0.0023671,0.1983,0.19377,1,0
2,NEGATIVE REGULATION OF APOPTOSIS,0.0045306,0.19749,0.14667,1,0
2,BIOCARTA VEGF PATHWAY,0.016339,0.19397,0.15974,1,0
2,SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.02268,0.19303,0.17871,1,0
2,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.029719,0.19077,0.12094,1,0
2,BIOCARTA ACTINY PATHWAY,0.038561,0.18805,0.16811,1,0
2,BASOLATERAL PLASMA MEMBRANE,0.022165,0.18735,0.18643,1,0
2,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.030383,0.18667,0.1259,1,0
2,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.03245,0.18622,0.18675,1,0
2,REACTOME S PHASE,0.0053338,0.18254,0.15832,1,0
2,REACTOME COLLAGEN FORMATION,0.018836,0.18132,0.23149,1,0
2,GROWTH FACTOR ACTIVITY,0.014841,0.17943,0.17178,1,0
2,REACTOME GLUCOSE TRANSPORT,0.031059,0.17876,0.13479,1,0
2,ENDOMEMBRANE SYSTEM,0.00026003,0.17858,0.13944,1,0
2,CYTOPLASMIC VESICLE MEMBRANE,0.02068,0.17715,0.12101,1,0
2,CYTOPLASMIC VESICLE PART,0.02068,0.17715,0.12101,1,0
2,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,0.041093,0.17675,0.16074,1,0
2,VESICLE MEMBRANE,0.0090226,0.17624,0.13889,1,0
2,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,0.007729,0.17485,0.14038,1,0
2,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.018398,0.1733,0.15448,1,0
2,HEMOPOIESIS,0.0071468,0.17243,0.16663,1,0
2,REGULATION OF ANGIOGENESIS,0.013139,0.17092,0.22188,1,0
2,CYTOKINE BINDING,0.031059,0.16854,0.12103,1,0
2,NUCLEAR HORMONE RECEPTOR BINDING,0.0062634,0.16461,0.1207,1,0
2,HORMONE RECEPTOR BINDING,0.0062634,0.16461,0.1207,1,0
2,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,0.00040247,0.16376,0.14707,1,0
2,BIOCARTA MYOSIN PATHWAY,0.010506,0.16184,0.17512,1,0
2,AMINO ACID METABOLIC PROCESS,0.015574,0.16163,0.17897,1,0
2,KEGG ADHERENS JUNCTION,0.033894,0.1612,0.15617,1,0
2,REACTOME PHOSPHORYLATION OF THE APC C,0.033894,0.16096,0.14453,1,0
2,PID IL4 2PATHWAY,0.0036303,0.15301,0.21809,1,0
2,PROTEIN FOLDING,0.0073363,0.1522,0.18595,1,0
2,PID P73PATHWAY,0.017549,0.15092,0.1264,1,0
2,BIOCARTA GH PATHWAY,0.0030654,0.15059,0.19462,1,0
2,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,0.015203,0.14821,0.13969,1,0
2,PID BCR 5PATHWAY,0.022165,0.14814,0.12854,1,0
2,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.024288,0.14782,0.17192,1,0
2,KEGG HEMATOPOIETIC CELL LINEAGE,0.009256,0.14739,0.14854,1,0
2,PID BETACATENIN DEG PATHWAY,0.041967,0.14652,0.09733,1,0
2,LIPID METABOLIC PROCESS,0.0060989,0.14503,0.12789,1,0
2,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.016339,0.1447,0.092714,1,0
2,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.011326,0.14342,0.16954,1,0
2,PID CERAMIDE PATHWAY,0.02268,0.14271,0.13365,1,0
2,CELLULAR PROTEIN COMPLEX ASSEMBLY,0.03245,0.14196,0.096677,1,0
2,REACTOME NOD1 2 SIGNALING PATHWAY,0.027188,0.14165,0.14623,1,0
2,HELICASE ACTIVITY,0.0016129,0.1413,0.1485,1,0
2,PID ATM PATHWAY,0.0090226,0.13969,0.14229,1,0
2,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,0.027188,0.13947,0.19634,1,0
2,KEGG FOCAL ADHESION,0.018836,0.13913,0.15907,1,0
2,REACTOME DOUBLE STRAND BREAK REPAIR,0.036164,0.13842,0.1421,1,0
2,REACTOME IMMUNE SYSTEM,0.023205,0.13738,0.083225,1,0
2,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.024288,0.13687,0.12494,1,0
2,REACTOME ADAPTIVE IMMUNE SYSTEM,0.0067808,0.1329,0.096466,1,0
2,REACTOME TRNA AMINOACYLATION,0.042857,0.13259,0.21704,1,0
2,REGULATION OF CELL DIFFERENTIATION,0.0099891,0.13068,0.17527,1,0
2,KEGG NOTCH SIGNALING PATHWAY,0.042857,0.13007,0.10319,1,0
2,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.027803,0.12997,0.14117,1,0
2,THYROID HORMONE RECEPTOR BINDING,0.035393,0.12966,0.10526,1,0
2,REACTOME CELL CYCLE CHECKPOINTS,0.0049174,0.12752,0.15697,1,0
2,STRUCTURAL MOLECULE ACTIVITY,0.018836,0.12534,0.12771,1,0
2,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,0.014486,0.12514,0.097368,1,0
2,GTPASE ACTIVATOR ACTIVITY,0.011612,0.12285,0.16998,1,0
2,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0079323,0.12276,0.12054,1,0
2,KEGG PROSTATE CANCER,0.024288,0.12199,0.15703,1,0
2,RHO PROTEIN SIGNAL TRANSDUCTION,0.024288,0.1197,0.13985,1,0
2,MITOCHONDRION,0.0030654,0.11957,0.13587,1,0
2,PID ARF6 PATHWAY,0.029068,0.11871,0.1658,1,0
2,REACTOME M G1 TRANSITION,0.029068,0.11739,0.12095,1,0
2,KEGG REGULATION OF ACTIN CYTOSKELETON,0.016734,0.11693,0.12335,1,0
2,REGULATION OF METABOLIC PROCESS,0.0051916,0.10904,0.086738,1,0
2,REGULATION OF CELLULAR METABOLIC PROCESS,0.0031536,0.1088,0.089627,1,0
2,PID RAC1 PATHWAY,0.014138,0.10817,0.13286,1,0
2,KEGG MELANOMA,0.040234,0.10652,0.10569,1,0
2,UBIQUITIN CYCLE,0.040234,0.10471,0.097857,1,0
2,REACTOME G1 S TRANSITION,0.027803,0.10328,0.11891,1,0
2,METHYLTRANSFERASE ACTIVITY,0.017137,0.10255,0.10361,1,0
2,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.01282,0.10195,0.10618,1,0
2,PID ILK PATHWAY,0.03245,0.10035,0.10849,1,0
2,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.037747,0.099973,0.13003,1,0
2,KEGG GLIOMA,0.0056288,0.099734,0.11958,1,0
2,POSITIVE REGULATION OF CELL PROLIFERATION,0.027803,0.099423,0.091516,1,0
2,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.011326,0.096357,0.11673,1,0
2,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.011326,0.096357,0.11673,1,0
2,MYOSIN COMPLEX,0.033894,0.096238,0.1842,1,0
2,REACTOME REGULATORY RNA PATHWAYS,0.016734,0.094867,0.16102,1,0
2,CHROMOSOMEPERICENTRIC REGION,0.041967,0.094807,0.10654,1,0
2,REACTOME SIGNALING BY ILS,0.017549,0.093903,0.13228,1,0
2,REACTOME GLUCOSE METABOLISM,0.03939,0.092872,0.13856,1,0
2,MEMBRANE ORGANIZATION AND BIOGENESIS,0.029719,0.090209,0.085444,1,0
2,PID CMYB PATHWAY,0.030383,0.089625,0.1306,1,0
2,ACTIN CYTOSKELETON,0.033166,0.083307,0.11251,1,0
2,POSITIVE REGULATION OF TRANSCRIPTION,0.029719,0.076049,0.12464,1,0
2,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.033166,0.075951,0.073538,1,0
2,BIOPOLYMER CATABOLIC PROCESS,0.025414,0.075139,0.1072,1,0
2,PROTEIN METABOLIC PROCESS,0.042857,0.073873,0.057732,1,0
2,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.022165,0.070454,0.1218,1,0
2,PROTEIN AMINO ACID PHOSPHORYLATION,0.020205,0.069514,0.066263,1,0
2,NUCLEOLUS,0.021165,0.069154,0.12748,1,0
2,POST TRANSLATIONAL PROTEIN MODIFICATION,0.027803,0.063804,0.064445,1,0
2,TRANSCRIPTION,0.03245,0.061697,0.064657,1,0
2,CELLULAR PROTEIN METABOLIC PROCESS,0.042857,0.057714,0.056147,1,0
2,INTRACELLULAR ORGANELLE PART,0.016339,0.029747,0.05696,1,0
2,ORGANELLE PART,0.020205,0.028137,0.056327,1,0
2,TRANSMEMBRANE RECEPTOR ACTIVITY,0.018398,-0.058699,-0.11439,1,0
2,KEGG MELANOGENESIS,0.043763,-0.062273,-0.093532,1,0
2,COATED VESICLE,0.02068,-0.070042,-0.11595,1,0
2,CYTOSKELETAL PART,0.021165,-0.071423,-0.08226,1,0
2,TRANSCRIPTION COREPRESSOR ACTIVITY,0.018398,-0.078957,-0.095518,1,0
2,REACTOME SIGNALLING TO ERKS,0.015574,-0.085708,-0.095753,1,0
2,LAMELLIPODIUM,0.042857,-0.089602,-0.1426,1,0
2,CELL PROJECTION,0.00353,-0.091583,-0.15314,1,0
2,PID RET PATHWAY,0.02068,-0.092453,-0.13807,1,0
2,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.019739,-0.093025,-0.15829,1,0
2,REACTOME GPCR LIGAND BINDING,0.02268,-0.093662,-0.097525,1,0
2,KEGG MAPK SIGNALING PATHWAY,0.025414,-0.09757,-0.084235,1,0
2,CALCIUM ION BINDING,0.031748,-0.098015,-0.11055,1,0
2,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.033166,-0.10073,-0.14406,1,0
2,GLYCOPROTEIN METABOLIC PROCESS,0.024846,-0.10316,-0.14704,1,0
2,EXTRACELLULAR SPACE,0.036948,-0.10497,-0.14407,1,0
2,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.024288,-0.10983,-0.10965,1,0
2,KEGG LONG TERM POTENTIATION,0.029719,-0.11326,-0.11616,1,0
2,KINASE BINDING,0.00045924,-0.11869,-0.15514,1,0
2,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0040578,-0.12119,-0.16583,1,0
2,CHANNEL REGULATOR ACTIVITY,0.034637,-0.12238,-0.14922,1,0
2,CELL CELL ADHESION,0.0090226,-0.12385,-0.18807,1,0
2,GTPASE ACTIVITY,0.0039469,-0.12582,-0.13348,1,0
2,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.007729,-0.1268,-0.16544,1,0
2,G PROTEIN COUPLED RECEPTOR ACTIVITY,0.0071468,-0.12702,-0.11928,1,0
2,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.0032441,-0.12709,-0.11339,1,0
2,SA REG CASCADE OF CYCLIN EXPR,0.043763,-0.13024,-0.22114,1,0
2,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0075304,-0.13037,-0.18541,1,0
2,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00044439,-0.13424,-0.20591,1,0
2,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.013465,-0.13451,-0.17364,1,0
2,SECOND MESSENGER MEDIATED SIGNALING,0.00063551,-0.13461,-0.16103,1,0
2,REGULATION OF TRANSPORT,0.0069616,-0.13698,-0.14828,1,0
2,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.014841,-0.13744,-0.122,1,0
2,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0062634,-0.13753,-0.1602,1,0
2,REACTOME L1CAM INTERACTIONS,0.018398,-0.13755,-0.15928,1,0
2,DETECTION OF ABIOTIC STIMULUS,0.040234,-0.13807,-0.056057,1,0
2,REGULATION OF NEURON APOPTOSIS,0.029719,-0.13831,-0.20406,1,0
2,KEGG CELL ADHESION MOLECULES CAMS,0.0037331,-0.13855,-0.20165,1,0
2,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011047,-0.13872,-0.12632,1,0
2,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.027803,-0.14024,-0.15746,1,0
2,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0056288,-0.14046,-0.13017,1,0
2,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.0046564,-0.14057,-0.1675,1,0
2,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.01282,-0.14513,-0.16628,1,0
2,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.041093,-0.14628,-0.18906,1,0
2,PID P38ALPHABETAPATHWAY,0.017549,-0.15025,-0.13948,1,0
2,MAPKKK CASCADE GO 0000165,0.0023671,-0.15086,-0.16638,1,0
2,CARBOXYLESTERASE ACTIVITY,0.031748,-0.1516,-0.18964,1,0
2,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,0.0067808,-0.15164,-0.13657,1,0
2,REACTOME SIGNAL TRANSDUCTION BY L1,0.025994,-0.15232,-0.15655,1,0
2,MRNA BINDING,0.014486,-0.15359,-0.22258,1,0
2,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.029068,-0.15523,-0.18223,1,0
2,SYSTEM PROCESS,0.0021062,-0.15847,-0.14113,1,0
2,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.0047853,-0.15989,-0.1276,1,0
2,REACTOME DIABETES PATHWAYS,0.0059384,-0.16005,-0.14141,1,0
2,REGULATION OF RESPONSE TO STIMULUS,0.0087944,-0.16042,-0.15073,1,0
2,KEGG HEDGEHOG SIGNALING PATHWAY,0.037747,-0.16161,-0.12121,1,0
2,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.025994,-0.16301,-0.20446,1,0
2,CELL RECOGNITION,0.02843,-0.16327,-0.38141,1,0
2,MOTOR ACTIVITY,0.0079323,-0.16869,-0.19354,1,0
2,REACTOME RECYCLING PATHWAY OF L1,0.027188,-0.16892,-0.16851,1,0
2,CENTROSOME,0.01282,-0.16947,-0.11765,1,0
2,KEGG CARDIAC MUSCLE CONTRACTION,0.017137,-0.17268,-0.17585,1,0
2,PROTEIN KINASE BINDING,1.7118e-05,-0.17546,-0.19738,1,0
2,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,0.029068,-0.17745,-0.14296,1,0
2,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.0013872,-0.17896,-0.23431,1,0
2,MICROTUBULE ORGANIZING CENTER,0.0034322,-0.17953,-0.12734,1,0
2,PID S1P META PATHWAY,0.013139,-0.17964,-0.19287,1,0
2,ST JNK MAPK PATHWAY,0.00054072,-0.18072,-0.21375,1,0
2,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.009256,-0.18134,-0.21429,1,0
2,REACTOME CTLA4 INHIBITORY SIGNALING,0.033166,-0.18158,-0.18794,1,0
2,BIOCARTA NOS1 PATHWAY,0.02843,-0.18164,-0.19827,1,0
2,DEOXYRIBONUCLEASE ACTIVITY,0.021165,-0.18238,-0.15475,1,0
2,BEHAVIOR,0.0054795,-0.1847,-0.14313,1,0
2,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.015574,-0.18575,-0.15751,1,0
2,LEARNING AND OR MEMORY,0.03939,-0.18756,-0.17522,1,0
2,REACTOME ION CHANNEL TRANSPORT,0.004408,-0.18855,-0.19154,1,0
2,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.041093,-0.18921,-0.21365,1,0
2,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0028957,-0.19104,-0.19931,1,0
2,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.013465,-0.19134,-0.25012,1,0
2,NEUROLOGICAL SYSTEM PROCESS,0.0028957,-0.19175,-0.1547,1,0
2,PID REELINPATHWAY,0.015203,-0.19203,-0.18981,1,0
2,PID LYSOPHOSPHOLIPID PATHWAY,0.00042998,-0.19313,-0.1943,1,0
2,PID REG GR PATHWAY,0.0081404,-0.19387,-0.13898,1,0
2,REACTOME SIGNALING BY NOTCH4,0.031059,-0.19453,-0.15637,1,0
2,FEEDING BEHAVIOR,0.0015653,-0.19679,-0.20813,1,0
2,PID ERBB1 INTERNALIZATION PATHWAY,0.0028957,-0.19753,-0.17483,1,0
2,BIOCARTA NDKDYNAMIN PATHWAY,0.0028957,-0.19773,-0.23819,1,0
2,PID S1P S1P4 PATHWAY,0.015574,-0.19808,-0.21868,1,0
2,KEGG BETA ALANINE METABOLISM,0.022165,-0.19905,-0.27545,1,0
2,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.0081404,-0.19983,-0.18146,1,0
2,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.011904,-0.20081,-0.16604,1,0
2,PID LIS1PATHWAY,0.007729,-0.20111,-0.19213,1,0
2,INSULIN RECEPTOR SIGNALING PATHWAY,0.0090226,-0.20121,-0.25015,1,0
2,KEGG TYPE II DIABETES MELLITUS,0.014841,-0.20138,-0.15736,1,0
2,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.023741,-0.20341,-0.16382,1,0
2,AMINE BINDING,0.014841,-0.20427,-0.21201,1,0
2,AXON,0.022165,-0.20753,-0.3445,1,0
2,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.0090226,-0.20819,-0.26918,1,0
2,CENTROSOME ORGANIZATION AND BIOGENESIS,0.0040578,-0.20961,-0.14474,1,0
2,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.0066042,-0.21063,-0.20006,1,0
2,SECRETION,7.8282e-05,-0.21184,-0.26767,1,0
2,REACTOME MEIOTIC SYNAPSIS,0.031748,-0.21217,-0.15867,1,0
2,PROTEIN SECRETION,0.014138,-0.21287,-0.26301,1,0
2,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.0015189,-0.21387,-0.20068,1,0
2,NEURON PROJECTION,0.017137,-0.2153,-0.30156,1,0
2,NERVOUS SYSTEM DEVELOPMENT,0.00019753,-0.21635,-0.25825,1,0
2,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,0.027188,-0.21689,-0.16433,1,0
2,REACTOME CGMP EFFECTS,0.0053338,-0.21846,-0.20388,1,0
2,REACTOME G ALPHA S SIGNALLING EVENTS,0.00017796,-0.22021,-0.21406,1,0
2,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00014935,-0.22168,-0.24384,1,0
2,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.00090094,-0.22194,-0.18959,1,0
2,TUBULIN BINDING,6.0504e-05,-0.22371,-0.25793,1,0
2,SYNAPSE PART,0.0081404,-0.22503,-0.26049,1,0
2,REACTOME AMINE LIGAND BINDING RECEPTORS,0.00026903,-0.22801,-0.21427,1,0
2,REACTOME DAG AND IP3 SIGNALING,0.00081984,-0.22957,-0.22455,1,0
2,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,8.4205e-05,-0.23003,-0.23842,1,0
2,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00069957,-0.23058,-0.18765,1,0
2,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,6.5149e-05,-0.2338,-0.24099,1,0
2,BIOCARTA DREAM PATHWAY,0.0083534,-0.23391,-0.23277,1,0
2,KINASE REGULATOR ACTIVITY,0.001228,-0.23415,-0.25479,1,0
2,COVALENT CHROMATIN MODIFICATION,0.00012964,-0.23453,-0.17354,1,0
2,HISTONE MODIFICATION,0.00012964,-0.23453,-0.17354,1,0
2,ION TRANSPORT,0.0012662,-0.24119,-0.18724,1,0
2,PID HNF3APATHWAY,0.026586,-0.2417,-0.19997,1,0
2,CELL CELL SIGNALING,2.6307e-05,-0.24229,-0.24521,1,0
2,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.00050664,-0.24278,-0.2272,1,0
2,SODIUM CHANNEL ACTIVITY,0.023205,-0.24314,-0.26702,1,0
2,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.018836,-0.24377,-0.28044,1,0
2,NEURON DEVELOPMENT,0.02268,-0.2447,-0.18976,1,0
2,PID S1P S1P3 PATHWAY,0.0028141,-0.24633,-0.26576,1,0
2,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,5.0226e-05,-0.24688,-0.26501,1,0
2,CAMP MEDIATED SIGNALING,5.0226e-05,-0.24688,-0.26501,1,0
2,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.018836,-0.24977,-0.24083,1,0
2,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.0017123,-0.25062,-0.22266,1,0
2,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,1.0311e-06,-0.25232,-0.28957,1,0
2,NEUROTRANSMITTER BINDING,0.0073363,-0.25254,-0.22281,1,0
2,MICROTUBULE BINDING,7.8282e-05,-0.25282,-0.31509,1,0
2,ST WNT BETA CATENIN PATHWAY,0.00084609,-0.25313,-0.32151,1,0
2,CALCIUM ION TRANSPORT,0.0023671,-0.25328,-0.2788,1,0
2,SIG CD40PATHWAYMAP,0.00057693,-0.25399,-0.23406,1,0
2,SECRETORY PATHWAY,5.4121e-05,-0.25407,-0.28738,1,0
2,POLYSACCHARIDE METABOLIC PROCESS,0.0030654,-0.25433,-0.24456,1,0
2,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.018398,-0.25715,-0.21708,1,0
2,REACTOME INTEGRATION OF ENERGY METABOLISM,0.00014935,-0.25736,-0.2575,1,0
2,BIOCARTA IL2 PATHWAY,0.02268,-0.25838,-0.19474,1,0
2,SECRETION BY CELL,2.0033e-05,-0.2589,-0.28067,1,0
2,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.0026572,-0.26137,-0.2465,1,0
2,REACTOME G ALPHA Z SIGNALLING EVENTS,0.0016129,-0.26169,-0.26501,1,0
2,MICROTUBULE CYTOSKELETON,1.4609e-05,-0.26193,-0.24441,1,0
2,NEURITE DEVELOPMENT,0.033894,-0.26344,-0.21622,1,0
2,BIOCARTA CDK5 PATHWAY,0.0049174,-0.26669,-0.26396,1,0
2,NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0085714,-0.26717,-0.22697,1,0
2,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,0.021165,-0.26904,-0.19584,1,0
2,SH2 DOMAIN BINDING,0.0028141,-0.26946,-0.31131,1,0
2,BIOGENIC AMINE METABOLIC PROCESS,0.0028957,-0.27373,-0.22353,1,0
2,PID P38 MK2PATHWAY,0.0062634,-0.27636,-0.23611,1,0
2,PID S1P S1P2 PATHWAY,0.00027832,-0.27868,-0.28319,1,0
2,NEUROGENESIS,0.0057817,-0.28177,-0.21336,1,0
2,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00029782,-0.28479,-0.23124,1,0
2,PID P38 MKK3 6PATHWAY,0.0010206,-0.28759,-0.24985,1,0
2,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.00063551,-0.28868,-0.29484,1,0
2,REACTOME GABA B RECEPTOR ACTIVATION,0.00032948,-0.28981,-0.33699,1,0
2,AXONOGENESIS,0.015574,-0.29362,-0.28035,1,0
2,SPHINGOLIPID METABOLIC PROCESS,4.8379e-05,-0.29368,-0.33522,1,0
2,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,0.0013457,-0.29388,-0.23797,1,0
2,RESPONSE TO HYPOXIA,0.043763,-0.29593,-0.21746,1,0
2,PID LPA4 PATHWAY,0.0007696,-0.2988,-0.333,1,0
2,AMINE RECEPTOR ACTIVITY,0.00013917,-0.29997,-0.26721,1,0
2,APOPTOTIC MITOCHONDRIAL CHANGES,0.0040578,-0.30096,-0.36688,1,0
2,POSITIVE REGULATION OF SECRETION,0.0053338,-0.30166,-0.27712,1,0
2,REACTOME PACKAGING OF TELOMERE ENDS,0.021165,-0.30323,-0.29254,1,0
2,REGULATION OF IMMUNE RESPONSE,0.013139,-0.30439,-0.25413,1,0
2,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.00087311,-0.30576,-0.2563,1,0
2,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001986,-0.3091,-0.32259,1,0
2,ACTIVATION OF IMMUNE RESPONSE,0.00092958,-0.31073,-0.32908,1,0
2,GLUTAMATE SIGNALING PATHWAY,0.010773,-0.31224,-0.28943,1,0
2,REGULATION OF MEMBRANE POTENTIAL,0.00035231,-0.3167,-0.35949,1,0
2,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,0.012508,-0.31693,-0.25147,1,0
2,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.0011199,-0.32361,-0.29981,1,0
2,GENERATION OF NEURONS,0.0022992,-0.32502,-0.25149,1,0
2,BIOCARTA ARENRF2 PATHWAY,0.01282,-0.32557,-0.32682,1,0
2,BIOCARTA ETS PATHWAY,0.0006154,-0.32583,-0.33249,1,0
2,CATION TRANSPORT,9.0551e-05,-0.32731,-0.25613,1,0
2,NEURON DIFFERENTIATION,0.00084609,-0.32761,-0.30253,1,0
2,LIGAND GATED CHANNEL ACTIVITY,3.4728e-06,-0.32956,-0.36907,1,0
2,INACTIVATION OF MAPK ACTIVITY,0.0010206,-0.33132,-0.3603,1,0
2,MICROTUBULE MOTOR ACTIVITY,0.00084609,-0.33218,-0.33816,1,0
2,DETECTION OF STIMULUS,0.0017123,-0.33251,-0.26723,1,0
2,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,0.00027832,-0.33341,-0.30646,1,0
2,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.021165,-0.33443,-0.30956,1,0
2,REGULATION OF NEUROGENESIS,0.033166,-0.33475,-0.327,1,0
2,BIOCARTA CCR5 PATHWAY,0.00016595,-0.33729,-0.44214,1,0
2,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00012512,-0.34353,-0.30835,1,0
2,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.0007696,-0.34938,-0.43307,1,0
2,CHROMATIN REMODELING COMPLEX,0.0050528,-0.35038,-0.25421,1,0
2,POSITIVE REGULATION OF IMMUNE RESPONSE,0.00084609,-0.3579,-0.34521,1,0
2,METAL ION TRANSPORT,0.00023468,-0.35799,-0.27195,1,0
2,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.0014738,-0.35882,-0.29105,1,0
2,POTASSIUM ION TRANSPORT,0.0017641,-0.36188,-0.29632,1,0
2,GABA RECEPTOR ACTIVITY,0.00069957,-0.36251,-0.44247,1,0
2,PID SYNDECAN 3 PATHWAY,0.00095906,-0.36849,-0.3795,1,0
2,SECRETORY GRANULE,0.031059,-0.36959,-0.27114,1,0
2,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,0.00074557,-0.37076,-0.29428,1,0
2,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.01282,-0.37235,-0.28818,1,0
2,PROTEIN KINASE REGULATOR ACTIVITY,0.00084609,-0.37434,-0.32192,1,0
2,SA TRKA RECEPTOR,3.9418e-06,-0.3765,-0.46236,1,0
2,SYNAPTIC TRANSMISSION,2.6307e-05,-0.37694,-0.3811,1,0
2,REACTOME INWARDLY RECTIFYING K CHANNELS,0.0010528,-0.3786,-0.34147,1,0
2,REACTOME GABA RECEPTOR ACTIVATION,0.00016023,-0.3787,-0.36865,1,0
2,REACTOME NEURONAL SYSTEM,7.013e-05,-0.37938,-0.33665,1,0
2,ACETYLCHOLINE BINDING,0.00040247,-0.38217,-0.42083,1,0
2,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,4.4878e-05,-0.38414,-0.33625,1,0
2,TRANSMISSION OF NERVE IMPULSE,1.8521e-05,-0.38639,-0.36553,1,0
2,ST GRANULE CELL SURVIVAL PATHWAY,1.2962e-05,-0.3866,-0.34242,1,0
2,ACTIVATION OF PROTEIN KINASE ACTIVITY,2.7343e-05,-0.3868,-0.33767,1,0
2,CENTRAL NERVOUS SYSTEM DEVELOPMENT,4.3218e-05,-0.38956,-0.31813,1,0
2,REACTOME REGULATION OF INSULIN SECRETION,3.1888e-05,-0.39157,-0.3614,1,0
2,SYNAPSE,6.0504e-05,-0.39258,-0.36242,1,0
2,ION CHANNEL ACTIVITY,4.4878e-05,-0.3939,-0.34067,1,0
2,REACTOME G PROTEIN ACTIVATION,0.0039469,-0.3943,-0.29087,1,0
2,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,0.00072223,-0.39477,-0.48345,1,0
2,MONOVALENT INORGANIC CATION TRANSPORT,0.00023468,-0.40827,-0.32325,1,0
2,POTASSIUM CHANNEL REGULATOR ACTIVITY,0.0001165,-0.41019,-0.39703,1,0
2,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,0.00032948,-0.42911,-0.43199,1,0
2,BRAIN DEVELOPMENT,0.00072223,-0.4337,-0.31542,1,0
2,DETECTION OF CHEMICAL STIMULUS,0.001986,-0.43395,-0.38949,1,0
2,GATED CHANNEL ACTIVITY,1.4609e-05,-0.43763,-0.39457,1,0
2,CELL PROJECTION PART,3.5759e-05,-0.43764,-0.40882,1,0
2,CARBONATE DEHYDRATASE ACTIVITY,0.00040247,-0.44511,-0.45037,1,0
2,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.00069957,-0.4486,-0.38085,1,0
2,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,0.019283,-0.44929,-0.32121,1,0
2,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,0.00041602,-0.45476,-0.40135,1,0
2,CATION CHANNEL ACTIVITY,3.1888e-05,-0.4632,-0.39913,1,0
2,MICROTUBULE ASSOCIATED COMPLEX,3.3287e-06,-0.46563,-0.5098,1,0
2,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,0.0007696,-0.46923,-0.42576,1,0
2,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,0.015953,-0.46936,-0.37874,1,0
2,REGULATION OF SECRETION,4.8379e-05,-0.47341,-0.43576,1,0
2,POTASSIUM CHANNEL ACTIVITY,0.0040578,-0.47629,-0.30724,1,0
2,DENDRITE,6.7596e-05,-0.47861,-0.46864,1,0
2,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,0.00017796,-0.48033,-0.40164,1,0
2,HORMONE ACTIVITY,7.547e-05,-0.48583,-0.43544,1,0
2,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,1.1267e-06,-0.48716,-0.51987,1,0
2,VOLTAGE GATED CHANNEL ACTIVITY,5.8301e-05,-0.49197,-0.4334,1,0
2,REACTOME CRMPS IN SEMA3A SIGNALING,0.038561,-0.50831,-0.43588,1,0
2,KINESIN COMPLEX,7.547e-05,-0.50833,-0.49949,1,0
2,REACTOME REGULATION OF BETA CELL DEVELOPMENT,0.00037661,-0.51268,-0.44367,1,0
2,SODIUM ION TRANSPORT,1.4609e-05,-0.5135,-0.54124,1,0
2,GLYCOLIPID METABOLIC PROCESS,2.8418e-05,-0.51672,-0.51609,1,0
2,VOLTAGE GATED CATION CHANNEL ACTIVITY,5.8301e-05,-0.52339,-0.44671,1,0
2,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,0.0019282,-0.5251,-0.46575,1,0
2,HOMOPHILIC CELL ADHESION,1.2962e-05,-0.53007,-0.6424,1,0
2,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,4.4712e-06,-0.53097,-0.51785,1,0
2,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,0.0012662,-0.53486,-0.46284,1,0
2,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.0069616,-0.53585,-0.37911,1,0
2,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,0.0015189,-0.53641,-0.37219,1,0
2,CALCIUM CHANNEL ACTIVITY,1.1267e-06,-0.54883,-0.60385,1,0
2,REACTOME BOTULINUM NEUROTOXICITY,1.5201e-05,-0.56105,-0.58772,1,0
2,KINASE INHIBITOR ACTIVITY,5.4121e-05,-0.565,-0.51154,1,0
2,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,0.0023671,-0.5695,-0.4645,1,0
2,REACTOME POTASSIUM CHANNELS,1.5201e-05,-0.57179,-0.44551,1,0
2,PROTEIN KINASE INHIBITOR ACTIVITY,5.8301e-05,-0.57206,-0.5309,1,0
2,REACTOME GABA A RECEPTOR ACTIVATION,0.00098941,-0.58376,-0.53462,1,0
2,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,1.4609e-05,-0.62704,-0.67487,1,0
2,LEUKOCYTE MIGRATION,0.0032441,-0.6401,-0.42239,1,0
2,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,0.0041716,-0.65493,-0.44354,1,0
2,REACTOME NEUROTRANSMITTER RELEASE CYCLE,5.6174e-05,-0.69775,-0.60179,1,0
2,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.00079435,-0.70701,-0.72735,1,0
2,EXOCYTOSIS,1.7118e-05,-0.7096,-0.73657,1,0
2,REGULATION OF NEUROTRANSMITTER LEVELS,9.3916e-06,-0.71878,-0.6577,1,0
2,SYNAPTIC VESICLE,0.0036303,-0.73225,-0.51084,1,0
2,GLUTAMATE RECEPTOR ACTIVITY,0.00010092,-0.7502,-0.75778,1,0
2,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,8.2505e-07,-0.7791,-0.849,1,0
2,HORMONE SECRETION,0.00050664,-0.84651,-0.64767,1,0
2,REACTOME AMINE DERIVED HORMONES,2.3654e-06,-0.88059,-0.74217,1,0
2,REGULATED SECRETORY PATHWAY,8.6584e-06,-0.90792,-0.78597,1,0
2,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,1.349e-05,-0.91793,-0.85424,1,0
2,REGULATION OF HORMONE SECRETION,7.6603e-06,-1.0251,-0.82251,1,0
2,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,2.5308e-05,-1.066,-0.81648,1,0
2,KEGG TYPE I DIABETES MELLITUS,1.5816e-05,-1.0708,-0.70691,1,0
2,REACTOME INSULIN SYNTHESIS AND PROCESSING,1.906e-06,-1.1135,-0.9787,1,0
2,NEUROTRANSMITTER SECRETION,5.9841e-06,-1.1795,-0.99778,1,0
2,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,1.7474e-06,-1.4077,-1.08,1,0
2,PID INTEGRIN5 PATHWAY,0.26471,0.52028,0.2406,0,1
2,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.055956,0.34677,0.25241,0,1
2,SARCOMERE,0.14526,0.33964,0.19865,0,1
2,PID INTEGRIN CS PATHWAY,0.05824,0.33025,0.25612,0,1
2,BIOCARTA RELA PATHWAY,0.11434,0.30862,0.15991,0,1
2,KEGG RENIN ANGIOTENSIN SYSTEM,0.11235,0.30805,0.15692,0,1
2,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.097379,0.30749,0.27868,0,1
2,MEIOTIC RECOMBINATION,0.050569,0.30332,0.19178,0,1
2,REACTOME CHOLESTEROL BIOSYNTHESIS,0.32077,0.29358,0.17595,0,1
2,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,0.049546,0.29329,0.19854,0,1
2,REACTOME METAL ION SLC TRANSPORTERS,0.044685,0.26383,0.17373,0,1
2,ENDOCYTIC VESICLE,0.11039,0.26333,0.17777,0,1
2,KEGG GALACTOSE METABOLISM,0.066855,0.25682,0.14256,0,1
2,PID MYC REPRESSPATHWAY,0.04854,0.2509,0.20275,0,1
2,HEPARIN BINDING,0.057089,0.24482,0.1984,0,1
2,BIOCARTA TFF PATHWAY,0.068167,0.23688,0.19123,0,1
2,REGULATION OF ENDOCYTOSIS,0.050569,0.23267,0.14778,0,1
2,AMINOPEPTIDASE ACTIVITY,0.053746,0.2269,0.17412,0,1
2,RESPONSE TO OTHER ORGANISM,0.060602,0.22158,0.11519,0,1
2,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0695,0.21591,0.1055,0,1
2,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.05824,0.21521,0.16092,0,1
2,BIOCARTA AKT PATHWAY,0.085627,0.21348,0.17484,0,1
2,REACTOME STRIATED MUSCLE CONTRACTION,0.19095,0.21075,0.1197,0,1
2,REACTOME MUSCLE CONTRACTION,0.064293,0.20856,0.16917,0,1
2,BIOCARTA HER2 PATHWAY,0.11039,0.20625,0.13528,0,1
2,BIOCARTA FIBRINOLYSIS PATHWAY,0.11636,0.20389,0.073503,0,1
2,REGULATION OF T CELL ACTIVATION,0.2,0.1994,0.092011,0,1
2,KEGG BUTANOATE METABOLISM,0.26847,0.19521,0.07029,0,1
2,KEGG OTHER GLYCAN DEGRADATION,0.18219,0.19501,0.15096,0,1
2,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.05824,0.19341,0.16893,0,1
2,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.087232,0.19021,0.17364,0,1
2,REACTOME RNA POL III CHAIN ELONGATION,0.063042,0.19016,0.17487,0,1
2,PID PDGFRAPATHWAY,0.21256,0.18939,0.10905,0,1
2,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.0695,0.18356,0.092479,0,1
2,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,0.060602,0.18325,0.16142,0,1
2,SULFUR METABOLIC PROCESS,0.11636,0.18293,0.098409,0,1
2,PID ALPHASYNUCLEIN PATHWAY,0.18508,0.17547,0.10384,0,1
2,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.070855,0.17412,0.14816,0,1
2,REACTOME REGULATION OF APOPTOSIS,0.057089,0.17277,0.11599,0,1
2,PHOSPHATASE BINDING,0.20937,0.17258,0.12551,0,1
2,PID ECADHERIN KERATINOCYTE PATHWAY,0.072231,0.1725,0.19475,0,1
2,BIOCARTA HSP27 PATHWAY,0.12473,0.17071,0.15901,0,1
2,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.16828,0.17049,0.15467,0,1
2,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.16828,0.17049,0.15467,0,1
2,BIOCARTA GSK3 PATHWAY,0.087232,0.17029,0.15272,0,1
2,LYMPHOCYTE DIFFERENTIATION,0.14769,0.16799,0.11787,0,1
2,MICROSOME,0.15015,0.16797,0.10392,0,1
2,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.12689,0.16554,0.11427,0,1
2,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.14048,0.16436,0.13013,0,1
2,CONTRACTILE FIBER PART,0.25001,0.1632,0.097493,0,1
2,REACTOME SHC1 EVENTS IN EGFR SIGNALING,0.050569,0.16297,0.16574,0,1
2,OXIDOREDUCTASE ACTIVITY GO 0016705,0.15773,0.16103,0.081155,0,1
2,MITOCHONDRIAL RIBOSOME,0.093897,0.15837,0.15148,0,1
2,ORGANELLAR RIBOSOME,0.093897,0.15837,0.15148,0,1
2,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.088862,0.15346,0.11495,0,1
2,AMINO SUGAR METABOLIC PROCESS,0.33373,0.15321,0.092213,0,1
2,MONOCARBOXYLIC ACID TRANSPORT,0.7495,0.15069,-0.0054537,0,1
2,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.22905,0.14879,0.090351,0,1
2,BIOCARTA ATRBRCA PATHWAY,0.057089,0.14095,0.12858,0,1
2,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.55487,0.13938,0.077324,0,1
2,SIGNAL SEQUENCE BINDING,0.18219,0.13906,0.084436,0,1
2,REACTOME G2 M CHECKPOINTS,0.068167,0.13831,0.12207,0,1
2,CARBOHYDRATE BINDING,0.065563,0.13709,0.13473,0,1
2,BIOCARTA IL2RB PATHWAY,0.26471,0.13587,0.071266,0,1
2,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.075049,0.1356,0.10777,0,1
2,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.15015,0.13513,0.13531,0,1
2,PID NOTCH PATHWAY,0.22568,0.13358,0.069307,0,1
2,KEGG BASE EXCISION REPAIR,0.064293,0.13257,0.11485,0,1
2,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.12689,0.13149,0.086406,0,1
2,KEGG N GLYCAN BIOSYNTHESIS,0.19393,0.12816,0.040776,0,1
2,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.16828,0.12753,0.08953,0,1
2,BIOCARTA IGF1MTOR PATHWAY,0.060602,0.12611,0.094357,0,1
2,PHOSPHOINOSITIDE METABOLIC PROCESS,0.049546,0.12591,0.079419,0,1
2,LEUKOCYTE ACTIVATION,0.48131,0.12488,0.040519,0,1
2,PID BETACATENIN NUC PATHWAY,0.077957,0.12381,0.13457,0,1
2,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.0695,0.12345,0.092822,0,1
2,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.11039,0.11954,0.070253,0,1
2,ST ADRENERGIC,0.26098,0.11926,0.074165,0,1
2,REACTOME RNA POL III TRANSCRIPTION,0.12049,0.11822,0.071993,0,1
2,KEGG REGULATION OF AUTOPHAGY,0.047551,0.11816,0.12359,0,1
2,KEGG DRUG METABOLISM OTHER ENZYMES,0.38888,0.117,0.044031,0,1
2,POSITIVE REGULATION OF T CELL ACTIVATION,0.59664,0.11693,0.026812,0,1
2,REACTOME NUCLEAR SIGNALING BY ERBB4,0.05824,0.11631,0.097608,0,1
2,PID PI3KCIPATHWAY,0.084046,0.11378,0.16549,0,1
2,VIRAL GENOME REPLICATION,0.097379,0.11329,0.070546,0,1
2,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.084046,0.11281,0.14008,0,1
2,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.17374,0.1128,0.12895,0,1
2,PID SYNDECAN 2 PATHWAY,0.15264,0.11177,0.10311,0,1
2,MITOCHONDRIAL RESPIRATORY CHAIN,0.16294,0.11116,0.10072,0,1
2,ACTIN FILAMENT BINDING,0.25001,0.11072,0.098573,0,1
2,BIOCARTA G1 PATHWAY,0.14285,0.11061,0.11571,0,1
2,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.20937,0.10951,0.066903,0,1
2,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.26847,0.10452,0.051017,0,1
2,KEGG ACUTE MYELOID LEUKEMIA,0.075049,0.10452,0.10064,0,1
2,NITROGEN COMPOUND CATABOLIC PROCESS,0.064293,0.10148,0.11704,0,1
2,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.055956,0.098312,0.088091,0,1
2,ER NUCLEAR SIGNALING PATHWAY,0.12049,0.097196,0.10461,0,1
2,REACTOME GLOBAL GENOMIC NER GG NER,0.092194,0.096956,0.058965,0,1
2,DNA POLYMERASE ACTIVITY,0.095625,0.096712,0.071884,0,1
2,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.14285,0.093518,0.076421,0,1
2,MICROTUBULE BASED PROCESS,0.1313,0.093123,0.087774,0,1
2,LIPID BINDING,0.095625,0.091642,0.077663,0,1
2,REACTOME TRANSCRIPTION,0.15264,0.090946,0.06251,0,1
2,CYTOSOL,0.060602,0.090565,0.071926,0,1
2,REACTOME NUCLEOTIDE EXCISION REPAIR,0.15264,0.090397,0.049604,0,1
2,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,0.085627,0.087099,0.071591,0,1
2,KEGG VIRAL MYOCARDITIS,0.055956,0.086677,0.11695,0,1
2,MRNA METABOLIC PROCESS,0.063042,0.086614,0.052534,0,1
2,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.19393,0.08627,0.099493,0,1
2,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.47049,0.084383,0.02431,0,1
2,VIRAL INFECTIOUS CYCLE,0.059411,0.083655,0.068498,0,1
2,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,0.049546,0.083634,0.064137,0,1
2,REACTOME PERK REGULATED GENE EXPRESSION,0.095625,0.082961,0.11847,0,1
2,CHROMATIN REMODELING,0.093897,0.082543,0.13559,0,1
2,NEGATIVE REGULATION OF CELL ADHESION,0.13355,0.079844,0.19033,0,1
2,BIOSYNTHETIC PROCESS,0.066855,0.079299,0.072518,0,1
2,DNA DIRECTED RNA POLYMERASE COMPLEX,0.14526,0.079152,0.084452,0,1
2,RNA POLYMERASE COMPLEX,0.14526,0.079152,0.084452,0,1
2,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.14526,0.079152,0.084452,0,1
2,KEGG NUCLEOTIDE EXCISION REPAIR,0.17374,0.078556,0.049715,0,1
2,STRUCTURAL CONSTITUENT OF MUSCLE,0.14285,0.078381,0.10396,0,1
2,REGULATION OF DEFENSE RESPONSE,0.83713,0.076965,0.02143,0,1
2,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.32506,0.075768,0.076039,0,1
2,RESPONSE TO LIGHT STIMULUS,0.4978,0.074071,0.033644,0,1
2,REACTOME SIGNALING BY INSULIN RECEPTOR,0.072231,0.073817,0.054978,0,1
2,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,0.13583,0.072039,0.059997,0,1
2,PID SMAD2 3NUCLEARPATHWAY,0.19393,0.067884,0.065153,0,1
2,GOLGI VESICLE TRANSPORT,0.092194,0.066883,0.089969,0,1
2,BIOCARTA ECM PATHWAY,0.31232,0.066674,0.088231,0,1
2,REACTOME SIGNALING BY NODAL,0.076492,0.066361,0.09924,0,1
2,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.34702,0.064468,0.029603,0,1
2,PID THROMBIN PAR1 PATHWAY,0.3746,0.062093,0.052827,0,1
2,CELL CYCLE PHASE,0.049546,0.059246,0.068035,0,1
2,ORGANELLE ORGANIZATION AND BIOGENESIS,0.066855,0.058983,0.041675,0,1
2,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.068167,0.045067,0.058349,0,1
2,BIOCARTA INTRINSIC PATHWAY,0.15264,0.37735,0.17998,0,0
2,BIOCARTA AMI PATHWAY,0.16032,0.37426,0.23797,0,0
2,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.060602,0.34818,0.23511,0,0
2,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.044685,0.32604,0.23557,0,0
2,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.077957,0.31311,0.22337,0,0
2,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,0.055956,0.29347,0.18533,0,0
2,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,0.053746,0.29038,0.30203,0,0
2,BIOCARTA NFKB PATHWAY,0.13583,0.28623,0.12827,0,0
2,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,0.04854,0.28259,0.19914,0,0
2,EXONUCLEASE ACTIVITY,0.22235,0.27067,0.12193,0,0
2,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,0.14048,0.2698,0.31792,0,0
2,REACTOME TRANSLATION,0.093897,0.26058,0.17384,0,0
2,KEGG STEROID BIOSYNTHESIS,0.23245,0.24986,0.14544,0,0
2,STRUCTURAL CONSTITUENT OF RIBOSOME,0.21256,0.2498,0.15197,0,0
2,MYOBLAST DIFFERENTIATION,0.13355,0.24742,0.1498,0,0
2,BIOCARTA CASPASE PATHWAY,0.10465,0.24588,0.24764,0,0
2,KEGG RIBOSOME,0.11841,0.24036,0.19644,0,0
2,PID UPA UPAR PATHWAY,0.52594,0.23654,0.05822,0,0
2,POSITIVE REGULATION OF TRANSLATION,0.054842,0.23647,0.087906,0,0
2,REACTOME PEPTIDE CHAIN ELONGATION,0.15264,0.23609,0.18595,0,0
2,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,0.093897,0.23575,0.25365,0,0
2,BIOCARTA INFLAM PATHWAY,0.30815,0.23091,0.092249,0,0
2,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,0.3746,0.22718,0.11724,0,0
2,PID IL27PATHWAY,0.060602,0.22496,0.11616,0,0
2,PID CASPASE PATHWAY,0.20621,0.22414,0.14498,0,0
2,PROTEASE INHIBITOR ACTIVITY,0.073629,0.22413,0.17001,0,0
2,PID TNFPATHWAY,0.23589,0.22222,0.083966,0,0
2,APICAL PLASMA MEMBRANE,0.14769,0.22172,0.1118,0,0
2,REACTOME HDL MEDIATED LIPID TRANSPORT,0.082489,0.22075,0.21109,0,0
2,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.18219,0.21631,0.10616,0,0
2,PID HIVNEFPATHWAY,0.15517,0.21614,0.14366,0,0
2,BIOCARTA EXTRINSIC PATHWAY,0.10465,0.21445,0.20183,0,0
2,NEGATIVE REGULATION OF TRANSLATION,0.045624,0.21335,0.19145,0,0
2,ST TUMOR NECROSIS FACTOR PATHWAY,0.14526,0.20935,0.093733,0,0
2,PID TAP63PATHWAY,0.080955,0.20773,0.15735,0,0
2,ER GOLGI INTERMEDIATE COMPARTMENT,0.046579,0.20585,0.14764,0,0
2,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.066855,0.20216,0.15371,0,0
2,ST INTERLEUKIN 4 PATHWAY,0.079444,0.20116,0.13765,0,0
2,KEGG COMPLEMENT AND COAGULATION CASCADES,0.12259,0.20034,0.076552,0,0
2,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,0.19695,0.19772,0.076738,0,0
2,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.059411,0.19689,0.17591,0,0
2,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,0.063042,0.19647,0.1125,0,0
2,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.13583,0.19418,0.17199,0,0
2,PID TRAIL PATHWAY,0.05161,0.1936,0.15544,0,0
2,APICAL PART OF CELL,0.12473,0.19277,0.11804,0,0
2,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.14769,0.19193,0.16832,0,0
2,RESPONSE TO VIRUS,0.21905,0.19178,0.083701,0,0
2,BIOCARTA CERAMIDE PATHWAY,0.085627,0.19109,0.15371,0,0
2,BIOCARTA SODD PATHWAY,0.16032,0.18615,0.16874,0,0
2,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.070855,0.18582,0.15478,0,0
2,MUSCLE CELL DIFFERENTIATION,0.23245,0.18564,0.10903,0,0
2,REACTOME INFLUENZA LIFE CYCLE,0.066855,0.1852,0.17139,0,0
2,REACTOME LIPOPROTEIN METABOLISM,0.16559,0.18133,0.1559,0,0
2,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.27999,0.18116,0.11943,0,0
2,AMINE BIOSYNTHETIC PROCESS,0.38888,0.18066,0.091023,0,0
2,BIOCARTA GATA3 PATHWAY,0.18219,0.18031,0.054876,0,0
2,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.20621,0.17852,0.089707,0,0
2,BIOCARTA SPRY PATHWAY,0.063042,0.17828,0.15267,0,0
2,BIOCARTA LAIR PATHWAY,0.60883,0.17818,0.058604,0,0
2,PID RAC1 REG PATHWAY,0.17934,0.17675,0.11883,0,0
2,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,0.063042,0.17631,0.113,0,0
2,RHO GTPASE ACTIVATOR ACTIVITY,0.10654,0.17402,0.13862,0,0
2,PID SYNDECAN 4 PATHWAY,0.34256,0.17381,0.099654,0,0
2,BIOCARTA P53HYPOXIA PATHWAY,0.26847,0.17296,0.10661,0,0
2,BIOCARTA NKCELLS PATHWAY,0.14048,0.17293,0.26293,0,0
2,REACTOME INTERFERON SIGNALING,0.18219,0.16989,0.076607,0,0
2,KEGG STEROID HORMONE BIOSYNTHESIS,0.21905,0.16854,0.11962,0,0
2,BIOCARTA HIVNEF PATHWAY,0.14769,0.16757,0.15389,0,0
2,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.055956,0.1672,0.31099,0,0
2,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,0.076492,0.16649,0.12799,0,0
2,VESICULAR FRACTION,0.099158,0.16499,0.12281,0,0
2,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,0.14769,0.16487,0.089906,0,0
2,PHOSPHOLIPID TRANSPORTER ACTIVITY,0.11841,0.16374,0.16334,0,0
2,MULTI ORGANISM PROCESS,0.12049,0.16132,0.073104,0,0
2,REGULATION OF JNK ACTIVITY,0.070855,0.16055,0.12855,0,0
2,PHOSPHOLIPASE C ACTIVATION,0.073629,0.16007,0.15237,0,0
2,LIPID TRANSPORT,0.17934,0.1593,0.096229,0,0
2,REACTOME P75NTR SIGNALS VIA NFKB,0.52594,0.15914,0.047183,0,0
2,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.2839,0.15856,0.050231,0,0
2,PID INTEGRIN A4B1 PATHWAY,0.073629,0.15846,0.14173,0,0
2,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.10096,0.15746,0.18123,0,0
2,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.17934,0.15611,0.13156,0,0
2,EARLY ENDOSOME,0.20621,0.15566,0.14633,0,0
2,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.12908,0.15481,0.085684,0,0
2,I KAPPAB KINASE NF KAPPAB CASCADE,0.22235,0.15393,0.082453,0,0
2,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,0.14048,0.15364,0.11878,0,0
2,PID TCPTP PATHWAY,0.066855,0.15268,0.12385,0,0
2,LEUKOCYTE DIFFERENTIATION,0.21579,0.15198,0.070093,0,0
2,ACTIN FILAMENT BUNDLE FORMATION,0.055956,0.15183,0.16996,0,0
2,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.20309,0.15176,0.095579,0,0
2,GOLGI MEMBRANE,0.070855,0.15144,0.11423,0,0
2,BIOCARTA TOB1 PATHWAY,0.31653,0.15089,0.080767,0,0
2,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.059411,0.15016,0.12323,0,0
2,REGULATION OF MYELOID CELL DIFFERENTIATION,0.27999,0.14969,0.087157,0,0
2,IMMUNE EFFECTOR PROCESS,0.72969,0.14848,0.0041074,0,0
2,PID INTEGRIN A9B1 PATHWAY,0.55487,0.14742,0.039173,0,0
2,REACTOME INTERFERON ALPHA BETA SIGNALING,0.62732,0.14687,0.005036,0,0
2,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.30402,0.14588,0.19618,0,0
2,LIPID HOMEOSTASIS,0.29586,0.14546,0.10918,0,0
2,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.066855,0.14502,0.10432,0,0
2,BIOCARTA FAS PATHWAY,0.099158,0.14437,0.17136,0,0
2,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,0.12689,0.14402,0.098574,0,0
2,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.099158,0.14365,0.15761,0,0
2,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,0.053746,0.14297,0.14312,0,0
2,KEGG CIRCADIAN RHYTHM MAMMAL,0.35153,0.14267,0.12681,0,0
2,PID INTEGRIN1 PATHWAY,0.14769,0.14265,0.16681,0,0
2,CELL SUBSTRATE ADHERENS JUNCTION,0.075049,0.14113,0.18684,0,0
2,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,0.068167,0.14112,0.090581,0,0
2,REACTOME PYRUVATE METABOLISM,0.36064,0.13994,0.061765,0,0
2,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.049546,0.13956,0.17576,0,0
2,INTERCELLULAR JUNCTION,0.13583,0.13887,0.1095,0,0
2,CELL JUNCTION,0.14769,0.13858,0.10215,0,0
2,NEGATIVE REGULATION OF CELL MIGRATION,0.31232,0.1384,0.11944,0,0
2,PID IL12 2PATHWAY,0.070855,0.13747,0.070903,0,0
2,PID IFNGPATHWAY,0.082489,0.13742,0.10489,0,0
2,BIOCARTA CARDIACEGF PATHWAY,0.34256,0.13704,0.016529,0,0
2,REACTOME KERATAN SULFATE KERATIN METABOLISM,0.19095,0.13513,0.094276,0,0
2,ACTIVATION OF JNK ACTIVITY,0.1028,0.13489,0.10385,0,0
2,COPPER ION BINDING,0.188,0.1346,0.12193,0,0
2,KEGG JAK STAT SIGNALING PATHWAY,0.075049,0.13392,0.075876,0,0
2,STRIATED MUSCLE DEVELOPMENT,0.40349,0.1337,0.052316,0,0
2,KEGG STARCH AND SUCROSE METABOLISM,0.068167,0.13344,0.12225,0,0
2,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.084046,0.1331,0.065295,0,0
2,TISSUE MORPHOGENESIS,0.14048,0.13299,0.20104,0,0
2,MUSCLE DEVELOPMENT,0.053746,0.13278,0.092589,0,0
2,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,0.065563,0.13267,0.079215,0,0
2,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.10654,0.13089,0.066899,0,0
2,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.42347,0.1302,0.039778,0,0
2,KEGG ARGININE AND PROLINE METABOLISM,0.22568,0.12938,0.099715,0,0
2,BIOCARTA ALK PATHWAY,0.27227,0.12802,0.076741,0,0
2,REACTOME BASIGIN INTERACTIONS,0.62732,0.12747,0.0052936,0,0
2,POSITIVE REGULATION OF JNK ACTIVITY,0.16032,0.12718,0.083721,0,0
2,PHOSPHOLIPASE ACTIVITY,0.054842,0.12663,0.11086,0,0
2,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.059411,0.12583,0.12171,0,0
2,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.16032,0.12543,0.088034,0,0
2,BIOCARTA GLEEVEC PATHWAY,0.17653,0.12532,0.10402,0,0
2,REGULATION OF PHOSPHORYLATION,0.13583,0.12467,0.078017,0,0
2,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.04854,0.12439,0.17926,0,0
2,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.62113,0.12382,0.051022,0,0
2,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,0.072231,0.12361,0.10574,0,0
2,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.061812,0.12262,0.14811,0,0
2,PID TOLL ENDOGENOUS PATHWAY,0.32506,0.12215,0.070113,0,0
2,CORTICAL ACTIN CYTOSKELETON,0.33812,0.12161,0.077277,0,0
2,RESPONSE TO UV,0.20621,0.12112,0.058455,0,0
2,PEPTIDASE ACTIVITY,0.19095,0.12076,0.036505,0,0
2,BIOCARTA IL12 PATHWAY,0.17374,0.12055,0.10147,0,0
2,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.17099,0.11778,0.11414,0,0
2,SKELETAL MUSCLE DEVELOPMENT,0.65866,0.11759,0.022049,0,0
2,BIOCARTA CDMAC PATHWAY,0.3746,0.11724,0.054723,0,0
2,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.47588,0.1172,0.089382,0,0
2,KEGG LYSOSOME,0.32506,0.11714,0.025735,0,0
2,BIOCARTA AKAP13 PATHWAY,0.13355,0.11681,0.1347,0,0
2,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.3746,0.11675,0.10828,0,0
2,KINASE ACTIVATOR ACTIVITY,0.16828,0.11648,0.11324,0,0
2,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,0.30815,0.11567,0.051749,0,0
2,REGULATION OF CELL MIGRATION,0.046579,0.11566,0.21359,0,0
2,SA PROGRAMMED CELL DEATH,0.36526,0.11525,0.060569,0,0
2,REACTOME INTERFERON GAMMA SIGNALING,0.33812,0.11506,0.05413,0,0
2,DEACETYLASE ACTIVITY,0.13814,0.11502,0.081987,0,0
2,TISSUE REMODELING,0.093897,0.11467,0.13272,0,0
2,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.061812,0.11443,0.11314,0,0
2,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,0.065563,0.11428,0.16956,0,0
2,PID SYNDECAN 1 PATHWAY,0.0695,0.11365,0.14281,0,0
2,REACTOME IRON UPTAKE AND TRANSPORT,0.16828,0.11338,0.0864,0,0
2,BIOCARTA CHREBP2 PATHWAY,0.26471,0.11291,0.063553,0,0
2,TRANSPORT VESICLE,0.4545,0.11249,0.047982,0,0
2,PID EPHA2 FWDPATHWAY,0.080955,0.11178,0.14111,0,0
2,PID HIF1APATHWAY,0.044685,0.11168,0.20204,0,0
2,ANION TRANSPORT,0.077957,0.1116,0.17014,0,0
2,INTERLEUKIN BINDING,0.063042,0.11151,0.11082,0,0
2,BIOCARTA IL1R PATHWAY,0.25729,0.11143,0.051283,0,0
2,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.4598,0.11061,0.12427,0,0
2,BIOCARTA HDAC PATHWAY,0.046579,0.11025,0.14436,0,0
2,ENDOPLASMIC RETICULUM,0.05824,0.11016,0.064569,0,0
2,CYTOSOLIC PART,0.14769,0.10985,0.13914,0,0
2,ONE CARBON COMPOUND METABOLIC PROCESS,0.18508,0.10972,0.064223,0,0
2,PHAGOCYTOSIS,0.26098,0.10945,0.089517,0,0
2,ANTIGEN BINDING,0.066855,0.10937,0.1342,0,0
2,BIOCARTA ERK PATHWAY,0.2,0.10923,0.077505,0,0
2,RESPONSE TO BIOTIC STIMULUS,0.12259,0.10904,0.057083,0,0
2,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,0.16828,0.10882,0.062855,0,0
2,ACTIN FILAMENT,0.13355,0.10827,0.12606,0,0
2,CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.053746,0.10711,0.10989,0,0
2,BIOCARTA TALL1 PATHWAY,0.2,0.10704,0.08543,0,0
2,RIBOSOME,0.21905,0.10681,0.093163,0,0
2,MEMBRANE FRACTION,0.099158,0.10624,0.068623,0,0
2,PID IL6 7PATHWAY,0.0695,0.10561,0.11691,0,0
2,REGULATION OF GTPASE ACTIVITY,0.30402,0.10492,0.071607,0,0
2,PID CIRCADIANPATHWAY,0.3746,0.10486,0.085398,0,0
2,LIPID KINASE ACTIVITY,0.11235,0.10483,0.16449,0,0
2,KEGG TRYPTOPHAN METABOLISM,0.12473,0.10444,0.17204,0,0
2,MYOFIBRIL,0.22905,0.10429,0.11808,0,0
2,PID RETINOIC ACID PATHWAY,0.19393,0.10386,0.092472,0,0
2,PID HIF1 TFPATHWAY,0.73628,0.10376,-0.0019888,0,0
2,CELLULAR LIPID METABOLIC PROCESS,0.061812,0.10323,0.078819,0,0
2,BIOCARTA RAS PATHWAY,0.10465,0.10317,0.094289,0,0
2,REACTOME SHC MEDIATED CASCADE,0.095625,0.10289,0.12165,0,0
2,PID P38GAMMADELTAPATHWAY,0.25001,0.10258,0.22185,0,0
2,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.11235,0.10174,0.091396,0,0
2,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.17934,0.1015,0.049757,0,0
2,REACTOME IL 3 5 AND GM CSF SIGNALING,0.28785,0.10145,0.12494,0,0
2,BIOCARTA MTOR PATHWAY,0.065563,0.10143,0.099974,0,0
2,EPIDERMIS DEVELOPMENT,0.057089,0.10115,0.18367,0,0
2,BIOCARTA CBL PATHWAY,0.33373,0.10113,0.091666,0,0
2,REACTOME EGFR DOWNREGULATION,0.095625,0.10106,0.11323,0,0
2,REACTOME INNATE IMMUNE SYSTEM,0.05824,0.10105,0.073489,0,0
2,REACTOME FRS2 MEDIATED CASCADE,0.073629,0.10074,0.12374,0,0
2,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.14526,0.1007,0.20287,0,0
2,RNA DEPENDENT ATPASE ACTIVITY,0.11235,0.10033,0.090021,0,0
2,ATP DEPENDENT RNA HELICASE ACTIVITY,0.13355,0.10015,0.092587,0,0
2,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,0.36526,0.099636,0.046458,0,0
2,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,0.43367,0.099524,0.055033,0,0
2,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.049546,0.099442,0.17359,0,0
2,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.077957,0.098041,0.095249,0,0
2,AMINE CATABOLIC PROCESS,0.27611,0.097632,0.071072,0,0
2,CELL ACTIVATION,0.50337,0.097538,0.046447,0,0
2,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.53742,0.09721,-0.11756,0,0
2,IMMUNE SYSTEM PROCESS,0.21256,0.096885,0.040348,0,0
2,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20937,0.096674,0.12288,0,0
2,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,0.24288,0.096603,0.08428,0,0
2,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.19095,0.096216,0.12515,0,0
2,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.39858,0.095727,0.057954,0,0
2,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.69707,0.095303,-0.0063421,0,0
2,VIRAL REPRODUCTION,0.21256,0.095074,0.046794,0,0
2,KINETOCHORE,0.076492,0.09497,0.11581,0,0
2,SEQUENCE SPECIFIC DNA BINDING,0.04854,0.094792,0.16075,0,0
2,CORTICAL CYTOSKELETON,0.73628,0.094283,0.014758,0,0
2,KEGG CHEMOKINE SIGNALING PATHWAY,0.29586,0.094194,0.040096,0,0
2,REACTOME MRNA 3 END PROCESSING,0.049546,0.094171,0.14763,0,0
2,PROTEIN COMPLEX ASSEMBLY,0.04854,0.094116,0.075533,0,0
2,KEGG ECM RECEPTOR INTERACTION,0.15264,0.093999,0.20323,0,0
2,BIOCARTA TID PATHWAY,0.19095,0.093735,0.11216,0,0
2,KEGG HOMOLOGOUS RECOMBINATION,0.057089,0.093676,0.12583,0,0
2,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.26847,0.093028,0.09384,0,0
2,LYMPHOCYTE ACTIVATION,0.77618,0.092625,-0.0019685,0,0
2,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.14769,0.092389,0.073188,0,0
2,PID RAS PATHWAY,0.67137,0.091691,0.029398,0,0
2,SA PTEN PATHWAY,0.54903,0.091412,0.025932,0,0
2,NITROGEN COMPOUND METABOLIC PROCESS,0.076492,0.091379,0.08319,0,0
2,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,0.47049,0.090123,0.009245,0,0
2,INFLAMMATORY RESPONSE,0.073629,0.089935,0.089683,0,0
2,CELLULAR DEFENSE RESPONSE,0.52025,0.089443,0.019854,0,0
2,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.21256,0.089356,0.056943,0,0
2,COLLAGEN,0.19095,0.089253,0.097937,0,0
2,NEGATIVE REGULATION OF TRANSPORT,0.29992,0.089236,0.11194,0,0
2,DNA INTEGRITY CHECKPOINT,0.14526,0.089119,0.082501,0,0
2,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.63354,0.089102,0.010552,0,0
2,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11235,0.088964,0.20153,0,0
2,BIOCARTA STRESS PATHWAY,0.13355,0.088948,0.10222,0,0
2,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.64605,0.088797,0.054425,0,0
2,BIOCARTA MET PATHWAY,0.084046,0.088778,0.090772,0,0
2,FEMALE PREGNANCY,0.46512,0.088776,0.023999,0,0
2,PID HEDGEHOG 2PATHWAY,0.53167,0.088776,0.097114,0,0
2,PID TXA2PATHWAY,0.2839,0.088513,0.040523,0,0
2,KEGG PENTOSE PHOSPHATE PATHWAY,0.23245,0.088369,0.088536,0,0
2,KEGG ABC TRANSPORTERS,0.25363,0.088314,0.075315,0,0
2,REACTOME MRNA CAPPING,0.04854,0.088133,0.088633,0,0
2,REGULATION OF SIGNAL TRANSDUCTION,0.15773,0.087976,0.070321,0,0
2,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,0.2,0.087828,0.094927,0,0
2,CELL PROLIFERATION GO 0008283,0.047551,0.08706,0.058184,0,0
2,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,0.32506,0.08704,0.02985,0,0
2,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.088862,0.086869,0.10244,0,0
2,RESPONSE TO EXTERNAL STIMULUS,0.25001,0.08657,0.027458,0,0
2,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.05824,0.086247,0.069525,0,0
2,REACTOME CELL CELL COMMUNICATION,0.29184,0.086208,0.037269,0,0
2,CYTOKINE PRODUCTION,0.42855,0.086129,0.029848,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.188,0.086,0.1146,0,0
2,REGULATION OF MITOTIC CELL CYCLE,0.05161,0.085968,0.11422,0,0
2,KEGG RENAL CELL CARCINOMA,0.17653,0.085774,0.086412,0,0
2,GOLGI APPARATUS PART,0.10845,0.085751,0.063342,0,0
2,ELECTRON TRANSPORT GO 0006118,0.14285,0.085014,0.1109,0,0
2,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,0.092194,0.084859,0.056622,0,0
2,KEGG PPAR SIGNALING PATHWAY,0.060602,0.084756,0.11279,0,0
2,ECTODERM DEVELOPMENT,0.076492,0.084738,0.17356,0,0
2,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.072231,0.08473,0.079849,0,0
2,REGULATION OF APOPTOSIS,0.060602,0.084219,0.078281,0,0
2,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.48678,0.083772,0.12624,0,0
2,LIPASE ACTIVITY,0.076492,0.083281,0.094734,0,0
2,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,0.56666,0.082802,0.013396,0,0
2,KEGG OXIDATIVE PHOSPHORYLATION,0.20937,0.08278,0.072551,0,0
2,PID BARD1PATHWAY,0.092194,0.082141,0.098356,0,0
2,SKELETAL DEVELOPMENT,0.087232,0.082083,0.13375,0,0
2,SA G1 AND S PHASES,0.22235,0.081786,0.06156,0,0
2,CONTRACTILE FIBER,0.41341,0.081445,0.058366,0,0
2,DEPHOSPHORYLATION,0.72969,0.081153,0.012665,0,0
2,PID CD8TCRDOWNSTREAMPATHWAY,0.21579,0.081132,0.054546,0,0
2,ATP DEPENDENT HELICASE ACTIVITY,0.057089,0.080469,0.11417,0,0
2,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.12473,0.08024,0.13436,0,0
2,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.15015,0.080238,0.062411,0,0
2,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.21905,0.080172,0.066085,0,0
2,ST MYOCYTE AD PATHWAY,0.71006,0.080009,0.026266,0,0
2,PID PTP1BPATHWAY,0.12689,0.079877,0.10849,0,0
2,PROTEIN UBIQUITINATION,0.11841,0.079727,0.087244,0,0
2,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.052669,0.079379,0.11235,0,0
2,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.15773,0.079374,0.096005,0,0
2,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,0.95466,0.078746,-0.039737,0,0
2,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,0.76281,0.078729,0.025522,0,0
2,KEGG O GLYCAN BIOSYNTHESIS,0.41341,0.078695,0.040496,0,0
2,PEROXISOME ORGANIZATION AND BIOGENESIS,0.22905,0.078509,0.082987,0,0
2,BIOCARTA IGF1 PATHWAY,0.50896,0.078469,0.015516,0,0
2,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,0.59664,0.07792,0.072956,0,0
2,NUCLEOLAR PART,0.10845,0.077667,0.16244,0,0
2,HEART DEVELOPMENT,0.29586,0.077657,0.044314,0,0
2,METALLOPEPTIDASE ACTIVITY,0.44924,0.077291,0.0041129,0,0
2,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,0.48678,0.077186,0.047435,0,0
2,CELL FATE COMMITMENT,0.14048,0.076254,0.16008,0,0
2,PID ERBB4 PATHWAY,0.53167,0.076015,0.027939,0,0
2,PID FGF PATHWAY,0.11434,0.075799,0.080882,0,0
2,REACTOME HEMOSTASIS,0.090515,0.075432,0.043078,0,0
2,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,0.66501,0.075289,0.0028298,0,0
2,REACTOME UNFOLDED PROTEIN RESPONSE,0.17374,0.075274,0.080564,0,0
2,B CELL ACTIVATION,0.55487,0.075036,0.030861,0,0
2,KEGG PATHWAYS IN CANCER,0.097379,0.074861,0.085687,0,0
2,REGULATION OF PROGRAMMED CELL DEATH,0.072231,0.074836,0.075822,0,0
2,CELLULAR CATABOLIC PROCESS,0.05824,0.074821,0.09308,0,0
2,REACTOME COMPLEMENT CASCADE,0.19393,0.07472,0.079802,0,0
2,REACTOME SYNTHESIS OF DNA,0.12908,0.074686,0.072213,0,0
2,PID IGF1 PATHWAY,0.14769,0.074652,0.062326,0,0
2,KEGG MTOR SIGNALING PATHWAY,0.20309,0.074256,0.061506,0,0
2,CHROMOSOME CONDENSATION,0.31653,0.073963,0.046155,0,0
2,DEFENSE RESPONSE,0.11039,0.073522,0.05914,0,0
2,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,0.12049,0.073122,0.11207,0,0
2,COFACTOR BINDING,0.34256,0.072602,0.11674,0,0
2,IMMUNE RESPONSE,0.40349,0.071894,0.01025,0,0
2,NEGATIVE REGULATION OF CELLULAR PROCESS,0.099158,0.071564,0.055941,0,0
2,POSITIVE REGULATION OF DNA BINDING,0.23245,0.071445,0.056732,0,0
2,ACTIN FILAMENT BASED MOVEMENT,0.045624,0.070959,0.18189,0,0
2,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.10096,0.070939,0.083321,0,0
2,PURINE NUCLEOTIDE BINDING,0.054842,0.070816,0.064095,0,0
2,REACTOME EXTENSION OF TELOMERES,0.14769,0.070617,0.092759,0,0
2,MITOCHONDRIAL MEMBRANE PART,0.20621,0.070464,0.073566,0,0
2,REACTOME TOLL RECEPTOR CASCADES,0.14285,0.070432,0.053904,0,0
2,KEGG DNA REPLICATION,0.32938,0.070156,0.076551,0,0
2,SERINE TYPE PEPTIDASE ACTIVITY,0.77618,0.070044,-0.0047678,0,0
2,INTERLEUKIN RECEPTOR ACTIVITY,0.35153,0.069722,0.048368,0,0
2,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,0.12689,0.069299,0.10172,0,0
2,MACROMOLECULE LOCALIZATION,0.17374,0.069008,0.044817,0,0
2,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,0.23245,0.068969,0.042429,0,0
2,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,0.59664,0.06892,0.041782,0,0
2,CALCIUM MEDIATED SIGNALING,0.80312,0.06873,-0.062028,0,0
2,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.40843,0.068724,0.028428,0,0
2,PID HES HEYPATHWAY,0.7495,0.068477,0.015232,0,0
2,STEROID BIOSYNTHETIC PROCESS,0.84397,0.068363,-0.030818,0,0
2,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.43367,0.068158,0.036917,0,0
2,APOPTOTIC PROGRAM,0.81668,0.068131,-0.023621,0,0
2,ORGAN DEVELOPMENT,0.31232,0.068076,0.049003,0,0
2,REACTOME DNA REPAIR,0.17934,0.067932,0.043071,0,0
2,AMINE METABOLIC PROCESS,0.093897,0.067549,0.085751,0,0
2,CATABOLIC PROCESS,0.064293,0.067546,0.091264,0,0
2,SENSORY ORGAN DEVELOPMENT,0.51459,0.067449,0.033543,0,0
2,ORGANIC ACID TRANSPORT,0.18219,0.067342,0.11693,0,0
2,CARBOXYLIC ACID TRANSPORT,0.18219,0.067342,0.11693,0,0
2,PROTEIN DIMERIZATION ACTIVITY,0.053746,0.067224,0.084786,0,0
2,SPLICEOSOME ASSEMBLY,0.44402,0.067125,0.044227,0,0
2,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.14769,0.066522,0.14627,0,0
2,MACROMOLECULE BIOSYNTHETIC PROCESS,0.12473,0.066432,0.059825,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.39858,0.06634,0.0091647,0,0
2,CYTOPLASMIC PART,0.092194,0.066295,0.042235,0,0
2,PEPTIDE BINDING,0.54903,0.066289,0.01338,0,0
2,PURINE RIBONUCLEOTIDE BINDING,0.046579,0.06602,0.062933,0,0
2,ANATOMICAL STRUCTURE FORMATION,0.19095,0.065385,0.064878,0,0
2,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.21256,0.065338,0.095914,0,0
2,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.31653,0.065282,0.069792,0,0
2,REACTOME SIGNALING BY NOTCH2,0.60272,0.064059,0.032954,0,0
2,ENDOSOME,0.3746,0.064051,0.050729,0,0
2,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.90599,0.063973,-0.024767,0,0
2,ATP BINDING,0.11039,0.063311,0.052245,0,0
2,SYMPORTER ACTIVITY,0.28785,0.063214,0.067826,0,0
2,MACROMOLECULE CATABOLIC PROCESS,0.053746,0.062982,0.099307,0,0
2,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.44402,0.062919,0.061316,0,0
2,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,0.17099,0.062678,0.10833,0,0
2,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,0.54321,0.062442,0.0069103,0,0
2,PROTEOLYSIS,0.28785,0.061893,0.049292,0,0
2,HYDRO LYASE ACTIVITY,0.98255,0.061879,0.0028348,0,0
2,PID FANCONI PATHWAY,0.42855,0.061268,0.047669,0,0
2,REACTOME GLYCOLYSIS,0.22905,0.061183,0.13397,0,0
2,PID LYMPHANGIOGENESIS PATHWAY,0.94073,0.060793,-0.032136,0,0
2,REACTOME TIE2 SIGNALING,0.33812,0.060749,0.10643,0,0
2,REACTOME THE ACTIVATION OF ARYLSULFATASES,0.85082,0.06041,0.01679,0,0
2,ST GA12 PATHWAY,0.04854,0.060241,0.1193,0,0
2,AGING,0.55487,0.06015,0.07303,0,0
2,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.72969,0.060132,0.016375,0,0
2,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.14048,0.059699,0.063211,0,0
2,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,0.24288,0.05954,0.10885,0,0
2,BIOCARTA IL22BP PATHWAY,0.43367,0.05932,0.056219,0,0
2,TRNA METABOLIC PROCESS,0.55487,0.059114,0.071808,0,0
2,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.81668,0.059113,-0.017798,0,0
2,REACTOME MITOTIC M M G1 PHASES,0.1313,0.059023,0.076223,0,0
2,POSITIVE REGULATION OF CELL DIFFERENTIATION,0.39858,0.058869,0.08624,0,0
2,REGULATION OF PROTEIN STABILITY,0.22568,0.058819,0.073021,0,0
2,RESPONSE TO WOUNDING,0.24288,0.058792,0.047127,0,0
2,REACTOME SIGNAL AMPLIFICATION,0.67137,0.058643,0.038426,0,0
2,NUCLEOTIDE BINDING,0.088862,0.058057,0.058341,0,0
2,NUCLEOTIDE METABOLIC PROCESS,0.12908,0.058045,0.082127,0,0
2,REGULATION OF CELL PROLIFERATION,0.15517,0.057998,0.043716,0,0
2,MYELOID LEUKOCYTE DIFFERENTIATION,0.56075,0.057729,0.026411,0,0
2,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,0.41842,0.057702,0.076942,0,0
2,SERINE HYDROLASE ACTIVITY,0.88523,0.057442,-0.012961,0,0
2,APOPTOSIS GO,0.15517,0.057441,0.055621,0,0
2,REPRODUCTIVE PROCESS,0.42855,0.057433,0.016107,0,0
2,BIOCARTA PDGF PATHWAY,0.34702,0.057326,0.062567,0,0
2,PID NFAT 3PATHWAY,0.38888,0.057076,0.030311,0,0
2,AMINO ACID CATABOLIC PROCESS,0.31232,0.056954,0.079868,0,0
2,PID ARF6 TRAFFICKINGPATHWAY,0.50337,0.056448,0.023082,0,0
2,SIG IL4RECEPTOR IN B LYPHOCYTES,0.23937,0.056425,0.10572,0,0
2,N ACETYLTRANSFERASE ACTIVITY,0.12259,0.056377,0.1193,0,0
2,N ACYLTRANSFERASE ACTIVITY,0.12259,0.056377,0.1193,0,0
2,ACTIN FILAMENT ORGANIZATION,0.29184,0.056342,0.060534,0,0
2,BIOCARTA NKT PATHWAY,0.57857,0.056298,0.026215,0,0
2,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.41341,0.056236,-0.002231,0,0
2,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.18219,0.056101,0.054232,0,0
2,POSITIVE REGULATION OF CELLULAR PROCESS,0.084046,0.056005,0.069541,0,0
2,REACTOME SIGNALING BY NOTCH,0.21579,0.055937,0.053012,0,0
2,PROGRAMMED CELL DEATH,0.16828,0.055799,0.053739,0,0
2,CELL FRACTION,0.52025,0.05579,0.016213,0,0
2,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.69061,0.055702,0.0080965,0,0
2,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.56666,0.055309,0.073978,0,0
2,PROTEIN LOCALIZATION,0.24288,0.054886,0.041662,0,0
2,REGULATION OF ACTIN FILAMENT LENGTH,0.23937,0.054578,0.21609,0,0
2,REGULATION OF DEVELOPMENTAL PROCESS,0.11434,0.054514,0.063024,0,0
2,REACTOME ACTIVATION OF GENES BY ATF4,0.11841,0.054256,0.10955,0,0
2,DNA DAMAGE CHECKPOINT,0.30402,0.054168,0.06085,0,0
2,CELLULAR MACROMOLECULE METABOLIC PROCESS,0.05161,0.053987,0.053346,0,0
2,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.98255,0.053712,-0.0027837,0,0
2,CARBOHYDRATE KINASE ACTIVITY,0.71006,0.053256,-0.060447,0,0
2,REACTOME SPHINGOLIPID METABOLISM,0.87833,0.053007,-0.028982,0,0
2,ST G ALPHA I PATHWAY,0.43367,0.052977,0.041153,0,0
2,KEGG ALZHEIMERS DISEASE,0.12689,0.052939,0.069532,0,0
2,PID FOXOPATHWAY,0.4978,0.052778,0.034897,0,0
2,SIG CHEMOTAXIS,0.38888,0.052708,0.043658,0,0
2,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.38408,0.052466,0.040665,0,0
2,REACTOME HS GAG DEGRADATION,0.47588,0.052462,0.11309,0,0
2,KINASE ACTIVITY,0.11235,0.052442,0.047684,0,0
2,REACTOME REGULATION OF SIGNALING BY CBL,0.64605,0.052404,0.13951,0,0
2,REACTOME SHC MEDIATED SIGNALLING,0.83713,0.052206,0.019312,0,0
2,PID DNAPK PATHWAY,0.049546,0.052106,0.1066,0,0
2,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.84397,0.051936,-0.010805,0,0
2,LIPID RAFT,0.53167,0.051637,0.010319,0,0
2,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,0.90599,0.05147,0.026362,0,0
2,GROWTH,0.93377,0.051291,0.0070651,0,0
2,PID AR TF PATHWAY,0.12908,0.051181,0.081101,0,0
2,ACTIN FILAMENT BASED PROCESS,0.20621,0.051177,0.059871,0,0
2,PHOSPHORYLATION,0.093897,0.051121,0.049534,0,0
2,MYELOID CELL DIFFERENTIATION,0.23245,0.050942,0.076174,0,0
2,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,0.047551,0.050414,0.15636,0,0
2,ADAPTIVE IMMUNE RESPONSE,0.36526,0.050292,-0.00044796,0,0
2,REACTOME MITOTIC G1 G1 S PHASES,0.064293,0.050256,0.09549,0,0
2,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.40349,0.050219,0.03415,0,0
2,KEGG PANCREATIC CANCER,0.060602,0.049898,0.089822,0,0
2,REACTOME RAP1 SIGNALLING,0.91293,0.049862,-0.0048678,0,0
2,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.53167,0.049785,0.020227,0,0
2,DIGESTION,0.9686,0.049629,0.010238,0,0
2,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,0.36526,0.049463,0.14561,0,0
2,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.39858,0.049374,0.045684,0,0
2,PROTEIN MODIFICATION PROCESS,0.13814,0.048902,0.039926,0,0
2,REACTOME FANCONI ANEMIA PATHWAY,0.30815,0.048689,0.046413,0,0
2,REACTOME DNA REPLICATION,0.50896,0.048612,0.041677,0,0
2,BIOCARTA NFAT PATHWAY,0.31232,0.048231,0.046478,0,0
2,GTPASE REGULATOR ACTIVITY,0.16559,0.048118,0.079754,0,0
2,BIOPOLYMER MODIFICATION,0.13583,0.047929,0.040784,0,0
2,EMBRYONIC DEVELOPMENT,0.75615,0.047886,0.010317,0,0
2,INTRINSIC TO ORGANELLE MEMBRANE,0.70355,0.047845,0.004775,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.061812,0.047617,0.05501,0,0
2,INORGANIC ANION TRANSPORT,0.81668,0.047454,0.0056225,0,0
2,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.12908,0.047172,0.050975,0,0
2,LYASE ACTIVITY,0.92682,0.046768,-0.0081687,0,0
2,REACTOME METABOLISM OF CARBOHYDRATES,0.19695,0.046738,0.06648,0,0
2,REACTOME IL RECEPTOR SHC SIGNALING,0.49227,0.046297,0.086364,0,0
2,RESPONSE TO STRESS,0.47588,0.046116,0.018129,0,0
2,ENDOPEPTIDASE ACTIVITY,0.67137,0.045839,-0.012889,0,0
2,CHROMOSOME SEGREGATION,0.15264,0.045695,0.09275,0,0
2,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.24643,0.04569,0.051102,0,0
2,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,0.23245,0.045636,0.074445,0,0
2,CHEMOKINE ACTIVITY,0.16559,0.045301,0.081154,0,0
2,CHEMOKINE RECEPTOR BINDING,0.16559,0.045301,0.081154,0,0
2,AMINO ACID TRANSPORT,0.20621,0.045194,0.1348,0,0
2,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.60272,0.044793,0.01157,0,0
2,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.73628,0.044524,0.062771,0,0
2,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.29184,0.043954,0.029767,0,0
2,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.64605,0.043925,0.0082752,0,0
2,REACTOME PI 3K CASCADE,0.47588,0.043749,0.037449,0,0
2,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.29184,0.043643,0.055069,0,0
2,CELL CYCLE PROCESS,0.21905,0.043359,0.048521,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.39371,0.043334,0.05546,0,0
2,BIOCARTA ERK5 PATHWAY,0.29586,0.043068,0.098338,0,0
2,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.70355,0.042736,0.037068,0,0
2,CARBOHYDRATE CATABOLIC PROCESS,0.70355,0.042736,0.037068,0,0
2,APOPTOTIC NUCLEAR CHANGES,0.87144,0.042671,0.006687,0,0
2,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,0.72313,0.042658,0.011566,0,0
2,REGULATION OF DNA REPLICATION,0.39858,0.042593,0.066553,0,0
2,REACTOME CELL CYCLE MITOTIC,0.25729,0.042548,0.045752,0,0
2,ST GAQ PATHWAY,0.14769,0.042544,0.10398,0,0
2,REACTOME CIRCADIAN CLOCK,0.32938,0.04248,0.077407,0,0
2,BIOPOLYMER BIOSYNTHETIC PROCESS,0.68418,0.042465,-0.061747,0,0
2,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.19393,0.042447,0.038087,0,0
2,REACTOME METABOLISM OF PROTEINS,0.17374,0.04238,0.064757,0,0
2,LIPID BIOSYNTHETIC PROCESS,0.80989,0.042352,-0.0095448,0,0
2,GOLGI APPARATUS,0.21905,0.042319,0.030682,0,0
2,PID AURORA B PATHWAY,0.54903,0.041552,0.046805,0,0
2,REGULATION OF BINDING,0.56075,0.04153,0.025351,0,0
2,BIOCARTA SHH PATHWAY,0.34256,0.041425,0.10651,0,0
2,INTEGRAL TO ORGANELLE MEMBRANE,0.74288,0.041422,0.0051391,0,0
2,KEGG AXON GUIDANCE,0.81668,0.0413,-0.038188,0,0
2,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.30402,0.041112,0.035359,0,0
2,BIOCARTA BAD PATHWAY,0.50337,0.040694,0.071754,0,0
2,BIOCARTA MEF2D PATHWAY,0.60883,0.039863,0.040682,0,0
2,CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.61497,0.039785,0.018419,0,0
2,MAINTENANCE OF PROTEIN LOCALIZATION,0.59664,0.039699,0.073739,0,0
2,REGULATION OF CELLULAR COMPONENT SIZE,0.17653,0.039588,0.20889,0,0
2,POSITIVE REGULATION OF BIOLOGICAL PROCESS,0.15517,0.03909,0.055217,0,0
2,CELL CORTEX PART,0.76281,0.038776,0.015673,0,0
2,REACTOME P38MAPK EVENTS,0.66501,0.038292,0.0054767,0,0
2,REACTOME HS GAG BIOSYNTHESIS,0.51459,0.038285,0.066847,0,0
2,KEGG HISTIDINE METABOLISM,0.69707,0.037917,0.052236,0,0
2,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.71658,0.037698,0.023855,0,0
2,ST ERK1 ERK2 MAPK PATHWAY,0.74288,0.037467,0.0080884,0,0
2,ANATOMICAL STRUCTURE MORPHOGENESIS,0.14769,0.037467,0.058868,0,0
2,BIOCARTA CFTR PATHWAY,0.78962,0.03718,0.016891,0,0
2,ST G ALPHA S PATHWAY,0.50337,0.037053,0.035686,0,0
2,BONE REMODELING,0.26847,0.037034,0.080263,0,0
2,ALCOHOL METABOLIC PROCESS,0.67776,0.037006,0.01426,0,0
2,PID IL3 PATHWAY,0.71658,0.036989,0.035523,0,0
2,PID INTEGRIN3 PATHWAY,0.40349,0.036869,0.095894,0,0
2,PID MTOR 4PATHWAY,0.18508,0.036833,0.060937,0,0
2,CELL DEVELOPMENT,0.70355,0.036657,0.0061172,0,0
2,PID TCRCALCIUMPATHWAY,0.55487,0.035586,0.018838,0,0
2,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.17374,0.035452,0.050712,0,0
2,CYTOKINE ACTIVITY,0.94073,0.034938,-0.014623,0,0
2,REGULATION OF MITOSIS,0.099158,0.033542,0.069596,0,0
2,POSITIVE REGULATION OF BINDING,0.38408,0.033534,0.039344,0,0
2,KEGG PYRIMIDINE METABOLISM,0.47588,0.033455,0.022813,0,0
2,MRNA PROCESSING GO 0006397,0.71006,0.033115,0.0092808,0,0
2,SINGLE STRANDED DNA BINDING,0.26098,0.032993,0.089758,0,0
2,KEGG P53 SIGNALING PATHWAY,0.71658,0.032895,0.026494,0,0
2,CELL MATRIX JUNCTION,0.18508,0.032705,0.14224,0,0
2,WNT SIGNALING,0.52025,0.032502,0.045682,0,0
2,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.74288,0.032317,0.027544,0,0
2,RHYTHMIC PROCESS,0.33812,0.032269,0.048857,0,0
2,ESTABLISHMENT OF PROTEIN LOCALIZATION,0.43367,0.032111,0.027157,0,0
2,PID SHP2 PATHWAY,0.36064,0.031292,0.051778,0,0
2,RESPONSE TO ABIOTIC STIMULUS,0.50337,0.03092,0.03151,0,0
2,PID AMB2 NEUTROPHILS PATHWAY,0.67776,0.030819,-0.076735,0,0
2,CATION HOMEOSTASIS,0.68418,0.030804,-0.00095886,0,0
2,TRANSCRIPTION FACTOR ACTIVITY,0.74288,0.030796,0.013785,0,0
2,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.48678,0.030656,0.036206,0,0
2,KEGG LEISHMANIA INFECTION,0.19095,0.03053,0.078783,0,0
2,VESICLE MEDIATED TRANSPORT,1,0.030496,-0.0051123,0,0
2,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.14285,0.030425,0.043183,0,0
2,DNA DEPENDENT DNA REPLICATION,0.87144,0.030303,0.02302,0,0
2,DNA CATABOLIC PROCESS,0.55487,0.030244,0.049443,0,0
2,KEGG RNA POLYMERASE,0.29184,0.029832,0.096833,0,0
2,ISOMERASE ACTIVITY,0.80989,0.029418,0.054395,0,0
2,REACTOME CELL CYCLE,0.5726,0.029311,0.027533,0,0
2,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.34256,0.029125,0.052882,0,0
2,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.72313,0.029025,0.11768,0,0
2,RESPONSE TO ORGANIC SUBSTANCE,0.56075,0.028999,-0.094861,0,0
2,GLYCOSAMINOGLYCAN BINDING,0.64605,0.028387,0.046609,0,0
2,POLYSACCHARIDE BINDING,0.64605,0.028387,0.046609,0,0
2,SPINDLE MICROTUBULE,0.68418,0.028218,0.038477,0,0
2,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.63978,0.028217,0.040376,0,0
2,MACROMOLECULAR COMPLEX,0.24288,0.028128,0.027769,0,0
2,RESPONSE TO RADIATION,0.56075,0.028057,0.0311,0,0
2,CARBON OXYGEN LYASE ACTIVITY,0.90599,0.027705,-0.012609,0,0
2,PROTEIN KINASE ACTIVITY,0.4545,0.027049,0.023213,0,0
2,BASE EXCISION REPAIR,0.89215,0.027034,0.011035,0,0
2,PID TRKRPATHWAY,0.76948,0.026497,0.005482,0,0
2,REACTOME DNA STRAND ELONGATION,0.85082,0.026304,0.006955,0,0
2,PID INTEGRIN2 PATHWAY,0.89907,0.026026,-0.084625,0,0
2,KEGG BASAL TRANSCRIPTION FACTORS,0.62113,0.025913,0.045662,0,0
2,REACTOME CELL JUNCTION ORGANIZATION,0.62732,0.025556,0.022131,0,0
2,EXOPEPTIDASE ACTIVITY,0.66501,0.025502,0.067911,0,0
2,REACTOME SIGNALING BY SCF KIT,0.34702,0.025341,0.058036,0,0
2,TRANSCRIPTION ACTIVATOR ACTIVITY,0.27611,0.025324,0.039876,0,0
2,REACTOME IL 7 SIGNALING,0.94073,0.024251,-0.028578,0,0
2,BIOCARTA BCR PATHWAY,0.43883,0.024187,0.065228,0,0
2,ANGIOGENESIS,0.67137,0.023983,0.020397,0,0
2,PID E2F PATHWAY,0.61497,0.023949,0.029839,0,0
2,PID CONE PATHWAY,0.52025,0.023886,0.25343,0,0
2,REACTOME O LINKED GLYCOSYLATION OF MUCINS,0.44924,0.023602,0.0010763,0,0
2,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.49227,0.023487,0.056995,0,0
2,REACTOME SIGNALING BY NOTCH3,0.85768,0.023474,0.00023882,0,0
2,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.36991,0.023462,0.055831,0,0
2,REACTOME GLUCONEOGENESIS,0.38888,0.02346,0.076777,0,0
2,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.12049,0.023434,0.057946,0,0
2,REACTOME MITOTIC PROMETAPHASE,0.77618,0.023321,0.032612,0,0
2,PROTEIN AMINO ACID LIPIDATION,0.91293,0.023274,0.044986,0,0
2,BIOCARTA CALCINEURIN PATHWAY,0.80312,0.023216,-0.049983,0,0
2,REGULATION OF HOMEOSTATIC PROCESS,0.96163,0.023158,-0.015643,0,0
2,CYTOKINESIS,0.50337,0.022726,0.075759,0,0
2,REACTOME REGULATION OF KIT SIGNALING,0.96163,0.022538,0.010077,0,0
2,HOMEOSTATIC PROCESS,0.59059,0.02234,0.0095545,0,0
2,RESPONSE TO ENDOGENOUS STIMULUS,0.29184,0.022331,0.056751,0,0
2,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.53742,0.02179,0.048108,0,0
2,CONDENSED NUCLEAR CHROMOSOME,0.94073,0.021673,0.0059712,0,0
2,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.77618,0.021673,0.013301,0,0
2,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.69061,0.021604,0.029235,0,0
2,AEROBIC RESPIRATION,0.73628,0.02142,0.04712,0,0
2,PROTEIN COMPLEX,0.4545,0.021226,0.016982,0,0
2,BASEMENT MEMBRANE,0.55487,0.020995,0.08529,0,0
2,PID BMPPATHWAY,0.29184,0.020914,0.10654,0,0
2,BIOCARTA CCR3 PATHWAY,0.86455,0.020773,0.0002939,0,0
2,ENZYME REGULATOR ACTIVITY,0.4978,0.020734,0.017868,0,0
2,KEGG TIGHT JUNCTION,0.84397,0.02073,0.0096705,0,0
2,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.70355,0.020725,0.049252,0,0
2,PID TGFBRPATHWAY,0.29992,0.020484,0.053866,0,0
2,CHROMATIN MODIFICATION,0.34256,0.019824,0.035416,0,0
2,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.89215,0.019484,0.0085819,0,0
2,KEGG TGF BETA SIGNALING PATHWAY,0.88523,0.019353,0.019445,0,0
2,PROTEOGLYCAN METABOLIC PROCESS,0.52025,0.019031,0.032674,0,0
2,KEGG GAP JUNCTION,0.71658,0.018943,-0.036033,0,0
2,MEMBRANE COAT,0.32938,0.018729,0.07404,0,0
2,COATED MEMBRANE,0.32938,0.018729,0.07404,0,0
2,CELLULAR CATION HOMEOSTASIS,0.78289,0.018378,-0.0064673,0,0
2,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.77618,0.018377,-0.069112,0,0
2,PID PI3KPLCTRKPATHWAY,0.91987,0.018173,-0.0020319,0,0
2,REGULATION OF CYTOKINE PRODUCTION,0.76281,0.017805,-0.080241,0,0
2,KEGG INSULIN SIGNALING PATHWAY,0.34702,0.017479,0.034698,0,0
2,REACTOME MYOGENESIS,0.80989,0.017249,-0.014104,0,0
2,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.60883,0.017166,0.054644,0,0
2,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.24643,0.016938,0.11194,0,0
2,ATPASE ACTIVITY,0.57857,0.016869,0.0042617,0,0
2,BIOCARTA STATHMIN PATHWAY,0.85768,0.016645,-0.0085911,0,0
2,KEGG WNT SIGNALING PATHWAY,0.78289,0.016539,-0.003265,0,0
2,CARBOHYDRATE TRANSPORT,0.96163,0.016499,-0.017962,0,0
2,GUANYL NUCLEOTIDE BINDING,0.76281,0.016266,0.017122,0,0
2,VESICLE COAT,0.29586,0.016019,0.092633,0,0
2,REACTOME ADP SIGNALLING THROUGH P2RY1,0.95466,0.015948,0.022159,0,0
2,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.96163,0.015652,-0.012144,0,0
2,IDENTICAL PROTEIN BINDING,0.76948,0.01543,-0.014239,0,0
2,REACTOME DSCAM INTERACTIONS,0.72969,0.015371,-0.083072,0,0
2,BIOCARTA ACH PATHWAY,0.22568,0.01537,0.13239,0,0
2,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.66501,0.015093,0.027232,0,0
2,CELLULAR LOCALIZATION,0.52594,0.014777,0.010762,0,0
2,INSOLUBLE FRACTION,0.54321,0.014689,0.071668,0,0
2,UNFOLDED PROTEIN BINDING,0.95466,0.014591,0.016528,0,0
2,BIOCARTA MTA3 PATHWAY,0.67137,0.014559,0.050033,0,0
2,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.52594,0.014531,0.033759,0,0
2,SIGNAL TRANSDUCTION,0.84397,0.014241,-0.017979,0,0
2,CELL SUBSTRATE ADHESION,0.91987,0.014156,-0.019047,0,0
2,CELL MATRIX ADHESION,0.91987,0.014156,-0.019047,0,0
2,ENDONUCLEASE ACTIVITY,0.30815,0.014147,0.11013,0,0
2,BIOCARTA NO1 PATHWAY,0.63978,0.014113,0.027242,0,0
2,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.36526,0.014024,0.06235,0,0
2,MAINTENANCE OF LOCALIZATION,0.46512,0.013777,0.05598,0,0
2,GROWTH FACTOR BINDING,0.66501,0.012988,0.0093474,0,0
2,GALACTOSYLTRANSFERASE ACTIVITY,0.52594,0.012495,0.056245,0,0
2,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.94769,0.012391,-0.013312,0,0
2,VACUOLE,0.94769,0.012347,-0.032579,0,0
2,REACTOME SIGNALING BY BMP,0.52025,0.012343,0.11124,0,0
2,MITOTIC CELL CYCLE CHECKPOINT,0.94769,0.012311,-0.011964,0,0
2,PID CDC42 PATHWAY,0.98953,0.012175,0.0073216,0,0
2,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.7495,0.012151,-0.034857,0,0
2,PID IL1PATHWAY,0.11636,0.012078,0.10226,0,0
2,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,1,0.0119,0.025011,0,0
2,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.67776,0.011891,0.024707,0,0
2,REACTOME ACTIVATED TLR4 SIGNALLING,0.59059,0.011486,0.0070824,0,0
2,PID AR NONGENOMIC PATHWAY,0.36991,0.011334,0.083075,0,0
2,ESTABLISHMENT OF CELLULAR LOCALIZATION,0.43367,0.011309,0.014115,0,0
2,PATTERN BINDING,0.51459,0.011226,0.044745,0,0
2,STEROID METABOLIC PROCESS,0.94073,0.011067,-0.0074341,0,0
2,REGULATION OF BIOLOGICAL QUALITY,0.77618,0.011062,-0.012834,0,0
2,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.5726,0.010916,-0.046564,0,0
2,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.94073,0.010834,-0.0036932,0,0
2,PID MAPKTRKPATHWAY,0.63354,0.010621,-0.031294,0,0
2,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.93377,0.010523,0.0046614,0,0
2,PROTEIN HOMODIMERIZATION ACTIVITY,0.76281,0.010401,0.012577,0,0
2,THIOLESTER HYDROLASE ACTIVITY,0.85768,0.010276,0.0074015,0,0
2,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,0.9686,0.010243,-0.041458,0,0
2,EXTRACELLULAR MATRIX PART,0.4598,0.010205,0.071179,0,0
2,REACTOME SHC RELATED EVENTS,0.98255,0.0099741,-0.010721,0,0
2,BIOCARTA MAPK PATHWAY,0.87833,0.0099149,0.014556,0,0
2,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.5726,0.0098359,-0.03869,0,0
2,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.60272,0.0094731,0.035383,0,0
2,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.98255,0.0092229,-0.01579,0,0
2,PID P53DOWNSTREAMPATHWAY,0.85082,0.0089562,0.01382,0,0
2,COATED VESICLE MEMBRANE,0.39371,0.0080402,0.081327,0,0
2,RESPONSE TO DRUG,0.97557,0.0078155,0.010508,0,0
2,PID EPHRINBREVPATHWAY,0.88523,0.0077774,-0.0048586,0,0
2,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.71658,0.0076905,0.013306,0,0
2,PHOSPHOLIPID METABOLIC PROCESS,0.97557,0.0074506,-0.013357,0,0
2,KEGG SPHINGOLIPID METABOLISM,0.98255,0.0074184,-0.012327,0,0
2,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.90599,0.0072758,-0.0013455,0,0
2,PID AP1 PATHWAY,0.89215,0.0071925,-0.029709,0,0
2,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.72313,0.0071045,0.022967,0,0
2,BIOCARTA PPARA PATHWAY,0.36991,0.0069557,0.060911,0,0
2,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.85082,0.0063488,-0.0028727,0,0
2,REACTOME CA DEPENDENT EVENTS,0.85082,0.0061797,-0.011803,0,0
2,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,0.42855,0.0059171,0.089436,0,0
2,REACTOME GAP JUNCTION ASSEMBLY,0.67137,0.0058987,-0.0066127,0,0
2,BIOCARTA TNFR2 PATHWAY,0.94073,0.0058407,-0.046153,0,0
2,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.87144,0.0058021,0.0063509,0,0
2,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.79636,0.0057234,-0.023323,0,0
2,CELLULAR HOMEOSTASIS,0.63354,0.0055956,-0.037265,0,0
2,NEGATIVE REGULATION OF GROWTH,0.70355,0.0053337,-0.038991,0,0
2,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.50896,0.0051403,0.026153,0,0
2,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.94769,0.0051233,0.010371,0,0
2,HORMONE METABOLIC PROCESS,0.95466,0.0049502,-0.0056262,0,0
2,RESPONSE TO CHEMICAL STIMULUS,0.89215,0.0046295,-0.014297,0,0
2,BIOCARTA EGF PATHWAY,0.8303,0.0045152,0.012534,0,0
2,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.88523,0.0044152,-0.020193,0,0
2,NUCLEAR BODY,0.63978,0.0043047,-0.030468,0,0
2,BIOCARTA TCR PATHWAY,0.95466,0.0041211,-0.0082166,0,0
2,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.90599,0.0040413,-0.0076753,0,0
2,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.66501,0.0038673,0.041676,0,0
2,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.60272,0.0035359,-0.026692,0,0
2,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.99651,0.0033512,-0.0072252,0,0
2,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.36064,0.0031618,-0.1237,0,0
2,BIOCARTA MPR PATHWAY,0.85768,0.0030109,-0.010833,0,0
2,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.80989,0.0029342,-0.025171,0,0
2,BIOCARTA CARM ER PATHWAY,0.26471,0.0024257,0.088259,0,0
2,UBIQUITIN LIGASE COMPLEX,0.65234,0.002215,0.064491,0,0
2,SMALL GTPASE REGULATOR ACTIVITY,0.44402,0.0021697,0.048589,0,0
2,NEGATIVE REGULATION OF METABOLIC PROCESS,0.58456,0.0018991,-0.027313,0,0
2,NEGATIVE REGULATION OF TRANSCRIPTION,0.90599,0.0018621,-0.0084284,0,0
2,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.63978,0.0016297,0.039584,0,0
2,TRANSPORT,0.42347,0.0012059,-0.033556,0,0
2,REGULATION OF ACTION POTENTIAL,0.71006,0.0011071,-0.066671,0,0
2,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,0.96163,0.0011037,-0.033475,0,0
2,DNA METABOLIC PROCESS,0.78289,0.0010985,0.021826,0,0
2,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.89907,0.00086311,0.0092916,0,0
2,CELLULAR LIPID CATABOLIC PROCESS,0.89215,0.00065788,0.0024764,0,0
2,REACTOME SIGNALING BY FGFR IN DISEASE,0.73628,0.00014861,0.017663,0,0
2,TIGHT JUNCTION,0.82348,0.00011967,0.04106,0,0
2,MITOSIS,0.87144,-8.7045e-05,0.02137,0,0
2,PID PLK1 PATHWAY,0.73628,-0.00016536,-0.024633,0,0
2,REACTOME SIGNALING BY FGFR3 MUTANTS,0.56666,-0.0005138,-0.073566,0,0
2,REACTOME RNA POL I TRANSCRIPTION,0.80989,-0.00062023,-0.0020884,0,0
2,NUCLEAR CHROMOSOME PART,0.86455,-0.00083162,-0.033883,0,0
2,REACTOME PLC BETA MEDIATED EVENTS,0.79636,-0.0010237,-0.022163,0,0
2,REACTOME PROTEIN FOLDING,0.96163,-0.0011375,-0.0091665,0,0
2,MEMBRANE,0.52025,-0.0011428,-0.034693,0,0
2,DNA BINDING,0.69707,-0.0013972,0.021778,0,0
2,ST GA13 PATHWAY,0.62113,-0.0014299,0.025371,0,0
2,LIPID CATABOLIC PROCESS,0.85082,-0.0014883,0.0064267,0,0
2,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.68418,-0.0017151,-0.03813,0,0
2,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.49227,-0.0017324,0.04315,0,0
2,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.94769,-0.0018218,-0.011226,0,0
2,PID CXCR4 PATHWAY,0.62732,-0.0019406,0.03944,0,0
2,BIOCARTA MCALPAIN PATHWAY,0.33812,-0.002387,0.078133,0,0
2,KEGG PARKINSONS DISEASE,0.63978,-0.0024008,0.026862,0,0
2,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,0.30815,-0.0026001,0.095353,0,0
2,RNA POLYMERASE ACTIVITY,0.77618,-0.002969,0.026804,0,0
2,BIOCARTA BIOPEPTIDES PATHWAY,0.54903,-0.0030672,-0.050403,0,0
2,REACTOME SIGNALLING BY NGF,0.89215,-0.0031263,-0.00098715,0,0
2,TRANSCRIPTION COACTIVATOR ACTIVITY,0.99651,-0.0031903,0.01485,0,0
2,JNK CASCADE,0.65866,-0.0033412,-0.012537,0,0
2,ORGAN MORPHOGENESIS,0.87833,-0.0034177,0.010419,0,0
2,KEGG TYROSINE METABOLISM,0.60883,-0.0034986,0.044529,0,0
2,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.52025,-0.003554,-0.03458,0,0
2,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.61497,-0.0036976,0.034318,0,0
2,ATPASE ACTIVITY COUPLED,0.92682,-0.0037612,-0.011333,0,0
2,REACTOME SIGNALING BY NOTCH1,0.47588,-0.0039373,-0.038218,0,0
2,PROTEINACEOUS EXTRACELLULAR MATRIX,0.85082,-0.0039822,0.032113,0,0
2,EXTRACELLULAR MATRIX,0.85082,-0.0039822,0.032113,0,0
2,GLUCOSE METABOLIC PROCESS,0.83713,-0.0040047,-0.023512,0,0
2,KEGG BASAL CELL CARCINOMA,0.58456,-0.0041344,-0.059613,0,0
2,INTRACELLULAR SIGNALING CASCADE,0.51459,-0.0042506,-0.027592,0,0
2,REACTOME ELONGATION ARREST AND RECOVERY,0.87144,-0.0042803,0.0089045,0,0
2,MEIOTIC CELL CYCLE,0.70355,-0.0046515,-0.028761,0,0
2,SENSORY PERCEPTION,0.54321,-0.0049605,0.062831,0,0
2,NUCLEASE ACTIVITY,0.76281,-0.005119,0.046663,0,0
2,BIOCARTA INSULIN PATHWAY,0.79636,-0.0053438,0.012631,0,0
2,ST WNT CA2 CYCLIC GMP PATHWAY,0.78289,-0.0054793,0.056796,0,0
2,REGULATION OF GENE EXPRESSION EPIGENETIC,0.75615,-0.0055374,0.024079,0,0
2,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.8303,-0.0055397,0.04208,0,0
2,NON MEMBRANE BOUND ORGANELLE,0.85768,-0.005597,0.0056656,0,0
2,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.85768,-0.005597,0.0056656,0,0
2,PID FRA PATHWAY,0.83713,-0.0058122,-0.031755,0,0
2,CIRCADIAN RHYTHM,0.57857,-0.0060972,-0.054429,0,0
2,BIOCARTA KERATINOCYTE PATHWAY,0.80989,-0.0063108,0.0083604,0,0
2,HUMORAL IMMUNE RESPONSE,0.93377,-0.0065498,-0.061862,0,0
2,MEMBRANE PART,0.44924,-0.0068628,-0.038593,0,0
2,CHROMATIN BINDING,0.66501,-0.007274,-0.0081954,0,0
2,BIOCARTA PGC1A PATHWAY,0.94769,-0.0073887,-0.0037732,0,0
2,PID SMAD2 3PATHWAY,0.87144,-0.0075369,0.012445,0,0
2,ACTIN BINDING,0.73628,-0.0077155,-0.022399,0,0
2,BIOCARTA IGF1R PATHWAY,0.51459,-0.0078509,0.054503,0,0
2,LIPID TRANSPORTER ACTIVITY,0.66501,-0.007881,0.0089606,0,0
2,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.75615,-0.008257,-0.020695,0,0
2,POSITIVE REGULATION OF TRANSPORT,0.97557,-0.008287,0.00063618,0,0
2,REACTOME IL 2 SIGNALING,0.93377,-0.0082905,0.013871,0,0
2,KEGG GNRH SIGNALING PATHWAY,0.56075,-0.0087938,-0.031792,0,0
2,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,0.8303,-0.0088406,-0.0003493,0,0
2,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.85768,-0.0088429,-0.0087695,0,0
2,PID IL23PATHWAY,0.85082,-0.0091269,-0.028345,0,0
2,LIPOPROTEIN BINDING,0.88523,-0.0092697,-0.049305,0,0
2,BIOCARTA PYK2 PATHWAY,0.53742,-0.0093335,-0.067001,0,0
2,BIOCARTA CXCR4 PATHWAY,0.55487,-0.0093849,-0.043346,0,0
2,BIOCARTA CSK PATHWAY,0.91293,-0.0093993,-0.013348,0,0
2,CELL CYCLE CHECKPOINT GO 0000075,0.67776,-0.0094359,0.037159,0,0
2,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.48131,-0.0096926,-0.018883,0,0
2,TRANSCRIPTION FACTOR BINDING,0.68418,-0.0099539,0.021552,0,0
2,REACTOME TRIF MEDIATED TLR3 SIGNALING,0.80989,-0.010046,-0.024244,0,0
2,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.80989,-0.01013,0.019328,0,0
2,REACTOME NEPHRIN INTERACTIONS,0.94073,-0.010314,0.030692,0,0
2,REACTOME TIGHT JUNCTION INTERACTIONS,0.82348,-0.010653,0.0093028,0,0
2,PID NFAT TFPATHWAY,0.93377,-0.010877,-0.0052622,0,0
2,REPRODUCTION,0.69707,-0.010982,-0.030666,0,0
2,DNA REPAIR,0.47588,-0.011701,-0.021369,0,0
2,REACTOME COMMON PATHWAY,0.9686,-0.01188,0.00079254,0,0
2,REGULATION OF DNA METABOLIC PROCESS,0.54903,-0.012253,0.036275,0,0
2,TRANSCRIPTION REPRESSOR ACTIVITY,0.87144,-0.012498,0.0084664,0,0
2,PROTEIN COMPLEX BINDING,0.7495,-0.012514,-0.038129,0,0
2,DNA PACKAGING,0.8303,-0.012552,-0.006048,0,0
2,CELLULAR RESPIRATION,0.87833,-0.012933,-0.0061933,0,0
2,ST STAT3 PATHWAY,0.85082,-0.012936,-0.0081951,0,0
2,ESTABLISHMENT OF LOCALIZATION,0.2839,-0.013033,-0.04039,0,0
2,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.47049,-0.013147,0.04151,0,0
2,CHEMICAL HOMEOSTASIS,0.67776,-0.013402,-0.035422,0,0
2,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.82348,-0.013524,-0.0052315,0,0
2,KEGG MISMATCH REPAIR,0.66501,-0.013667,-0.070278,0,0
2,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.83713,-0.013702,-0.016408,0,0
2,DNA REPLICATION,0.82348,-0.014023,0.011105,0,0
2,REACTOME GAB1 SIGNALOSOME,0.9686,-0.014289,0.003094,0,0
2,REACTOME G ALPHA Q SIGNALLING EVENTS,0.87833,-0.014464,-0.00040523,0,0
2,SPINDLE,0.53167,-0.015283,0.061345,0,0
2,REACTOME GAP JUNCTION TRAFFICKING,0.69061,-0.01529,0.005324,0,0
2,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.68418,-0.015401,-0.04306,0,0
2,REACTOME G1 PHASE,0.72313,-0.015609,0.026144,0,0
2,M PHASE OF MITOTIC CELL CYCLE,0.85082,-0.015703,0.022649,0,0
2,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,0.85082,-0.01573,-0.0093527,0,0
2,CONDENSED CHROMOSOME,0.60883,-0.016461,-0.027034,0,0
2,PID ERBB1 DOWNSTREAM PATHWAY,0.96163,-0.01675,0.0029187,0,0
2,REACTOME SIGNALING BY ERBB2,0.76948,-0.016858,-0.012935,0,0
2,BLOOD COAGULATION,0.88523,-0.017249,-0.0033396,0,0
2,REACTOME BASE EXCISION REPAIR,0.60883,-0.01726,-0.034148,0,0
2,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,0.95466,-0.017434,0.016161,0,0
2,BIOCARTA NTHI PATHWAY,0.50896,-0.017753,-0.063484,0,0
2,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.60272,-0.017921,0.080833,0,0
2,VASCULATURE DEVELOPMENT,0.86455,-0.018024,-0.018082,0,0
2,VITAMIN TRANSPORT,0.7495,-0.018194,-0.026027,0,0
2,INTEGRAL TO MEMBRANE,0.20309,-0.0183,-0.057131,0,0
2,PLASMA MEMBRANE,0.21579,-0.018398,-0.057123,0,0
2,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.98953,-0.018429,-0.0040559,0,0
2,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.30402,-0.019055,-0.048537,0,0
2,DETECTION OF EXTERNAL STIMULUS,0.17934,-0.019536,-0.031428,0,0
2,PID RHOA PATHWAY,0.80989,-0.019719,0.022506,0,0
2,PROTEIN KINASE CASCADE,0.91293,-0.020041,-0.012911,0,0
2,REGULATION OF MAP KINASE ACTIVITY,0.78289,-0.02014,-0.016342,0,0
2,REGULATION OF DNA BINDING,0.67137,-0.020505,0.023406,0,0
2,BIOCARTA TOLL PATHWAY,0.76948,-0.020587,-0.062998,0,0
2,REACTOME GLYCOSPHINGOLIPID METABOLISM,0.56075,-0.02089,-0.042701,0,0
2,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.88523,-0.021061,0.032677,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,0.74288,-0.021212,-0.040651,0,0
2,ION BINDING,0.20309,-0.021267,-0.051455,0,0
2,REACTOME SEMAPHORIN INTERACTIONS,0.68418,-0.021665,-0.070611,0,0
2,PROTEIN DOMAIN SPECIFIC BINDING,0.76948,-0.021692,-0.020073,0,0
2,NEGATIVE REGULATION OF CELL PROLIFERATION,0.74288,-0.021967,-0.010264,0,0
2,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.98255,-0.02199,0.0012666,0,0
2,HEMOSTASIS,0.4545,-0.021992,-0.027378,0,0
2,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.80989,-0.022075,-0.03917,0,0
2,PID NCADHERINPATHWAY,0.68418,-0.022686,-0.035181,0,0
2,DAMAGED DNA BINDING,0.14526,-0.022738,-0.066633,0,0
2,INTEGRIN COMPLEX,0.78962,-0.022924,0.081642,0,0
2,RECEPTOR BINDING,0.26847,-0.023471,-0.05713,0,0
2,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.59059,-0.02353,0.064892,0,0
2,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,0.62732,-0.024348,-0.082457,0,0
2,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.59664,-0.024512,-0.070378,0,0
2,APICAL JUNCTION COMPLEX,0.98953,-0.024651,0.013682,0,0
2,APICOLATERAL PLASMA MEMBRANE,0.98953,-0.024651,0.013682,0,0
2,PID ATR PATHWAY,0.75615,-0.024687,0.03368,0,0
2,PID RHODOPSIN PATHWAY,0.52594,-0.024848,0.081537,0,0
2,PLASMA MEMBRANE PART,0.20621,-0.025292,-0.059507,0,0
2,ENZYME BINDING,0.25001,-0.025393,-0.033502,0,0
2,PID DELTANP63PATHWAY,0.97557,-0.025474,0.039353,0,0
2,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.40843,-0.025752,-0.018974,0,0
2,PID LKB1 PATHWAY,0.65234,-0.025805,0.02007,0,0
2,REGULATION OF CELL GROWTH,0.96163,-0.025808,-0.013446,0,0
2,ION HOMEOSTASIS,0.39371,-0.026141,-0.05825,0,0
2,KEGG COLORECTAL CANCER,0.9686,-0.026162,0.020634,0,0
2,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,0.39858,-0.026731,0.046429,0,0
2,INNATE IMMUNE RESPONSE,0.14048,-0.027226,-0.19037,0,0
2,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,0.72313,-0.027379,-0.029982,0,0
2,KEGG CELL CYCLE,0.60272,-0.027505,0.0034679,0,0
2,CELL SURFACE,0.76281,-0.028073,0.025986,0,0
2,INTRINSIC TO MEMBRANE,0.15517,-0.028519,-0.061527,0,0
2,ST P38 MAPK PATHWAY,0.91293,-0.028534,-0.016094,0,0
2,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.93377,-0.02881,0.0042159,0,0
2,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.80312,-0.029165,-0.010826,0,0
2,PROTEIN POLYMERIZATION,0.97557,-0.029253,0.078483,0,0
2,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.52594,-0.029306,-0.081417,0,0
2,STRUCTURE SPECIFIC DNA BINDING,1,-0.029466,0.039923,0,0
2,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.63978,-0.029504,-0.0080767,0,0
2,COLLAGEN BINDING,0.46512,-0.029548,-0.14755,0,0
2,ANATOMICAL STRUCTURE DEVELOPMENT,0.5726,-0.02962,-0.02357,0,0
2,BIOCARTA AGPCR PATHWAY,0.59059,-0.029773,0.09949,0,0
2,BIOCARTA IL7 PATHWAY,0.65234,-0.029977,0.044482,0,0
2,PML BODY,0.39858,-0.030155,-0.11151,0,0
2,EXTRACELLULAR REGION,0.33812,-0.030184,-0.063842,0,0
2,REGULATION OF HYDROLASE ACTIVITY,0.51459,-0.030297,-0.029437,0,0
2,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.4545,-0.030395,-0.033616,0,0
2,M PHASE,0.94073,-0.031135,0.012866,0,0
2,PID AURORA A PATHWAY,0.78962,-0.031213,-0.023492,0,0
2,GTP BINDING,0.95466,-0.031429,0.0013145,0,0
2,REGULATION OF PROTEIN KINASE ACTIVITY,0.21579,-0.031495,-0.042464,0,0
2,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.52025,-0.031593,-0.023866,0,0
2,BIOCARTA AT1R PATHWAY,0.32506,-0.031898,-0.069506,0,0
2,PID AVB3 OPN PATHWAY,0.38888,-0.032029,-0.061825,0,0
2,PROTEIN PROCESSING,0.58456,-0.032274,-0.027691,0,0
2,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.35607,-0.032359,-0.10297,0,0
2,REACTOME GLYCOSAMINOGLYCAN METABOLISM,0.98255,-0.032518,-0.00094215,0,0
2,PID CDC42 REG PATHWAY,0.50337,-0.032647,-0.034904,0,0
2,BIOCARTA CREB PATHWAY,0.52025,-0.033102,-0.066806,0,0
2,KEGG NITROGEN METABOLISM,0.96163,-0.0334,0.031016,0,0
2,CARBOHYDRATE METABOLIC PROCESS,0.18508,-0.033513,-0.074513,0,0
2,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.9686,-0.034098,0.0013325,0,0
2,CASPASE ACTIVATION,0.33373,-0.034173,-0.059803,0,0
2,REGULATION OF KINASE ACTIVITY,0.20621,-0.034441,-0.039956,0,0
2,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.7495,-0.034484,-0.0155,0,0
2,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.94769,-0.034582,0.0085923,0,0
2,REACTOME SIGNALING BY EGFR IN CANCER,0.22905,-0.034806,-0.038017,0,0
2,REACTOME SIGNALING BY FGFR,0.69061,-0.034872,-0.010469,0,0
2,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.48678,-0.034923,-0.044812,0,0
2,RECEPTOR COMPLEX,0.87833,-0.034944,0.023514,0,0
2,BILE ACID METABOLIC PROCESS,0.78962,-0.034974,0.11217,0,0
2,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.41842,-0.035088,-0.046377,0,0
2,CYTOSKELETON,0.32938,-0.035474,-0.023133,0,0
2,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.30815,-0.035735,-0.052114,0,0
2,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.4978,-0.035861,-0.02676,0,0
2,PID VEGFR1 PATHWAY,0.67137,-0.035926,-0.056628,0,0
2,PID CD40 PATHWAY,0.68418,-0.036716,-0.043814,0,0
2,RECEPTOR ACTIVITY,0.10845,-0.037451,-0.081392,0,0
2,CALCIUM INDEPENDENT CELL CELL ADHESION,0.70355,-0.037481,-0.04352,0,0
2,INTEGRAL TO PLASMA MEMBRANE,0.15773,-0.037574,-0.064741,0,0
2,COAGULATION,0.58456,-0.03763,-0.024118,0,0
2,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.60883,-0.037763,-0.026943,0,0
2,BIOCARTA D4GDI PATHWAY,0.92682,-0.038135,0.070657,0,0
2,LYTIC VACUOLE,0.60883,-0.038154,-0.059129,0,0
2,LYSOSOME,0.60883,-0.038154,-0.059129,0,0
2,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.41842,-0.038197,-0.031606,0,0
2,SISTER CHROMATID SEGREGATION,0.44402,-0.038297,-0.031752,0,0
2,PID HEDGEHOG GLIPATHWAY,0.53742,-0.038304,-0.02464,0,0
2,REACTOME MITOTIC G2 G2 M PHASES,0.188,-0.038322,-0.059944,0,0
2,REGULATION OF IMMUNE SYSTEM PROCESS,0.18508,-0.040002,-0.10665,0,0
2,BIOCARTA TNFR1 PATHWAY,0.94769,-0.040252,0.037916,0,0
2,PID TCRRASPATHWAY,0.44402,-0.040312,-0.066888,0,0
2,PROTEIN OLIGOMERIZATION,0.65234,-0.040345,0.041561,0,0
2,NOTCH SIGNALING PATHWAY,0.15015,-0.040747,-0.11736,0,0
2,REACTOME PYRIMIDINE METABOLISM,0.62732,-0.040839,-0.069364,0,0
2,PID GMCSF PATHWAY,0.67776,-0.04169,-0.022255,0,0
2,TRANSCRIPTION INITIATION,0.59059,-0.041759,-0.0042356,0,0
2,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.14285,-0.042186,-0.079895,0,0
2,PID HDAC CLASSII PATHWAY,0.188,-0.042574,-0.080174,0,0
2,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.96163,-0.042586,-0.025558,0,0
2,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.29586,-0.042646,-0.045019,0,0
2,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.42347,-0.04288,-0.097778,0,0
2,REGULATION OF TRANSFERASE ACTIVITY,0.188,-0.042954,-0.04469,0,0
2,ST FAS SIGNALING PATHWAY,0.066855,-0.043417,-0.10634,0,0
2,REACTOME ION TRANSPORT BY P TYPE ATPASES,0.31232,-0.043978,-0.066621,0,0
2,ACTIVATION OF MAPK ACTIVITY,0.71006,-0.04415,-0.017691,0,0
2,REGULATION OF HEART CONTRACTION,0.25363,-0.044782,-0.080574,0,0
2,MICROTUBULE BASED MOVEMENT,0.15773,-0.045123,-0.091666,0,0
2,BIOCARTA PLCE PATHWAY,0.69061,-0.045179,-0.026934,0,0
2,REACTOME CS DS DEGRADATION,0.2839,-0.045537,-0.17309,0,0
2,REACTOME ARMS MEDIATED ACTIVATION,0.15015,-0.04555,-0.071492,0,0
2,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.30402,-0.045779,-0.051565,0,0
2,T CELL ACTIVATION,0.69061,-0.0458,-0.05694,0,0
2,INTRINSIC TO PLASMA MEMBRANE,0.11636,-0.04583,-0.070628,0,0
2,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.80989,-0.046357,0.089705,0,0
2,ENZYME INHIBITOR ACTIVITY,0.20309,-0.046412,-0.080973,0,0
2,CELLULAR COMPONENT DISASSEMBLY,0.66501,-0.046792,-0.027926,0,0
2,BIOCARTA G2 PATHWAY,0.63354,-0.047094,-0.026518,0,0
2,RESPONSE TO EXTRACELLULAR STIMULUS,0.51459,-0.047104,-0.02469,0,0
2,SYSTEM DEVELOPMENT,0.19393,-0.047144,-0.059007,0,0
2,BIOCARTA BCELLSURVIVAL PATHWAY,0.59059,-0.04729,-0.067976,0,0
2,RESPONSE TO DNA DAMAGE STIMULUS,0.51459,-0.047462,-0.013484,0,0
2,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.4978,-0.047666,-0.018825,0,0
2,PID P75NTRPATHWAY,0.57857,-0.04772,-0.032331,0,0
2,BIOCARTA TGFB PATHWAY,0.89215,-0.048026,0.0083391,0,0
2,TRANSCRIPTION COFACTOR ACTIVITY,0.26847,-0.048092,-0.019152,0,0
2,MEMBRANE BOUND VESICLE,0.14048,-0.04832,-0.087535,0,0
2,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.32938,-0.048946,-0.068143,0,0
2,RUFFLE,0.77618,-0.049304,0.019172,0,0
2,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,0.33373,-0.049399,-0.054606,0,0
2,PATTERN SPECIFICATION PROCESS,0.54903,-0.049449,-0.057272,0,0
2,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.44924,-0.050059,-0.032559,0,0
2,PEPTIDE RECEPTOR ACTIVITY,0.67137,-0.050341,-0.049698,0,0
2,REACTOME G0 AND EARLY G1,0.4598,-0.050523,-0.050903,0,0
2,MONOOXYGENASE ACTIVITY,0.99651,-0.050656,0.00096937,0,0
2,MITOTIC SISTER CHROMATID SEGREGATION,0.21579,-0.051625,-0.064269,0,0
2,CATION BINDING,0.12689,-0.052512,-0.068138,0,0
2,ENDOSOME TRANSPORT,0.68418,-0.052764,-0.016379,0,0
2,WOUND HEALING,0.69707,-0.053461,-0.020579,0,0
2,REACTOME DARPP 32 EVENTS,0.64605,-0.053687,0.033864,0,0
2,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,0.89215,-0.053948,0.021079,0,0
2,METALLOEXOPEPTIDASE ACTIVITY,0.71658,-0.054047,0.042319,0,0
2,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.31653,-0.054636,-0.07297,0,0
2,KEGG DORSO VENTRAL AXIS FORMATION,0.91987,-0.054963,0.029617,0,0
2,KEGG PURINE METABOLISM,0.73628,-0.055003,0.044944,0,0
2,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.063042,-0.055342,-0.06324,0,0
2,PROTEIN AUTOPROCESSING,0.80989,-0.055508,-0.0066445,0,0
2,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.38888,-0.05582,-0.045592,0,0
2,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.29586,-0.056091,-0.035038,0,0
2,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.50337,-0.056294,-0.032064,0,0
2,MAGNESIUM ION BINDING,0.25729,-0.056374,-0.045479,0,0
2,UDP GLYCOSYLTRANSFERASE ACTIVITY,0.63978,-0.056579,-0.055115,0,0
2,REACTOME SIGNALING BY FGFR1 MUTANTS,1,-0.057331,0.017062,0,0
2,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.11841,-0.057913,-0.057328,0,0
2,CELL DIVISION,0.7495,-0.05792,0.05062,0,0
2,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.62732,-0.058451,-0.015998,0,0
2,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.25729,-0.058935,-0.042323,0,0
2,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.27999,-0.059177,-0.11081,0,0
2,NEURON APOPTOSIS,0.24288,-0.059394,-0.12388,0,0
2,BIOCARTA AGR PATHWAY,0.78962,-0.059512,-0.019484,0,0
2,PID NFKAPPABATYPICALPATHWAY,0.49227,-0.05975,-0.048666,0,0
2,VESICLE,0.092194,-0.059933,-0.094638,0,0
2,PYROPHOSPHATASE ACTIVITY,0.12908,-0.060217,-0.056033,0,0
2,CELL MIGRATION,0.62732,-0.060241,-0.024427,0,0
2,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.082489,-0.060344,-0.094246,0,0
2,EXTRACELLULAR REGION PART,0.18219,-0.060477,-0.089593,0,0
2,REGULATION OF BODY FLUID LEVELS,0.19695,-0.0605,-0.054321,0,0
2,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.055956,-0.060704,-0.098727,0,0
2,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.097379,-0.061016,-0.086032,0,0
2,REACTOME SIGNALING BY GPCR,0.082489,-0.061309,-0.064036,0,0
2,ANION CHANNEL ACTIVITY,0.4598,-0.061619,-0.069834,0,0
2,CHLORIDE CHANNEL ACTIVITY,0.4598,-0.061619,-0.069834,0,0
2,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.25001,-0.061717,-0.069187,0,0
2,PROTEIN C TERMINUS BINDING,0.25729,-0.061752,-0.061649,0,0
2,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.30402,-0.062058,-0.049838,0,0
2,CHROMOSOME,0.52594,-0.062203,-0.0091804,0,0
2,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.72313,-0.06224,0.0084234,0,0
2,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.47588,-0.062283,-0.025755,0,0
2,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.48678,-0.062546,-0.043719,0,0
2,PID ENDOTHELINPATHWAY,0.44924,-0.062597,-0.041367,0,0
2,VACUOLE ORGANIZATION AND BIOGENESIS,0.83713,-0.063127,-0.0067046,0,0
2,REACTOME HYALURONAN METABOLISM,0.58456,-0.063521,-0.052577,0,0
2,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.51459,-0.063585,-0.029964,0,0
2,PHOSPHOLIPID BINDING,0.44924,-0.063694,-0.047693,0,0
2,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.95466,-0.063758,0.0013252,0,0
2,SOLUBLE FRACTION,0.12259,-0.064282,-0.097126,0,0
2,CHROMATIN ASSEMBLY,0.52025,-0.064762,-0.058662,0,0
2,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.12049,-0.066275,-0.099839,0,0
2,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.27227,-0.067097,-0.067208,0,0
2,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.91987,-0.06712,0.03273,0,0
2,CELLULAR RESPONSE TO STIMULUS,0.48678,-0.067166,-0.0022638,0,0
2,REACTOME INFLAMMASOMES,0.8303,-0.067174,-0.078647,0,0
2,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,0.65866,-0.067628,-0.043994,0,0
2,REACTOME SIGNALING BY PDGF,0.93377,-0.067734,0.011026,0,0
2,BIOCARTA ATM PATHWAY,0.64605,-0.067913,-0.014045,0,0
2,CHROMOSOMAL PART,0.47049,-0.06806,-0.0076849,0,0
2,CYTOSKELETAL PROTEIN BINDING,0.055956,-0.068377,-0.098002,0,0
2,EXCRETION,0.31653,-0.068761,-0.071009,0,0
2,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.41341,-0.068919,-0.062342,0,0
2,BIOCARTA TPO PATHWAY,0.37932,-0.068935,-0.069472,0,0
2,DOUBLE STRANDED DNA BINDING,0.85768,-0.06942,0.088235,0,0
2,AXON GUIDANCE,0.32506,-0.069582,-0.11665,0,0
2,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.62113,-0.069698,-0.024848,0,0
2,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.41341,-0.07021,-0.067739,0,0
2,AMINE TRANSPORT,0.8303,-0.070513,-0.0042272,0,0
2,LIPOPROTEIN METABOLIC PROCESS,0.66501,-0.071558,0.010193,0,0
2,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.26471,-0.071771,-0.038332,0,0
2,KEGG CALCIUM SIGNALING PATHWAY,0.085627,-0.07195,-0.075444,0,0
2,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.24643,-0.07235,-0.053777,0,0
2,INTERMEDIATE FILAMENT CYTOSKELETON,0.35607,-0.072352,-0.034452,0,0
2,INTERMEDIATE FILAMENT,0.35607,-0.072352,-0.034452,0,0
2,REGULATION OF GROWTH,0.2,-0.072628,-0.071347,0,0
2,SYNAPSE ORGANIZATION AND BIOGENESIS,0.11841,-0.072978,-0.19537,0,0
2,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.69707,-0.073079,-0.013538,0,0
2,MEMBRANE LIPID METABOLIC PROCESS,0.11039,-0.073326,-0.076069,0,0
2,SA B CELL RECEPTOR COMPLEXES,0.56666,-0.073381,-0.023377,0,0
2,S PHASE,0.087232,-0.073706,-0.131,0,0
2,EXTERNAL SIDE OF PLASMA MEMBRANE,0.63978,-0.073869,-0.036248,0,0
2,CLATHRIN COATED VESICLE,0.055956,-0.074641,-0.10706,0,0
2,INTEGRIN BINDING,0.71658,-0.074682,-0.045664,0,0
2,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.25729,-0.074815,-0.05683,0,0
2,N METHYLTRANSFERASE ACTIVITY,0.59059,-0.075602,-0.054807,0,0
2,REGULATION OF MOLECULAR FUNCTION,0.14526,-0.0762,-0.050581,0,0
2,REACTOME STEROID HORMONES,0.31232,-0.076413,-0.087514,0,0
2,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,0.35153,-0.077003,-0.056828,0,0
2,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.084046,-0.077548,-0.10819,0,0
2,REACTOME G ALPHA I SIGNALLING EVENTS,0.049546,-0.077624,-0.084804,0,0
2,CYTOPLASMIC VESICLE,0.060602,-0.077921,-0.10239,0,0
2,ZINC ION BINDING,0.14769,-0.078039,-0.068111,0,0
2,BIOCARTA CELLCYCLE PATHWAY,0.35153,-0.078347,-0.058766,0,0
2,REACTOME CELL CELL JUNCTION ORGANIZATION,0.26471,-0.078609,-0.079309,0,0
2,POSITIVE REGULATION OF CASPASE ACTIVITY,0.60272,-0.078918,-0.032104,0,0
2,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.15773,-0.07934,-0.05604,0,0
2,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.59664,-0.079602,0.0057095,0,0
2,REACTOME GPCR DOWNSTREAM SIGNALING,0.047551,-0.079802,-0.070459,0,0
2,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.30815,-0.080247,-0.078058,0,0
2,SMALL CONJUGATING PROTEIN BINDING,0.13355,-0.0804,-0.10137,0,0
2,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.29184,-0.081117,-0.048753,0,0
2,PID WNT NONCANONICAL PATHWAY,0.15517,-0.081597,-0.081751,0,0
2,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.88523,-0.081722,-0.010023,0,0
2,DNA DEPENDENT ATPASE ACTIVITY,0.42855,-0.081968,-0.059867,0,0
2,LYSOSOMAL TRANSPORT,0.41341,-0.082462,-0.11691,0,0
2,BIOCARTA AKAPCENTROSOME PATHWAY,0.4598,-0.082647,-0.065629,0,0
2,REACTOME OPIOID SIGNALLING,0.23589,-0.083316,-0.072732,0,0
2,REGULATION OF CATALYTIC ACTIVITY,0.046579,-0.083877,-0.06829,0,0
2,NUCLEAR ORGANIZATION AND BIOGENESIS,0.22235,-0.083956,-0.060642,0,0
2,PID IL2 1PATHWAY,0.29992,-0.084007,-0.062248,0,0
2,SULFOTRANSFERASE ACTIVITY,0.88523,-0.084051,-0.0087629,0,0
2,TRANSITION METAL ION BINDING,0.60883,-0.084143,-0.023426,0,0
2,ST INTEGRIN SIGNALING PATHWAY,0.38888,-0.084662,-0.049821,0,0
2,CHROMATIN,0.60883,-0.084823,-0.027516,0,0
2,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.42347,-0.086305,-0.11555,0,0
2,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.43883,-0.086429,-0.066497,0,0
2,EXTRINSIC TO PLASMA MEMBRANE,0.54903,-0.086678,-0.059776,0,0
2,REACTOME KINESINS,0.20309,-0.087724,-0.15506,0,0
2,PROTEIN DNA COMPLEX ASSEMBLY,0.05824,-0.087945,-0.070087,0,0
2,BIOCARTA PLATELETAPP PATHWAY,0.85082,-0.088121,0.069345,0,0
2,KEGG PRION DISEASES,0.13583,-0.088755,-0.095177,0,0
2,KEGG GLYCEROLIPID METABOLISM,0.42347,-0.089135,-0.040084,0,0
2,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.047551,-0.089634,-0.1594,0,0
2,PID CXCR3PATHWAY,0.068167,-0.089809,-0.10913,0,0
2,PID PI3KCIAKTPATHWAY,0.065563,-0.091204,-0.067002,0,0
2,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,0.049546,-0.092335,-0.16931,0,0
2,PID WNT SIGNALING PATHWAY,0.50896,-0.092911,-0.11802,0,0
2,PID NEPHRIN NEPH1 PATHWAY,0.25729,-0.093263,-0.079799,0,0
2,LEADING EDGE,0.2,-0.093295,-0.063273,0,0
2,KEGG OOCYTE MEIOSIS,0.11636,-0.093638,-0.055975,0,0
2,REACTOME CD28 CO STIMULATION,0.26471,-0.094623,-0.041201,0,0
2,REACTOME AXON GUIDANCE,0.14769,-0.09487,-0.081555,0,0
2,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.39371,-0.095356,-0.043016,0,0
2,REACTOME PI3K AKT ACTIVATION,0.088862,-0.095615,-0.085416,0,0
2,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.81668,-0.096738,0.018368,0,0
2,MICROTUBULE ORGANIZING CENTER PART,0.26847,-0.097628,-0.067145,0,0
2,PID ER NONGENOMIC PATHWAY,0.093897,-0.098598,-0.11794,0,0
2,COFACTOR TRANSPORT,0.13814,-0.098688,-0.13432,0,0
2,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.070855,-0.099623,-0.11356,0,0
2,REACTOME DEVELOPMENTAL BIOLOGY,0.13583,-0.10047,-0.067954,0,0
2,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.13583,-0.10048,-0.086894,0,0
2,PID ERA GENOMIC PATHWAY,0.18219,-0.10055,-0.075751,0,0
2,PID NETRIN PATHWAY,0.11841,-0.10082,-0.11368,0,0
2,TRANS GOLGI NETWORK,1,-0.10095,0.023302,0,0
2,METALLOENDOPEPTIDASE ACTIVITY,0.188,-0.10116,-0.1242,0,0
2,KEGG GLYCOSAMINOGLYCAN DEGRADATION,0.51459,-0.1012,-0.058145,0,0
2,REGULATION OF JNK CASCADE,0.19393,-0.10209,-0.12381,0,0
2,TUBE DEVELOPMENT,0.27611,-0.10215,-0.10711,0,0
2,BIOCARTA GPCR PATHWAY,0.16294,-0.1027,-0.1031,0,0
2,RESPONSE TO NUTRIENT,0.24643,-0.1028,-0.12386,0,0
2,REACTOME SIGNALLING TO RAS,0.099158,-0.10342,-0.091278,0,0
2,RESPONSE TO NUTRIENT LEVELS,0.27999,-0.10411,-0.055553,0,0
2,REACTOME ERKS ARE INACTIVATED,0.23937,-0.10437,-0.10064,0,0
2,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.055956,-0.10513,-0.15088,0,0
2,REACTOME ERK MAPK TARGETS,0.13583,-0.10556,-0.11401,0,0
2,PID THROMBIN PAR4 PATHWAY,0.12908,-0.10559,-0.099578,0,0
2,PID ARF6DOWNSTREAMPATHWAY,0.25729,-0.10568,-0.063412,0,0
2,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.1313,-0.10593,-0.10316,0,0
2,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.33373,-0.1062,-0.063088,0,0
2,BIOCARTA EPO PATHWAY,0.11235,-0.10795,-0.14763,0,0
2,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.10096,-0.10799,-0.13624,0,0
2,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.10096,-0.10799,-0.13624,0,0
2,NEGATIVE REGULATION OF DNA BINDING,0.36991,-0.11063,-0.11909,0,0
2,NEGATIVE REGULATION OF BINDING,0.47588,-0.11142,-0.084039,0,0
2,SIALYLTRANSFERASE ACTIVITY,0.47588,-0.11174,-0.096079,0,0
2,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.050569,-0.11183,-0.076752,0,0
2,BIOCARTA RB PATHWAY,0.94769,-0.11214,0.012946,0,0
2,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.26471,-0.11235,-0.053847,0,0
2,REACTOME NCAM1 INTERACTIONS,0.52594,-0.11332,-0.052368,0,0
2,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.047551,-0.11401,-0.078766,0,0
2,KEGG LONG TERM DEPRESSION,0.23937,-0.11455,-0.075526,0,0
2,PID IL12 STAT4PATHWAY,0.1313,-0.11463,-0.16211,0,0
2,REACTOME SIGNALING BY ROBO RECEPTOR,0.055956,-0.11529,-0.14106,0,0
2,NUCLEAR CHROMOSOME,0.12473,-0.11605,-0.08889,0,0
2,BIOCARTA MCM PATHWAY,0.25729,-0.11763,-0.066906,0,0
2,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.52025,-0.11861,-0.04017,0,0
2,PID ALK1PATHWAY,0.47049,-0.11893,-0.08124,0,0
2,KEGG OLFACTORY TRANSDUCTION,0.095625,-0.12205,-0.071209,0,0
2,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.21905,-0.12428,-0.044314,0,0
2,REACTOME TELOMERE MAINTENANCE,0.14048,-0.12444,-0.11853,0,0
2,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.24643,-0.12503,-0.085916,0,0
2,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.10096,-0.12512,-0.1711,0,0
2,REGULATION OF MAPKKK CASCADE,0.092194,-0.1252,-0.12434,0,0
2,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.60883,-0.12591,-0.031252,0,0
2,PID ANTHRAXPATHWAY,0.77618,-0.12787,0.0092876,0,0
2,REACTOME ENOS ACTIVATION AND REGULATION,0.10845,-0.12985,-0.14334,0,0
2,RESPIRATORY GASEOUS EXCHANGE,0.44402,-0.13012,-0.072565,0,0
2,KEGG DILATED CARDIOMYOPATHY,0.0695,-0.13098,-0.11781,0,0
2,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.097379,-0.13152,-0.16655,0,0
2,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.093897,-0.13201,-0.15712,0,0
2,REACTOME INSULIN RECEPTOR RECYCLING,0.14048,-0.13268,-0.15766,0,0
2,PID PRLSIGNALINGEVENTSPATHWAY,0.41341,-0.13296,-0.053027,0,0
2,SEXUAL REPRODUCTION,0.090515,-0.13298,-0.08125,0,0
2,TUBE MORPHOGENESIS,0.39371,-0.13311,-0.091512,0,0
2,REACTOME MEIOTIC RECOMBINATION,0.12908,-0.13422,-0.11873,0,0
2,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,0.11235,-0.13441,-0.11751,0,0
2,BIOCARTA NUCLEARRS PATHWAY,0.27611,-0.13445,-0.084188,0,0
2,BIOCARTA IL6 PATHWAY,0.56075,-0.13459,-0.05321,0,0
2,NEUROPEPTIDE BINDING,0.15264,-0.13461,-0.13017,0,0
2,NEUROPEPTIDE RECEPTOR ACTIVITY,0.15264,-0.13461,-0.13017,0,0
2,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.26847,-0.13548,-0.17545,0,0
2,REGULATION OF BLOOD PRESSURE,0.16294,-0.13551,-0.201,0,0
2,PROTEIN HOMOOLIGOMERIZATION,0.36526,-0.13673,-0.071754,0,0
2,KEGG PROTEIN EXPORT,0.14048,-0.13698,-0.1015,0,0
2,VACUOLAR TRANSPORT,0.18219,-0.13735,-0.16622,0,0
2,PID AJDISS 2PATHWAY,0.21256,-0.13852,-0.081241,0,0
2,REACTOME CHROMOSOME MAINTENANCE,0.11434,-0.13894,-0.083635,0,0
2,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.26847,-0.13965,-0.053283,0,0
2,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.26847,-0.13965,-0.053283,0,0
2,EXTRINSIC TO MEMBRANE,0.34702,-0.14041,-0.090416,0,0
2,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.20309,-0.14109,-0.063315,0,0
2,GAMETE GENERATION,0.088862,-0.14211,-0.093847,0,0
2,REACTOME NETRIN1 SIGNALING,0.099158,-0.14352,-0.12047,0,0
2,REACTOME PLATELET HOMEOSTASIS,0.19695,-0.14607,-0.072931,0,0
2,LOCOMOTORY BEHAVIOR,0.068167,-0.14693,-0.11985,0,0
2,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.26098,-0.14735,-0.054307,0,0
2,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.16032,-0.14932,-0.11969,0,0
2,SPINDLE POLE,0.63354,-0.14978,-0.0048242,0,0
2,REACTOME ADHERENS JUNCTIONS INTERACTIONS,0.052669,-0.1502,-0.16407,0,0
2,BIOCARTA EGFR SMRTE PATHWAY,0.88523,-0.1505,0.0014853,0,0
2,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.05161,-0.15073,-0.16959,0,0
2,PHOSPHATASE REGULATOR ACTIVITY,0.073629,-0.15118,-0.13252,0,0
2,G PROTEIN COUPLED RECEPTOR BINDING,0.22905,-0.15279,-0.090137,0,0
2,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,0.16032,-0.15314,-0.075872,0,0
2,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,0.044685,-0.15321,-0.22224,0,0
2,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.12259,-0.15464,-0.083097,0,0
2,REACTOME ADP SIGNALLING THROUGH P2RY12,0.088862,-0.15547,-0.1704,0,0
2,PID ERBB2ERBB3PATHWAY,0.059411,-0.15553,-0.077738,0,0
2,CYTOKINE SECRETION,0.24643,-0.15767,-0.12494,0,0
2,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.22568,-0.16124,-0.10497,0,0
2,REGIONALIZATION,0.046579,-0.1613,-0.17826,0,0
2,MICROTUBULE,0.070855,-0.16274,-0.12096,0,0
2,REGULATION OF CYTOKINE SECRETION,0.30402,-0.16409,-0.1228,0,0
2,BIOCARTA CACAM PATHWAY,0.21905,-0.1641,-0.092272,0,0
2,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,0.14769,-0.16776,-0.12152,0,0
2,PID FASPATHWAY,0.088862,-0.17217,-0.11059,0,0
2,REACTOME AMYLOIDS,0.12908,-0.17367,-0.13023,0,0
2,PID GLYPICAN 1PATHWAY,0.15773,-0.17813,-0.13311,0,0
2,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.19095,-0.17914,-0.18756,0,0
2,REGULATION OF PROTEIN SECRETION,0.085627,-0.17957,-0.17531,0,0
2,PID HNF3BPATHWAY,0.25363,-0.17971,-0.093701,0,0
2,REACTOME MEIOSIS,0.076492,-0.18074,-0.097738,0,0
2,ARYLSULFATASE ACTIVITY,0.34702,-0.18659,-0.16399,0,0
2,PHOSPHOINOSITIDE BINDING,0.099158,-0.1886,-0.11736,0,0
2,DEVELOPMENTAL MATURATION,0.36064,-0.19143,-0.061433,0,0
2,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.066855,-0.19204,-0.19478,0,0
2,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.21905,-0.19331,-0.11582,0,0
2,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.36064,-0.19707,-0.1285,0,0
2,BIOCARTA 41BB PATHWAY,0.15015,-0.19739,-0.13246,0,0
2,CELL MATURATION,0.22568,-0.19784,-0.10581,0,0
2,KEGG PHENYLALANINE METABOLISM,0.15015,-0.19982,-0.18854,0,0
2,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,0.51459,-0.20447,-0.044355,0,0
2,PID EPHBFWDPATHWAY,0.05824,-0.2071,-0.1115,0,0
2,PID ATF2 PATHWAY,0.04854,-0.22045,-0.158,0,0
2,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.063042,-0.22092,-0.1821,0,0
2,MAP KINASE ACTIVITY,0.11039,-0.22377,-0.14457,0,0
2,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.082489,-0.22692,-0.18819,0,0
2,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,0.077957,-0.22872,-0.16904,0,0
2,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.065563,-0.23307,-0.17509,0,0
2,KEGG MATURITY ONSET DIABETES OF THE YOUNG,0.088862,-0.23356,-0.16276,0,0
2,REACTOME RNA POL I PROMOTER OPENING,0.076492,-0.24065,-0.18195,0,0
2,SULFURIC ESTER HYDROLASE ACTIVITY,0.054842,-0.24084,-0.26024,0,0
2,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.34256,-0.24703,-0.092401,0,0
2,REACTOME N GLYCAN ANTENNAE ELONGATION,0.082489,-0.25148,-0.20869,0,0
2,BIOCARTA NGF PATHWAY,0.046579,-0.25264,-0.16864,0,0
2,KEGG TASTE TRANSDUCTION,0.52025,-0.25755,-0.054819,0,0
2,BIOCARTA CK1 PATHWAY,0.76281,-0.27137,0.018266,0,0
2,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,0.20621,-0.27331,-0.11803,0,0
2,ADENYLATE CYCLASE ACTIVATION,0.10465,-0.27948,-0.18477,0,0
2,SH3 DOMAIN BINDING,0.52025,-0.30789,-0.067343,0,0
2,PID ERB GENOMIC PATHWAY,0.41842,-0.31807,-0.10801,0,0
3,REACTOME GABA A RECEPTOR ACTIVATION,3.4728e-06,1.1321,1.0074,1,1
3,GABA RECEPTOR ACTIVITY,6.8936e-07,0.79709,0.78637,1,1
3,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,2.4346e-05,0.79537,0.71991,1,1
3,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.00010092,0.78134,0.68277,1,1
3,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,2.3418e-05,0.73144,0.65727,1,1
3,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.2837e-06,0.73115,0.58478,1,1
3,GLUTAMATE SIGNALING PATHWAY,8.3127e-06,0.707,0.66411,1,1
3,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,9.7346e-05,0.6172,0.55299,1,1
3,SIALYLTRANSFERASE ACTIVITY,0.00072223,0.60489,0.55134,1,1
3,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,8.1192e-05,0.59207,0.54433,1,1
3,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.00013433,0.59033,0.50878,1,1
3,REACTOME INWARDLY RECTIFYING K CHANNELS,2.3418e-05,0.53545,0.47721,1,1
3,STRUCTURAL CONSTITUENT OF RIBOSOME,0.0032441,0.52629,0.46722,1,1
3,PID MYC PATHWAY,0.0045306,0.52044,0.3665,1,1
3,PROTEIN POLYMERIZATION,5.508e-06,0.51995,0.48333,1,1
3,REACTOME PEPTIDE CHAIN ELONGATION,0.0037331,0.5122,0.48384,1,1
3,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,6.2786e-05,0.50256,0.45064,1,1
3,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.0032441,0.47873,0.45065,1,1
3,NEURON DIFFERENTIATION,4.3218e-05,0.47656,0.41804,1,1
3,BIOCARTA NO1 PATHWAY,1.7118e-05,0.46987,0.38122,1,1
3,MAINTENANCE OF PROTEIN LOCALIZATION,8.7323e-05,0.45385,0.44952,1,1
3,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.00050664,0.4529,0.45019,1,1
3,KEGG RIBOSOME,0.0038387,0.45234,0.45499,1,1
3,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,0.00017796,0.44875,0.48902,1,1
3,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,8.3127e-06,0.44772,0.48402,1,1
3,REACTOME GABA RECEPTOR ACTIVATION,1.2308e-06,0.43385,0.44941,1,1
3,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.001986,0.43168,0.43442,1,1
3,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.0033369,0.426,0.39682,1,1
3,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,7.8282e-05,0.41915,0.48105,1,1
3,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.0040578,0.41718,0.4033,1,1
3,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.00031859,0.41712,0.3007,1,1
3,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.0006154,0.4166,0.34774,1,1
3,GENERATION OF NEURONS,5.2139e-05,0.41431,0.36019,1,1
3,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.00052342,0.409,0.41236,1,1
3,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00010092,0.40794,0.37965,1,1
3,RESPIRATORY GASEOUS EXCHANGE,0.043763,0.38855,0.20911,1,1
3,EXOCYTOSIS,0.0040578,0.38431,0.41712,1,1
3,NEUROGENESIS,2.5308e-05,0.37728,0.35789,1,1
3,REACTOME GLYCOLYSIS,0.0011549,0.37581,0.34308,1,1
3,CHROMATIN REMODELING COMPLEX,0.0017641,0.37078,0.28337,1,1
3,ACTIN FILAMENT POLYMERIZATION,0.00013917,0.36897,0.38645,1,1
3,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,6.7596e-05,0.36764,0.32985,1,1
3,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.0054795,0.3658,0.37987,1,1
3,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,4.6623e-06,0.35954,0.28464,1,1
3,REACTOME INFLUENZA LIFE CYCLE,0.0031536,0.35519,0.3628,1,1
3,BIOCARTA NDKDYNAMIN PATHWAY,0.00353,0.3513,0.27185,1,1
3,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,0.0045306,0.3512,0.26585,1,1
3,REACTOME RNA POL III CHAIN ELONGATION,4.6597e-05,0.34641,0.32169,1,1
3,LIGAND GATED CHANNEL ACTIVITY,0.0034322,0.34601,0.30137,1,1
3,FOCAL ADHESION,0.023205,0.34573,0.25962,1,1
3,AMINO ACID TRANSPORT,0.00032948,0.33308,0.30351,1,1
3,RIBOSOME BIOGENESIS AND ASSEMBLY,0.0015653,0.33142,0.35401,1,1
3,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.0006154,0.32903,0.2928,1,1
3,CARBOHYDRATE KINASE ACTIVITY,0.00057693,0.3279,0.33512,1,1
3,REGULATION OF ENDOCYTOSIS,0.0066042,0.32594,0.23936,1,1
3,PID MYC ACTIVPATHWAY,0.0017641,0.32569,0.28253,1,1
3,RRNA PROCESSING,0.0024367,0.32337,0.35687,1,1
3,RRNA METABOLIC PROCESS,0.0024367,0.32337,0.35687,1,1
3,BIOCARTA EIF PATHWAY,0.00050664,0.3213,0.33,1,1
3,TRANSLATION INITIATION FACTOR ACTIVITY,0.0022992,0.31748,0.30481,1,1
3,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.01282,0.31598,0.32825,1,1
3,EXTRINSIC TO PLASMA MEMBRANE,0.0021062,0.31312,0.28489,1,1
3,NEURON PROJECTION,0.010773,0.31029,0.29473,1,1
3,SA TRKA RECEPTOR,0.001872,0.30856,0.35588,1,1
3,ISOMERASE ACTIVITY,6.5149e-05,0.30846,0.25802,1,1
3,INTEGRIN BINDING,0.00353,0.30749,0.27878,1,1
3,REACTOME TRANSLATION,0.010506,0.30694,0.31515,1,1
3,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.001986,0.30673,0.21964,1,1
3,PID REELINPATHWAY,0.016734,0.30149,0.21149,1,1
3,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,1.4039e-05,0.29808,0.31156,1,1
3,PID P38GAMMADELTAPATHWAY,0.012508,0.29434,0.27357,1,1
3,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,0.0069616,0.29317,0.26705,1,1
3,MITOCHONDRIAL RESPIRATORY CHAIN,0.0010859,0.291,0.24797,1,1
3,KEGG GLYCOLYSIS GLUCONEOGENESIS,0.0025083,0.28898,0.23484,1,1
3,CYTOSOLIC PART,0.00012964,0.28859,0.2517,1,1
3,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.00063551,0.28784,0.32164,1,1
3,SYNAPSE PART,0.00013433,0.28622,0.33167,1,1
3,NUCLEOLAR PART,0.026586,0.28576,0.22545,1,1
3,EXTRINSIC TO MEMBRANE,0.00069957,0.28151,0.31057,1,1
3,PID S1P S1P2 PATHWAY,0.031748,0.27995,0.17343,1,1
3,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.00034072,0.277,0.27279,1,1
3,REACTOME RNA POL III TRANSCRIPTION TERMINATION,7.013e-05,0.27475,0.29421,1,1
3,VACUOLE ORGANIZATION AND BIOGENESIS,0.01282,0.27179,0.22388,1,1
3,MITOCHONDRIAL MEMBRANE PART,0.0029794,0.26997,0.2149,1,1
3,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.001986,0.2679,0.38676,1,1
3,REACTOME L1CAM INTERACTIONS,8.4205e-05,0.26482,0.2781,1,1
3,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00087311,0.26448,0.25264,1,1
3,PID CDC42 REG PATHWAY,0.0050528,0.26351,0.18091,1,1
3,KEGG CITRATE CYCLE TCA CYCLE,0.00030804,0.26337,0.29231,1,1
3,BIOCARTA CHREBP2 PATHWAY,0.00041602,0.26296,0.22824,1,1
3,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.018836,0.26177,0.2006,1,1
3,DNA DEPENDENT ATPASE ACTIVITY,0.0059384,0.25978,0.19188,1,1
3,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.00036427,0.25778,0.33303,1,1
3,MITOCHONDRIAL INNER MEMBRANE,0.00024286,0.25755,0.2548,1,1
3,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.0064317,0.25592,0.27432,1,1
3,PROTEOGLYCAN METABOLIC PROCESS,0.0053338,0.25536,0.22036,1,1
3,MAINTENANCE OF LOCALIZATION,0.00074557,0.25257,0.26253,1,1
3,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,9.7346e-05,0.25035,0.22866,1,1
3,MICROTUBULE BINDING,0.0010859,0.24923,0.24214,1,1
3,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0001165,0.24714,0.22417,1,1
3,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,5.4121e-05,0.24557,0.24319,1,1
3,PIGMENT METABOLIC PROCESS,0.001228,0.2446,0.2348,1,1
3,DNA HELICASE ACTIVITY,4.6597e-05,0.2439,0.23001,1,1
3,REACTOME MYOGENESIS,0.019283,0.2418,0.24084,1,1
3,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,0.00069957,0.24087,0.21322,1,1
3,CAMP MEDIATED SIGNALING,0.00069957,0.24087,0.21322,1,1
3,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.0073363,0.24028,0.18782,1,1
3,KEGG ARGININE AND PROLINE METABOLISM,0.0067808,0.2384,0.22679,1,1
3,ORGANIC ACID TRANSPORT,0.00037661,0.23665,0.24878,1,1
3,CARBOXYLIC ACID TRANSPORT,0.00037661,0.23665,0.24878,1,1
3,CELL SUBSTRATE ADHESION,0.014841,0.23611,0.15323,1,1
3,CELL MATRIX ADHESION,0.014841,0.23611,0.15323,1,1
3,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,1.0604e-05,0.2351,0.30001,1,1
3,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.034637,0.23415,0.19585,1,1
3,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.00031859,0.23357,0.23417,1,1
3,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,8.7323e-05,0.23356,0.23926,1,1
3,KEGG HOMOLOGOUS RECOMBINATION,0.001872,0.23309,0.22059,1,1
3,CARBON OXYGEN LYASE ACTIVITY,0.037747,0.22921,0.15603,1,1
3,PID LKB1 PATHWAY,2.0033e-05,0.22848,0.21513,1,1
3,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.00029782,0.22762,0.40425,1,1
3,PIGMENT BIOSYNTHETIC PROCESS,0.022165,0.22546,0.15263,1,1
3,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,2.4346e-05,0.22264,0.22943,1,1
3,POSITIVE REGULATION OF DNA BINDING,0.00019753,0.22215,0.18346,1,1
3,BIOCARTA ARAP PATHWAY,0.0066042,0.2212,0.16979,1,1
3,REACTOME PROTEIN FOLDING,0.0013457,0.21865,0.18059,1,1
3,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,3.8583e-05,0.21452,0.29449,1,1
3,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.033894,0.20963,0.14145,1,1
3,NEUROTRANSMITTER BINDING,0.0042883,0.20893,0.21405,1,1
3,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.00017186,0.20632,0.19544,1,1
3,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.0015653,0.20608,0.20027,1,1
3,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.0045306,0.20383,0.19933,1,1
3,PHAGOCYTOSIS,0.012508,0.20327,0.21758,1,1
3,NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0051916,0.20167,0.21533,1,1
3,REACTOME METABOLISM OF NON CODING RNA,0.0022992,0.20069,0.20402,1,1
3,REACTOME RNA POL III TRANSCRIPTION,7.0571e-06,0.19995,0.23185,1,1
3,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.037747,0.19548,0.15925,1,1
3,REACTOME GLUCONEOGENESIS,0.0069616,0.19351,0.18182,1,1
3,REACTOME RECYCLING PATHWAY OF L1,0.01282,0.19088,0.16954,1,1
3,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.00092958,0.18991,0.19811,1,1
3,DNA INTEGRITY CHECKPOINT,0.0036303,0.1896,0.1898,1,1
3,REGULATION OF CELL MIGRATION,0.02268,0.1889,0.18096,1,1
3,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.0011549,0.18876,0.18906,1,1
3,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,0.02268,0.18605,0.12946,1,1
3,REGULATION OF GTPASE ACTIVITY,0.036164,0.18539,0.14104,1,1
3,KEGG PYRUVATE METABOLISM,0.013798,0.18487,0.20533,1,1
3,VACUOLAR TRANSPORT,0.004408,0.18354,0.2334,1,1
3,ORGANELLE INNER MEMBRANE,0.00052342,0.18227,0.18373,1,1
3,KEGG RNA POLYMERASE,0.0032441,0.18187,0.2189,1,1
3,KEGG PURINE METABOLISM,0.0018173,0.17819,0.14264,1,1
3,BIOCARTA MTOR PATHWAY,0.02843,0.17808,0.1289,1,1
3,REACTOME PKB MEDIATED EVENTS,0.016734,0.17784,0.13322,1,1
3,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.012508,0.17586,0.14558,1,1
3,METHYLTRANSFERASE ACTIVITY,0.001191,0.17551,0.19298,1,1
3,MEDIATOR COMPLEX,0.0015653,0.17485,0.1781,1,1
3,REACTOME G2 M CHECKPOINTS,0.0062634,0.17095,0.15281,1,1
3,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.0038387,0.16981,0.16677,1,1
3,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0015653,0.16798,0.18482,1,1
3,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.023205,0.16632,0.15012,1,1
3,REACTOME MRNA PROCESSING,0.00019079,0.1647,0.1716,1,1
3,PID CXCR3PATHWAY,0.030383,0.16262,0.13265,1,1
3,REACTOME MRNA SPLICING MINOR PATHWAY,0.0047853,0.1601,0.17191,1,1
3,NEGATIVE REGULATION OF CELL ADHESION,0.011047,0.15989,0.19997,1,1
3,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.00057693,0.15647,0.16754,1,1
3,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.011047,0.1554,0.19268,1,1
3,SECONDARY METABOLIC PROCESS,0.019283,0.15491,0.12957,1,1
3,SMALL GTPASE REGULATOR ACTIVITY,0.010245,0.15274,0.13465,1,1
3,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.004408,0.15156,0.15362,1,1
3,REACTOME MRNA SPLICING,0.00057693,0.15016,0.17093,1,1
3,PID HDAC CLASSII PATHWAY,0.036164,0.14779,0.14215,1,1
3,RESPONSE TO UV,0.02843,0.14658,0.12169,1,1
3,REACTOME G1 S TRANSITION,0.013465,0.14358,0.12639,1,1
3,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.0099891,0.14162,0.14434,1,1
3,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.0099891,0.14138,0.13364,1,1
3,REACTOME MRNA 3 END PROCESSING,0.011612,0.14114,0.13852,1,1
3,DNA DEPENDENT DNA REPLICATION,0.0073363,0.14059,0.14169,1,1
3,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.017969,0.14032,0.14303,1,1
3,SPLICEOSOME,0.0015189,0.13715,0.16937,1,1
3,REACTOME METABOLISM OF MRNA,0.017137,0.13487,0.18796,1,1
3,REACTOME REGULATORY RNA PATHWAYS,0.011612,0.13477,0.16467,1,1
3,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.033166,0.13386,0.11763,1,1
3,AEROBIC RESPIRATION,0.033894,0.13281,0.1491,1,1
3,REACTOME METABOLISM OF RNA,0.012203,0.13107,0.19233,1,1
3,POSITIVE REGULATION OF BINDING,0.0020453,0.13107,0.12086,1,1
3,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,0.0015653,0.13036,0.12825,1,1
3,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.00045924,0.12971,0.19266,1,1
3,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.012508,0.12857,0.12236,1,1
3,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.025414,0.1285,0.13278,1,1
3,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.017137,0.12769,0.13572,1,1
3,REACTOME RNA POL II TRANSCRIPTION,0.0046564,0.12625,0.10879,1,1
3,RNA PROCESSING,0.001662,0.12354,0.12888,1,1
3,RIBONUCLEOPROTEIN COMPLEX,0.0051916,0.12262,0.15263,1,1
3,MRNA PROCESSING GO 0006397,0.015574,0.1209,0.1006,1,1
3,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.024846,0.12054,0.091913,1,1
3,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.024846,0.12054,0.091913,1,1
3,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.030383,0.11798,0.087162,1,1
3,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.012508,0.11711,0.11201,1,1
3,KEGG GLYCEROLIPID METABOLISM,0.018398,0.11511,0.13962,1,1
3,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,0.034637,0.11417,0.13919,1,1
3,REACTOME SIGNALING BY RHO GTPASES,0.026586,0.11349,0.10388,1,1
3,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.00087311,0.11316,0.12732,1,1
3,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,0.0045306,0.10101,0.11402,1,1
3,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.043763,0.09982,0.11905,1,1
3,ORGANELLE ENVELOPE,0.042857,0.097025,0.060912,1,1
3,ENVELOPE,0.042857,0.097025,0.060912,1,1
3,NUCLEOLUS,0.017969,0.095039,0.11242,1,1
3,REACTOME HIV LIFE CYCLE,0.0085714,0.094056,0.10247,1,1
3,KEGG MTOR SIGNALING PATHWAY,0.040234,0.092799,0.070893,1,1
3,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.027188,0.082956,0.098332,1,1
3,DNA REPLICATION,0.016734,0.082603,0.073102,1,1
3,REACTOME SIGNALLING BY NGF,0.03939,0.079718,0.068107,1,1
3,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.031748,0.079392,0.081891,1,1
3,REACTOME ELONGATION ARREST AND RECOVERY,0.042857,0.067362,0.11471,1,1
3,MRNA METABOLIC PROCESS,0.020205,0.066341,0.073503,1,1
3,KEGG BASE EXCISION REPAIR,0.041967,0.062111,0.092834,1,1
3,MACROMOLECULAR COMPLEX,0.036164,0.034349,0.044182,1,1
3,GLUTAMATE RECEPTOR ACTIVITY,3.7145e-05,0.6437,0.70886,1,0
3,AXONOGENESIS,3.7145e-05,0.5287,0.50938,1,0
3,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,1.1964e-05,0.50758,0.53138,1,0
3,NEURITE DEVELOPMENT,1.7118e-05,0.5011,0.48264,1,0
3,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,7.0571e-06,0.47478,0.59512,1,0
3,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,0.0007696,0.47282,0.41951,1,0
3,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,5.0226e-05,0.46525,0.44385,1,0
3,NEURON DEVELOPMENT,7.2754e-05,0.41831,0.3655,1,0
3,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,0.0028141,0.39927,0.38363,1,0
3,AXON GUIDANCE,0.0026572,0.39313,0.3849,1,0
3,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.00031859,0.3427,0.46165,1,0
3,REACTOME GABA B RECEPTOR ACTIVATION,0.00040247,0.32462,0.30826,1,0
3,BIOCARTA CACAM PATHWAY,0.00017796,0.3214,0.37705,1,0
3,VOLTAGE GATED CATION CHANNEL ACTIVITY,0.00054072,0.31764,0.34935,1,0
3,SYNAPSE ORGANIZATION AND BIOGENESIS,0.0059384,0.31106,0.27708,1,0
3,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0056288,0.31028,0.30099,1,0
3,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.02268,0.30971,0.28563,1,0
3,REACTOME PURINE METABOLISM,0.001228,0.30592,0.26954,1,0
3,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.0001547,0.30298,0.36272,1,0
3,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,9.389e-05,0.29414,0.28509,1,0
3,PID NETRIN PATHWAY,0.00044439,0.28804,0.29382,1,0
3,POTASSIUM ION TRANSPORT,0.0018173,0.28062,0.28832,1,0
3,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,0.00090094,0.27666,0.37666,1,0
3,AMINO SUGAR METABOLIC PROCESS,0.00044439,0.27388,0.27475,1,0
3,REACTOME METABOLISM OF NUCLEOTIDES,0.00063551,0.27369,0.24563,1,0
3,VOLTAGE GATED CHANNEL ACTIVITY,0.00090094,0.26031,0.31884,1,0
3,POTASSIUM CHANNEL ACTIVITY,0.0069616,0.2601,0.27962,1,0
3,ADENYLATE CYCLASE ACTIVATION,0.02166,0.25999,0.25154,1,0
3,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,0.00036427,0.23808,0.26013,1,0
3,SYNAPTIC TRANSMISSION,0.00022676,0.23714,0.2568,1,0
3,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00057693,0.2365,0.27671,1,0
3,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00057693,0.2365,0.27671,1,0
3,BIOCARTA PROTEASOME PATHWAY,0.011326,0.23416,0.18422,1,0
3,COLLAGEN BINDING,0.031748,0.23393,0.13338,1,0
3,CATION CHANNEL ACTIVITY,0.0026572,0.23232,0.26458,1,0
3,PID RAC1 REG PATHWAY,0.00087311,0.23104,0.24955,1,0
3,GATED CHANNEL ACTIVITY,0.0020453,0.22872,0.25772,1,0
3,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,0.042857,0.22754,0.18906,1,0
3,REACTOME NEURONAL SYSTEM,0.0018173,0.22515,0.22492,1,0
3,LYSOSOMAL TRANSPORT,0.0085714,0.22399,0.25066,1,0
3,REACTOME POTASSIUM CHANNELS,0.0033369,0.21595,0.26352,1,0
3,RIBONUCLEOTIDE METABOLIC PROCESS,0.0049174,0.21505,0.20556,1,0
3,BIOCARTA NOS1 PATHWAY,0.0064317,0.21412,0.28901,1,0
3,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.033894,0.21201,0.26932,1,0
3,RIBOSOME,0.012203,0.20645,0.23822,1,0
3,PROTEIN COMPLEX BINDING,0.020205,0.20586,0.13999,1,0
3,ACETYLCHOLINE BINDING,0.037747,0.20571,0.24586,1,0
3,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,0.019283,0.20507,0.16289,1,0
3,REACTOME HDL MEDIATED LIPID TRANSPORT,0.040234,0.20421,0.21716,1,0
3,TRANSMISSION OF NERVE IMPULSE,0.00084609,0.2033,0.21886,1,0
3,PID ILK PATHWAY,0.0029794,0.20308,0.17159,1,0
3,PROTEIN FOLDING,0.0017123,0.20267,0.16955,1,0
3,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,0.0029794,0.20072,0.19765,1,0
3,REGULATION OF TRANSLATIONAL INITIATION,0.011326,0.20059,0.17819,1,0
3,FEEDING BEHAVIOR,0.015574,0.19949,0.20012,1,0
3,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.00020448,0.1985,0.22162,1,0
3,REACTOME NETRIN1 SIGNALING,0.021165,0.19556,0.19941,1,0
3,SYNAPSE,0.0069616,0.19542,0.18824,1,0
3,KEGG CARDIAC MUSCLE CONTRACTION,0.0021062,0.19401,0.19955,1,0
3,CHROMATIN ASSEMBLY,0.02166,0.19374,0.1684,1,0
3,TRANSLATIONAL INITIATION,0.010245,0.19371,0.18298,1,0
3,PID HDAC CLASSIII PATHWAY,0.015203,0.19192,0.20026,1,0
3,HETEROCYCLE METABOLIC PROCESS,0.031059,0.19168,0.15131,1,0
3,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.013139,0.19119,0.22281,1,0
3,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.009256,0.18932,0.14703,1,0
3,SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.025994,0.18727,0.14853,1,0
3,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,0.010773,0.18649,0.19848,1,0
3,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.014841,0.1797,0.17673,1,0
3,CARBOHYDRATE CATABOLIC PROCESS,0.014841,0.1797,0.17673,1,0
3,PID S1P S1P4 PATHWAY,0.027803,0.1778,0.18432,1,0
3,ST MYOCYTE AD PATHWAY,0.041093,0.17746,0.14833,1,0
3,PROTEIN RNA COMPLEX ASSEMBLY,0.0022332,0.17426,0.16876,1,0
3,KEGG AXON GUIDANCE,0.010245,0.17363,0.16234,1,0
3,PID LIS1PATHWAY,0.0025817,0.17261,0.2321,1,0
3,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0081404,0.16786,0.24294,1,0
3,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.027803,0.16558,0.17763,1,0
3,BASAL LAMINA,0.017549,0.16512,0.26198,1,0
3,REACTOME SIGNALING BY ROBO RECEPTOR,0.018836,0.16247,0.19372,1,0
3,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.0049174,0.15904,0.19737,1,0
3,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.015953,0.15784,0.20946,1,0
3,ION CHANNEL ACTIVITY,0.014138,0.15462,0.19308,1,0
3,PID FOXM1PATHWAY,0.026586,0.15398,0.12811,1,0
3,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.0085714,0.15372,0.16658,1,0
3,REACTOME RAP1 SIGNALLING,0.009256,0.1527,0.2782,1,0
3,PID AR TF PATHWAY,0.0069616,0.15177,0.13895,1,0
3,AMINE TRANSPORT,0.0059384,0.15049,0.19044,1,0
3,PID TELOMERASEPATHWAY,0.0016129,0.14986,0.1461,1,0
3,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.0015653,0.14862,0.15761,1,0
3,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.026586,0.14739,0.15918,1,0
3,MITOCHONDRIAL PART,0.016734,0.14736,0.13315,1,0
3,HEART DEVELOPMENT,0.010245,0.14015,0.17994,1,0
3,REACTOME TRNA AMINOACYLATION,0.013798,0.14009,0.2451,1,0
3,SECOND MESSENGER MEDIATED SIGNALING,0.0033369,0.13734,0.13337,1,0
3,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0083534,0.13696,0.12681,1,0
3,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.015953,0.13634,0.13699,1,0
3,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.029068,0.13623,0.11144,1,0
3,AMINE METABOLIC PROCESS,0.0073363,0.13229,0.10933,1,0
3,REACTOME BASIGIN INTERACTIONS,0.036164,0.13165,0.12803,1,0
3,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.016734,0.12965,0.13875,1,0
3,ST G ALPHA I PATHWAY,0.0087944,0.12702,0.13959,1,0
3,MITOCHONDRIAL MEMBRANE,0.025414,0.127,0.10486,1,0
3,REACTOME PYRIMIDINE METABOLISM,0.036948,0.12698,0.1112,1,0
3,JNK CASCADE,0.010773,0.12642,0.12179,1,0
3,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.043763,0.12541,0.1659,1,0
3,CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.023205,0.12449,0.095821,1,0
3,REACTOME NUCLEOTIDE EXCISION REPAIR,0.0028957,0.12331,0.13968,1,0
3,METALLOENDOPEPTIDASE ACTIVITY,0.02268,0.12312,0.12749,1,0
3,ST INTEGRIN SIGNALING PATHWAY,0.020205,0.11965,0.10423,1,0
3,KEGG DNA REPLICATION,0.041093,0.11891,0.11548,1,0
3,REACTOME FANCONI ANEMIA PATHWAY,0.020205,0.11868,0.14601,1,0
3,NUCLEAR PORE,0.036164,0.11568,0.11921,1,0
3,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.0099891,0.1154,0.1205,1,0
3,KEGG RNA DEGRADATION,0.0033369,0.11415,0.13117,1,0
3,REACTOME M G1 TRANSITION,0.03245,0.11371,0.11397,1,0
3,REACTOME MRNA CAPPING,0.0066042,0.11353,0.13044,1,0
3,TRANSITION METAL ION BINDING,0.022165,0.10822,0.075661,1,0
3,KEGG CALCIUM SIGNALING PATHWAY,0.012508,0.10701,0.11192,1,0
3,SIGNAL SEQUENCE BINDING,0.017969,0.10514,0.1445,1,0
3,NERVOUS SYSTEM DEVELOPMENT,0.013465,0.10307,0.16622,1,0
3,MITOCHONDRIAL ENVELOPE,0.016339,0.10256,0.11591,1,0
3,HELICASE ACTIVITY,0.0027346,0.10021,0.1692,1,0
3,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,0.019283,0.1001,0.2724,1,0
3,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.0014299,0.098431,0.13644,1,0
3,REACTOME AXON GUIDANCE,0.014138,0.090374,0.12316,1,0
3,REACTOME GLUCOSE METABOLISM,0.040234,0.089035,0.12134,1,0
3,G PROTEIN COUPLED RECEPTOR ACTIVITY,0.023741,0.088956,0.086663,1,0
3,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.031059,0.083334,0.1164,1,0
3,RNA SPLICING,0.010245,0.080755,0.10034,1,0
3,PID ANTHRAXPATHWAY,0.02166,0.080251,0.13284,1,0
3,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.033166,0.075548,0.095128,1,0
3,REACTOME GLOBAL GENOMIC NER GG NER,0.035393,0.07528,0.11034,1,0
3,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.026586,0.074209,0.074769,1,0
3,REACTOME MITOTIC G1 G1 S PHASES,0.016339,0.072574,0.11382,1,0
3,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.026586,0.071122,0.21074,1,0
3,KEGG SPLICEOSOME,0.023741,0.069208,0.093339,1,0
3,REACTOME DEVELOPMENTAL BIOLOGY,0.041093,0.067849,0.081133,1,0
3,TRANSCRIPTION COREPRESSOR ACTIVITY,0.015953,0.063415,0.102,1,0
3,GTPASE REGULATOR ACTIVITY,0.02843,0.061271,0.092016,1,0
3,KEGG PATHWAYS IN CANCER,0.031748,-0.024242,-0.11634,1,0
3,PROTEIN CATABOLIC PROCESS,0.042857,-0.039659,-0.080379,1,0
3,REACTOME ADAPTIVE IMMUNE SYSTEM,0.031059,-0.052722,-0.078166,1,0
3,MULTI ORGANISM PROCESS,0.037747,-0.055197,-0.13097,1,0
3,CYTOSKELETAL PART,0.024288,-0.056638,-0.066317,1,0
3,CELLULAR PROTEIN CATABOLIC PROCESS,0.034637,-0.06098,-0.10669,1,0
3,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.025994,-0.061759,-0.07604,1,0
3,REACTOME PHOSPHOLIPID METABOLISM,0.023741,-0.067162,-0.09043,1,0
3,ORGANELLE MEMBRANE,0.035393,-0.068308,-0.078335,1,0
3,REGULATION OF GROWTH,0.037747,-0.068807,-0.1092,1,0
3,RESPONSE TO OTHER ORGANISM,0.010245,-0.069695,-0.13728,1,0
3,MACROMOLECULE LOCALIZATION,0.0040578,-0.075229,-0.097038,1,0
3,NUCLEAR BODY,0.034637,-0.075549,-0.084836,1,0
3,ESTABLISHMENT OF PROTEIN LOCALIZATION,0.010506,-0.076622,-0.10265,1,0
3,PROTEIN METABOLIC PROCESS,0.033894,-0.077595,-0.064846,1,0
3,CLATHRIN COATED VESICLE,0.03245,-0.078637,-0.10154,1,0
3,KEGG VIRAL MYOCARDITIS,0.0094949,-0.080478,-0.17596,1,0
3,PURINE RIBONUCLEOTIDE BINDING,0.00095906,-0.080546,-0.1026,1,0
3,PROTEIN LOCALIZATION,0.0053338,-0.080952,-0.10212,1,0
3,INTRINSIC TO ORGANELLE MEMBRANE,0.033894,-0.08239,-0.12575,1,0
3,CELLULAR MACROMOLECULE METABOLIC PROCESS,0.031059,-0.082638,-0.060847,1,0
3,INTEGRAL TO ORGANELLE MEMBRANE,0.017969,-0.083045,-0.1461,1,0
3,IMMUNE RESPONSE,0.034637,-0.083127,-0.13797,1,0
3,REGULATION OF IMMUNE SYSTEM PROCESS,0.033166,-0.083472,-0.13381,1,0
3,ADENYL NUCLEOTIDE BINDING,0.0099891,-0.083657,-0.08296,1,0
3,CELLULAR PROTEIN METABOLIC PROCESS,0.024846,-0.08599,-0.063641,1,0
3,KEGG ACUTE MYELOID LEUKEMIA,0.043763,-0.086039,-0.07906,1,0
3,BIOCARTA IGF1R PATHWAY,0.041093,-0.086999,-0.13894,1,0
3,REGULATION OF BODY FLUID LEVELS,0.034637,-0.087605,-0.13777,1,0
3,AMINOPEPTIDASE ACTIVITY,0.034637,-0.087788,-0.19292,1,0
3,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.025994,-0.0884,-0.22509,1,0
3,PURINE NUCLEOTIDE BINDING,0.0006154,-0.08937,-0.10515,1,0
3,EXTRACELLULAR REGION,0.031748,-0.089528,-0.12292,1,0
3,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0032441,-0.089715,-0.10637,1,0
3,BIOCARTA MAL PATHWAY,0.025414,-0.089812,-0.093659,1,0
3,POST TRANSLATIONAL PROTEIN MODIFICATION,0.0062634,-0.090079,-0.075242,1,0
3,BIOPOLYMER MODIFICATION,0.0028141,-0.0901,-0.089291,1,0
3,RESPONSE TO STRESS,0.014486,-0.091053,-0.097944,1,0
3,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,0.023205,-0.091118,-0.10231,1,0
3,PROTEIN KINASE ACTIVITY,0.0075304,-0.091449,-0.091085,1,0
3,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.042857,-0.091517,-0.12021,1,0
3,ADENYL RIBONUCLEOTIDE BINDING,0.014138,-0.091657,-0.078615,1,0
3,HEMOSTASIS,0.014138,-0.092294,-0.16791,1,0
3,PHOSPHOLIPID BINDING,0.016734,-0.092603,-0.13663,1,0
3,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.02268,-0.092686,-0.12785,1,0
3,PROTEIN MODIFICATION PROCESS,0.001986,-0.093057,-0.094709,1,0
3,CYTOSKELETON,0.0057817,-0.093284,-0.098562,1,0
3,REACTOME SEMAPHORIN INTERACTIONS,0.035393,-0.093389,-0.12436,1,0
3,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,0.017549,-0.09365,-0.12561,1,0
3,NUCLEOTIDE BINDING,0.00044439,-0.093879,-0.10782,1,0
3,PEPTIDASE ACTIVITY,0.004408,-0.094315,-0.11542,1,0
3,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.024846,-0.094666,-0.10657,1,0
3,GOLGI APPARATUS,0.00050664,-0.09492,-0.11132,1,0
3,REGULATION OF MITOSIS,0.031059,-0.095227,-0.096689,1,0
3,PID P53DOWNSTREAMPATHWAY,0.027803,-0.095764,-0.14027,1,0
3,RECEPTOR BINDING,0.030383,-0.097228,-0.092602,1,0
3,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.024288,-0.097616,-0.14725,1,0
3,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0087944,-0.098236,-0.11912,1,0
3,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.011612,-0.099632,-0.14218,1,0
3,KEGG VEGF SIGNALING PATHWAY,0.016339,-0.10017,-0.12014,1,0
3,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.021165,-0.10057,-0.14196,1,0
3,LIPID BINDING,0.03245,-0.10074,-0.11724,1,0
3,SECRETION,0.019739,-0.10375,-0.12632,1,0
3,REACTOME O LINKED GLYCOSYLATION OF MUCINS,0.011612,-0.10409,-0.23085,1,0
3,REACTOME COMMON PATHWAY,0.031059,-0.10565,-0.22822,1,0
3,CELLULAR LIPID METABOLIC PROCESS,0.02268,-0.10635,-0.12986,1,0
3,REACTOME IMMUNE SYSTEM,0.00021909,-0.10663,-0.152,1,0
3,KEGG ENDOMETRIAL CANCER,0.013798,-0.10695,-0.13211,1,0
3,ENDOMEMBRANE SYSTEM,0.0007696,-0.10701,-0.12185,1,0
3,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.00010462,-0.10923,-0.14414,1,0
3,NEGATIVE REGULATION OF CELLULAR PROCESS,0.0056288,-0.10923,-0.099672,1,0
3,REACTOME DIABETES PATHWAYS,0.011047,-0.1094,-0.17038,1,0
3,REGULATION OF BIOLOGICAL QUALITY,0.007729,-0.11017,-0.10374,1,0
3,PID IL1PATHWAY,0.023741,-0.11099,-0.15495,1,0
3,NEGATIVE REGULATION OF METABOLIC PROCESS,0.00010845,-0.11146,-0.14423,1,0
3,DEPHOSPHORYLATION,0.013139,-0.11169,-0.13112,1,0
3,KEGG MELANOGENESIS,0.0045306,-0.11198,-0.11775,1,0
3,ENZYME ACTIVATOR ACTIVITY,0.03939,-0.11232,-0.094208,1,0
3,PID FOXOPATHWAY,0.015953,-0.11242,-0.10648,1,0
3,KEGG GNRH SIGNALING PATHWAY,0.018836,-0.11265,-0.098148,1,0
3,PID MET PATHWAY,0.0073363,-0.11324,-0.12908,1,0
3,ACTIN BINDING,0.03245,-0.11548,-0.10895,1,0
3,PID IL12 2PATHWAY,0.017137,-0.11629,-0.14658,1,0
3,PID ANGIOPOIETINRECEPTOR PATHWAY,0.014841,-0.11681,-0.18344,1,0
3,LIPID METABOLIC PROCESS,0.031748,-0.11718,-0.10859,1,0
3,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,0.00353,-0.11718,-0.10483,1,0
3,PID RHODOPSIN PATHWAY,0.022165,-0.11743,-0.15731,1,0
3,PROTEIN BINDING BRIDGING,0.019739,-0.11756,-0.17477,1,0
3,REACTOME SIGNALLING TO ERKS,0.0087944,-0.11765,-0.11519,1,0
3,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0014738,-0.11845,-0.099082,1,0
3,CHROMOSOME CONDENSATION,0.031748,-0.11862,-0.14781,1,0
3,PROTEIN HETERODIMERIZATION ACTIVITY,0.00057693,-0.11895,-0.14168,1,0
3,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.012203,-0.11895,-0.10407,1,0
3,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.011904,-0.11926,-0.10843,1,0
3,IDENTICAL PROTEIN BINDING,0.0010206,-0.12169,-0.12954,1,0
3,IMMUNE SYSTEM PROCESS,0.0037331,-0.12191,-0.16209,1,0
3,PID CD8TCRPATHWAY,0.0060989,-0.12233,-0.1528,1,0
3,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.0073363,-0.12306,-0.18345,1,0
3,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.014841,-0.12365,-0.13428,1,0
3,REACTOME CALNEXIN CALRETICULIN CYCLE,0.035393,-0.12386,-0.25094,1,0
3,BLOOD COAGULATION,0.015953,-0.12434,-0.18135,1,0
3,BIOCARTA PAR1 PATHWAY,0.02166,-0.12434,-0.14716,1,0
3,NEGATIVE REGULATION OF TRANSCRIPTION,0.00098941,-0.1244,-0.13621,1,0
3,PROTEIN OLIGOMERIZATION,0.019283,-0.12467,-0.14465,1,0
3,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.034637,-0.12503,-0.15706,1,0
3,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.012203,-0.12535,-0.12608,1,0
3,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.0049174,-0.1261,-0.1778,1,0
3,REACTOME ACTIVATED TLR4 SIGNALLING,0.0067808,-0.12633,-0.1408,1,0
3,REACTOME SPHINGOLIPID METABOLISM,0.0022332,-0.12643,-0.18312,1,0
3,RESPONSE TO CHEMICAL STIMULUS,0.0045306,-0.12663,-0.13568,1,0
3,PROTEIN HOMODIMERIZATION ACTIVITY,0.0053338,-0.12669,-0.12794,1,0
3,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.023741,-0.1272,-0.17768,1,0
3,PROTEIN AUTOPROCESSING,0.017137,-0.12847,-0.11443,1,0
3,PID PI3KPLCTRKPATHWAY,0.030383,-0.1298,-0.1128,1,0
3,DETECTION OF EXTERNAL STIMULUS,0.013798,-0.13019,-0.15505,1,0
3,REGULATION OF ANGIOGENESIS,0.015203,-0.13036,-0.20859,1,0
3,BIOCARTA EDG1 PATHWAY,0.015203,-0.13043,-0.17237,1,0
3,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.0067808,-0.13052,-0.12374,1,0
3,BIOCARTA TFF PATHWAY,0.019283,-0.131,-0.23399,1,0
3,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,0.023741,-0.13126,-0.1663,1,0
3,ECTODERM DEVELOPMENT,0.017137,-0.13159,-0.15503,1,0
3,PID SHP2 PATHWAY,0.0099891,-0.13216,-0.17567,1,0
3,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.0085714,-0.13255,-0.15822,1,0
3,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.0034322,-0.13275,-0.14489,1,0
3,KEGG MELANOMA,0.034637,-0.13276,-0.1003,1,0
3,DOUBLE STRANDED RNA BINDING,0.0017123,-0.13279,-0.17027,1,0
3,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0025817,-0.13305,-0.20845,1,0
3,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.0036303,-0.13327,-0.17174,1,0
3,BIOCARTA ACH PATHWAY,0.023741,-0.13334,-0.15775,1,0
3,REACTOME PI METABOLISM,0.0090226,-0.13367,-0.10723,1,0
3,PROTEIN PROCESSING,0.00029782,-0.13392,-0.16522,1,0
3,PROTEIN UBIQUITINATION,0.0023671,-0.1349,-0.14434,1,0
3,EPIDERMIS DEVELOPMENT,0.010773,-0.135,-0.17046,1,0
3,CELL PROJECTION,0.001191,-0.13513,-0.14932,1,0
3,KEGG LYSOSOME,0.013465,-0.13578,-0.20779,1,0
3,PID TCR PATHWAY,0.0050528,-0.13597,-0.16627,1,0
3,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,0.017137,-0.13617,-0.12391,1,0
3,KEGG NOTCH SIGNALING PATHWAY,0.0033369,-0.13684,-0.16329,1,0
3,REACTOME COMPLEMENT CASCADE,0.0012662,-0.13765,-0.31512,1,0
3,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,0.00079435,-0.13806,-0.20497,1,0
3,REACTOME GAP JUNCTION TRAFFICKING,0.017549,-0.13864,-0.16756,1,0
3,KEGG FC EPSILON RI SIGNALING PATHWAY,0.024288,-0.13964,-0.11906,1,0
3,NEGATIVE REGULATION OF CELL PROLIFERATION,0.0039469,-0.13964,-0.11686,1,0
3,KEGG STEROID HORMONE BIOSYNTHESIS,0.036948,-0.14003,-0.25242,1,0
3,BIOCARTA UCALPAIN PATHWAY,0.02068,-0.14034,-0.18613,1,0
3,GROWTH FACTOR ACTIVITY,0.011047,-0.14036,-0.20599,1,0
3,PID PTP1BPATHWAY,0.010245,-0.14085,-0.18381,1,0
3,INACTIVATION OF MAPK ACTIVITY,0.021165,-0.14091,-0.26734,1,0
3,KEGG VIBRIO CHOLERAE INFECTION,0.0047853,-0.14109,-0.15764,1,0
3,DEOXYRIBONUCLEASE ACTIVITY,0.036164,-0.14171,-0.11609,1,0
3,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.0079323,-0.14209,-0.1926,1,0
3,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.00031859,-0.14227,-0.22213,1,0
3,BIOCARTA RAS PATHWAY,0.0057817,-0.14287,-0.135,1,0
3,GOLGI APPARATUS PART,0.00059588,-0.14486,-0.15401,1,0
3,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.041093,-0.14528,-0.31539,1,0
3,TRANSCRIPTION FACTOR COMPLEX,0.00012074,-0.14638,-0.13673,1,0
3,ENDOPLASMIC RETICULUM MEMBRANE,0.0053338,-0.14692,-0.17743,1,0
3,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00030804,-0.147,-0.1891,1,0
3,REGULATION OF MAP KINASE ACTIVITY,0.022165,-0.14792,-0.12295,1,0
3,HISTONE DEACETYLASE COMPLEX,0.026586,-0.14845,-0.11254,1,0
3,PID BCR 5PATHWAY,0.0010528,-0.1489,-0.19502,1,0
3,RESPONSE TO EXTERNAL STIMULUS,0.00013917,-0.14966,-0.18109,1,0
3,PID IL2 1PATHWAY,0.0085714,-0.15037,-0.15064,1,0
3,BIOCARTA GH PATHWAY,0.0085714,-0.15096,-0.15723,1,0
3,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.00040247,-0.15132,-0.15025,1,0
3,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,0.011904,-0.15161,-0.25621,1,0
3,REACTOME GAP JUNCTION ASSEMBLY,0.031059,-0.15234,-0.19022,1,0
3,KEGG REGULATION OF AUTOPHAGY,0.018836,-0.15335,-0.14824,1,0
3,REACTOME SIGNALING BY FGFR MUTANTS,0.00098941,-0.15346,-0.16762,1,0
3,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.00065623,-0.15365,-0.1845,1,0
3,ORGANELLE OUTER MEMBRANE,0.00092958,-0.15377,-0.21097,1,0
3,APOPTOSIS GO,8.7323e-05,-0.15522,-0.17092,1,0
3,VESICLE MEMBRANE,0.0097392,-0.15584,-0.15115,1,0
3,BIOCARTA TCR PATHWAY,0.022165,-0.15614,-0.13961,1,0
3,CALCIUM ION TRANSPORT,0.043763,-0.1576,-0.16959,1,0
3,BIOCARTA D4GDI PATHWAY,0.024288,-0.15779,-0.26019,1,0
3,PID GMCSF PATHWAY,0.0090226,-0.15831,-0.17399,1,0
3,PID FCER1PATHWAY,0.00023468,-0.15841,-0.22253,1,0
3,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,5.0226e-05,-0.15848,-0.16483,1,0
3,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.0027346,-0.15907,-0.18887,1,0
3,REACTOME TOLL RECEPTOR CASCADES,0.0022332,-0.15959,-0.16355,1,0
3,ENZYME INHIBITOR ACTIVITY,0.0015653,-0.16018,-0.17863,1,0
3,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.042857,-0.16028,-0.11547,1,0
3,POSITIVE REGULATION OF BIOLOGICAL PROCESS,0.00026903,-0.16147,-0.1526,1,0
3,PROTEIN DIMERIZATION ACTIVITY,0.00018427,-0.1624,-0.15123,1,0
3,BIOCARTA BIOPEPTIDES PATHWAY,0.041093,-0.16248,-0.12889,1,0
3,POSITIVE REGULATION OF CELLULAR PROCESS,0.00021167,-0.16411,-0.15781,1,0
3,KEGG ETHER LIPID METABOLISM,0.0079323,-0.16436,-0.20288,1,0
3,REACTOME BIOLOGICAL OXIDATIONS,0.011612,-0.16463,-0.17957,1,0
3,REACTOME SHC1 EVENTS IN EGFR SIGNALING,0.007729,-0.1649,-0.2267,1,0
3,BIOCARTA NFKB PATHWAY,0.0018173,-0.16589,-0.27023,1,0
3,STEROID METABOLIC PROCESS,0.0032441,-0.1662,-0.22743,1,0
3,PROGRAMMED CELL DEATH,7.547e-05,-0.16626,-0.17658,1,0
3,KEGG PRIMARY IMMUNODEFICIENCY,0.014486,-0.16628,-0.19144,1,0
3,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0022992,-0.16647,-0.18065,1,0
3,PID RAC1 PATHWAY,0.0021062,-0.16757,-0.18361,1,0
3,CELL CELL ADHESION,0.0034322,-0.16769,-0.18452,1,0
3,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.016734,-0.16777,-0.16308,1,0
3,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.0023671,-0.16882,-0.2268,1,0
3,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.014138,-0.16887,-0.12833,1,0
3,PID TCRRASPATHWAY,0.022165,-0.16894,-0.17806,1,0
3,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0042883,-0.17,-0.15027,1,0
3,UBIQUITIN CYCLE,0.0013054,-0.17061,-0.16566,1,0
3,ACID AMINO ACID LIGASE ACTIVITY,0.00031859,-0.17093,-0.17082,1,0
3,RESPONSE TO BIOTIC STIMULUS,0.0059384,-0.17097,-0.1349,1,0
3,EMBRYONIC DEVELOPMENT,0.010245,-0.17182,-0.1652,1,0
3,BIOCARTA MCALPAIN PATHWAY,0.015953,-0.17184,-0.19447,1,0
3,ACTIN CYTOSKELETON,0.00016595,-0.17263,-0.18187,1,0
3,ENDOCYTIC VESICLE,0.027803,-0.17371,-0.25259,1,0
3,GTP BINDING,0.0030654,-0.17401,-0.14534,1,0
3,PID TXA2PATHWAY,0.0021689,-0.17412,-0.16829,1,0
3,REACTOME DOWNSTREAM TCR SIGNALING,0.0054795,-0.17478,-0.20039,1,0
3,PID ALPHASYNUCLEIN PATHWAY,0.011326,-0.17594,-0.18097,1,0
3,ENDOPLASMIC RETICULUM PART,0.0021062,-0.17618,-0.19869,1,0
3,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.0097392,-0.17671,-0.13778,1,0
3,PID ECADHERIN STABILIZATION PATHWAY,0.0041716,-0.17685,-0.24319,1,0
3,ST INTERLEUKIN 4 PATHWAY,0.015953,-0.17716,-0.21931,1,0
3,REGULATION OF HYDROLASE ACTIVITY,0.0028141,-0.17772,-0.13059,1,0
3,SPHINGOLIPID METABOLIC PROCESS,0.023741,-0.17827,-0.1531,1,0
3,REGULATION OF TRANSLATION,0.001191,-0.17865,-0.19972,1,0
3,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016734,-0.17903,-0.2281,1,0
3,PROTEIN KINASE CASCADE,0.00027832,-0.18008,-0.19026,1,0
3,ST FAS SIGNALING PATHWAY,0.00029782,-0.18019,-0.14436,1,0
3,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0050528,-0.18082,-0.22544,1,0
3,ANTI APOPTOSIS,0.0087944,-0.18102,-0.1537,1,0
3,COFACTOR BINDING,0.025994,-0.18104,-0.18772,1,0
3,PID SMAD2 3PATHWAY,0.016339,-0.18123,-0.17044,1,0
3,RESPONSE TO VIRUS,0.00074557,-0.18178,-0.21962,1,0
3,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00063551,-0.18178,-0.20886,1,0
3,REGULATION OF DEVELOPMENTAL PROCESS,0.00021909,-0.18192,-0.15866,1,0
3,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,0.0069616,-0.18242,-0.22028,1,0
3,RESPONSE TO WOUNDING,0.00063551,-0.18351,-0.19552,1,0
3,MEMBRANE COAT,0.011904,-0.18361,-0.18983,1,0
3,COATED MEMBRANE,0.011904,-0.18361,-0.18983,1,0
3,PID HES HEYPATHWAY,0.0040578,-0.18379,-0.16368,1,0
3,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,0.0011549,-0.18388,-0.22616,1,0
3,PROTEIN KINASE REGULATOR ACTIVITY,0.034637,-0.18411,-0.13127,1,0
3,REGULATION OF APOPTOSIS,4.3218e-05,-0.18455,-0.18981,1,0
3,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,0.0030654,-0.18497,-0.17724,1,0
3,HUMORAL IMMUNE RESPONSE,0.0031536,-0.18525,-0.23155,1,0
3,CYTOKINE ACTIVITY,0.007729,-0.18568,-0.20918,1,0
3,LOCOMOTORY BEHAVIOR,0.0056288,-0.18588,-0.18599,1,0
3,BIOCARTA EPO PATHWAY,0.020205,-0.18726,-0.21808,1,0
3,NUCLEAR CHROMOSOME,0.0090226,-0.18735,-0.14972,1,0
3,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.023205,-0.18737,-0.20933,1,0
3,CYTOPLASMIC VESICLE MEMBRANE,0.0064317,-0.18855,-0.1609,1,0
3,CYTOPLASMIC VESICLE PART,0.0064317,-0.18855,-0.1609,1,0
3,NEGATIVE REGULATION OF ANGIOGENESIS,0.012203,-0.18877,-0.24349,1,0
3,CONDENSED CHROMOSOME,0.0067808,-0.18882,-0.1736,1,0
3,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,3.3287e-06,-0.18913,-0.24067,1,0
3,MAGNESIUM ION BINDING,0.00049035,-0.1892,-0.16947,1,0
3,REACTOME SIGNALLING TO RAS,0.0015189,-0.18987,-0.16146,1,0
3,KEGG P53 SIGNALING PATHWAY,0.0045306,-0.18989,-0.18976,1,0
3,REGULATION OF RESPONSE TO STIMULUS,0.042857,-0.18994,-0.1474,1,0
3,REGULATION OF DEFENSE RESPONSE,0.0007696,-0.1901,-0.26145,1,0
3,ANION CHANNEL ACTIVITY,0.02068,-0.19013,-0.16356,1,0
3,CHLORIDE CHANNEL ACTIVITY,0.02068,-0.19013,-0.16356,1,0
3,AGING,0.042857,-0.19013,-0.20331,1,0
3,PID HIF2PATHWAY,0.033166,-0.1908,-0.20798,1,0
3,KEGG HEMATOPOIETIC CELL LINEAGE,0.0001165,-0.19336,-0.25573,1,0
3,PID MAPKTRKPATHWAY,0.020205,-0.19338,-0.12942,1,0
3,REACTOME MEMBRANE TRAFFICKING,5.8301e-05,-0.19388,-0.20654,1,0
3,MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0014738,-0.19412,-0.23555,1,0
3,PHOSPHOLIPASE C ACTIVATION,0.017969,-0.19449,-0.20365,1,0
3,LYSOSOME,0.018836,-0.19581,-0.16672,1,0
3,LYTIC VACUOLE,0.018836,-0.19581,-0.16672,1,0
3,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.010245,-0.19588,-0.25144,1,0
3,REGULATION OF PROGRAMMED CELL DEATH,4.1617e-05,-0.1968,-0.19686,1,0
3,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.038561,-0.19751,-0.15,1,0
3,INTEGRIN COMPLEX,0.0075304,-0.19786,-0.28195,1,0
3,KINASE INHIBITOR ACTIVITY,0.037747,-0.19857,-0.19245,1,0
3,ENDOSOME,1.0184e-05,-0.19869,-0.23416,1,0
3,CELLULAR RESPONSE TO STIMULUS,0.030383,-0.19905,-0.13193,1,0
3,BIOCARTA FCER1 PATHWAY,0.010506,-0.19956,-0.1699,1,0
3,PID INTEGRIN2 PATHWAY,0.0067808,-0.19991,-0.27397,1,0
3,REACTOME CELL CELL COMMUNICATION,0.0001165,-0.20025,-0.22919,1,0
3,BIOCARTA CSK PATHWAY,0.018398,-0.20039,-0.19733,1,0
3,EXTRACELLULAR SPACE,0.00034072,-0.20067,-0.20987,1,0
3,PID PI3KCIPATHWAY,0.0012662,-0.20132,-0.21765,1,0
3,KINASE REGULATOR ACTIVITY,0.020205,-0.20139,-0.14137,1,0
3,G PROTEIN COUPLED RECEPTOR BINDING,0.0037331,-0.20168,-0.22778,1,0
3,GUANYL NUCLEOTIDE BINDING,0.001191,-0.20215,-0.16284,1,0
3,COATED VESICLE MEMBRANE,0.014841,-0.20232,-0.17804,1,0
3,REACTOME IL1 SIGNALING,9.7346e-05,-0.20234,-0.2555,1,0
3,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.022165,-0.20237,-0.23221,1,0
3,KEGG HISTIDINE METABOLISM,0.031748,-0.2036,-0.18037,1,0
3,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,0.017969,-0.20361,-0.22138,1,0
3,CALCIUM MEDIATED SIGNALING,0.033166,-0.20423,-0.20292,1,0
3,PID NFAT 3PATHWAY,0.0012662,-0.2043,-0.1879,1,0
3,BIOCARTA PML PATHWAY,0.043763,-0.20475,-0.21358,1,0
3,BIOCARTA AMI PATHWAY,0.011047,-0.20513,-0.34825,1,0
3,VASCULATURE DEVELOPMENT,0.0054795,-0.20612,-0.20459,1,0
3,G1 PHASE,0.012508,-0.20647,-0.2064,1,0
3,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,0.00057693,-0.20648,-0.26846,1,0
3,REPRODUCTIVE PROCESS,0.00038934,-0.20695,-0.20581,1,0
3,BIOCARTA BCELLSURVIVAL PATHWAY,0.011326,-0.20721,-0.25715,1,0
3,BIOCARTA PDGF PATHWAY,0.034637,-0.20739,-0.15555,1,0
3,IMMUNE EFFECTOR PROCESS,0.00047456,-0.20783,-0.27548,1,0
3,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,1.349e-05,-0.20894,-0.2721,1,0
3,CHROMATIN,0.0067808,-0.20949,-0.17016,1,0
3,MICROBODY,0.00055855,-0.2095,-0.21335,1,0
3,PEROXISOME,0.00055855,-0.2095,-0.21335,1,0
3,BIOCARTA IL2RB PATHWAY,0.00037661,-0.20978,-0.23327,1,0
3,VESICLE LOCALIZATION,0.0081404,-0.21054,-0.30673,1,0
3,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00063551,-0.21124,-0.21037,1,0
3,REGULATION OF MEMBRANE POTENTIAL,0.031748,-0.21137,-0.25648,1,0
3,REACTOME ACYL CHAIN REMODELLING OF PC,0.021165,-0.21154,-0.20101,1,0
3,REACTOME CELL JUNCTION ORGANIZATION,3.5759e-05,-0.21322,-0.29233,1,0
3,DETECTION OF ABIOTIC STIMULUS,0.0054795,-0.21367,-0.22308,1,0
3,BIOCARTA ETS PATHWAY,0.03245,-0.21494,-0.15168,1,0
3,BIOCARTA ECM PATHWAY,0.001872,-0.21506,-0.26129,1,0
3,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,6.7596e-05,-0.21519,-0.20499,1,0
3,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.0025817,-0.21701,-0.18681,1,0
3,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,0.0087944,-0.21756,-0.27392,1,0
3,IMMUNE SYSTEM DEVELOPMENT,7.8282e-05,-0.21781,-0.22859,1,0
3,PHOSPHOLIPASE C ACTIVITY,0.010245,-0.21783,-0.20651,1,0
3,ANATOMICAL STRUCTURE FORMATION,0.00090094,-0.21802,-0.23794,1,0
3,REGULATION OF SIGNAL TRANSDUCTION,5.4121e-05,-0.21808,-0.23136,1,0
3,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.0037331,-0.21866,-0.17433,1,0
3,REACTOME SIGNALING BY SCF KIT,6.0504e-05,-0.22022,-0.22851,1,0
3,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,2.9532e-05,-0.22127,-0.25258,1,0
3,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.0064317,-0.22182,-0.19373,1,0
3,CYTOKINE BIOSYNTHETIC PROCESS,0.00025131,-0.22251,-0.30388,1,0
3,FATTY ACID METABOLIC PROCESS,0.0041716,-0.2227,-0.24852,1,0
3,PID TAP63PATHWAY,0.0036303,-0.22312,-0.25168,1,0
3,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.00034072,-0.22354,-0.23583,1,0
3,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.010245,-0.22392,-0.19124,1,0
3,NEGATIVE REGULATION OF APOPTOSIS,0.0023671,-0.22435,-0.17502,1,0
3,SIG PIP3 SIGNALING IN B LYMPHOCYTES,8.7323e-05,-0.22454,-0.2631,1,0
3,TRANSPORT VESICLE,0.0033369,-0.22502,-0.19158,1,0
3,CELLULAR DEFENSE RESPONSE,0.00045924,-0.22522,-0.33135,1,0
3,BIOCARTA BCR PATHWAY,0.013465,-0.22577,-0.18061,1,0
3,REGULATION OF CELL DIFFERENTIATION,0.00010092,-0.22642,-0.24284,1,0
3,REACTOME INNATE IMMUNE SYSTEM,2.8077e-06,-0.22644,-0.26457,1,0
3,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,2.1663e-05,-0.22647,-0.20804,1,0
3,INFLAMMATORY RESPONSE,1.5201e-05,-0.22778,-0.28275,1,0
3,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,2.4346e-05,-0.22806,-0.20413,1,0
3,KEGG TIGHT JUNCTION,7.889e-07,-0.22812,-0.22628,1,0
3,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.030383,-0.22833,-0.32393,1,0
3,REACTOME APOPTOSIS,1.6015e-06,-0.22854,-0.25592,1,0
3,KEGG RENIN ANGIOTENSIN SYSTEM,0.011047,-0.23006,-0.31323,1,0
3,PROTEOLYSIS,1.6452e-07,-0.23019,-0.28442,1,0
3,BIOCARTA GSK3 PATHWAY,0.011047,-0.23042,-0.22715,1,0
3,ISOPRENOID METABOLIC PROCESS,0.025414,-0.23153,-0.19868,1,0
3,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,0.0012662,-0.23155,-0.19139,1,0
3,REACTOME LYSOSOME VESICLE BIOGENESIS,0.0010528,-0.23222,-0.33653,1,0
3,PID TNFPATHWAY,0.00024286,-0.23244,-0.24917,1,0
3,OXYGEN BINDING,0.021165,-0.23287,-0.19585,1,0
3,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.00095906,-0.23343,-0.29551,1,0
3,B CELL ACTIVATION,0.0053338,-0.23362,-0.23364,1,0
3,PEROXISOME ORGANIZATION AND BIOGENESIS,0.00023468,-0.23408,-0.24925,1,0
3,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,0.0025817,-0.23417,-0.22095,1,0
3,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.023205,-0.23454,-0.21624,1,0
3,KEGG APOPTOSIS,4.3218e-05,-0.2351,-0.27227,1,0
3,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.00038934,-0.23512,-0.25733,1,0
3,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,0.0010528,-0.23521,-0.30658,1,0
3,PID TCPTP PATHWAY,0.0027346,-0.23534,-0.27877,1,0
3,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.027803,-0.23541,-0.19718,1,0
3,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,5.4121e-05,-0.23575,-0.24266,1,0
3,LEUKOCYTE DIFFERENTIATION,0.0010528,-0.23579,-0.28173,1,0
3,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.0036303,-0.23718,-0.18422,1,0
3,CONDENSED NUCLEAR CHROMOSOME,0.024846,-0.2377,-0.1529,1,0
3,ANGIOGENESIS,0.00055855,-0.23854,-0.27392,1,0
3,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,0.00032948,-0.23936,-0.28014,1,0
3,GAMETE GENERATION,0.00020448,-0.24047,-0.27325,1,0
3,BIOCARTA TNFR1 PATHWAY,0.0027346,-0.24101,-0.20622,1,0
3,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0034322,-0.24139,-0.21169,1,0
3,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,5.0226e-05,-0.24163,-0.2413,1,0
3,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.00098941,-0.24164,-0.23629,1,0
3,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,9.389e-05,-0.24176,-0.25401,1,0
3,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.02166,-0.24192,-0.17063,1,0
3,PID WNT CANONICAL PATHWAY,0.0083534,-0.24318,-0.20982,1,0
3,KEGG RETINOL METABOLISM,0.0018173,-0.24321,-0.28064,1,0
3,BIOCARTA TPO PATHWAY,0.014841,-0.24349,-0.18961,1,0
3,REACTOME PHASE II CONJUGATION,0.007729,-0.24408,-0.25243,1,0
3,VESICLE COAT,0.0057817,-0.24496,-0.22154,1,0
3,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.00014935,-0.24535,-0.28321,1,0
3,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0081404,-0.24544,-0.21291,1,0
3,PID P38ALPHABETADOWNSTREAMPATHWAY,0.0017123,-0.24656,-0.22121,1,0
3,REPRODUCTION,9.389e-05,-0.24697,-0.22159,1,0
3,CYTOKINE METABOLIC PROCESS,0.00019079,-0.24792,-0.30856,1,0
3,BIOCARTA TGFB PATHWAY,0.023741,-0.24795,-0.20595,1,0
3,REACTOME INTERFERON GAMMA SIGNALING,0.00095906,-0.24802,-0.31477,1,0
3,LIPID HOMEOSTASIS,0.029068,-0.2489,-0.29421,1,0
3,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.013139,-0.24925,-0.17063,1,0
3,PID BMPPATHWAY,0.0018173,-0.2497,-0.23826,1,0
3,KEGG SPHINGOLIPID METABOLISM,0.0001165,-0.25106,-0.27892,1,0
3,SUGAR BINDING,0.00014418,-0.25148,-0.33726,1,0
3,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,7.013e-05,-0.25194,-0.27307,1,0
3,KEGG ADHERENS JUNCTION,2.2658e-06,-0.25269,-0.28872,1,0
3,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00087311,-0.2528,-0.2399,1,0
3,BIOCARTA SPRY PATHWAY,0.00025131,-0.25321,-0.41248,1,0
3,UBIQUITIN PROTEIN LIGASE ACTIVITY,2.0033e-05,-0.25337,-0.20804,1,0
3,GLYCOPROTEIN METABOLIC PROCESS,7.013e-05,-0.25511,-0.26464,1,0
3,PID NFKAPPABCANONICALPATHWAY,0.0037331,-0.25578,-0.25607,1,0
3,REACTOME REGULATION OF INSULIN SECRETION,0.012508,-0.25724,-0.16546,1,0
3,DIGESTION,0.0020453,-0.25741,-0.36303,1,0
3,VACUOLE,9.7346e-05,-0.25888,-0.28267,1,0
3,REACTOME INTERFERON SIGNALING,2.3418e-05,-0.26048,-0.3481,1,0
3,BIOCARTA RELA PATHWAY,0.0027346,-0.26078,-0.29053,1,0
3,REACTOME SIGNALING BY ILS,3.0576e-06,-0.26105,-0.28376,1,0
3,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,0.0001547,-0.26119,-0.34985,1,0
3,BIOCARTA SPPA PATHWAY,0.00081984,-0.26132,-0.25385,1,0
3,REACTOME INSULIN RECEPTOR RECYCLING,0.0039469,-0.26156,-0.29292,1,0
3,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.00098941,-0.26175,-0.36175,1,0
3,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,4.6623e-06,-0.26178,-0.28671,1,0
3,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.014841,-0.26187,-0.16943,1,0
3,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.014841,-0.26187,-0.16943,1,0
3,PID CIRCADIANPATHWAY,0.03939,-0.26298,-0.1977,1,0
3,DEFENSE RESPONSE,3.1904e-06,-0.26424,-0.28341,1,0
3,DEVELOPMENTAL MATURATION,0.0075304,-0.26479,-0.26913,1,0
3,APOPTOTIC PROGRAM,2.3418e-05,-0.26517,-0.2472,1,0
3,BIOCARTA EGF PATHWAY,0.0054795,-0.26523,-0.22848,1,0
3,SH2 DOMAIN BINDING,0.0015189,-0.26542,-0.38677,1,0
3,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.043763,-0.26561,-0.18625,1,0
3,SA MMP CYTOKINE CONNECTION,0.0010859,-0.26595,-0.36338,1,0
3,PID CMYB PATHWAY,6.5149e-05,-0.26656,-0.24917,1,0
3,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00028792,-0.2675,-0.26296,1,0
3,BIOGENIC AMINE METABOLIC PROCESS,0.0097392,-0.26777,-0.21446,1,0
3,GOLGI MEMBRANE,0.00017186,-0.26814,-0.29848,1,0
3,REACTOME IL 3 5 AND GM CSF SIGNALING,6.5149e-05,-0.26847,-0.29856,1,0
3,KEGG DRUG METABOLISM CYTOCHROME P450,0.0017123,-0.26924,-0.267,1,0
3,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,9.389e-05,-0.2709,-0.34272,1,0
3,BILE ACID METABOLIC PROCESS,0.0059384,-0.27212,-0.27325,1,0
3,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.014841,-0.27304,-0.23522,1,0
3,BIOCARTA MPR PATHWAY,0.0050528,-0.27355,-0.19155,1,0
3,BIOCARTA IL2 PATHWAY,0.0069616,-0.27403,-0.23586,1,0
3,BIOCARTA NUCLEARRS PATHWAY,0.00029782,-0.27471,-0.35236,1,0
3,RESPONSE TO NUTRIENT LEVELS,0.0097392,-0.27659,-0.18434,1,0
3,TISSUE MORPHOGENESIS,3.8583e-05,-0.27719,-0.40437,1,0
3,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,9.389e-05,-0.27731,-0.31298,1,0
3,REACTOME N GLYCAN ANTENNAE ELONGATION,0.014486,-0.27793,-0.23793,1,0
3,REACTOME ACYL CHAIN REMODELLING OF PE,0.0015189,-0.27917,-0.29059,1,0
3,CELL MATURATION,0.041967,-0.28002,-0.20146,1,0
3,PID HNF3BPATHWAY,0.0049174,-0.28165,-0.26709,1,0
3,PHOSPHOINOSITIDE BINDING,0.016339,-0.28235,-0.17019,1,0
3,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.017137,-0.28238,-0.22504,1,0
3,REACTOME SIGNALING BY HIPPO,0.0010859,-0.2825,-0.38086,1,0
3,BIOCARTA RHO PATHWAY,0.001872,-0.28369,-0.25123,1,0
3,POSITIVE REGULATION OF CASPASE ACTIVITY,0.00023468,-0.28409,-0.27045,1,0
3,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,1.4609e-05,-0.28556,-0.2657,1,0
3,PID ECADHERIN NASCENTAJ PATHWAY,5.7413e-06,-0.28827,-0.29582,1,0
3,PROTEIN TETRAMERIZATION,0.0047853,-0.28919,-0.23967,1,0
3,BIOCARTA FAS PATHWAY,9.0551e-05,-0.28971,-0.3321,1,0
3,HEMOPOIESIS,1.4039e-05,-0.28997,-0.27828,1,0
3,KEGG MATURITY ONSET DIABETES OF THE YOUNG,0.0073363,-0.29004,-0.29345,1,0
3,REACTOME TIE2 SIGNALING,0.00021909,-0.29004,-0.33754,1,0
3,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00084609,-0.29009,-0.29338,1,0
3,NUCLEAR CHROMOSOME PART,0.00041602,-0.29082,-0.26291,1,0
3,BIOCARTA TID PATHWAY,0.020205,-0.29101,-0.19952,1,0
3,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,3.8583e-05,-0.29119,-0.39409,1,0
3,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.6597e-05,-0.29193,-0.3329,1,0
3,PID NFKAPPABATYPICALPATHWAY,0.0019282,-0.29323,-0.30164,1,0
3,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,0.00017186,-0.29558,-0.28606,1,0
3,CELL JUNCTION,1.4039e-05,-0.29592,-0.28472,1,0
3,ICOSANOID METABOLIC PROCESS,0.0013872,-0.2964,-0.50265,1,0
3,PID IL23PATHWAY,1.5816e-05,-0.29745,-0.33763,1,0
3,STEROID BINDING,0.014841,-0.30207,-0.35437,1,0
3,PID FASPATHWAY,0.00024286,-0.30314,-0.30756,1,0
3,CYTOKINE PRODUCTION,1.8521e-05,-0.30524,-0.34382,1,0
3,MICROTUBULE MOTOR ACTIVITY,0.0054795,-0.30672,-0.23499,1,0
3,PROTEIN SECRETION,0.00037661,-0.30905,-0.34583,1,0
3,KEGG PHENYLALANINE METABOLISM,0.011326,-0.30932,-0.33521,1,0
3,REGULATION OF CYTOKINE PRODUCTION,0.0012662,-0.30959,-0.35277,1,0
3,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,1.8521e-05,-0.31016,-0.31925,1,0
3,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00012964,-0.31111,-0.38889,1,0
3,CASPASE ACTIVATION,0.00012512,-0.31198,-0.27503,1,0
3,PID A6B1 A6B4 INTEGRIN PATHWAY,0.0032441,-0.31348,-0.34258,1,0
3,ACTIN FILAMENT,0.0042883,-0.31387,-0.24466,1,0
3,BIOCARTA CBL PATHWAY,0.0029794,-0.31437,-0.3068,1,0
3,REACTOME SIGNALING BY FGFR1 MUTANTS,3.1904e-06,-0.31457,-0.32131,1,0
3,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,5.4121e-05,-0.31518,-0.3461,1,0
3,REACTOME APOPTOTIC EXECUTION PHASE,2.7578e-07,-0.31564,-0.36738,1,0
3,PID KITPATHWAY,3.3287e-06,-0.31588,-0.30519,1,0
3,CYTOKINE SECRETION,0.0073363,-0.31688,-0.25523,1,0
3,REACTOME IL RECEPTOR SHC SIGNALING,7.547e-05,-0.31828,-0.36764,1,0
3,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,5.4121e-05,-0.31939,-0.34205,1,0
3,SODIUM ION TRANSPORT,0.011612,-0.32059,-0.30964,1,0
3,REGULATION OF CELLULAR COMPONENT SIZE,0.015574,-0.32072,-0.32041,1,0
3,CONTRACTILE FIBER,8.7323e-05,-0.32086,-0.31855,1,0
3,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,1.0779e-06,-0.32285,-0.36171,1,0
3,MYELOID CELL DIFFERENTIATION,3.4421e-05,-0.32434,-0.36842,1,0
3,BIOCARTA GATA3 PATHWAY,0.0041716,-0.32556,-0.24099,1,0
3,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.026586,-0.32932,-0.2912,1,0
3,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,0.00020448,-0.32962,-0.31281,1,0
3,SIG BCR SIGNALING PATHWAY,5.6174e-05,-0.3304,-0.29817,1,0
3,BIOCARTA HSP27 PATHWAY,3.5759e-05,-0.332,-0.32883,1,0
3,INTERCELLULAR JUNCTION,9.7801e-06,-0.33246,-0.33436,1,0
3,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,7.0571e-06,-0.33247,-0.34547,1,0
3,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,9.0551e-05,-0.33262,-0.31501,1,0
3,PID IL4 2PATHWAY,3.9418e-06,-0.33268,-0.36504,1,0
3,POSITIVE REGULATION OF TRANSPORT,9.7346e-05,-0.33302,-0.35646,1,0
3,CONTRACTILE FIBER PART,3.0689e-05,-0.3331,-0.37252,1,0
3,PID THROMBIN PAR4 PATHWAY,0.011612,-0.33351,-0.21517,1,0
3,PID CASPASE PATHWAY,0.00092958,-0.33377,-0.33574,1,0
3,BIOCARTA HER2 PATHWAY,6.2786e-05,-0.33584,-0.36301,1,0
3,REACTOME IL 2 SIGNALING,2.4692e-06,-0.33872,-0.41038,1,0
3,REACTOME P38MAPK EVENTS,3.7145e-05,-0.34233,-0.33446,1,0
3,CELL RECOGNITION,0.033894,-0.34389,-0.25437,1,0
3,LIPID RAFT,0.0017123,-0.34736,-0.38921,1,0
3,PID ERB GENOMIC PATHWAY,0.0050528,-0.34813,-0.31008,1,0
3,REACTOME CELL CELL JUNCTION ORGANIZATION,0.00028792,-0.34822,-0.35157,1,0
3,DETECTION OF STIMULUS,0.00017186,-0.34941,-0.27821,1,0
3,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,0.024846,-0.35044,-0.2942,1,0
3,ST TUMOR NECROSIS FACTOR PATHWAY,7.0571e-06,-0.35147,-0.38059,1,0
3,I KAPPAB KINASE NF KAPPAB CASCADE,2.2658e-06,-0.35401,-0.40715,1,0
3,REGULATION OF ACTION POTENTIAL,0.00037661,-0.35539,-0.3699,1,0
3,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0046564,-0.35557,-0.32291,1,0
3,BIOCARTA IL22BP PATHWAY,0.00013917,-0.3577,-0.43368,1,0
3,NEGATIVE REGULATION OF TRANSLATION,0.00016023,-0.35781,-0.31818,1,0
3,RESPONSE TO NUTRIENT,0.007729,-0.36087,-0.3055,1,0
3,PID TRAIL PATHWAY,1.4609e-05,-0.36218,-0.37886,1,0
3,BIOCARTA PLATELETAPP PATHWAY,0.034637,-0.36306,-0.37468,1,0
3,KEGG CIRCADIAN RHYTHM MAMMAL,0.014138,-0.36315,-0.24426,1,0
3,KEGG TYPE I DIABETES MELLITUS,0.0064317,-0.36363,-0.21889,1,0
3,BIOCARTA HIVNEF PATHWAY,5.9841e-06,-0.36598,-0.38042,1,0
3,GALACTOSYLTRANSFERASE ACTIVITY,0.0019282,-0.36648,-0.36039,1,0
3,KEGG RIBOFLAVIN METABOLISM,0.0015653,-0.36663,-0.32184,1,0
3,REGULATION OF PROTEIN SECRETION,7.8282e-05,-0.36979,-0.32813,1,0
3,SEXUAL REPRODUCTION,1.6455e-05,-0.37078,-0.32519,1,0
3,TUBE DEVELOPMENT,0.00028792,-0.37106,-0.35551,1,0
3,PROTEASE INHIBITOR ACTIVITY,0.00024286,-0.37181,-0.44311,1,0
3,MYOFIBRIL,0.00017796,-0.37602,-0.33993,1,0
3,REGULATION OF MYELOID CELL DIFFERENTIATION,0.00038934,-0.37656,-0.41885,1,0
3,REGULATION OF ACTIN FILAMENT LENGTH,0.0073363,-0.38144,-0.36469,1,0
3,MYELOID LEUKOCYTE DIFFERENTIATION,0.00072223,-0.38524,-0.4658,1,0
3,REACTOME GLUTATHIONE CONJUGATION,0.0042883,-0.38556,-0.36769,1,0
3,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,6.4994e-06,-0.38632,-0.36874,1,0
3,PID EPOPATHWAY,3.0576e-06,-0.39274,-0.37361,1,0
3,REGULATION OF CYTOKINE SECRETION,0.004408,-0.39759,-0.29557,1,0
3,REACTOME NOD1 2 SIGNALING PATHWAY,7.2111e-07,-0.39998,-0.42439,1,0
3,PID ECADHERIN KERATINOCYTE PATHWAY,4.5813e-07,-0.40232,-0.46872,1,0
3,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,9.0221e-07,-0.40277,-0.4581,1,0
3,STRUCTURAL CONSTITUENT OF MUSCLE,6.8936e-07,-0.40499,-0.44533,1,0
3,HORMONE ACTIVITY,0.004408,-0.40531,-0.33557,1,0
3,LIPID TRANSPORTER ACTIVITY,9.3916e-06,-0.40894,-0.4492,1,0
3,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,1.0311e-06,-0.41087,-0.45953,1,0
3,TIGHT JUNCTION,3.7145e-05,-0.41136,-0.44277,1,0
3,BIOCARTA KERATINOCYTE PATHWAY,5.7413e-06,-0.41567,-0.36197,1,0
3,REACTOME SIGNALING BY NOTCH3,7.2111e-07,-0.41603,-0.49031,1,0
3,MAP KINASE ACTIVITY,9.389e-05,-0.41694,-0.40827,1,0
3,MOTOR ACTIVITY,0.00017186,-0.41871,-0.32959,1,0
3,TUBE MORPHOGENESIS,1.4609e-05,-0.42052,-0.46598,1,0
3,POSITIVE REGULATION OF CELL DIFFERENTIATION,4.3218e-05,-0.42433,-0.48994,1,0
3,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0011549,-0.42461,-0.39661,1,0
3,UDP GLYCOSYLTRANSFERASE ACTIVITY,9.389e-05,-0.43581,-0.41099,1,0
3,BIOCARTA CERAMIDE PATHWAY,1.9904e-06,-0.45,-0.44132,1,0
3,SA PROGRAMMED CELL DEATH,8.4205e-05,-0.45225,-0.39488,1,0
3,BIOCARTA CHEMICAL PATHWAY,9.3916e-06,-0.45495,-0.4018,1,0
3,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,9.8628e-07,-0.45532,-0.43471,1,0
3,PID AJDISS 2PATHWAY,1.104e-05,-0.45589,-0.40643,1,0
3,REGULATION OF HORMONE SECRETION,0.017969,-0.46836,-0.23435,1,0
3,APICAL JUNCTION COMPLEX,8.3127e-06,-0.47178,-0.45765,1,0
3,APICOLATERAL PLASMA MEMBRANE,8.3127e-06,-0.47178,-0.45765,1,0
3,CELL PROJECTION PART,0.00019079,-0.47361,-0.3758,1,0
3,ACTIN FILAMENT BINDING,0.0025083,-0.47472,-0.31636,1,0
3,REACTOME SIGNALING BY NOTCH2,2.7578e-07,-0.47488,-0.52235,1,0
3,DETECTION OF CHEMICAL STIMULUS,0.0032441,-0.4763,-0.35919,1,0
3,BIOCARTA IL7 PATHWAY,5.508e-06,-0.47698,-0.46578,1,0
3,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,1.3605e-07,-0.48269,-0.53826,1,0
3,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,1.9263e-05,-0.48533,-0.44874,1,0
3,SA CASPASE CASCADE,1.7806e-05,-0.4944,-0.46008,1,0
3,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,0.0023671,-0.49524,-0.47682,1,0
3,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,9.4334e-07,-0.49997,-0.47422,1,0
3,REACTOME SIGNALING BY NOTCH4,1.2308e-06,-0.50188,-0.52206,1,0
3,KERATINOCYTE DIFFERENTIATION,2.4692e-06,-0.50677,-0.57052,1,0
3,SECRETORY GRANULE,0.00045924,-0.51312,-0.43841,1,0
3,CORNIFIED ENVELOPE,1.5816e-05,-0.51478,-0.57812,1,0
3,REACTOME INTERFERON ALPHA BETA SIGNALING,1.4039e-05,-0.51975,-0.65625,1,0
3,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,0.0032441,-0.52545,-0.28514,1,0
3,REGULATION OF SECRETION,8.7323e-05,-0.52654,-0.39486,1,0
3,BIOCARTA DEATH PATHWAY,4.5813e-07,-0.52759,-0.55031,1,0
3,BIOCARTA BAD PATHWAY,5.4121e-05,-0.53201,-0.41192,1,0
3,EARLY ENDOSOME,9.0179e-06,-0.53665,-0.49007,1,0
3,PID HIVNEFPATHWAY,3.4772e-07,-0.53854,-0.50565,1,0
3,POSITIVE REGULATION OF SECRETION,0.00010845,-0.54215,-0.46517,1,0
3,MORPHOGENESIS OF AN EPITHELIUM,3.6228e-06,-0.54479,-0.60837,1,0
3,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.00010845,-0.54724,-0.56095,1,0
3,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,2.1831e-07,-0.5496,-0.62829,1,0
3,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,5.2533e-07,-0.55397,-0.5176,1,0
3,MYOSIN COMPLEX,1.4963e-07,-0.55921,-0.55752,1,0
3,PID DELTANP63PATHWAY,8.3127e-06,-0.5622,-0.51509,1,0
3,CALCIUM INDEPENDENT CELL CELL ADHESION,0.00069957,-0.56953,-0.51536,1,0
3,APICAL PART OF CELL,6.8936e-07,-0.57557,-0.61456,1,0
3,BIOCARTA CASPASE PATHWAY,3.3202e-07,-0.59555,-0.62796,1,0
3,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,0.00012512,-0.60487,-0.55598,1,0
3,APICAL PLASMA MEMBRANE,4.5813e-07,-0.60802,-0.64872,1,0
3,KEGG DORSO VENTRAL AXIS FORMATION,4.1802e-07,-0.61129,-0.53819,1,0
3,BIOCARTA NKCELLS PATHWAY,2.3654e-06,-0.61526,-0.70293,1,0
3,GLAND DEVELOPMENT,4.0073e-05,-0.62177,-0.58233,1,0
3,BIOCARTA SODD PATHWAY,3.3202e-07,-0.62615,-0.66161,1,0
3,LEUKOCYTE MIGRATION,0.00035231,-0.641,-0.53332,1,0
3,PID NECTIN PATHWAY,5.4977e-07,-0.66541,-0.58726,1,0
3,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,1.8084e-07,-0.68194,-0.77005,1,0
3,PHOSPHOLIPID TRANSPORTER ACTIVITY,2.5774e-06,-0.68803,-0.59626,1,0
3,REACTOME TIGHT JUNCTION INTERACTIONS,3.3132e-05,-0.70402,-0.61124,1,0
3,REACTOME REGULATION OF KIT SIGNALING,7.9801e-06,-0.72302,-0.66058,1,0
3,BIOCARTA MITOCHONDRIA PATHWAY,2.5122e-07,-0.73341,-0.7045,1,0
3,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,4.4712e-06,-0.76802,-0.71578,1,0
3,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,4.7955e-07,-0.79659,-0.8008,1,0
3,HORMONE SECRETION,0.00038934,-0.79911,-0.5929,1,0
3,REACTOME CS DS DEGRADATION,0.075049,0.46791,0.20367,0,1
3,CELL SUBSTRATE ADHERENS JUNCTION,0.050569,0.2896,0.18223,0,1
3,CELL MATRIX JUNCTION,0.099158,0.26271,0.14889,0,1
3,BIOCARTA ARF PATHWAY,0.065563,0.24519,0.21067,0,1
3,ACTIVATION OF IMMUNE RESPONSE,0.060602,0.2373,0.17659,0,1
3,BIOCARTA NKT PATHWAY,0.11841,0.22404,0.16868,0,1
3,COPPER ION BINDING,0.11841,0.22144,0.11699,0,1
3,MRNA BINDING,0.054842,0.20984,0.1666,0,1
3,RNA POLYMERASE ACTIVITY,0.055956,0.19883,0.13077,0,1
3,INSULIN RECEPTOR SIGNALING PATHWAY,0.090515,0.19874,0.11657,0,1
3,HYDRO LYASE ACTIVITY,0.055956,0.19793,0.13978,0,1
3,BIOCARTA AKT PATHWAY,0.073629,0.19562,0.11161,0,1
3,KEGG FATTY ACID METABOLISM,0.12908,0.19025,0.071384,0,1
3,PID HEDGEHOG 2PATHWAY,0.13355,0.18686,0.082767,0,1
3,KEGG ONE CARBON POOL BY FOLATE,0.088862,0.18513,0.17751,0,1
3,REACTOME G1 PHASE,0.047551,0.18452,0.13316,0,1
3,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,0.045624,0.18321,0.12732,0,1
3,NEGATIVE REGULATION OF TRANSPORT,0.097379,0.17804,0.13833,0,1
3,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.050569,0.1765,0.093263,0,1
3,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,0.29184,0.17413,0.1033,0,1
3,BIOCARTA CDK5 PATHWAY,0.11636,0.15457,0.12291,0,1
3,KEGG PRION DISEASES,0.053746,0.14817,0.11658,0,1
3,REACTOME PI3K AKT ACTIVATION,0.044685,0.14438,0.10717,0,1
3,BIOCARTA HDAC PATHWAY,0.066855,0.1443,0.11385,0,1
3,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.12689,0.14161,0.07846,0,1
3,BIOCARTA AKAPCENTROSOME PATHWAY,0.16559,0.13945,0.12028,0,1
3,REGULATION OF HEART CONTRACTION,0.28785,0.1383,0.037811,0,1
3,CELL SURFACE,0.064293,0.13485,0.14914,0,1
3,PID ARF6DOWNSTREAMPATHWAY,0.16032,0.1302,0.078806,0,1
3,PID ATR PATHWAY,0.064293,0.12988,0.11707,0,1
3,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.084046,0.12642,0.15044,0,1
3,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.23937,0.11718,0.063478,0,1
3,NUCLEAR ORGANIZATION AND BIOGENESIS,0.19393,0.11557,0.062655,0,1
3,REACTOME GLUCOSE TRANSPORT,0.21579,0.11121,0.090106,0,1
3,PID RHOA REG PATHWAY,0.14285,0.10979,0.052017,0,1
3,ENDONUCLEASE ACTIVITY,0.088862,0.10806,0.067625,0,1
3,REACTOME MICRORNA MIRNA BIOGENESIS,0.084046,0.10771,0.11682,0,1
3,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.20621,0.10493,0.084607,0,1
3,REGULATION OF TRANSPORT,0.49227,0.095503,0.042095,0,1
3,ACTIN FILAMENT ORGANIZATION,0.088862,0.09543,0.10383,0,1
3,CYTOKINESIS,0.072231,0.093792,0.13357,0,1
3,NUCLEOTIDE EXCISION REPAIR,0.049546,0.090986,0.10455,0,1
3,REACTOME TRANSCRIPTION,0.12473,0.090913,0.067847,0,1
3,REACTOME PI3K CASCADE,0.054842,0.088777,0.076449,0,1
3,BIOCARTA IGF1MTOR PATHWAY,0.60883,0.087243,0.0052251,0,1
3,KEGG INSULIN SIGNALING PATHWAY,0.046579,0.074711,0.064618,0,1
3,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.12049,0.072268,0.057769,0,1
3,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.085627,0.071171,0.091354,0,1
3,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.26098,0.044279,0.058877,0,1
3,NUCLEAR MEMBRANE PART,0.41842,0.0408,0.024792,0,1
3,ST GRANULE CELL SURVIVAL PATHWAY,0.4545,0.029866,0.055888,0,1
3,PROTEIN COMPLEX,0.099158,0.028666,0.029565,0,1
3,PID PDGFRAPATHWAY,0.077957,0.30008,0.2118,0,0
3,REACTOME METABOLISM OF PORPHYRINS,0.054842,0.29272,0.2286,0,0
3,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,0.063042,0.28489,0.1348,0,0
3,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.17653,0.24396,0.12281,0,0
3,BIOCARTA CDMAC PATHWAY,0.073629,0.23929,0.13818,0,0
3,ARYLSULFATASE ACTIVITY,0.050569,0.23383,0.17539,0,0
3,BIOCARTA ACTINY PATHWAY,0.059411,0.23124,0.17236,0,0
3,REACTOME LIPOPROTEIN METABOLISM,0.097379,0.22436,0.13792,0,0
3,REGULATION OF DNA REPLICATION,0.045624,0.20186,0.1527,0,0
3,MONOCARBOXYLIC ACID TRANSPORT,0.16294,0.19396,0.12658,0,0
3,RHO GTPASE ACTIVATOR ACTIVITY,0.095625,0.18806,0.16203,0,0
3,REGULATION OF NEUROGENESIS,0.1028,0.18752,0.24329,0,0
3,REACTOME BOTULINUM NEUROTOXICITY,0.061812,0.18742,0.18253,0,0
3,BIOCARTA WNT PATHWAY,0.47588,0.18601,0.041745,0,0
3,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.073629,0.18547,0.11344,0,0
3,MITOCHONDRIAL MATRIX,0.049546,0.18216,0.17287,0,0
3,MITOCHONDRIAL LUMEN,0.049546,0.18216,0.17287,0,0
3,AXON,0.42347,0.18168,0.096415,0,0
3,REGULATION OF MAPKKK CASCADE,0.0695,0.18143,0.12565,0,0
3,BIOCARTA EGFR SMRTE PATHWAY,0.055956,0.17844,0.17017,0,0
3,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,0.22235,0.17586,0.093966,0,0
3,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.32938,0.17465,0.089389,0,0
3,TRANSLATION REGULATOR ACTIVITY,0.047551,0.17321,0.14203,0,0
3,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.16828,0.17202,0.25091,0,0
3,REACTOME NEUROTRANSMITTER RELEASE CYCLE,0.10096,0.17151,0.20214,0,0
3,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.12908,0.17102,0.10826,0,0
3,REGULATION OF CELL ADHESION,0.15773,0.1676,0.053333,0,0
3,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,0.15773,0.16705,0.089441,0,0
3,NUCLEOTIDE KINASE ACTIVITY,0.15015,0.16502,0.15063,0,0
3,PID INTEGRIN4 PATHWAY,0.28785,0.16492,0.081258,0,0
3,BIOCARTA PTDINS PATHWAY,0.044685,0.16371,0.16741,0,0
3,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,0.11841,0.1611,0.094395,0,0
3,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,0.10845,0.15945,0.10122,0,0
3,KEGG SELENOAMINO ACID METABOLISM,0.077957,0.15942,0.14262,0,0
3,REACTOME EGFR DOWNREGULATION,0.26471,0.15649,0.067801,0,0
3,REGIONALIZATION,0.48678,0.15246,0.064409,0,0
3,REGULATION OF JNK CASCADE,0.30815,0.15181,0.075125,0,0
3,REACTOME DARPP 32 EVENTS,0.055956,0.15147,0.14848,0,0
3,AMINE BINDING,0.084046,0.15097,0.14072,0,0
3,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.58456,0.15082,0.040591,0,0
3,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.18508,0.14801,0.12522,0,0
3,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.27227,0.14731,0.12823,0,0
3,PID ARF 3PATHWAY,0.068167,0.14686,0.13922,0,0
3,N METHYLTRANSFERASE ACTIVITY,0.080955,0.14653,0.12177,0,0
3,KEGG GALACTOSE METABOLISM,0.057089,0.14486,0.17468,0,0
3,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.2839,0.14431,0.063174,0,0
3,RESPONSE TO OXIDATIVE STRESS,0.19393,0.14363,0.053605,0,0
3,CORTICAL CYTOSKELETON,0.099158,0.14326,0.17311,0,0
3,BIOCARTA ERK PATHWAY,0.11841,0.14207,0.089451,0,0
3,PEPTIDE RECEPTOR ACTIVITY,0.065563,0.14203,0.1033,0,0
3,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.20937,0.14151,0.084379,0,0
3,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.19095,0.14105,0.068663,0,0
3,PID RXR VDR PATHWAY,0.10845,0.14048,0.10729,0,0
3,ST WNT BETA CATENIN PATHWAY,0.19393,0.14028,0.11524,0,0
3,CARBOXYLESTERASE ACTIVITY,0.14048,0.1394,0.1082,0,0
3,MITOCHONDRIAL TRANSPORT,0.12689,0.1368,0.075295,0,0
3,REACTOME P75NTR SIGNALS VIA NFKB,0.3746,0.13605,0.042886,0,0
3,AMINE BIOSYNTHETIC PROCESS,0.52025,0.13442,0.040415,0,0
3,SULFUR METABOLIC PROCESS,0.12259,0.13273,0.079632,0,0
3,PROTEINACEOUS EXTRACELLULAR MATRIX,0.10845,0.13253,0.077096,0,0
3,EXTRACELLULAR MATRIX,0.10845,0.13253,0.077096,0,0
3,PID RAS PATHWAY,0.16294,0.13213,0.1125,0,0
3,SYNAPTIC VESICLE,0.11434,0.13088,0.22617,0,0
3,REACTOME REGULATION OF APOPTOSIS,0.12259,0.13008,0.076644,0,0
3,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.29586,0.12953,0.064076,0,0
3,SODIUM CHANNEL ACTIVITY,0.25363,0.12906,0.16331,0,0
3,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.24288,0.129,0.088295,0,0
3,KEGG PROPANOATE METABOLISM,0.068167,0.12885,0.16217,0,0
3,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.14285,0.12812,0.12082,0,0
3,S PHASE,0.22235,0.12807,0.13952,0,0
3,REACTOME ZINC TRANSPORTERS,0.11039,0.12633,0.099715,0,0
3,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.17653,0.12618,0.12657,0,0
3,COFACTOR TRANSPORT,0.62113,0.12603,0.038678,0,0
3,REACTOME HS GAG BIOSYNTHESIS,0.34702,0.12584,0.074123,0,0
3,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.095625,0.12559,0.11012,0,0
3,REACTOME NEPHRIN INTERACTIONS,0.20621,0.1253,0.065347,0,0
3,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.23245,0.12371,0.084169,0,0
3,REACTOME NCAM1 INTERACTIONS,0.10096,0.12307,0.14604,0,0
3,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.17099,0.12207,0.16449,0,0
3,REACTOME PYRUVATE METABOLISM,0.15773,0.12201,0.14637,0,0
3,DNA DAMAGE CHECKPOINT,0.063042,0.11888,0.087371,0,0
3,NOTCH SIGNALING PATHWAY,0.2839,0.1187,0.075155,0,0
3,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.19393,0.11716,0.11248,0,0
3,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,0.78962,0.11701,-0.0068433,0,0
3,RESPONSE TO DRUG,0.91987,0.11517,-0.04587,0,0
3,PROTEIN AMINO ACID LIPIDATION,0.70355,0.11512,-0.027021,0,0
3,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.24643,0.11478,0.070212,0,0
3,CARBOHYDRATE METABOLIC PROCESS,0.065563,0.1133,0.068113,0,0
3,KEGG DILATED CARDIOMYOPATHY,0.16559,0.11318,0.07176,0,0
3,BIOCARTA PGC1A PATHWAY,0.10465,0.11285,0.16485,0,0
3,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.29586,0.11125,0.068165,0,0
3,BIOCARTA ATM PATHWAY,0.2839,0.11117,0.069492,0,0
3,BIOCARTA LAIR PATHWAY,0.15773,0.10951,0.019047,0,0
3,BIOCARTA TALL1 PATHWAY,0.11235,0.10896,0.072345,0,0
3,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,0.14285,0.10835,0.090515,0,0
3,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.17374,0.10804,0.072248,0,0
3,NUCLEAR HORMONE RECEPTOR BINDING,0.34256,0.1077,0.048958,0,0
3,HORMONE RECEPTOR BINDING,0.34256,0.1077,0.048958,0,0
3,BIOCARTA NGF PATHWAY,0.26098,0.10722,0.10559,0,0
3,BRAIN DEVELOPMENT,0.14526,0.10565,0.14777,0,0
3,CENTROSOME ORGANIZATION AND BIOGENESIS,0.077957,0.10505,0.11626,0,0
3,CELL MIGRATION,0.26098,0.10497,0.074943,0,0
3,BONE REMODELING,0.075049,0.10489,0.16029,0,0
3,OXIDOREDUCTASE ACTIVITY GO 0016705,0.31232,0.10459,0.05566,0,0
3,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,0.23937,0.10435,0.029448,0,0
3,KEGG MISMATCH REPAIR,0.10654,0.10427,0.10353,0,0
3,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.12908,0.10419,0.092172,0,0
3,BIOCARTA IL12 PATHWAY,0.099158,0.10358,0.11471,0,0
3,PID FRA PATHWAY,0.19695,0.10355,0.034322,0,0
3,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,0.088862,0.10307,0.076834,0,0
3,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,0.39858,0.10293,0.086003,0,0
3,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.16032,0.10272,0.10068,0,0
3,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.62113,0.10234,-0.022074,0,0
3,SYMPORTER ACTIVITY,0.21905,0.10225,0.059537,0,0
3,REACTOME GAB1 SIGNALOSOME,0.36526,0.10181,0.039818,0,0
3,CELLULAR RESPIRATION,0.11235,0.10165,0.093867,0,0
3,BIOCARTA EIF4 PATHWAY,0.3746,0.10138,0.031954,0,0
3,REACTOME BASE EXCISION REPAIR,0.2839,0.1013,0.057332,0,0
3,SKELETAL DEVELOPMENT,0.36991,0.1009,0.045254,0,0
3,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.061812,0.10042,0.087005,0,0
3,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.3746,0.10036,0.034222,0,0
3,CARBONATE DEHYDRATASE ACTIVITY,0.62113,0.099934,0.029286,0,0
3,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.13814,0.099255,0.12905,0,0
3,REACTOME COLLAGEN FORMATION,0.37932,0.099207,0.0189,0,0
3,PID LYSOPHOSPHOLIPID PATHWAY,0.58456,0.098584,0.022556,0,0
3,PID PS1PATHWAY,0.12689,0.098458,0.058021,0,0
3,SPLICEOSOME ASSEMBLY,0.14285,0.098428,0.091768,0,0
3,LYASE ACTIVITY,0.55487,0.098419,0.018801,0,0
3,PID S1P META PATHWAY,0.25363,0.098418,0.045441,0,0
3,LAMELLIPODIUM,0.19095,0.098081,0.070552,0,0
3,SPINDLE POLE,0.12049,0.097304,0.088041,0,0
3,REACTOME S PHASE,0.070855,0.096832,0.10534,0,0
3,COFACTOR METABOLIC PROCESS,0.17934,0.096094,0.061282,0,0
3,KEGG DRUG METABOLISM OTHER ENZYMES,0.43367,0.095285,0.03694,0,0
3,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.78962,0.095213,0.031737,0,0
3,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.35153,0.094867,0.053076,0,0
3,KEGG LONG TERM DEPRESSION,0.045624,0.094705,0.11116,0,0
3,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.11039,0.094251,0.10073,0,0
3,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.097379,0.094072,0.18983,0,0
3,PID ERBB1 INTERNALIZATION PATHWAY,0.50896,0.094061,0.04242,0,0
3,PEPTIDE BINDING,0.15773,0.093773,0.052408,0,0
3,SECRETORY PATHWAY,0.093897,0.093019,0.09997,0,0
3,PROTEIN DNA COMPLEX ASSEMBLY,0.19095,0.092842,0.063748,0,0
3,PID EPHA FWDPATHWAY,0.24288,0.092817,0.096377,0,0
3,REGULATION OF DNA METABOLIC PROCESS,0.047551,0.092331,0.077664,0,0
3,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,0.66501,0.090777,0.008947,0,0
3,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.28785,0.090507,0.047071,0,0
3,PID E2F PATHWAY,0.05824,0.090187,0.075772,0,0
3,POLYSACCHARIDE METABOLIC PROCESS,0.77618,0.089956,0.0093046,0,0
3,TRNA METABOLIC PROCESS,0.099158,0.089816,0.13915,0,0
3,PORE COMPLEX,0.15517,0.08971,0.071604,0,0
3,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.70355,0.089251,-0.012203,0,0
3,VITAMIN TRANSPORT,0.2839,0.08884,0.10054,0,0
3,ZINC ION BINDING,0.064293,0.088799,0.061247,0,0
3,REACTOME SPRY REGULATION OF FGF SIGNALING,0.63354,0.088733,-0.01369,0,0
3,DEFENSE RESPONSE TO BACTERIUM,0.2,0.088388,0.043159,0,0
3,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,0.69061,0.087918,0.070878,0,0
3,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,0.35607,0.086905,0.10263,0,0
3,MICROTUBULE,0.097379,0.086878,0.10539,0,0
3,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.49227,0.086396,0.031613,0,0
3,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.40843,0.086329,0.046836,0,0
3,DEACETYLASE ACTIVITY,0.32506,0.086266,0.062763,0,0
3,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.23245,0.086194,0.061506,0,0
3,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,0.1313,0.086052,0.059389,0,0
3,PID CONE PATHWAY,0.088862,0.085848,0.011289,0,0
3,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.049546,0.08531,0.091805,0,0
3,NITROGEN COMPOUND METABOLIC PROCESS,0.052669,0.0848,0.074644,0,0
3,MITOCHONDRIAL RIBOSOME,0.044685,0.084712,0.20158,0,0
3,ORGANELLAR RIBOSOME,0.044685,0.084712,0.20158,0,0
3,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,0.72969,0.084352,-0.027606,0,0
3,KEGG PENTOSE PHOSPHATE PATHWAY,0.13814,0.08429,0.12107,0,0
3,TRANSMEMBRANE RECEPTOR ACTIVITY,0.36526,0.084214,0.021179,0,0
3,REACTOME KINESINS,0.26098,0.083624,0.096637,0,0
3,REGULATION OF NEURON APOPTOSIS,0.10845,0.083205,0.10919,0,0
3,BIOCARTA RACCYCD PATHWAY,0.41842,0.083167,0.016272,0,0
3,RECEPTOR ACTIVITY,0.1028,0.082842,0.054286,0,0
3,WNT SIGNALING,0.084046,0.082704,0.088103,0,0
3,KEGG NON SMALL CELL LUNG CANCER,0.24643,0.082689,0.052142,0,0
3,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.28785,0.082665,0.062277,0,0
3,PID IGF1 PATHWAY,0.29992,0.082629,0.035016,0,0
3,DNA RECOMBINATION,0.070855,0.082032,0.093506,0,0
3,NEUROLOGICAL SYSTEM PROCESS,0.17099,0.081845,0.063029,0,0
3,CARBOHYDRATE TRANSPORT,0.71658,0.080492,0.010329,0,0
3,KEGG PYRIMIDINE METABOLISM,0.068167,0.080034,0.054444,0,0
3,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,0.60272,0.079901,-0.15186,0,0
3,SULFOTRANSFERASE ACTIVITY,0.49227,0.079842,0.057489,0,0
3,KEGG OXIDATIVE PHOSPHORYLATION,0.28785,0.07958,0.042157,0,0
3,BIOCARTA VIP PATHWAY,0.2,0.078511,0.077058,0,0
3,STRUCTURAL MOLECULE ACTIVITY,0.29992,0.078364,0.045612,0,0
3,CORTICAL ACTIN CYTOSKELETON,0.39371,0.078165,0.10427,0,0
3,PID ERA GENOMIC PATHWAY,0.37932,0.078076,0.063348,0,0
3,REACTOME G ALPHA S SIGNALLING EVENTS,0.064293,0.077727,0.10042,0,0
3,REACTOME SYNTHESIS OF PC,0.88523,0.077299,-0.0048721,0,0
3,NUCLEOTIDE METABOLIC PROCESS,0.050569,0.077155,0.10339,0,0
3,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.36991,0.077008,0.10431,0,0
3,REACTOME ION CHANNEL TRANSPORT,0.061812,0.076451,0.13059,0,0
3,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,0.26098,0.07621,0.070578,0,0
3,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.56075,0.075897,0.02357,0,0
3,ANTIGEN BINDING,0.52025,0.075841,0.013246,0,0
3,TUBULIN BINDING,0.12049,0.074834,0.096174,0,0
3,BIOCARTA BARR MAPK PATHWAY,0.087232,0.07441,0.14847,0,0
3,REACTOME METABOLISM OF PROTEINS,0.097379,0.073193,0.072488,0,0
3,PROTEIN IMPORT INTO NUCLEUS,0.23245,0.073144,0.036939,0,0
3,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.29992,0.073094,0.083354,0,0
3,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.39371,0.072738,0.045802,0,0
3,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.36064,0.072564,0.047171,0,0
3,HEPARIN BINDING,0.64605,0.072548,0.015101,0,0
3,KINESIN COMPLEX,0.61497,0.071419,0.095271,0,0
3,KEGG PARKINSONS DISEASE,0.087232,0.071395,0.086214,0,0
3,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.87144,0.071151,0.011073,0,0
3,COENZYME METABOLIC PROCESS,0.3746,0.071056,0.028936,0,0
3,KEGG CYSTEINE AND METHIONINE METABOLISM,0.14048,0.070886,0.11114,0,0
3,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,0.29586,0.070734,0.079679,0,0
3,BIOCARTA GCR PATHWAY,0.39858,0.070705,0.041117,0,0
3,RIBONUCLEASE ACTIVITY,0.188,0.070657,0.071172,0,0
3,PROTEASOME COMPLEX,0.43883,0.070536,0.030405,0,0
3,PID EPHBFWDPATHWAY,0.40349,0.070429,0.049345,0,0
3,ST ADRENERGIC,0.21256,0.07031,0.072483,0,0
3,RAS GTPASE BINDING,0.23589,0.069949,0.051544,0,0
3,ELECTRON TRANSPORT GO 0006118,0.11039,0.069486,0.11152,0,0
3,REACTOME EXTENSION OF TELOMERES,0.087232,0.069469,0.10641,0,0
3,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,0.82348,0.068812,-0.035795,0,0
3,INTRINSIC TO PLASMA MEMBRANE,0.25729,0.068306,0.036073,0,0
3,ONE CARBON COMPOUND METABOLIC PROCESS,0.39858,0.067391,0.034012,0,0
3,BIOCARTA CK1 PATHWAY,0.34256,0.066972,0.14005,0,0
3,BIOCARTA IGF1 PATHWAY,0.63354,0.066912,0.034344,0,0
3,LIPID KINASE ACTIVITY,0.18219,0.066521,0.079825,0,0
3,THIOLESTER HYDROLASE ACTIVITY,0.63978,0.066474,0.026966,0,0
3,REACTOME PERK REGULATED GENE EXPRESSION,0.35153,0.065866,0.075509,0,0
3,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,0.40843,0.065598,0.0060306,0,0
3,REACTOME OPIOID SIGNALLING,0.41842,0.065489,0.055739,0,0
3,CELL CORTEX PART,0.19393,0.06544,0.12687,0,0
3,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.56075,0.065264,0.11994,0,0
3,BIOCARTA CTCF PATHWAY,0.36526,0.065252,0.051818,0,0
3,BIOCARTA INFLAM PATHWAY,0.14285,0.064887,0.063592,0,0
3,POTASSIUM CHANNEL REGULATOR ACTIVITY,1,0.064848,0.010849,0,0
3,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.16294,0.064753,0.098449,0,0
3,RNA BINDING,0.095625,0.064281,0.10522,0,0
3,REACTOME PLATELET HOMEOSTASIS,0.16559,0.064246,0.08274,0,0
3,BIOCARTA RARRXR PATHWAY,0.099158,0.063876,0.11171,0,0
3,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.27611,0.063611,0.064743,0,0
3,BIOCARTA IL1R PATHWAY,0.27611,0.063499,0.0073986,0,0
3,COFACTOR BIOSYNTHETIC PROCESS,0.35607,0.063358,0.046579,0,0
3,MEIOSIS I,0.80989,0.06333,0.011959,0,0
3,DNA REPAIR,0.090515,0.063299,0.049831,0,0
3,ST GA12 PATHWAY,0.20309,0.06245,0.063042,0,0
3,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.43367,0.062369,0.042917,0,0
3,NUCLEOCYTOPLASMIC TRANSPORT,0.32506,0.062079,0.034128,0,0
3,PID HIF1APATHWAY,0.53742,0.06204,0.096773,0,0
3,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.53742,0.062025,0.011346,0,0
3,SH3 SH2 ADAPTOR ACTIVITY,0.52594,0.061995,-0.05628,0,0
3,VESICLE MEDIATED TRANSPORT,0.42855,0.061919,0.025189,0,0
3,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.29184,0.061627,0.035312,0,0
3,PID ARF6 PATHWAY,0.36991,0.061582,0.058183,0,0
3,NUCLEAR TRANSPORT,0.33373,0.061529,0.02971,0,0
3,PID ER NONGENOMIC PATHWAY,0.30815,0.061529,0.045668,0,0
3,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.52594,0.061286,0.045258,0,0
3,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.46512,0.061188,0.030857,0,0
3,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.34256,0.061185,0.046729,0,0
3,KEGG BLADDER CANCER,0.29184,0.060834,0.035955,0,0
3,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,0.17099,0.060259,0.067843,0,0
3,BIOCARTA HCMV PATHWAY,0.91987,0.060087,-0.0069418,0,0
3,RESPONSE TO BACTERIUM,0.34702,0.059433,0.012544,0,0
3,DNA CATABOLIC PROCESS,0.82348,0.059096,0.0055516,0,0
3,INSOLUBLE FRACTION,0.96163,0.058792,-0.01721,0,0
3,BASE EXCISION REPAIR,0.72969,0.058521,0.022816,0,0
3,REACTOME SYNTHESIS OF PA,0.94073,0.058355,-0.027784,0,0
3,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,0.44402,0.058119,0.018202,0,0
3,CIRCADIAN RHYTHM,0.54321,0.057985,0.045,0,0
3,CALCIUM CHANNEL ACTIVITY,0.35607,0.057952,0.12096,0,0
3,REACTOME CELL CYCLE MITOTIC,0.26471,0.057846,0.040491,0,0
3,INTEGRAL TO PLASMA MEMBRANE,0.41842,0.057832,0.022057,0,0
3,REACTOME ACTIVATION OF GENES BY ATF4,0.32938,0.05715,0.088363,0,0
3,BIOCARTA DREAM PATHWAY,0.31232,0.056544,0.13606,0,0
3,MONOVALENT INORGANIC CATION TRANSPORT,0.32077,0.056499,0.10824,0,0
3,KEGG WNT SIGNALING PATHWAY,0.19393,0.055682,0.042134,0,0
3,SULFURIC ESTER HYDROLASE ACTIVITY,0.34702,0.055554,0.065016,0,0
3,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.36064,0.055513,0.055811,0,0
3,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,0.15015,0.055221,0.12995,0,0
3,INTERPHASE OF MITOTIC CELL CYCLE,0.4978,0.055118,0.028742,0,0
3,GLYCOLIPID METABOLIC PROCESS,0.98953,0.054703,-0.0017479,0,0
3,REACTOME GPCR DOWNSTREAM SIGNALING,0.19393,0.054433,0.04781,0,0
3,PID P73PATHWAY,0.34256,0.054068,0.043488,0,0
3,REACTOME METABOLISM OF CARBOHYDRATES,0.17934,0.053628,0.06099,0,0
3,SYSTEM PROCESS,0.18508,0.053529,0.055906,0,0
3,BIOCARTA CARM ER PATHWAY,0.85082,0.053428,-0.019065,0,0
3,BIOCARTA NTHI PATHWAY,0.60883,0.05301,0.002959,0,0
3,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.076492,0.052983,0.096472,0,0
3,REACTOME MUSCLE CONTRACTION,0.94769,0.052646,-0.045193,0,0
3,KEGG OLFACTORY TRANSDUCTION,0.17934,0.052194,0.058857,0,0
3,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,0.4545,0.052096,0.034116,0,0
3,BIOCARTA INTEGRIN PATHWAY,0.72313,0.052028,-0.0079613,0,0
3,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.87144,0.051645,-0.00017232,0,0
3,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.54903,0.051621,0.01425,0,0
3,SPINDLE,0.30815,0.051571,0.057706,0,0
3,SKELETAL MUSCLE DEVELOPMENT,0.62113,0.051553,0.012475,0,0
3,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.088862,0.051367,0.079808,0,0
3,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.60883,0.051238,-0.00035518,0,0
3,SMALL GTPASE BINDING,0.066855,0.051032,0.075927,0,0
3,REACTOME SIGNALING BY EGFR IN CANCER,0.31653,0.050251,0.02284,0,0
3,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.052669,0.050189,0.080791,0,0
3,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.82348,0.049375,0.014611,0,0
3,PID P53REGULATIONPATHWAY,0.24643,0.049304,0.041595,0,0
3,AROMATIC COMPOUND METABOLIC PROCESS,0.8303,0.048775,0.012589,0,0
3,KEGG ERBB SIGNALING PATHWAY,0.67776,0.048646,0.010048,0,0
3,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.36991,0.048189,0.041889,0,0
3,REACTOME ERKS ARE INACTIVATED,0.49227,0.048066,0.070489,0,0
3,PROTEIN IMPORT,0.20621,0.047634,0.028027,0,0
3,KEGG GAP JUNCTION,0.48678,0.047585,0.02313,0,0
3,DNA PACKAGING,0.46512,0.047574,0.013252,0,0
3,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.64605,0.047444,0.0022286,0,0
3,SIG CHEMOTAXIS,0.14769,0.047361,0.074784,0,0
3,REGULATION OF DNA BINDING,0.44402,0.047348,0.026198,0,0
3,MITOCHONDRION,0.16828,0.046941,0.060588,0,0
3,KEGG FOCAL ADHESION,0.89215,0.04687,-0.033818,0,0
3,MICROTUBULE ORGANIZING CENTER PART,0.72313,0.04665,0.028154,0,0
3,PID SMAD2 3NUCLEARPATHWAY,0.52594,0.046403,0.025601,0,0
3,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.87144,0.046367,-0.017572,0,0
3,BIOCARTA CELLCYCLE PATHWAY,0.67776,0.045835,0.01915,0,0
3,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.24288,0.045759,0.101,0,0
3,MUSCLE DEVELOPMENT,0.35153,0.045567,0.03294,0,0
3,BIOCARTA FMLP PATHWAY,0.41341,0.045145,0.046019,0,0
3,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.83713,0.045082,-0.027283,0,0
3,KEGG COLORECTAL CANCER,0.40843,0.044326,0.041726,0,0
3,MOLECULAR ADAPTOR ACTIVITY,0.63978,0.043547,-0.035779,0,0
3,REACTOME HS GAG DEGRADATION,0.9686,0.043079,-0.021545,0,0
3,CELLULAR PROTEIN COMPLEX ASSEMBLY,0.23245,0.042989,0.039221,0,0
3,PID ARF6 TRAFFICKINGPATHWAY,0.32077,0.042988,0.042119,0,0
3,AMINO ACID METABOLIC PROCESS,0.36526,0.042879,0.074975,0,0
3,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,0.38408,0.042477,0.24656,0,0
3,RHYTHMIC PROCESS,0.94769,0.042363,-0.014884,0,0
3,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.31653,0.042163,0.044795,0,0
3,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.67137,0.041801,0.0073961,0,0
3,KEGG LYSINE DEGRADATION,0.43883,0.041439,0.039734,0,0
3,TRANSCRIPTION FACTOR ACTIVITY,0.099158,0.041423,0.040846,0,0
3,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,0.95466,0.041213,0.0063616,0,0
3,KEGG BASAL CELL CARCINOMA,0.91987,0.040852,-0.015124,0,0
3,VIRAL GENOME REPLICATION,0.53742,0.040828,0.035309,0,0
3,KEGG HEDGEHOG SIGNALING PATHWAY,0.59664,0.040521,0.034788,0,0
3,PHOSPHATASE BINDING,0.89215,0.040484,-0.011479,0,0
3,PLASMA MEMBRANE PART,0.48678,0.040318,0.015735,0,0
3,REACTOME DNA REPAIR,0.084046,0.04025,0.066247,0,0
3,TRANSLATION,0.31653,0.039953,0.06347,0,0
3,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.53167,0.039869,0.03034,0,0
3,REACTOME GLYCOSAMINOGLYCAN METABOLISM,0.53742,0.03956,0.013642,0,0
3,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.98953,0.039359,-0.047682,0,0
3,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.54321,0.039256,0.020173,0,0
3,GLUCOSE METABOLIC PROCESS,0.54903,0.03923,0.027385,0,0
3,KEGG PPAR SIGNALING PATHWAY,0.14526,0.038731,0.093283,0,0
3,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.75615,0.038617,0.0025602,0,0
3,REGULATION OF PROTEIN MODIFICATION PROCESS,0.38408,0.038205,0.037044,0,0
3,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.60883,0.038186,0.016474,0,0
3,GTPASE BINDING,0.11434,0.038169,0.070161,0,0
3,CELL CYCLE CHECKPOINT GO 0000075,0.36526,0.037889,0.011761,0,0
3,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.39371,0.037862,0.059755,0,0
3,KEGG NUCLEOTIDE EXCISION REPAIR,0.23937,0.037499,0.059499,0,0
3,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.30815,0.037251,0.042179,0,0
3,BIOCARTA SHH PATHWAY,0.42855,0.037178,0.049662,0,0
3,PID AURORA B PATHWAY,0.4598,0.036914,0.056978,0,0
3,BIOCARTA MTA3 PATHWAY,0.26471,0.036835,0.106,0,0
3,BIOCARTA NFAT PATHWAY,0.78962,0.036819,0.012858,0,0
3,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.71658,0.036813,-0.00023127,0,0
3,KEGG SMALL CELL LUNG CANCER,0.83713,0.036518,-0.0059334,0,0
3,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.11039,0.036281,0.088644,0,0
3,CELL FATE COMMITMENT,0.72313,0.036188,-0.067298,0,0
3,KEGG BASAL TRANSCRIPTION FACTORS,0.85768,0.03617,-0.0057606,0,0
3,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.25001,0.036044,0.056721,0,0
3,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.70355,0.036033,0.017809,0,0
3,VITAMIN METABOLIC PROCESS,0.96163,0.035865,-0.0057797,0,0
3,CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.30402,0.035834,0.09387,0,0
3,KINETOCHORE,0.90599,0.03582,-0.010228,0,0
3,NUCLEAR IMPORT,0.5726,0.035757,0.0016163,0,0
3,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.65234,0.035679,0.058965,0,0
3,KEGG MAPK SIGNALING PATHWAY,0.39858,0.035174,0.034167,0,0
3,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.24643,0.034939,0.040099,0,0
3,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.38888,0.034849,0.047668,0,0
3,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.85082,0.034472,0.011428,0,0
3,REACTOME MITOTIC M M G1 PHASES,0.31653,0.034369,0.042415,0,0
3,BIOCARTA CARDIACEGF PATHWAY,0.40349,0.034361,0.00028868,0,0
3,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.88523,0.033949,0.010841,0,0
3,COLLAGEN,0.79636,0.033485,-0.058711,0,0
3,COVALENT CHROMATIN MODIFICATION,0.48131,0.033322,0.047813,0,0
3,HISTONE MODIFICATION,0.48131,0.033322,0.047813,0,0
3,ST T CELL SIGNAL TRANSDUCTION,0.44402,0.033254,0.031947,0,0
3,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.48131,0.033242,0.03521,0,0
3,PID S1P S1P1 PATHWAY,0.47049,0.033055,0.053707,0,0
3,PID NEPHRIN NEPH1 PATHWAY,0.29586,0.033031,0.055737,0,0
3,SENSORY ORGAN DEVELOPMENT,0.57857,0.032928,0.12266,0,0
3,REACTOME PI 3K CASCADE,0.33812,0.032589,0.044165,0,0
3,TRANS GOLGI NETWORK,0.22568,0.032501,0.058145,0,0
3,REACTOME G ALPHA I SIGNALLING EVENTS,0.4545,0.032486,0.018497,0,0
3,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.99651,0.032209,-0.010832,0,0
3,REACTOME KERATAN SULFATE KERATIN METABOLISM,0.69707,0.032188,0.0096453,0,0
3,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.52025,0.032121,0.023806,0,0
3,INTRINSIC TO MEMBRANE,0.51459,0.032116,0.014182,0,0
3,REACTOME CGMP EFFECTS,0.54321,0.031265,0.055508,0,0
3,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.47588,0.031203,0.019102,0,0
3,BIOCARTA AKAP13 PATHWAY,0.60883,0.031087,0.039997,0,0
3,PID THROMBIN PAR1 PATHWAY,0.54903,0.030987,0.042189,0,0
3,KEGG ABC TRANSPORTERS,0.92682,0.030874,-0.0066527,0,0
3,MEIOTIC RECOMBINATION,0.65234,0.030347,0.037451,0,0
3,REACTOME HEMOSTASIS,0.74288,0.030075,0.0075192,0,0
3,PID INTEGRIN1 PATHWAY,0.90599,0.029879,-0.082158,0,0
3,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.5726,0.02987,0.047615,0,0
3,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,0.67137,0.029001,-0.062129,0,0
3,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.52594,0.028514,0.02387,0,0
3,CHROMOSOMEPERICENTRIC REGION,0.62113,0.028163,0.019598,0,0
3,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.40843,0.028013,0.029736,0,0
3,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.97557,0.0278,-0.00338,0,0
3,APOPTOTIC NUCLEAR CHANGES,0.49227,0.027711,0.041309,0,0
3,MESODERM DEVELOPMENT,0.43883,0.027551,-0.17427,0,0
3,PID P38 MKK3 6PATHWAY,0.90599,0.027329,-0.011348,0,0
3,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.84397,0.027192,0.014087,0,0
3,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.99651,0.02694,-0.0047468,0,0
3,MICROSOME,0.14526,0.026791,-0.11578,0,0
3,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.93377,0.026614,0.015546,0,0
3,KEGG HUNTINGTONS DISEASE,0.96163,0.026301,-0.0091034,0,0
3,REACTOME MITOTIC G2 G2 M PHASES,0.68418,0.026272,0.020519,0,0
3,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.54903,0.026035,-0.059479,0,0
3,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.78289,0.025324,-0.032597,0,0
3,DNA METABOLIC PROCESS,0.15517,0.025316,0.036361,0,0
3,REACTOME SIGNALING BY GPCR,0.35153,0.025166,0.032209,0,0
3,REACTOME SMOOTH MUSCLE CONTRACTION,0.93377,0.024744,-0.11041,0,0
3,CELLULAR COMPONENT DISASSEMBLY,0.65234,0.024578,0.021964,0,0
3,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.66501,0.024395,0.018978,0,0
3,PID PI3KCIAKTPATHWAY,0.27999,0.024302,0.044814,0,0
3,CELLULAR BIOSYNTHETIC PROCESS,0.31653,0.024233,0.06387,0,0
3,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.087232,0.024094,0.082151,0,0
3,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.41842,0.023611,0.028137,0,0
3,REACTOME GPCR LIGAND BINDING,0.86455,0.023533,0.0010422,0,0
3,ION TRANSPORT,0.94073,0.023115,0.0043616,0,0
3,PLASMA MEMBRANE,0.61497,0.022765,0.010968,0,0
3,INTEGRAL TO MEMBRANE,0.74288,0.022606,0.0030324,0,0
3,PML BODY,0.65866,0.022521,-0.07948,0,0
3,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.89215,0.02249,0.0015423,0,0
3,CELL PROJECTION BIOGENESIS,0.99651,0.02234,-0.011987,0,0
3,REGULATION OF IMMUNE RESPONSE,0.97557,0.022303,-0.010664,0,0
3,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.93377,0.021572,-0.008207,0,0
3,BIOCARTA P38MAPK PATHWAY,0.51459,0.021494,0.029589,0,0
3,PID S1P S1P3 PATHWAY,0.87144,0.021489,-0.011643,0,0
3,BIOCARTA AGR PATHWAY,0.9686,0.021267,-0.00956,0,0
3,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,0.98255,0.021105,-0.049572,0,0
3,BIOCARTA TOB1 PATHWAY,0.95466,0.021002,-0.053911,0,0
3,KEGG NITROGEN METABOLISM,0.8303,0.020613,-0.032474,0,0
3,VESICLE,0.94769,0.020286,-0.012531,0,0
3,BIOCARTA MCM PATHWAY,0.52594,0.020208,0.055741,0,0
3,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.44924,0.019771,0.031007,0,0
3,PID ATM PATHWAY,0.92682,0.019585,0.0091098,0,0
3,BIOCARTA ERK5 PATHWAY,0.49227,0.019536,0.079964,0,0
3,REACTOME METAL ION SLC TRANSPORTERS,0.9686,0.01953,-0.020925,0,0
3,POSITIVE REGULATION OF PHOSPHORYLATION,0.94769,0.01941,0.022972,0,0
3,VIRAL INFECTIOUS CYCLE,0.68418,0.019287,0.01203,0,0
3,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,0.93377,0.019196,-0.020813,0,0
3,REACTOME ARMS MEDIATED ACTIVATION,0.31232,0.019186,0.065562,0,0
3,SA G1 AND S PHASES,0.44402,0.018959,0.062925,0,0
3,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.3746,0.018583,-0.090116,0,0
3,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.89907,0.018466,-0.00028966,0,0
3,REACTOME DNA STRAND ELONGATION,0.25363,0.018186,0.10421,0,0
3,VESICULAR FRACTION,0.24643,0.017932,-0.10456,0,0
3,LEUKOCYTE ACTIVATION,0.36991,0.017893,-0.070746,0,0
3,PID TRKRPATHWAY,0.76281,0.01761,0.017082,0,0
3,REGULATION OF CELL GROWTH,0.70355,0.017592,-0.049758,0,0
3,ACTIN FILAMENT BASED MOVEMENT,0.40349,0.017508,-0.1459,0,0
3,PEPTIDYL TYROSINE MODIFICATION,0.82348,0.017372,-0.040123,0,0
3,BEHAVIOR,0.99651,0.016775,-0.014326,0,0
3,DRUG BINDING,0.4978,0.016774,0.063415,0,0
3,CATION BINDING,0.62732,0.016604,0.011889,0,0
3,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,0.84397,0.016242,0.0098328,0,0
3,EXTRACELLULAR MATRIX PART,0.19695,0.016078,0.064338,0,0
3,REGULATION OF PHOSPHORYLATION,0.73628,0.016068,0.0020729,0,0
3,MACROMOLECULE CATABOLIC PROCESS,0.90599,0.015861,-0.0028766,0,0
3,KEGG PANCREATIC CANCER,0.87144,0.015826,-0.0012398,0,0
3,REACTOME STEROID HORMONES,0.92682,0.015724,-0.055106,0,0
3,NEGATIVE REGULATION OF CELL MIGRATION,0.65234,0.015704,0.054727,0,0
3,PID HDAC CLASSI PATHWAY,0.95466,0.015495,0.0015304,0,0
3,REACTOME G ALPHA Q SIGNALLING EVENTS,0.62732,0.01538,0.026744,0,0
3,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,0.7495,0.015251,-0.083568,0,0
3,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,0.71006,0.014913,-0.074312,0,0
3,SYSTEM DEVELOPMENT,0.4598,0.01489,0.028283,0,0
3,CELL DIVISION,0.85082,0.01443,0.016263,0,0
3,TRANSCRIPTION INITIATION,0.67137,0.014411,0.015097,0,0
3,PEPTIDYL TYROSINE PHOSPHORYLATION,0.87144,0.014181,-0.017417,0,0
3,REACTOME CA DEPENDENT EVENTS,0.94073,0.013937,-0.012353,0,0
3,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.81668,0.013816,-0.02217,0,0
3,KEGG CELL CYCLE,0.76948,0.013463,-0.010461,0,0
3,RNA METABOLIC PROCESS,0.65234,0.013302,0.0092356,0,0
3,POSITIVE REGULATION OF IMMUNE RESPONSE,0.85768,0.013297,0.0073136,0,0
3,ACETYLTRANSFERASE ACTIVITY,0.85082,0.012995,0.016073,0,0
3,UNFOLDED PROTEIN BINDING,0.51459,0.012866,-0.045609,0,0
3,KEGG LINOLEIC ACID METABOLISM,0.72313,0.01259,-0.071566,0,0
3,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.26847,0.012188,0.099419,0,0
3,ST GA13 PATHWAY,0.94073,0.011081,-0.0094645,0,0
3,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,0.82348,0.010971,-0.04966,0,0
3,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.77618,0.010945,0.015217,0,0
3,HORMONE METABOLIC PROCESS,0.70355,0.010598,-0.071005,0,0
3,RESPONSE TO ORGANIC SUBSTANCE,0.81668,0.010542,-0.045315,0,0
3,REACTOME DAG AND IP3 SIGNALING,0.84397,0.010437,-0.0065212,0,0
3,RESPONSE TO ABIOTIC STIMULUS,0.89215,0.010424,-0.0033419,0,0
3,TRANSPORT,0.48678,0.010355,0.014576,0,0
3,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,0.99651,0.01032,-0.0046287,0,0
3,PID CD40 PATHWAY,0.99651,0.010291,-0.032769,0,0
3,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.62732,0.010201,-0.039414,0,0
3,REACTOME DNA REPLICATION,0.54903,0.010158,0.025767,0,0
3,PID BETACATENIN NUC PATHWAY,0.76281,0.010043,-0.00042787,0,0
3,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.52594,0.009993,0.016075,0,0
3,MEMBRANE LIPID METABOLIC PROCESS,0.66501,0.0098942,-0.03474,0,0
3,REACTOME SIGNALING BY NOTCH1,0.90599,0.0097274,0.0050271,0,0
3,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,1,0.0096984,-0.021333,0,0
3,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,0.80312,0.0096905,-0.0043904,0,0
3,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.9686,0.0092171,-0.024307,0,0
3,KEGG CHEMOKINE SIGNALING PATHWAY,0.28785,0.009132,0.032276,0,0
3,BIOCARTA ALK PATHWAY,0.49227,0.0091301,0.034175,0,0
3,MEMBRANE BOUND VESICLE,0.62732,0.008733,-0.029084,0,0
3,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.60272,0.0082615,0.018232,0,0
3,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.67776,0.0073367,0.012375,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,0.72969,0.0068531,0.015558,0,0
3,REACTOME THE ACTIVATION OF ARYLSULFATASES,0.71006,0.0066502,-0.080776,0,0
3,SECRETION BY CELL,0.78289,0.0063799,-0.022626,0,0
3,GROWTH FACTOR BINDING,0.98953,0.0061075,-0.020619,0,0
3,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.8303,0.0057705,0.0024508,0,0
3,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.60883,0.0057101,-0.023998,0,0
3,MONOOXYGENASE ACTIVITY,0.59664,0.0056609,0.002121,0,0
3,PID CXCR4 PATHWAY,0.74288,0.0055879,0.0033658,0,0
3,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.63978,0.0054981,0.071335,0,0
3,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.61497,0.0054289,0.017803,0,0
3,ESTABLISHMENT OF LOCALIZATION,0.79636,0.0053561,-0.00143,0,0
3,CYTOPLASMIC VESICLE,0.88523,0.005348,-0.01393,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,0.44924,0.0050421,0.083327,0,0
3,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.60883,0.0045314,-0.029922,0,0
3,REACTOME CELL CYCLE,0.54903,0.0045307,0.022853,0,0
3,DNA BINDING,0.91293,0.00437,0.00021029,0,0
3,MEIOTIC CELL CYCLE,0.42347,0.003648,-0.078927,0,0
3,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.9686,0.0034015,-0.00020269,0,0
3,BIOCARTA INSULIN PATHWAY,0.87144,0.0031736,-0.010342,0,0
3,RESPONSE TO LIGHT STIMULUS,0.99651,0.002812,0.0014214,0,0
3,PID AURORA A PATHWAY,0.60883,0.0027934,-0.038053,0,0
3,BIOCARTA TEL PATHWAY,0.93377,0.0027081,-0.021224,0,0
3,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.85082,0.0026717,0.019924,0,0
3,REACTOME PLC BETA MEDIATED EVENTS,0.83713,0.0022233,0.030924,0,0
3,RECEPTOR COMPLEX,0.65234,0.0020745,-0.04792,0,0
3,ORGANELLE LUMEN,0.33812,0.0019863,0.031226,0,0
3,MEMBRANE ENCLOSED LUMEN,0.33812,0.0019863,0.031226,0,0
3,BIOCARTA CFTR PATHWAY,0.97557,0.0017568,0.0091681,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,0.80989,0.0017163,-0.020413,0,0
3,REACTOME SIGNALING BY INSULIN RECEPTOR,0.74288,0.0010782,0.0049367,0,0
3,EXCRETION,0.51459,0.00098323,-0.071055,0,0
3,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.75615,0.00084634,-0.019127,0,0
3,KEGG GLIOMA,0.92682,0.00071463,-0.0021348,0,0
3,PID SYNDECAN 1 PATHWAY,0.81668,0.0005068,-0.084617,0,0
3,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.76948,0.0004585,0.011766,0,0
3,GROWTH,0.56666,0.00038496,-0.036581,0,0
3,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,0.23245,0.00036827,-0.1755,0,0
3,ESTABLISHMENT OF CELLULAR LOCALIZATION,0.31232,4.6478e-05,-0.034408,0,0
3,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.57857,-0.00051927,0.018724,0,0
3,EXTERNAL SIDE OF PLASMA MEMBRANE,0.84397,-0.00065905,-0.011629,0,0
3,REGULATION OF CATALYTIC ACTIVITY,0.74288,-0.0011972,-0.012688,0,0
3,BIOCARTA AGPCR PATHWAY,0.96163,-0.0015694,0.013063,0,0
3,ORGANELLE ORGANIZATION AND BIOGENESIS,0.98953,-0.0016963,-0.0030511,0,0
3,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.69061,-0.0018084,0.029423,0,0
3,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,0.72969,-0.0019003,0.0057161,0,0
3,TRANSCRIPTION COFACTOR ACTIVITY,0.94073,-0.0019411,0.0096198,0,0
3,RECEPTOR MEDIATED ENDOCYTOSIS,0.92682,-0.0020667,-0.0070055,0,0
3,T CELL ACTIVATION,0.17653,-0.0022705,-0.13,0,0
3,CELL CYCLE ARREST GO 0007050,0.82348,-0.0023433,-0.020466,0,0
3,PID IL8CXCR2 PATHWAY,0.98255,-0.0026906,-0.00072198,0,0
3,BIOCARTA GLEEVEC PATHWAY,0.52025,-0.002694,0.055733,0,0
3,CELLULAR LOCALIZATION,0.41842,-0.0027375,-0.029632,0,0
3,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.54321,-0.0030346,-0.086006,0,0
3,PID FANCONI PATHWAY,0.91987,-0.0032487,0.010183,0,0
3,PID TOLL ENDOGENOUS PATHWAY,0.23937,-0.0037902,-0.15666,0,0
3,CELL CYCLE PROCESS,0.44924,-0.0038275,-0.023432,0,0
3,PHOSPHOINOSITIDE METABOLIC PROCESS,0.68418,-0.0042837,-0.028238,0,0
3,PID ERBB4 PATHWAY,0.59664,-0.0043611,0.034477,0,0
3,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,0.94769,-0.0044774,-0.014618,0,0
3,PID BETACATENIN DEG PATHWAY,0.69061,-0.0044918,-0.020921,0,0
3,REACTOME INFLAMMASOMES,0.71006,-0.0045307,-0.015926,0,0
3,NEGATIVE REGULATION OF CELL CYCLE,0.92682,-0.004598,-0.0049213,0,0
3,CHROMOSOME SEGREGATION,0.87144,-0.0046932,-0.011815,0,0
3,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,0.8303,-0.0046933,-0.041961,0,0
3,ST G ALPHA S PATHWAY,0.96163,-0.0047896,0.00020205,0,0
3,CATABOLIC PROCESS,0.92682,-0.0049048,-0.0066716,0,0
3,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,0.92682,-0.004921,-0.0015835,0,0
3,ANATOMICAL STRUCTURE DEVELOPMENT,0.72313,-0.0050655,0.011008,0,0
3,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.72313,-0.0050794,-0.034387,0,0
3,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.88523,-0.0053769,0.001279,0,0
3,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.96163,-0.0054224,-0.0025176,0,0
3,PROTEIN TARGETING,0.75615,-0.0058231,-0.019705,0,0
3,MEMBRANE PART,0.96163,-0.0060638,-0.0049801,0,0
3,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.4545,-0.0062161,-0.068149,0,0
3,NUCLEAR LUMEN,0.64605,-0.0063987,0.021286,0,0
3,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,0.47588,-0.0066843,-0.047779,0,0
3,REACTOME TRIF MEDIATED TLR3 SIGNALING,0.38408,-0.0067249,-0.055811,0,0
3,PID BARD1PATHWAY,0.94073,-0.0070231,-0.0037518,0,0
3,REACTOME CD28 CO STIMULATION,0.54903,-0.0072093,-0.069642,0,0
3,REGULATION OF PROTEIN STABILITY,0.76281,-0.0072716,-0.029301,0,0
3,CELLULAR CATABOLIC PROCESS,0.80989,-0.0076691,-0.009474,0,0
3,KEGG STARCH AND SUCROSE METABOLISM,0.93377,-0.0080282,-0.01222,0,0
3,ATP DEPENDENT HELICASE ACTIVITY,0.42347,-0.0081076,0.090275,0,0
3,BIOCARTA PTEN PATHWAY,0.76948,-0.0081251,-0.059513,0,0
3,NUCLEUS,0.97557,-0.0083594,0.0036934,0,0
3,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.5726,-0.0085548,-0.028643,0,0
3,PID WNT SIGNALING PATHWAY,0.59059,-0.0086035,-0.075133,0,0
3,SINGLE STRANDED DNA BINDING,0.87833,-0.0087824,-0.022862,0,0
3,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.77618,-0.0088921,-0.0022861,0,0
3,REACTOME HIV INFECTION,1,-0.008964,-0.0033663,0,0
3,REACTOME G PROTEIN ACTIVATION,0.33373,-0.0096523,0.092573,0,0
3,KEGG LONG TERM POTENTIATION,0.83713,-0.010024,-0.010414,0,0
3,REGULATION OF BINDING,0.46512,-0.010084,-0.047272,0,0
3,BIOCARTA PPARA PATHWAY,0.51459,-0.010125,-0.025524,0,0
3,REACTOME SIGNALING BY FGFR,0.88523,-0.010159,-0.005669,0,0
3,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.71006,-0.010223,-0.017594,0,0
3,ENDOSOME TRANSPORT,0.20621,-0.010408,-0.10967,0,0
3,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.88523,-0.01051,-0.0063864,0,0
3,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.63978,-0.010581,-0.066362,0,0
3,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.93377,-0.010622,0.014134,0,0
3,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,0.85082,-0.01068,-0.0021642,0,0
3,REACTOME SYNTHESIS OF DNA,0.62113,-0.01077,0.037693,0,0
3,METAL ION TRANSPORT,0.64605,-0.010844,0.05008,0,0
3,MACROMOLECULAR COMPLEX ASSEMBLY,0.61497,-0.010938,0.011395,0,0
3,PROTEIN KINASE BINDING,0.59059,-0.011012,-0.021438,0,0
3,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.90599,-0.011036,-0.0090537,0,0
3,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,0.44402,-0.011218,-0.073622,0,0
3,PHOSPHOLIPASE ACTIVITY,0.62732,-0.011248,0.017821,0,0
3,KEGG ALZHEIMERS DISEASE,0.8303,-0.011342,-0.0038064,0,0
3,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.90599,-0.011943,-0.018125,0,0
3,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.55487,-0.012,-0.019201,0,0
3,SPINDLE MICROTUBULE,0.94769,-0.012017,0.0013192,0,0
3,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.88523,-0.012305,0.00026966,0,0
3,NUCLEAR PART,0.98953,-0.012512,0.011372,0,0
3,VIRAL REPRODUCTIVE PROCESS,0.98953,-0.012713,-0.021606,0,0
3,PID RET PATHWAY,0.63978,-0.012788,-0.032193,0,0
3,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.76281,-0.01306,0.020479,0,0
3,MITOTIC CELL CYCLE,0.38408,-0.013205,-0.025548,0,0
3,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,0.89215,-0.01324,-0.037894,0,0
3,ST GAQ PATHWAY,0.92682,-0.013539,-0.015349,0,0
3,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.53742,-0.013585,0.028428,0,0
3,PID ERBB2ERBB3PATHWAY,0.86455,-0.013595,0.024675,0,0
3,KEGG REGULATION OF ACTIN CYTOSKELETON,0.42347,-0.013627,-0.048454,0,0
3,MICROTUBULE ASSOCIATED COMPLEX,0.5726,-0.01369,0.097989,0,0
3,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.79636,-0.013747,-0.012651,0,0
3,PID DNAPK PATHWAY,0.26471,-0.013786,-0.09456,0,0
3,REACTOME REGULATION OF BETA CELL DEVELOPMENT,0.89907,-0.013828,-0.0040703,0,0
3,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.28785,-0.014205,-0.054567,0,0
3,REGULATION OF MUSCLE CONTRACTION,0.50896,-0.014401,-0.077611,0,0
3,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.91987,-0.014505,0.019091,0,0
3,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.96163,-0.014625,0.0045332,0,0
3,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.64605,-0.015252,-0.011876,0,0
3,PID RB 1PATHWAY,0.67137,-0.015441,-0.020239,0,0
3,PID PDGFRBPATHWAY,0.52025,-0.015459,-0.025149,0,0
3,PROTEIN N TERMINUS BINDING,0.87144,-0.015576,-0.015769,0,0
3,BIOCARTA RAC1 PATHWAY,0.99651,-0.015983,-0.0018639,0,0
3,LIPASE ACTIVITY,0.81668,-0.016133,-0.017513,0,0
3,PID LYMPHANGIOGENESIS PATHWAY,0.70355,-0.016542,-0.047479,0,0
3,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.72313,-0.016578,0.021088,0,0
3,ST ERK1 ERK2 MAPK PATHWAY,0.32077,-0.016751,-0.0805,0,0
3,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.85082,-0.016787,-0.017033,0,0
3,REGULATION OF CELL SHAPE,0.67776,-0.017334,-0.05048,0,0
3,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.85082,-0.017387,-0.047244,0,0
3,REACTOME MITOTIC PROMETAPHASE,0.76948,-0.017645,-0.014367,0,0
3,STRIATED MUSCLE DEVELOPMENT,0.88523,-0.0178,-0.025957,0,0
3,REGULATION OF RAS GTPASE ACTIVITY,0.76281,-0.018113,-0.035099,0,0
3,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.30402,-0.018153,-0.02829,0,0
3,STRUCTURE SPECIFIC DNA BINDING,0.4598,-0.018297,-0.048131,0,0
3,ST STAT3 PATHWAY,0.61497,-0.018707,-0.04403,0,0
3,TRANSCRIPTION FACTOR BINDING,0.20937,-0.018711,-0.0249,0,0
3,INTERLEUKIN BINDING,0.35153,-0.018884,-0.11821,0,0
3,REGULATION OF MOLECULAR FUNCTION,0.50337,-0.018902,-0.025055,0,0
3,NUCLEAR ENVELOPE,0.27227,-0.019203,-0.043575,0,0
3,NUCLEOPLASM,0.24288,-0.019366,-0.020341,0,0
3,PHOSPHOLIPID METABOLIC PROCESS,0.81668,-0.019392,-0.020216,0,0
3,NEUROPEPTIDE BINDING,0.85082,-0.019655,-0.011821,0,0
3,NEUROPEPTIDE RECEPTOR ACTIVITY,0.85082,-0.019655,-0.011821,0,0
3,BIOPOLYMER CATABOLIC PROCESS,0.36064,-0.019734,-0.030314,0,0
3,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.54903,-0.020426,-0.023511,0,0
3,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.76281,-0.020753,0.047609,0,0
3,ACTIN FILAMENT BUNDLE FORMATION,0.92682,-0.020807,-0.0076248,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.89215,-0.020894,-0.056463,0,0
3,PID ALK1PATHWAY,0.52594,-0.021236,0.077022,0,0
3,KINASE BINDING,0.80312,-0.021281,-0.014143,0,0
3,LIPID BIOSYNTHETIC PROCESS,0.27227,-0.021589,-0.094195,0,0
3,RNA EXPORT FROM NUCLEUS,0.82348,-0.022105,-0.013722,0,0
3,ANATOMICAL STRUCTURE MORPHOGENESIS,0.49227,-0.022105,-0.02861,0,0
3,REGULATION OF JNK ACTIVITY,0.4978,-0.022139,-0.061266,0,0
3,MEMBRANE,0.74288,-0.02234,-0.014871,0,0
3,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.81668,-0.022601,-0.030577,0,0
3,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.9686,-0.022729,0.013712,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.72313,-0.022805,-0.035902,0,0
3,DAMAGED DNA BINDING,0.8303,-0.023004,0.0086199,0,0
3,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.49227,-0.023108,-0.057871,0,0
3,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,0.26847,-0.023155,-0.15061,0,0
3,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.40843,-0.023205,-0.089852,0,0
3,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.59059,-0.023627,-0.077357,0,0
3,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.95466,-0.024175,-0.0050563,0,0
3,PID AVB3 OPN PATHWAY,0.36991,-0.024339,-0.11706,0,0
3,TRANSCRIPTION DNA DEPENDENT,0.41341,-0.024566,-0.016187,0,0
3,BIOCARTA VEGF PATHWAY,0.52025,-0.024615,-0.080299,0,0
3,DENDRITE,0.85768,-0.024652,-0.023589,0,0
3,RNA BIOSYNTHETIC PROCESS,0.42347,-0.024701,-0.016074,0,0
3,PID FAK PATHWAY,0.53167,-0.024754,-0.06894,0,0
3,KEGG TYPE II DIABETES MELLITUS,0.77618,-0.024758,0.037204,0,0
3,POSITIVE REGULATION OF CELL CYCLE,0.41341,-0.024853,-0.1094,0,0
3,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.78289,-0.024999,-0.022943,0,0
3,REACTOME IL 7 SIGNALING,0.7495,-0.025039,0.080259,0,0
3,REGULATION OF RNA METABOLIC PROCESS,0.41842,-0.025096,-0.023293,0,0
3,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.82348,-0.025164,0.019007,0,0
3,KEGG RENAL CELL CARCINOMA,0.81668,-0.02522,-0.015347,0,0
3,KINASE ACTIVITY,0.22235,-0.025561,-0.035293,0,0
3,CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.53742,-0.025575,-0.038507,0,0
3,CELL CYCLE PHASE,0.16294,-0.02571,-0.045972,0,0
3,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.65234,-0.025981,-0.042173,0,0
3,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.79636,-0.026001,-0.019097,0,0
3,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,0.84397,-0.026102,-0.041332,0,0
3,REGULATION OF CELL CYCLE,0.32938,-0.026137,-0.035883,0,0
3,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,0.48131,-0.026259,-0.09502,0,0
3,REACTOME SIGNALING BY NOTCH,0.54321,-0.026423,-0.025977,0,0
3,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.39858,-0.026524,-0.025221,0,0
3,CELL ACTIVATION,0.42347,-0.02653,-0.061597,0,0
3,REACTOME CELL CYCLE CHECKPOINTS,0.98953,-0.027014,7.6554e-05,0,0
3,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.26098,-0.027167,-0.083797,0,0
3,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.30402,-0.027199,-0.05137,0,0
3,PID IL8CXCR1 PATHWAY,0.72969,-0.027617,-0.024156,0,0
3,PID INSULIN PATHWAY,0.54903,-0.028009,-0.050162,0,0
3,REACTOME BILE ACID AND BILE SALT METABOLISM,0.16828,-0.028248,-0.14799,0,0
3,KEGG BUTANOATE METABOLISM,0.67137,-0.028551,-0.027689,0,0
3,REACTOME AMYLOIDS,0.28785,-0.029205,-0.11892,0,0
3,PID IL12 STAT4PATHWAY,0.29184,-0.029229,-0.1185,0,0
3,TRANSCRIPTION REPRESSOR ACTIVITY,0.69707,-0.029511,-0.014404,0,0
3,NUCLEAR EXPORT,0.60883,-0.029707,-0.011686,0,0
3,REACTOME CHROMOSOME MAINTENANCE,0.76281,-0.029805,-0.013558,0,0
3,POSITIVE REGULATION OF JNK ACTIVITY,0.72313,-0.030065,-0.034476,0,0
3,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.53742,-0.030075,-0.035915,0,0
3,MEMBRANE ORGANIZATION AND BIOGENESIS,0.33373,-0.030165,-0.035203,0,0
3,PID SYNDECAN 3 PATHWAY,0.49227,-0.030174,-0.081696,0,0
3,REACTOME TCR SIGNALING,0.25363,-0.030327,-0.063413,0,0
3,REGULATION OF CELL MORPHOGENESIS,0.56075,-0.030436,-0.058516,0,0
3,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.97557,-0.030436,0.0039645,0,0
3,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,0.33812,-0.030532,-0.053359,0,0
3,ACTIVATION OF MAPK ACTIVITY,0.16032,-0.030624,-0.09179,0,0
3,REACTOME SHC MEDIATED SIGNALLING,0.48131,-0.030669,-0.073987,0,0
3,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.51459,-0.030718,-0.048049,0,0
3,BIOCARTA TOLL PATHWAY,0.40349,-0.030793,-0.081477,0,0
3,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.54321,-0.03084,-0.061613,0,0
3,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.54321,-0.03084,-0.061613,0,0
3,POSITIVE REGULATION OF METABOLIC PROCESS,0.56075,-0.031032,-0.033742,0,0
3,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.83713,-0.031064,0.00024458,0,0
3,OXIDOREDUCTASE ACTIVITY,0.65234,-0.031304,-0.055812,0,0
3,REACTOME SIGNALING BY ERBB2,0.33812,-0.031341,-0.031349,0,0
3,RESPONSE TO RADIATION,0.61497,-0.03201,-0.010826,0,0
3,NEGATIVE REGULATION OF GROWTH,0.23589,-0.032243,-0.067654,0,0
3,CELL CYCLE GO 0007049,0.23937,-0.032457,-0.032675,0,0
3,PROTEIN COMPLEX ASSEMBLY,0.34702,-0.032487,-0.04925,0,0
3,BIOCARTA P53 PATHWAY,0.28785,-0.032584,-0.10648,0,0
3,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,0.12473,-0.03259,-0.054876,0,0
3,CHROMATIN MODIFICATION,0.66501,-0.032795,-0.0016029,0,0
3,BIOCARTA MAPK PATHWAY,0.56075,-0.032835,-0.01871,0,0
3,ION BINDING,0.40349,-0.032964,-0.026407,0,0
3,KEGG CELL ADHESION MOLECULES CAMS,0.33812,-0.03304,-0.069016,0,0
3,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.4598,-0.033471,-0.044434,0,0
3,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,0.97557,-0.033508,-0.029443,0,0
3,PID HEDGEHOG GLIPATHWAY,0.58456,-0.033533,-0.014108,0,0
3,ENZYME BINDING,0.27227,-0.033773,-0.028894,0,0
3,CALCIUM ION BINDING,0.40843,-0.034051,-0.042152,0,0
3,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.91293,-0.034072,0.023145,0,0
3,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.43883,-0.034225,-0.03157,0,0
3,PID RHOA PATHWAY,0.43883,-0.034858,-0.054955,0,0
3,TRANSCRIPTION,0.2,-0.035275,-0.031694,0,0
3,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.95466,-0.035391,0.010614,0,0
3,REACTOME CTLA4 INHIBITORY SIGNALING,0.22905,-0.035508,-0.09378,0,0
3,M PHASE,0.22568,-0.035684,-0.036792,0,0
3,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,0.94073,-0.0359,-0.031261,0,0
3,TRANSCRIPTION COACTIVATOR ACTIVITY,0.12473,-0.036105,-0.032681,0,0
3,CYTOKINE BINDING,0.23589,-0.036128,-0.11308,0,0
3,ACTIVATION OF JNK ACTIVITY,0.36991,-0.036354,-0.073609,0,0
3,KEGG OOCYTE MEIOSIS,0.53167,-0.036419,-0.018816,0,0
3,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.15773,-0.036534,-0.035196,0,0
3,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.2,-0.036674,-0.13965,0,0
3,SIGNAL TRANSDUCTION,0.17934,-0.036788,-0.048962,0,0
3,LIGASE ACTIVITY,0.75615,-0.036818,-0.015869,0,0
3,REGULATION OF RHO GTPASE ACTIVITY,0.47588,-0.036852,-0.055508,0,0
3,KEGG COMPLEMENT AND COAGULATION CASCADES,0.090515,-0.037075,-0.20276,0,0
3,KEGG TRYPTOPHAN METABOLISM,0.89215,-0.037109,0.0050836,0,0
3,VIRAL REPRODUCTION,0.58456,-0.037129,-0.049719,0,0
3,MICROTUBULE BASED PROCESS,0.22235,-0.037609,-0.065508,0,0
3,PID ERBB NETWORK PATHWAY,0.4598,-0.037725,-0.11407,0,0
3,LIPOPROTEIN METABOLIC PROCESS,0.49227,-0.037808,-0.063111,0,0
3,ACTIN FILAMENT BASED PROCESS,0.19695,-0.038097,-0.066579,0,0
3,CELLULAR COMPONENT ASSEMBLY,0.64605,-0.03812,-0.011358,0,0
3,PID WNT NONCANONICAL PATHWAY,0.12049,-0.038191,-0.079558,0,0
3,OXIDOREDUCTASE ACTIVITY GO 0016616,0.65866,-0.038386,-0.076455,0,0
3,MICROTUBULE CYTOSKELETON,0.84397,-0.038624,0.012304,0,0
3,M PHASE OF MITOTIC CELL CYCLE,0.10845,-0.038806,-0.052325,0,0
3,TISSUE DEVELOPMENT,0.86455,-0.038991,-0.038244,0,0
3,CARBOXYLIC ACID METABOLIC PROCESS,0.89215,-0.039056,-0.020527,0,0
3,BIOCARTA FIBRINOLYSIS PATHWAY,0.8303,-0.039112,-0.11186,0,0
3,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,0.87144,-0.039334,-0.01922,0,0
3,REGULATION OF CELLULAR METABOLIC PROCESS,0.15773,-0.039341,-0.0383,0,0
3,CELL PROLIFERATION GO 0008283,0.24288,-0.039381,-0.051361,0,0
3,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.87833,-0.039407,0.03911,0,0
3,PID INTEGRIN5 PATHWAY,0.70355,-0.039412,0.059371,0,0
3,REACTOME SIGNALING BY PDGF,0.19095,-0.039517,-0.06369,0,0
3,RNA HELICASE ACTIVITY,0.67776,-0.039567,0.053025,0,0
3,REACTOME TELOMERE MAINTENANCE,0.60883,-0.040096,-0.037174,0,0
3,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,0.96163,-0.040154,-0.035099,0,0
3,ENDOPLASMIC RETICULUM,0.31653,-0.040316,-0.052296,0,0
3,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.15264,-0.040829,-0.039344,0,0
3,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.80312,-0.040847,-0.012612,0,0
3,BIOSYNTHETIC PROCESS,0.87833,-0.041018,-0.011104,0,0
3,REGULATION OF KINASE ACTIVITY,0.3746,-0.041092,-0.038566,0,0
3,PEPTIDYL AMINO ACID MODIFICATION,0.066855,-0.041403,-0.081474,0,0
3,JAK STAT CASCADE,0.54903,-0.041442,-0.080931,0,0
3,PID VEGFR1 PATHWAY,0.70355,-0.041884,-0.019804,0,0
3,WOUND HEALING,0.47588,-0.041959,-0.085662,0,0
3,ADAPTIVE IMMUNE RESPONSE,0.16559,-0.041979,-0.14254,0,0
3,ENDOPEPTIDASE ACTIVITY,0.32506,-0.041979,-0.055962,0,0
3,REACTOME SIGNALING BY ERBB4,0.20621,-0.042012,-0.05134,0,0
3,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.72313,-0.042094,-0.04352,0,0
3,INTRACELLULAR TRANSPORT,0.075049,-0.042216,-0.059481,0,0
3,SEQUENCE SPECIFIC DNA BINDING,0.1313,-0.042287,-0.079934,0,0
3,MACROMOLECULE BIOSYNTHETIC PROCESS,0.94769,-0.04234,-0.010198,0,0
3,BIOPOLYMER METABOLIC PROCESS,0.12908,-0.042608,-0.027596,0,0
3,HOMOPHILIC CELL ADHESION,0.89215,-0.042641,0.017945,0,0
3,INTRACELLULAR ORGANELLE PART,0.13355,-0.042802,-0.024282,0,0
3,ORGANIC ACID METABOLIC PROCESS,0.87144,-0.042805,-0.016108,0,0
3,LIPID CATABOLIC PROCESS,0.14526,-0.042904,-0.11141,0,0
3,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,0.29184,-0.043128,-0.086109,0,0
3,REGULATION OF METABOLIC PROCESS,0.15015,-0.043222,-0.039259,0,0
3,REGULATION OF PROTEIN KINASE ACTIVITY,0.38408,-0.043227,-0.035473,0,0
3,REACTOME ADP SIGNALLING THROUGH P2RY12,0.81668,-0.043515,0.0094537,0,0
3,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.14048,-0.043531,-0.085118,0,0
3,REGULATION OF TRANSCRIPTION,0.11636,-0.043703,-0.042228,0,0
3,REACTOME PPARA ACTIVATES GENE EXPRESSION,0.52025,-0.043895,-0.047371,0,0
3,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.42855,-0.044125,-0.071117,0,0
3,REACTOME FRS2 MEDIATED CASCADE,0.72969,-0.044216,-0.0087948,0,0
3,REACTOME SIGNALING BY WNT,0.76948,-0.044586,-0.045658,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.14769,-0.044698,-0.0398,0,0
3,CELL CELL SIGNALING,0.4978,-0.044698,-0.025926,0,0
3,KEGG ENDOCYTOSIS,0.42855,-0.045124,-0.021958,0,0
3,PID IFNGPATHWAY,0.4598,-0.045489,-0.048752,0,0
3,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.2,-0.04554,-0.050787,0,0
3,KEGG CHRONIC MYELOID LEUKEMIA,0.48131,-0.045619,-0.025485,0,0
3,INORGANIC ANION TRANSPORT,0.56075,-0.045848,-0.069704,0,0
3,REGULATION OF TRANSFERASE ACTIVITY,0.39858,-0.045932,-0.032786,0,0
3,ORGANELLE PART,0.087232,-0.046016,-0.02771,0,0
3,ST JNK MAPK PATHWAY,0.51459,-0.046433,-0.040047,0,0
3,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.43883,-0.046437,-0.083773,0,0
3,REACTOME SHC MEDIATED CASCADE,0.77618,-0.046599,-0.018448,0,0
3,PID INTEGRIN A4B1 PATHWAY,0.24288,-0.046793,-0.099068,0,0
3,KEGG PEROXISOME,0.47588,-0.046932,-0.048493,0,0
3,PYROPHOSPHATASE ACTIVITY,0.16294,-0.047259,-0.039896,0,0
3,RESPONSE TO ENDOGENOUS STIMULUS,0.12473,-0.047989,-0.044667,0,0
3,RESPONSE TO DNA DAMAGE STIMULUS,0.40349,-0.048052,-0.020556,0,0
3,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.33812,-0.048097,-0.043846,0,0
3,BIOCARTA TNFR2 PATHWAY,0.16294,-0.048188,-0.13771,0,0
3,REACTOME SIGNALING BY FGFR IN DISEASE,0.12689,-0.048238,-0.061882,0,0
3,PROTEIN TRANSPORT,0.14285,-0.048382,-0.059301,0,0
3,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.36991,-0.048583,-0.060921,0,0
3,CYTOSOL,0.23937,-0.048658,-0.046542,0,0
3,MITOSIS,0.095625,-0.04872,-0.056707,0,0
3,ATP BINDING,0.095625,-0.048794,-0.049366,0,0
3,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.67137,-0.048841,-0.078545,0,0
3,REGULATION OF HOMEOSTATIC PROCESS,0.49227,-0.048864,-0.13153,0,0
3,DNA POLYMERASE ACTIVITY,0.65866,-0.049487,-0.016611,0,0
3,POSITIVE REGULATION OF RNA METABOLIC PROCESS,0.25729,-0.049552,-0.054903,0,0
3,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.25729,-0.049552,-0.054903,0,0
3,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.14526,-0.049552,-0.14334,0,0
3,REACTOME SIGNAL TRANSDUCTION BY L1,0.54903,-0.049754,-0.036942,0,0
3,POSITIVE REGULATION OF T CELL ACTIVATION,0.32077,-0.049793,-0.12823,0,0
3,BIOCARTA IL6 PATHWAY,0.69707,-0.04982,-0.038589,0,0
3,TRANSCRIPTION ACTIVATOR ACTIVITY,0.13814,-0.049879,-0.036791,0,0
3,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.39371,-0.049931,-0.045322,0,0
3,PID INTEGRIN CS PATHWAY,0.4545,-0.050096,-0.11276,0,0
3,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.25363,-0.050098,-0.087737,0,0
3,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,0.8303,-0.050109,-0.014611,0,0
3,PID P75NTRPATHWAY,0.17934,-0.050147,-0.095804,0,0
3,PID EPHA2 FWDPATHWAY,0.75615,-0.050232,-0.054774,0,0
3,PID CDC42 PATHWAY,0.44402,-0.050239,-0.051932,0,0
3,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.33373,-0.05034,-0.077844,0,0
3,REACTOME SHC RELATED EVENTS,0.15773,-0.050833,-0.10663,0,0
3,INTERLEUKIN RECEPTOR ACTIVITY,0.20309,-0.051413,-0.16748,0,0
3,KEGG ECM RECEPTOR INTERACTION,0.63978,-0.051681,-0.087402,0,0
3,KEGG PROTEASOME,0.39858,-0.051962,-0.10812,0,0
3,PID RETINOIC ACID PATHWAY,0.83713,-0.052044,-0.00088767,0,0
3,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.32938,-0.052335,-0.045555,0,0
3,LEADING EDGE,0.12473,-0.052507,-0.11809,0,0
3,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.077957,-0.052522,-0.053496,0,0
3,KEGG TYROSINE METABOLISM,0.60272,-0.052667,-0.045761,0,0
3,NUCLEASE ACTIVITY,0.38888,-0.052717,-0.043212,0,0
3,REGULATION OF CELL PROLIFERATION,0.082489,-0.052844,-0.071819,0,0
3,CELLULAR LIPID CATABOLIC PROCESS,0.13583,-0.052975,-0.11657,0,0
3,MICROTUBULE ORGANIZING CENTER,0.20621,-0.053388,-0.041057,0,0
3,KEGG THYROID CANCER,0.76948,-0.053817,-0.018376,0,0
3,NON MEMBRANE BOUND ORGANELLE,0.077957,-0.053823,-0.040252,0,0
3,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.077957,-0.053823,-0.040252,0,0
3,BIOCARTA PYK2 PATHWAY,0.69707,-0.053848,-0.0037688,0,0
3,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.33373,-0.054074,-0.075644,0,0
3,ENZYME REGULATOR ACTIVITY,0.188,-0.054233,-0.041131,0,0
3,INTERPHASE,0.18508,-0.054392,-0.063943,0,0
3,BIOCARTA G1 PATHWAY,0.95466,-0.054416,-0.012296,0,0
3,MICROTUBULE BASED MOVEMENT,0.71006,-0.054733,0.012737,0,0
3,ADHERENS JUNCTION,0.27611,-0.054885,-0.12041,0,0
3,EMBRYONIC MORPHOGENESIS,0.72313,-0.055244,-0.058107,0,0
3,PID REG GR PATHWAY,0.32077,-0.055352,-0.077356,0,0
3,LIPID TRANSPORT,0.42855,-0.055476,-0.10171,0,0
3,KEGG TGF BETA SIGNALING PATHWAY,0.33812,-0.055658,-0.061983,0,0
3,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.72313,-0.056377,0.10468,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.52025,-0.056486,-0.066016,0,0
3,ION HOMEOSTASIS,0.15773,-0.056541,-0.074083,0,0
3,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.065563,-0.056609,-0.059662,0,0
3,CATION TRANSPORT,0.98255,-0.05724,0.009989,0,0
3,BIOCARTA G2 PATHWAY,0.71006,-0.057495,-0.017413,0,0
3,BIOCARTA CCR5 PATHWAY,0.59664,-0.057517,-0.038497,0,0
3,PID ENDOTHELINPATHWAY,0.77618,-0.057607,-0.017917,0,0
3,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.34256,-0.058008,-0.071544,0,0
3,REACTOME STRIATED MUSCLE CONTRACTION,0.77618,-0.05807,-0.032692,0,0
3,CYTOPLASMIC PART,0.12049,-0.058437,-0.048134,0,0
3,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.27227,-0.05853,-0.059369,0,0
3,REACTOME ERK MAPK TARGETS,0.57857,-0.05856,-0.034316,0,0
3,RHO PROTEIN SIGNAL TRANSDUCTION,0.35153,-0.058573,-0.056588,0,0
3,BIOCARTA LONGEVITY PATHWAY,0.38408,-0.058796,-0.073224,0,0
3,ORGAN DEVELOPMENT,0.27227,-0.059793,-0.047726,0,0
3,PROTEIN AMINO ACID PHOSPHORYLATION,0.15264,-0.059924,-0.038029,0,0
3,CYTOSKELETAL PROTEIN BINDING,0.29992,-0.060014,-0.035802,0,0
3,COAGULATION,0.17374,-0.060186,-0.12404,0,0
3,BIOCARTA P53HYPOXIA PATHWAY,0.20937,-0.060373,-0.14901,0,0
3,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,0.047551,-0.060754,-0.097995,0,0
3,REGULATION OF GENE EXPRESSION,0.053746,-0.061093,-0.052985,0,0
3,CELL FRACTION,0.15517,-0.061186,-0.06439,0,0
3,PROTEIN DOMAIN SPECIFIC BINDING,0.17653,-0.061346,-0.063545,0,0
3,ER NUCLEAR SIGNALING PATHWAY,0.14285,-0.061405,-0.1013,0,0
3,ST P38 MAPK PATHWAY,0.71658,-0.061469,-0.030823,0,0
3,MITOTIC CELL CYCLE CHECKPOINT,0.48678,-0.061538,-0.059229,0,0
3,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.84397,-0.061539,-0.028594,0,0
3,KEGG INOSITOL PHOSPHATE METABOLISM,0.092194,-0.061637,-0.069571,0,0
3,REACTOME DSCAM INTERACTIONS,0.77618,-0.061872,-0.048872,0,0
3,CHEMICAL HOMEOSTASIS,0.084046,-0.062301,-0.092423,0,0
3,CELLULAR HOMEOSTASIS,0.27227,-0.062633,-0.062907,0,0
3,KEGG GLUTATHIONE METABOLISM,0.26847,-0.063006,-0.12733,0,0
3,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,0.22905,-0.06303,-0.056212,0,0
3,NUCLEOPLASM PART,0.047551,-0.063254,-0.042189,0,0
3,PID AP1 PATHWAY,0.16559,-0.063269,-0.15066,0,0
3,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.69707,-0.063489,-0.029558,0,0
3,BIOCARTA ATRBRCA PATHWAY,0.35607,-0.063676,-0.072564,0,0
3,INTRACELLULAR PROTEIN TRANSPORT,0.19095,-0.063833,-0.056258,0,0
3,NUCLEAR MEMBRANE,0.32506,-0.064214,-0.048326,0,0
3,REGULATED SECRETORY PATHWAY,0.71658,-0.064412,0.15595,0,0
3,REACTOME SIGNALING BY BMP,0.28785,-0.064442,-0.11358,0,0
3,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.12689,-0.065239,-0.10358,0,0
3,PID MTOR 4PATHWAY,0.30815,-0.065247,-0.045382,0,0
3,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,0.78289,-0.065315,-0.053437,0,0
3,POSITIVE REGULATION OF TRANSCRIPTION,0.11039,-0.065659,-0.065205,0,0
3,ST B CELL ANTIGEN RECEPTOR,0.38408,-0.06586,-0.043736,0,0
3,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.084046,-0.066125,-0.069347,0,0
3,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.15517,-0.066339,-0.086706,0,0
3,KEGG BETA ALANINE METABOLISM,0.56666,-0.066377,-0.049381,0,0
3,PHOSPHORYLATION,0.073629,-0.066426,-0.04593,0,0
3,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.11636,-0.06643,-0.11869,0,0
3,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,0.22905,-0.066547,-0.07989,0,0
3,CYTOPLASM,0.057089,-0.066663,-0.053792,0,0
3,N ACETYLTRANSFERASE ACTIVITY,0.087232,-0.066764,-0.080948,0,0
3,N ACYLTRANSFERASE ACTIVITY,0.087232,-0.066764,-0.080948,0,0
3,KEGG STEROID BIOSYNTHESIS,0.73628,-0.067075,-0.031314,0,0
3,SOLUBLE FRACTION,0.51459,-0.067501,-0.047866,0,0
3,EXOPEPTIDASE ACTIVITY,0.40349,-0.067533,-0.069565,0,0
3,PATTERN SPECIFICATION PROCESS,0.26098,-0.067606,-0.133,0,0
3,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,0.11434,-0.067788,-0.15122,0,0
3,PID UPA UPAR PATHWAY,0.3746,-0.067814,-0.15317,0,0
3,REACTOME PHOSPHORYLATION OF THE APC C,0.17934,-0.067858,-0.088021,0,0
3,KEGG PROTEIN EXPORT,0.27611,-0.067923,-0.090401,0,0
3,CELL CORTEX,0.23589,-0.068081,-0.073019,0,0
3,SERINE TYPE PEPTIDASE ACTIVITY,0.065563,-0.068301,-0.13409,0,0
3,KEGG O GLYCAN BIOSYNTHESIS,0.093897,-0.068471,-0.16162,0,0
3,KEGG N GLYCAN BIOSYNTHESIS,0.085627,-0.068602,-0.12683,0,0
3,SERINE HYDROLASE ACTIVITY,0.095625,-0.068643,-0.12382,0,0
3,INTRACELLULAR SIGNALING CASCADE,0.073629,-0.069006,-0.067473,0,0
3,OUTER MEMBRANE,0.073629,-0.069047,-0.11345,0,0
3,THYROID HORMONE RECEPTOR BINDING,0.24288,-0.069234,-0.036876,0,0
3,COATED VESICLE,0.073629,-0.069262,-0.069382,0,0
3,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.25001,-0.069458,-0.12752,0,0
3,LYMPHOCYTE ACTIVATION,0.055956,-0.070106,-0.13982,0,0
3,PID IL2 PI3KPATHWAY,0.093897,-0.070334,-0.12411,0,0
3,PID AR NONGENOMIC PATHWAY,0.9686,-0.070739,0.013768,0,0
3,BIOCARTA MYOSIN PATHWAY,0.36991,-0.070838,-0.057008,0,0
3,LEARNING AND OR MEMORY,0.76948,-0.070845,-0.0016937,0,0
3,BIOPOLYMER BIOSYNTHETIC PROCESS,0.52594,-0.071196,-0.048261,0,0
3,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.10465,-0.071508,-0.068217,0,0
3,POSITIVE REGULATION OF CELL PROLIFERATION,0.12473,-0.071511,-0.093118,0,0
3,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.94769,-0.071567,-0.0044754,0,0
3,REGULATION OF PROTEIN METABOLIC PROCESS,0.22568,-0.071671,-0.081626,0,0
3,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.57857,-0.071917,-0.049312,0,0
3,UBIQUITIN LIGASE COMPLEX,0.18508,-0.072053,-0.059489,0,0
3,ORGAN MORPHOGENESIS,0.092194,-0.073039,-0.081653,0,0
3,SENSORY PERCEPTION,0.1028,-0.073082,-0.06897,0,0
3,PID SYNDECAN 2 PATHWAY,0.19695,-0.073165,-0.11287,0,0
3,PID ERBB1 DOWNSTREAM PATHWAY,0.049546,-0.073679,-0.11367,0,0
3,AMINE CATABOLIC PROCESS,0.38888,-0.07393,-0.074775,0,0
3,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.32077,-0.074023,-0.073308,0,0
3,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.46512,-0.07408,-0.02675,0,0
3,PROTEIN C TERMINUS BINDING,0.087232,-0.074181,-0.062426,0,0
3,MEMBRANE FRACTION,0.17653,-0.074233,-0.064688,0,0
3,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,0.04854,-0.074293,-0.1164,0,0
3,MAPKKK CASCADE GO 0000165,0.24288,-0.07461,-0.068258,0,0
3,REACTOME NUCLEAR SIGNALING BY ERBB4,0.36526,-0.07534,-0.063295,0,0
3,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,0.12908,-0.075405,-0.13744,0,0
3,CELL DEVELOPMENT,0.052669,-0.075566,-0.065755,0,0
3,BASEMENT MEMBRANE,0.69707,-0.075582,0.035539,0,0
3,RAS GTPASE ACTIVATOR ACTIVITY,0.27999,-0.075626,-0.081157,0,0
3,ALCOHOL METABOLIC PROCESS,0.095625,-0.075633,-0.10769,0,0
3,PID AR PATHWAY,0.19095,-0.075715,-0.089862,0,0
3,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.1313,-0.076115,-0.10309,0,0
3,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,0.70355,-0.076774,-0.059983,0,0
3,ATPASE ACTIVITY,0.14769,-0.077131,-0.049516,0,0
3,REGULATION OF GENE EXPRESSION EPIGENETIC,0.17099,-0.077477,-0.069675,0,0
3,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,0.43367,-0.077574,-0.072386,0,0
3,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.092194,-0.077583,-0.1046,0,0
3,BIOCARTA CXCR4 PATHWAY,0.56666,-0.077657,-0.027435,0,0
3,CHROMATIN BINDING,0.41341,-0.077931,-0.0302,0,0
3,FEMALE PREGNANCY,0.053746,-0.077941,-0.16251,0,0
3,BIOCARTA MET PATHWAY,0.21256,-0.078032,-0.11121,0,0
3,HOMEOSTASIS OF NUMBER OF CELLS,0.10845,-0.078596,-0.1433,0,0
3,ELECTRON CARRIER ACTIVITY,0.23245,-0.079104,-0.11386,0,0
3,GOLGI VESICLE TRANSPORT,0.063042,-0.079531,-0.11491,0,0
3,REACTOME REGULATION OF SIGNALING BY CBL,0.32938,-0.079613,-0.085704,0,0
3,SMALL CONJUGATING PROTEIN BINDING,0.36064,-0.079714,-0.044556,0,0
3,PID HIF1 TFPATHWAY,0.96163,-0.079887,-0.02604,0,0
3,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,0.59664,-0.080171,-0.070561,0,0
3,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.16032,-0.08057,-0.094162,0,0
3,PID PLK1 PATHWAY,0.24643,-0.080637,-0.0662,0,0
3,MEMBRANE FUSION,0.19695,-0.080844,-0.085173,0,0
3,DNA DIRECTED RNA POLYMERASE COMPLEX,0.63354,-0.081169,-0.03025,0,0
3,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.63354,-0.081169,-0.03025,0,0
3,RNA POLYMERASE COMPLEX,0.63354,-0.081169,-0.03025,0,0
3,REACTOME MEIOTIC SYNAPSIS,0.29184,-0.081183,-0.11086,0,0
3,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.4978,-0.081372,-0.031593,0,0
3,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.10654,-0.08161,-0.086705,0,0
3,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.21256,-0.08162,-0.099247,0,0
3,SH3 DOMAIN BINDING,0.36526,-0.081698,-0.043482,0,0
3,PID IL27PATHWAY,0.32506,-0.082149,-0.13665,0,0
3,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.95466,-0.082214,-0.02227,0,0
3,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.052669,-0.08222,-0.083585,0,0
3,BIOCARTA BARRESTIN SRC PATHWAY,0.52025,-0.082223,0.052382,0,0
3,KEGG JAK STAT SIGNALING PATHWAY,0.10096,-0.082253,-0.10186,0,0
3,PID LPA4 PATHWAY,0.80312,-0.08231,-0.0024643,0,0
3,GTPASE ACTIVITY,0.1028,-0.08328,-0.070219,0,0
3,PERINUCLEAR REGION OF CYTOPLASM,0.31653,-0.08335,-0.053271,0,0
3,POSITIVE REGULATION OF TRANSLATION,0.33373,-0.083565,-0.14838,0,0
3,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,0.4598,-0.083793,-0.071484,0,0
3,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.10465,-0.084198,-0.14879,0,0
3,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.088862,-0.084587,-0.070679,0,0
3,BIOCARTA AT1R PATHWAY,0.18219,-0.084746,-0.1139,0,0
3,BIOCARTA PLCE PATHWAY,0.092194,-0.084818,-0.14941,0,0
3,CHANNEL REGULATOR ACTIVITY,0.4978,-0.084827,-0.041772,0,0
3,CHROMOSOME,0.11434,-0.084829,-0.052333,0,0
3,MYOBLAST DIFFERENTIATION,0.14048,-0.084857,-0.15877,0,0
3,AMINO ACID CATABOLIC PROCESS,0.42855,-0.085769,-0.091839,0,0
3,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.045624,-0.085893,-0.10091,0,0
3,EXTRACELLULAR REGION PART,0.090515,-0.086102,-0.11229,0,0
3,DOUBLE STRANDED DNA BINDING,0.52025,-0.086129,-0.047021,0,0
3,REACTOME DOUBLE STRAND BREAK REPAIR,0.16032,-0.086245,-0.1083,0,0
3,CHROMOSOMAL PART,0.047551,-0.08628,-0.065741,0,0
3,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.22568,-0.086369,-0.089996,0,0
3,REACTOME SIGNAL AMPLIFICATION,0.28785,-0.086565,-0.073057,0,0
3,TISSUE REMODELING,0.88523,-0.087263,-0.00029987,0,0
3,PID MYC REPRESSPATHWAY,0.087232,-0.087347,-0.15096,0,0
3,MUSCLE CELL DIFFERENTIATION,0.05161,-0.087473,-0.1765,0,0
3,REACTOME RNA POL I TRANSCRIPTION,0.33812,-0.088294,-0.083607,0,0
3,NEURON APOPTOSIS,0.28785,-0.088471,-0.03602,0,0
3,REGULATION OF BLOOD PRESSURE,0.63978,-0.08899,-0.087537,0,0
3,REACTOME ADP SIGNALLING THROUGH P2RY1,0.29586,-0.089077,-0.079832,0,0
3,SA B CELL RECEPTOR COMPLEXES,0.19095,-0.089477,-0.12145,0,0
3,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.11636,-0.089544,-0.1626,0,0
3,COENZYME BINDING,0.25001,-0.090033,-0.13585,0,0
3,KEGG LEISHMANIA INFECTION,0.10096,-0.090233,-0.11201,0,0
3,REACTOME ER PHAGOSOME PATHWAY,0.48678,-0.090244,-0.10495,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.29992,-0.090649,-0.15891,0,0
3,PATTERN BINDING,0.65234,-0.091414,-0.021776,0,0
3,CATION HOMEOSTASIS,0.13583,-0.091513,-0.073627,0,0
3,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.54321,-0.092404,-0.044291,0,0
3,BIOCARTA EXTRINSIC PATHWAY,0.12473,-0.092589,-0.24877,0,0
3,PID AVB3 INTEGRIN PATHWAY,0.21905,-0.093063,-0.11862,0,0
3,CENTROSOME,0.087232,-0.09353,-0.069253,0,0
3,REACTOME SIGNALING BY FGFR3 MUTANTS,0.30815,-0.093556,-0.091199,0,0
3,KEGG TASTE TRANSDUCTION,0.19393,-0.094159,-0.071533,0,0
3,RAS PROTEIN SIGNAL TRANSDUCTION,0.48678,-0.094394,-0.038901,0,0
3,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.44924,-0.094452,-0.055886,0,0
3,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.11235,-0.09499,-0.064582,0,0
3,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.12908,-0.095059,-0.07944,0,0
3,REACTOME HYALURONAN METABOLISM,0.16032,-0.095275,-0.13894,0,0
3,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.30402,-0.095637,-0.08328,0,0
3,REACTOME IRON UPTAKE AND TRANSPORT,0.11434,-0.095841,-0.11295,0,0
3,ORGANELLE LOCALIZATION,0.066855,-0.095926,-0.094131,0,0
3,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.58456,-0.096124,-0.068778,0,0
3,CELLULAR CATION HOMEOSTASIS,0.12473,-0.096131,-0.082041,0,0
3,REACTOME ADHERENS JUNCTIONS INTERACTIONS,0.31232,-0.096483,-0.10318,0,0
3,POLYSACCHARIDE BINDING,0.89215,-0.096764,-0.0092012,0,0
3,GLYCOSAMINOGLYCAN BINDING,0.89215,-0.096764,-0.0092012,0,0
3,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,0.37932,-0.096832,-0.11874,0,0
3,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.14285,-0.096893,-0.11689,0,0
3,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,0.53167,-0.097022,-0.033064,0,0
3,REACTOME MEIOSIS,0.17099,-0.097437,-0.097955,0,0
3,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.16828,-0.097574,-0.13822,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.30402,-0.097609,-0.14543,0,0
3,AMINE RECEPTOR ACTIVITY,0.18219,-0.097714,-0.071979,0,0
3,KEGG GLYCOSAMINOGLYCAN DEGRADATION,0.084046,-0.098086,-0.18682,0,0
3,METALLOEXOPEPTIDASE ACTIVITY,0.05824,-0.09813,-0.15644,0,0
3,PID IL2 STAT5PATHWAY,0.23937,-0.098249,-0.12882,0,0
3,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.047551,-0.098757,-0.10967,0,0
3,LYMPHOCYTE DIFFERENTIATION,0.12259,-0.099397,-0.12978,0,0
3,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.32506,-0.1002,-0.093836,0,0
3,KEGG PROSTATE CANCER,0.15264,-0.10033,-0.098307,0,0
3,ATPASE ACTIVITY COUPLED,0.05161,-0.10034,-0.074621,0,0
3,REGULATION OF MITOTIC CELL CYCLE,0.27227,-0.10102,-0.097696,0,0
3,REACTOME INTEGRATION OF ENERGY METABOLISM,0.15015,-0.10131,-0.060931,0,0
3,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.075049,-0.10163,-0.1274,0,0
3,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.41842,-0.10198,-0.071784,0,0
3,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,0.69061,-0.10215,-0.01454,0,0
3,REACTOME REGULATION OF MITOTIC CELL CYCLE,0.29992,-0.103,-0.064816,0,0
3,REGULATION OF T CELL ACTIVATION,0.097379,-0.10357,-0.17208,0,0
3,CALMODULIN BINDING,0.44924,-0.10562,-0.065444,0,0
3,HOMEOSTATIC PROCESS,0.059411,-0.10579,-0.088067,0,0
3,PROTEIN HOMOOLIGOMERIZATION,0.16294,-0.10695,-0.15466,0,0
3,BASOLATERAL PLASMA MEMBRANE,0.22905,-0.1073,-0.13076,0,0
3,INTERACTION WITH HOST,0.33812,-0.10731,-0.099505,0,0
3,SIG CD40PATHWAYMAP,0.1028,-0.10744,-0.091375,0,0
3,REACTOME MEIOTIC RECOMBINATION,0.11235,-0.10753,-0.15573,0,0
3,RUFFLE,0.188,-0.10782,-0.13154,0,0
3,PID P38ALPHABETAPATHWAY,0.19393,-0.10821,-0.09245,0,0
3,PID VEGFR1 2 PATHWAY,0.064293,-0.10848,-0.10903,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.32077,-0.10864,-0.14213,0,0
3,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.19695,-0.10869,-0.11938,0,0
3,NITROGEN COMPOUND CATABOLIC PROCESS,0.47049,-0.1087,-0.042043,0,0
3,PID SYNDECAN 4 PATHWAY,0.092194,-0.10898,-0.21931,0,0
3,REACTOME CIRCADIAN CLOCK,0.58456,-0.1096,-0.045568,0,0
3,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.14048,-0.10963,-0.099336,0,0
3,PID NFAT TFPATHWAY,0.079444,-0.10996,-0.13765,0,0
3,G1 PHASE OF MITOTIC CELL CYCLE,0.76948,-0.10998,-0.015923,0,0
3,GOLGI ASSOCIATED VESICLE,0.29586,-0.10999,-0.052857,0,0
3,RNA DEPENDENT ATPASE ACTIVITY,0.83713,-0.11051,0.030329,0,0
3,ATP DEPENDENT RNA HELICASE ACTIVITY,0.87144,-0.11056,0.03038,0,0
3,GTPASE ACTIVATOR ACTIVITY,0.41341,-0.1106,-0.041691,0,0
3,PID CERAMIDE PATHWAY,0.05824,-0.11079,-0.098556,0,0
3,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.44924,-0.11155,-0.052575,0,0
3,PID TGFBRPATHWAY,0.052669,-0.11263,-0.14851,0,0
3,PID INSULIN GLUCOSE PATHWAY,0.16559,-0.11268,-0.1083,0,0
3,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,0.064293,-0.11269,-0.29982,0,0
3,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.61497,-0.11338,-0.051092,0,0
3,SIG IL4RECEPTOR IN B LYPHOCYTES,0.2,-0.11384,-0.067744,0,0
3,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,0.13355,-0.11409,-0.12807,0,0
3,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.17099,-0.1145,-0.076953,0,0
3,REACTOME CHOLESTEROL BIOSYNTHESIS,0.74288,-0.1158,0.070345,0,0
3,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.14769,-0.11617,-0.10707,0,0
3,REGULATION OF LYMPHOCYTE ACTIVATION,0.15264,-0.11664,-0.13738,0,0
3,PID GLYPICAN 1PATHWAY,0.14769,-0.11673,-0.093371,0,0
3,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,0.053746,-0.11709,-0.17678,0,0
3,PID CD8TCRDOWNSTREAMPATHWAY,0.075049,-0.11774,-0.11017,0,0
3,PID HNF3APATHWAY,0.13814,-0.11805,-0.11775,0,0
3,PID EPHRINBREVPATHWAY,0.23937,-0.11916,-0.067807,0,0
3,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.15264,-0.11927,-0.16469,0,0
3,PID NOTCH PATHWAY,0.097379,-0.11972,-0.093503,0,0
3,PROTEIN TYROSINE KINASE ACTIVITY,0.10465,-0.12257,-0.14531,0,0
3,REACTOME AMINE LIGAND BINDING RECEPTORS,0.15517,-0.12285,-0.072256,0,0
3,REACTOME G ALPHA Z SIGNALLING EVENTS,0.34702,-0.12303,-0.057893,0,0
3,PID AMB2 NEUTROPHILS PATHWAY,0.1313,-0.12342,-0.13169,0,0
3,BIOCARTA MEF2D PATHWAY,0.16559,-0.12362,-0.10372,0,0
3,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.76281,-0.12367,-0.024811,0,0
3,REACTOME PEROXISOMAL LIPID METABOLISM,0.32077,-0.12386,-0.11232,0,0
3,REGULATION OF INTRACELLULAR TRANSPORT,0.1028,-0.12475,-0.14752,0,0
3,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,0.29586,-0.12478,-0.068206,0,0
3,PID P38 MK2PATHWAY,0.22568,-0.12482,-0.086485,0,0
3,REACTOME ION TRANSPORT BY P TYPE ATPASES,0.075049,-0.12485,-0.094688,0,0
3,CARBOHYDRATE BINDING,0.075049,-0.12572,-0.11999,0,0
3,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,0.64605,-0.12637,0.16342,0,0
3,REACTOME GLYCOSPHINGOLIPID METABOLISM,0.12473,-0.12649,-0.15133,0,0
3,PHOSPHATASE REGULATOR ACTIVITY,0.31232,-0.12733,-0.083827,0,0
3,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.099158,-0.1274,-0.087824,0,0
3,SA PTEN PATHWAY,0.092194,-0.128,-0.11142,0,0
3,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.14769,-0.12808,-0.085841,0,0
3,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.14048,-0.12857,-0.11485,0,0
3,REACTOME G0 AND EARLY G1,0.068167,-0.12901,-0.13209,0,0
3,BIOCARTA 41BB PATHWAY,0.3746,-0.12918,-0.061895,0,0
3,ANION TRANSPORT,0.39371,-0.12938,-0.06048,0,0
3,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.24288,-0.1311,-0.11768,0,0
3,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.16559,-0.1313,-0.095022,0,0
3,BIOCARTA CCR3 PATHWAY,0.060602,-0.13157,-0.098706,0,0
3,SARCOMERE,0.16559,-0.1319,-0.14167,0,0
3,METALLOPEPTIDASE ACTIVITY,0.080955,-0.13215,-0.10176,0,0
3,REACTOME UNFOLDED PROTEIN RESPONSE,0.099158,-0.13225,-0.11514,0,0
3,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.061812,-0.13359,-0.15413,0,0
3,CHROMATIN REMODELING,0.188,-0.13398,-0.059474,0,0
3,PID INTEGRIN3 PATHWAY,0.53742,-0.13426,-0.10408,0,0
3,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,0.11841,-0.13426,-0.15244,0,0
3,PID PRLSIGNALINGEVENTSPATHWAY,0.052669,-0.13452,-0.18649,0,0
3,BIOCARTA CALCINEURIN PATHWAY,0.16032,-0.13474,-0.11049,0,0
3,NEGATIVE REGULATION OF BINDING,0.35607,-0.13574,-0.073752,0,0
3,LIPOPROTEIN BINDING,0.21256,-0.1368,-0.090343,0,0
3,PID IL3 PATHWAY,0.057089,-0.13845,-0.12359,0,0
3,ER GOLGI INTERMEDIATE COMPARTMENT,0.057089,-0.14027,-0.19973,0,0
3,STEROID BIOSYNTHETIC PROCESS,0.0695,-0.14406,-0.23198,0,0
3,ST WNT CA2 CYCLIC GMP PATHWAY,0.087232,-0.14477,-0.10963,0,0
3,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,0.16294,-0.14635,-0.20813,0,0
3,RESPONSE TO HORMONE STIMULUS,0.1313,-0.14662,-0.14998,0,0
3,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.050569,-0.14764,-0.16603,0,0
3,INNATE IMMUNE RESPONSE,0.17374,-0.14888,-0.10066,0,0
3,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,0.11039,-0.1493,-0.19254,0,0
3,PID TCRJNKPATHWAY,0.088862,-0.14987,-0.14078,0,0
3,REACTOME PACKAGING OF TELOMERE ENDS,0.34702,-0.15211,-0.15542,0,0
3,INTERMEDIATE FILAMENT CYTOSKELETON,0.31653,-0.15271,-0.12278,0,0
3,INTERMEDIATE FILAMENT,0.31653,-0.15271,-0.12278,0,0
3,BIOCARTA INTRINSIC PATHWAY,0.16294,-0.15338,-0.22318,0,0
3,SA REG CASCADE OF CYCLIN EXPR,0.40349,-0.15378,-0.042701,0,0
3,PID FGF PATHWAY,0.053746,-0.15388,-0.12848,0,0
3,KINASE ACTIVATOR ACTIVITY,0.12049,-0.15401,-0.11078,0,0
3,KEGG OTHER GLYCAN DEGRADATION,0.22905,-0.15462,-0.18061,0,0
3,CHEMOKINE ACTIVITY,0.085627,-0.15692,-0.17958,0,0
3,CHEMOKINE RECEPTOR BINDING,0.085627,-0.15692,-0.17958,0,0
3,EXONUCLEASE ACTIVITY,0.073629,-0.15747,-0.18205,0,0
3,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.093897,-0.15776,-0.12657,0,0
3,PID INTEGRIN A9B1 PATHWAY,0.054842,-0.15807,-0.21729,0,0
3,RNA CATABOLIC PROCESS,0.10845,-0.16007,-0.11376,0,0
3,PID NCADHERINPATHWAY,0.17653,-0.16152,-0.07447,0,0
3,REACTOME SULFUR AMINO ACID METABOLISM,0.095625,-0.16323,-0.13621,0,0
3,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,0.1313,-0.16392,-0.15246,0,0
3,PID TCRCALCIUMPATHWAY,0.12689,-0.16586,-0.141,0,0
3,REACTOME ENOS ACTIVATION AND REGULATION,0.050569,-0.16874,-0.18994,0,0
3,BIOCARTA GPCR PATHWAY,0.17934,-0.1726,-0.095849,0,0
3,NEUROTRANSMITTER SECRETION,0.74288,-0.17416,0.20273,0,0
3,BIOCARTA STRESS PATHWAY,0.04854,-0.17454,-0.15684,0,0
3,BIOCARTA IL10 PATHWAY,0.25729,-0.17622,-0.14312,0,0
3,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.066855,-0.1771,-0.15187,0,0
3,SISTER CHROMATID SEGREGATION,0.055956,-0.18354,-0.12237,0,0
3,MITOTIC SISTER CHROMATID SEGREGATION,0.070855,-0.18602,-0.12197,0,0
3,PROTEIN KINASE INHIBITOR ACTIVITY,0.047551,-0.18938,-0.18534,0,0
3,APOPTOTIC MITOCHONDRIAL CHANGES,0.072231,-0.19684,-0.18329,0,0
3,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.079444,-0.19928,-0.098461,0,0
3,NEGATIVE REGULATION OF DNA BINDING,0.18219,-0.20093,-0.11585,0,0
3,REACTOME CRMPS IN SEMA3A SIGNALING,0.41842,-0.20287,-0.019692,0,0
3,BIOCARTA CREB PATHWAY,0.16294,-0.20457,-0.10565,0,0
3,REACTOME SIGNALING BY NODAL,0.046579,-0.20708,-0.13941,0,0
3,RESPONSE TO EXTRACELLULAR STIMULUS,0.057089,-0.20749,-0.12696,0,0
3,RESPONSE TO HYPOXIA,0.10654,-0.20749,-0.15352,0,0
3,PID IL6 7PATHWAY,0.049546,-0.21382,-0.16755,0,0
3,BIOCARTA RB PATHWAY,0.13355,-0.21424,-0.11144,0,0
3,BIOCARTA ARENRF2 PATHWAY,0.05161,-0.21836,-0.20958,0,0
3,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.064293,-0.22302,-0.14389,0,0
3,FATTY ACID OXIDATION,0.04854,-0.22316,-0.2229,0,0
3,PID ATF2 PATHWAY,0.11235,-0.22454,-0.13764,0,0
3,DEAMINASE ACTIVITY,0.050569,-0.22755,-0.19507,0,0
3,ANTIOXIDANT ACTIVITY,0.070855,-0.22973,-0.19168,0,0
3,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.049546,-0.23022,-0.25864,0,0
3,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.047551,-0.2345,-0.2647,0,0
3,KEGG ARACHIDONIC ACID METABOLISM,0.22235,-0.236,-0.12247,0,0
3,BIOCARTA CELL2CELL PATHWAY,0.16032,-0.23734,-0.14099,0,0
3,CYTOPLASM ORGANIZATION AND BIOGENESIS,0.095625,-0.25595,-0.28603,0,0
3,REGULATION OF NEUROTRANSMITTER LEVELS,0.20309,-0.26393,-0.09781,0,0
3,BIOCARTA STATHMIN PATHWAY,0.065563,-0.26877,-0.1233,0,0
3,REACTOME INSULIN SYNTHESIS AND PROCESSING,0.23589,-0.26944,-0.04429,0,0
3,REACTOME RNA POL I PROMOTER OPENING,0.093897,-0.30252,-0.25695,0,0
3,REACTOME AMINE DERIVED HORMONES,0.05161,-0.39727,-0.27935,0,0
4,REGULATION OF MYELOID CELL DIFFERENTIATION,5.7413e-06,0.77748,0.69961,1,1
4,REACTOME INTERFERON ALPHA BETA SIGNALING,0.00044439,0.76903,0.58447,1,1
4,MYELOID LEUKOCYTE DIFFERENTIATION,0.00054072,0.74557,0.55648,1,1
4,BIOCARTA NKCELLS PATHWAY,1.7118e-05,0.71951,0.66661,1,1
4,REGULATION OF BLOOD PRESSURE,2.3418e-05,0.71596,0.59165,1,1
4,POSITIVE REGULATION OF CELL DIFFERENTIATION,3.7791e-06,0.71439,0.67874,1,1
4,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,0.0001165,0.68156,0.58939,1,1
4,SECRETORY GRANULE,1.0184e-05,0.67215,0.60975,1,1
4,DIGESTION,0.00010462,0.66652,0.58736,1,1
4,REGULATION OF CYTOKINE PRODUCTION,0.0001165,0.64969,0.48342,1,1
4,SH2 DOMAIN BINDING,4.8612e-06,0.63147,0.56033,1,1
4,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,3.9418e-06,0.62676,0.67348,1,1
4,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,0.00031859,0.62123,0.47385,1,1
4,REACTOME LYSOSOME VESICLE BIOGENESIS,3.3132e-05,0.59896,0.5011,1,1
4,STEROID BIOSYNTHETIC PROCESS,4.2876e-06,0.59748,0.56155,1,1
4,LIPID TRANSPORTER ACTIVITY,4.4878e-05,0.59016,0.48332,1,1
4,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,0.0022992,0.581,0.55622,1,1
4,MYELOID CELL DIFFERENTIATION,1.0184e-05,0.57557,0.52409,1,1
4,KEGG PHENYLALANINE METABOLISM,5.4121e-05,0.56594,0.52671,1,1
4,APICAL PLASMA MEMBRANE,2.8418e-05,0.56327,0.47289,1,1
4,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,4.2876e-06,0.54698,0.51379,1,1
4,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.029068,0.54656,0.29718,1,1
4,SODIUM ION TRANSPORT,3.4421e-05,0.54602,0.56409,1,1
4,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00021909,0.54088,0.51335,1,1
4,REACTOME INTERFERON GAMMA SIGNALING,5.8301e-05,0.52476,0.44114,1,1
4,KEGG MATURITY ONSET DIABETES OF THE YOUNG,4.6597e-05,0.51712,0.42829,1,1
4,BIOCARTA IL2 PATHWAY,1.1776e-06,0.51487,0.52802,1,1
4,APICAL PART OF CELL,2.9532e-05,0.5126,0.48358,1,1
4,ADENYLATE CYCLASE ACTIVATION,0.0028957,0.51113,0.35057,1,1
4,REACTOME INTERFERON SIGNALING,0.00010845,0.50566,0.36551,1,1
4,PROTEIN HOMOOLIGOMERIZATION,2.8418e-05,0.50262,0.45009,1,1
4,UDP GLYCOSYLTRANSFERASE ACTIVITY,2.3418e-05,0.50117,0.46194,1,1
4,LIPID RAFT,0.00047456,0.4993,0.38415,1,1
4,HOMOPHILIC CELL ADHESION,0.00098941,0.49121,0.44333,1,1
4,CYTOKINE METABOLIC PROCESS,1.5816e-05,0.49067,0.41832,1,1
4,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.00013433,0.48935,0.41677,1,1
4,REACTOME O LINKED GLYCOSYLATION OF MUCINS,5.2139e-05,0.48771,0.40353,1,1
4,SA B CELL RECEPTOR COMPLEXES,1.1267e-06,0.48656,0.52583,1,1
4,DEAMINASE ACTIVITY,1.5816e-05,0.48563,0.46576,1,1
4,CYTOKINE BIOSYNTHETIC PROCESS,1.7806e-05,0.48481,0.41053,1,1
4,BIOCARTA IL22BP PATHWAY,0.00037661,0.46782,0.41637,1,1
4,CALCIUM INDEPENDENT CELL CELL ADHESION,0.00026003,0.4663,0.51288,1,1
4,NEGATIVE REGULATION OF TRANSLATION,9.0551e-05,0.46398,0.36923,1,1
4,BIOCARTA D4GDI PATHWAY,7.9801e-06,0.46364,0.42412,1,1
4,BIOCARTA IL7 PATHWAY,6.2367e-06,0.46161,0.5306,1,1
4,REACTOME INSULIN RECEPTOR RECYCLING,1.104e-05,0.46108,0.4745,1,1
4,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,4.8612e-06,0.46057,0.44843,1,1
4,PML BODY,2.0833e-05,0.44557,0.48273,1,1
4,STEROID METABOLIC PROCESS,1.2454e-05,0.44546,0.39348,1,1
4,BIOCARTA MITOCHONDRIA PATHWAY,6.0504e-05,0.43992,0.4638,1,1
4,REACTOME SIGNALING BY NOTCH2,5.9841e-06,0.43898,0.46829,1,1
4,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.1617e-05,0.43896,0.40096,1,1
4,TUBE MORPHOGENESIS,9.389e-05,0.4383,0.46298,1,1
4,BIOCARTA NFKB PATHWAY,0.00095906,0.43775,0.30072,1,1
4,EXONUCLEASE ACTIVITY,0.0001547,0.43693,0.39498,1,1
4,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,2.6307e-05,0.43611,0.45121,1,1
4,TUBE DEVELOPMENT,0.00019079,0.43239,0.40855,1,1
4,BIOCARTA ARENRF2 PATHWAY,0.00017796,0.42737,0.43848,1,1
4,REACTOME TIGHT JUNCTION INTERACTIONS,0.00055855,0.42642,0.42533,1,1
4,CELLULAR DEFENSE RESPONSE,0.0037331,0.42326,0.26464,1,1
4,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,1.1493e-05,0.42146,0.38157,1,1
4,PID ERB GENOMIC PATHWAY,3.0689e-05,0.4184,0.44582,1,1
4,I KAPPAB KINASE NF KAPPAB CASCADE,0.00018427,0.41768,0.31121,1,1
4,BIOCARTA EPO PATHWAY,4.4712e-06,0.41438,0.44057,1,1
4,VACUOLE,5.7413e-06,0.41226,0.37481,1,1
4,CYTOKINE PRODUCTION,3.0576e-06,0.41175,0.38911,1,1
4,LEUKOCYTE MIGRATION,5.0226e-05,0.41012,0.52267,1,1
4,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00013433,0.4091,0.34696,1,1
4,LEUKOCYTE DIFFERENTIATION,0.00028792,0.40779,0.36348,1,1
4,REACTOME SIGNALING BY NOTCH4,9.4334e-07,0.40738,0.47424,1,1
4,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00019753,0.40667,0.35234,1,1
4,GALACTOSYLTRANSFERASE ACTIVITY,0.00057693,0.40617,0.38495,1,1
4,REACTOME SIGNALING BY NOTCH3,7.0571e-06,0.40346,0.41809,1,1
4,REACTOME REGULATION OF BETA CELL DEVELOPMENT,0.00021909,0.4026,0.37681,1,1
4,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,7.8282e-05,0.40071,0.39802,1,1
4,APICAL JUNCTION COMPLEX,0.00025131,0.39805,0.3618,1,1
4,APICOLATERAL PLASMA MEMBRANE,0.00025131,0.39805,0.3618,1,1
4,PHOSPHOLIPID TRANSPORTER ACTIVITY,0.00010845,0.39766,0.44013,1,1
4,BIOCARTA CASPASE PATHWAY,0.001228,0.39706,0.3422,1,1
4,GLYCOPROTEIN METABOLIC PROCESS,4.8379e-05,0.39544,0.3389,1,1
4,REACTOME AMINE DERIVED HORMONES,0.00035231,0.39505,0.49988,1,1
4,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,0.00019079,0.3946,0.42558,1,1
4,MORPHOGENESIS OF AN EPITHELIUM,0.011612,0.39013,0.31811,1,1
4,SEXUAL REPRODUCTION,2.9301e-06,0.38905,0.35742,1,1
4,BIOCARTA TOLL PATHWAY,3.0689e-05,0.38732,0.36938,1,1
4,REACTOME REGULATION OF KIT SIGNALING,0.017549,0.38534,0.33366,1,1
4,SODIUM CHANNEL ACTIVITY,0.0021689,0.3849,0.34499,1,1
4,ST INTERLEUKIN 4 PATHWAY,8.4205e-05,0.38484,0.3193,1,1
4,LYSOSOME,1.2962e-05,0.38444,0.33909,1,1
4,LYTIC VACUOLE,1.2962e-05,0.38444,0.33909,1,1
4,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,9.7801e-06,0.38407,0.39829,1,1
4,BIOCARTA SODD PATHWAY,0.0010528,0.38229,0.33106,1,1
4,BIOCARTA DEATH PATHWAY,0.00054072,0.38209,0.36463,1,1
4,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,0.00025131,0.37724,0.3923,1,1
4,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,3.0689e-05,0.37478,0.32174,1,1
4,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,0.00014418,0.37379,0.31106,1,1
4,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,0.0073363,0.37187,0.32494,1,1
4,REACTOME ACYL CHAIN REMODELLING OF PE,7.013e-05,0.37095,0.34388,1,1
4,SIG BCR SIGNALING PATHWAY,1.7118e-05,0.36967,0.35305,1,1
4,TIGHT JUNCTION,0.00090094,0.36565,0.33953,1,1
4,GLAND DEVELOPMENT,0.007729,0.36418,0.35959,1,1
4,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.0057817,0.36109,0.23571,1,1
4,COENZYME BINDING,0.0006154,0.3586,0.3093,1,1
4,INTEGRIN COMPLEX,0.0036303,0.35567,0.23935,1,1
4,CELLULAR LIPID CATABOLIC PROCESS,4.1617e-05,0.34862,0.33449,1,1
4,COFACTOR BINDING,0.00026003,0.34705,0.28477,1,1
4,EXCRETION,0.0001547,0.34705,0.27162,1,1
4,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,5.0226e-05,0.34538,0.29767,1,1
4,REACTOME N GLYCAN ANTENNAE ELONGATION,0.02843,0.34341,0.29929,1,1
4,BIOCARTA ETS PATHWAY,4.1617e-05,0.34296,0.36485,1,1
4,KEGG STEROID BIOSYNTHESIS,0.0018173,0.34293,0.42276,1,1
4,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,0.00059588,0.34083,0.36995,1,1
4,PROTEIN KINASE INHIBITOR ACTIVITY,0.00067758,0.34082,0.4117,1,1
4,PID HNF3BPATHWAY,7.013e-05,0.33998,0.36618,1,1
4,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00040247,0.33881,0.27516,1,1
4,KEGG PROTEIN EXPORT,0.00040247,0.33823,0.29952,1,1
4,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,8.4205e-05,0.3348,0.30635,1,1
4,KEGG O GLYCAN BIOSYNTHESIS,0.00030804,0.3341,0.39441,1,1
4,REACTOME IL 2 SIGNALING,6.2786e-05,0.33287,0.35646,1,1
4,MONOVALENT INORGANIC CATION TRANSPORT,0.00035231,0.33281,0.31462,1,1
4,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,1.5201e-05,0.3321,0.33689,1,1
4,LIPID CATABOLIC PROCESS,4.3218e-05,0.33111,0.31979,1,1
4,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,0.00055855,0.33086,0.23097,1,1
4,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,0.00010092,0.33044,0.27525,1,1
4,KINASE INHIBITOR ACTIVITY,0.00026003,0.33022,0.43145,1,1
4,PID AVB3 OPN PATHWAY,0.0033369,0.32926,0.27058,1,1
4,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.00038934,0.32913,0.29663,1,1
4,BIOCARTA 41BB PATHWAY,0.00014418,0.32862,0.31377,1,1
4,REACTOME NOD1 2 SIGNALING PATHWAY,0.00044439,0.32817,0.28434,1,1
4,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,0.0011549,0.3271,0.22043,1,1
4,HORMONE ACTIVITY,0.00054072,0.3259,0.38215,1,1
4,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,9.7346e-05,0.32587,0.33196,1,1
4,ALCOHOL METABOLIC PROCESS,4.2876e-06,0.32057,0.28916,1,1
4,INFLAMMATORY RESPONSE,0.00027832,0.32054,0.23904,1,1
4,BIOCARTA BCELLSURVIVAL PATHWAY,0.0050528,0.31459,0.24312,1,1
4,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.0020453,0.30792,0.32013,1,1
4,LIPID BIOSYNTHETIC PROCESS,4.1617e-05,0.30624,0.26316,1,1
4,BIOCARTA IL1R PATHWAY,0.0006154,0.30622,0.22315,1,1
4,REACTOME SYNTHESIS OF PC,0.0013872,0.30594,0.27602,1,1
4,REACTOME P75NTR SIGNALS VIA NFKB,0.041093,0.30578,0.16146,1,1
4,PID ALPHASYNUCLEIN PATHWAY,0.0001547,0.30558,0.3144,1,1
4,REACTOME ACTIVATED TLR4 SIGNALLING,4.4712e-06,0.30308,0.29036,1,1
4,RNA CATABOLIC PROCESS,0.0019282,0.30241,0.2338,1,1
4,BIOCARTA CERAMIDE PATHWAY,8.7323e-05,0.30238,0.29952,1,1
4,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.00014418,0.3022,0.28349,1,1
4,INTERCELLULAR JUNCTION,0.0011549,0.30214,0.22979,1,1
4,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,1.7474e-06,0.30108,0.30418,1,1
4,REACTOME CD28 CO STIMULATION,0.0022992,0.30086,0.25661,1,1
4,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,0.0010528,0.30071,0.32542,1,1
4,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,0.0021062,0.29812,0.32567,1,1
4,GAMETE GENERATION,0.00022676,0.29695,0.28155,1,1
4,MICROTUBULE MOTOR ACTIVITY,0.00040247,0.29628,0.32928,1,1
4,TRANSPORT VESICLE,0.0010528,0.29485,0.21755,1,1
4,DEFENSE RESPONSE,0.00044439,0.29433,0.23922,1,1
4,SIG PIP3 SIGNALING IN B LYMPHOCYTES,5.4121e-05,0.29396,0.32732,1,1
4,PID WNT SIGNALING PATHWAY,0.014841,0.2936,0.23609,1,1
4,BIOCARTA IL2RB PATHWAY,7.2754e-05,0.29208,0.2913,1,1
4,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,0.0087944,0.29037,0.25351,1,1
4,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.00040247,0.28861,0.25297,1,1
4,MICROSOME,0.00065623,0.28685,0.26531,1,1
4,BIOCARTA KERATINOCYTE PATHWAY,0.00012074,0.28603,0.29091,1,1
4,REACTOME HS GAG BIOSYNTHESIS,0.0047853,0.28509,0.31684,1,1
4,TISSUE REMODELING,0.0081404,0.28479,0.20431,1,1
4,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.00012964,0.28453,0.3221,1,1
4,BIOCARTA IL6 PATHWAY,0.00049035,0.28401,0.26436,1,1
4,PID IL1PATHWAY,3.5759e-05,0.28348,0.27699,1,1
4,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.28302,0.29021,1,1
4,PROTEIN OLIGOMERIZATION,0.00013917,0.28286,0.27631,1,1
4,INSOLUBLE FRACTION,5.0226e-05,0.28219,0.33392,1,1
4,PID NFKAPPABATYPICALPATHWAY,0.00087311,0.28216,0.37274,1,1
4,REACTOME CELL CELL JUNCTION ORGANIZATION,0.00087311,0.28196,0.31441,1,1
4,REACTOME TOLL RECEPTOR CASCADES,6.4994e-06,0.28186,0.29028,1,1
4,HEMOPOIESIS,1.104e-05,0.27959,0.30864,1,1
4,STEROID BINDING,0.019739,0.27949,0.30678,1,1
4,REACTOME IRON UPTAKE AND TRANSPORT,0.00014418,0.27858,0.2422,1,1
4,REACTOME IL RECEPTOR SHC SIGNALING,0.013465,0.27804,0.19533,1,1
4,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.016734,0.2776,0.25183,1,1
4,CELLULAR LIPID METABOLIC PROCESS,9.3916e-06,0.27666,0.26041,1,1
4,PID HIVNEFPATHWAY,0.00023468,0.27468,0.2845,1,1
4,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.024846,0.27463,0.18838,1,1
4,KEGG LINOLEIC ACID METABOLISM,0.00090094,0.27383,0.25786,1,1
4,PROTEIN BINDING BRIDGING,0.018836,0.27376,0.16643,1,1
4,PID IL2 PI3KPATHWAY,0.043763,0.27321,0.16958,1,1
4,REACTOME IL1 SIGNALING,0.00019079,0.27248,0.22606,1,1
4,REPRODUCTION,9.3916e-06,0.27247,0.23448,1,1
4,SA PROGRAMMED CELL DEATH,0.00022676,0.27246,0.32159,1,1
4,KEGG SPHINGOLIPID METABOLISM,8.4205e-05,0.27116,0.29689,1,1
4,PID HNF3APATHWAY,0.00012074,0.27068,0.35321,1,1
4,SIG IL4RECEPTOR IN B LYPHOCYTES,0.00052342,0.26955,0.23128,1,1
4,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,0.017969,0.26945,0.19034,1,1
4,KEGG ETHER LIPID METABOLISM,0.0057817,0.26802,0.14402,1,1
4,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.00023468,0.2663,0.23151,1,1
4,PID AJDISS 2PATHWAY,0.0031536,0.26607,0.23206,1,1
4,KEGG DORSO VENTRAL AXIS FORMATION,9.7346e-05,0.26518,0.33955,1,1
4,REACTOME IL 3 5 AND GM CSF SIGNALING,0.00069957,0.2649,0.26634,1,1
4,KEGG LEISHMANIA INFECTION,0.00010845,0.26427,0.24458,1,1
4,CATION TRANSPORT,0.00027832,0.26419,0.25183,1,1
4,PID GMCSF PATHWAY,0.00035231,0.26391,0.25185,1,1
4,REGULATION OF ACTION POTENTIAL,0.0062634,0.26292,0.28071,1,1
4,PID TCRJNKPATHWAY,0.001662,0.26186,0.24393,1,1
4,REACTOME ACYL CHAIN REMODELLING OF PC,0.00036427,0.26145,0.26885,1,1
4,SUGAR BINDING,0.0032441,0.26002,0.24831,1,1
4,PID IL3 PATHWAY,0.0057817,0.25743,0.20514,1,1
4,BIOCARTA EGF PATHWAY,0.00045924,0.25697,0.23273,1,1
4,ST TUMOR NECROSIS FACTOR PATHWAY,0.00055855,0.25695,0.21501,1,1
4,ANION CHANNEL ACTIVITY,0.00353,0.25558,0.20742,1,1
4,CHLORIDE CHANNEL ACTIVITY,0.00353,0.25558,0.20742,1,1
4,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.029719,0.25455,0.15738,1,1
4,ACTIN FILAMENT BINDING,0.0026572,0.25324,0.25127,1,1
4,PID IL4 2PATHWAY,0.00079435,0.25211,0.25833,1,1
4,ENDOSOME TRANSPORT,0.0073363,0.25174,0.16025,1,1
4,RESPONSE TO ORGANIC SUBSTANCE,0.001872,0.25113,0.25178,1,1
4,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,0.00069957,0.24883,0.20501,1,1
4,PID NECTIN PATHWAY,0.0053338,0.24752,0.26947,1,1
4,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.026586,0.2475,0.20865,1,1
4,LIPID METABOLIC PROCESS,5.6174e-05,0.2474,0.21719,1,1
4,REGULATION OF TRANSLATION,0.00063551,0.24726,0.20578,1,1
4,CYTOKINE ACTIVITY,0.001872,0.24596,0.19903,1,1
4,STRUCTURE SPECIFIC DNA BINDING,0.00022676,0.24575,0.19365,1,1
4,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.012508,0.24563,0.17787,1,1
4,REACTOME INNATE IMMUNE SYSTEM,4.0073e-05,0.24555,0.26082,1,1
4,BIOCARTA HIVNEF PATHWAY,0.00079435,0.24499,0.2254,1,1
4,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.00084609,0.24462,0.19665,1,1
4,EXTRACELLULAR SPACE,0.0047853,0.24455,0.16407,1,1
4,CHEMICAL HOMEOSTASIS,0.00036427,0.24399,0.18954,1,1
4,DOUBLE STRANDED DNA BINDING,0.0060989,0.24397,0.16955,1,1
4,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,9.389e-05,0.2435,0.26146,1,1
4,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.010773,0.24217,0.2212,1,1
4,RESPONSE TO WOUNDING,0.0027346,0.24161,0.16623,1,1
4,CELLULAR CATION HOMEOSTASIS,0.0014299,0.24085,0.21288,1,1
4,METAL ION TRANSPORT,0.0014299,0.24031,0.23952,1,1
4,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.00092958,0.24013,0.25575,1,1
4,CELLULAR HOMEOSTASIS,0.0025083,0.23852,0.18387,1,1
4,IMMUNE SYSTEM DEVELOPMENT,0.00014418,0.23762,0.24966,1,1
4,PID IL23PATHWAY,0.0010206,0.23754,0.2145,1,1
4,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,0.0062634,0.23663,0.26877,1,1
4,REACTOME REGULATION OF SIGNALING BY CBL,0.0094949,0.23622,0.2265,1,1
4,KEGG N GLYCAN BIOSYNTHESIS,0.00065623,0.23564,0.2119,1,1
4,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.0014738,0.23553,0.21254,1,1
4,POTASSIUM CHANNEL REGULATOR ACTIVITY,0.041093,0.23518,0.22932,1,1
4,REACTOME TRIF MEDIATED TLR3 SIGNALING,0.0001165,0.23503,0.22608,1,1
4,REPRODUCTIVE PROCESS,0.00013433,0.23473,0.20347,1,1
4,KEGG RETINOL METABOLISM,0.025994,0.23412,0.15937,1,1
4,SOLUBLE FRACTION,0.00034072,0.23317,0.19943,1,1
4,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,1.4609e-05,0.23312,0.27783,1,1
4,KEGG NOTCH SIGNALING PATHWAY,0.0040578,0.23272,0.21014,1,1
4,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0013054,0.23247,0.19082,1,1
4,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,7.2754e-05,0.23065,0.20927,1,1
4,PID REG GR PATHWAY,0.0007696,0.23034,0.22412,1,1
4,KEGG APOPTOSIS,0.00074557,0.22993,0.19446,1,1
4,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0085714,0.22993,0.15605,1,1
4,REACTOME SPHINGOLIPID METABOLISM,0.00047456,0.22977,0.22093,1,1
4,DEOXYRIBONUCLEASE ACTIVITY,0.00029782,0.22893,0.23318,1,1
4,PID IL6 7PATHWAY,0.0015653,0.22637,0.23803,1,1
4,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,0.0046564,0.22553,0.16325,1,1
4,ION HOMEOSTASIS,0.00092958,0.22508,0.19761,1,1
4,BIOCARTA INSULIN PATHWAY,0.00065623,0.22496,0.2158,1,1
4,CELL CELL ADHESION,0.001662,0.22395,0.2128,1,1
4,HOMEOSTATIC PROCESS,0.00031859,0.22386,0.1745,1,1
4,PHOSPHOINOSITIDE BINDING,0.0022992,0.22286,0.20957,1,1
4,CATION HOMEOSTASIS,0.00084609,0.22256,0.21102,1,1
4,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,0.00023468,0.2225,0.30399,1,1
4,PID HIF2PATHWAY,0.012203,0.22144,0.22488,1,1
4,PID S1P S1P3 PATHWAY,0.022165,0.22133,0.18102,1,1
4,PID TOLL ENDOGENOUS PATHWAY,0.0015189,0.2211,0.26288,1,1
4,REACTOME ERK MAPK TARGETS,0.0031536,0.22081,0.19268,1,1
4,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00026903,0.22052,0.19487,1,1
4,PID P38 MKK3 6PATHWAY,0.0032441,0.22034,0.20893,1,1
4,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,0.00034072,0.21969,0.21231,1,1
4,PID IL12 STAT4PATHWAY,0.025994,0.21916,0.1919,1,1
4,BIOCARTA GLEEVEC PATHWAY,0.011326,0.21877,0.17454,1,1
4,RESPONSE TO OTHER ORGANISM,0.0020453,0.2178,0.17881,1,1
4,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,9.0551e-05,0.21772,0.23443,1,1
4,PHOSPHOLIPID METABOLIC PROCESS,1.8521e-05,0.21772,0.22896,1,1
4,PID CASPASE PATHWAY,0.007729,0.21763,0.1668,1,1
4,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,0.00035231,0.21728,0.20946,1,1
4,REACTOME KERATAN SULFATE KERATIN METABOLISM,0.013465,0.21714,0.16853,1,1
4,ST GRANULE CELL SURVIVAL PATHWAY,0.025414,0.21675,0.1953,1,1
4,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.001872,0.21674,0.17085,1,1
4,REACTOME CELL JUNCTION ORGANIZATION,0.0014738,0.21656,0.22316,1,1
4,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.0020453,0.21624,0.15513,1,1
4,N ACETYLTRANSFERASE ACTIVITY,0.00036427,0.21466,0.21515,1,1
4,N ACYLTRANSFERASE ACTIVITY,0.00036427,0.21466,0.21515,1,1
4,PID EPOPATHWAY,0.00020448,0.21398,0.28983,1,1
4,IMMUNE RESPONSE,0.0016129,0.21397,0.17435,1,1
4,BIOCARTA TNFR2 PATHWAY,0.021165,0.21348,0.17226,1,1
4,PEPTIDE BINDING,0.00035231,0.21331,0.17124,1,1
4,BIOCARTA BIOPEPTIDES PATHWAY,0.029719,0.2129,0.13799,1,1
4,REACTOME BIOLOGICAL OXIDATIONS,0.0085714,0.21224,0.16686,1,1
4,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.0069616,0.21213,0.15619,1,1
4,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.0050528,0.21213,0.19646,1,1
4,KEGG CIRCADIAN RHYTHM MAMMAL,0.041967,0.21138,0.26589,1,1
4,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,0.00067758,0.21137,0.17998,1,1
4,VESICULAR FRACTION,0.0020453,0.21087,0.21145,1,1
4,DOUBLE STRANDED RNA BINDING,0.0097392,0.21055,0.179,1,1
4,BIOCARTA BCR PATHWAY,0.0013872,0.21015,0.2616,1,1
4,CELLULAR RESPIRATION,0.00042998,0.20976,0.27103,1,1
4,PROTEOLYSIS,0.00042998,0.20906,0.19975,1,1
4,BIOCARTA FCER1 PATHWAY,0.00052342,0.20879,0.23478,1,1
4,AEROBIC RESPIRATION,0.00079435,0.20869,0.24051,1,1
4,IMMUNE SYSTEM PROCESS,0.00030804,0.20857,0.20538,1,1
4,PID S1P S1P2 PATHWAY,0.011047,0.20849,0.21039,1,1
4,KEGG TYPE II DIABETES MELLITUS,0.0023671,0.20823,0.21069,1,1
4,NUCLEAR BODY,0.00025131,0.20707,0.196,1,1
4,BIOCARTA PDGF PATHWAY,0.00032948,0.20705,0.21401,1,1
4,BIOCARTA CCR5 PATHWAY,0.019739,0.20652,0.25673,1,1
4,ANION TRANSPORT,0.015953,0.20573,0.26276,1,1
4,PID BCR 5PATHWAY,0.00040247,0.20375,0.21657,1,1
4,MULTI ORGANISM PROCESS,0.00087311,0.20359,0.18816,1,1
4,ST B CELL ANTIGEN RECEPTOR,0.004408,0.20344,0.15031,1,1
4,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.0015189,0.20224,0.19844,1,1
4,PID FASPATHWAY,0.011326,0.20192,0.17477,1,1
4,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.0085714,0.20179,0.15205,1,1
4,PID IL12 2PATHWAY,0.0010528,0.20113,0.20192,1,1
4,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.00067758,0.20055,0.19294,1,1
4,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.031059,0.19964,0.12652,1,1
4,PID RAC1 PATHWAY,0.00017796,0.19947,0.21351,1,1
4,BIOCARTA GH PATHWAY,0.007729,0.19943,0.15761,1,1
4,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.029068,0.19814,0.18219,1,1
4,REACTOME SIGNALING BY ILS,9.389e-05,0.19759,0.23756,1,1
4,REGULATION OF CELL DIFFERENTIATION,0.00042998,0.19685,0.23481,1,1
4,MAGNESIUM ION BINDING,0.00090094,0.19681,0.18461,1,1
4,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,7.013e-05,0.19671,0.20326,1,1
4,PID PI3KCIPATHWAY,0.0057817,0.19523,0.21409,1,1
4,BIOCARTA TPO PATHWAY,0.0038387,0.1939,0.22286,1,1
4,FEMALE PREGNANCY,0.014486,0.19309,0.13698,1,1
4,MEMBRANE LIPID METABOLIC PROCESS,0.00017186,0.19255,0.19272,1,1
4,PID FOXOPATHWAY,0.0021689,0.19187,0.17164,1,1
4,REGULATION OF BIOLOGICAL QUALITY,0.00020448,0.18996,0.15651,1,1
4,PID P38ALPHABETADOWNSTREAMPATHWAY,0.0014299,0.1894,0.20695,1,1
4,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,0.014486,0.18926,0.24085,1,1
4,REACTOME MEMBRANE TRAFFICKING,0.0029794,0.18799,0.15132,1,1
4,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,0.024846,0.1879,0.20528,1,1
4,DETECTION OF STIMULUS,0.0079323,0.18783,0.20607,1,1
4,SIG CD40PATHWAYMAP,0.00092958,0.18741,0.19446,1,1
4,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.025414,0.18556,0.13562,1,1
4,PROTEIN KINASE CASCADE,0.00074557,0.18447,0.17413,1,1
4,BIOCARTA ATM PATHWAY,0.00079435,0.18336,0.21097,1,1
4,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.00353,0.18333,0.16879,1,1
4,MOLECULAR ADAPTOR ACTIVITY,0.019739,0.1833,0.16689,1,1
4,BIOCARTA STRESS PATHWAY,0.00063551,0.18266,0.22572,1,1
4,PID ATF2 PATHWAY,0.01282,0.18156,0.20544,1,1
4,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.0064317,0.18098,0.1417,1,1
4,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.0087944,0.18036,0.16227,1,1
4,REACTOME PHOSPHOLIPID METABOLISM,0.00010462,0.18003,0.17543,1,1
4,PID SMAD2 3PATHWAY,0.0066042,0.17825,0.20324,1,1
4,ORGANELLE OUTER MEMBRANE,0.023205,0.17811,0.13588,1,1
4,CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.007729,0.17808,0.1122,1,1
4,POTASSIUM CHANNEL ACTIVITY,0.038561,0.17734,0.23403,1,1
4,KEGG OXIDATIVE PHOSPHORYLATION,0.00095906,0.17719,0.16292,1,1
4,REACTOME IMMUNE SYSTEM,0.00042998,0.1767,0.16171,1,1
4,BIOCARTA HSP27 PATHWAY,0.013465,0.17598,0.17724,1,1
4,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,0.00353,0.17343,0.16834,1,1
4,PEPTIDE RECEPTOR ACTIVITY,0.0075304,0.17321,0.1662,1,1
4,ACTIN BINDING,0.00057693,0.17206,0.18477,1,1
4,BIOCARTA TCR PATHWAY,0.001986,0.17137,0.2173,1,1
4,CARBOHYDRATE TRANSPORT,0.037747,0.16996,0.13551,1,1
4,PID IL2 1PATHWAY,0.00031859,0.16975,0.2485,1,1
4,BIOCARTA IGF1 PATHWAY,0.013139,0.16968,0.14884,1,1
4,SH3 SH2 ADAPTOR ACTIVITY,0.036164,0.16945,0.16738,1,1
4,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.015574,0.16786,0.14202,1,1
4,BIOCARTA NGF PATHWAY,0.0071468,0.16763,0.18269,1,1
4,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.041967,0.16562,0.11377,1,1
4,PID IFNGPATHWAY,0.0023671,0.16484,0.17493,1,1
4,MACROMOLECULE BIOSYNTHETIC PROCESS,0.00052342,0.16393,0.15394,1,1
4,REACTOME SIGNALING BY SCF KIT,0.0031536,0.16359,0.19762,1,1
4,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.0024367,0.16327,0.19757,1,1
4,PID MET PATHWAY,0.0051916,0.16303,0.123,1,1
4,RESPONSE TO EXTERNAL STIMULUS,0.0087944,0.16165,0.11664,1,1
4,KEGG ALZHEIMERS DISEASE,0.00026903,0.16126,0.16703,1,1
4,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.029068,0.1606,0.1796,1,1
4,CELL FRACTION,0.0049174,0.16033,0.13135,1,1
4,PID HIF1APATHWAY,0.03245,0.16001,0.19285,1,1
4,IDENTICAL PROTEIN BINDING,0.00052342,0.15995,0.14317,1,1
4,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.0087944,0.1598,0.14015,1,1
4,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.0069616,0.1594,0.19228,1,1
4,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,0.024846,0.1567,0.1108,1,1
4,BIOCARTA TNFR1 PATHWAY,0.011047,0.1563,0.12804,1,1
4,CALCIUM ION BINDING,0.0037331,0.1552,0.13086,1,1
4,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.00032948,0.15458,0.18219,1,1
4,BASE EXCISION REPAIR,0.0066042,0.15407,0.19193,1,1
4,PID RHOA PATHWAY,0.0027346,0.15359,0.15178,1,1
4,KEGG PARKINSONS DISEASE,0.017137,0.15339,0.12816,1,1
4,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.010245,0.15064,0.13533,1,1
4,HEMOSTASIS,0.027803,0.15058,0.12309,1,1
4,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,0.0036303,0.15051,0.11103,1,1
4,PID MAPKTRKPATHWAY,0.0021689,0.14846,0.18213,1,1
4,BIOSYNTHETIC PROCESS,0.00032948,0.14566,0.15548,1,1
4,CELL CELL SIGNALING,0.013465,0.14524,0.12996,1,1
4,PID ERBB1 DOWNSTREAM PATHWAY,0.0040578,0.14423,0.13825,1,1
4,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.015574,0.14376,0.11986,1,1
4,MONOOXYGENASE ACTIVITY,0.02268,0.14176,0.14739,1,1
4,PID FCER1PATHWAY,0.00081984,0.14084,0.17248,1,1
4,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.019283,0.13997,0.1303,1,1
4,CONDENSED CHROMOSOME,0.0051916,0.13952,0.21665,1,1
4,REACTOME SIGNALING BY NOTCH,0.030383,0.13926,0.14214,1,1
4,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.024846,0.13861,0.16669,1,1
4,PROTEIN COMPLEX ASSEMBLY,0.0057817,0.13677,0.11327,1,1
4,PID FGF PATHWAY,0.029068,0.13662,0.11282,1,1
4,REACTOME BASE EXCISION REPAIR,0.009256,0.13649,0.14391,1,1
4,ACETYLTRANSFERASE ACTIVITY,0.011904,0.13525,0.13433,1,1
4,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.0025817,0.13475,0.18541,1,1
4,CARBOHYDRATE METABOLIC PROCESS,0.02268,0.13428,0.094712,1,1
4,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.030383,0.13423,0.087304,1,1
4,BIOCARTA ECM PATHWAY,0.019283,0.13335,0.12959,1,1
4,RESPONSE TO BIOTIC STIMULUS,0.011047,0.13323,0.11529,1,1
4,CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.010773,0.13279,0.089264,1,1
4,KEGG FC EPSILON RI SIGNALING PATHWAY,0.0022332,0.13216,0.16145,1,1
4,PHOSPHOLIPID BINDING,0.018836,0.13092,0.11663,1,1
4,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.027803,0.13025,0.25871,1,1
4,SINGLE STRANDED DNA BINDING,0.027188,0.12898,0.10226,1,1
4,REACTOME APOPTOSIS,0.0042883,0.12853,0.13878,1,1
4,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.02068,0.126,0.10109,1,1
4,NUCLEASE ACTIVITY,0.00024286,0.12555,0.15582,1,1
4,RESPONSE TO HYPOXIA,0.011047,0.12525,0.26837,1,1
4,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,0.017969,0.12213,0.087828,1,1
4,PROGRAMMED CELL DEATH,0.0021689,0.12163,0.12748,1,1
4,REGULATION OF PROGRAMMED CELL DEATH,0.0045306,0.11865,0.12718,1,1
4,BIOCARTA CXCR4 PATHWAY,0.0085714,0.11818,0.17302,1,1
4,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.0099891,0.11727,0.11552,1,1
4,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.0067808,0.11725,0.11935,1,1
4,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.0028141,0.11718,0.10624,1,1
4,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.022165,0.11681,0.084767,1,1
4,ACTIN CYTOSKELETON,0.027188,0.11642,0.086268,1,1
4,KEGG MELANOGENESIS,0.011904,0.11641,0.11036,1,1
4,ENDOSOME,0.0038387,0.11469,0.17747,1,1
4,PLASMA MEMBRANE,0.02166,0.11435,0.10239,1,1
4,APOPTOSIS GO,0.0030654,0.11416,0.11947,1,1
4,PID PTP1BPATHWAY,0.040234,0.11326,0.12708,1,1
4,PID LYSOPHOSPHOLIPID PATHWAY,0.042857,0.11292,0.11222,1,1
4,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.041967,0.11013,0.1443,1,1
4,PID ERBB2ERBB3PATHWAY,0.035393,0.10964,0.086205,1,1
4,RESPONSE TO ENDOGENOUS STIMULUS,0.01282,0.10867,0.079257,1,1
4,MEMBRANE PART,0.012508,0.10738,0.097507,1,1
4,REGULATION OF APOPTOSIS,0.0064317,0.10512,0.11709,1,1
4,INTRACELLULAR SIGNALING CASCADE,0.004408,0.1041,0.10599,1,1
4,INTEGRAL TO MEMBRANE,0.013465,0.10351,0.10514,1,1
4,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.0079323,0.10307,0.097847,1,1
4,SYSTEM PROCESS,0.016339,0.10248,0.098549,1,1
4,NEGATIVE REGULATION OF METABOLIC PROCESS,0.0081404,0.10228,0.09732,1,1
4,INTEGRAL TO PLASMA MEMBRANE,0.025414,0.10118,0.10015,1,1
4,PLASMA MEMBRANE PART,0.033166,0.099249,0.093284,1,1
4,MEMBRANE,0.015203,0.098495,0.098191,1,1
4,PROTEIN KINASE ACTIVITY,0.0045306,0.097432,0.10527,1,1
4,PROTEIN METABOLIC PROCESS,0.0060989,0.095085,0.088413,1,1
4,INTRINSIC TO MEMBRANE,0.021165,0.093975,0.098726,1,1
4,REACTOME SIGNALING BY INSULIN RECEPTOR,0.010773,0.090804,0.06635,1,1
4,BIOPOLYMER MODIFICATION,0.0060989,0.090642,0.091364,1,1
4,INTRINSIC TO PLASMA MEMBRANE,0.036948,0.089296,0.092431,1,1
4,BIOCARTA MAPK PATHWAY,0.013465,0.088508,0.11134,1,1
4,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.042857,0.08829,0.081665,1,1
4,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.016734,0.087884,0.079057,1,1
4,SIGNAL TRANSDUCTION,0.019739,0.086668,0.088621,1,1
4,PROTEIN MODIFICATION PROCESS,0.0099891,0.086608,0.08839,1,1
4,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0066042,0.086351,0.08418,1,1
4,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.011904,0.084336,0.090219,1,1
4,CELLULAR MACROMOLECULE METABOLIC PROCESS,0.0066042,0.079868,0.085732,1,1
4,CELLULAR PROTEIN METABOLIC PROCESS,0.0062634,0.07795,0.087107,1,1
4,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.031748,0.075708,0.08336,1,1
4,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.019739,0.075295,0.11911,1,1
4,NUCLEOTIDE BINDING,0.013465,0.075001,0.069445,1,1
4,ADENYL RIBONUCLEOTIDE BINDING,0.040234,0.07487,0.068423,1,1
4,ION BINDING,0.011326,0.074542,0.084348,1,1
4,PURINE NUCLEOTIDE BINDING,0.016734,0.073772,0.06968,1,1
4,ADENYL NUCLEOTIDE BINDING,0.017137,0.069941,0.075793,1,1
4,KINASE ACTIVITY,0.033894,0.069666,0.074013,1,1
4,NON MEMBRANE BOUND ORGANELLE,0.035393,0.068352,0.049859,1,1
4,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.035393,0.068352,0.049859,1,1
4,ENZYME BINDING,0.013139,0.064992,0.079231,1,1
4,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.040234,0.059337,0.067832,1,1
4,ICOSANOID METABOLIC PROCESS,0.00026903,0.65021,0.63662,1,0
4,REGULATION OF HOMEOSTATIC PROCESS,0.0081404,0.51833,0.34947,1,0
4,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,0.0059384,0.44856,0.38707,1,0
4,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.00027832,0.42931,0.31753,1,0
4,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.00030804,0.41633,0.30662,1,0
4,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,0.010506,0.40327,0.26565,1,0
4,REACTOME ER PHAGOSOME PATHWAY,0.03939,0.38228,0.20262,1,0
4,BIOCARTA NUCLEARRS PATHWAY,0.00037661,0.36913,0.3511,1,0
4,KEGG LYSOSOME,0.00072223,0.36903,0.28296,1,0
4,BIOCARTA IL10 PATHWAY,0.0064317,0.35909,0.30213,1,0
4,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.007729,0.35563,0.35863,1,0
4,HORMONE SECRETION,0.0020453,0.34348,0.46178,1,0
4,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00098941,0.33258,0.2702,1,0
4,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,0.010506,0.33142,0.26486,1,0
4,REACTOME CALNEXIN CALRETICULIN CYCLE,0.0094949,0.32808,0.26512,1,0
4,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,0.0060989,0.32343,0.26504,1,0
4,REACTOME GLYCOSPHINGOLIPID METABOLISM,0.0015189,0.31506,0.26342,1,0
4,PID TRAIL PATHWAY,0.00045924,0.31179,0.28425,1,0
4,CELL PROJECTION PART,0.00034072,0.30558,0.35096,1,0
4,FATTY ACID METABOLIC PROCESS,0.00030804,0.29813,0.28944,1,0
4,FATTY ACID OXIDATION,0.02166,0.2959,0.2365,1,0
4,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.023205,0.29543,0.2132,1,0
4,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,0.036948,0.29089,0.18721,1,0
4,BIOCARTA RELA PATHWAY,0.0056288,0.28769,0.22673,1,0
4,REGULATION OF MEMBRANE POTENTIAL,0.007729,0.28333,0.28026,1,0
4,KEGG STEROID HORMONE BIOSYNTHESIS,0.02166,0.28319,0.28699,1,0
4,MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00079435,0.27873,0.22834,1,0
4,PROTEIN SECRETION,0.0014299,0.27489,0.32818,1,0
4,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,0.033894,0.27352,0.21378,1,0
4,NEGATIVE REGULATION OF ANGIOGENESIS,0.041093,0.2711,0.15628,1,0
4,PID TNFPATHWAY,0.0051916,0.26763,0.1719,1,0
4,REACTOME CHOLESTEROL BIOSYNTHESIS,0.041093,0.26471,0.27728,1,0
4,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,0.00041602,0.26368,0.21846,1,0
4,REACTOME HS GAG DEGRADATION,0.015953,0.26067,0.37138,1,0
4,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.030383,0.25885,0.26166,1,0
4,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0053338,0.25879,0.25496,1,0
4,SA CASPASE CASCADE,0.0031536,0.25794,0.28577,1,0
4,REACTOME STEROID HORMONES,0.001191,0.25773,0.2412,1,0
4,REACTOME AMYLOIDS,0.0028957,0.25555,0.30362,1,0
4,POSITIVE REGULATION OF SECRETION,0.0027346,0.25446,0.31967,1,0
4,DETECTION OF CHEMICAL STIMULUS,0.014486,0.25296,0.30561,1,0
4,KEGG PRIMARY IMMUNODEFICIENCY,0.021165,0.25228,0.18076,1,0
4,BILE ACID METABOLIC PROCESS,0.013798,0.25169,0.21132,1,0
4,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,0.034637,0.25109,0.17273,1,0
4,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.0032441,0.25025,0.22323,1,0
4,PID TCPTP PATHWAY,0.011904,0.25007,0.19863,1,0
4,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,0.0057817,0.24665,0.18728,1,0
4,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,0.03245,0.24222,0.34293,1,0
4,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.0064317,0.23901,0.21221,1,0
4,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,0.027188,0.23571,0.17206,1,0
4,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0081404,0.23533,0.17634,1,0
4,RESPONSE TO DRUG,0.014138,0.23411,0.27603,1,0
4,KEGG ARACHIDONIC ACID METABOLISM,0.00072223,0.23387,0.27396,1,0
4,BIOCARTA GSK3 PATHWAY,0.019739,0.23319,0.21068,1,0
4,BIOCARTA P53HYPOXIA PATHWAY,0.029719,0.23298,0.12317,1,0
4,PID AP1 PATHWAY,0.033166,0.23114,0.1703,1,0
4,PHOSPHOLIPASE ACTIVITY,0.010773,0.22906,0.18014,1,0
4,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.0062634,0.22711,0.1928,1,0
4,POSITIVE REGULATION OF TRANSLATION,0.015203,0.22448,0.15177,1,0
4,PEROXISOME ORGANIZATION AND BIOGENESIS,0.00084609,0.22393,0.20311,1,0
4,RESPONSE TO VIRUS,0.0040578,0.22233,0.20585,1,0
4,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,0.02843,0.22162,0.1483,1,0
4,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,0.0097392,0.22155,0.17792,1,0
4,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.009256,0.22069,0.21956,1,0
4,SPHINGOLIPID METABOLIC PROCESS,0.0094949,0.22054,0.22251,1,0
4,SECRETION,9.7346e-05,0.21937,0.22989,1,0
4,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.011612,0.21765,0.21544,1,0
4,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.0010859,0.21586,0.25392,1,0
4,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.0029794,0.21562,0.19227,1,0
4,PID CD40 PATHWAY,0.0085714,0.21471,0.1678,1,0
4,ION TRANSPORT,0.00042998,0.21301,0.21733,1,0
4,GLUCOSE METABOLIC PROCESS,0.00098941,0.21268,0.25315,1,0
4,REACTOME SIGNALING BY WNT,0.025994,0.21198,0.15019,1,0
4,KEGG HISTIDINE METABOLISM,0.0062634,0.2089,0.24907,1,0
4,BIOCARTA PML PATHWAY,0.016339,0.20728,0.14236,1,0
4,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.00028792,0.20715,0.2684,1,0
4,KEGG ABC TRANSPORTERS,0.0054795,0.20671,0.18312,1,0
4,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.020205,0.20321,0.18299,1,0
4,KEGG TYROSINE METABOLISM,0.0039469,0.20184,0.1907,1,0
4,POLYSACCHARIDE METABOLIC PROCESS,0.035393,0.20113,0.20404,1,0
4,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.017549,0.20086,0.15776,1,0
4,KEGG PEROXISOME,0.017137,0.19952,0.12989,1,0
4,KEGG TYPE I DIABETES MELLITUS,0.016734,0.19863,0.33355,1,0
4,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,0.015574,0.1983,0.12619,1,0
4,LYASE ACTIVITY,0.0083534,0.19404,0.15838,1,0
4,MAP KINASE ACTIVITY,0.015574,0.19369,0.22893,1,0
4,APOPTOTIC PROGRAM,0.0018173,0.18949,0.18303,1,0
4,CARBON OXYGEN LYASE ACTIVITY,0.018398,0.18595,0.17128,1,0
4,GOLGI MEMBRANE,0.022165,0.18542,0.16848,1,0
4,LIPASE ACTIVITY,0.013798,0.18306,0.16012,1,0
4,PID HES HEYPATHWAY,0.014486,0.18069,0.19497,1,0
4,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.016339,0.18041,0.17222,1,0
4,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,0.037747,0.17783,0.14742,1,0
4,ST ERK1 ERK2 MAPK PATHWAY,0.013798,0.17771,0.19232,1,0
4,MOTOR ACTIVITY,0.013465,0.1773,0.1993,1,0
4,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0042883,0.17529,0.16384,1,0
4,DEVELOPMENTAL MATURATION,0.014841,0.17496,0.21999,1,0
4,PID HIF1 TFPATHWAY,0.024288,0.17216,0.23198,1,0
4,REGULATION OF PROTEIN METABOLIC PROCESS,0.0045306,0.17167,0.13056,1,0
4,LIPOPROTEIN METABOLIC PROCESS,0.0028957,0.1712,0.16243,1,0
4,REGULATION OF PROTEIN SECRETION,0.021165,0.16991,0.19034,1,0
4,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.0094949,0.16913,0.24268,1,0
4,INTEGRAL TO ORGANELLE MEMBRANE,0.0069616,0.16894,0.14887,1,0
4,INORGANIC ANION TRANSPORT,0.033166,0.16766,0.28562,1,0
4,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.02268,0.16691,0.13194,1,0
4,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.013465,0.16619,0.11615,1,0
4,KEGG COMPLEMENT AND COAGULATION CASCADES,0.016734,0.16525,0.10798,1,0
4,REGULATION OF SIGNAL TRANSDUCTION,0.010506,0.16417,0.13446,1,0
4,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.021165,0.16404,0.17438,1,0
4,PID P53DOWNSTREAMPATHWAY,0.013465,0.1638,0.13919,1,0
4,INTRINSIC TO ORGANELLE MEMBRANE,0.0069616,0.16356,0.13662,1,0
4,MICROBODY,0.0085714,0.15448,0.14392,1,0
4,PEROXISOME,0.0085714,0.15448,0.14392,1,0
4,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.02166,0.15319,0.1387,1,0
4,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02166,0.15319,0.1387,1,0
4,CHROMOSOME CONDENSATION,0.0081404,0.15101,0.21405,1,0
4,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,0.0090226,0.14973,0.1131,1,0
4,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,0.025994,0.14968,0.11418,1,0
4,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.011047,0.14946,0.18016,1,0
4,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,0.0038387,0.14915,0.15011,1,0
4,KEGG GNRH SIGNALING PATHWAY,0.0015189,0.14904,0.14373,1,0
4,ST WNT CA2 CYCLIC GMP PATHWAY,0.038561,0.14698,0.14801,1,0
4,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.038561,0.14594,0.13232,1,0
4,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.0028141,0.14422,0.12674,1,0
4,OUTER MEMBRANE,0.007729,0.1438,0.15846,1,0
4,NUCLEAR CHROMOSOME,0.0060989,0.14335,0.17257,1,0
4,RESPONSE TO BACTERIUM,0.015574,0.14318,0.119,1,0
4,ER GOLGI INTERMEDIATE COMPARTMENT,0.037747,0.14298,0.16198,1,0
4,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,0.015574,0.1427,0.11873,1,0
4,RESPONSE TO CHEMICAL STIMULUS,0.00079435,0.14244,0.13272,1,0
4,SECRETION BY CELL,0.0056288,0.14073,0.16009,1,0
4,REGULATION OF SECRETION,0.0071468,0.13944,0.26187,1,0
4,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.031059,0.13928,0.10372,1,0
4,LOCOMOTORY BEHAVIOR,0.0020453,0.13858,0.14342,1,0
4,ACID AMINO ACID LIGASE ACTIVITY,0.036164,0.13783,0.091216,1,0
4,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02166,0.13731,0.12329,1,0
4,KINASE REGULATOR ACTIVITY,0.02166,0.13592,0.21015,1,0
4,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.0097392,0.13554,0.088657,1,0
4,OXIDOREDUCTASE ACTIVITY GO 0016616,0.016339,0.13327,0.16841,1,0
4,MEMBRANE BOUND VESICLE,0.0036303,0.13306,0.12342,1,0
4,CARBOXYLIC ACID METABOLIC PROCESS,0.012508,0.13304,0.12566,1,0
4,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.035393,0.13264,0.11347,1,0
4,CARBOXYLESTERASE ACTIVITY,0.02268,0.1325,0.24103,1,0
4,ELECTRON CARRIER ACTIVITY,0.027803,0.13231,0.13559,1,0
4,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.02268,0.13141,0.14726,1,0
4,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.0038387,0.13101,0.15441,1,0
4,REGULATION OF BODY FLUID LEVELS,0.0073363,0.13039,0.13619,1,0
4,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.0012662,0.1302,0.12385,1,0
4,RIBOSOME,0.026586,0.1275,0.1963,1,0
4,REACTOME DIABETES PATHWAYS,0.017549,0.12695,0.12465,1,0
4,DEFENSE RESPONSE TO BACTERIUM,0.02068,0.12527,0.12258,1,0
4,HISTONE MODIFICATION,0.0053338,0.12434,0.13216,1,0
4,COVALENT CHROMATIN MODIFICATION,0.0053338,0.12434,0.13216,1,0
4,PID DELTANP63PATHWAY,0.033166,0.12403,0.20423,1,0
4,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,0.009256,0.12365,0.15536,1,0
4,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.015574,0.12272,0.11227,1,0
4,ST STAT3 PATHWAY,0.035393,0.12186,0.17726,1,0
4,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.015203,0.12103,0.17041,1,0
4,PROTEIN KINASE REGULATOR ACTIVITY,0.038561,0.12069,0.21923,1,0
4,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.021165,0.12066,0.16708,1,0
4,MEMBRANE FRACTION,0.023205,0.11975,0.11721,1,0
4,ORGANIC ACID METABOLIC PROCESS,0.013465,0.11919,0.12045,1,0
4,BIOCARTA MAL PATHWAY,0.03245,0.1171,0.08937,1,0
4,CYTOPLASMIC VESICLE,0.0075304,0.1163,0.11523,1,0
4,OXIDOREDUCTASE ACTIVITY,0.010773,0.11596,0.13914,1,0
4,REACTOME METABOLISM OF PROTEINS,0.040234,0.11512,0.086786,1,0
4,PID CERAMIDE PATHWAY,0.0067808,0.11267,0.11397,1,0
4,PROTEIN HETERODIMERIZATION ACTIVITY,0.013798,0.11255,0.081698,1,0
4,VESICLE,0.010773,0.11217,0.10599,1,0
4,RECEPTOR BINDING,0.041093,0.11144,0.08376,1,0
4,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015574,0.11143,0.096421,1,0
4,ESTABLISHMENT OF PROTEIN LOCALIZATION,0.019739,0.10966,0.078679,1,0
4,PROTEIN LOCALIZATION,0.023741,0.10857,0.074211,1,0
4,PID ERA GENOMIC PATHWAY,0.035393,0.10827,0.12813,1,0
4,KEGG REGULATION OF AUTOPHAGY,0.0073363,0.10821,0.1809,1,0
4,RESPONSE TO STRESS,0.0017641,0.1076,0.1136,1,0
4,ENDOPLASMIC RETICULUM PART,0.01282,0.1072,0.14011,1,0
4,KEGG JAK STAT SIGNALING PATHWAY,0.029719,0.10687,0.1057,1,0
4,SMALL CONJUGATING PROTEIN BINDING,0.02268,0.10668,0.11938,1,0
4,REACTOME CELL CELL COMMUNICATION,0.017549,0.1064,0.1422,1,0
4,PID IGF1 PATHWAY,0.0097392,0.10519,0.1152,1,0
4,MACROMOLECULE LOCALIZATION,0.017549,0.1046,0.073098,1,0
4,REGULATION OF DEVELOPMENTAL PROCESS,0.0067808,0.10442,0.10956,1,0
4,HOMEOSTASIS OF NUMBER OF CELLS,0.034637,0.10334,0.15961,1,0
4,CELLULAR CATABOLIC PROCESS,0.0066042,0.10288,0.092896,1,0
4,REACTOME ADAPTIVE IMMUNE SYSTEM,0.0087944,0.10246,0.087569,1,0
4,KEGG NITROGEN METABOLISM,0.043763,0.096855,0.16036,1,0
4,PROTEIN HOMODIMERIZATION ACTIVITY,0.011326,0.095341,0.11853,1,0
4,POSITIVE REGULATION OF CELLULAR PROCESS,0.0064317,0.094852,0.099242,1,0
4,RESPONSE TO HORMONE STIMULUS,0.017137,0.094606,0.18542,1,0
4,ESTABLISHMENT OF LOCALIZATION,0.001872,0.093048,0.095774,1,0
4,NEGATIVE REGULATION OF CELL PROLIFERATION,0.019283,0.092767,0.10292,1,0
4,POSITIVE REGULATION OF BIOLOGICAL PROCESS,0.0045306,0.092092,0.10052,1,0
4,KEGG P53 SIGNALING PATHWAY,0.019739,0.091755,0.13159,1,0
4,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.0027346,0.090379,0.18064,1,0
4,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.037747,0.089949,0.09817,1,0
4,REACTOME PI METABOLISM,0.03939,0.089757,0.10215,1,0
4,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.027803,0.088467,0.087941,1,0
4,CATABOLIC PROCESS,0.0094949,0.087901,0.081493,1,0
4,PROTEIN DIMERIZATION ACTIVITY,0.03245,0.086364,0.085001,1,0
4,CYTOPLASMIC PART,0.0054795,0.085891,0.079568,1,0
4,GOLGI APPARATUS PART,0.0062634,0.085416,0.11641,1,0
4,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.020205,0.084878,0.086138,1,0
4,ENDOPLASMIC RETICULUM MEMBRANE,0.016339,0.084243,0.12635,1,0
4,CYTOPLASM,0.0054795,0.079591,0.078238,1,0
4,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,0.02843,0.078522,0.087239,1,0
4,TRANSPORT,0.0083534,0.077811,0.081754,1,0
4,ST FAS SIGNALING PATHWAY,0.0090226,0.074232,0.10946,1,0
4,ESTABLISHMENT OF CELLULAR LOCALIZATION,0.016734,0.073097,0.065024,1,0
4,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.031748,0.072871,0.11117,1,0
4,PURINE RIBONUCLEOTIDE BINDING,0.023205,0.072216,0.063651,1,0
4,CONDENSED NUCLEAR CHROMOSOME,0.041967,0.071176,0.17198,1,0
4,PID KITPATHWAY,0.013139,0.068511,0.19874,1,0
4,GOLGI APPARATUS,0.02068,0.066059,0.082028,1,0
4,CELLULAR LOCALIZATION,0.036948,0.065521,0.057592,1,0
4,REACTOME HIV LIFE CYCLE,0.036948,-0.07114,-0.089869,1,0
4,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.02268,-0.084207,-0.1019,1,0
4,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,0.022165,-0.086277,-0.074118,1,0
4,SYNAPSE PART,0.03245,-0.088472,-0.19987,1,0
4,PID LKB1 PATHWAY,0.011612,-0.089537,-0.11773,1,0
4,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.0053338,-0.092125,-0.12172,1,0
4,RNA SPLICING,0.010773,-0.094851,-0.091572,1,0
4,REACTOME TRANSCRIPTION,0.015574,-0.096446,-0.081671,1,0
4,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.042857,-0.097475,-0.08994,1,0
4,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.0090226,-0.098569,-0.12294,1,0
4,RNA PROCESSING,0.016734,-0.099316,-0.088708,1,0
4,NUCLEAR MEMBRANE,0.029068,-0.099635,-0.1153,1,0
4,REACTOME RNA POL II TRANSCRIPTION,0.0018173,-0.10342,-0.11701,1,0
4,MRNA PROCESSING GO 0006397,0.02166,-0.10366,-0.0822,1,0
4,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.043763,-0.1077,-0.1324,1,0
4,MAINTENANCE OF LOCALIZATION,0.012508,-0.11203,-0.21341,1,0
4,REACTOME MRNA SPLICING,0.0081404,-0.1122,-0.12145,1,0
4,PORE COMPLEX,0.019283,-0.11233,-0.11946,1,0
4,KEGG BASAL TRANSCRIPTION FACTORS,0.011326,-0.11359,-0.16244,1,0
4,SPLICEOSOME,0.029068,-0.11376,-0.10307,1,0
4,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.013798,-0.11383,-0.10837,1,0
4,REACTOME FRS2 MEDIATED CASCADE,0.015203,-0.11391,-0.11116,1,0
4,REGULATION OF DNA METABOLIC PROCESS,0.023205,-0.11416,-0.14419,1,0
4,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.024288,-0.11545,-0.14365,1,0
4,REACTOME MICRORNA MIRNA BIOGENESIS,0.018398,-0.1167,-0.12173,1,0
4,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.024846,-0.11694,-0.12976,1,0
4,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.015574,-0.11885,-0.13876,1,0
4,NUCLEAR PORE,0.0097392,-0.12361,-0.14872,1,0
4,HELICASE ACTIVITY,0.0075304,-0.12378,-0.12348,1,0
4,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.018398,-0.12394,-0.10373,1,0
4,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.027188,-0.12546,-0.14825,1,0
4,DNA HELICASE ACTIVITY,0.026586,-0.12579,-0.14982,1,0
4,PID EPHBFWDPATHWAY,0.029719,-0.12773,-0.15565,1,0
4,PID VEGFR1 PATHWAY,0.024846,-0.1279,-0.19072,1,0
4,NEUROGENESIS,0.024288,-0.12825,-0.22017,1,0
4,REACTOME MRNA CAPPING,0.0081404,-0.12843,-0.13988,1,0
4,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.022165,-0.13031,-0.12177,1,0
4,ST INTEGRIN SIGNALING PATHWAY,0.024846,-0.13262,-0.11866,1,0
4,PROTEINACEOUS EXTRACELLULAR MATRIX,0.0097392,-0.13266,-0.25324,1,0
4,EXTRACELLULAR MATRIX,0.0097392,-0.13266,-0.25324,1,0
4,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.016339,-0.13347,-0.13972,1,0
4,AMINO SUGAR METABOLIC PROCESS,0.014486,-0.13353,-0.20192,1,0
4,GENERATION OF NEURONS,0.040234,-0.13415,-0.21325,1,0
4,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.00065623,-0.13516,-0.16724,1,0
4,ACTIN FILAMENT BASED MOVEMENT,0.018836,-0.13551,-0.16574,1,0
4,REACTOME RNA POL III TRANSCRIPTION,0.0021689,-0.13743,-0.14237,1,0
4,MICROTUBULE,0.016734,-0.1396,-0.14916,1,0
4,NEURON DIFFERENTIATION,0.01282,-0.14025,-0.27237,1,0
4,COLLAGEN,0.014841,-0.14233,-0.30323,1,0
4,LEARNING AND OR MEMORY,0.02843,-0.14334,-0.17569,1,0
4,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.027803,-0.14438,-0.10158,1,0
4,REACTOME MRNA PROCESSING,0.0040578,-0.14556,-0.12016,1,0
4,CELL CYCLE CHECKPOINT GO 0000075,0.0069616,-0.148,-0.11642,1,0
4,REACTOME REGULATORY RNA PATHWAYS,0.0071468,-0.14853,-0.14308,1,0
4,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.033166,-0.15171,-0.16746,1,0
4,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.03939,-0.15208,-0.23045,1,0
4,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.0030654,-0.15533,-0.16467,1,0
4,SKELETAL DEVELOPMENT,0.010506,-0.16065,-0.19147,1,0
4,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.0032441,-0.16109,-0.18893,1,0
4,REACTOME SHC MEDIATED CASCADE,0.0053338,-0.16414,-0.16208,1,0
4,EXTRACELLULAR MATRIX PART,0.0025083,-0.1665,-0.31021,1,0
4,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.0094949,-0.17048,-0.17013,1,0
4,G1 PHASE OF MITOTIC CELL CYCLE,0.031059,-0.17164,-0.17533,1,0
4,PID MYC ACTIVPATHWAY,0.024846,-0.1718,-0.20114,1,0
4,HEART DEVELOPMENT,0.0090226,-0.17329,-0.1664,1,0
4,MICROTUBULE BINDING,0.02843,-0.17541,-0.16598,1,0
4,EMBRYONIC MORPHOGENESIS,0.029068,-0.17601,-0.22459,1,0
4,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.0041716,-0.17706,-0.17391,1,0
4,NEURON DEVELOPMENT,0.019739,-0.17778,-0.2224,1,0
4,REACTOME RNA POL III CHAIN ELONGATION,0.020205,-0.17813,-0.18514,1,0
4,REACTOME EXTENSION OF TELOMERES,0.0034322,-0.18354,-0.16703,1,0
4,NUCLEAR HORMONE RECEPTOR BINDING,0.0011199,-0.18379,-0.17783,1,0
4,HORMONE RECEPTOR BINDING,0.0011199,-0.18379,-0.17783,1,0
4,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02843,-0.18462,-0.22542,1,0
4,PID RETINOIC ACID PATHWAY,0.012203,-0.18593,-0.18176,1,0
4,BIOCARTA CHREBP2 PATHWAY,0.0010528,-0.18779,-0.19617,1,0
4,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.023741,-0.18981,-0.20294,1,0
4,REACTOME DNA STRAND ELONGATION,0.0033369,-0.19216,-0.17145,1,0
4,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0069616,-0.19269,-0.18241,1,0
4,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,0.00074557,-0.19567,-0.24073,1,0
4,PID ARF6DOWNSTREAMPATHWAY,0.017549,-0.19598,-0.15079,1,0
4,LAMELLIPODIUM,0.0021062,-0.19645,-0.18213,1,0
4,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.020205,-0.19853,-0.15256,1,0
4,MITOTIC CELL CYCLE CHECKPOINT,0.0028141,-0.19856,-0.24115,1,0
4,ACTIVATION OF IMMUNE RESPONSE,0.029068,-0.19863,-0.20032,1,0
4,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.007729,-0.19872,-0.15674,1,0
4,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.0019282,-0.19927,-0.19392,1,0
4,BIOCARTA CELL2CELL PATHWAY,0.011326,-0.20143,-0.23007,1,0
4,BASEMENT MEMBRANE,0.012508,-0.20472,-0.24943,1,0
4,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,0.0097392,-0.20538,-0.29872,1,0
4,BIOCARTA SHH PATHWAY,0.00028792,-0.20576,-0.30204,1,0
4,KEGG HOMOLOGOUS RECOMBINATION,0.0047853,-0.20692,-0.18303,1,0
4,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.022165,-0.21014,-0.22212,1,0
4,AXONOGENESIS,0.014841,-0.21243,-0.32109,1,0
4,PID NETRIN PATHWAY,0.0011549,-0.21698,-0.24804,1,0
4,REACTOME COLLAGEN FORMATION,0.03245,-0.21903,-0.24479,1,0
4,PID LIS1PATHWAY,0.0085714,-0.21938,-0.20423,1,0
4,INTEGRIN BINDING,0.0071468,-0.22568,-0.23509,1,0
4,AXON GUIDANCE,0.026586,-0.22776,-0.31668,1,0
4,REGULATION OF ENDOCYTOSIS,0.029719,-0.23091,-0.20565,1,0
4,DNA INTEGRITY CHECKPOINT,9.7346e-05,-0.23268,-0.26294,1,0
4,NEURITE DEVELOPMENT,0.0046564,-0.23649,-0.33052,1,0
4,BIOCARTA AKAP13 PATHWAY,0.015574,-0.2374,-0.2364,1,0
4,REACTOME SIGNALING BY BMP,0.0059384,-0.23883,-0.25011,1,0
4,BIOCARTA ARF PATHWAY,0.004408,-0.23907,-0.25745,1,0
4,CHROMATIN ASSEMBLY,0.019739,-0.24198,-0.18314,1,0
4,REACTOME MRNA SPLICING MINOR PATHWAY,0.00095906,-0.24484,-0.19579,1,0
4,CYTOKINESIS,0.0019282,-0.24801,-0.2234,1,0
4,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.0085714,-0.24837,-0.25429,1,0
4,DNA DAMAGE CHECKPOINT,0.00042998,-0.24917,-0.24179,1,0
4,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.0010528,-0.25698,-0.23133,1,0
4,RHO GTPASE ACTIVATOR ACTIVITY,0.0067808,-0.25816,-0.25103,1,0
4,CHROMATIN REMODELING COMPLEX,0.031059,-0.25946,-0.19675,1,0
4,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.0018173,-0.27301,-0.24242,1,0
4,REACTOME NCAM1 INTERACTIONS,0.017549,-0.28913,-0.27707,1,0
4,SENSORY ORGAN DEVELOPMENT,0.0024367,-0.29232,-0.29734,1,0
4,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,8.1192e-05,-0.29977,-0.30572,1,0
4,BASAL LAMINA,0.019283,-0.30087,-0.26049,1,0
4,REACTOME SIGNALING BY FGFR3 MUTANTS,0.00026003,-0.30357,-0.29688,1,0
4,GABA RECEPTOR ACTIVITY,0.0013457,-0.31566,-0.37681,1,0
4,ACTIN FILAMENT POLYMERIZATION,0.0040578,-0.32108,-0.30049,1,0
4,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.022165,-0.33368,-0.24632,1,0
4,PID INTEGRIN4 PATHWAY,0.041967,-0.3416,-0.43773,1,0
4,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.0025817,-0.34434,-0.329,1,0
4,PROTEIN POLYMERIZATION,0.00353,-0.35491,-0.28545,1,0
4,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,0.0024367,-0.36935,-0.40538,1,0
4,MAINTENANCE OF PROTEIN LOCALIZATION,0.00057693,-0.39824,-0.32244,1,0
4,REGULATION OF CELL MIGRATION,1.1493e-05,-0.43153,-0.51121,1,0
4,CELL MATRIX JUNCTION,2.0833e-05,-0.47181,-0.49403,1,0
4,CELL SUBSTRATE ADHERENS JUNCTION,0.00026003,-0.50863,-0.42046,1,0
4,NEGATIVE REGULATION OF CELL MIGRATION,6.2786e-05,-0.5168,-0.49476,1,0
4,FOCAL ADHESION,0.00010845,-0.65328,-0.53344,1,0
4,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.050569,0.41988,0.26255,0,1
4,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.053746,0.29838,0.22057,0,1
4,PROTEIN TYROSINE KINASE ACTIVITY,0.064293,0.26975,0.15575,0,1
4,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.080955,0.25364,0.30635,0,1
4,VESICLE LOCALIZATION,0.188,0.25063,0.11683,0,1
4,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.060602,0.24389,0.21332,0,1
4,BIOCARTA DREAM PATHWAY,0.068167,0.23748,0.18115,0,1
4,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.1313,0.22991,0.17103,0,1
4,PID IL2 STAT5PATHWAY,0.079444,0.228,0.14503,0,1
4,LYMPHOCYTE ACTIVATION,0.15264,0.21601,0.086891,0,1
4,LEUKOCYTE ACTIVATION,0.26098,0.2102,0.06333,0,1
4,CYTOKINE BINDING,0.066855,0.20856,0.10866,0,1
4,T CELL ACTIVATION,0.24643,0.20509,0.08708,0,1
4,ANATOMICAL STRUCTURE FORMATION,0.065563,0.20456,0.10286,0,1
4,CELL ACTIVATION,0.19695,0.20262,0.069817,0,1
4,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.16032,0.19698,0.1362,0,1
4,BIOCARTA BARR MAPK PATHWAY,0.16828,0.19685,0.12599,0,1
4,BIOCARTA GPCR PATHWAY,0.095625,0.19635,0.13625,0,1
4,LYMPHOCYTE DIFFERENTIATION,0.046579,0.18826,0.17898,0,1
4,EXTRACELLULAR REGION,0.070855,0.18712,0.083572,0,1
4,REACTOME IL 7 SIGNALING,0.11636,0.18226,0.12915,0,1
4,CATION CHANNEL ACTIVITY,0.075049,0.1795,0.15559,0,1
4,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.099158,0.17585,0.11778,0,1
4,REACTOME ION TRANSPORT BY P TYPE ATPASES,0.054842,0.17386,0.11446,0,1
4,CASPASE ACTIVATION,0.065563,0.17283,0.10261,0,1
4,POTASSIUM ION TRANSPORT,0.054842,0.17225,0.19119,0,1
4,PID CIRCADIANPATHWAY,0.12689,0.16587,0.16304,0,1
4,BIOCARTA HER2 PATHWAY,0.12473,0.16136,0.11934,0,1
4,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,0.063042,0.16112,0.13601,0,1
4,JAK STAT CASCADE,0.15773,0.15868,0.067988,0,1
4,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.070855,0.15587,0.17277,0,1
4,ION CHANNEL ACTIVITY,0.061812,0.15418,0.14102,0,1
4,MRNA BINDING,0.10465,0.15389,0.13094,0,1
4,CELL JUNCTION,0.084046,0.15168,0.10163,0,1
4,REACTOME SIGNALLING TO RAS,0.057089,0.14654,0.098998,0,1
4,BIOCARTA FAS PATHWAY,0.090515,0.1454,0.090955,0,1
4,HUMORAL IMMUNE RESPONSE,0.052669,0.1405,0.18235,0,1
4,BIOCARTA TGFB PATHWAY,0.15015,0.13938,0.085984,0,1
4,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.076492,0.13797,0.13726,0,1
4,LIPID BINDING,0.10096,0.13415,0.072365,0,1
4,EXTRACELLULAR REGION PART,0.29992,0.13324,0.035912,0,1
4,PROTEIN DOMAIN SPECIFIC BINDING,0.044685,0.13086,0.091395,0,1
4,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.057089,0.12798,0.11381,0,1
4,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.23245,0.12619,0.044899,0,1
4,REACTOME ION CHANNEL TRANSPORT,0.085627,0.12486,0.10949,0,1
4,REGULATION OF NEURON APOPTOSIS,0.34256,0.12483,0.087575,0,1
4,BIOCARTA PPARA PATHWAY,0.25363,0.12372,0.06343,0,1
4,EXOPEPTIDASE ACTIVITY,0.099158,0.1228,0.081642,0,1
4,TRANSMEMBRANE RECEPTOR ACTIVITY,0.090515,0.12235,0.073219,0,1
4,BIOCARTA FMLP PATHWAY,0.072231,0.11596,0.093213,0,1
4,GTPASE ACTIVATOR ACTIVITY,0.53742,0.11573,0.031537,0,1
4,REACTOME GPCR LIGAND BINDING,0.090515,0.11562,0.066963,0,1
4,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.17374,0.11437,0.063614,0,1
4,PID WNT NONCANONICAL PATHWAY,0.11636,0.11363,0.098037,0,1
4,G PROTEIN COUPLED RECEPTOR ACTIVITY,0.11039,0.11329,0.067762,0,1
4,SKELETAL MUSCLE DEVELOPMENT,0.54321,0.11152,0.021062,0,1
4,BIOCARTA ATRBRCA PATHWAY,0.12259,0.11091,0.073705,0,1
4,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.092194,0.1096,0.10477,0,1
4,BIOCARTA G2 PATHWAY,0.0695,0.10853,0.11138,0,1
4,CENTROSOME,0.090515,0.10832,0.078495,0,1
4,ANTIGEN BINDING,0.13583,0.10736,0.076921,0,1
4,CELL PROJECTION,0.12259,0.10695,0.061485,0,1
4,PID INSULIN GLUCOSE PATHWAY,0.188,0.10689,0.095309,0,1
4,CELL CORTEX,0.27611,0.10619,0.056437,0,1
4,SULFOTRANSFERASE ACTIVITY,0.26471,0.10397,0.072,0,1
4,PID CD8TCRDOWNSTREAMPATHWAY,0.072231,0.10256,0.12576,0,1
4,REGULATION OF HYDROLASE ACTIVITY,0.097379,0.10218,0.071338,0,1
4,CELLULAR PROTEIN CATABOLIC PROCESS,0.17934,0.1012,0.046874,0,1
4,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.23245,0.10034,0.052506,0,1
4,PID SHP2 PATHWAY,0.11434,0.10004,0.076901,0,1
4,UBIQUITIN CYCLE,0.079444,0.099729,0.089387,0,1
4,PID CD8TCRPATHWAY,0.43883,0.098567,0.073094,0,1
4,REACTOME G ALPHA S SIGNALLING EVENTS,0.16828,0.096875,0.072426,0,1
4,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.079444,0.096495,0.12341,0,1
4,NEGATIVE REGULATION OF TRANSCRIPTION,0.084046,0.094961,0.065462,0,1
4,MICROTUBULE ORGANIZING CENTER,0.10654,0.094504,0.067802,0,1
4,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.17099,0.092772,0.064948,0,1
4,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.30402,0.086137,0.058479,0,1
4,ECTODERM DEVELOPMENT,0.061812,0.085194,0.049436,0,1
4,CHROMATIN BINDING,0.11039,0.084248,0.075062,0,1
4,REACTOME SIGNALING BY GPCR,0.188,0.082918,0.051586,0,1
4,PROTEIN CATABOLIC PROCESS,0.36526,0.082686,0.025428,0,1
4,ATP BINDING,0.054842,0.08235,0.058766,0,1
4,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.21579,0.082098,0.042508,0,1
4,BIOCARTA RAS PATHWAY,0.046579,0.081221,0.094258,0,1
4,MACROMOLECULAR COMPLEX ASSEMBLY,0.11235,0.080457,0.044025,0,1
4,CELLULAR COMPONENT ASSEMBLY,0.076492,0.079697,0.045457,0,1
4,BIOCARTA BARRESTIN SRC PATHWAY,0.43883,0.077557,0.052273,0,1
4,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.046579,0.076606,0.10533,0,1
4,EPIDERMIS DEVELOPMENT,0.12259,0.075577,0.033462,0,1
4,PID PDGFRBPATHWAY,0.10096,0.074942,0.079071,0,1
4,PROTEIN UBIQUITINATION,0.19695,0.074052,0.07337,0,1
4,UBIQUITIN LIGASE COMPLEX,0.16032,0.072593,0.049424,0,1
4,PID ERBB1 INTERNALIZATION PATHWAY,0.090515,0.069993,0.10501,0,1
4,ENZYME ACTIVATOR ACTIVITY,0.20309,0.06958,0.063679,0,1
4,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.04854,0.069015,0.09488,0,1
4,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.12908,0.066815,0.061258,0,1
4,CATION BINDING,0.10654,0.0668,0.055052,0,1
4,ANATOMICAL STRUCTURE MORPHOGENESIS,0.33373,0.066035,0.026647,0,1
4,CYTOSOL,0.19393,0.065604,0.023527,0,1
4,PID PLK1 PATHWAY,0.37932,0.063921,0.043957,0,1
4,GTPASE REGULATOR ACTIVITY,0.72313,0.061732,0.0072715,0,1
4,TRANSCRIPTION ACTIVATOR ACTIVITY,0.0695,0.060779,0.05386,0,1
4,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.8303,0.058672,0.0018731,0,1
4,KEGG OOCYTE MEIOSIS,0.080955,0.058001,0.060924,0,1
4,KEGG INSULIN SIGNALING PATHWAY,0.061812,0.04954,0.06438,0,1
4,BIOPOLYMER CATABOLIC PROCESS,0.10465,0.048558,0.041163,0,1
4,PHOSPHORYLATION,0.052669,0.047438,0.057588,0,1
4,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.71658,0.045219,0.018032,0,1
4,PID CXCR4 PATHWAY,0.16559,0.044511,0.097217,0,1
4,MACROMOLECULE CATABOLIC PROCESS,0.092194,0.041779,0.049651,0,1
4,BIOPOLYMER METABOLIC PROCESS,0.054842,0.041295,0.047474,0,1
4,PROTEIN AMINO ACID PHOSPHORYLATION,0.15015,0.040411,0.04545,0,1
4,LIPID TRANSPORT,0.046579,0.32613,0.1813,0,0
4,REACTOME THE ACTIVATION OF ARYLSULFATASES,0.045624,0.27588,0.20484,0,0
4,REACTOME GLUTATHIONE CONJUGATION,0.05824,0.27367,0.23294,0,0
4,EXOCYTOSIS,0.055956,0.27254,0.29756,0,0
4,RESPIRATORY GASEOUS EXCHANGE,0.088862,0.2711,0.14982,0,0
4,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,0.049546,0.26622,0.13493,0,0
4,LIPID HOMEOSTASIS,0.088862,0.2662,0.2088,0,0
4,REACTOME ADHERENS JUNCTIONS INTERACTIONS,0.057089,0.26095,0.20831,0,0
4,REGULATION OF NEUROTRANSMITTER LEVELS,0.12473,0.25864,0.23058,0,0
4,KEGG PROTEASOME,0.10096,0.25771,0.15841,0,0
4,B CELL ACTIVATION,0.046579,0.23562,0.14041,0,0
4,ANTIOXIDANT ACTIVITY,0.049546,0.2353,0.20773,0,0
4,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,0.044685,0.23137,0.18918,0,0
4,REGULATION OF ANGIOGENESIS,0.15517,0.23015,0.10574,0,0
4,REACTOME PEROXISOMAL LIPID METABOLISM,0.080955,0.2287,0.17116,0,0
4,BIOCARTA MTA3 PATHWAY,0.05161,0.22692,0.23298,0,0
4,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.04854,0.22544,0.21975,0,0
4,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,0.063042,0.22446,0.16296,0,0
4,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,0.073629,0.22328,0.14997,0,0
4,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,0.10465,0.2228,0.12557,0,0
4,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,0.060602,0.22033,0.14047,0,0
4,VACUOLE ORGANIZATION AND BIOGENESIS,0.088862,0.21819,0.14381,0,0
4,PID TAP63PATHWAY,0.11434,0.21813,0.12875,0,0
4,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.066855,0.21261,0.17554,0,0
4,KEGG GLYCOSAMINOGLYCAN DEGRADATION,0.070855,0.20989,0.1721,0,0
4,REACTOME COMPLEMENT CASCADE,0.046579,0.20942,0.090435,0,0
4,PROTEASE INHIBITOR ACTIVITY,0.049546,0.20875,0.13474,0,0
4,KEGG DRUG METABOLISM CYTOCHROME P450,0.079444,0.20821,0.13503,0,0
4,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.19695,0.20654,0.15872,0,0
4,KEGG GLUTATHIONE METABOLISM,0.26471,0.20123,0.11141,0,0
4,EARLY ENDOSOME,0.23589,0.20088,0.10538,0,0
4,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,0.061812,0.20066,0.11831,0,0
4,APOPTOTIC MITOCHONDRIAL CHANGES,0.04854,0.19834,0.2226,0,0
4,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,0.13583,0.19561,0.13396,0,0
4,VOLTAGE GATED CHANNEL ACTIVITY,0.10465,0.19334,0.1604,0,0
4,BONE REMODELING,0.2,0.19313,0.062993,0,0
4,MUSCLE CELL DIFFERENTIATION,0.16828,0.18909,0.095801,0,0
4,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.088862,0.18874,0.18846,0,0
4,MYOBLAST DIFFERENTIATION,0.27227,0.18638,0.080724,0,0
4,CARBONATE DEHYDRATASE ACTIVITY,0.10465,0.18498,0.22157,0,0
4,G PROTEIN COUPLED RECEPTOR BINDING,0.05161,0.18431,0.13132,0,0
4,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.33812,0.18326,0.078974,0,0
4,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.14285,0.18284,0.11408,0,0
4,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,0.088862,0.18093,0.08363,0,0
4,VOLTAGE GATED CATION CHANNEL ACTIVITY,0.12908,0.18088,0.15604,0,0
4,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,0.085627,0.18043,0.068035,0,0
4,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,0.27227,0.17967,0.052118,0,0
4,BIOCARTA BAD PATHWAY,0.090515,0.17853,0.15391,0,0
4,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.061812,0.17834,0.15506,0,0
4,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.084046,0.17684,0.13991,0,0
4,COFACTOR BIOSYNTHETIC PROCESS,0.065563,0.17563,0.14455,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,0.60272,0.17543,0.060753,0,0
4,METALLOEXOPEPTIDASE ACTIVITY,0.066855,0.17523,0.12299,0,0
4,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.053746,0.17369,0.16474,0,0
4,CYTOPLASMIC VESICLE MEMBRANE,0.052669,0.17342,0.12305,0,0
4,CYTOPLASMIC VESICLE PART,0.052669,0.17342,0.12305,0,0
4,KEGG RENIN ANGIOTENSIN SYSTEM,0.097379,0.17239,0.12884,0,0
4,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.21905,0.16925,0.11559,0,0
4,PHOSPHOLIPASE C ACTIVATION,0.13355,0.16913,0.1526,0,0
4,REACTOME TIE2 SIGNALING,0.16559,0.1666,0.10247,0,0
4,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,0.17934,0.16652,0.15064,0,0
4,INNATE IMMUNE RESPONSE,0.12473,0.1655,0.074578,0,0
4,TISSUE MORPHOGENESIS,0.44924,0.16408,0.033193,0,0
4,REGULATION OF PHOSPHORYLATION,0.055956,0.1633,0.1011,0,0
4,BIOCARTA AT1R PATHWAY,0.11235,0.16253,0.10147,0,0
4,ENDOCYTIC VESICLE,0.22235,0.16047,0.11352,0,0
4,SA MMP CYTOKINE CONNECTION,0.1028,0.15908,0.045247,0,0
4,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,0.10465,0.15894,0.20312,0,0
4,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.40349,0.15878,0.075472,0,0
4,COFACTOR METABOLIC PROCESS,0.12473,0.15812,0.097158,0,0
4,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.05161,0.1581,0.23781,0,0
4,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.21579,0.15696,0.16077,0,0
4,VESICLE MEMBRANE,0.082489,0.15676,0.10934,0,0
4,PID A6B1 A6B4 INTEGRIN PATHWAY,0.188,0.15613,0.099974,0,0
4,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,0.050569,0.15579,0.10733,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.05824,0.15466,0.16662,0,0
4,BIOCARTA CDMAC PATHWAY,0.10845,0.15213,0.13664,0,0
4,REACTOME CTLA4 INHIBITORY SIGNALING,0.11235,0.15037,0.15606,0,0
4,KEGG OTHER GLYCAN DEGRADATION,0.082489,0.15004,0.24577,0,0
4,CHEMOKINE ACTIVITY,0.055956,0.14951,0.11543,0,0
4,CHEMOKINE RECEPTOR BINDING,0.055956,0.14951,0.11543,0,0
4,ANGIOGENESIS,0.10654,0.1488,0.09212,0,0
4,REACTOME PHASE II CONJUGATION,0.082489,0.14828,0.13245,0,0
4,PID ECADHERIN STABILIZATION PATHWAY,0.32077,0.14795,0.038139,0,0
4,REACTOME HYALURONAN METABOLISM,0.2,0.14723,0.053944,0,0
4,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.22905,0.14722,0.085313,0,0
4,REACTOME REGULATION OF INSULIN SECRETION,0.054842,0.14692,0.16413,0,0
4,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.15015,0.14635,0.09676,0,0
4,INACTIVATION OF MAPK ACTIVITY,0.10096,0.14608,0.21144,0,0
4,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.059411,0.14602,0.075387,0,0
4,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.18508,0.1453,0.14219,0,0
4,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.087232,0.14354,0.10675,0,0
4,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,0.10096,0.14227,0.09578,0,0
4,REGULATION OF CELLULAR COMPONENT SIZE,0.23937,0.14113,0.12785,0,0
4,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.18508,0.14055,0.10702,0,0
4,COENZYME METABOLIC PROCESS,0.13814,0.14055,0.11049,0,0
4,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,0.54321,0.14031,0.081433,0,0
4,INTERLEUKIN RECEPTOR ACTIVITY,0.2,0.1398,0.076747,0,0
4,CHANNEL REGULATOR ACTIVITY,0.084046,0.13838,0.14376,0,0
4,CELLULAR COMPONENT DISASSEMBLY,0.5726,0.13794,0.02574,0,0
4,NEGATIVE REGULATION OF APOPTOSIS,0.053746,0.13599,0.087296,0,0
4,MITOCHONDRIAL RESPIRATORY CHAIN,0.14285,0.13424,0.095096,0,0
4,CHROMATIN,0.26471,0.13419,0.069386,0,0
4,CELL MATURATION,0.057089,0.13335,0.19788,0,0
4,REACTOME ZINC TRANSPORTERS,0.17934,0.13306,0.064107,0,0
4,REACTOME METAL ION SLC TRANSPORTERS,0.055956,0.13256,0.10226,0,0
4,REACTOME LIPOPROTEIN METABOLISM,0.55487,0.13254,0.061492,0,0
4,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,0.5726,0.13085,0.10442,0,0
4,BIOCARTA TID PATHWAY,0.065563,0.12976,0.12472,0,0
4,REACTOME PHOSPHORYLATION OF THE APC C,0.11434,0.12947,0.11068,0,0
4,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,0.16032,0.12881,0.25735,0,0
4,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.32938,0.12844,0.071709,0,0
4,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,0.16828,0.12771,0.10467,0,0
4,HISTONE DEACETYLASE COMPLEX,0.15015,0.12747,0.058918,0,0
4,BIOCARTA CK1 PATHWAY,0.75615,0.12701,0.03613,0,0
4,BLOOD COAGULATION,0.087232,0.12686,0.10565,0,0
4,REACTOME APOPTOTIC EXECUTION PHASE,0.059411,0.12661,0.11164,0,0
4,BIOCARTA CHEMICAL PATHWAY,0.061812,0.1265,0.15153,0,0
4,REACTOME GLYCOSAMINOGLYCAN METABOLISM,0.055956,0.12588,0.12399,0,0
4,PID WNT CANONICAL PATHWAY,0.095625,0.12581,0.1118,0,0
4,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.046579,0.12509,0.15522,0,0
4,CONTRACTILE FIBER PART,0.42855,0.12509,0.050022,0,0
4,HYDRO LYASE ACTIVITY,0.068167,0.12481,0.1439,0,0
4,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.095625,0.12388,0.081424,0,0
4,MAPKKK CASCADE GO 0000165,0.070855,0.12353,0.098327,0,0
4,PID TXA2PATHWAY,0.14526,0.12347,0.12136,0,0
4,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.073629,0.12314,0.10083,0,0
4,PID INTEGRIN CS PATHWAY,0.53167,0.12292,0.028709,0,0
4,BIOCARTA CSK PATHWAY,0.25729,0.12282,0.089872,0,0
4,PID INTEGRIN5 PATHWAY,0.68418,0.12244,-0.025098,0,0
4,PID IL27PATHWAY,0.54321,0.12222,-0.0064616,0,0
4,REGULATION OF ACTIN FILAMENT LENGTH,0.17099,0.12072,0.16128,0,0
4,PID MYC REPRESSPATHWAY,0.068167,0.11988,0.088925,0,0
4,PID THROMBIN PAR4 PATHWAY,0.092194,0.11979,0.15985,0,0
4,BIOCARTA SPPA PATHWAY,0.18508,0.11874,0.088823,0,0
4,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.075049,0.11854,0.072812,0,0
4,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,0.27611,0.11839,0.043751,0,0
4,REACTOME SULFUR AMINO ACID METABOLISM,0.28785,0.11814,0.066106,0,0
4,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.25729,0.11804,0.084799,0,0
4,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.095625,0.11768,0.13885,0,0
4,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.53167,0.11762,0.048227,0,0
4,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13814,0.11746,0.094243,0,0
4,CALCIUM ION TRANSPORT,0.080955,0.1172,0.15482,0,0
4,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.059411,0.11712,0.08534,0,0
4,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.12049,0.11691,0.14414,0,0
4,RECEPTOR COMPLEX,0.11039,0.11679,0.082914,0,0
4,PID CMYB PATHWAY,0.063042,0.11673,0.12598,0,0
4,PHOSPHOLIPASE C ACTIVITY,0.13355,0.11661,0.10071,0,0
4,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.20937,0.11581,0.058992,0,0
4,DNA CATABOLIC PROCESS,0.38408,0.11453,0.047929,0,0
4,COATED VESICLE MEMBRANE,0.19695,0.11451,0.069766,0,0
4,VESICLE COAT,0.12473,0.11424,0.098795,0,0
4,INSULIN RECEPTOR SIGNALING PATHWAY,0.34702,0.11356,0.073121,0,0
4,COAGULATION,0.13355,0.1134,0.091329,0,0
4,PID TCRCALCIUMPATHWAY,0.1313,0.11312,0.15096,0,0
4,COATED VESICLE,0.13355,0.11301,0.074219,0,0
4,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,0.31653,0.11289,0.066563,0,0
4,KEGG GLYCEROLIPID METABOLISM,0.087232,0.11246,0.10758,0,0
4,PID ANGIOPOIETINRECEPTOR PATHWAY,0.073629,0.11166,0.082788,0,0
4,BIOCARTA RHO PATHWAY,0.22905,0.11165,0.077836,0,0
4,PID S1P S1P1 PATHWAY,0.54903,0.11139,0.01999,0,0
4,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.045624,0.11038,0.13958,0,0
4,REACTOME PKB MEDIATED EVENTS,0.14285,0.10997,0.087327,0,0
4,GATED CHANNEL ACTIVITY,0.22568,0.10986,0.10785,0,0
4,REACTOME INTEGRATION OF ENERGY METABOLISM,0.19095,0.10937,0.097078,0,0
4,CALCIUM MEDIATED SIGNALING,0.087232,0.10919,0.14188,0,0
4,KERATINOCYTE DIFFERENTIATION,0.12473,0.10893,0.14114,0,0
4,OXIDOREDUCTASE ACTIVITY GO 0016705,0.23937,0.10887,0.098809,0,0
4,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.11434,0.10793,0.066725,0,0
4,IMMUNE EFFECTOR PROCESS,0.36064,0.10729,0.061256,0,0
4,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.27227,0.10701,0.047582,0,0
4,KEGG RENAL CELL CARCINOMA,0.057089,0.10689,0.10611,0,0
4,REGULATION OF HORMONE SECRETION,0.44924,0.10684,0.19009,0,0
4,SECRETORY PATHWAY,0.090515,0.1067,0.09633,0,0
4,REACTOME P38MAPK EVENTS,0.11039,0.10646,0.14133,0,0
4,PID RET PATHWAY,0.090515,0.10572,0.10631,0,0
4,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.064293,0.10537,0.13105,0,0
4,KEGG RIBOFLAVIN METABOLISM,0.053746,0.10519,0.23642,0,0
4,BIOCARTA PGC1A PATHWAY,0.4978,0.1049,0.060263,0,0
4,ELECTRON TRANSPORT GO 0006118,0.087232,0.10467,0.10768,0,0
4,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.30402,0.10465,0.075908,0,0
4,CARBOHYDRATE CATABOLIC PROCESS,0.30402,0.10465,0.075908,0,0
4,ER NUCLEAR SIGNALING PATHWAY,0.63354,0.10452,0.020187,0,0
4,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,0.55487,0.10448,0.032665,0,0
4,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.25729,0.10356,0.076379,0,0
4,VASCULATURE DEVELOPMENT,0.14769,0.10333,0.079722,0,0
4,KEGG VIBRIO CHOLERAE INFECTION,0.070855,0.10323,0.084191,0,0
4,BIOCARTA NTHI PATHWAY,0.090515,0.10311,0.098815,0,0
4,PID ARF6 PATHWAY,0.068167,0.10273,0.155,0,0
4,BIOCARTA EDG1 PATHWAY,0.32938,0.1025,0.062471,0,0
4,GLYCOLIPID METABOLIC PROCESS,0.44924,0.10161,0.10585,0,0
4,MITOCHONDRIAL MATRIX,0.11235,0.10084,0.11476,0,0
4,MITOCHONDRIAL LUMEN,0.11235,0.10084,0.11476,0,0
4,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.079444,0.10036,0.10821,0,0
4,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,0.075049,0.10031,0.10152,0,0
4,REACTOME BOTULINUM NEUROTOXICITY,0.19695,0.099266,0.14833,0,0
4,BIOCARTA MET PATHWAY,0.10845,0.099259,0.089605,0,0
4,REACTOME UNFOLDED PROTEIN RESPONSE,0.093897,0.098047,0.073427,0,0
4,ORGANELLAR RIBOSOME,0.073629,0.097457,0.17966,0,0
4,MITOCHONDRIAL RIBOSOME,0.073629,0.097457,0.17966,0,0
4,REGULATION OF PROTEIN MODIFICATION PROCESS,0.26098,0.096712,0.033163,0,0
4,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.63354,0.096573,0.030097,0,0
4,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.0695,0.0965,0.08119,0,0
4,PID PDGFRAPATHWAY,0.43883,0.095921,-0.002628,0,0
4,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.084046,0.095864,0.091156,0,0
4,DETECTION OF ABIOTIC STIMULUS,0.73628,0.09548,-0.00046749,0,0
4,MEMBRANE FUSION,0.15773,0.095327,0.081407,0,0
4,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,0.40843,0.095207,0.031721,0,0
4,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.14526,0.094757,0.079783,0,0
4,MITOCHONDRIAL MEMBRANE,0.10845,0.094549,0.056026,0,0
4,MEMBRANE COAT,0.20309,0.094385,0.060031,0,0
4,COATED MEMBRANE,0.20309,0.094385,0.060031,0,0
4,REACTOME CIRCADIAN CLOCK,0.12049,0.094173,0.10683,0,0
4,PID NFKAPPABCANONICALPATHWAY,0.50337,0.094153,0.010806,0,0
4,NITROGEN COMPOUND METABOLIC PROCESS,0.060602,0.094014,0.067887,0,0
4,REACTOME REGULATION OF MITOTIC CELL CYCLE,0.061812,0.093784,0.10378,0,0
4,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,0.044685,0.093471,0.13136,0,0
4,MITOCHONDRIAL PART,0.10096,0.092766,0.069664,0,0
4,REACTOME GAP JUNCTION ASSEMBLY,0.18508,0.092653,0.047259,0,0
4,KEGG CALCIUM SIGNALING PATHWAY,0.27611,0.091275,0.037491,0,0
4,PID INTEGRIN A4B1 PATHWAY,0.2,0.090988,0.10646,0,0
4,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,0.59664,0.090864,-0.00052976,0,0
4,DETECTION OF EXTERNAL STIMULUS,0.37932,0.090545,0.020404,0,0
4,PID S1P META PATHWAY,0.22235,0.090494,0.11016,0,0
4,REACTOME BILE ACID AND BILE SALT METABOLISM,0.092194,0.090265,0.12025,0,0
4,THIOLESTER HYDROLASE ACTIVITY,0.10096,0.090215,0.10285,0,0
4,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.23245,0.08965,0.081837,0,0
4,REGULATION OF INTRACELLULAR TRANSPORT,0.27611,0.089469,0.059894,0,0
4,PID INTEGRIN A9B1 PATHWAY,0.19095,0.089307,0.12634,0,0
4,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,0.49227,0.089209,0.053329,0,0
4,ST P38 MAPK PATHWAY,0.084046,0.089181,0.11957,0,0
4,TRANSLATION,0.10465,0.088983,0.096343,0,0
4,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.33373,0.088805,0.041569,0,0
4,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,0.079444,0.088593,0.054478,0,0
4,MITOCHONDRIAL TRANSPORT,0.26098,0.087977,0.064108,0,0
4,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.12049,0.087816,0.081235,0,0
4,INTERLEUKIN BINDING,0.29992,0.087329,0.041777,0,0
4,RAS PROTEIN SIGNAL TRANSDUCTION,0.24288,0.087251,0.057437,0,0
4,PID AR TF PATHWAY,0.075049,0.087008,0.094646,0,0
4,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,0.26098,0.086937,0.045702,0,0
4,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.30815,0.086741,0.048596,0,0
4,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.75615,0.086524,0.013217,0,0
4,KEGG ADHERENS JUNCTION,0.23245,0.085641,0.060973,0,0
4,PID HDAC CLASSIII PATHWAY,0.2,0.085502,0.10496,0,0
4,REGULATION OF DEFENSE RESPONSE,0.14285,0.084826,0.064621,0,0
4,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.34256,0.084754,0.075406,0,0
4,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.3746,0.084586,0.083991,0,0
4,REACTOME SIGNALING BY FGFR1 MUTANTS,0.35153,0.084138,0.059387,0,0
4,KEGG HEMATOPOIETIC CELL LINEAGE,0.32506,0.084133,0.01612,0,0
4,REACTOME SHC RELATED EVENTS,0.077957,0.083949,0.12184,0,0
4,PID RB 1PATHWAY,0.12908,0.083784,0.06491,0,0
4,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,0.31653,0.083068,0.028829,0,0
4,PID LPA4 PATHWAY,0.16294,0.08268,0.12234,0,0
4,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,0.14285,0.082633,0.087226,0,0
4,PROTEIN TRANSPORT,0.073629,0.082433,0.044931,0,0
4,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.30815,0.082393,0.065998,0,0
4,CELLULAR BIOSYNTHETIC PROCESS,0.15517,0.082188,0.081874,0,0
4,REACTOME POTASSIUM CHANNELS,0.27999,0.081429,0.12456,0,0
4,APOPTOTIC NUCLEAR CHANGES,0.50896,0.081107,0.034964,0,0
4,REACTOME GPCR DOWNSTREAM SIGNALING,0.18508,0.080879,0.053157,0,0
4,REACTOME NEUROTRANSMITTER RELEASE CYCLE,0.54321,0.080581,0.095401,0,0
4,KEGG INOSITOL PHOSPHATE METABOLISM,0.049546,0.080572,0.086803,0,0
4,ST JNK MAPK PATHWAY,0.044685,0.080392,0.13862,0,0
4,BIOCARTA GATA3 PATHWAY,0.50896,0.080134,0.034305,0,0
4,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.64605,0.07914,0.029782,0,0
4,STRIATED MUSCLE DEVELOPMENT,0.96163,0.079015,-0.0089701,0,0
4,BIOCARTA LONGEVITY PATHWAY,0.54903,0.078939,-0.009575,0,0
4,KEGG CELL ADHESION MOLECULES CAMS,0.28785,0.078927,0.12155,0,0
4,MICROTUBULE ORGANIZING CENTER PART,0.53167,0.078823,0.045058,0,0
4,PID CXCR3PATHWAY,0.39858,0.078799,0.036141,0,0
4,CORTICAL ACTIN CYTOSKELETON,0.91293,0.078706,-0.0079418,0,0
4,NUCLEOTIDE KINASE ACTIVITY,0.26471,0.07867,0.14735,0,0
4,REGULATED SECRETORY PATHWAY,0.71006,0.078519,0.10528,0,0
4,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.39858,0.078315,0.03017,0,0
4,KEGG PATHWAYS IN CANCER,0.27999,0.078256,0.040331,0,0
4,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,0.59059,0.078177,0.10546,0,0
4,NEUROPEPTIDE BINDING,0.23937,0.077791,0.11461,0,0
4,NEUROPEPTIDE RECEPTOR ACTIVITY,0.23937,0.077791,0.11461,0,0
4,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.065563,0.077375,0.092177,0,0
4,BIOCARTA RB PATHWAY,0.85082,0.077362,0.011615,0,0
4,ENDOPLASMIC RETICULUM,0.17653,0.077349,0.062321,0,0
4,PHOSPHOINOSITIDE METABOLIC PROCESS,0.25363,0.077286,0.041083,0,0
4,MYOFIBRIL,0.38888,0.077214,0.054239,0,0
4,PID HEDGEHOG GLIPATHWAY,0.29586,0.07696,0.042922,0,0
4,NEGATIVE REGULATION OF CELLULAR PROCESS,0.079444,0.076743,0.051939,0,0
4,CLATHRIN COATED VESICLE,0.16294,0.076446,0.077254,0,0
4,NUCLEAR CHROMOSOME PART,0.23937,0.076412,0.11068,0,0
4,CAMP MEDIATED SIGNALING,0.41341,0.076295,0.05314,0,0
4,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,0.41341,0.076295,0.05314,0,0
4,CYTOSKELETON,0.14048,0.075879,0.047946,0,0
4,ENDOPEPTIDASE ACTIVITY,0.17099,0.075317,0.068226,0,0
4,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.10845,0.075235,0.11909,0,0
4,AXON,0.4978,0.075216,0.082623,0,0
4,AMINO ACID METABOLIC PROCESS,0.11636,0.075195,0.063211,0,0
4,SA PTEN PATHWAY,0.31232,0.075068,0.064035,0,0
4,AROMATIC COMPOUND METABOLIC PROCESS,0.28785,0.075017,0.056112,0,0
4,ANTI APOPTOSIS,0.39371,0.074894,0.018418,0,0
4,ST GA12 PATHWAY,0.2839,0.074855,0.041637,0,0
4,PID ECADHERIN KERATINOCYTE PATHWAY,0.53742,0.074398,0.038582,0,0
4,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.89907,0.074315,-0.026444,0,0
4,PID NFAT TFPATHWAY,0.25729,0.074164,0.13832,0,0
4,NEUROTRANSMITTER BINDING,0.47588,0.074042,0.063615,0,0
4,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,0.53167,0.073908,0.015331,0,0
4,SULFURIC ESTER HYDROLASE ACTIVITY,0.43883,0.073684,0.069043,0,0
4,SH3 DOMAIN BINDING,0.56075,0.073521,0.066142,0,0
4,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.31232,0.073497,0.037818,0,0
4,PID EPHRINBREVPATHWAY,0.55487,0.073206,0.02785,0,0
4,BIOCARTA CREB PATHWAY,0.86455,0.072832,-0.0052561,0,0
4,ENZYME INHIBITOR ACTIVITY,0.065563,0.072823,0.090609,0,0
4,MEIOTIC CELL CYCLE,0.41842,0.072823,0.062567,0,0
4,NEUROTRANSMITTER RECEPTOR ACTIVITY,0.4598,0.07206,0.06945,0,0
4,REGULATION OF T CELL ACTIVATION,0.65866,0.071718,-0.079991,0,0
4,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.42347,0.071604,0.023328,0,0
4,REACTOME DOWNSTREAM TCR SIGNALING,0.47588,0.071443,0.040046,0,0
4,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.33373,0.071376,0.071684,0,0
4,REACTOME GLUCONEOGENESIS,0.38408,0.071273,0.060588,0,0
4,INTERMEDIATE FILAMENT CYTOSKELETON,0.43883,0.071231,0.029084,0,0
4,INTERMEDIATE FILAMENT,0.43883,0.071231,0.029084,0,0
4,KEGG PROSTATE CANCER,0.29586,0.07103,0.047431,0,0
4,CALCIUM CHANNEL ACTIVITY,0.54903,0.070737,0.074309,0,0
4,GROWTH FACTOR BINDING,0.35607,0.070724,0.045559,0,0
4,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.30815,0.070461,0.093757,0,0
4,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.50896,0.070136,0.035836,0,0
4,NUCLEAR ORGANIZATION AND BIOGENESIS,0.32506,0.069764,0.052147,0,0
4,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.49227,0.069717,0.022103,0,0
4,MITOTIC SISTER CHROMATID SEGREGATION,0.21579,0.069499,0.081676,0,0
4,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.33812,0.069439,0.075701,0,0
4,REACTOME MEIOTIC SYNAPSIS,0.60883,0.069329,0.048418,0,0
4,UNFOLDED PROTEIN BINDING,0.084046,0.068979,0.10674,0,0
4,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.39371,0.068977,0.061399,0,0
4,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.29586,0.068482,0.12835,0,0
4,BIOCARTA IGF1R PATHWAY,0.62113,0.068454,0.017504,0,0
4,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,0.092194,0.068327,0.082002,0,0
4,PID SYNDECAN 4 PATHWAY,0.93377,0.068256,-0.050514,0,0
4,UBIQUITIN PROTEIN LIGASE ACTIVITY,0.12908,0.068119,0.063944,0,0
4,REACTOME ERKS ARE INACTIVATED,0.36526,0.067971,0.05948,0,0
4,REACTOME CELL CYCLE CHECKPOINTS,0.23589,0.067937,0.054746,0,0
4,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.98953,0.067875,-0.011792,0,0
4,BIOCARTA ALK PATHWAY,0.90599,0.067631,0.0087191,0,0
4,ONE CARBON COMPOUND METABOLIC PROCESS,0.19095,0.067627,0.10636,0,0
4,REACTOME COMMON PATHWAY,0.14526,0.067387,0.07246,0,0
4,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,0.17099,0.067325,0.057935,0,0
4,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,0.99651,0.067286,-0.013981,0,0
4,DAMAGED DNA BINDING,0.63978,0.066886,0.021105,0,0
4,INTRACELLULAR PROTEIN TRANSPORT,0.14285,0.066808,0.035827,0,0
4,GOLGI ASSOCIATED VESICLE,0.12908,0.066751,0.061623,0,0
4,SERINE TYPE PEPTIDASE ACTIVITY,0.073629,0.066721,0.15135,0,0
4,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,0.22905,0.066554,0.086615,0,0
4,STRUCTURAL CONSTITUENT OF MUSCLE,0.082489,0.066199,0.12758,0,0
4,BIOCARTA CARM ER PATHWAY,0.56075,0.066152,0.013983,0,0
4,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.38408,0.065849,0.043388,0,0
4,PEPTIDYL AMINO ACID MODIFICATION,0.58456,0.065772,0.019818,0,0
4,LIGAND GATED CHANNEL ACTIVITY,0.59664,0.06571,0.03446,0,0
4,BIOCARTA PAR1 PATHWAY,0.4598,0.06545,0.076313,0,0
4,SECOND MESSENGER MEDIATED SIGNALING,0.36991,0.06537,0.031778,0,0
4,CYTOKINE SECRETION,0.44924,0.06536,0.069557,0,0
4,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.74288,0.065288,0.0052314,0,0
4,ORGAN MORPHOGENESIS,0.49227,0.065036,0.024781,0,0
4,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.15517,0.065022,0.12296,0,0
4,INTERPHASE,0.30402,0.064871,0.050356,0,0
4,TRANSCRIPTION COACTIVATOR ACTIVITY,0.075049,0.064778,0.049355,0,0
4,REACTOME REGULATION OF APOPTOSIS,0.39371,0.063842,0.042713,0,0
4,PID AMB2 NEUTROPHILS PATHWAY,0.47588,0.063747,0.056501,0,0
4,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.44924,0.063693,0.021725,0,0
4,PID ER NONGENOMIC PATHWAY,0.29586,0.063534,0.049645,0,0
4,KEGG TRYPTOPHAN METABOLISM,0.20621,0.063194,0.045596,0,0
4,DNA POLYMERASE ACTIVITY,0.11434,0.06315,0.078679,0,0
4,VIRAL REPRODUCTION,0.25729,0.062722,0.048227,0,0
4,KEGG THYROID CANCER,0.30815,0.062521,0.071172,0,0
4,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.14769,0.062507,0.058604,0,0
4,RECEPTOR ACTIVITY,0.24288,0.062355,0.052067,0,0
4,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.41842,0.062288,0.053872,0,0
4,REGULATION OF IMMUNE SYSTEM PROCESS,0.42347,0.062069,0.025176,0,0
4,REACTOME METABOLISM OF CARBOHYDRATES,0.12049,0.06193,0.077294,0,0
4,REGULATION OF CELL PROLIFERATION,0.12473,0.061719,0.047936,0,0
4,BIOCARTA UCALPAIN PATHWAY,0.59664,0.06158,-0.00018891,0,0
4,REACTOME SIGNALING BY NOTCH1,0.10654,0.061503,0.12591,0,0
4,KEGG PENTOSE PHOSPHATE PATHWAY,0.18219,0.061165,0.1264,0,0
4,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,0.15015,0.061036,0.043645,0,0
4,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.15517,0.060834,0.060102,0,0
4,CELL PROLIFERATION GO 0008283,0.054842,0.06072,0.063601,0,0
4,SYNAPTIC VESICLE,0.66501,0.060702,0.10433,0,0
4,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.63354,0.060697,0.013378,0,0
4,AMINOPEPTIDASE ACTIVITY,0.89907,0.060382,-0.032235,0,0
4,WOUND HEALING,0.60272,0.060328,0.024586,0,0
4,PID SMAD2 3NUCLEARPATHWAY,0.34702,0.060313,0.023208,0,0
4,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.060602,0.060004,0.098001,0,0
4,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,0.58456,0.05998,0.056654,0,0
4,CYTOSKELETAL PROTEIN BINDING,0.15015,0.059593,0.06491,0,0
4,AMINE METABOLIC PROCESS,0.12049,0.059466,0.049653,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.35607,0.059337,0.055922,0,0
4,KINASE BINDING,0.23245,0.058733,0.071634,0,0
4,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.5726,0.058711,0.01766,0,0
4,MITOCHONDRION,0.12049,0.058531,0.052261,0,0
4,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.29992,0.058497,0.081203,0,0
4,POST TRANSLATIONAL PROTEIN MODIFICATION,0.11039,0.058485,0.049931,0,0
4,CELL DEVELOPMENT,0.10654,0.058333,0.064172,0,0
4,REGULATION OF PROTEIN STABILITY,0.8303,0.057878,0.019146,0,0
4,BIOCARTA GCR PATHWAY,0.52025,0.057462,0.058208,0,0
4,ADAPTIVE IMMUNE RESPONSE,0.33373,0.057281,0.014413,0,0
4,NEURON APOPTOSIS,0.52025,0.057043,0.038686,0,0
4,PID PI3KCIAKTPATHWAY,0.24288,0.056539,0.083069,0,0
4,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.36064,0.056419,0.04066,0,0
4,REACTOME SIGNALING BY NODAL,0.25001,0.056258,0.071635,0,0
4,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.41341,0.056055,0.063108,0,0
4,REACTOME SYNTHESIS OF PA,0.89215,0.055818,-0.013947,0,0
4,PID MTOR 4PATHWAY,0.085627,0.05568,0.079153,0,0
4,PID ILK PATHWAY,0.36991,0.055128,0.008119,0,0
4,KEGG HUNTINGTONS DISEASE,0.054842,0.054727,0.064342,0,0
4,REGULATION OF CATALYTIC ACTIVITY,0.23245,0.054684,0.043779,0,0
4,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.1313,0.053594,0.089507,0,0
4,PID P38 MK2PATHWAY,0.24643,0.052789,0.084922,0,0
4,CONTRACTILE FIBER,0.65234,0.052767,0.032087,0,0
4,PEPTIDASE ACTIVITY,0.12473,0.052626,0.067869,0,0
4,PROTEIN KINASE BINDING,0.16559,0.052378,0.09173,0,0
4,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,0.37932,0.052249,0.044252,0,0
4,SERINE HYDROLASE ACTIVITY,0.079444,0.051964,0.14883,0,0
4,PID VEGFR1 2 PATHWAY,0.56075,0.051883,0.011452,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.78962,0.051845,-0.015947,0,0
4,PID ECADHERIN NASCENTAJ PATHWAY,0.26098,0.051824,0.055885,0,0
4,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.16032,0.051722,0.071975,0,0
4,AGING,0.79636,0.051109,0.027667,0,0
4,RESPONSE TO NUTRIENT,0.27999,0.050555,0.1173,0,0
4,BIOPOLYMER BIOSYNTHETIC PROCESS,0.12689,0.050527,0.14482,0,0
4,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.17374,0.050439,0.052474,0,0
4,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.21579,0.050403,0.037702,0,0
4,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.34256,0.050188,0.032072,0,0
4,BEHAVIOR,0.33812,0.05003,0.033746,0,0
4,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.25729,0.049864,0.10895,0,0
4,INTRACELLULAR TRANSPORT,0.18219,0.049832,0.023514,0,0
4,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.53167,0.049753,0.048559,0,0
4,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.49227,0.049654,0.032041,0,0
4,REACTOME PPARA ACTIVATES GENE EXPRESSION,0.81668,0.048703,-0.0067699,0,0
4,PROTEASOME COMPLEX,0.80312,0.048569,0.013752,0,0
4,BIOCARTA TFF PATHWAY,0.34256,0.048538,0.039789,0,0
4,PID P75NTRPATHWAY,0.24288,0.048525,0.055369,0,0
4,REGULATION OF METABOLIC PROCESS,0.082489,0.048433,0.043196,0,0
4,RESPONSE TO DNA DAMAGE STIMULUS,0.12473,0.048211,0.049047,0,0
4,BIOCARTA RAC1 PATHWAY,0.71006,0.047619,0.0024549,0,0
4,KEGG LONG TERM POTENTIATION,0.35607,0.047512,0.042632,0,0
4,ORGANELLE MEMBRANE,0.072231,0.047504,0.058664,0,0
4,POSITIVE REGULATION OF PHOSPHORYLATION,0.71658,0.046969,-0.024202,0,0
4,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.9686,0.046946,0.0012343,0,0
4,REGULATION OF CELLULAR METABOLIC PROCESS,0.11636,0.046597,0.039805,0,0
4,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.15264,0.046554,0.046242,0,0
4,BIOCARTA MPR PATHWAY,0.23245,0.045995,0.085292,0,0
4,MEMBRANE ORGANIZATION AND BIOGENESIS,0.22235,0.04549,0.047715,0,0
4,RESPONSE TO OXIDATIVE STRESS,0.67137,0.045443,0.0080317,0,0
4,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.17374,0.045398,0.1143,0,0
4,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.51459,0.04527,0.049998,0,0
4,REACTOME PLC BETA MEDIATED EVENTS,0.89215,0.045176,-0.020098,0,0
4,PID RHODOPSIN PATHWAY,0.18508,0.044915,0.050167,0,0
4,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.35607,0.044855,0.074757,0,0
4,REACTOME SIGNAL TRANSDUCTION BY L1,0.33373,0.044789,0.074659,0,0
4,KEGG BETA ALANINE METABOLISM,0.55487,0.044099,0.029407,0,0
4,PID AR PATHWAY,0.56075,0.043954,0.020732,0,0
4,MITOCHONDRIAL ENVELOPE,0.15264,0.043824,0.050096,0,0
4,TRANSCRIPTION FACTOR BINDING,0.16294,0.043772,0.042109,0,0
4,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.69707,0.043412,0.017125,0,0
4,AMINE CATABOLIC PROCESS,0.65234,0.04324,0.019911,0,0
4,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.70355,0.043057,0.011483,0,0
4,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.65234,0.04293,0.030037,0,0
4,REGULATION OF GENE EXPRESSION,0.12473,0.042638,0.038814,0,0
4,ENZYME REGULATOR ACTIVITY,0.47588,0.042383,0.028888,0,0
4,ST GAQ PATHWAY,0.4978,0.042251,0.030548,0,0
4,BIOCARTA ERK5 PATHWAY,0.75615,0.042227,0.0034977,0,0
4,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,0.48131,0.041671,0.050064,0,0
4,SENSORY PERCEPTION,0.25001,0.041409,0.035534,0,0
4,SISTER CHROMATID SEGREGATION,0.31653,0.041284,0.067822,0,0
4,BIOCARTA AGR PATHWAY,0.97557,0.041279,0.025375,0,0
4,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.69061,0.041201,0.026428,0,0
4,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.16032,0.040758,0.044167,0,0
4,KEGG MAPK SIGNALING PATHWAY,0.76281,0.040654,0.0067867,0,0
4,BIOCARTA TALL1 PATHWAY,0.50896,0.040629,0.034968,0,0
4,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,0.91987,0.040411,-0.029847,0,0
4,PROTEIN AMINO ACID LIPIDATION,0.72313,0.040047,0.017516,0,0
4,VIRAL REPRODUCTIVE PROCESS,0.93377,0.039512,-0.010662,0,0
4,KEGG OLFACTORY TRANSDUCTION,0.084046,0.039358,0.15218,0,0
4,PID P38ALPHABETAPATHWAY,0.1313,0.039315,0.10024,0,0
4,PID RHOA REG PATHWAY,0.44402,0.039183,0.031141,0,0
4,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,0.62732,0.039178,0.025726,0,0
4,POSITIVE REGULATION OF TRANSPORT,0.44402,0.039167,0.078914,0,0
4,SA TRKA RECEPTOR,0.32077,0.039055,-0.11812,0,0
4,PID TCR PATHWAY,0.47588,0.038891,0.04174,0,0
4,LIPOPROTEIN BINDING,0.33373,0.03889,0.094977,0,0
4,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,0.53742,0.038783,0.0016227,0,0
4,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.76948,0.038693,-0.018632,0,0
4,AMINO ACID CATABOLIC PROCESS,0.39858,0.038617,0.034512,0,0
4,ENDOMEMBRANE SYSTEM,0.34702,0.038457,0.043907,0,0
4,REGULATION OF TRANSPORT,0.49227,0.037929,0.024868,0,0
4,PID HDAC CLASSI PATHWAY,0.4598,0.037914,0.024152,0,0
4,CELL CYCLE PHASE,0.19695,0.037706,0.031135,0,0
4,MEIOSIS I,0.60883,0.037439,0.040488,0,0
4,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.98953,0.037291,-0.068114,0,0
4,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.85768,0.037278,0.011456,0,0
4,GTP BINDING,0.40349,0.036838,0.029784,0,0
4,REACTOME SIGNALING BY ERBB4,0.54321,0.036555,0.0052493,0,0
4,RNA EXPORT FROM NUCLEUS,0.66501,0.036389,0.0021308,0,0
4,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.39371,0.036272,0.073216,0,0
4,WNT SIGNALING,0.30815,0.036236,0.049856,0,0
4,PROTEIN TETRAMERIZATION,0.82348,0.036181,0.029003,0,0
4,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.5726,0.036091,0.030525,0,0
4,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.42855,0.036046,0.03781,0,0
4,RHO PROTEIN SIGNAL TRANSDUCTION,0.3746,0.035929,0.03603,0,0
4,BIOCARTA PLATELETAPP PATHWAY,0.43883,0.035702,0.10929,0,0
4,REGULATION OF RESPONSE TO STIMULUS,0.67137,0.035479,0.027161,0,0
4,ORGANELLE LUMEN,0.26847,0.035342,0.02782,0,0
4,MEMBRANE ENCLOSED LUMEN,0.26847,0.035342,0.02782,0,0
4,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.2,0.035274,0.053082,0,0
4,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.77618,0.035132,-0.0099355,0,0
4,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.52025,0.03507,0.025359,0,0
4,CYTOPLASM ORGANIZATION AND BIOGENESIS,0.95466,0.035016,-0.045671,0,0
4,EXTRINSIC TO PLASMA MEMBRANE,0.44924,0.034974,0.093254,0,0
4,TRANSCRIPTION COFACTOR ACTIVITY,0.22905,0.034851,0.038296,0,0
4,ORGANELLE LOCALIZATION,0.4598,0.0348,0.035637,0,0
4,REACTOME NEURONAL SYSTEM,0.77618,0.034404,0.04309,0,0
4,BIOGENIC AMINE METABOLIC PROCESS,0.36064,0.034074,0.05325,0,0
4,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.32938,0.033961,0.066599,0,0
4,KEGG LONG TERM DEPRESSION,0.19695,0.033931,0.075794,0,0
4,REACTOME AMINE LIGAND BINDING RECEPTORS,0.32938,0.033694,0.079736,0,0
4,BIOCARTA INTEGRIN PATHWAY,0.47588,0.033571,0.0062118,0,0
4,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.85768,0.03353,0.03037,0,0
4,CARBOHYDRATE BINDING,0.38888,0.033365,0.042139,0,0
4,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.17653,0.033182,0.039909,0,0
4,CHROMATIN MODIFICATION,0.20621,0.033167,0.045829,0,0
4,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.11039,0.033165,0.091086,0,0
4,REACTOME INSULIN SYNTHESIS AND PROCESSING,0.30815,0.032993,0.22763,0,0
4,MITOCHONDRIAL MEMBRANE PART,0.48131,0.032983,0.02261,0,0
4,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,0.69061,0.03297,0.0049893,0,0
4,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.59664,0.032952,0.017081,0,0
4,TRANS GOLGI NETWORK,0.56075,0.03269,-0.037758,0,0
4,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.3746,0.032666,0.042339,0,0
4,AMINE TRANSPORT,0.52025,0.032641,0.034972,0,0
4,PROTEIN TARGETING,0.39371,0.032589,0.016055,0,0
4,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.98953,0.032511,-0.0077822,0,0
4,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.35153,0.032171,0.03167,0,0
4,ORGAN DEVELOPMENT,0.59059,0.031945,0.013327,0,0
4,POSITIVE REGULATION OF CELL PROLIFERATION,0.35607,0.031909,0.023805,0,0
4,VIRAL GENOME REPLICATION,0.93377,0.031755,-0.026706,0,0
4,ORGANELLE PART,0.088862,0.031705,0.031639,0,0
4,INTRACELLULAR ORGANELLE PART,0.092194,0.031398,0.031572,0,0
4,REACTOME RECYCLING PATHWAY OF L1,0.77618,0.030991,0.018862,0,0
4,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,0.62732,0.030833,0.0036745,0,0
4,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.2839,0.030669,0.10074,0,0
4,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.72313,0.030588,0.02535,0,0
4,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.94073,0.030328,-0.01563,0,0
4,REGIONALIZATION,0.99651,0.030239,0.0027522,0,0
4,PID PS1PATHWAY,0.77618,0.030141,0.008894,0,0
4,VITAMIN METABOLIC PROCESS,0.90599,0.030096,-0.012846,0,0
4,PID P53REGULATIONPATHWAY,0.74288,0.030083,0.013336,0,0
4,REACTOME SIGNALLING TO ERKS,0.3746,0.030055,0.037909,0,0
4,DNA METABOLIC PROCESS,0.32938,0.029951,0.025331,0,0
4,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.75615,0.029832,0.014644,0,0
4,RIBONUCLEASE ACTIVITY,0.3746,0.029683,0.043676,0,0
4,REACTOME DARPP 32 EVENTS,0.40843,0.02952,-0.073736,0,0
4,PEPTIDYL TYROSINE MODIFICATION,0.56666,0.029426,0.0094987,0,0
4,REGULATION OF MOLECULAR FUNCTION,0.19393,0.029326,0.043741,0,0
4,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.85082,0.029164,-0.012861,0,0
4,REGULATION OF TRANSCRIPTION,0.21256,0.029054,0.030485,0,0
4,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.23245,0.029036,0.12572,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,0.73628,0.028981,-0.020428,0,0
4,REGULATION OF RHO GTPASE ACTIVITY,0.50896,0.028933,0.027768,0,0
4,PID IL8CXCR1 PATHWAY,0.9686,0.028777,0.0047995,0,0
4,NEUROLOGICAL SYSTEM PROCESS,0.38888,0.028676,0.047203,0,0
4,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.78289,0.028608,0.023234,0,0
4,KEGG PANCREATIC CANCER,0.84397,0.028569,-0.0070924,0,0
4,REGULATION OF HEART CONTRACTION,0.26471,0.028498,0.096796,0,0
4,PID AURORA A PATHWAY,0.31653,0.02825,0.060896,0,0
4,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,0.9686,0.027816,0.13797,0,0
4,GTPASE ACTIVITY,0.58456,0.027731,0.017156,0,0
4,GUANYL NUCLEOTIDE BINDING,0.37932,0.027591,0.033529,0,0
4,REGULATION OF RNA METABOLIC PROCESS,0.39371,0.027567,0.019029,0,0
4,RESPONSE TO NUTRIENT LEVELS,0.35607,0.02744,0.077379,0,0
4,ACTIN FILAMENT BASED PROCESS,0.84397,0.027436,-0.012826,0,0
4,TRANSCRIPTION FACTOR COMPLEX,0.17653,0.027408,0.044918,0,0
4,BIOCARTA NDKDYNAMIN PATHWAY,0.89907,0.027401,-0.006498,0,0
4,DENDRITE,0.82348,0.027392,-0.05975,0,0
4,BIOCARTA AGPCR PATHWAY,0.38408,0.027174,-0.11724,0,0
4,RESPONSE TO ABIOTIC STIMULUS,0.4545,0.027009,0.017511,0,0
4,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.56075,0.026822,-0.034652,0,0
4,PID ENDOTHELINPATHWAY,0.23589,0.026668,0.058538,0,0
4,CIRCADIAN RHYTHM,0.86455,0.026426,-0.0037974,0,0
4,GROWTH FACTOR ACTIVITY,0.32938,0.026359,0.055606,0,0
4,CELLULAR PROTEIN COMPLEX ASSEMBLY,0.4598,0.026336,0.031199,0,0
4,REACTOME GAB1 SIGNALOSOME,0.88523,0.025921,-0.016147,0,0
4,BIOCARTA AKT PATHWAY,0.34256,0.025605,0.069631,0,0
4,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.38408,0.025589,0.02132,0,0
4,ST T CELL SIGNAL TRANSDUCTION,0.71658,0.025159,0.021215,0,0
4,NUCLEUS,0.088862,0.025127,0.035439,0,0
4,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,0.59059,0.025119,0.032973,0,0
4,REACTOME G ALPHA Q SIGNALLING EVENTS,0.92682,0.025062,0.0061024,0,0
4,KEGG CHEMOKINE SIGNALING PATHWAY,0.68418,0.024982,0.014375,0,0
4,PID P73PATHWAY,0.27611,0.024894,0.065232,0,0
4,BIOCARTA LAIR PATHWAY,0.93377,0.024813,-0.054536,0,0
4,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.36526,0.024301,0.022714,0,0
4,CELL RECOGNITION,0.66501,0.024243,0.057975,0,0
4,SMALL GTPASE REGULATOR ACTIVITY,0.87144,0.024126,0.0091406,0,0
4,TRANSMISSION OF NERVE IMPULSE,0.87144,0.024107,0.029619,0,0
4,KEGG ECM RECEPTOR INTERACTION,0.76948,0.024085,-0.085206,0,0
4,KINASE ACTIVATOR ACTIVITY,0.67776,0.023976,0.056255,0,0
4,DNA REPAIR,0.31232,0.023767,0.028133,0,0
4,ORGANELLE ORGANIZATION AND BIOGENESIS,0.91987,0.023583,-0.0038146,0,0
4,CELL CYCLE PROCESS,0.33812,0.023523,0.027171,0,0
4,BIOCARTA MEF2D PATHWAY,0.4545,0.023466,0.098014,0,0
4,BIOCARTA HDAC PATHWAY,0.95466,0.023354,0.01185,0,0
4,PROTEIN PROCESSING,0.24643,0.023044,0.054621,0,0
4,BIOCARTA P53 PATHWAY,0.50896,0.023029,0.042862,0,0
4,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,0.40349,0.023024,-0.13444,0,0
4,BIOCARTA MCALPAIN PATHWAY,0.33812,0.022845,0.066666,0,0
4,LIGASE ACTIVITY,0.97557,0.02281,-0.0093138,0,0
4,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,0.33373,0.022769,0.10019,0,0
4,KEGG ARGININE AND PROLINE METABOLISM,0.63354,0.022735,0.033905,0,0
4,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.71658,0.022625,-0.012132,0,0
4,TRANSCRIPTION DNA DEPENDENT,0.22235,0.022481,0.034862,0,0
4,CHROMOSOMAL PART,0.62732,0.022286,0.029753,0,0
4,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.077957,0.022195,0.058041,0,0
4,PID NEPHRIN NEPH1 PATHWAY,0.60883,0.022141,0.031275,0,0
4,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.85768,0.022058,-0.052376,0,0
4,KEGG TIGHT JUNCTION,0.50896,0.022043,0.0302,0,0
4,REACTOME DAG AND IP3 SIGNALING,0.65234,0.02184,-0.037863,0,0
4,KEGG BASE EXCISION REPAIR,0.51459,0.02182,0.035844,0,0
4,RNA BIOSYNTHETIC PROCESS,0.22905,0.021688,0.03423,0,0
4,REACTOME G0 AND EARLY G1,0.98255,0.021496,0.013689,0,0
4,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.36526,0.021478,0.10189,0,0
4,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.36526,0.021478,0.10189,0,0
4,CELL CYCLE GO 0007049,0.69061,0.021409,0.012893,0,0
4,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.91987,0.021286,-0.0075938,0,0
4,BIOCARTA INFLAM PATHWAY,0.67776,0.020868,-0.039162,0,0
4,GOLGI VESICLE TRANSPORT,0.70355,0.020646,-0.0026266,0,0
4,KEGG MELANOMA,0.77618,0.020159,-0.021666,0,0
4,PID REELINPATHWAY,0.96163,0.020072,-0.0046496,0,0
4,REACTOME INFLAMMASOMES,0.56666,0.020003,0.042346,0,0
4,BIOCARTA SPRY PATHWAY,0.4598,0.019931,0.064798,0,0
4,KEGG BUTANOATE METABOLISM,0.49227,0.019574,0.075889,0,0
4,AMINE RECEPTOR ACTIVITY,0.27999,0.019526,0.073972,0,0
4,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.96163,0.01952,-0.010389,0,0
4,MITOTIC CELL CYCLE,0.87833,0.01901,0.0035975,0,0
4,INTERPHASE OF MITOTIC CELL CYCLE,0.52025,0.018995,-0.037468,0,0
4,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.52594,0.01893,0.067277,0,0
4,CORNIFIED ENVELOPE,0.53167,0.018268,0.055412,0,0
4,TRANSCRIPTION,0.15773,0.018193,0.040895,0,0
4,DNA BINDING,0.27611,0.017851,0.027335,0,0
4,REACTOME SPRY REGULATION OF FGF SIGNALING,0.63354,0.017606,0.062571,0,0
4,KEGG MTOR SIGNALING PATHWAY,0.72969,0.017318,0.0010234,0,0
4,REGULATION OF BINDING,0.55487,0.017254,0.015209,0,0
4,NUCLEOPLASM PART,0.62732,0.016785,0.012289,0,0
4,BIOCARTA ACH PATHWAY,0.63978,0.016492,0.041443,0,0
4,REACTOME G ALPHA I SIGNALLING EVENTS,0.9686,0.016115,-0.012562,0,0
4,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.46512,0.015935,0.10334,0,0
4,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,0.66501,0.015929,0.055484,0,0
4,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.26098,0.015887,0.093963,0,0
4,REACTOME CGMP EFFECTS,0.36991,0.015828,0.087328,0,0
4,CYTOSKELETAL PART,0.96163,0.01579,-0.0071933,0,0
4,PID INSULIN PATHWAY,0.99651,0.015639,-0.0031858,0,0
4,CHROMOSOME,0.33373,0.015451,0.05071,0,0
4,REGULATION OF MUSCLE CONTRACTION,0.59664,0.014837,-0.10883,0,0
4,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.69061,0.014617,0.032267,0,0
4,SMALL GTPASE BINDING,0.95466,0.014107,-0.01378,0,0
4,NUCLEOPLASM,0.47588,0.013966,0.015123,0,0
4,ANATOMICAL STRUCTURE DEVELOPMENT,0.95466,0.013544,-0.010676,0,0
4,NUCLEAR LUMEN,0.82348,0.013296,0.010151,0,0
4,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.82348,0.013068,-0.00037476,0,0
4,POSITIVE REGULATION OF CASPASE ACTIVITY,0.54903,0.013024,0.038946,0,0
4,PID TCRRASPATHWAY,0.3746,0.012939,0.097029,0,0
4,PATTERN BINDING,0.98953,0.012505,-0.014329,0,0
4,PID NOTCH PATHWAY,0.4978,0.012325,0.047882,0,0
4,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.29586,0.01229,0.026673,0,0
4,REGULATION OF MAPKKK CASCADE,0.76281,0.012233,0.01068,0,0
4,PID CDC42 PATHWAY,0.48131,0.012223,0.037473,0,0
4,KEGG TASTE TRANSDUCTION,0.27611,0.012213,0.12536,0,0
4,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.76281,0.012198,-0.016352,0,0
4,KEGG CHRONIC MYELOID LEUKEMIA,0.47588,0.012176,0.029575,0,0
4,ATPASE ACTIVITY,0.71006,0.011948,0.010545,0,0
4,KEGG WNT SIGNALING PATHWAY,0.84397,0.0119,0.0033057,0,0
4,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,0.85082,0.011825,0.0060554,0,0
4,KEGG VEGF SIGNALING PATHWAY,0.4545,0.011716,0.036771,0,0
4,KEGG PURINE METABOLISM,0.5726,0.011209,0.020516,0,0
4,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.31232,0.011145,0.041245,0,0
4,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.50337,0.011118,0.097313,0,0
4,PID UPA UPAR PATHWAY,0.65234,0.010947,-0.12621,0,0
4,VESICLE MEDIATED TRANSPORT,0.35153,0.010766,0.044644,0,0
4,TRANSCRIPTION FACTOR ACTIVITY,0.89215,0.01066,0.00083346,0,0
4,PROTEIN C TERMINUS BINDING,0.54321,0.010658,0.017393,0,0
4,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.99651,0.010638,-0.0050054,0,0
4,REACTOME FANCONI ANEMIA PATHWAY,0.99651,0.010369,-0.010106,0,0
4,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.59664,0.010365,0.013785,0,0
4,PHOSPHATASE BINDING,0.64605,0.010311,-0.047802,0,0
4,REGULATION OF JNK ACTIVITY,0.66501,0.010152,-0.047701,0,0
4,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.82348,0.010052,-0.013903,0,0
4,ENDONUCLEASE ACTIVITY,0.57857,0.0099245,0.017651,0,0
4,BIOCARTA EGFR SMRTE PATHWAY,0.88523,0.0096922,-0.050188,0,0
4,REACTOME SHC1 EVENTS IN EGFR SIGNALING,0.28785,0.0095892,0.056538,0,0
4,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.62732,0.0095849,0.0080772,0,0
4,REACTOME GLUCOSE METABOLISM,0.77618,0.0094967,0.0044157,0,0
4,KEGG CELL CYCLE,0.80312,0.0094644,0.0007176,0,0
4,REACTOME PURINE METABOLISM,0.52025,0.0093627,0.058597,0,0
4,REACTOME PROTEIN FOLDING,0.35153,0.0093251,-0.079066,0,0
4,MICROTUBULE CYTOSKELETON,0.88523,0.008857,0.0059296,0,0
4,KEGG VIRAL MYOCARDITIS,0.46512,0.0087308,0.029799,0,0
4,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.74288,0.0085619,-0.025433,0,0
4,SYSTEM DEVELOPMENT,0.85768,0.0081755,-0.019405,0,0
4,REACTOME PI3K CASCADE,0.97557,0.0081346,-0.012558,0,0
4,NUCLEOTIDE EXCISION REPAIR,0.67776,0.0077918,-0.013979,0,0
4,NUCLEAR PART,0.97557,0.0077658,0.0033147,0,0
4,OXYGEN BINDING,0.79636,0.0076619,0.023926,0,0
4,REGULATION OF CYTOKINE SECRETION,0.60272,0.0074953,0.059276,0,0
4,REACTOME PI3K AKT ACTIVATION,0.54903,0.0074686,0.026029,0,0
4,METALLOPEPTIDASE ACTIVITY,0.9686,0.0071839,-0.013036,0,0
4,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.77618,0.0070962,-0.0081673,0,0
4,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.77618,0.0070962,-0.0081673,0,0
4,KEGG GLIOMA,0.87144,0.0070267,0.0073703,0,0
4,KEGG ERBB SIGNALING PATHWAY,0.86455,0.006871,-0.018448,0,0
4,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.21905,0.006681,0.088716,0,0
4,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.77618,0.006229,0.03497,0,0
4,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.70355,0.006025,0.021825,0,0
4,BIOCARTA ACTINY PATHWAY,0.56666,0.0060128,0.038522,0,0
4,KEGG PPAR SIGNALING PATHWAY,0.9686,0.0058301,-0.0042371,0,0
4,RNA POLYMERASE COMPLEX,0.60272,0.0057586,0.061261,0,0
4,DNA DIRECTED RNA POLYMERASE COMPLEX,0.60272,0.0057586,0.061261,0,0
4,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.60272,0.0057586,0.061261,0,0
4,BIOCARTA MYOSIN PATHWAY,0.4545,0.0052996,0.089258,0,0
4,ST GA13 PATHWAY,0.72313,0.0051326,0.0058177,0,0
4,PID BARD1PATHWAY,0.89215,0.0050365,-0.0046345,0,0
4,GTPASE BINDING,0.89907,0.0049176,-0.021676,0,0
4,BIOCARTA EXTRINSIC PATHWAY,0.58456,0.0048876,-0.023372,0,0
4,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.67137,0.0048658,-0.057357,0,0
4,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.75615,0.0044939,-0.018861,0,0
4,TUBULIN BINDING,0.62732,0.0044839,-0.033646,0,0
4,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,0.43367,0.0038017,-0.051329,0,0
4,REACTOME SIGNALLING BY NGF,0.56075,0.0038004,0.022619,0,0
4,MEIOTIC RECOMBINATION,0.56075,0.0035525,0.048006,0,0
4,THYROID HORMONE RECEPTOR BINDING,0.67776,0.0033026,-0.041818,0,0
4,NUCLEOTIDE METABOLIC PROCESS,0.40843,0.0030544,0.042077,0,0
4,BIOCARTA PTEN PATHWAY,0.96163,0.0028682,-0.007797,0,0
4,ATPASE ACTIVITY COUPLED,0.58456,0.002565,0.017407,0,0
4,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.88523,0.0024094,-0.0031787,0,0
4,PID EPHA FWDPATHWAY,0.98953,0.0021977,-0.013333,0,0
4,REGULATION OF JNK CASCADE,0.99651,0.001641,-0.018144,0,0
4,MYOSIN COMPLEX,0.43367,0.0013588,0.068529,0,0
4,MITOCHONDRIAL INNER MEMBRANE,0.95466,0.0013464,-0.020869,0,0
4,RNA METABOLIC PROCESS,0.62113,0.0010795,0.013098,0,0
4,REACTOME HEMOSTASIS,0.86455,0.0010045,0.0083912,0,0
4,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.67776,0.00025864,0.041884,0,0
4,VACUOLAR TRANSPORT,0.77618,6.2981e-05,0.030894,0,0
4,POSITIVE REGULATION OF T CELL ACTIVATION,0.54321,-7.2567e-05,-0.099916,0,0
4,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.87144,-0.0001122,0.018247,0,0
4,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.91293,-0.00018024,-0.053217,0,0
4,REGULATION OF CELL GROWTH,0.78962,-0.00019052,0.0053678,0,0
4,NITROGEN COMPOUND CATABOLIC PROCESS,0.83713,-0.0001973,-0.002483,0,0
4,REGULATION OF TRANSFERASE ACTIVITY,0.78962,-0.00036419,0.014781,0,0
4,SARCOMERE,0.76948,-0.00064898,-0.077488,0,0
4,TISSUE DEVELOPMENT,0.98953,-0.0014227,-0.037101,0,0
4,ZINC ION BINDING,0.96163,-0.0014259,-0.0095685,0,0
4,TRANSCRIPTION REPRESSOR ACTIVITY,0.89215,-0.0019686,0.016445,0,0
4,REACTOME PYRUVATE METABOLISM,0.67776,-0.0023229,0.030094,0,0
4,RESPONSE TO EXTRACELLULAR STIMULUS,0.66501,-0.0026469,0.033753,0,0
4,CELLULAR RESPONSE TO STIMULUS,0.74288,-0.003003,0.024748,0,0
4,REACTOME NUCLEAR SIGNALING BY ERBB4,0.42347,-0.0032243,-0.046237,0,0
4,BIOCARTA CDK5 PATHWAY,0.83713,-0.0033965,0.016604,0,0
4,REACTOME ENOS ACTIVATION AND REGULATION,0.29992,-0.0034189,0.10527,0,0
4,MITOSIS,0.99651,-0.0035216,0.0070393,0,0
4,ACTIN FILAMENT,0.72313,-0.0036551,-0.049904,0,0
4,PID TGFBRPATHWAY,0.94769,-0.0036786,-0.049516,0,0
4,ST G ALPHA S PATHWAY,0.76948,-0.0040153,-0.015797,0,0
4,BIOCARTA IL12 PATHWAY,0.71006,-0.0040212,-0.034727,0,0
4,MONOCARBOXYLIC ACID TRANSPORT,0.7495,-0.0040376,0.032139,0,0
4,KEGG DRUG METABOLISM OTHER ENZYMES,0.90599,-0.0041672,-0.033055,0,0
4,PID AR NONGENOMIC PATHWAY,0.63354,-0.0043239,0.038205,0,0
4,PROTEIN DNA COMPLEX ASSEMBLY,0.2839,-0.0043795,-0.063455,0,0
4,PID P38GAMMADELTAPATHWAY,0.85082,-0.0045116,-0.019916,0,0
4,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.65234,-0.0045847,0.027088,0,0
4,RIBONUCLEOPROTEIN COMPLEX,0.72313,-0.0047362,0.020352,0,0
4,KEGG STARCH AND SUCROSE METABOLISM,0.76281,-0.0047518,0.0023945,0,0
4,REACTOME EGFR DOWNREGULATION,0.81668,-0.0047667,-0.015247,0,0
4,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.68418,-0.0047955,0.046542,0,0
4,ST ADRENERGIC,0.90599,-0.0048075,-0.016114,0,0
4,INTERACTION WITH HOST,0.62113,-0.0052814,0.013355,0,0
4,KEGG FOCAL ADHESION,0.65234,-0.0053607,-0.062302,0,0
4,MACROMOLECULAR COMPLEX,0.91293,-0.0053632,0.009146,0,0
4,REGULATION OF CELL SHAPE,0.64605,-0.0053813,-0.07403,0,0
4,KEGG GAP JUNCTION,0.56075,-0.0055857,-0.035754,0,0
4,PEPTIDYL TYROSINE PHOSPHORYLATION,0.66501,-0.0056373,0.0084203,0,0
4,REGULATION OF PROTEIN KINASE ACTIVITY,0.99651,-0.0057858,0.0033981,0,0
4,REACTOME GAP JUNCTION TRAFFICKING,0.71006,-0.0060148,-0.045254,0,0
4,DEACETYLASE ACTIVITY,0.99651,-0.0061289,0.011562,0,0
4,BIOCARTA STATHMIN PATHWAY,0.44402,-0.0063865,-0.032863,0,0
4,VIRAL INFECTIOUS CYCLE,0.89215,-0.0068084,0.019412,0,0
4,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.94073,-0.0068806,0.0048738,0,0
4,KEGG ENDOCYTOSIS,0.86455,-0.0069175,-0.011238,0,0
4,REGULATION OF RAS GTPASE ACTIVITY,0.94073,-0.0075718,-0.007322,0,0
4,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.78289,-0.0078828,-0.04341,0,0
4,POSITIVE REGULATION OF TRANSCRIPTION,0.64605,-0.0080742,-0.025237,0,0
4,PROTEIN COMPLEX,0.98953,-0.0080769,0.0096624,0,0
4,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.72969,-0.0082891,-0.019378,0,0
4,NUCLEOLUS,0.94073,-0.0085457,-0.001428,0,0
4,BASOLATERAL PLASMA MEMBRANE,0.99651,-0.0086248,-0.021144,0,0
4,REACTOME GLUCOSE TRANSPORT,0.77618,-0.0086793,0.020321,0,0
4,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.98255,-0.0088929,-0.0053356,0,0
4,STRUCTURAL MOLECULE ACTIVITY,0.48678,-0.0091834,-0.048738,0,0
4,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,0.91987,-0.0092592,-0.018615,0,0
4,KEGG ACUTE MYELOID LEUKEMIA,0.91987,-0.0096803,0.0058326,0,0
4,ORGANELLE INNER MEMBRANE,0.95466,-0.0097235,-0.0040041,0,0
4,REGULATION OF KINASE ACTIVITY,0.97557,-0.010004,0.0016677,0,0
4,RHYTHMIC PROCESS,0.39858,-0.010205,-0.059774,0,0
4,ENVELOPE,0.78962,-0.010244,-0.018494,0,0
4,ORGANELLE ENVELOPE,0.78962,-0.010244,-0.018494,0,0
4,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.54903,-0.010366,-0.12012,0,0
4,PID S1P S1P4 PATHWAY,0.68418,-0.010568,-0.03934,0,0
4,M PHASE,0.89907,-0.010638,0.012317,0,0
4,BIOCARTA PTDINS PATHWAY,0.58456,-0.010668,0.043968,0,0
4,REACTOME SIGNALING BY PDGF,0.58456,-0.010779,-0.020016,0,0
4,ISOPRENOID METABOLIC PROCESS,0.73628,-0.010931,0.068109,0,0
4,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.95466,-0.010958,-0.010494,0,0
4,PYROPHOSPHATASE ACTIVITY,0.97557,-0.01104,0.0026573,0,0
4,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.97557,-0.011074,0.0046302,0,0
4,REGULATION OF MAP KINASE ACTIVITY,0.95466,-0.011119,-0.0055045,0,0
4,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.35607,-0.01134,-0.13666,0,0
4,PROTEIN FOLDING,0.71006,-0.01193,-0.034102,0,0
4,M PHASE OF MITOTIC CELL CYCLE,0.94769,-0.01213,0.0088525,0,0
4,SEQUENCE SPECIFIC DNA BINDING,0.2839,-0.012397,-0.070883,0,0
4,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.78962,-0.012564,0.028254,0,0
4,PID PRLSIGNALINGEVENTSPATHWAY,0.67137,-0.012841,0.036582,0,0
4,BIOCARTA PYK2 PATHWAY,0.94769,-0.012907,-0.012367,0,0
4,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.44402,-0.013325,-0.13001,0,0
4,REACTOME HIV INFECTION,0.85082,-0.013376,0.0057983,0,0
4,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.67776,-0.013379,-0.014485,0,0
4,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.98255,-0.013439,-0.0041487,0,0
4,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,0.46512,-0.013442,-0.061965,0,0
4,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.26098,-0.013485,-0.060323,0,0
4,POSITIVE REGULATION OF RNA METABOLIC PROCESS,0.26098,-0.013485,-0.060323,0,0
4,KEGG BASAL CELL CARCINOMA,0.62732,-0.013557,-0.035435,0,0
4,BIOCARTA P38MAPK PATHWAY,0.64605,-0.013695,-0.02832,0,0
4,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.35607,-0.01379,-0.041677,0,0
4,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.35607,-0.01379,-0.041677,0,0
4,PID ERBB NETWORK PATHWAY,0.79636,-0.013918,-0.068097,0,0
4,DNA REPLICATION,0.89215,-0.014413,-0.01459,0,0
4,PID INTEGRIN2 PATHWAY,0.98953,-0.015042,-0.022189,0,0
4,POSITIVE REGULATION OF METABOLIC PROCESS,0.98255,-0.015113,-0.010851,0,0
4,REGULATION OF MITOSIS,0.80312,-0.015235,-0.019922,0,0
4,ACTIVATION OF MAPK ACTIVITY,0.19095,-0.015287,-0.08209,0,0
4,KEGG MISMATCH REPAIR,0.50896,-0.015429,-0.036422,0,0
4,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.89215,-0.015437,0.0029032,0,0
4,REACTOME SIGNALING BY FGFR IN DISEASE,0.87833,-0.015524,0.014346,0,0
4,NUCLEAR IMPORT,0.72969,-0.015741,-0.034107,0,0
4,REACTOME SEMAPHORIN INTERACTIONS,0.69707,-0.015913,-0.01607,0,0
4,RECEPTOR MEDIATED ENDOCYTOSIS,0.79636,-0.016004,-0.0098361,0,0
4,RAS GTPASE BINDING,0.99651,-0.016249,-0.010914,0,0
4,KEGG TGF BETA SIGNALING PATHWAY,0.32938,-0.016311,-0.067048,0,0
4,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,0.99651,-0.016444,-0.031185,0,0
4,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,0.68418,-0.016554,0.01976,0,0
4,REACTOME ACTIVATION OF GENES BY ATF4,0.56666,-0.016614,-0.054413,0,0
4,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.53742,-0.016651,-0.057725,0,0
4,MUSCLE DEVELOPMENT,0.35153,-0.016905,-0.073661,0,0
4,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.74288,-0.017266,-0.036383,0,0
4,DRUG BINDING,0.65866,-0.017421,0.058129,0,0
4,REACTOME GLYCOLYSIS,0.66501,-0.017719,-0.051116,0,0
4,PID FAK PATHWAY,0.90599,-0.017739,-0.037752,0,0
4,KEGG CARDIAC MUSCLE CONTRACTION,0.56666,-0.017927,-0.056633,0,0
4,CHROMOSOME SEGREGATION,0.8303,-0.018371,0.01911,0,0
4,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.88523,-0.018737,-0.0095132,0,0
4,HEPARIN BINDING,0.2,-0.018802,-0.17453,0,0
4,SYNAPTIC TRANSMISSION,0.83713,-0.018818,0.008509,0,0
4,KEGG NUCLEOTIDE EXCISION REPAIR,0.9686,-0.018986,0.0039478,0,0
4,REACTOME M G1 TRANSITION,0.89215,-0.019067,-0.0083752,0,0
4,PID EPHA2 FWDPATHWAY,0.51459,-0.019209,-0.060501,0,0
4,PID FOXM1PATHWAY,0.93377,-0.019305,-0.016442,0,0
4,HORMONE METABOLIC PROCESS,0.99651,-0.0194,-0.0058572,0,0
4,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.52025,-0.02025,0.085585,0,0
4,REACTOME PERK REGULATED GENE EXPRESSION,0.72969,-0.020398,-0.041914,0,0
4,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.76948,-0.020581,0.030615,0,0
4,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.90599,-0.020818,-0.019362,0,0
4,PID THROMBIN PAR1 PATHWAY,0.70355,-0.020901,-0.016246,0,0
4,LYSOSOMAL TRANSPORT,0.92682,-0.021147,-0.0032713,0,0
4,KEGG GLYCOLYSIS GLUCONEOGENESIS,0.85082,-0.021602,-0.0075274,0,0
4,PID E2F PATHWAY,0.78289,-0.022282,-0.021012,0,0
4,REACTOME METABOLISM OF PORPHYRINS,0.50337,-0.022333,-0.14454,0,0
4,REACTOME SIGNALING BY FGFR MUTANTS,0.4545,-0.022389,-0.035669,0,0
4,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.36064,-0.022538,-0.049336,0,0
4,BIOCARTA HCMV PATHWAY,0.68418,-0.022577,0.023995,0,0
4,PHAGOCYTOSIS,0.91987,-0.022857,-0.00099247,0,0
4,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.1313,-0.023185,-0.10094,0,0
4,RNA DEPENDENT ATPASE ACTIVITY,0.54321,-0.02336,-0.043476,0,0
4,GROWTH,0.57857,-0.023477,-0.031352,0,0
4,NEGATIVE REGULATION OF BINDING,0.77618,-0.023556,-0.036418,0,0
4,REACTOME SIGNALING BY ERBB2,0.61497,-0.0239,-0.01852,0,0
4,KEGG FATTY ACID METABOLISM,0.52594,-0.024071,-0.078578,0,0
4,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.85082,-0.024863,-0.015279,0,0
4,PID BMPPATHWAY,0.87833,-0.024891,-0.021716,0,0
4,BIOCARTA MTOR PATHWAY,0.73628,-0.024924,-0.026587,0,0
4,POSITIVE REGULATION OF CELL CYCLE,0.93377,-0.024956,-0.056752,0,0
4,NEGATIVE REGULATION OF DNA BINDING,0.89907,-0.025128,-0.022475,0,0
4,DNA PACKAGING,0.94073,-0.025348,0.010811,0,0
4,ACTIN FILAMENT BUNDLE FORMATION,0.81668,-0.025436,-0.007183,0,0
4,KEGG HEDGEHOG SIGNALING PATHWAY,0.61497,-0.025447,-0.026411,0,0
4,BIOCARTA NFAT PATHWAY,0.53742,-0.025551,-0.028945,0,0
4,REGULATION OF DNA BINDING,0.56666,-0.026075,-0.030775,0,0
4,GLUTAMATE RECEPTOR ACTIVITY,0.35153,-0.026278,-0.12418,0,0
4,KEGG DILATED CARDIOMYOPATHY,0.36526,-0.02633,-0.068224,0,0
4,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.65234,-0.026352,-0.054072,0,0
4,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.41341,-0.026454,-0.014794,0,0
4,CHROMATIN REMODELING,0.54321,-0.026602,-0.027775,0,0
4,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,1,-0.026908,0.0025285,0,0
4,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.23937,-0.027225,-0.052208,0,0
4,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.81668,-0.027582,-0.0099026,0,0
4,REACTOME DEVELOPMENTAL BIOLOGY,0.27227,-0.027685,-0.042495,0,0
4,KEGG COLORECTAL CANCER,0.56075,-0.027748,-0.020064,0,0
4,PROTEIN IMPORT,0.46512,-0.027892,-0.038564,0,0
4,TRANSLATIONAL INITIATION,0.50896,-0.028034,-0.060196,0,0
4,BIOCARTA VEGF PATHWAY,0.71658,-0.028139,-0.048738,0,0
4,REGULATION OF IMMUNE RESPONSE,0.66501,-0.02842,-0.022323,0,0
4,RNA BINDING,0.91293,-0.028929,0.0083205,0,0
4,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,0.68418,-0.029089,-0.013178,0,0
4,REGULATION OF GENE EXPRESSION EPIGENETIC,0.70355,-0.029115,-0.023043,0,0
4,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,0.75615,-0.029267,-0.013219,0,0
4,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,0.78289,-0.029478,-0.028708,0,0
4,PROTEOGLYCAN METABOLIC PROCESS,0.56075,-0.029519,-0.063983,0,0
4,SULFUR METABOLIC PROCESS,0.8303,-0.029541,-0.017129,0,0
4,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,0.99651,-0.029814,-0.015708,0,0
4,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.23589,-0.029922,-0.091091,0,0
4,NEGATIVE REGULATION OF GROWTH,0.75615,-0.030063,0.009355,0,0
4,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.4545,-0.03019,0.075116,0,0
4,CENTROSOME ORGANIZATION AND BIOGENESIS,0.92682,-0.030192,0.045468,0,0
4,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.44924,-0.03028,-0.042251,0,0
4,PID BETACATENIN DEG PATHWAY,0.80989,-0.030323,-0.0086851,0,0
4,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,0.41341,-0.030896,-0.094582,0,0
4,CELL PROJECTION BIOGENESIS,0.12259,-0.030907,-0.098457,0,0
4,REGULATION OF CELL CYCLE,0.32938,-0.031583,-0.028047,0,0
4,REACTOME SYNTHESIS OF DNA,0.69061,-0.031643,-0.016017,0,0
4,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.42347,-0.031764,-0.10093,0,0
4,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.26471,-0.031877,-0.10588,0,0
4,RESPONSE TO RADIATION,0.15773,-0.031919,-0.066898,0,0
4,REACTOME OPIOID SIGNALLING,0.42855,-0.032368,-0.046544,0,0
4,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.79636,-0.032667,-0.013681,0,0
4,SPINDLE,0.36526,-0.032775,-0.04964,0,0
4,REACTOME MEIOSIS,0.78289,-0.033265,0.032332,0,0
4,REGULATION OF GROWTH,0.55487,-0.033416,-0.027525,0,0
4,REGULATION OF CELL MORPHOGENESIS,0.59059,-0.033797,-0.069282,0,0
4,RUFFLE,0.92682,-0.033973,-0.036682,0,0
4,NUCLEAR EXPORT,0.34702,-0.034264,-0.049269,0,0
4,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.33373,-0.034441,-0.062831,0,0
4,PID TELOMERASEPATHWAY,0.53167,-0.034626,-0.055812,0,0
4,KEGG CITRATE CYCLE TCA CYCLE,0.85768,-0.034675,-0.035017,0,0
4,DEPHOSPHORYLATION,0.46512,-0.034748,-0.058719,0,0
4,REACTOME GLOBAL GENOMIC NER GG NER,0.30402,-0.03534,-0.054535,0,0
4,NOTCH SIGNALING PATHWAY,0.68418,-0.035441,-0.029612,0,0
4,PID CDC42 REG PATHWAY,0.53742,-0.03551,-0.042494,0,0
4,PID SYNDECAN 3 PATHWAY,0.78962,-0.035569,0.028403,0,0
4,COFACTOR TRANSPORT,0.69707,-0.035975,-0.056412,0,0
4,ATP DEPENDENT RNA HELICASE ACTIVITY,0.60883,-0.036084,-0.040541,0,0
4,JNK CASCADE,0.54903,-0.036086,-0.019391,0,0
4,REACTOME SIGNALING BY EGFR IN CANCER,0.88523,-0.036155,-0.00065933,0,0
4,BIOCARTA IGF1MTOR PATHWAY,0.17934,-0.036319,-0.10378,0,0
4,REACTOME METABOLISM OF MRNA,0.76281,-0.036516,-0.022965,0,0
4,ISOMERASE ACTIVITY,0.4978,-0.036532,-0.06053,0,0
4,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.72969,-0.036787,-0.016095,0,0
4,ST G ALPHA I PATHWAY,0.39371,-0.036922,-0.043745,0,0
4,KEGG SMALL CELL LUNG CANCER,0.27999,-0.037211,-0.080018,0,0
4,PIGMENT METABOLIC PROCESS,0.85768,-0.037366,-0.02142,0,0
4,REGULATION OF MITOTIC CELL CYCLE,0.8303,-0.037376,-0.0062828,0,0
4,KEGG REGULATION OF ACTIN CYTOSKELETON,0.98255,-0.037707,0.0059464,0,0
4,PID NCADHERINPATHWAY,0.72969,-0.037729,-0.039303,0,0
4,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,0.38408,-0.038045,-0.037907,0,0
4,NEUROTRANSMITTER SECRETION,0.68418,-0.038084,0.14284,0,0
4,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.61497,-0.038249,-0.078792,0,0
4,KEGG PYRIMIDINE METABOLISM,0.4545,-0.03827,-0.026144,0,0
4,BIOCARTA FIBRINOLYSIS PATHWAY,0.3746,-0.038561,-0.16909,0,0
4,REACTOME PI 3K CASCADE,0.16559,-0.038569,-0.060447,0,0
4,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.36526,-0.038779,-0.075934,0,0
4,REACTOME SHC MEDIATED SIGNALLING,0.62113,-0.039289,0.030505,0,0
4,REACTOME METABOLISM OF RNA,0.54903,-0.039322,-0.036508,0,0
4,REACTOME TCR SIGNALING,0.60272,-0.040501,-0.03447,0,0
4,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.10845,-0.040572,-0.12285,0,0
4,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.093897,-0.040685,-0.084824,0,0
4,REACTOME MEIOTIC RECOMBINATION,0.99651,-0.041245,0.032325,0,0
4,PROTEIN AUTOPROCESSING,0.9686,-0.041263,0.00026039,0,0
4,LEADING EDGE,0.48678,-0.041298,-0.060885,0,0
4,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.56075,-0.041304,-0.035481,0,0
4,BIOCARTA NO1 PATHWAY,0.11841,-0.041485,-0.13886,0,0
4,REACTOME CS DS DEGRADATION,0.53167,-0.041814,-0.11064,0,0
4,PID IL8CXCR2 PATHWAY,0.46512,-0.042116,-0.06401,0,0
4,REACTOME MITOTIC M M G1 PHASES,0.4978,-0.042374,-0.025787,0,0
4,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.38408,-0.042975,-0.059195,0,0
4,REACTOME DNA REPAIR,0.60272,-0.043006,-0.016174,0,0
4,REACTOME DNA REPLICATION,0.29586,-0.043085,-0.0308,0,0
4,CELL MIGRATION,0.28785,-0.043211,-0.08727,0,0
4,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,0.75615,-0.043441,-0.00056921,0,0
4,SA G1 AND S PHASES,0.78289,-0.04349,-0.0045783,0,0
4,TRNA METABOLIC PROCESS,0.48131,-0.043957,-0.053559,0,0
4,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,0.52594,-0.04401,-0.064808,0,0
4,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.93377,-0.044276,-0.0018453,0,0
4,KEGG ENDOMETRIAL CANCER,0.12908,-0.044406,-0.079702,0,0
4,TRANSITION METAL ION BINDING,0.53167,-0.044663,-0.032251,0,0
4,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,0.67776,-0.044927,-0.038251,0,0
4,MESODERM DEVELOPMENT,0.68418,-0.045055,-0.056937,0,0
4,NUCLEAR MEMBRANE PART,0.16032,-0.045186,-0.07402,0,0
4,BIOCARTA NKT PATHWAY,0.84397,-0.045543,-0.067878,0,0
4,PROTEIN COMPLEX BINDING,0.25729,-0.045904,-0.066341,0,0
4,POLYSACCHARIDE BINDING,0.55487,-0.046078,-0.069528,0,0
4,GLYCOSAMINOGLYCAN BINDING,0.55487,-0.046078,-0.069528,0,0
4,EMBRYONIC DEVELOPMENT,0.77618,-0.046162,-0.005486,0,0
4,POSITIVE REGULATION OF IMMUNE RESPONSE,0.66501,-0.046164,-0.012284,0,0
4,PID FANCONI PATHWAY,0.63978,-0.046204,-0.010719,0,0
4,BIOCARTA CCR3 PATHWAY,0.78289,-0.046428,0.03554,0,0
4,PROTEIN IMPORT INTO NUCLEUS,0.26471,-0.046702,-0.083051,0,0
4,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.50337,-0.046776,-0.051597,0,0
4,REACTOME PLATELET HOMEOSTASIS,0.68418,-0.047424,-0.012313,0,0
4,ATP DEPENDENT HELICASE ACTIVITY,0.42347,-0.047891,-0.041677,0,0
4,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.28785,-0.048302,-0.039469,0,0
4,AMINE BIOSYNTHETIC PROCESS,0.58456,-0.048381,-0.087509,0,0
4,TRANSCRIPTION INITIATION,0.12908,-0.04858,-0.065041,0,0
4,PHOSPHATASE REGULATOR ACTIVITY,0.33812,-0.048607,-0.10742,0,0
4,REACTOME MITOTIC G2 G2 M PHASES,0.12049,-0.048795,-0.066816,0,0
4,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.27611,-0.04899,-0.054927,0,0
4,REACTOME STRIATED MUSCLE CONTRACTION,0.2,-0.049011,-0.14199,0,0
4,BIOCARTA RACCYCD PATHWAY,0.33373,-0.049241,-0.061923,0,0
4,REGULATION OF TRANSLATIONAL INITIATION,0.32506,-0.049435,-0.090214,0,0
4,MICROTUBULE BASED PROCESS,0.57857,-0.049719,-0.018291,0,0
4,REACTOME KINESINS,0.59664,-0.049952,-0.037704,0,0
4,PID GLYPICAN 1PATHWAY,0.88523,-0.050317,-0.012184,0,0
4,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.47049,-0.050333,-0.06253,0,0
4,REACTOME NUCLEOTIDE EXCISION REPAIR,0.085627,-0.050506,-0.075976,0,0
4,RAS GTPASE ACTIVATOR ACTIVITY,0.41341,-0.050623,-0.073721,0,0
4,REACTOME SIGNALING BY RHO GTPASES,0.35607,-0.051412,-0.03948,0,0
4,CORTICAL CYTOSKELETON,0.19695,-0.05163,-0.10891,0,0
4,KINETOCHORE,0.47049,-0.052462,-0.012846,0,0
4,REACTOME ELONGATION ARREST AND RECOVERY,0.19095,-0.052639,-0.061733,0,0
4,PID ATR PATHWAY,0.16032,-0.053357,-0.065366,0,0
4,MRNA METABOLIC PROCESS,0.072231,-0.053431,-0.053596,0,0
4,PID HEDGEHOG 2PATHWAY,0.33373,-0.053521,-0.089656,0,0
4,PATTERN SPECIFICATION PROCESS,0.47049,-0.05385,-0.059983,0,0
4,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.050569,-0.053907,-0.074921,0,0
4,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.44924,-0.053999,-0.079911,0,0
4,TRANSCRIPTION COREPRESSOR ACTIVITY,0.67776,-0.054204,-0.020636,0,0
4,PIGMENT BIOSYNTHETIC PROCESS,0.53167,-0.054517,-0.045782,0,0
4,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.63354,-0.055429,0.062149,0,0
4,ORGANIC ACID TRANSPORT,0.72969,-0.055498,-0.045179,0,0
4,CARBOXYLIC ACID TRANSPORT,0.72969,-0.055498,-0.045179,0,0
4,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.3746,-0.055525,-0.060351,0,0
4,NERVOUS SYSTEM DEVELOPMENT,0.12908,-0.055651,-0.10425,0,0
4,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.3746,-0.05591,-0.056937,0,0
4,S PHASE,0.44402,-0.056205,-0.044065,0,0
4,REACTOME MITOTIC G1 G1 S PHASES,0.11039,-0.056944,-0.069621,0,0
4,KEGG PYRUVATE METABOLISM,0.50337,-0.056998,-0.071167,0,0
4,REGULATION OF CELL ADHESION,0.30815,-0.057404,-0.092292,0,0
4,DNA DEPENDENT DNA REPLICATION,0.33812,-0.05742,-0.055757,0,0
4,REACTOME SIGNAL AMPLIFICATION,0.090515,-0.057793,-0.12942,0,0
4,RESPONSE TO LIGHT STIMULUS,0.10654,-0.057804,-0.093743,0,0
4,PROTEIN N TERMINUS BINDING,0.20621,-0.058383,-0.049908,0,0
4,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.13814,-0.058411,-0.078399,0,0
4,NUCLEAR TRANSPORT,0.27611,-0.058694,-0.061884,0,0
4,CARBOHYDRATE KINASE ACTIVITY,0.56075,-0.058782,-0.043521,0,0
4,CYTOSOLIC PART,0.082489,-0.058959,-0.12876,0,0
4,REGULATION OF DNA REPLICATION,0.31653,-0.059675,-0.11218,0,0
4,RNA HELICASE ACTIVITY,0.26098,-0.06077,-0.07613,0,0
4,KEGG AXON GUIDANCE,0.1028,-0.060845,-0.11946,0,0
4,REACTOME CELL CYCLE,0.12049,-0.060982,-0.042802,0,0
4,AMINO ACID TRANSPORT,0.54321,-0.061222,-0.075251,0,0
4,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.072231,-0.061348,-0.097336,0,0
4,REACTOME RNA POL I PROMOTER OPENING,0.8303,-0.061375,0.073946,0,0
4,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,0.82348,-0.061639,-0.035055,0,0
4,BIOCARTA G1 PATHWAY,0.42855,-0.061707,-0.065429,0,0
4,KEGG GALACTOSE METABOLISM,0.60883,-0.062459,-0.032338,0,0
4,REACTOME INFLUENZA LIFE CYCLE,0.65234,-0.062549,-0.048082,0,0
4,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.66501,-0.062599,-0.058382,0,0
4,NUCLEOCYTOPLASMIC TRANSPORT,0.29586,-0.062738,-0.061487,0,0
4,REACTOME SIGNALING BY FGFR,0.43367,-0.062924,-0.023716,0,0
4,METHYLTRANSFERASE ACTIVITY,0.10465,-0.063015,-0.079741,0,0
4,CELL SURFACE,0.16294,-0.063145,-0.084851,0,0
4,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.99651,-0.063212,0.002304,0,0
4,REACTOME NEPHRIN INTERACTIONS,0.52025,-0.063247,-0.042359,0,0
4,REACTOME S PHASE,0.10654,-0.063642,-0.084372,0,0
4,KEGG SPLICEOSOME,0.085627,-0.0638,-0.07653,0,0
4,NUCLEAR ENVELOPE,0.15015,-0.063849,-0.069571,0,0
4,BIOCARTA CFTR PATHWAY,0.36991,-0.063963,-0.10224,0,0
4,PERINUCLEAR REGION OF CYTOPLASM,0.98255,-0.064503,0.0008444,0,0
4,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,0.58456,-0.064879,-0.071042,0,0
4,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.73628,-0.064956,-0.023565,0,0
4,REACTOME TRANSLATION,0.90599,-0.06506,-0.027131,0,0
4,CELL CORTEX PART,0.27999,-0.065617,-0.092949,0,0
4,PID ARF6 TRAFFICKINGPATHWAY,0.94073,-0.065714,-0.0020977,0,0
4,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.27611,-0.065859,-0.12545,0,0
4,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.47588,-0.06613,-0.062715,0,0
4,ST MYOCYTE AD PATHWAY,0.24643,-0.066449,-0.089066,0,0
4,REACTOME MYOGENESIS,0.11039,-0.066577,-0.1249,0,0
4,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.84397,-0.067102,0.0099041,0,0
4,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.40843,-0.067264,-0.039913,0,0
4,PID FRA PATHWAY,0.36991,-0.068141,-0.12939,0,0
4,REGULATION OF LYMPHOCYTE ACTIVATION,0.19695,-0.068209,-0.15231,0,0
4,SA REG CASCADE OF CYCLIN EXPR,0.93377,-0.068398,0.014096,0,0
4,REACTOME G1 S TRANSITION,0.18219,-0.068442,-0.06212,0,0
4,REACTOME CHROMOSOME MAINTENANCE,0.69707,-0.068672,-0.019002,0,0
4,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.98255,-0.069309,0.045279,0,0
4,PID ARF 3PATHWAY,0.16559,-0.069353,-0.12807,0,0
4,KEGG NON SMALL CELL LUNG CANCER,0.13814,-0.069479,-0.080363,0,0
4,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.26471,-0.069555,-0.11406,0,0
4,REACTOME SIGNALING BY HIPPO,0.29586,-0.069665,-0.16071,0,0
4,AMINE BINDING,0.60883,-0.069733,-0.048488,0,0
4,REACTOME G PROTEIN ACTIVATION,0.25729,-0.069886,-0.092832,0,0
4,REACTOME AXON GUIDANCE,0.12473,-0.07068,-0.091386,0,0
4,BIOCARTA PLCE PATHWAY,0.27227,-0.071055,-0.13597,0,0
4,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.33812,-0.071236,-0.12253,0,0
4,ACTIVATION OF JNK ACTIVITY,0.2839,-0.071305,-0.079115,0,0
4,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.088862,-0.071654,-0.078004,0,0
4,PID RAC1 REG PATHWAY,0.35607,-0.072983,-0.07292,0,0
4,BIOCARTA INTRINSIC PATHWAY,0.87144,-0.073845,-0.040891,0,0
4,SIG CHEMOTAXIS,0.2,-0.07415,-0.058357,0,0
4,RNA POLYMERASE ACTIVITY,0.21579,-0.074153,-0.10115,0,0
4,PID CONE PATHWAY,0.045624,-0.074246,-0.13138,0,0
4,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.057089,-0.074293,-0.10014,0,0
4,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.51459,-0.074537,-0.063245,0,0
4,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.16559,-0.074608,-0.065305,0,0
4,REACTOME CA DEPENDENT EVENTS,0.11636,-0.074934,-0.12024,0,0
4,LIPID KINASE ACTIVITY,0.22905,-0.075138,-0.10515,0,0
4,REACTOME ARMS MEDIATED ACTIVATION,0.4545,-0.075484,-0.029802,0,0
4,G1 PHASE,0.78289,-0.075543,-0.028452,0,0
4,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.063042,-0.075982,-0.1017,0,0
4,KINESIN COMPLEX,0.25001,-0.076361,-0.05768,0,0
4,KEGG RNA DEGRADATION,0.37932,-0.076481,-0.034185,0,0
4,BIOCARTA CALCINEURIN PATHWAY,0.49227,-0.076525,-0.016452,0,0
4,CHROMOSOMEPERICENTRIC REGION,0.4978,-0.076601,-0.013307,0,0
4,SIGNAL SEQUENCE BINDING,0.40843,-0.077045,-0.06552,0,0
4,POSITIVE REGULATION OF JNK ACTIVITY,0.16559,-0.077572,-0.10964,0,0
4,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.4545,-0.077612,-0.051116,0,0
4,ACETYLCHOLINE BINDING,0.33812,-0.07863,-0.1114,0,0
4,PID TRKRPATHWAY,0.12689,-0.078924,-0.076385,0,0
4,STRUCTURAL CONSTITUENT OF RIBOSOME,0.81668,-0.079238,-0.037014,0,0
4,BIOCARTA MCM PATHWAY,0.35153,-0.079293,-0.088167,0,0
4,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.82348,-0.079456,0.020382,0,0
4,REACTOME DOUBLE STRAND BREAK REPAIR,0.34256,-0.079938,-0.050204,0,0
4,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.54903,-0.080077,-0.018563,0,0
4,REACTOME TRNA AMINOACYLATION,0.41341,-0.080672,-0.087039,0,0
4,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,0.41842,-0.081178,-0.069377,0,0
4,ST WNT BETA CATENIN PATHWAY,0.35607,-0.081409,-0.079636,0,0
4,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,0.9686,-0.081511,0.009579,0,0
4,REACTOME SIGNALING BY ROBO RECEPTOR,0.21905,-0.081529,-0.099844,0,0
4,SYMPORTER ACTIVITY,0.71658,-0.082798,-0.0092097,0,0
4,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.32506,-0.0829,-0.05073,0,0
4,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.066855,-0.083093,-0.095846,0,0
4,REACTOME PEPTIDE CHAIN ELONGATION,0.80312,-0.083216,-0.038123,0,0
4,RIBONUCLEOTIDE METABOLIC PROCESS,0.40349,-0.083317,-0.068468,0,0
4,REACTOME L1CAM INTERACTIONS,0.33373,-0.08355,-0.063803,0,0
4,PROTEIN RNA COMPLEX ASSEMBLY,0.14769,-0.084272,-0.09681,0,0
4,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.37932,-0.084644,-0.064367,0,0
4,NUCLEOLAR PART,0.39858,-0.084663,-0.077791,0,0
4,REACTOME BASIGIN INTERACTIONS,0.87144,-0.085083,-0.011013,0,0
4,KEGG ONE CARBON POOL BY FOLATE,0.077957,-0.085591,-0.17815,0,0
4,CELL DIVISION,0.059411,-0.086049,-0.14223,0,0
4,DNA DEPENDENT ATPASE ACTIVITY,0.15264,-0.086616,-0.12859,0,0
4,PID DNAPK PATHWAY,0.1313,-0.086927,-0.078334,0,0
4,BIOCARTA TOB1 PATHWAY,0.72313,-0.087053,-0.012725,0,0
4,MICROTUBULE ASSOCIATED COMPLEX,0.20937,-0.087112,-0.054262,0,0
4,REACTOME METABOLISM OF NUCLEOTIDES,0.46512,-0.087165,-0.04814,0,0
4,REACTOME G1 PHASE,0.11636,-0.087387,-0.09696,0,0
4,REGULATION OF GTPASE ACTIVITY,0.10654,-0.087859,-0.13214,0,0
4,REACTOME G ALPHA Z SIGNALLING EVENTS,0.33812,-0.087879,-0.078333,0,0
4,ARYLSULFATASE ACTIVITY,0.60883,-0.087904,-0.076884,0,0
4,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.71006,-0.089019,-0.031604,0,0
4,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.33373,-0.089326,-0.064744,0,0
4,KEGG DNA REPLICATION,0.11235,-0.089444,-0.088599,0,0
4,TRANSLATION REGULATOR ACTIVITY,0.14526,-0.089709,-0.14011,0,0
4,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.1313,-0.090371,-0.084346,0,0
4,RESPONSE TO UV,0.10096,-0.09099,-0.096109,0,0
4,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.23245,-0.091247,-0.074107,0,0
4,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,0.20621,-0.091479,-0.13007,0,0
4,BIOCARTA ERK PATHWAY,0.58456,-0.091679,-0.033723,0,0
4,BIOCARTA EIF PATHWAY,0.40349,-0.092535,-0.11238,0,0
4,MEDIATOR COMPLEX,0.085627,-0.092544,-0.1106,0,0
4,BIOCARTA VIP PATHWAY,0.17653,-0.092861,-0.088838,0,0
4,PID ERBB4 PATHWAY,0.088862,-0.092998,-0.087389,0,0
4,BIOCARTA CTCF PATHWAY,0.19095,-0.093292,-0.096842,0,0
4,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.11039,-0.093551,-0.060734,0,0
4,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.099158,-0.09397,-0.10848,0,0
4,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.44402,-0.094614,-0.10259,0,0
4,REACTOME MUSCLE CONTRACTION,0.15264,-0.095185,-0.17062,0,0
4,REACTOME GABA A RECEPTOR ACTIVATION,0.93377,-0.095315,-0.077764,0,0
4,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.35607,-0.095984,-0.057723,0,0
4,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.10465,-0.096468,-0.1051,0,0
4,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.26847,-0.096532,-0.1088,0,0
4,BIOCARTA RARRXR PATHWAY,0.087232,-0.096953,-0.14334,0,0
4,REACTOME DSCAM INTERACTIONS,0.24288,-0.097034,-0.10165,0,0
4,PID INTEGRIN1 PATHWAY,0.23245,-0.098011,-0.17426,0,0
4,SPLICEOSOME ASSEMBLY,0.10096,-0.098275,-0.097313,0,0
4,KEGG RIBOSOME,0.74288,-0.098851,-0.038095,0,0
4,KEGG SELENOAMINO ACID METABOLISM,0.10654,-0.099147,-0.14433,0,0
4,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.15773,-0.099437,-0.059685,0,0
4,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.66501,-0.099928,-0.054661,0,0
4,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.29184,-0.099983,-0.09311,0,0
4,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.080955,-0.10062,-0.14416,0,0
4,REACTOME MITOTIC PROMETAPHASE,0.24643,-0.10063,-0.047297,0,0
4,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,0.19095,-0.10081,-0.10599,0,0
4,REACTOME G2 M CHECKPOINTS,0.084046,-0.10094,-0.11723,0,0
4,MICROTUBULE BASED MOVEMENT,0.22568,-0.10102,-0.085125,0,0
4,REACTOME PYRIMIDINE METABOLISM,0.32506,-0.10109,-0.071538,0,0
4,NEGATIVE REGULATION OF CELL CYCLE,0.16294,-0.10114,-0.065722,0,0
4,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.36064,-0.10129,-0.070825,0,0
4,KEGG LYSINE DEGRADATION,0.22905,-0.10197,-0.064294,0,0
4,DNA RECOMBINATION,0.19695,-0.10223,-0.069448,0,0
4,BIOCARTA PROTEASOME PATHWAY,0.56075,-0.10279,-0.058,0,0
4,REACTOME GABA B RECEPTOR ACTIVATION,0.18219,-0.10283,-0.11129,0,0
4,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.16828,-0.10293,-0.14985,0,0
4,REACTOME CELL CYCLE MITOTIC,0.057089,-0.10318,-0.059066,0,0
4,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.095625,-0.10336,-0.083758,0,0
4,PID AURORA B PATHWAY,0.084046,-0.10338,-0.11667,0,0
4,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,0.4978,-0.10352,-0.065766,0,0
4,REACTOME ADP SIGNALLING THROUGH P2RY1,0.087232,-0.10403,-0.14192,0,0
4,PID ALK1PATHWAY,0.045624,-0.10477,-0.19073,0,0
4,PID HDAC CLASSII PATHWAY,0.25363,-0.10503,-0.089874,0,0
4,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,0.35607,-0.10568,-0.066768,0,0
4,KEGG BLADDER CANCER,0.1028,-0.10628,-0.10435,0,0
4,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.054842,-0.10676,-0.15959,0,0
4,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.14285,-0.1074,-0.10494,0,0
4,PID BETACATENIN NUC PATHWAY,0.060602,-0.10751,-0.12521,0,0
4,KEGG PROPANOATE METABOLISM,0.52594,-0.10756,-0.039788,0,0
4,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,0.20309,-0.10781,-0.087028,0,0
4,SECONDARY METABOLIC PROCESS,0.075049,-0.10814,-0.11063,0,0
4,REACTOME NETRIN1 SIGNALING,0.13814,-0.10842,-0.12839,0,0
4,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.2,-0.10843,-0.12785,0,0
4,BIOCARTA AMI PATHWAY,0.80312,-0.10844,-0.059658,0,0
4,PID SYNDECAN 1 PATHWAY,0.085627,-0.10844,-0.19746,0,0
4,PID NFAT 3PATHWAY,0.7495,-0.1085,0.0057698,0,0
4,SPINDLE MICROTUBULE,0.29586,-0.10897,-0.065441,0,0
4,PID SYNDECAN 2 PATHWAY,0.11039,-0.10956,-0.13428,0,0
4,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.69707,-0.10997,-0.05855,0,0
4,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,0.090515,-0.11003,-0.12241,0,0
4,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.055956,-0.11053,-0.14971,0,0
4,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.17653,-0.11069,-0.078359,0,0
4,POSITIVE REGULATION OF DNA BINDING,0.33812,-0.11079,-0.053866,0,0
4,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,0.11841,-0.11256,-0.18261,0,0
4,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.54903,-0.11269,-0.074894,0,0
4,KEGG RNA POLYMERASE,0.090515,-0.11436,-0.085839,0,0
4,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.12908,-0.1149,-0.11043,0,0
4,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.092194,-0.11497,-0.11484,0,0
4,VITAMIN TRANSPORT,0.15015,-0.11503,-0.1304,0,0
4,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.69061,-0.11506,-0.023566,0,0
4,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,0.21579,-0.11526,-0.17903,0,0
4,BIOCARTA AKAPCENTROSOME PATHWAY,0.26098,-0.11534,-0.14101,0,0
4,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,0.83713,-0.11598,-0.021547,0,0
4,SYNAPSE,0.17099,-0.11602,-0.090263,0,0
4,PID RAS PATHWAY,0.47049,-0.11607,-0.068911,0,0
4,NEGATIVE REGULATION OF TRANSPORT,0.057089,-0.11625,-0.14053,0,0
4,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,0.22905,-0.11649,-0.15517,0,0
4,PID ATM PATHWAY,0.099158,-0.11653,-0.074311,0,0
4,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,0.0695,-0.11725,-0.15834,0,0
4,BIOCARTA CELLCYCLE PATHWAY,0.46512,-0.11798,-0.049627,0,0
4,GLUTAMATE SIGNALING PATHWAY,0.31232,-0.11829,-0.14063,0,0
4,REACTOME RNA POL I TRANSCRIPTION,0.60883,-0.11927,-0.0089853,0,0
4,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.21905,-0.11969,-0.10879,0,0
4,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.53742,-0.12061,-0.063281,0,0
4,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,0.79636,-0.12138,-0.053081,0,0
4,CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.22568,-0.12144,-0.076751,0,0
4,BIOCARTA CARDIACEGF PATHWAY,0.60883,-0.12233,-0.07009,0,0
4,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.12908,-0.12426,-0.19236,0,0
4,TRANSLATION INITIATION FACTOR ACTIVITY,0.11235,-0.12435,-0.18297,0,0
4,BIOCARTA TEL PATHWAY,0.099158,-0.12535,-0.15831,0,0
4,POSITIVE REGULATION OF BINDING,0.35607,-0.12579,-0.039744,0,0
4,BIOCARTA WNT PATHWAY,0.2839,-0.12589,-0.092988,0,0
4,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.36991,-0.12603,-0.10118,0,0
4,PID AVB3 INTEGRIN PATHWAY,0.11434,-0.12735,-0.14319,0,0
4,CELL SUBSTRATE ADHESION,0.0695,-0.12806,-0.1279,0,0
4,CELL MATRIX ADHESION,0.0695,-0.12806,-0.1279,0,0
4,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.15015,-0.12807,-0.15745,0,0
4,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.12259,-0.12919,-0.15563,0,0
4,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.1028,-0.13066,-0.088879,0,0
4,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.0695,-0.1309,-0.14004,0,0
4,METALLOENDOPEPTIDASE ACTIVITY,0.063042,-0.13117,-0.13268,0,0
4,CELL CYCLE ARREST GO 0007050,0.11434,-0.133,-0.08882,0,0
4,BIOCARTA CACAM PATHWAY,0.53742,-0.13477,-0.079638,0,0
4,HETEROCYCLE METABOLIC PROCESS,0.17934,-0.13523,-0.11651,0,0
4,PID ANTHRAXPATHWAY,0.054842,-0.13665,-0.16951,0,0
4,REACTOME GABA RECEPTOR ACTIVATION,0.25363,-0.13691,-0.095872,0,0
4,FEEDING BEHAVIOR,0.085627,-0.1371,-0.10195,0,0
4,PID LYMPHANGIOGENESIS PATHWAY,0.64605,-0.13815,-0.075928,0,0
4,REACTOME RAP1 SIGNALLING,0.16559,-0.1386,-0.12516,0,0
4,PID MYC PATHWAY,0.04854,-0.1386,-0.19029,0,0
4,N METHYLTRANSFERASE ACTIVITY,0.11434,-0.13888,-0.093127,0,0
4,PID PI3KPLCTRKPATHWAY,0.17374,-0.13991,-0.075574,0,0
4,SPINDLE POLE,0.46512,-0.14,-0.050869,0,0
4,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.079444,-0.14263,-0.18417,0,0
4,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.084046,-0.14314,-0.11085,0,0
4,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.27611,-0.14449,-0.068298,0,0
4,ACTIN FILAMENT ORGANIZATION,0.11039,-0.14499,-0.095675,0,0
4,REACTOME ADP SIGNALLING THROUGH P2RY12,0.082489,-0.14568,-0.16502,0,0
4,PID RXR VDR PATHWAY,0.15015,-0.14763,-0.11432,0,0
4,REACTOME SMOOTH MUSCLE CONTRACTION,0.15015,-0.1478,-0.23565,0,0
4,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.21905,-0.14873,-0.10589,0,0
4,SYNAPSE ORGANIZATION AND BIOGENESIS,0.64605,-0.14942,-0.041037,0,0
4,KEGG CYSTEINE AND METHIONINE METABOLISM,0.047551,-0.14981,-0.14774,0,0
4,NEGATIVE REGULATION OF CELL ADHESION,0.085627,-0.15036,-0.16089,0,0
4,REACTOME HDL MEDIATED LIPID TRANSPORT,0.35153,-0.15229,-0.11129,0,0
4,COLLAGEN BINDING,0.079444,-0.15262,-0.22043,0,0
4,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.25363,-0.155,-0.069213,0,0
4,SIALYLTRANSFERASE ACTIVITY,0.14285,-0.15509,-0.22773,0,0
4,REACTOME METABOLISM OF NON CODING RNA,0.10096,-0.15515,-0.11302,0,0
4,KEGG PRION DISEASES,0.18508,-0.15543,-0.07581,0,0
4,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.04854,-0.15584,-0.24825,0,0
4,REACTOME MRNA 3 END PROCESSING,0.092194,-0.15595,-0.089125,0,0
4,CELL FATE COMMITMENT,0.54903,-0.1564,-0.035785,0,0
4,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,0.10465,-0.15649,-0.17634,0,0
4,BIOCARTA CBL PATHWAY,0.26847,-0.16041,-0.12538,0,0
4,EXTRINSIC TO MEMBRANE,0.22568,-0.16061,-0.12488,0,0
4,BIOCARTA ARAP PATHWAY,0.059411,-0.16079,-0.16402,0,0
4,NEURON PROJECTION,0.25001,-0.1609,-0.10034,0,0
4,BIOCARTA EIF4 PATHWAY,0.044685,-0.16307,-0.13282,0,0
4,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.42347,-0.16749,-0.096485,0,0
4,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.046579,-0.16885,-0.12881,0,0
4,CALMODULIN BINDING,0.53742,-0.17008,-0.055165,0,0
4,PID INTEGRIN3 PATHWAY,0.4545,-0.17311,-0.13975,0,0
4,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.14048,-0.17582,-0.13677,0,0
4,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,0.085627,-0.17723,-0.17971,0,0
4,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.10465,-0.1775,-0.24792,0,0
4,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.070855,-0.17837,-0.18628,0,0
4,SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.093897,-0.17899,-0.15355,0,0
4,REACTOME PACKAGING OF TELOMERE ENDS,0.80312,-0.17944,0.0045477,0,0
4,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.11039,-0.18782,-0.13242,0,0
4,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.093897,-0.19456,-0.17974,0,0
4,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.052669,-0.19584,-0.24062,0,0
4,BRAIN DEVELOPMENT,0.061812,-0.19613,-0.15283,0,0
4,REACTOME INWARDLY RECTIFYING K CHANNELS,0.11434,-0.19719,-0.16874,0,0
4,RRNA PROCESSING,0.063042,-0.19903,-0.17474,0,0
4,RRNA METABOLIC PROCESS,0.063042,-0.19903,-0.17474,0,0
4,REACTOME TELOMERE MAINTENANCE,0.26098,-0.20249,-0.072938,0,0
4,EXTERNAL SIDE OF PLASMA MEMBRANE,0.061812,-0.20815,-0.14051,0,0
4,BIOCARTA NOS1 PATHWAY,0.077957,-0.20924,-0.1742,0,0
4,RIBOSOME BIOGENESIS AND ASSEMBLY,0.085627,-0.20981,-0.16827,0,0
4,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.19095,-0.21046,-0.12303,0,0
4,COPPER ION BINDING,0.27999,-0.2117,-0.10407,0,0
4,REACTOME CRMPS IN SEMA3A SIGNALING,0.15015,-0.21321,-0.10293,0,0
4,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.17374,-0.21374,-0.084827,0,0
4,ADHERENS JUNCTION,0.046579,-0.21701,-0.18594,0,0
4,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.068167,-0.22159,-0.16356,0,0
4,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.14048,-0.28157,-0.13739,0,0
4,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,0.065563,-0.28729,-0.21837,0,0
4,REGULATION OF NEUROGENESIS,0.097379,-0.32776,-0.27199,0,0
5,PID SYNDECAN 3 PATHWAY,0.0019282,0.48914,0.38171,1,1
5,ACTIVATION OF IMMUNE RESPONSE,0.0026572,0.38244,0.29792,1,1
5,CHROMATIN REMODELING COMPLEX,0.00045924,0.37418,0.3561,1,1
5,EMBRYONIC MORPHOGENESIS,0.0083534,0.34396,0.26869,1,1
5,BIOCARTA CSK PATHWAY,0.013139,0.3056,0.2134,1,1
5,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,0.0027346,0.2886,0.26823,1,1
5,REACTOME G0 AND EARLY G1,0.0025817,0.25357,0.22688,1,1
5,BIOCARTA BAD PATHWAY,0.0057817,0.24359,0.24817,1,1
5,EMBRYONIC DEVELOPMENT,0.0039469,0.22956,0.1881,1,1
5,PATTERN SPECIFICATION PROCESS,0.019739,0.22332,0.16479,1,1
5,REACTOME DSCAM INTERACTIONS,0.02068,0.22164,0.19986,1,1
5,MICROTUBULE BASED MOVEMENT,0.025994,0.22104,0.20736,1,1
5,SPLICEOSOME ASSEMBLY,0.0018173,0.22085,0.19468,1,1
5,SPINDLE MICROTUBULE,0.014138,0.21441,0.17106,1,1
5,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.0032441,0.21206,0.20404,1,1
5,SA G1 AND S PHASES,0.0028141,0.2077,0.21636,1,1
5,MICROTUBULE ORGANIZING CENTER PART,0.0069616,0.20568,0.19147,1,1
5,MICROTUBULE CYTOSKELETON,0.00037661,0.18946,0.17291,1,1
5,POSITIVE REGULATION OF IMMUNE RESPONSE,0.031748,0.18811,0.19449,1,1
5,CENTROSOME,0.0026572,0.18638,0.15832,1,1
5,BIOCARTA MCM PATHWAY,0.0051916,0.16862,0.19644,1,1
5,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.013139,0.16807,0.10951,1,1
5,REACTOME MRNA 3 END PROCESSING,0.027803,0.15536,0.11535,1,1
5,MICROTUBULE ORGANIZING CENTER,0.0024367,0.15427,0.14069,1,1
5,ACTIN FILAMENT ORGANIZATION,0.025414,0.14294,0.11069,1,1
5,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.035393,0.13919,0.17946,1,1
5,MRNA PROCESSING GO 0006397,0.0040578,0.13538,0.10745,1,1
5,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,0.043763,0.13298,0.17442,1,1
5,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.018836,0.093619,0.10849,1,1
5,REACTOME CRMPS IN SEMA3A SIGNALING,0.00032948,0.39722,0.55811,1,0
5,SA REG CASCADE OF CYCLIN EXPR,0.0024367,0.33184,0.28505,1,0
5,KINESIN COMPLEX,0.00049035,0.29981,0.3423,1,0
5,MICROTUBULE ASSOCIATED COMPLEX,0.0014299,0.26434,0.29475,1,0
5,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.0071468,0.25873,0.2481,1,0
5,MICROTUBULE,0.016339,0.16402,0.15247,1,0
5,MICROTUBULE BINDING,0.016734,0.16286,0.18128,1,0
5,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.015574,0.1557,0.18334,1,0
5,CHANNEL REGULATOR ACTIVITY,0.043763,0.15485,0.15925,1,0
5,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.030383,0.14953,0.16625,1,0
5,BIOCARTA SHH PATHWAY,0.037747,0.14381,0.16695,1,0
5,CHROMATIN,0.03939,0.13333,0.12616,1,0
5,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.02068,0.12919,0.16616,1,0
5,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.014841,0.12075,0.14327,1,0
5,KEGG TASTE TRANSDUCTION,0.040234,0.11405,0.20431,1,0
5,CHROMOSOMAL PART,0.020205,0.059162,0.094344,1,0
5,NUCLEUS,0.014841,-0.03744,-0.048285,1,0
5,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.031748,-0.039081,-0.10841,1,0
5,NON MEMBRANE BOUND ORGANELLE,0.027188,-0.039414,-0.052233,1,0
5,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.027188,-0.039414,-0.052233,1,0
5,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.043763,-0.044126,-0.052009,1,0
5,INTRACELLULAR ORGANELLE PART,0.013798,-0.048642,-0.044523,1,0
5,ORGANELLE PART,0.016734,-0.049308,-0.04345,1,0
5,ENDONUCLEASE ACTIVITY,0.033166,-0.052785,-0.11993,1,0
5,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0013457,-0.053981,-0.065437,1,0
5,RNA BIOSYNTHETIC PROCESS,0.036164,-0.055335,-0.054742,1,0
5,RNA METABOLIC PROCESS,0.013798,-0.056362,-0.053766,1,0
5,TRANSCRIPTION DNA DEPENDENT,0.035393,-0.056849,-0.054984,1,0
5,REGULATION OF CELLULAR METABOLIC PROCESS,0.0041716,-0.057381,-0.077584,1,0
5,PROTEIN COMPLEX,0.0031536,-0.058508,-0.0582,1,0
5,CYTOPLASMIC VESICLE,0.02843,-0.05941,-0.096541,1,0
5,PID CXCR4 PATHWAY,0.026586,-0.059573,-0.12032,1,0
5,REGULATION OF GENE EXPRESSION,0.015203,-0.060058,-0.067263,1,0
5,TRANSCRIPTION,0.023741,-0.060721,-0.056035,1,0
5,REGULATION OF DNA BINDING,0.041093,-0.060953,-0.10147,1,0
5,REGULATION OF METABOLIC PROCESS,0.0038387,-0.061259,-0.078916,1,0
5,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.024846,-0.062088,-0.10004,1,0
5,MEMBRANE BOUND VESICLE,0.016734,-0.063308,-0.10318,1,0
5,METHYLTRANSFERASE ACTIVITY,0.041967,-0.065539,-0.10281,1,0
5,VESICLE,0.014486,-0.06707,-0.10258,1,0
5,BIOPOLYMER METABOLIC PROCESS,0.00065623,-0.069008,-0.08041,1,0
5,PHOSPHORYLATION,0.019739,-0.069084,-0.083355,1,0
5,KEGG CHEMOKINE SIGNALING PATHWAY,0.016339,-0.069683,-0.1001,1,0
5,ENDOMEMBRANE SYSTEM,0.0067808,-0.072038,-0.1057,1,0
5,PEPTIDASE ACTIVITY,0.0090226,-0.073408,-0.12349,1,0
5,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,0.038561,-0.074831,-0.099937,1,0
5,TRANSCRIPTION COFACTOR ACTIVITY,0.033894,-0.07685,-0.062694,1,0
5,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.0041716,-0.077473,-0.10304,1,0
5,ST B CELL ANTIGEN RECEPTOR,0.01282,-0.077642,-0.13054,1,0
5,CARBOHYDRATE METABOLIC PROCESS,0.0094949,-0.077703,-0.10777,1,0
5,PEPTIDYL AMINO ACID MODIFICATION,0.033894,-0.077772,-0.094336,1,0
5,TRANSITION METAL ION BINDING,0.036948,-0.078494,-0.093259,1,0
5,MEMBRANE ENCLOSED LUMEN,0.0036303,-0.078914,-0.076775,1,0
5,ORGANELLE LUMEN,0.0036303,-0.078914,-0.076775,1,0
5,PID CASPASE PATHWAY,0.029719,-0.080665,-0.1491,1,0
5,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.043763,-0.080676,-0.1219,1,0
5,PHOSPHOLIPID METABOLIC PROCESS,0.029068,-0.080954,-0.09286,1,0
5,TRANSCRIPTION FACTOR BINDING,0.031748,-0.081044,-0.062215,1,0
5,MACROMOLECULAR COMPLEX,0.00087311,-0.081505,-0.069653,1,0
5,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.035393,-0.082527,-0.15896,1,0
5,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.029068,-0.082779,-0.087197,1,0
5,ORGAN DEVELOPMENT,0.0045306,-0.083048,-0.11132,1,0
5,PROTEIN AMINO ACID PHOSPHORYLATION,0.009256,-0.08333,-0.093893,1,0
5,SMALL GTPASE BINDING,0.026586,-0.084097,-0.098349,1,0
5,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,0.0090226,-0.084536,-0.099705,1,0
5,REGULATION OF BINDING,0.035393,-0.084948,-0.093463,1,0
5,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.019739,-0.085324,-0.1062,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.015953,-0.086043,-0.1417,1,0
5,ION BINDING,0.0094949,-0.087212,-0.081129,1,0
5,KEGG LONG TERM POTENTIATION,0.034637,-0.087537,-0.11256,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.010506,-0.087577,-0.13784,1,0
5,REGULATION OF BODY FLUID LEVELS,0.023205,-0.090317,-0.12764,1,0
5,REGULATION OF MOLECULAR FUNCTION,0.0038387,-0.090329,-0.099304,1,0
5,KEGG MELANOMA,0.041967,-0.090377,-0.089232,1,0
5,REACTOME PERK REGULATED GENE EXPRESSION,0.042857,-0.090848,-0.12256,1,0
5,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,0.020205,-0.092049,-0.11022,1,0
5,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.010245,-0.092359,-0.21568,1,0
5,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.015203,-0.092521,-0.20925,1,0
5,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,0.014486,-0.092759,-0.20557,1,0
5,SENSORY PERCEPTION,0.014486,-0.092836,-0.091,1,0
5,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,-0.092988,-0.10793,1,0
5,GROWTH,0.013139,-0.093145,-0.10791,1,0
5,IMMUNE SYSTEM PROCESS,0.03939,-0.093263,-0.12012,1,0
5,REACTOME SHC RELATED EVENTS,0.036948,-0.093355,-0.12423,1,0
5,PID IGF1 PATHWAY,0.012203,-0.093806,-0.12182,1,0
5,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.03245,-0.093911,-0.10755,1,0
5,RESPONSE TO STRESS,0.0023671,-0.094102,-0.11806,1,0
5,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.025994,-0.094761,-0.085334,1,0
5,REGULATION OF CELL ADHESION,0.0090226,-0.094883,-0.20597,1,0
5,REACTOME SIGNALING BY ERBB4,0.0028141,-0.095558,-0.11845,1,0
5,REGULATION OF KINASE ACTIVITY,0.043763,-0.095673,-0.074095,1,0
5,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.036164,-0.096248,-0.11502,1,0
5,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.0097392,-0.096393,-0.12824,1,0
5,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.0050528,-0.096789,-0.10766,1,0
5,KEGG PYRIMIDINE METABOLISM,0.010506,-0.096946,-0.1427,1,0
5,MACROMOLECULAR COMPLEX ASSEMBLY,9.389e-05,-0.096981,-0.11238,1,0
5,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.035393,-0.097278,-0.089474,1,0
5,GOLGI APPARATUS,0.00067758,-0.09733,-0.10665,1,0
5,NUCLEOTIDE BINDING,0.0013457,-0.097332,-0.10642,1,0
5,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.011047,-0.09737,-0.16689,1,0
5,NEUROLOGICAL SYSTEM PROCESS,0.038561,-0.097659,-0.077831,1,0
5,ENZYME REGULATOR ACTIVITY,0.001872,-0.098132,-0.12344,1,0
5,POSITIVE REGULATION OF METABOLIC PROCESS,0.0032441,-0.098812,-0.10518,1,0
5,PID P53DOWNSTREAMPATHWAY,0.030383,-0.099299,-0.15217,1,0
5,CELLULAR COMPONENT ASSEMBLY,0.00032948,-0.099983,-0.10635,1,0
5,CYTOSOL,0.00021167,-0.10077,-0.13131,1,0
5,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.016339,-0.10129,-0.087703,1,0
5,REACTOME DIABETES PATHWAYS,0.0064317,-0.10174,-0.15979,1,0
5,ATP BINDING,0.0066042,-0.10178,-0.10106,1,0
5,REACTOME G ALPHA Q SIGNALLING EVENTS,0.02843,-0.10238,-0.088416,1,0
5,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.0017123,-0.10252,-0.13904,1,0
5,SERINE HYDROLASE ACTIVITY,0.0016129,-0.10252,-0.23179,1,0
5,KEGG TGF BETA SIGNALING PATHWAY,0.031748,-0.10276,-0.12204,1,0
5,PURINE RIBONUCLEOTIDE BINDING,0.00036427,-0.10301,-0.11909,1,0
5,PHOSPHOLIPID BINDING,0.042857,-0.10342,-0.10995,1,0
5,NEGATIVE REGULATION OF CELL PROLIFERATION,0.0067808,-0.1037,-0.12881,1,0
5,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.0032441,-0.10375,-0.10912,1,0
5,SERINE TYPE PEPTIDASE ACTIVITY,0.0019282,-0.10419,-0.22948,1,0
5,CELLULAR LOCALIZATION,2.0033e-05,-0.10464,-0.11533,1,0
5,ADENYL NUCLEOTIDE BINDING,0.0020453,-0.10481,-0.10978,1,0
5,MACROMOLECULE LOCALIZATION,0.00013917,-0.10555,-0.11472,1,0
5,KEGG GNRH SIGNALING PATHWAY,0.012508,-0.10633,-0.11295,1,0
5,RESPONSE TO BACTERIUM,0.0040578,-0.10635,-0.15126,1,0
5,ADENYL RIBONUCLEOTIDE BINDING,0.0036303,-0.10638,-0.1077,1,0
5,PID BCR 5PATHWAY,0.030383,-0.10665,-0.10905,1,0
5,REACTOME ADAPTIVE IMMUNE SYSTEM,0.0013457,-0.10666,-0.11672,1,0
5,INTRINSIC TO ORGANELLE MEMBRANE,0.010773,-0.10714,-0.1368,1,0
5,TRANSMEMBRANE RECEPTOR ACTIVITY,0.013465,-0.10717,-0.098762,1,0
5,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,0.031748,-0.10799,-0.12415,1,0
5,EPIDERMIS DEVELOPMENT,0.02268,-0.10801,-0.17011,1,0
5,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.027803,-0.10802,-0.11603,1,0
5,PID ERBB1 DOWNSTREAM PATHWAY,0.009256,-0.10873,-0.11935,1,0
5,NEGATIVE REGULATION OF CELLULAR PROCESS,0.0014299,-0.10904,-0.1174,1,0
5,IMMUNE RESPONSE,0.018836,-0.10957,-0.14456,1,0
5,ESTABLISHMENT OF CELLULAR LOCALIZATION,1.1493e-05,-0.11016,-0.1239,1,0
5,PROTEIN AMINO ACID LIPIDATION,0.0064317,-0.11017,-0.15736,1,0
5,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.015203,-0.11017,-0.1007,1,0
5,POST TRANSLATIONAL PROTEIN MODIFICATION,0.0011549,-0.11034,-0.10852,1,0
5,PROTEIN IMPORT INTO NUCLEUS,0.036164,-0.11044,-0.12226,1,0
5,ENDOPEPTIDASE ACTIVITY,0.0025083,-0.11084,-0.14804,1,0
5,PROTEIN COMPLEX BINDING,0.0066042,-0.11088,-0.16815,1,0
5,INTEGRAL TO ORGANELLE MEMBRANE,0.009256,-0.11092,-0.14689,1,0
5,MULTI ORGANISM PROCESS,0.011612,-0.11143,-0.13826,1,0
5,PROTEIN KINASE ACTIVITY,0.0025083,-0.11171,-0.1165,1,0
5,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,0.001228,-0.11194,-0.12014,1,0
5,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.00084609,-0.11219,-0.11713,1,0
5,REGULATION OF PROTEIN KINASE ACTIVITY,0.041967,-0.1124,-0.078399,1,0
5,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.034637,-0.11257,-0.13013,1,0
5,CELLULAR CATION HOMEOSTASIS,0.009256,-0.11366,-0.13003,1,0
5,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.015953,-0.11382,-0.13714,1,0
5,PURINE NUCLEOTIDE BINDING,0.00026903,-0.11484,-0.12032,1,0
5,TRANSPORT,1.7118e-05,-0.11499,-0.13179,1,0
5,KEGG MAPK SIGNALING PATHWAY,0.0021062,-0.11505,-0.11378,1,0
5,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.022165,-0.11519,-0.12473,1,0
5,COAGULATION,0.029719,-0.11526,-0.16572,1,0
5,PID IFNGPATHWAY,0.0028957,-0.11532,-0.18144,1,0
5,CATION BINDING,0.0037331,-0.1157,-0.10204,1,0
5,REACTOME GLYCOLYSIS,0.029068,-0.11576,-0.23078,1,0
5,ION HOMEOSTASIS,0.0079323,-0.11581,-0.12259,1,0
5,KEGG PARKINSONS DISEASE,0.0075304,-0.11605,-0.1474,1,0
5,WOUND HEALING,0.014138,-0.11606,-0.16439,1,0
5,MEMBRANE ORGANIZATION AND BIOGENESIS,0.00042998,-0.1161,-0.15479,1,0
5,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.019739,-0.11658,-0.16994,1,0
5,PID TGFBRPATHWAY,0.023205,-0.11674,-0.15746,1,0
5,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.0090226,-0.11679,-0.20459,1,0
5,REGULATION OF CATALYTIC ACTIVITY,0.0066042,-0.11688,-0.098102,1,0
5,REACTOME SIGNALING BY GPCR,0.012203,-0.11694,-0.09319,1,0
5,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0025817,-0.11707,-0.1677,1,0
5,CATION HOMEOSTASIS,0.0060989,-0.11718,-0.13586,1,0
5,CALCIUM ION BINDING,0.018836,-0.11723,-0.11199,1,0
5,KINASE ACTIVITY,0.00079435,-0.11739,-0.11485,1,0
5,CYTOSOLIC PART,0.031059,-0.11764,-0.1326,1,0
5,REACTOME SIGNALING BY ILS,0.0045306,-0.11784,-0.16054,1,0
5,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0033369,-0.11809,-0.17129,1,0
5,ESTABLISHMENT OF LOCALIZATION,2.1663e-05,-0.11827,-0.13738,1,0
5,BIOPOLYMER MODIFICATION,0.00030804,-0.11827,-0.11889,1,0
5,REACTOME SIGNALING BY INSULIN RECEPTOR,0.00010462,-0.1183,-0.12789,1,0
5,BIOCARTA ERK PATHWAY,0.019739,-0.11844,-0.14697,1,0
5,KEGG ETHER LIPID METABOLISM,0.011612,-0.11871,-0.18415,1,0
5,REACTOME MEMBRANE TRAFFICKING,0.0015653,-0.11897,-0.16426,1,0
5,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,0.01282,-0.1195,-0.24954,1,0
5,KEGG COMPLEMENT AND COAGULATION CASCADES,0.00353,-0.11955,-0.25024,1,0
5,BIOCARTA MAL PATHWAY,0.0024367,-0.11974,-0.13036,1,0
5,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0083534,-0.11975,-0.10317,1,0
5,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.01282,-0.11982,-0.1247,1,0
5,PROTEIN HETERODIMERIZATION ACTIVITY,0.0010528,-0.11985,-0.1317,1,0
5,PROTEIN MODIFICATION PROCESS,0.00047456,-0.11989,-0.1191,1,0
5,KEGG PATHWAYS IN CANCER,0.0045306,-0.11993,-0.13598,1,0
5,PROTEOLYSIS,0.0083534,-0.1202,-0.14834,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.00014935,-0.12054,-0.12233,1,0
5,ORGAN MORPHOGENESIS,0.013798,-0.12061,-0.11945,1,0
5,GOLGI APPARATUS PART,0.00021909,-0.12071,-0.14717,1,0
5,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.027188,-0.12121,-0.14089,1,0
5,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.019283,-0.12202,-0.19566,1,0
5,KEGG REGULATION OF ACTIN CYTOSKELETON,0.0047853,-0.12244,-0.14146,1,0
5,RESPONSE TO EXTERNAL STIMULUS,0.0024367,-0.12299,-0.14394,1,0
5,PID CDC42 REG PATHWAY,0.017137,-0.12315,-0.16026,1,0
5,INTRACELLULAR TRANSPORT,5.4121e-05,-0.12321,-0.1216,1,0
5,PROTEIN LOCALIZATION,0.00010845,-0.12343,-0.12977,1,0
5,REGULATION OF RAS GTPASE ACTIVITY,0.014138,-0.12357,-0.14522,1,0
5,REACTOME ACYL CHAIN REMODELLING OF PC,0.031059,-0.1236,-0.16353,1,0
5,REACTOME GPCR DOWNSTREAM SIGNALING,0.0083534,-0.12381,-0.10218,1,0
5,REACTOME BILE ACID AND BILE SALT METABOLISM,0.021165,-0.12385,-0.15666,1,0
5,VESICLE MEMBRANE,0.03939,-0.12393,-0.12874,1,0
5,KEGG SPHINGOLIPID METABOLISM,0.02843,-0.12399,-0.13329,1,0
5,PID CMYB PATHWAY,0.042857,-0.12408,-0.10528,1,0
5,RECEPTOR BINDING,0.0020453,-0.12437,-0.13443,1,0
5,NUCLEASE ACTIVITY,0.017549,-0.12457,-0.098991,1,0
5,KEGG LONG TERM DEPRESSION,0.0036303,-0.12464,-0.15366,1,0
5,LIGASE ACTIVITY,0.0014299,-0.12468,-0.14092,1,0
5,PID GMCSF PATHWAY,0.027803,-0.12476,-0.16688,1,0
5,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.029719,-0.12535,-0.13312,1,0
5,INTRACELLULAR SIGNALING CASCADE,0.0047853,-0.12569,-0.11273,1,0
5,ENVELOPE,2.1663e-05,-0.12622,-0.13646,1,0
5,ORGANELLE ENVELOPE,2.1663e-05,-0.12622,-0.13646,1,0
5,BIOCARTA MET PATHWAY,0.020205,-0.1266,-0.13859,1,0
5,KEGG HUNTINGTONS DISEASE,0.00014418,-0.1268,-0.14058,1,0
5,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,0.0014738,-0.12722,-0.15717,1,0
5,PERINUCLEAR REGION OF CYTOPLASM,0.0064317,-0.12735,-0.11417,1,0
5,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.025994,-0.12747,-0.14713,1,0
5,REACTOME IMMUNE SYSTEM,0.00074557,-0.12795,-0.15108,1,0
5,REPRODUCTIVE PROCESS,0.02268,-0.12795,-0.12733,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,0.036164,-0.12796,-0.15283,1,0
5,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015574,-0.12829,-0.14756,1,0
5,REACTOME GPCR LIGAND BINDING,0.0099891,-0.12919,-0.10017,1,0
5,SIGNAL SEQUENCE BINDING,0.0071468,-0.12989,-0.16658,1,0
5,BIOPOLYMER CATABOLIC PROCESS,0.0017641,-0.1299,-0.11822,1,0
5,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.00022676,-0.13015,-0.14857,1,0
5,PID IL2 PI3KPATHWAY,0.027188,-0.13037,-0.15532,1,0
5,TRANSLATION REGULATOR ACTIVITY,0.0049174,-0.13067,-0.22787,1,0
5,RECEPTOR ACTIVITY,0.00074557,-0.13113,-0.13476,1,0
5,PROTEIN TRANSPORT,7.2754e-05,-0.13131,-0.14137,1,0
5,ECTODERM DEVELOPMENT,0.024846,-0.13132,-0.1644,1,0
5,SIGNAL TRANSDUCTION,0.001986,-0.13172,-0.11856,1,0
5,BIOCARTA NFKB PATHWAY,0.021165,-0.13195,-0.22458,1,0
5,RESPONSE TO CHEMICAL STIMULUS,0.00084609,-0.13232,-0.13548,1,0
5,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.00055855,-0.13252,-0.1359,1,0
5,PROTEIN KINASE CASCADE,0.0087944,-0.13281,-0.14179,1,0
5,KEGG GAP JUNCTION,0.0039469,-0.13324,-0.12885,1,0
5,LIPID BINDING,0.0046564,-0.13328,-0.14162,1,0
5,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.012508,-0.13334,-0.1249,1,0
5,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,0.0079323,-0.13406,-0.18345,1,0
5,REACTOME HEMOSTASIS,0.00044439,-0.13412,-0.13416,1,0
5,CELL PROLIFERATION GO 0008283,7.013e-05,-0.13425,-0.1524,1,0
5,KEGG DRUG METABOLISM OTHER ENZYMES,0.0041716,-0.13455,-0.23274,1,0
5,NUCLEOCYTOPLASMIC TRANSPORT,0.0090226,-0.1347,-0.11904,1,0
5,REACTOME EGFR DOWNREGULATION,0.0085714,-0.13471,-0.21029,1,0
5,KEGG MELANOGENESIS,0.022165,-0.13498,-0.10051,1,0
5,PID SYNDECAN 1 PATHWAY,0.013465,-0.13511,-0.24242,1,0
5,CYTOPLASM,1.6015e-06,-0.1352,-0.14015,1,0
5,SECOND MESSENGER MEDIATED SIGNALING,0.0085714,-0.13532,-0.11431,1,0
5,VESICULAR FRACTION,0.036948,-0.13544,-0.14007,1,0
5,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.0099891,-0.13551,-0.20635,1,0
5,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.0032441,-0.13555,-0.14498,1,0
5,REGULATION OF CELL PROLIFERATION,0.00035231,-0.13565,-0.13938,1,0
5,PROTEIN COMPLEX ASSEMBLY,0.00030804,-0.13576,-0.15329,1,0
5,KEGG RENAL CELL CARCINOMA,0.042857,-0.13584,-0.10914,1,0
5,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.0023671,-0.13589,-0.17303,1,0
5,NUCLEAR TRANSPORT,0.0090226,-0.13604,-0.11748,1,0
5,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.00044439,-0.13604,-0.12775,1,0
5,SECRETION,0.015953,-0.13605,-0.1335,1,0
5,BIOCARTA FMLP PATHWAY,0.013798,-0.13618,-0.12757,1,0
5,ENDOPLASMIC RETICULUM PART,0.0067808,-0.13643,-0.14565,1,0
5,ESTABLISHMENT OF PROTEIN LOCALIZATION,3.5759e-05,-0.13684,-0.14863,1,0
5,IMMUNE SYSTEM DEVELOPMENT,0.0020453,-0.13712,-0.17551,1,0
5,GOLGI ASSOCIATED VESICLE,0.013798,-0.1375,-0.12149,1,0
5,PID RB 1PATHWAY,0.0060989,-0.13809,-0.11926,1,0
5,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.012203,-0.13828,-0.17583,1,0
5,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,0.040234,-0.1383,-0.17147,1,0
5,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.0085714,-0.13839,-0.22068,1,0
5,MEMBRANE,0.00014935,-0.13881,-0.14893,1,0
5,TISSUE DEVELOPMENT,0.0053338,-0.13891,-0.1718,1,0
5,TRANSPORT VESICLE,0.023741,-0.13901,-0.17892,1,0
5,PEPTIDE BINDING,0.0001547,-0.1394,-0.15555,1,0
5,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.0036303,-0.13962,-0.14603,1,0
5,CELLULAR PROTEIN COMPLEX ASSEMBLY,2.1663e-05,-0.13964,-0.18796,1,0
5,ORGANIC ACID TRANSPORT,0.015203,-0.13992,-0.17478,1,0
5,CARBOXYLIC ACID TRANSPORT,0.015203,-0.13992,-0.17478,1,0
5,MEMBRANE PART,0.00025131,-0.13998,-0.14474,1,0
5,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00087311,-0.14008,-0.16607,1,0
5,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.00057693,-0.14009,-0.14972,1,0
5,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.036164,-0.14064,-0.12935,1,0
5,ST GA13 PATHWAY,0.0012662,-0.141,-0.15873,1,0
5,REGULATION OF BIOLOGICAL QUALITY,0.00034072,-0.14141,-0.14251,1,0
5,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.011612,-0.14156,-0.16858,1,0
5,PROTEIN FOLDING,0.0017123,-0.1419,-0.19653,1,0
5,REGULATION OF MAP KINASE ACTIVITY,0.029068,-0.14207,-0.1138,1,0
5,REACTOME PROTEIN FOLDING,0.001191,-0.14222,-0.17447,1,0
5,REACTOME LYSOSOME VESICLE BIOGENESIS,0.036948,-0.1423,-0.22873,1,0
5,LIPID BIOSYNTHETIC PROCESS,0.0057817,-0.14255,-0.16885,1,0
5,POSITIVE REGULATION OF BIOLOGICAL PROCESS,0.0021689,-0.14268,-0.13631,1,0
5,THIOLESTER HYDROLASE ACTIVITY,0.024846,-0.14276,-0.15241,1,0
5,GOLGI VESICLE TRANSPORT,0.0079323,-0.14285,-0.13088,1,0
5,AMINO ACID TRANSPORT,0.03939,-0.1429,-0.20965,1,0
5,RESPONSE TO OXIDATIVE STRESS,0.0062634,-0.14292,-0.18586,1,0
5,PID MET PATHWAY,0.0030654,-0.14295,-0.13139,1,0
5,CELLULAR MACROMOLECULE METABOLIC PROCESS,1.0184e-05,-0.14309,-0.14506,1,0
5,KEGG RNA POLYMERASE,0.027803,-0.14318,-0.19513,1,0
5,REACTOME PI3K CASCADE,0.00059588,-0.14328,-0.13663,1,0
5,PROTEIN METABOLIC PROCESS,1.2962e-05,-0.14333,-0.14478,1,0
5,IDENTICAL PROTEIN BINDING,0.0010206,-0.14342,-0.13721,1,0
5,REACTOME PHOSPHOLIPID METABOLISM,7.2754e-05,-0.14378,-0.16655,1,0
5,RIBONUCLEASE ACTIVITY,0.0062634,-0.1438,-0.17598,1,0
5,PLASMA MEMBRANE PART,0.00079435,-0.14382,-0.14662,1,0
5,CYTOPLASMIC PART,1.1267e-06,-0.14444,-0.14507,1,0
5,CHEMICAL HOMEOSTASIS,0.0022992,-0.14447,-0.13925,1,0
5,SMALL GTPASE REGULATOR ACTIVITY,0.021165,-0.1445,-0.12374,1,0
5,CARBOHYDRATE TRANSPORT,0.019283,-0.14455,-0.12265,1,0
5,POSITIVE REGULATION OF CELLULAR PROCESS,0.0025817,-0.14461,-0.13709,1,0
5,PID EPHA FWDPATHWAY,0.014841,-0.14493,-0.19454,1,0
5,INTRINSIC TO MEMBRANE,0.00029782,-0.14523,-0.15385,1,0
5,KEGG CALCIUM SIGNALING PATHWAY,0.00090094,-0.14524,-0.14519,1,0
5,CELL CYCLE ARREST GO 0007050,0.0047853,-0.14586,-0.15842,1,0
5,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.00017186,-0.14592,-0.15939,1,0
5,CELLULAR HOMEOSTASIS,0.0039469,-0.14603,-0.14251,1,0
5,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.0039469,-0.14607,-0.1087,1,0
5,INTEGRAL TO MEMBRANE,0.00026003,-0.1464,-0.15544,1,0
5,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.0069616,-0.14659,-0.17788,1,0
5,ORGANELLE MEMBRANE,0.00022676,-0.14677,-0.13128,1,0
5,RNA BINDING,0.0042883,-0.14681,-0.15038,1,0
5,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.035393,-0.14684,-0.23006,1,0
5,SULFUR METABOLIC PROCESS,0.012203,-0.14691,-0.16319,1,0
5,BIOCARTA AT1R PATHWAY,0.016734,-0.14712,-0.14849,1,0
5,PROTEIN DIMERIZATION ACTIVITY,0.0021062,-0.14724,-0.13242,1,0
5,REGULATION OF DNA REPLICATION,0.02166,-0.14729,-0.208,1,0
5,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.0013457,-0.14757,-0.18503,1,0
5,BIOCARTA ARAP PATHWAY,0.009256,-0.14764,-0.18945,1,0
5,PID HDAC CLASSIII PATHWAY,0.0083534,-0.14805,-0.19314,1,0
5,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02268,-0.14806,-0.19597,1,0
5,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,0.0021689,-0.14806,-0.18418,1,0
5,CELLULAR PROTEIN METABOLIC PROCESS,1.2454e-05,-0.14813,-0.14498,1,0
5,GTP BINDING,0.012508,-0.14839,-0.12297,1,0
5,STEROID METABOLIC PROCESS,0.0060989,-0.14893,-0.22967,1,0
5,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.0066042,-0.14894,-0.12303,1,0
5,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.024846,-0.14914,-0.15604,1,0
5,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,0.014486,-0.14942,-0.12064,1,0
5,DEFENSE RESPONSE,0.011047,-0.14949,-0.15903,1,0
5,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.037747,-0.14976,-0.16556,1,0
5,CELL DEVELOPMENT,0.00034072,-0.14982,-0.14103,1,0
5,PLASMA MEMBRANE,0.00044439,-0.1501,-0.15534,1,0
5,PEPTIDE RECEPTOR ACTIVITY,0.017137,-0.15029,-0.12169,1,0
5,REACTOME CELL JUNCTION ORGANIZATION,0.041093,-0.15041,-0.14479,1,0
5,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,0.011047,-0.15092,-0.17166,1,0
5,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.0011199,-0.15119,-0.15715,1,0
5,BIOCARTA EDG1 PATHWAY,0.014138,-0.15129,-0.11871,1,0
5,APOPTOSIS GO,0.0001547,-0.1514,-0.16334,1,0
5,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0073363,-0.15151,-0.11146,1,0
5,ENDOPLASMIC RETICULUM,8.7323e-05,-0.15187,-0.15405,1,0
5,KEGG NOTCH SIGNALING PATHWAY,0.027803,-0.15193,-0.14405,1,0
5,DNA POLYMERASE ACTIVITY,0.0047853,-0.15195,-0.15978,1,0
5,REACTOME INNATE IMMUNE SYSTEM,0.0015189,-0.15221,-0.18182,1,0
5,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0038387,-0.15291,-0.25622,1,0
5,NEGATIVE REGULATION OF CELL CYCLE,0.0045306,-0.15298,-0.15038,1,0
5,RESPONSE TO WOUNDING,0.0019282,-0.1531,-0.19068,1,0
5,REACTOME NUCLEAR SIGNALING BY ERBB4,0.014486,-0.15325,-0.14432,1,0
5,REGULATION OF MUSCLE CONTRACTION,0.041093,-0.15336,-0.12642,1,0
5,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,0.021165,-0.15343,-0.22496,1,0
5,DEVELOPMENTAL MATURATION,0.037747,-0.15347,-0.19207,1,0
5,ORGANELLE INNER MEMBRANE,0.00029782,-0.15356,-0.1719,1,0
5,ST G ALPHA I PATHWAY,0.0011199,-0.15371,-0.1774,1,0
5,REGULATION OF DEVELOPMENTAL PROCESS,0.00034072,-0.15409,-0.16353,1,0
5,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.0071468,-0.15416,-0.13081,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.023741,-0.15442,-0.10558,1,0
5,KEGG OXIDATIVE PHOSPHORYLATION,0.0010206,-0.15448,-0.18599,1,0
5,REACTOME GLUCOSE TRANSPORT,0.001872,-0.15495,-0.20382,1,0
5,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.03245,-0.15548,-0.14842,1,0
5,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,6.0504e-05,-0.15577,-0.18336,1,0
5,PID VEGFR1 2 PATHWAY,0.0059384,-0.15581,-0.14696,1,0
5,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.0069616,-0.15652,-0.12645,1,0
5,GROWTH FACTOR BINDING,0.018836,-0.15668,-0.1587,1,0
5,BIOCARTA TALL1 PATHWAY,0.0049174,-0.15672,-0.16083,1,0
5,REACTOME SHC1 EVENTS IN EGFR SIGNALING,0.025414,-0.15681,-0.17794,1,0
5,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0049174,-0.15712,-0.23455,1,0
5,COPPER ION BINDING,0.02068,-0.1575,-0.24811,1,0
5,INTRINSIC TO PLASMA MEMBRANE,0.00049035,-0.15784,-0.1577,1,0
5,BIOCARTA CHREBP2 PATHWAY,0.011326,-0.15804,-0.15074,1,0
5,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.0075304,-0.15831,-0.16993,1,0
5,CELL MATRIX ADHESION,0.012508,-0.15837,-0.16709,1,0
5,CELL SUBSTRATE ADHESION,0.012508,-0.15837,-0.16709,1,0
5,ENDOPLASMIC RETICULUM MEMBRANE,0.00353,-0.15852,-0.15003,1,0
5,RECEPTOR COMPLEX,0.025414,-0.15901,-0.1496,1,0
5,BIOCARTA TOLL PATHWAY,0.00079435,-0.15929,-0.20485,1,0
5,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,0.019739,-0.15934,-0.12512,1,0
5,CAMP MEDIATED SIGNALING,0.019739,-0.15934,-0.12512,1,0
5,EXTRACELLULAR REGION,0.0011549,-0.15964,-0.17461,1,0
5,REACTOME SIGNALING BY NOTCH1,0.0056288,-0.15975,-0.17451,1,0
5,REGULATION OF RHO GTPASE ACTIVITY,0.02166,-0.15979,-0.14548,1,0
5,INTEGRAL TO PLASMA MEMBRANE,0.00042998,-0.16,-0.15875,1,0
5,KEGG REGULATION OF AUTOPHAGY,0.010773,-0.16015,-0.18202,1,0
5,KEGG ENDOCYTOSIS,0.001662,-0.16016,-0.13223,1,0
5,PROTEIN IMPORT,0.0022332,-0.1602,-0.14508,1,0
5,POSITIVE REGULATION OF PHOSPHORYLATION,0.019283,-0.16043,-0.24667,1,0
5,REGULATION OF JNK ACTIVITY,0.034637,-0.16046,-0.13795,1,0
5,BIOCARTA RARRXR PATHWAY,0.033166,-0.16049,-0.15047,1,0
5,NUCLEAR IMPORT,0.0066042,-0.16075,-0.15247,1,0
5,HEMOPOIESIS,0.0059384,-0.16081,-0.17043,1,0
5,SYMPORTER ACTIVITY,0.041967,-0.1611,-0.14433,1,0
5,PID TNFPATHWAY,0.0040578,-0.1613,-0.20982,1,0
5,ANGIOGENESIS,0.0087944,-0.16159,-0.2045,1,0
5,PID ER NONGENOMIC PATHWAY,0.013798,-0.16171,-0.14503,1,0
5,LIPOPROTEIN METABOLIC PROCESS,0.0015653,-0.16184,-0.19317,1,0
5,VESICLE MEDIATED TRANSPORT,7.9801e-06,-0.1622,-0.16375,1,0
5,EXTRACELLULAR REGION PART,0.0090226,-0.16231,-0.15926,1,0
5,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,0.031059,-0.16231,-0.18538,1,0
5,INFLAMMATORY RESPONSE,0.0069616,-0.16233,-0.19074,1,0
5,KEGG CARDIAC MUSCLE CONTRACTION,0.0085714,-0.16247,-0.15387,1,0
5,CELLULAR MACROMOLECULE CATABOLIC PROCESS,3.1888e-05,-0.1625,-0.17658,1,0
5,PID AR PATHWAY,0.0051916,-0.1625,-0.16501,1,0
5,RUFFLE,0.015953,-0.16257,-0.20965,1,0
5,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0062634,-0.16259,-0.12735,1,0
5,CELLULAR LIPID METABOLIC PROCESS,7.013e-05,-0.16305,-0.21832,1,0
5,PROGRAMMED CELL DEATH,0.00016023,-0.16337,-0.16782,1,0
5,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.016734,-0.16366,-0.13175,1,0
5,BIOCARTA INTEGRIN PATHWAY,0.0022992,-0.16366,-0.19014,1,0
5,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,0.00090094,-0.16409,-0.23556,1,0
5,NUCLEOLUS,0.001191,-0.1641,-0.14833,1,0
5,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.0025817,-0.1641,-0.18444,1,0
5,ALCOHOL METABOLIC PROCESS,0.00049035,-0.1641,-0.1941,1,0
5,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.00012074,-0.16413,-0.20122,1,0
5,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,0.024288,-0.16443,-0.20004,1,0
5,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,0.0049174,-0.16447,-0.20118,1,0
5,HOMEOSTATIC PROCESS,0.00087311,-0.16447,-0.15606,1,0
5,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023205,-0.16451,-0.10763,1,0
5,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0031536,-0.16458,-0.13922,1,0
5,PROTEIN HOMODIMERIZATION ACTIVITY,0.0017641,-0.16461,-0.16553,1,0
5,CYTOKINE BIOSYNTHETIC PROCESS,0.0069616,-0.16469,-0.2806,1,0
5,FEMALE PREGNANCY,0.019739,-0.16472,-0.16024,1,0
5,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.0012662,-0.16499,-0.17705,1,0
5,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,8.1192e-05,-0.16501,-0.1973,1,0
5,KEGG DILATED CARDIOMYOPATHY,0.0045306,-0.16529,-0.17429,1,0
5,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,0.0045306,-0.16551,-0.16512,1,0
5,VITAMIN METABOLIC PROCESS,0.016339,-0.16611,-0.19174,1,0
5,REGULATION OF TRANSLATIONAL INITIATION,0.0037331,-0.16626,-0.21999,1,0
5,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.010245,-0.16644,-0.13845,1,0
5,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00079435,-0.16644,-0.16654,1,0
5,REACTOME SHC MEDIATED SIGNALLING,0.0026572,-0.16669,-0.14519,1,0
5,REACTOME COMMON PATHWAY,0.0059384,-0.16677,-0.25673,1,0
5,REGULATION OF CELL SHAPE,0.0085714,-0.16677,-0.20159,1,0
5,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,0.0028141,-0.16684,-0.25695,1,0
5,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,0.013465,-0.16687,-0.23148,1,0
5,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0031536,-0.1669,-0.1547,1,0
5,PID THROMBIN PAR1 PATHWAY,0.0016129,-0.16692,-0.18211,1,0
5,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.00045924,-0.16709,-0.1789,1,0
5,SYSTEM PROCESS,0.0032441,-0.1672,-0.11593,1,0
5,KEGG JAK STAT SIGNALING PATHWAY,0.0033369,-0.16723,-0.16989,1,0
5,RAS GTPASE ACTIVATOR ACTIVITY,0.030383,-0.16723,-0.16975,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.024846,-0.16738,-0.31023,1,0
5,BIOCARTA BIOPEPTIDES PATHWAY,0.02843,-0.16801,-0.16326,1,0
5,ANATOMICAL STRUCTURE MORPHOGENESIS,0.0011199,-0.16808,-0.13445,1,0
5,NITROGEN COMPOUND CATABOLIC PROCESS,0.00353,-0.16819,-0.19249,1,0
5,LIPASE ACTIVITY,0.00045924,-0.16821,-0.19029,1,0
5,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.0007696,-0.16834,-0.17835,1,0
5,MUSCLE DEVELOPMENT,0.0036303,-0.16841,-0.15204,1,0
5,INTRACELLULAR PROTEIN TRANSPORT,3.5759e-05,-0.16848,-0.16027,1,0
5,PID INSULIN PATHWAY,0.0025817,-0.16849,-0.15494,1,0
5,SECRETION BY CELL,0.0062634,-0.16852,-0.15698,1,0
5,REGULATION OF APOPTOSIS,0.00024286,-0.16894,-0.17545,1,0
5,DEFENSE RESPONSE TO BACTERIUM,0.00017796,-0.16922,-0.20838,1,0
5,KEGG STEROID BIOSYNTHESIS,0.03245,-0.16933,-0.22075,1,0
5,PID CERAMIDE PATHWAY,0.00050664,-0.16937,-0.16742,1,0
5,AMINE CATABOLIC PROCESS,0.0016129,-0.16952,-0.19867,1,0
5,NEGATIVE REGULATION OF TRANSLATION,0.036164,-0.16953,-0.19497,1,0
5,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.036164,-0.16995,-0.13411,1,0
5,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,0.014486,-0.17004,-0.21776,1,0
5,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.0039469,-0.17013,-0.19656,1,0
5,ACTIN BINDING,0.0022332,-0.17035,-0.15868,1,0
5,REACTOME REGULATION OF MITOTIC CELL CYCLE,0.0097392,-0.17079,-0.17068,1,0
5,REGULATION OF PROTEIN METABOLIC PROCESS,4.0073e-05,-0.17083,-0.20607,1,0
5,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.00030804,-0.1711,-0.17194,1,0
5,ST ERK1 ERK2 MAPK PATHWAY,0.0049174,-0.17147,-0.17738,1,0
5,KEGG INSULIN SIGNALING PATHWAY,6.0504e-05,-0.17154,-0.15476,1,0
5,REACTOME STEROID HORMONES,0.0033369,-0.17156,-0.20238,1,0
5,PID CIRCADIANPATHWAY,0.036948,-0.17182,-0.17424,1,0
5,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.00084609,-0.17258,-0.16945,1,0
5,MACROMOLECULE CATABOLIC PROCESS,9.0551e-05,-0.17335,-0.15411,1,0
5,PID IL1PATHWAY,0.00014418,-0.17353,-0.23577,1,0
5,BIOCARTA VIP PATHWAY,0.0069616,-0.17383,-0.17506,1,0
5,PID RHOA PATHWAY,0.0010528,-0.17402,-0.16877,1,0
5,CYTOKINE METABOLIC PROCESS,0.012508,-0.17423,-0.26623,1,0
5,PID RAC1 PATHWAY,0.0062634,-0.17424,-0.15308,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.016734,-0.17433,-0.30075,1,0
5,UNFOLDED PROTEIN BINDING,0.018836,-0.17435,-0.18104,1,0
5,EXTRACELLULAR MATRIX PART,0.02268,-0.17444,-0.21646,1,0
5,BIOCARTA MTA3 PATHWAY,0.013798,-0.17458,-0.19877,1,0
5,BIOCARTA AKAP13 PATHWAY,0.041093,-0.17491,-0.1782,1,0
5,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,3.1888e-05,-0.17541,-0.21154,1,0
5,PEROXISOME ORGANIZATION AND BIOGENESIS,0.0046564,-0.17546,-0.17378,1,0
5,REACTOME SIGNALING BY RHO GTPASES,0.0029794,-0.17566,-0.14347,1,0
5,KEGG OLFACTORY TRANSDUCTION,0.0037331,-0.17575,-0.15699,1,0
5,GUANYL NUCLEOTIDE BINDING,0.0046564,-0.17579,-0.14503,1,0
5,ST P38 MAPK PATHWAY,0.0067808,-0.17597,-0.1596,1,0
5,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.011612,-0.17601,-0.20968,1,0
5,EXCRETION,0.00055855,-0.17614,-0.2437,1,0
5,KEGG O GLYCAN BIOSYNTHESIS,0.0094949,-0.17655,-0.23169,1,0
5,ION TRANSPORT,0.0057817,-0.17665,-0.156,1,0
5,INTEGRIN BINDING,0.042857,-0.1772,-0.17423,1,0
5,KEGG N GLYCAN BIOSYNTHESIS,0.009256,-0.17726,-0.16869,1,0
5,ISOMERASE ACTIVITY,0.00049035,-0.17728,-0.22347,1,0
5,PID RXR VDR PATHWAY,0.004408,-0.17734,-0.20043,1,0
5,REACTOME ACTIVATED TLR4 SIGNALLING,7.8282e-05,-0.17745,-0.20287,1,0
5,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.009256,-0.178,-0.17258,1,0
5,REGULATION OF PROGRAMMED CELL DEATH,0.00019079,-0.17818,-0.18103,1,0
5,BIOCARTA NTHI PATHWAY,0.0056288,-0.17822,-0.22867,1,0
5,BIOCARTA P53HYPOXIA PATHWAY,0.0038387,-0.17869,-0.27667,1,0
5,PID PDGFRBPATHWAY,0.00012964,-0.1788,-0.195,1,0
5,PID RHOA REG PATHWAY,0.0028141,-0.17893,-0.19884,1,0
5,RECEPTOR MEDIATED ENDOCYTOSIS,6.7596e-05,-0.17929,-0.19361,1,0
5,ST INTERLEUKIN 4 PATHWAY,0.0038387,-0.17963,-0.24237,1,0
5,BIOCARTA VEGF PATHWAY,0.010773,-0.17984,-0.20066,1,0
5,GTPASE REGULATOR ACTIVITY,0.0042883,-0.18028,-0.1475,1,0
5,REGULATION OF CELL MORPHOGENESIS,0.011326,-0.18063,-0.19006,1,0
5,REACTOME TRIF MEDIATED TLR3 SIGNALING,5.6174e-05,-0.18087,-0.19809,1,0
5,TRANSLATIONAL INITIATION,0.0017123,-0.18087,-0.23141,1,0
5,STRUCTURAL CONSTITUENT OF MUSCLE,0.0013457,-0.181,-0.20172,1,0
5,REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034322,-0.18123,-0.23923,1,0
5,ANION CHANNEL ACTIVITY,0.03245,-0.18158,-0.15286,1,0
5,CHLORIDE CHANNEL ACTIVITY,0.03245,-0.18158,-0.15286,1,0
5,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.027188,-0.18161,-0.16236,1,0
5,REACTOME NOD1 2 SIGNALING PATHWAY,0.02268,-0.18162,-0.18348,1,0
5,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.00014935,-0.1818,-0.19564,1,0
5,MITOCHONDRIAL MEMBRANE,2.7343e-05,-0.182,-0.21319,1,0
5,PHOSPHOLIPASE ACTIVITY,0.00014418,-0.18203,-0.22075,1,0
5,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.014841,-0.18218,-0.20049,1,0
5,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0085714,-0.18256,-0.12972,1,0
5,PID FOXM1PATHWAY,0.021165,-0.18308,-0.16212,1,0
5,REACTOME METAL ION SLC TRANSPORTERS,0.016339,-0.18328,-0.16782,1,0
5,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0069616,-0.18346,-0.13324,1,0
5,BIOCARTA GCR PATHWAY,0.0059384,-0.18349,-0.2155,1,0
5,BIOCARTA PML PATHWAY,0.027803,-0.18356,-0.18941,1,0
5,BIOCARTA ERK5 PATHWAY,0.0056288,-0.18368,-0.18063,1,0
5,REACTOME GLYCOSAMINOGLYCAN METABOLISM,0.0067808,-0.1837,-0.17968,1,0
5,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.015953,-0.18376,-0.1539,1,0
5,POSITIVE REGULATION OF CELL PROLIFERATION,0.0013457,-0.18389,-0.18235,1,0
5,CELLULAR RESPIRATION,0.0059384,-0.18392,-0.19753,1,0
5,KEGG PPAR SIGNALING PATHWAY,0.0019282,-0.18402,-0.19367,1,0
5,CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.6174e-05,-0.18441,-0.18478,1,0
5,KEGG SMALL CELL LUNG CANCER,0.0020453,-0.18444,-0.21432,1,0
5,KEGG WNT SIGNALING PATHWAY,0.00038934,-0.1846,-0.15982,1,0
5,EXOPEPTIDASE ACTIVITY,0.0033369,-0.18474,-0.1919,1,0
5,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.0073363,-0.18512,-0.2128,1,0
5,KEGG BLADDER CANCER,0.018398,-0.18517,-0.15396,1,0
5,REACTOME REGULATION OF APOPTOSIS,0.0094949,-0.18541,-0.16501,1,0
5,GROWTH FACTOR ACTIVITY,0.0051916,-0.18649,-0.22653,1,0
5,MICROBODY,0.00059588,-0.18675,-0.2059,1,0
5,PEROXISOME,0.00059588,-0.18675,-0.2059,1,0
5,PID ARF 3PATHWAY,0.00035231,-0.18681,-0.25865,1,0
5,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.001872,-0.18692,-0.18202,1,0
5,RIBONUCLEOPROTEIN COMPLEX,0.0014738,-0.18721,-0.15949,1,0
5,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.011047,-0.18734,-0.26642,1,0
5,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.00038934,-0.18789,-0.229,1,0
5,JAK STAT CASCADE,0.015574,-0.18805,-0.18736,1,0
5,BIOCARTA INSULIN PATHWAY,0.015574,-0.18806,-0.13794,1,0
5,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.0011549,-0.18842,-0.21881,1,0
5,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,0.009256,-0.18868,-0.206,1,0
5,I KAPPAB KINASE NF KAPPAB CASCADE,0.041093,-0.18918,-0.216,1,0
5,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,0.02166,-0.18956,-0.17091,1,0
5,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,0.0041716,-0.18965,-0.16829,1,0
5,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.017549,-0.1899,-0.17477,1,0
5,ST TUMOR NECROSIS FACTOR PATHWAY,0.0021689,-0.19005,-0.23077,1,0
5,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.013139,-0.19028,-0.17162,1,0
5,PROTEIN TARGETING,7.2754e-05,-0.19035,-0.17583,1,0
5,KEGG TRYPTOPHAN METABOLISM,0.00014935,-0.19052,-0.26095,1,0
5,CATABOLIC PROCESS,7.0571e-06,-0.19068,-0.19077,1,0
5,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00012512,-0.191,-0.20192,1,0
5,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00040247,-0.19129,-0.19047,1,0
5,NEGATIVE REGULATION OF APOPTOSIS,9.389e-05,-0.19149,-0.21907,1,0
5,REACTOME METABOLISM OF PROTEINS,1.3441e-06,-0.19193,-0.24374,1,0
5,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.00067758,-0.1922,-0.24598,1,0
5,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,1.2454e-05,-0.19238,-0.19467,1,0
5,BIOCARTA GSK3 PATHWAY,0.036164,-0.19255,-0.17617,1,0
5,PID WNT NONCANONICAL PATHWAY,0.0019282,-0.19271,-0.20255,1,0
5,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.001662,-0.19385,-0.2318,1,0
5,REGULATION OF HEART CONTRACTION,0.0036303,-0.19455,-0.19437,1,0
5,PID MTOR 4PATHWAY,5.9841e-06,-0.19484,-0.20323,1,0
5,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,5.4121e-05,-0.19493,-0.22286,1,0
5,PID FAK PATHWAY,0.001872,-0.19494,-0.21191,1,0
5,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.0017641,-0.195,-0.17147,1,0
5,BIOCARTA INTRINSIC PATHWAY,0.031059,-0.19507,-0.30469,1,0
5,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,0.00016023,-0.1952,-0.19759,1,0
5,BIOCARTA RELA PATHWAY,0.0069616,-0.19547,-0.27627,1,0
5,REACTOME SPHINGOLIPID METABOLISM,0.00034072,-0.19558,-0.21181,1,0
5,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,2.2524e-05,-0.19582,-0.21678,1,0
5,PID LYMPHANGIOGENESIS PATHWAY,0.018398,-0.19586,-0.26255,1,0
5,PROTEASOME COMPLEX,0.02166,-0.19599,-0.16018,1,0
5,PROTEINACEOUS EXTRACELLULAR MATRIX,0.0087944,-0.19612,-0.22779,1,0
5,EXTRACELLULAR MATRIX,0.0087944,-0.19612,-0.22779,1,0
5,MITOCHONDRIAL MEMBRANE PART,5.0226e-05,-0.19627,-0.25246,1,0
5,KEGG SELENOAMINO ACID METABOLISM,0.0012662,-0.19657,-0.30372,1,0
5,REACTOME IL1 SIGNALING,0.00012512,-0.19666,-0.23763,1,0
5,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.0079323,-0.19703,-0.28721,1,0
5,EXONUCLEASE ACTIVITY,0.01282,-0.19744,-0.24955,1,0
5,PID ERA GENOMIC PATHWAY,0.0040578,-0.19781,-0.18532,1,0
5,ANATOMICAL STRUCTURE FORMATION,0.0087944,-0.19803,-0.19425,1,0
5,REACTOME SMOOTH MUSCLE CONTRACTION,0.011047,-0.1981,-0.34422,1,0
5,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,0.010773,-0.19857,-0.23765,1,0
5,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,0.0015189,-0.19919,-0.23311,1,0
5,REACTOME RAP1 SIGNALLING,0.027188,-0.19994,-0.19781,1,0
5,PID MYC REPRESSPATHWAY,0.0049174,-0.2,-0.22772,1,0
5,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,3.1888e-05,-0.20028,-0.31934,1,0
5,CYTOKINE PRODUCTION,0.0087944,-0.20048,-0.24676,1,0
5,BIOCARTA CTCF PATHWAY,0.0051916,-0.20053,-0.19741,1,0
5,PROTEIN HOMOOLIGOMERIZATION,0.023205,-0.20064,-0.21873,1,0
5,PID SYNDECAN 4 PATHWAY,0.0099891,-0.20069,-0.27725,1,0
5,PID P73PATHWAY,0.00026903,-0.20079,-0.18727,1,0
5,CONTRACTILE FIBER,0.0024367,-0.20112,-0.21183,1,0
5,KEGG INOSITOL PHOSPHATE METABOLISM,3.7145e-05,-0.20176,-0.20585,1,0
5,BIOCARTA INFLAM PATHWAY,0.0028141,-0.20181,-0.29473,1,0
5,JNK CASCADE,0.0011199,-0.20204,-0.18092,1,0
5,KEGG CYSTEINE AND METHIONINE METABOLISM,0.014486,-0.20239,-0.21746,1,0
5,PID FRA PATHWAY,0.01282,-0.20241,-0.27172,1,0
5,REACTOME PYRUVATE METABOLISM,0.00067758,-0.20254,-0.31845,1,0
5,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.00027832,-0.20323,-0.19959,1,0
5,VIRAL INFECTIOUS CYCLE,0.012508,-0.2033,-0.14236,1,0
5,BIOCARTA STRESS PATHWAY,0.0007696,-0.20336,-0.21358,1,0
5,MITOCHONDRIAL INNER MEMBRANE,0.00018427,-0.20352,-0.22852,1,0
5,REACTOME TIE2 SIGNALING,0.014486,-0.20369,-0.18846,1,0
5,PID UPA UPAR PATHWAY,0.0073363,-0.20411,-0.32204,1,0
5,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.00087311,-0.20448,-0.28771,1,0
5,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,9.7801e-06,-0.20548,-0.20769,1,0
5,PID ARF6 TRAFFICKINGPATHWAY,0.00059588,-0.20565,-0.19344,1,0
5,COFACTOR TRANSPORT,0.018398,-0.20613,-0.20498,1,0
5,GLUCOSE METABOLIC PROCESS,0.0081404,-0.20665,-0.19218,1,0
5,BIOCARTA EIF PATHWAY,0.017137,-0.20692,-0.22309,1,0
5,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,0.00047456,-0.20762,-0.24565,1,0
5,APOPTOTIC NUCLEAR CHANGES,0.0094949,-0.2079,-0.14566,1,0
5,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,5.2139e-05,-0.20823,-0.23451,1,0
5,ANTI APOPTOSIS,0.00010092,-0.2087,-0.21979,1,0
5,KEGG LINOLEIC ACID METABOLISM,0.00067758,-0.20876,-0.3158,1,0
5,CELL SURFACE,0.0060989,-0.20886,-0.17361,1,0
5,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,0.02843,-0.20887,-0.22603,1,0
5,REACTOME P75NTR SIGNALS VIA NFKB,0.017137,-0.20905,-0.23936,1,0
5,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,0.03245,-0.20928,-0.26351,1,0
5,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.031748,-0.20933,-0.23955,1,0
5,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.014486,-0.20934,-0.25533,1,0
5,BIOCARTA TEL PATHWAY,0.015953,-0.2095,-0.22451,1,0
5,LIPID METABOLIC PROCESS,1.104e-05,-0.20986,-0.23429,1,0
5,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,0.0031536,-0.20996,-0.35725,1,0
5,AMINO ACID CATABOLIC PROCESS,0.0010859,-0.20999,-0.22962,1,0
5,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.00042998,-0.21007,-0.20205,1,0
5,PID ENDOTHELINPATHWAY,0.001872,-0.21031,-0.15636,1,0
5,PID AP1 PATHWAY,0.00029782,-0.21032,-0.32094,1,0
5,PID TOLL ENDOGENOUS PATHWAY,0.0018173,-0.21078,-0.25634,1,0
5,PID P38GAMMADELTAPATHWAY,0.029068,-0.21103,-0.22983,1,0
5,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00011241,-0.21114,-0.19807,1,0
5,ENDOSOME TRANSPORT,0.00032948,-0.21119,-0.22504,1,0
5,VASCULATURE DEVELOPMENT,0.0041716,-0.21195,-0.21478,1,0
5,BIOCARTA EPO PATHWAY,0.033166,-0.212,-0.19125,1,0
5,KEGG LEISHMANIA INFECTION,0.00020448,-0.21207,-0.24289,1,0
5,REACTOME TOLL RECEPTOR CASCADES,2.9532e-05,-0.21214,-0.22095,1,0
5,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.0042883,-0.21215,-0.23425,1,0
5,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,0.023205,-0.21223,-0.1371,1,0
5,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,0.00011241,-0.21253,-0.23154,1,0
5,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00019079,-0.21272,-0.2165,1,0
5,ENZYME ACTIVATOR ACTIVITY,0.00063551,-0.21276,-0.18725,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.00057693,-0.21301,-0.25514,1,0
5,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.00032948,-0.21406,-0.27602,1,0
5,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.018398,-0.21407,-0.20389,1,0
5,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.011047,-0.21411,-0.21659,1,0
5,REACTOME PEROXISOMAL LIPID METABOLISM,0.01282,-0.21411,-0.2423,1,0
5,CELLULAR CATABOLIC PROCESS,3.9418e-06,-0.21471,-0.21234,1,0
5,REGULATION OF TRANSLATION,0.00010845,-0.21473,-0.26049,1,0
5,CHEMOKINE RECEPTOR BINDING,0.0028957,-0.21484,-0.26028,1,0
5,CHEMOKINE ACTIVITY,0.0028957,-0.21484,-0.26028,1,0
5,CELL FRACTION,8.3127e-06,-0.21595,-0.21145,1,0
5,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.0056288,-0.21607,-0.23444,1,0
5,BIOCARTA PDGF PATHWAY,0.0066042,-0.21625,-0.1718,1,0
5,BIOCARTA MAPK PATHWAY,3.5759e-05,-0.21658,-0.20306,1,0
5,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.037747,-0.21663,-0.21139,1,0
5,VIRAL REPRODUCTION,0.0037331,-0.217,-0.15913,1,0
5,BIOCARTA NO1 PATHWAY,0.001228,-0.21717,-0.23055,1,0
5,COFACTOR BINDING,0.011904,-0.2174,-0.20745,1,0
5,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00011241,-0.21807,-0.19291,1,0
5,MACROMOLECULE BIOSYNTHETIC PROCESS,1.7474e-06,-0.21814,-0.21484,1,0
5,REACTOME HYALURONAN METABOLISM,0.0021062,-0.21822,-0.30909,1,0
5,REACTOME METABOLISM OF RNA,0.00036427,-0.21835,-0.26922,1,0
5,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.0059384,-0.21836,-0.22095,1,0
5,ICOSANOID METABOLIC PROCESS,0.027803,-0.2187,-0.38854,1,0
5,REACTOME ACYL CHAIN REMODELLING OF PE,0.018398,-0.21872,-0.21461,1,0
5,REACTOME BASIGIN INTERACTIONS,0.001872,-0.21904,-0.2321,1,0
5,MITOCHONDRIAL ENVELOPE,2.1702e-06,-0.21906,-0.23987,1,0
5,KEGG PYRUVATE METABOLISM,0.0025083,-0.21908,-0.25557,1,0
5,MONOOXYGENASE ACTIVITY,0.0066042,-0.21911,-0.20651,1,0
5,BIOCARTA GLEEVEC PATHWAY,0.0099891,-0.21951,-0.18478,1,0
5,KEGG PEROXISOME,1.7806e-05,-0.21955,-0.25659,1,0
5,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.019283,-0.2196,-0.18109,1,0
5,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.03939,-0.21991,-0.2143,1,0
5,LYASE ACTIVITY,4.8379e-05,-0.22052,-0.26456,1,0
5,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,0.0081404,-0.22128,-0.22228,1,0
5,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,0.031748,-0.22131,-0.20831,1,0
5,GOLGI MEMBRANE,0.00055855,-0.22145,-0.26023,1,0
5,REGULATION OF SIGNAL TRANSDUCTION,0.0037331,-0.22146,-0.17698,1,0
5,REACTOME UNFOLDED PROTEIN RESPONSE,5.8301e-05,-0.22146,-0.24085,1,0
5,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.0042883,-0.22152,-0.21486,1,0
5,RIBONUCLEOTIDE METABOLIC PROCESS,0.0069616,-0.22183,-0.21848,1,0
5,REACTOME SIGNALING BY NOTCH,0.0011549,-0.22229,-0.19351,1,0
5,KEGG RENIN ANGIOTENSIN SYSTEM,0.023205,-0.22234,-0.27084,1,0
5,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.0030654,-0.22273,-0.24849,1,0
5,VITAMIN TRANSPORT,0.0073363,-0.22348,-0.21374,1,0
5,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,9.7346e-05,-0.22382,-0.21848,1,0
5,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,0.00024286,-0.22402,-0.25627,1,0
5,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,0.00014935,-0.22412,-0.24115,1,0
5,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,0.007729,-0.22441,-0.22465,1,0
5,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,0.0079323,-0.22566,-0.2572,1,0
5,REACTOME METABOLISM OF MRNA,0.00037661,-0.22585,-0.28374,1,0
5,REGULATION OF JNK CASCADE,0.018836,-0.22674,-0.20999,1,0
5,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.0028141,-0.22681,-0.21495,1,0
5,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,0.00057693,-0.2269,-0.2563,1,0
5,HOMEOSTASIS OF NUMBER OF CELLS,0.0075304,-0.22704,-0.19771,1,0
5,KEGG NITROGEN METABOLISM,0.022165,-0.22734,-0.18193,1,0
5,VIRAL REPRODUCTIVE PROCESS,0.0011549,-0.22739,-0.20582,1,0
5,KEGG CITRATE CYCLE TCA CYCLE,0.00013917,-0.22818,-0.30617,1,0
5,SOLUBLE FRACTION,0.00022676,-0.22859,-0.22127,1,0
5,REACTOME GLUCONEOGENESIS,0.00014418,-0.22867,-0.26785,1,0
5,KEGG PURINE METABOLISM,3.9418e-06,-0.22887,-0.22781,1,0
5,PID ANGIOPOIETINRECEPTOR PATHWAY,0.00012964,-0.22922,-0.23327,1,0
5,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00081984,-0.22925,-0.29203,1,0
5,SA B CELL RECEPTOR COMPLEXES,0.0064317,-0.22997,-0.21389,1,0
5,KEGG RETINOL METABOLISM,0.001872,-0.23,-0.29401,1,0
5,CARBON OXYGEN LYASE ACTIVITY,0.00017186,-0.23068,-0.30043,1,0
5,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,0.0054795,-0.23074,-0.22251,1,0
5,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,7.6603e-06,-0.23098,-0.2312,1,0
5,BIOCARTA LAIR PATHWAY,0.00017186,-0.23112,-0.28331,1,0
5,BIOCARTA 41BB PATHWAY,0.0099891,-0.2314,-0.18461,1,0
5,EXTRINSIC TO PLASMA MEMBRANE,0.0069616,-0.23197,-0.26318,1,0
5,PID IL2 STAT5PATHWAY,0.0016129,-0.23206,-0.29531,1,0
5,LIPID RAFT,0.016339,-0.23263,-0.27981,1,0
5,REACTOME PKB MEDIATED EVENTS,3.0689e-05,-0.23311,-0.25676,1,0
5,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,0.004408,-0.23331,-0.2276,1,0
5,KEGG ALZHEIMERS DISEASE,3.3132e-05,-0.23338,-0.20473,1,0
5,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,0.010506,-0.23343,-0.26146,1,0
5,PID P38ALPHABETADOWNSTREAMPATHWAY,0.0024367,-0.23345,-0.20463,1,0
5,POSITIVE REGULATION OF TRANSLATION,1.104e-05,-0.23373,-0.33335,1,0
5,PID MYC PATHWAY,0.00059588,-0.23399,-0.3275,1,0
5,TRANSLATION INITIATION FACTOR ACTIVITY,0.0062634,-0.23439,-0.29141,1,0
5,KEGG ARGININE AND PROLINE METABOLISM,0.00028792,-0.23446,-0.29891,1,0
5,AMINE METABOLIC PROCESS,3.6228e-06,-0.23458,-0.238,1,0
5,CYTOKINE ACTIVITY,0.00017186,-0.23535,-0.26397,1,0
5,CONTRACTILE FIBER PART,0.00090094,-0.23568,-0.27936,1,0
5,PID PDGFRAPATHWAY,0.0034322,-0.23594,-0.26408,1,0
5,REACTOME IRON UPTAKE AND TRANSPORT,0.0007696,-0.23679,-0.21648,1,0
5,REACTOME KERATAN SULFATE KERATIN METABOLISM,0.00013917,-0.23686,-0.27469,1,0
5,BIOCARTA TID PATHWAY,0.0081404,-0.23696,-0.21186,1,0
5,ACETYLTRANSFERASE ACTIVITY,0.0022332,-0.23725,-0.24599,1,0
5,NITROGEN COMPOUND METABOLIC PROCESS,5.9841e-06,-0.23805,-0.24477,1,0
5,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,0.0037331,-0.23831,-0.27673,1,0
5,BIOCARTA PPARA PATHWAY,0.0007696,-0.23888,-0.20201,1,0
5,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.00028792,-0.23904,-0.26393,1,0
5,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,1.6015e-06,-0.24037,-0.25136,1,0
5,REACTOME METABOLISM OF CARBOHYDRATES,2.5308e-05,-0.24114,-0.22038,1,0
5,KEGG LYSOSOME,9.7801e-06,-0.24137,-0.30333,1,0
5,PID ILK PATHWAY,7.2754e-05,-0.24141,-0.28136,1,0
5,PID RAS PATHWAY,0.0049174,-0.24148,-0.25561,1,0
5,PROTEIN SECRETION,0.0053338,-0.24148,-0.30986,1,0
5,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.020205,-0.24181,-0.30083,1,0
5,PID WNT CANONICAL PATHWAY,0.0024367,-0.24242,-0.24286,1,0
5,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.00013917,-0.24301,-0.25955,1,0
5,REACTOME HS GAG BIOSYNTHESIS,0.03245,-0.24309,-0.20501,1,0
5,AMINE TRANSPORT,0.00047456,-0.24313,-0.21468,1,0
5,BIOSYNTHETIC PROCESS,5.4977e-07,-0.24342,-0.24204,1,0
5,REACTOME PPARA ACTIVATES GENE EXPRESSION,8.1192e-05,-0.24353,-0.25331,1,0
5,PID PS1PATHWAY,2.0033e-05,-0.24436,-0.24605,1,0
5,KEGG ABC TRANSPORTERS,0.0016129,-0.24473,-0.22991,1,0
5,REACTOME SYNTHESIS OF PA,0.0010528,-0.2449,-0.21007,1,0
5,MITOCHONDRION,4.3763e-07,-0.24502,-0.23951,1,0
5,VACUOLAR TRANSPORT,0.0019282,-0.24534,-0.1975,1,0
5,ELECTRON CARRIER ACTIVITY,2.0033e-05,-0.24607,-0.27994,1,0
5,PID IL8CXCR2 PATHWAY,0.0017641,-0.24708,-0.23979,1,0
5,DNA CATABOLIC PROCESS,0.0029794,-0.24724,-0.20499,1,0
5,PID EPHA2 FWDPATHWAY,0.0023671,-0.24738,-0.2036,1,0
5,BIOCARTA RHO PATHWAY,0.0056288,-0.24742,-0.21645,1,0
5,RRNA PROCESSING,0.021165,-0.2477,-0.27358,1,0
5,RRNA METABOLIC PROCESS,0.021165,-0.2477,-0.27358,1,0
5,LIPID CATABOLIC PROCESS,0.00031859,-0.24792,-0.26299,1,0
5,NEGATIVE REGULATION OF TRANSPORT,0.012203,-0.24881,-0.21353,1,0
5,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.0031536,-0.2499,-0.33083,1,0
5,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,0.0015653,-0.24999,-0.21326,1,0
5,STEROID BIOSYNTHETIC PROCESS,0.014486,-0.25102,-0.2929,1,0
5,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.00049035,-0.25127,-0.28425,1,0
5,REACTOME SIGNALING BY WNT,0.00090094,-0.25131,-0.24806,1,0
5,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0017123,-0.25161,-0.28325,1,0
5,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,2.6307e-05,-0.25175,-0.29416,1,0
5,VACUOLE,1.7118e-05,-0.2521,-0.30835,1,0
5,ST WNT CA2 CYCLIC GMP PATHWAY,8.1192e-05,-0.25217,-0.266,1,0
5,RIBOSOME BIOGENESIS AND ASSEMBLY,0.012508,-0.25241,-0.27922,1,0
5,MYELOID CELL DIFFERENTIATION,0.0030654,-0.25258,-0.27595,1,0
5,PID CD40 PATHWAY,0.00042998,-0.25272,-0.26678,1,0
5,GALACTOSYLTRANSFERASE ACTIVITY,0.013798,-0.25287,-0.26258,1,0
5,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.012203,-0.25301,-0.28192,1,0
5,POLYSACCHARIDE METABOLIC PROCESS,0.004408,-0.25321,-0.24518,1,0
5,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,9.7801e-06,-0.25348,-0.30723,1,0
5,RNA CATABOLIC PROCESS,0.0028957,-0.25368,-0.25279,1,0
5,MOLECULAR ADAPTOR ACTIVITY,0.00045924,-0.25407,-0.23992,1,0
5,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.0090226,-0.25445,-0.2327,1,0
5,LIPID HOMEOSTASIS,0.042857,-0.25499,-0.26524,1,0
5,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,0.0069616,-0.25568,-0.25885,1,0
5,MEMBRANE FRACTION,6.7728e-06,-0.25586,-0.23079,1,0
5,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.027803,-0.25691,-0.2241,1,0
5,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,0.0085714,-0.25769,-0.29146,1,0
5,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,7.3528e-06,-0.25813,-0.29291,1,0
5,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.00090094,-0.25861,-0.22664,1,0
5,REACTOME CIRCADIAN CLOCK,0.0011199,-0.25898,-0.23606,1,0
5,BASEMENT MEMBRANE,0.0059384,-0.259,-0.25053,1,0
5,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,9.7801e-06,-0.25943,-0.28029,1,0
5,REACTOME COLLAGEN FORMATION,0.0028141,-0.26015,-0.29481,1,0
5,PID TCPTP PATHWAY,0.0045306,-0.26033,-0.25395,1,0
5,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.0025817,-0.26073,-0.20605,1,0
5,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,4.4878e-05,-0.26091,-0.24282,1,0
5,KEGG FATTY ACID METABOLISM,4.1617e-05,-0.26105,-0.32795,1,0
5,NEGATIVE REGULATION OF ANGIOGENESIS,0.0011549,-0.26118,-0.30816,1,0
5,CELLULAR LIPID CATABOLIC PROCESS,0.00029782,-0.2615,-0.2744,1,0
5,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.00090094,-0.26157,-0.28207,1,0
5,AROMATIC COMPOUND METABOLIC PROCESS,0.00024286,-0.26159,-0.29238,1,0
5,RESPIRATORY GASEOUS EXCHANGE,0.022165,-0.26171,-0.20282,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.01282,-0.26187,-0.27743,1,0
5,MITOCHONDRIAL RESPIRATORY CHAIN,2.0033e-05,-0.26237,-0.31661,1,0
5,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,0.0047853,-0.26242,-0.28041,1,0
5,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.025414,-0.26258,-0.19131,1,0
5,DEAMINASE ACTIVITY,0.025994,-0.26275,-0.2244,1,0
5,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,7.547e-05,-0.26276,-0.29276,1,0
5,BIOCARTA IL12 PATHWAY,0.0062634,-0.26288,-0.22182,1,0
5,BIOCARTA CARDIACEGF PATHWAY,0.0011549,-0.26292,-0.33405,1,0
5,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,0.0001547,-0.26293,-0.29691,1,0
5,CARBOHYDRATE KINASE ACTIVITY,0.010773,-0.26305,-0.24312,1,0
5,AEROBIC RESPIRATION,0.00092958,-0.26332,-0.23583,1,0
5,SECONDARY METABOLIC PROCESS,0.00081984,-0.26342,-0.26739,1,0
5,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,0.00027832,-0.26389,-0.32624,1,0
5,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010859,-0.26414,-0.24694,1,0
5,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010859,-0.26414,-0.24694,1,0
5,PID ECADHERIN STABILIZATION PATHWAY,0.00030804,-0.26441,-0.28061,1,0
5,BIOCARTA IL6 PATHWAY,0.00029782,-0.26474,-0.33021,1,0
5,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.00012964,-0.2648,-0.28324,1,0
5,LYSOSOMAL TRANSPORT,0.00055855,-0.2664,-0.25909,1,0
5,KEGG FOCAL ADHESION,0.00049035,-0.26675,-0.25259,1,0
5,NUCLEOTIDE METABOLIC PROCESS,6.7596e-05,-0.26743,-0.2714,1,0
5,HYDRO LYASE ACTIVITY,0.00027832,-0.26778,-0.31453,1,0
5,KERATINOCYTE DIFFERENTIATION,0.0042883,-0.26788,-0.33847,1,0
5,KEGG GLUTATHIONE METABOLISM,0.00038934,-0.2679,-0.35541,1,0
5,RHO PROTEIN SIGNAL TRANSDUCTION,8.7323e-05,-0.26836,-0.24906,1,0
5,REACTOME ER PHAGOSOME PATHWAY,0.0090226,-0.26853,-0.28429,1,0
5,REACTOME ENOS ACTIVATION AND REGULATION,0.0018173,-0.26866,-0.26237,1,0
5,KEGG HISTIDINE METABOLISM,0.0022992,-0.26916,-0.29075,1,0
5,REACTOME GLUCOSE METABOLISM,2.2524e-05,-0.26934,-0.28109,1,0
5,INTERACTION WITH HOST,0.0001165,-0.26978,-0.29059,1,0
5,MITOCHONDRIAL PART,6.8936e-07,-0.26979,-0.29738,1,0
5,GTPASE ACTIVATOR ACTIVITY,0.0025083,-0.27022,-0.212,1,0
5,WNT SIGNALING,4.6597e-05,-0.27042,-0.23167,1,0
5,MONOCARBOXYLIC ACID METABOLIC PROCESS,6.7596e-05,-0.27069,-0.30087,1,0
5,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,1.3441e-06,-0.27146,-0.39426,1,0
5,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.0013457,-0.27195,-0.22873,1,0
5,BIOCARTA TOB1 PATHWAY,0.0014299,-0.27236,-0.33152,1,0
5,KEGG TYROSINE METABOLISM,1.4609e-05,-0.27258,-0.29584,1,0
5,CORNIFIED ENVELOPE,0.015953,-0.27282,-0.34281,1,0
5,ST GAQ PATHWAY,2.3418e-05,-0.27303,-0.28659,1,0
5,REACTOME ZINC TRANSPORTERS,0.00055855,-0.27365,-0.25063,1,0
5,BIOPOLYMER BIOSYNTHETIC PROCESS,0.0016129,-0.27471,-0.27912,1,0
5,BIOCARTA WNT PATHWAY,0.00035231,-0.27639,-0.28102,1,0
5,REGULATION OF MAPKKK CASCADE,0.0017641,-0.27677,-0.23396,1,0
5,STRUCTURAL MOLECULE ACTIVITY,1.2308e-06,-0.27691,-0.28504,1,0
5,SH3 SH2 ADAPTOR ACTIVITY,0.0010859,-0.27727,-0.25079,1,0
5,PID IL27PATHWAY,0.00079435,-0.27757,-0.29681,1,0
5,KEGG THYROID CANCER,4.6597e-05,-0.27853,-0.33259,1,0
5,OXIDOREDUCTASE ACTIVITY,3.3287e-06,-0.2786,-0.28946,1,0
5,TRNA METABOLIC PROCESS,0.001662,-0.2788,-0.27402,1,0
5,KEGG RIBOFLAVIN METABOLISM,0.0053338,-0.27886,-0.25185,1,0
5,INSOLUBLE FRACTION,0.001191,-0.27927,-0.2713,1,0
5,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.00038934,-0.27946,-0.29122,1,0
5,OXYGEN BINDING,0.0059384,-0.27946,-0.23712,1,0
5,RAS PROTEIN SIGNAL TRANSDUCTION,0.00014418,-0.27949,-0.23709,1,0
5,PID INTEGRIN1 PATHWAY,0.0022992,-0.28006,-0.35212,1,0
5,REACTOME GLYCOSPHINGOLIPID METABOLISM,4.8379e-05,-0.2802,-0.30109,1,0
5,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,0.0041716,-0.28118,-0.25674,1,0
5,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,0.0041716,-0.28229,-0.24111,1,0
5,REACTOME TRANSLATION,0.001191,-0.28253,-0.3683,1,0
5,MAINTENANCE OF PROTEIN LOCALIZATION,0.011326,-0.28279,-0.25075,1,0
5,PID TAP63PATHWAY,0.0059384,-0.28324,-0.24791,1,0
5,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.0060989,-0.28339,-0.29996,1,0
5,MYOFIBRIL,0.0010206,-0.28374,-0.29112,1,0
5,BIOCARTA NUCLEARRS PATHWAY,0.0027346,-0.28393,-0.31156,1,0
5,LYTIC VACUOLE,4.6623e-06,-0.28517,-0.31008,1,0
5,LYSOSOME,4.6623e-06,-0.28517,-0.31008,1,0
5,REACTOME INFLUENZA LIFE CYCLE,0.0013457,-0.28636,-0.36041,1,0
5,ER GOLGI INTERMEDIATE COMPARTMENT,0.00012964,-0.28762,-0.33791,1,0
5,BASOLATERAL PLASMA MEMBRANE,0.00014935,-0.28797,-0.28223,1,0
5,OXIDOREDUCTASE ACTIVITY GO 0016616,0.00021909,-0.28818,-0.31213,1,0
5,PID INTEGRIN A9B1 PATHWAY,0.0021062,-0.28859,-0.33824,1,0
5,KEGG PROTEASOME,0.0090226,-0.28909,-0.27857,1,0
5,BIOCARTA IL1R PATHWAY,2.6902e-06,-0.28989,-0.332,1,0
5,KEGG PROPANOATE METABOLISM,0.00038934,-0.29002,-0.32402,1,0
5,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,7.013e-05,-0.29095,-0.30523,1,0
5,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,0.00054072,-0.29134,-0.31701,1,0
5,BONE REMODELING,0.0013054,-0.29156,-0.28904,1,0
5,CELLULAR DEFENSE RESPONSE,0.00012074,-0.29196,-0.33136,1,0
5,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.00042998,-0.29232,-0.30771,1,0
5,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00353,-0.29255,-0.26613,1,0
5,BIOCARTA ALK PATHWAY,0.00024286,-0.29269,-0.27702,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,3.5759e-05,-0.29316,-0.29814,1,0
5,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,1.1964e-05,-0.29484,-0.2964,1,0
5,PID MYC ACTIVPATHWAY,0.0010859,-0.29495,-0.27191,1,0
5,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.00038934,-0.29627,-0.30709,1,0
5,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.0011549,-0.29631,-0.3591,1,0
5,BIOCARTA PGC1A PATHWAY,0.0038387,-0.29676,-0.24321,1,0
5,ELECTRON TRANSPORT GO 0006118,0.00031859,-0.29707,-0.26204,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,5.0683e-06,-0.29735,-0.29233,1,0
5,PROTEIN BINDING BRIDGING,6.2786e-05,-0.29762,-0.30125,1,0
5,REACTOME CS DS DEGRADATION,0.010245,-0.29768,-0.31969,1,0
5,PID INSULIN GLUCOSE PATHWAY,0.00054072,-0.29956,-0.27192,1,0
5,OXIDOREDUCTASE ACTIVITY GO 0016705,1.2454e-05,-0.30065,-0.35559,1,0
5,RESPONSE TO HORMONE STIMULUS,0.00036427,-0.30083,-0.34741,1,0
5,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.016734,-0.30105,-0.21659,1,0
5,AMINO ACID METABOLIC PROCESS,6.8936e-07,-0.30143,-0.33386,1,0
5,KEGG ARACHIDONIC ACID METABOLISM,0.0031536,-0.30215,-0.2587,1,0
5,ORGANIC ACID METABOLIC PROCESS,4.5813e-07,-0.30319,-0.31836,1,0
5,MEMBRANE FUSION,1.0604e-05,-0.30336,-0.34057,1,0
5,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.0021689,-0.30349,-0.42207,1,0
5,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.014138,-0.30361,-0.17752,1,0
5,PROTEIN TYROSINE KINASE ACTIVITY,0.00016595,-0.30409,-0.28099,1,0
5,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,0.02166,-0.30446,-0.3484,1,0
5,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,8.1192e-05,-0.30455,-0.29738,1,0
5,SUGAR BINDING,0.00054072,-0.30459,-0.32572,1,0
5,CARBOXYLIC ACID METABOLIC PROCESS,4.1802e-07,-0.30486,-0.32122,1,0
5,HETEROCYCLE METABOLIC PROCESS,2.1663e-05,-0.30575,-0.38113,1,0
5,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.001191,-0.30683,-0.28678,1,0
5,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.00016595,-0.30825,-0.32237,1,0
5,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,0.0026572,-0.30827,-0.36415,1,0
5,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.0022992,-0.30836,-0.39918,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,5.2139e-05,-0.30919,-0.32411,1,0
5,PID S1P S1P1 PATHWAY,0.00054072,-0.30951,-0.2747,1,0
5,REGULATION OF ANGIOGENESIS,4.0073e-05,-0.31065,-0.33081,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.00017186,-0.31072,-0.30473,1,0
5,ST MYOCYTE AD PATHWAY,0.0016129,-0.31093,-0.25596,1,0
5,PHOSPHOLIPASE C ACTIVITY,0.00057693,-0.31098,-0.268,1,0
5,KEGG ECM RECEPTOR INTERACTION,0.001228,-0.31122,-0.34253,1,0
5,REACTOME CALNEXIN CALRETICULIN CYCLE,9.7346e-05,-0.31277,-0.36394,1,0
5,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.025994,-0.31298,-0.23196,1,0
5,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,8.3127e-06,-0.31299,-0.40984,1,0
5,REACTOME MUSCLE CONTRACTION,0.00014418,-0.31359,-0.34962,1,0
5,LIPID TRANSPORT,4.4878e-05,-0.31531,-0.3743,1,0
5,BASAL LAMINA,0.00055855,-0.31541,-0.32831,1,0
5,BIOCARTA MEF2D PATHWAY,0.0071468,-0.31553,-0.26316,1,0
5,MITOCHONDRIAL TRANSPORT,9.0551e-05,-0.31618,-0.27024,1,0
5,REACTOME BIOLOGICAL OXIDATIONS,1.1964e-05,-0.31712,-0.32786,1,0
5,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.0023671,-0.31824,-0.38452,1,0
5,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,4.0073e-05,-0.31884,-0.29736,1,0
5,REACTOME STRIATED MUSCLE CONTRACTION,0.00024286,-0.31905,-0.3469,1,0
5,PROTEASE INHIBITOR ACTIVITY,0.00020448,-0.31916,-0.42675,1,0
5,SA MMP CYTOKINE CONNECTION,0.00044439,-0.31997,-0.39972,1,0
5,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,0.001662,-0.32414,-0.28859,1,0
5,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,0.00069957,-0.32439,-0.39702,1,0
5,ST STAT3 PATHWAY,0.0069616,-0.32552,-0.23993,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.0040578,-0.32556,-0.25609,1,0
5,METALLOEXOPEPTIDASE ACTIVITY,0.014841,-0.32607,-0.20971,1,0
5,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,0.0017641,-0.32634,-0.2693,1,0
5,PHAGOCYTOSIS,0.0012662,-0.32806,-0.31146,1,0
5,CELLULAR BIOSYNTHETIC PROCESS,3.3202e-07,-0.32822,-0.31851,1,0
5,PID A6B1 A6B4 INTEGRIN PATHWAY,0.00021909,-0.32854,-0.40223,1,0
5,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,4.1112e-06,-0.32876,-0.31535,1,0
5,PID INTEGRIN CS PATHWAY,0.0053338,-0.32904,-0.32454,1,0
5,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.001191,-0.32965,-0.30796,1,0
5,SULFURIC ESTER HYDROLASE ACTIVITY,0.0099891,-0.3314,-0.26873,1,0
5,CALMODULIN BINDING,0.024846,-0.33153,-0.1872,1,0
5,REGULATION OF INTRACELLULAR TRANSPORT,0.0014738,-0.33267,-0.29202,1,0
5,COENZYME METABOLIC PROCESS,2.9301e-06,-0.33326,-0.41109,1,0
5,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.0017123,-0.33372,-0.35682,1,0
5,PIGMENT BIOSYNTHETIC PROCESS,0.00021167,-0.33416,-0.3325,1,0
5,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.0017123,-0.33573,-0.44156,1,0
5,TRANSLATION,3.4728e-06,-0.3358,-0.33108,1,0
5,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0013872,-0.33591,-0.39399,1,0
5,PID IL6 7PATHWAY,4.8379e-05,-0.33627,-0.34603,1,0
5,REACTOME TRNA AMINOACYLATION,0.004408,-0.33719,-0.29518,1,0
5,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.0017123,-0.33823,-0.35398,1,0
5,BIOCARTA ACTINY PATHWAY,9.0551e-05,-0.33841,-0.36266,1,0
5,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.0032441,-0.33856,-0.25821,1,0
5,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.0019282,-0.33975,-0.32868,1,0
5,DRUG BINDING,0.0018173,-0.34008,-0.27596,1,0
5,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,6.5149e-05,-0.34126,-0.31186,1,0
5,NUCLEOLAR PART,9.7346e-05,-0.34388,-0.35754,1,0
5,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.00026003,-0.34448,-0.34814,1,0
5,KEGG PENTOSE PHOSPHATE PATHWAY,1.349e-05,-0.34659,-0.36594,1,0
5,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.025414,-0.34678,-0.36539,1,0
5,KEGG GLYCOLYSIS GLUCONEOGENESIS,8.3127e-06,-0.3468,-0.38297,1,0
5,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.0057817,-0.34895,-0.36018,1,0
5,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,0.001662,-0.34915,-0.30019,1,0
5,BIOCARTA P38MAPK PATHWAY,1.5331e-06,-0.34918,-0.37307,1,0
5,PID INTEGRIN3 PATHWAY,0.0024367,-0.35113,-0.38184,1,0
5,COENZYME BINDING,5.4121e-05,-0.35211,-0.37265,1,0
5,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.0040578,-0.35278,-0.37115,1,0
5,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,2.2524e-05,-0.3563,-0.34781,1,0
5,CARBOHYDRATE CATABOLIC PROCESS,2.2524e-05,-0.3563,-0.34781,1,0
5,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0014738,-0.35639,-0.30413,1,0
5,FATTY ACID METABOLIC PROCESS,1.5201e-05,-0.35662,-0.39402,1,0
5,RIBOSOME,2.3418e-05,-0.35794,-0.3925,1,0
5,PID IL8CXCR1 PATHWAY,0.0010528,-0.35804,-0.3033,1,0
5,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,0.0099891,-0.36031,-0.36664,1,0
5,PID HIF2PATHWAY,7.2754e-05,-0.36112,-0.35899,1,0
5,SARCOMERE,0.00017186,-0.36209,-0.36157,1,0
5,REACTOME SULFUR AMINO ACID METABOLISM,0.00013917,-0.36225,-0.33407,1,0
5,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.0010528,-0.36248,-0.46374,1,0
5,VACUOLE ORGANIZATION AND BIOGENESIS,0.00023468,-0.3629,-0.38051,1,0
5,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,5.7413e-06,-0.36314,-0.39502,1,0
5,BIOCARTA PTDINS PATHWAY,7.8282e-05,-0.36466,-0.31161,1,0
5,REACTOME LIPOPROTEIN METABOLISM,0.00036427,-0.36645,-0.3659,1,0
5,EXOCYTOSIS,0.036948,-0.36672,-0.23123,1,0
5,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,3.3287e-06,-0.36786,-0.37985,1,0
5,PID INTEGRIN5 PATHWAY,0.0042883,-0.36853,-0.45623,1,0
5,COFACTOR METABOLIC PROCESS,1.6729e-06,-0.36878,-0.42746,1,0
5,ORGANELLAR RIBOSOME,7.547e-05,-0.36927,-0.39731,1,0
5,MITOCHONDRIAL RIBOSOME,7.547e-05,-0.36927,-0.39731,1,0
5,REACTOME PHASE II CONJUGATION,5.2139e-05,-0.37338,-0.37043,1,0
5,FATTY ACID OXIDATION,0.001191,-0.37899,-0.36581,1,0
5,BIOCARTA PLATELETAPP PATHWAY,0.011326,-0.3808,-0.43469,1,0
5,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.001191,-0.3814,-0.3604,1,0
5,PID WNT SIGNALING PATHWAY,0.00038934,-0.38164,-0.35118,1,0
5,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00037661,-0.38537,-0.41351,1,0
5,TISSUE REMODELING,0.00017796,-0.39421,-0.34804,1,0
5,KEGG RIBOSOME,0.0015189,-0.397,-0.46041,1,0
5,BIOCARTA CDMAC PATHWAY,9.7346e-05,-0.39831,-0.35697,1,0
5,REACTOME PEPTIDE CHAIN ELONGATION,0.0014738,-0.39835,-0.49387,1,0
5,STRUCTURAL CONSTITUENT OF RIBOSOME,0.0007696,-0.39993,-0.49889,1,0
5,PIGMENT METABOLIC PROCESS,0.00014418,-0.40127,-0.37971,1,0
5,CYTOPLASM ORGANIZATION AND BIOGENESIS,0.018398,-0.4014,-0.40458,1,0
5,COFACTOR BIOSYNTHETIC PROCESS,4.3218e-05,-0.40223,-0.42578,1,0
5,KEGG STARCH AND SUCROSE METABOLISM,6.7728e-06,-0.40328,-0.38129,1,0
5,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,1.5201e-05,-0.40896,-0.37689,1,0
5,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,7.547e-05,-0.41073,-0.39145,1,0
5,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.001228,-0.41317,-0.34997,1,0
5,RESPONSE TO DRUG,0.00034072,-0.4176,-0.40128,1,0
5,REACTOME METABOLISM OF NUCLEOTIDES,9.389e-05,-0.41781,-0.33061,1,0
5,AMINE BIOSYNTHETIC PROCESS,0.00022676,-0.41789,-0.42014,1,0
5,PID HIF1 TFPATHWAY,8.1192e-05,-0.4187,-0.38358,1,0
5,REACTOME HDL MEDIATED LIPID TRANSPORT,0.00057693,-0.41886,-0.39553,1,0
5,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,5.8301e-05,-0.42298,-0.40889,1,0
5,REACTOME THE ACTIVATION OF ARYLSULFATASES,4.3218e-05,-0.42574,-0.48575,1,0
5,REACTOME METABOLISM OF PORPHYRINS,1.8521e-05,-0.43285,-0.55546,1,0
5,PID ARF6 PATHWAY,4.2876e-06,-0.43907,-0.40432,1,0
5,KEGG PHENYLALANINE METABOLISM,0.00057693,-0.44251,-0.40864,1,0
5,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,0.00026903,-0.45264,-0.37505,1,0
5,BIOCARTA IL10 PATHWAY,0.00026903,-0.46027,-0.46051,1,0
5,KEGG GALACTOSE METABOLISM,2.3418e-05,-0.461,-0.41459,1,0
5,ARYLSULFATASE ACTIVITY,0.0025083,-0.46366,-0.3629,1,0
5,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,0.0012662,-0.46554,-0.4302,1,0
5,REACTOME PURINE METABOLISM,1.2862e-06,-0.47031,-0.47225,1,0
5,MITOCHONDRIAL LUMEN,6.2367e-06,-0.47718,-0.42993,1,0
5,MITOCHONDRIAL MATRIX,6.2367e-06,-0.47718,-0.42993,1,0
5,STEROID BINDING,0.00016023,-0.50114,-0.52802,1,0
5,KEGG DRUG METABOLISM CYTOCHROME P450,9.7801e-06,-0.50868,-0.44387,1,0
5,ADENYLATE CYCLASE ACTIVATION,7.2754e-05,-0.51844,-0.44989,1,0
5,INORGANIC ANION TRANSPORT,0.00012512,-0.53035,-0.41799,1,0
5,PID INTEGRIN4 PATHWAY,0.0018173,-0.53504,-0.61347,1,0
5,REACTOME GLUTATHIONE CONJUGATION,4.1617e-05,-0.54287,-0.61021,1,0
5,KEGG OTHER GLYCAN DEGRADATION,6.2985e-07,-0.57598,-0.65207,1,0
5,ANION TRANSPORT,1.7474e-06,-0.63392,-0.54524,1,0
5,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.22568,0.27872,0.11398,0,1
5,PID NFKAPPABATYPICALPATHWAY,0.045624,0.26512,0.15707,0,1
5,INSULIN RECEPTOR SIGNALING PATHWAY,0.055956,0.25799,0.20352,0,1
5,MICROTUBULE MOTOR ACTIVITY,0.059411,0.24626,0.1914,0,1
5,REACTOME N GLYCAN ANTENNAE ELONGATION,0.2,0.20926,0.10562,0,1
5,BIOCARTA PLCE PATHWAY,0.047551,0.19979,0.14856,0,1
5,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.063042,0.18698,0.13981,0,1
5,REACTOME SIGNALING BY FGFR3 MUTANTS,0.097379,0.18364,0.12252,0,1
5,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,0.30402,0.17714,0.073553,0,1
5,POSITIVE REGULATION OF T CELL ACTIVATION,0.095625,0.17681,0.21348,0,1
5,SA PROGRAMMED CELL DEATH,0.082489,0.17564,0.17743,0,1
5,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.070855,0.16307,0.10966,0,1
5,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.15773,0.14754,0.077122,0,1
5,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.17099,0.14035,0.075336,0,1
5,PID FASPATHWAY,0.045624,0.14019,0.11788,0,1
5,CASPASE ACTIVATION,0.27227,0.13615,0.090409,0,1
5,BIOCARTA IL7 PATHWAY,0.35607,0.13432,0.0665,0,1
5,REGULATION OF DEFENSE RESPONSE,0.20309,0.1316,0.11117,0,1
5,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.063042,0.12861,0.11512,0,1
5,REACTOME DNA STRAND ELONGATION,0.049546,0.12701,0.12537,0,1
5,DNA DEPENDENT ATPASE ACTIVITY,0.41341,0.12484,0.05172,0,1
5,REGULATION OF IMMUNE SYSTEM PROCESS,0.15264,0.12288,0.099174,0,1
5,CYTOKINESIS,0.13814,0.1106,0.074246,0,1
5,REACTOME MITOTIC PROMETAPHASE,0.054842,0.10475,0.099482,0,1
5,REACTOME MRNA SPLICING,0.2,0.10303,0.066818,0,1
5,CYTOSKELETAL PART,0.15015,0.1016,0.051984,0,1
5,SPLICEOSOME,0.13355,0.098114,0.083301,0,1
5,REACTOME CD28 CO STIMULATION,0.23589,0.097048,0.022916,0,1
5,KINASE BINDING,0.046579,0.094893,0.074249,0,1
5,DNA PACKAGING,0.080955,0.091274,0.078975,0,1
5,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.080955,0.090264,0.11918,0,1
5,PROTEIN KINASE BINDING,0.059411,0.089306,0.071075,0,1
5,PID AURORA A PATHWAY,0.20309,0.085143,0.06754,0,1
5,M PHASE,0.26847,0.080469,0.03077,0,1
5,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.061812,0.077998,0.13706,0,1
5,PID ANTHRAXPATHWAY,0.066855,0.071182,0.085446,0,1
5,THYROID HORMONE RECEPTOR BINDING,0.2839,0.065888,0.055847,0,1
5,MITOSIS,0.25363,0.060733,0.033902,0,1
5,SPINDLE,0.21579,0.060719,0.065895,0,1
5,DAMAGED DNA BINDING,0.94073,0.051489,-0.0067491,0,1
5,M PHASE OF MITOTIC CELL CYCLE,0.25729,0.050652,0.036255,0,1
5,ORGANELLE LOCALIZATION,0.63978,0.048536,-0.011389,0,1
5,CHROMATIN BINDING,0.44924,0.041617,0.03361,0,1
5,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.4978,0.025559,0.023136,0,1
5,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.16294,0.024196,0.041644,0,1
5,REGULATION OF HORMONE SECRETION,0.076492,0.22401,0.26923,0,0
5,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,0.05824,0.20657,0.30868,0,0
5,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.045624,0.20109,0.15341,0,0
5,CHROMATIN ASSEMBLY,0.099158,0.19972,0.12432,0,0
5,REACTOME REGULATION OF KIT SIGNALING,0.080955,0.19955,0.25712,0,0
5,MOTOR ACTIVITY,0.063042,0.19716,0.15106,0,0
5,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.085627,0.19646,0.12595,0,0
5,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.054842,0.19573,0.12329,0,0
5,SH2 DOMAIN BINDING,0.16559,0.18329,0.1792,0,0
5,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.053746,0.1818,0.1564,0,0
5,BIOCARTA CDK5 PATHWAY,0.047551,0.17398,0.17447,0,0
5,CELL RECOGNITION,0.23245,0.16595,0.2091,0,0
5,REACTOME PACKAGING OF TELOMERE ENDS,0.23937,0.16092,0.17573,0,0
5,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,0.097379,0.15787,0.23916,0,0
5,SIALYLTRANSFERASE ACTIVITY,0.11841,0.15779,0.21808,0,0
5,T CELL ACTIVATION,0.084046,0.15336,0.16716,0,0
5,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.097379,0.15226,0.25092,0,0
5,REACTOME G PROTEIN ACTIVATION,0.093897,0.15212,0.13612,0,0
5,PID LIS1PATHWAY,0.065563,0.14943,0.1277,0,0
5,REACTOME REGULATION OF INSULIN SECRETION,0.19695,0.14929,0.125,0,0
5,REGULATION OF IMMUNE RESPONSE,0.10096,0.14425,0.14635,0,0
5,REACTOME INSULIN SYNTHESIS AND PROCESSING,0.045624,0.14205,0.30133,0,0
5,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.13814,0.14202,0.078898,0,0
5,REACTOME SIGNALING BY BMP,0.13814,0.14197,0.11796,0,0
5,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.050569,0.13957,0.13368,0,0
5,REACTOME GABA A RECEPTOR ACTIVATION,0.34702,0.13936,0.062181,0,0
5,REACTOME RECYCLING PATHWAY OF L1,0.19695,0.13745,0.090931,0,0
5,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,0.25001,0.13241,0.26624,0,0
5,S PHASE,0.10845,0.1303,0.095176,0,0
5,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.068167,0.12773,0.097414,0,0
5,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.13355,0.12407,0.081696,0,0
5,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.090515,0.12401,0.10833,0,0
5,BIOCARTA P53 PATHWAY,0.4978,0.1234,0.041144,0,0
5,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.11434,0.12178,0.16923,0,0
5,REACTOME REGULATION OF SIGNALING BY CBL,0.12908,0.11819,0.097246,0,0
5,REACTOME CTLA4 INHIBITORY SIGNALING,0.14526,0.11752,0.11143,0,0
5,PROTEIN KINASE INHIBITOR ACTIVITY,0.13355,0.11515,0.20084,0,0
5,REGULATION OF T CELL ACTIVATION,0.20937,0.11418,0.17241,0,0
5,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.18219,0.11354,0.12178,0,0
5,REACTOME DOUBLE STRAND BREAK REPAIR,0.32938,0.1133,0.065823,0,0
5,TUBULIN BINDING,0.13583,0.11329,0.10334,0,0
5,CALCIUM CHANNEL ACTIVITY,0.35153,0.11241,0.087805,0,0
5,NEGATIVE REGULATION OF CELL MIGRATION,0.2,0.11159,0.1161,0,0
5,REACTOME CGMP EFFECTS,0.14285,0.10984,0.11132,0,0
5,KINETOCHORE,0.19695,0.10962,0.047272,0,0
5,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.47049,0.10524,0.071299,0,0
5,POTASSIUM CHANNEL REGULATOR ACTIVITY,0.10096,0.10517,0.18297,0,0
5,KINASE INHIBITOR ACTIVITY,0.17934,0.10501,0.17633,0,0
5,PID ECADHERIN NASCENTAJ PATHWAY,0.076492,0.10287,0.085861,0,0
5,SPINDLE POLE,0.13583,0.098706,0.094812,0,0
5,NEURON APOPTOSIS,0.2839,0.098661,0.11069,0,0
5,INNATE IMMUNE RESPONSE,0.13355,0.098041,0.12293,0,0
5,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.69707,0.097809,0.02634,0,0
5,PROTEIN KINASE REGULATOR ACTIVITY,0.12689,0.09541,0.15011,0,0
5,BIOCARTA CHEMICAL PATHWAY,0.33373,0.095168,0.073213,0,0
5,BIOCARTA CFTR PATHWAY,0.14285,0.094439,0.10953,0,0
5,BIOCARTA BCELLSURVIVAL PATHWAY,0.17653,0.094437,0.097984,0,0
5,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.19393,0.094051,0.072329,0,0
5,CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.068167,0.093953,0.1474,0,0
5,GAMETE GENERATION,0.20621,0.093806,0.065576,0,0
5,NUCLEAR CHROMOSOME PART,0.11235,0.093652,0.11726,0,0
5,PID EPHRINBREVPATHWAY,0.0695,0.092948,0.1656,0,0
5,PID REELINPATHWAY,0.25001,0.092376,0.097415,0,0
5,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.097379,0.09192,0.081816,0,0
5,AMINE RECEPTOR ACTIVITY,0.15773,0.090837,0.077039,0,0
5,BIOCARTA RB PATHWAY,0.1313,0.089998,0.12215,0,0
5,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.20937,0.089958,0.12415,0,0
5,PROTEIN DNA COMPLEX ASSEMBLY,0.1028,0.088091,0.073469,0,0
5,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.60272,0.087922,-0.0013299,0,0
5,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.36526,0.087762,0.065801,0,0
5,RNA SPLICING,0.061812,0.08728,0.075753,0,0
5,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.76948,0.086301,-0.0068365,0,0
5,PID ECADHERIN KERATINOCYTE PATHWAY,0.1313,0.08589,0.10262,0,0
5,REACTOME INTEGRATION OF ENERGY METABOLISM,0.59059,0.085517,0.058207,0,0
5,REACTOME MRNA SPLICING MINOR PATHWAY,0.28785,0.085265,0.059378,0,0
5,KINASE REGULATOR ACTIVITY,0.12908,0.084075,0.13839,0,0
5,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,0.22235,0.083638,0.10627,0,0
5,REACTOME MEIOTIC SYNAPSIS,0.39371,0.083614,0.066354,0,0
5,REACTOME ADP SIGNALLING THROUGH P2RY1,0.15015,0.083551,0.10859,0,0
5,PID NEPHRIN NEPH1 PATHWAY,0.12049,0.083094,0.093678,0,0
5,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.11841,0.08291,0.096753,0,0
5,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.43367,0.082498,0.031711,0,0
5,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.39858,0.081729,0.049427,0,0
5,REACTOME NEPHRIN INTERACTIONS,0.51459,0.080058,0.039952,0,0
5,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.2839,0.079894,0.079474,0,0
5,MITOTIC CELL CYCLE CHECKPOINT,0.24643,0.078835,0.096929,0,0
5,BRAIN DEVELOPMENT,0.17099,0.078714,0.13057,0,0
5,LAMELLIPODIUM,0.42347,0.078057,0.049723,0,0
5,CHROMATIN REMODELING,0.47588,0.07713,0.042465,0,0
5,REACTOME TCR SIGNALING,0.17374,0.076817,0.068701,0,0
5,PID EPHBFWDPATHWAY,0.17653,0.076372,0.092064,0,0
5,PHOSPHATASE REGULATOR ACTIVITY,0.71006,0.07561,0.0031129,0,0
5,SEQUENCE SPECIFIC DNA BINDING,0.33812,0.074942,0.039568,0,0
5,DETECTION OF ABIOTIC STIMULUS,0.30815,0.074731,0.044797,0,0
5,REACTOME DOWNSTREAM TCR SIGNALING,0.43367,0.074402,0.050738,0,0
5,SISTER CHROMATID SEGREGATION,0.17934,0.074245,0.080982,0,0
5,PID LPA4 PATHWAY,0.39371,0.073791,0.056199,0,0
5,BIOCARTA MPR PATHWAY,0.27611,0.073562,0.061943,0,0
5,REACTOME SIGNALING BY FGFR1 MUTANTS,0.12259,0.07337,0.10116,0,0
5,CHROMOSOME CONDENSATION,0.31232,0.072928,0.040254,0,0
5,REACTOME CHOLESTEROL BIOSYNTHESIS,0.80312,0.07276,0.031496,0,0
5,SYNAPSE,0.3746,0.07138,0.066984,0,0
5,BIOGENIC AMINE METABOLIC PROCESS,0.093897,0.071243,0.12442,0,0
5,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.059411,0.069852,0.078132,0,0
5,BIOCARTA IGF1R PATHWAY,0.36064,0.068685,0.071716,0,0
5,PID FANCONI PATHWAY,0.18508,0.068677,0.075387,0,0
5,CENTROSOME ORGANIZATION AND BIOGENESIS,0.16032,0.068117,0.087626,0,0
5,PID ATM PATHWAY,0.25363,0.06766,0.062522,0,0
5,NEUROTRANSMITTER SECRETION,0.23937,0.067527,0.28101,0,0
5,DETECTION OF EXTERNAL STIMULUS,0.26098,0.06732,0.063397,0,0
5,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.53167,0.067295,0.025958,0,0
5,DENDRITE,0.2,0.067192,0.13365,0,0
5,REACTOME RNA POL I PROMOTER OPENING,0.27227,0.066978,0.14734,0,0
5,REACTOME MITOTIC G2 G2 M PHASES,0.087232,0.065163,0.072174,0,0
5,SYNAPTIC VESICLE,0.26847,0.06506,0.17896,0,0
5,NUCLEAR CHROMOSOME,0.19095,0.064995,0.081544,0,0
5,SENSORY ORGAN DEVELOPMENT,0.25729,0.064962,0.10241,0,0
5,MEIOTIC CELL CYCLE,0.54903,0.064918,0.044767,0,0
5,REACTOME DAG AND IP3 SIGNALING,0.38408,0.064849,0.047391,0,0
5,BIOCARTA RACCYCD PATHWAY,0.50337,0.064578,0.014941,0,0
5,KEGG DORSO VENTRAL AXIS FORMATION,0.94073,0.064082,-0.0054444,0,0
5,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.68418,0.063981,0.0076244,0,0
5,KINASE ACTIVATOR ACTIVITY,0.43367,0.063661,0.083067,0,0
5,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.42855,0.06339,0.08865,0,0
5,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.93377,0.063166,-0.013514,0,0
5,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.4978,0.063143,0.061965,0,0
5,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.4598,0.063028,0.015635,0,0
5,BIOCARTA CALCINEURIN PATHWAY,0.69707,0.0627,0.026908,0,0
5,REACTOME INFLAMMASOMES,0.18219,0.062492,0.1011,0,0
5,BIOCARTA DREAM PATHWAY,0.74288,0.061081,-0.031093,0,0
5,DNA DAMAGE CHECKPOINT,0.36526,0.061015,0.059478,0,0
5,CHROMOSOMEPERICENTRIC REGION,0.52025,0.060607,0.027039,0,0
5,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.91293,0.059769,-0.032329,0,0
5,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.51459,0.059304,0.013228,0,0
5,POSITIVE REGULATION OF TRANSPORT,0.26847,0.058919,0.097696,0,0
5,TRANSCRIPTION INITIATION,0.044685,0.058915,0.069857,0,0
5,CHROMOSOME SEGREGATION,0.40843,0.058849,0.03342,0,0
5,UBIQUITIN LIGASE COMPLEX,0.53167,0.058789,0.019351,0,0
5,PID BMPPATHWAY,0.15517,0.058704,0.065606,0,0
5,REGULATION OF MITOSIS,0.52594,0.058694,0.011071,0,0
5,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.15015,0.058531,0.083626,0,0
5,REACTOME DNA REPLICATION,0.48678,0.058362,0.03122,0,0
5,PID ERB GENOMIC PATHWAY,0.90599,0.058089,-0.018443,0,0
5,REACTOME SIGNALING BY HIPPO,0.50896,0.05803,0.0028417,0,0
5,CONDENSED CHROMOSOME,0.54321,0.057211,0.032652,0,0
5,KEGG HOMOLOGOUS RECOMBINATION,0.44924,0.055953,0.045343,0,0
5,REACTOME G2 M CHECKPOINTS,0.54903,0.054716,0.034397,0,0
5,NERVOUS SYSTEM DEVELOPMENT,0.16828,0.054224,0.097812,0,0
5,REACTOME SIGNALING BY SCF KIT,0.44402,0.053743,0.040911,0,0
5,CELL CYCLE CHECKPOINT GO 0000075,0.16559,0.05371,0.061877,0,0
5,REACTOME TELOMERE MAINTENANCE,0.26098,0.052988,0.09599,0,0
5,REGULATION OF MEMBRANE POTENTIAL,0.77618,0.052818,0.033776,0,0
5,LIPID KINASE ACTIVITY,0.19393,0.052032,0.069637,0,0
5,DETECTION OF STIMULUS,0.41842,0.051586,0.070892,0,0
5,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.27227,0.051555,0.063467,0,0
5,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.89907,0.051079,-0.0005462,0,0
5,BIOCARTA G2 PATHWAY,0.76948,0.050256,0.018834,0,0
5,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.34702,0.049947,0.032351,0,0
5,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.91987,0.049525,-0.041676,0,0
5,CORTICAL CYTOSKELETON,0.5726,0.049518,0.024178,0,0
5,SEXUAL REPRODUCTION,0.72969,0.049409,0.022177,0,0
5,CHROMOSOME,0.059411,0.049388,0.072366,0,0
5,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,0.36991,0.049385,0.075489,0,0
5,REACTOME MEIOSIS,0.34702,0.049356,0.059839,0,0
5,PID HES HEYPATHWAY,0.37932,0.048543,0.055718,0,0
5,REGULATION OF GENE EXPRESSION EPIGENETIC,0.064293,0.047394,0.11533,0,0
5,HUMORAL IMMUNE RESPONSE,0.48131,0.047117,0.022114,0,0
5,REACTOME CELL CYCLE,0.41842,0.04708,0.027248,0,0
5,FEEDING BEHAVIOR,0.48131,0.047013,0.046172,0,0
5,SINGLE STRANDED DNA BINDING,0.24288,0.046844,0.060531,0,0
5,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.25001,0.046809,0.047259,0,0
5,REACTOME SIGNAL AMPLIFICATION,0.3746,0.046755,0.041868,0,0
5,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.1028,0.046737,0.068823,0,0
5,PID HEDGEHOG 2PATHWAY,0.51459,0.046519,0.039755,0,0
5,PID BARD1PATHWAY,0.26471,0.0465,0.041655,0,0
5,BIOCARTA CELLCYCLE PATHWAY,0.30402,0.045785,0.060242,0,0
5,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.97557,0.044717,0.01279,0,0
5,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,0.67137,0.043883,0.027911,0,0
5,RNA EXPORT FROM NUCLEUS,0.48678,0.043866,0.015445,0,0
5,REACTOME CA DEPENDENT EVENTS,0.44402,0.043468,0.045594,0,0
5,REGULATION OF CELL MIGRATION,0.83713,0.043326,-0.045865,0,0
5,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,0.48678,0.042738,0.079316,0,0
5,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,1,0.042501,-0.0067131,0,0
5,REACTOME AMINE LIGAND BINDING RECEPTORS,0.62113,0.042324,0.021293,0,0
5,REACTOME CELL CYCLE MITOTIC,0.51459,0.042053,0.025918,0,0
5,REACTOME P38MAPK EVENTS,0.90599,0.041518,0.0060742,0,0
5,DNA REPAIR,0.50337,0.041355,0.022571,0,0
5,MITOTIC SISTER CHROMATID SEGREGATION,0.28785,0.041257,0.068763,0,0
5,REACTOME ELONGATION ARREST AND RECOVERY,0.53167,0.040984,0.02971,0,0
5,MEIOTIC RECOMBINATION,0.64605,0.040759,0.027038,0,0
5,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.48131,0.040537,0.027843,0,0
5,MRNA METABOLIC PROCESS,0.13583,0.039956,0.047791,0,0
5,PID PI3KCIAKTPATHWAY,0.15773,0.039556,0.056258,0,0
5,CELLULAR RESPONSE TO STIMULUS,0.81668,0.038967,0.0043312,0,0
5,KEGG BASAL TRANSCRIPTION FACTORS,0.15517,0.038494,0.056517,0,0
5,DETECTION OF CHEMICAL STIMULUS,0.44924,0.038346,0.091617,0,0
5,REACTOME G ALPHA Z SIGNALLING EVENTS,0.65234,0.037656,0.049998,0,0
5,NEGATIVE REGULATION OF DNA BINDING,0.95466,0.037468,0.014466,0,0
5,REACTOME RNA POL II TRANSCRIPTION,0.4598,0.037403,0.018871,0,0
5,APOPTOTIC MITOCHONDRIAL CHANGES,1,0.03732,0.017001,0,0
5,REGIONALIZATION,0.24643,0.037031,0.1051,0,0
5,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.17099,0.036671,0.10047,0,0
5,HORMONE SECRETION,0.47049,0.036367,0.22118,0,0
5,PID NFAT 3PATHWAY,0.53167,0.03614,0.031024,0,0
5,SIG IL4RECEPTOR IN B LYPHOCYTES,0.85768,0.035835,-0.038553,0,0
5,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.85768,0.035484,0.021845,0,0
5,LEARNING AND OR MEMORY,0.60272,0.035296,0.035393,0,0
5,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.87144,0.034752,0.010763,0,0
5,MAP KINASE ACTIVITY,0.41341,0.03464,0.10415,0,0
5,PROTEIN AUTOPROCESSING,0.44402,0.034121,0.050507,0,0
5,NUCLEOPLASM PART,0.35153,0.034042,0.021692,0,0
5,GLYCOSAMINOGLYCAN BINDING,0.96163,0.034038,-0.01491,0,0
5,POLYSACCHARIDE BINDING,0.96163,0.034038,-0.01491,0,0
5,PID ARF6DOWNSTREAMPATHWAY,0.4978,0.034022,0.046491,0,0
5,KEGG DNA REPLICATION,0.44924,0.033878,0.044884,0,0
5,REACTOME MEIOTIC RECOMBINATION,0.49227,0.033065,0.070787,0,0
5,BIOCARTA CREB PATHWAY,0.44924,0.032958,0.072435,0,0
5,KEGG BETA ALANINE METABOLISM,0.41341,0.032934,0.091939,0,0
5,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.57857,0.032706,0.030928,0,0
5,BIOCARTA GPCR PATHWAY,0.9686,0.0327,-0.0045063,0,0
5,RHYTHMIC PROCESS,0.77618,0.032649,0.0010829,0,0
5,PID AR NONGENOMIC PATHWAY,0.67776,0.032241,0.031525,0,0
5,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.63354,0.031739,0.036247,0,0
5,BIOCARTA RAS PATHWAY,0.66501,0.031577,0.017782,0,0
5,SYNAPSE PART,0.54321,0.031343,0.049349,0,0
5,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,0.32077,0.030986,0.12131,0,0
5,NUCLEAR BODY,0.9686,0.030751,-0.018544,0,0
5,REACTOME ADP SIGNALLING THROUGH P2RY12,0.36064,0.030667,0.069101,0,0
5,CELL DIVISION,0.52025,0.030614,0.035098,0,0
5,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.27611,0.030569,0.057882,0,0
5,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.59059,0.030182,0.035802,0,0
5,ST JNK MAPK PATHWAY,0.89907,0.030025,-0.026968,0,0
5,CALCIUM MEDIATED SIGNALING,0.95466,0.029893,-0.033596,0,0
5,MONOCARBOXYLIC ACID TRANSPORT,0.81668,0.029233,-0.06687,0,0
5,TRANSCRIPTION FACTOR COMPLEX,0.29992,0.028938,0.025111,0,0
5,RESPONSE TO DNA DAMAGE STIMULUS,0.41341,0.028131,0.024136,0,0
5,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.25363,0.028073,0.077655,0,0
5,ONE CARBON COMPOUND METABOLIC PROCESS,0.94769,0.027945,0.0027586,0,0
5,MEIOSIS I,0.84397,0.027855,0.012996,0,0
5,REACTOME CHROMOSOME MAINTENANCE,0.32077,0.027302,0.055415,0,0
5,DNA INTEGRITY CHECKPOINT,0.55487,0.026981,0.034915,0,0
5,REACTOME BASE EXCISION REPAIR,0.91293,0.026872,0.0011184,0,0
5,PROTEIN POLYMERIZATION,0.69707,0.026742,0.020474,0,0
5,BIOCARTA PAR1 PATHWAY,0.71658,0.026597,-0.038659,0,0
5,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.91987,0.026474,-0.066398,0,0
5,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.47049,0.025975,0.047123,0,0
5,ACTIN FILAMENT,0.76281,0.025781,0.03133,0,0
5,KEGG MISMATCH REPAIR,0.83713,0.025525,0.020948,0,0
5,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.79636,0.025471,0.0035285,0,0
5,RESPONSE TO RADIATION,0.34256,0.02529,0.029645,0,0
5,ACTIN FILAMENT BUNDLE FORMATION,0.85768,0.023998,-0.0010134,0,0
5,CELL ACTIVATION,0.50896,0.023946,0.051144,0,0
5,PID ATR PATHWAY,0.87833,0.023722,-0.017728,0,0
5,MAGNESIUM ION BINDING,0.87833,0.023695,0.0004138,0,0
5,REACTOME GAB1 SIGNALOSOME,0.4978,0.023537,0.029917,0,0
5,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,0.21256,0.023182,-0.12469,0,0
5,KEGG TYPE I DIABETES MELLITUS,0.44924,0.023113,0.17033,0,0
5,CELL PROJECTION PART,0.71006,0.022812,0.044115,0,0
5,PHOSPHATASE BINDING,0.55487,0.022444,0.019494,0,0
5,PID PI3KPLCTRKPATHWAY,0.36991,0.022206,0.056848,0,0
5,PID P38ALPHABETAPATHWAY,0.70355,0.021987,0.024306,0,0
5,PID TCRJNKPATHWAY,0.58456,0.021893,-0.05208,0,0
5,REACTOME GABA B RECEPTOR ACTIVATION,0.98953,0.021883,-0.0086006,0,0
5,RESPONSE TO LIGHT STIMULUS,0.40349,0.021603,0.028368,0,0
5,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.87144,0.020751,0.0067974,0,0
5,REACTOME RNA POL III CHAIN ELONGATION,0.23937,0.020537,-0.11273,0,0
5,PID THROMBIN PAR4 PATHWAY,0.91987,0.020453,0.011961,0,0
5,NUCLEAR MEMBRANE,0.72969,0.020199,0.0081939,0,0
5,CELL CYCLE PROCESS,0.8303,0.020106,0.0034461,0,0
5,PID ERBB1 INTERNALIZATION PATHWAY,0.98953,0.019726,-0.0053129,0,0
5,ACTIN FILAMENT POLYMERIZATION,0.76281,0.019475,0.02039,0,0
5,PID LKB1 PATHWAY,0.64605,0.019186,-0.038613,0,0
5,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,0.67776,0.019119,0.033292,0,0
5,NUCLEOPLASM,0.52025,0.019089,0.012985,0,0
5,BIOCARTA ACH PATHWAY,0.4545,0.018898,0.036228,0,0
5,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,0.188,0.018202,0.10073,0,0
5,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,0.5726,0.018174,0.077252,0,0
5,REACTOME FRS2 MEDIATED CASCADE,0.31653,0.018136,-0.057876,0,0
5,MICROTUBULE BASED PROCESS,0.59664,0.018086,0.025585,0,0
5,REACTOME DNA REPAIR,0.77618,0.017344,0.007985,0,0
5,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.33373,0.017335,0.11151,0,0
5,BIOCARTA MITOCHONDRIA PATHWAY,0.92682,0.017157,0.017814,0,0
5,REGULATED SECRETORY PATHWAY,0.56666,0.016983,0.15048,0,0
5,LEUKOCYTE ACTIVATION,0.72969,0.016658,0.036314,0,0
5,DNA HELICASE ACTIVITY,0.65866,0.016546,0.025933,0,0
5,REACTOME PI3K AKT ACTIVATION,0.47588,0.016489,0.020525,0,0
5,REACTOME SIGNALLING TO ERKS,0.81668,0.016242,0.010734,0,0
5,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.53742,0.016048,-0.049533,0,0
5,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.76948,0.016026,0.02269,0,0
5,COATED VESICLE,0.67137,0.013625,0.023812,0,0
5,REACTOME NCAM1 INTERACTIONS,0.76948,0.012562,0.013304,0,0
5,LIPID TRANSPORTER ACTIVITY,0.71658,0.012528,-0.074103,0,0
5,ADAPTIVE IMMUNE RESPONSE,0.81668,0.012278,-0.056265,0,0
5,REACTOME MICRORNA MIRNA BIOGENESIS,0.8303,0.011888,0.0093045,0,0
5,ACTIN FILAMENT BASED MOVEMENT,0.42347,0.011769,0.066364,0,0
5,BIOCARTA ECM PATHWAY,0.83713,0.01176,-0.026845,0,0
5,CELL MATRIX JUNCTION,0.78289,0.011396,-0.068535,0,0
5,PATTERN BINDING,0.65234,0.011381,-0.042555,0,0
5,NOTCH SIGNALING PATHWAY,0.75615,0.010917,-0.029646,0,0
5,PID PI3KCIPATHWAY,0.87144,0.010825,-0.013983,0,0
5,REACTOME INWARDLY RECTIFYING K CHANNELS,0.87833,0.010492,0.00049102,0,0
5,REACTOME EXTENSION OF TELOMERES,0.87833,0.010067,-0.00083469,0,0
5,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.80312,0.0098291,-0.023749,0,0
5,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.80989,0.0097122,0.019651,0,0
5,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,0.95466,0.0095494,-0.0061076,0,0
5,REGULATION OF RESPONSE TO STIMULUS,0.71006,0.0089677,0.0321,0,0
5,VESICLE LOCALIZATION,0.33812,0.0087819,-0.15303,0,0
5,CELL CORTEX PART,0.80312,0.0086504,0.0090211,0,0
5,PID S1P S1P4 PATHWAY,0.90599,0.0068871,-0.015097,0,0
5,REACTOME GABA RECEPTOR ACTIVATION,0.98255,0.0065629,0.0031218,0,0
5,REACTOME MITOTIC M M G1 PHASES,0.85082,0.0063314,0.0085369,0,0
5,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,0.3746,0.0061671,0.2553,0,0
5,ENZYME BINDING,0.57857,0.005689,0.007648,0,0
5,CELL CYCLE PHASE,0.56666,0.0052551,-0.01349,0,0
5,PID ERBB2ERBB3PATHWAY,0.67137,0.0052046,0.018763,0,0
5,REACTOME REGULATORY RNA PATHWAYS,0.68418,0.0047452,0.026554,0,0
5,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.86455,0.0046165,-0.061355,0,0
5,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.76281,0.0037956,-0.02864,0,0
5,LYMPHOCYTE DIFFERENTIATION,0.82348,0.0037505,0.0059269,0,0
5,TRANSCRIPTION FACTOR ACTIVITY,0.76948,0.003666,-0.008207,0,0
5,DNA REPLICATION,0.58456,0.0031759,-0.032615,0,0
5,BIOCARTA AKAPCENTROSOME PATHWAY,0.71658,0.0030351,0.029869,0,0
5,BIOCARTA TCR PATHWAY,0.59059,0.0027876,-0.017817,0,0
5,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,0.75615,0.0027224,0.021531,0,0
5,REACTOME TRANSCRIPTION,0.89215,0.0026931,0.0057813,0,0
5,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,0.71658,0.002649,0.0030799,0,0
5,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.58456,0.0022776,-0.067642,0,0
5,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.69061,0.0022264,-0.03359,0,0
5,PID AMB2 NEUTROPHILS PATHWAY,0.55487,0.0021103,0.02456,0,0
5,TISSUE MORPHOGENESIS,0.59664,0.0020315,-0.074265,0,0
5,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.31232,0.00073187,0.11466,0,0
5,KEGG CELL ADHESION MOLECULES CAMS,0.67776,0.00053955,-0.020513,0,0
5,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.76281,0.00028628,0.056185,0,0
5,ACTIVATION OF MAPK ACTIVITY,0.78962,0.00025835,0.031659,0,0
5,KEGG NUCLEOTIDE EXCISION REPAIR,0.78962,3.3586e-05,-0.017739,0,0
5,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.69707,2.5782e-05,-0.033782,0,0
5,REACTOME SIGNALLING TO RAS,0.69061,-1.2057e-05,-0.017133,0,0
5,REACTOME ARMS MEDIATED ACTIVATION,0.68418,-0.00037264,0.022227,0,0
5,REACTOME REGULATION OF BETA CELL DEVELOPMENT,0.47049,-0.00058631,-0.057578,0,0
5,HELICASE ACTIVITY,0.77618,-0.00079029,-0.020202,0,0
5,PID SMAD2 3PATHWAY,0.69061,-0.0011773,0.017522,0,0
5,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.93377,-0.0012552,0.0069084,0,0
5,PID TCRCALCIUMPATHWAY,1,-0.0016476,-0.012178,0,0
5,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.54321,-0.0018904,-0.027802,0,0
5,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.91293,-0.0019679,-0.0097385,0,0
5,LYMPHOCYTE ACTIVATION,0.71006,-0.0026976,0.041228,0,0
5,PROTEIN CATABOLIC PROCESS,0.65866,-0.0027496,-0.034269,0,0
5,PID FOXOPATHWAY,0.65866,-0.0027509,-0.026613,0,0
5,TRANS GOLGI NETWORK,0.88523,-0.002809,-0.017975,0,0
5,REACTOME SIGNALING BY ERBB2,0.59059,-0.0029801,-0.020467,0,0
5,KEGG OOCYTE MEIOSIS,0.75615,-0.0030204,-0.0073211,0,0
5,REGULATION OF GROWTH,0.89215,-0.0037511,-0.0029376,0,0
5,PID CXCR3PATHWAY,0.94073,-0.0039512,0.013673,0,0
5,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.81668,-0.0040696,0.021404,0,0
5,CALCIUM ION TRANSPORT,0.74288,-0.0042498,-0.035124,0,0
5,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.76948,-0.0044657,0.031999,0,0
5,CHROMATIN MODIFICATION,0.82348,-0.0046189,-0.0050528,0,0
5,PID BETACATENIN DEG PATHWAY,0.63978,-0.0047679,-0.020215,0,0
5,REACTOME PI METABOLISM,0.52025,-0.0049572,-0.025393,0,0
5,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.27611,-0.005552,-0.070419,0,0
5,DNA BINDING,0.52025,-0.0057529,-0.016105,0,0
5,PID IL23PATHWAY,0.78289,-0.0057696,-0.069714,0,0
5,REACTOME SHC MEDIATED CASCADE,0.16032,-0.0060182,-0.10048,0,0
5,PID PLK1 PATHWAY,0.80989,-0.0063155,-0.010279,0,0
5,MITOTIC CELL CYCLE,0.63978,-0.0064266,-0.012428,0,0
5,REGULATION OF GTPASE ACTIVITY,0.31653,-0.0066648,-0.10579,0,0
5,KEGG LYSINE DEGRADATION,0.67776,-0.0074333,-0.034978,0,0
5,BIOCARTA NDKDYNAMIN PATHWAY,0.30815,-0.0077228,-0.1018,0,0
5,DNA RECOMBINATION,0.81668,-0.008291,0.0099134,0,0
5,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.65866,-0.0083069,-0.081997,0,0
5,RESPONSE TO VIRUS,0.85768,-0.0085294,-0.024104,0,0
5,RESPONSE TO OTHER ORGANISM,0.32077,-0.0086179,-0.068349,0,0
5,STRUCTURE SPECIFIC DNA BINDING,0.69061,-0.008634,-0.02167,0,0
5,ACETYLCHOLINE BINDING,0.90599,-0.0087584,-0.0090478,0,0
5,PID RHODOPSIN PATHWAY,0.40843,-0.0088625,0.055341,0,0
5,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.8303,-0.0089628,0.013228,0,0
5,PID HEDGEHOG GLIPATHWAY,0.86455,-0.009103,-0.023113,0,0
5,BIOCARTA MYOSIN PATHWAY,0.52025,-0.0092489,-0.055153,0,0
5,REACTOME MRNA PROCESSING,0.99651,-0.0094308,-0.0072761,0,0
5,HISTONE DEACETYLASE COMPLEX,0.93377,-0.009684,0.011624,0,0
5,PID CDC42 PATHWAY,0.57857,-0.0098477,-0.018728,0,0
5,REACTOME SIGNALING BY ROBO RECEPTOR,0.78289,-0.010543,-0.020662,0,0
5,DEOXYRIBONUCLEASE ACTIVITY,0.89215,-0.010841,-0.011363,0,0
5,KEGG CELL CYCLE,0.80989,-0.010913,-0.0056705,0,0
5,KEGG ENDOMETRIAL CANCER,0.90599,-0.010929,-0.0014446,0,0
5,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.94769,-0.011223,-0.0035145,0,0
5,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.68418,-0.011243,-0.021145,0,0
5,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.63354,-0.011376,0.021107,0,0
5,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.63354,-0.011479,-0.03345,0,0
5,REACTOME SEMAPHORIN INTERACTIONS,0.92682,-0.011514,0.0096867,0,0
5,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.34256,-0.011709,-0.089828,0,0
5,PID DNAPK PATHWAY,0.27227,-0.011812,-0.068222,0,0
5,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,0.76281,-0.013362,-0.042416,0,0
5,ANTIOXIDANT ACTIVITY,0.39371,-0.013522,-0.10337,0,0
5,BASE EXCISION REPAIR,0.88523,-0.014178,-0.00099987,0,0
5,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,0.52594,-0.014574,-0.089312,0,0
5,REACTOME CELL CYCLE CHECKPOINTS,0.27227,-0.014844,-0.05349,0,0
5,COVALENT CHROMATIN MODIFICATION,0.33373,-0.015011,-0.072073,0,0
5,HISTONE MODIFICATION,0.33373,-0.015011,-0.072073,0,0
5,REACTOME FANCONI ANEMIA PATHWAY,0.51459,-0.015033,-0.040605,0,0
5,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.71658,-0.015228,-0.017396,0,0
5,BIOCARTA NGF PATHWAY,0.66501,-0.015565,-0.046487,0,0
5,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.76281,-0.01564,-0.032687,0,0
5,PID VEGFR1 PATHWAY,0.78962,-0.015766,0.027363,0,0
5,KEGG COLORECTAL CANCER,0.20937,-0.015809,-0.069293,0,0
5,BIOCARTA CK1 PATHWAY,0.66501,-0.015816,-0.047619,0,0
5,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.60883,-0.015843,-0.097296,0,0
5,PID NETRIN PATHWAY,0.98255,-0.016054,0.005101,0,0
5,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.14526,-0.016096,-0.072982,0,0
5,REGULATION OF SECRETION,0.94073,-0.016134,0.054083,0,0
5,PID TCR PATHWAY,0.55487,-0.016163,-0.037762,0,0
5,PID TXA2PATHWAY,0.37932,-0.01689,-0.063712,0,0
5,BIOCARTA CARM ER PATHWAY,0.26847,-0.017043,-0.046254,0,0
5,NUCLEAR EXPORT,0.50337,-0.017131,-0.022682,0,0
5,ST FAS SIGNALING PATHWAY,0.3746,-0.017164,-0.035134,0,0
5,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.65234,-0.017192,0.040404,0,0
5,PID P75NTRPATHWAY,0.50337,-0.017341,-0.040158,0,0
5,BIOCARTA ATRBRCA PATHWAY,0.88523,-0.017473,0.0090929,0,0
5,REACTOME SIGNALING BY FGFR MUTANTS,0.9686,-0.017548,0.0040689,0,0
5,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.1028,-0.017692,-0.057511,0,0
5,PID S1P S1P3 PATHWAY,0.60272,-0.017872,-0.029139,0,0
5,NEGATIVE REGULATION OF TRANSCRIPTION,0.48678,-0.01819,-0.022286,0,0
5,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.65866,-0.018295,-0.026137,0,0
5,IMMUNE EFFECTOR PROCESS,0.76948,-0.018386,-0.038961,0,0
5,PID NFAT TFPATHWAY,0.26847,-0.018543,-0.11799,0,0
5,CYTOSKELETON,0.47049,-0.018692,-0.02831,0,0
5,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.85768,-0.018752,-0.022522,0,0
5,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.93377,-0.019113,0.0077407,0,0
5,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.70355,-0.019124,-0.030804,0,0
5,CELLULAR PROTEIN CATABOLIC PROCESS,0.20937,-0.019259,-0.076986,0,0
5,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.69707,-0.019561,0.028795,0,0
5,KEGG VIRAL MYOCARDITIS,0.34256,-0.019732,-0.068518,0,0
5,CLATHRIN COATED VESICLE,0.82348,-0.019733,0.018105,0,0
5,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.35607,-0.020214,-0.040927,0,0
5,PID HDAC CLASSII PATHWAY,0.83713,-0.020386,-0.010302,0,0
5,PID RETINOIC ACID PATHWAY,0.25001,-0.020421,-0.06991,0,0
5,TRANSCRIPTION COACTIVATOR ACTIVITY,0.27227,-0.020502,-0.034175,0,0
5,NUCLEAR MEMBRANE PART,0.83713,-0.021409,-0.015471,0,0
5,REACTOME OPIOID SIGNALLING,0.40843,-0.022145,-0.047949,0,0
5,SPHINGOLIPID METABOLIC PROCESS,0.44402,-0.022534,-0.048362,0,0
5,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,0.32077,-0.022654,-0.0818,0,0
5,REGULATION OF NEUROTRANSMITTER LEVELS,0.96163,-0.022816,0.067089,0,0
5,CELL FATE COMMITMENT,0.62113,-0.023051,0.053221,0,0
5,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.20309,-0.023057,-0.044579,0,0
5,ST GRANULE CELL SURVIVAL PATHWAY,0.4598,-0.023315,-0.032751,0,0
5,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.65234,-0.023403,0.001196,0,0
5,ATPASE ACTIVITY,0.52594,-0.023466,-0.023107,0,0
5,BIOCARTA G1 PATHWAY,0.51459,-0.023561,-0.053959,0,0
5,KEGG PRION DISEASES,0.85082,-0.023707,-0.019598,0,0
5,DOUBLE STRANDED RNA BINDING,0.56075,-0.024132,-0.041175,0,0
5,NEGATIVE REGULATION OF BINDING,0.71658,-0.024216,-0.013485,0,0
5,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.8303,-0.024483,-0.014305,0,0
5,CYTOSKELETAL PROTEIN BINDING,0.16559,-0.02479,-0.059439,0,0
5,BIOCARTA TFF PATHWAY,0.54903,-0.025167,-0.052149,0,0
5,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.77618,-0.025386,0.047588,0,0
5,CARBOXYLESTERASE ACTIVITY,0.42855,-0.025398,-0.091925,0,0
5,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,0.93377,-0.025573,5.5611e-05,0,0
5,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.66501,-0.025754,-0.048158,0,0
5,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,0.71658,-0.025995,0.051507,0,0
5,EXTERNAL SIDE OF PLASMA MEMBRANE,0.9686,-0.026296,0.00075925,0,0
5,NEGATIVE REGULATION OF GROWTH,0.71658,-0.026329,-0.023839,0,0
5,NUCLEAR PART,0.35153,-0.026518,-0.021825,0,0
5,PYROPHOSPHATASE ACTIVITY,0.066855,-0.026947,-0.062832,0,0
5,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,0.48131,-0.027089,-0.035194,0,0
5,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.91987,-0.027204,0.0086263,0,0
5,REACTOME AMINE DERIVED HORMONES,0.78289,-0.027285,0.046409,0,0
5,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.48131,-0.027534,-0.045706,0,0
5,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.48131,-0.027534,-0.045706,0,0
5,BIOCARTA AGPCR PATHWAY,0.83713,-0.027764,0.012932,0,0
5,RNA PROCESSING,0.60883,-0.027808,-0.029876,0,0
5,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,0.39858,-0.027999,-0.065648,0,0
5,DNA METABOLIC PROCESS,0.29992,-0.028538,-0.030457,0,0
5,ORGANELLE ORGANIZATION AND BIOGENESIS,0.065563,-0.028563,-0.039869,0,0
5,ST INTEGRIN SIGNALING PATHWAY,0.48131,-0.028577,-0.040151,0,0
5,PID ERBB NETWORK PATHWAY,0.67137,-0.028625,-0.077987,0,0
5,BIOCARTA EIF4 PATHWAY,0.48131,-0.028732,-0.02858,0,0
5,RESPONSE TO ENDOGENOUS STIMULUS,0.23589,-0.028808,-0.037455,0,0
5,REACTOME ADHERENS JUNCTIONS INTERACTIONS,0.80989,-0.028994,-0.0087647,0,0
5,MAINTENANCE OF LOCALIZATION,0.54321,-0.029278,-0.060921,0,0
5,BIOCARTA AKT PATHWAY,0.56075,-0.029322,-0.041238,0,0
5,REACTOME RNA POL I TRANSCRIPTION,0.99651,-0.029521,0.016129,0,0
5,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.55487,-0.029685,-0.023564,0,0
5,ZINC ION BINDING,0.5726,-0.030238,-0.030928,0,0
5,CIRCADIAN RHYTHM,0.51459,-0.030404,-0.041526,0,0
5,POSITIVE REGULATION OF SECRETION,0.70355,-0.030604,-0.0077043,0,0
5,CONDENSED NUCLEAR CHROMOSOME,0.36991,-0.030692,-0.045934,0,0
5,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.74288,-0.030987,-0.014458,0,0
5,REACTOME SIGNAL TRANSDUCTION BY L1,0.83713,-0.031029,0.0117,0,0
5,REACTOME PI 3K CASCADE,0.48131,-0.031063,-0.027416,0,0
5,HEPARIN BINDING,0.34702,-0.031307,-0.13064,0,0
5,KEGG NON SMALL CELL LUNG CANCER,0.35153,-0.031385,-0.033317,0,0
5,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.48131,-0.032081,-0.041773,0,0
5,PID ERBB4 PATHWAY,0.2839,-0.03239,-0.05314,0,0
5,REGULATION OF PROTEIN STABILITY,0.13583,-0.032392,-0.11123,0,0
5,KEGG SPLICEOSOME,0.88523,-0.032425,0.0018537,0,0
5,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.51459,-0.032569,-0.035497,0,0
5,REACTOME ION TRANSPORT BY P TYPE ATPASES,0.9686,-0.032711,0.02427,0,0
5,PID SHP2 PATHWAY,0.32506,-0.032911,-0.079839,0,0
5,FOCAL ADHESION,0.82348,-0.032982,-0.045458,0,0
5,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,0.59059,-0.033071,-0.084198,0,0
5,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.41341,-0.0335,-0.050242,0,0
5,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.36991,-0.033624,-0.032218,0,0
5,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.74288,-0.034057,-0.048008,0,0
5,NUCLEAR LUMEN,0.087232,-0.034412,-0.039086,0,0
5,REGULATION OF PHOSPHORYLATION,0.31653,-0.034515,-0.092311,0,0
5,PID P38 MK2PATHWAY,1,-0.034569,-0.0081492,0,0
5,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.66501,-0.035098,-0.0065327,0,0
5,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.66501,-0.035098,-0.0065327,0,0
5,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.85768,-0.035874,0.0075987,0,0
5,PID E2F PATHWAY,0.38408,-0.035925,-0.03882,0,0
5,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.15264,-0.036071,-0.10484,0,0
5,PID ALPHASYNUCLEIN PATHWAY,0.22235,-0.036166,-0.10214,0,0
5,KEGG ADHERENS JUNCTION,0.25001,-0.036583,-0.075518,0,0
5,REACTOME MYOGENESIS,0.56075,-0.036604,-0.036701,0,0
5,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.52594,-0.037159,-0.018122,0,0
5,PROTEIN PROCESSING,0.43883,-0.037169,-0.035834,0,0
5,BIOCARTA GATA3 PATHWAY,0.25001,-0.037317,-0.090008,0,0
5,PID ALK1PATHWAY,0.27227,-0.037365,-0.077381,0,0
5,REGULATION OF RNA METABOLIC PROCESS,0.084046,-0.037798,-0.04969,0,0
5,REGULATION OF CELL CYCLE,0.072231,-0.037871,-0.057177,0,0
5,BIOCARTA HIVNEF PATHWAY,0.22235,-0.03844,-0.097273,0,0
5,PID RET PATHWAY,0.51459,-0.038472,-0.034686,0,0
5,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.41842,-0.038491,-0.025192,0,0
5,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.070855,-0.038513,-0.052891,0,0
5,PID P53REGULATIONPATHWAY,0.2,-0.038739,-0.038956,0,0
5,CELL PROJECTION,0.19393,-0.038812,-0.061727,0,0
5,NUCLEAR ENVELOPE,0.5726,-0.038841,-0.022955,0,0
5,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.56075,-0.039018,-0.034135,0,0
5,REACTOME GAP JUNCTION TRAFFICKING,0.89215,-0.039266,0.0027886,0,0
5,PID AR TF PATHWAY,0.49227,-0.039402,-0.048875,0,0
5,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.50896,-0.039534,-0.029428,0,0
5,NEGATIVE REGULATION OF METABOLIC PROCESS,0.51459,-0.039544,-0.02342,0,0
5,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.51459,-0.039734,-0.023336,0,0
5,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.27611,-0.040003,-0.048404,0,0
5,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.23937,-0.040186,-0.10045,0,0
5,REACTOME SIGNALING BY NOTCH4,0.91987,-0.040356,0.037115,0,0
5,REACTOME SIGNALING BY EGFR IN CANCER,0.050569,-0.040395,-0.066115,0,0
5,ATPASE ACTIVITY COUPLED,0.50337,-0.04041,-0.023295,0,0
5,CELL CYCLE GO 0007049,0.090515,-0.040419,-0.044126,0,0
5,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.65234,-0.040441,-0.017457,0,0
5,SYSTEM DEVELOPMENT,0.2839,-0.040496,-0.037767,0,0
5,REGULATION OF MITOTIC CELL CYCLE,0.36064,-0.040537,-0.051253,0,0
5,GLAND DEVELOPMENT,0.8303,-0.040775,-0.032102,0,0
5,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.19695,-0.040904,-0.15018,0,0
5,BIOCARTA NKCELLS PATHWAY,0.69061,-0.041291,-0.061422,0,0
5,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.65866,-0.041307,-0.074927,0,0
5,REACTOME PLATELET HOMEOSTASIS,0.73628,-0.041327,-0.010401,0,0
5,REACTOME GLOBAL GENOMIC NER GG NER,0.30815,-0.04138,-0.053569,0,0
5,BIOCARTA ETS PATHWAY,0.9686,-0.041494,0.0006069,0,0
5,PID AJDISS 2PATHWAY,0.91987,-0.041755,0.024135,0,0
5,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,0.53167,-0.042164,-0.029554,0,0
5,BIOCARTA HSP27 PATHWAY,0.4978,-0.042327,-0.051999,0,0
5,REACTOME KINESINS,0.188,-0.042428,0.13915,0,0
5,REPRODUCTION,0.25729,-0.042563,-0.051645,0,0
5,PID SYNDECAN 2 PATHWAY,0.74288,-0.042681,-0.053105,0,0
5,PID NCADHERINPATHWAY,0.36526,-0.04272,-0.070274,0,0
5,MEMBRANE LIPID METABOLIC PROCESS,0.080955,-0.042758,-0.082603,0,0
5,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.34702,-0.042823,-0.07695,0,0
5,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.34702,-0.042823,-0.07695,0,0
5,LEADING EDGE,0.23589,-0.043452,-0.071541,0,0
5,GLYCOPROTEIN METABOLIC PROCESS,0.4545,-0.043559,-0.072017,0,0
5,ST WNT BETA CATENIN PATHWAY,0.59664,-0.043669,-0.038356,0,0
5,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.40843,-0.043696,-0.030474,0,0
5,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.89907,-0.043794,0.011581,0,0
5,REACTOME G1 PHASE,0.74288,-0.043851,-0.0063104,0,0
5,REACTOME SIGNALING BY FGFR,0.24288,-0.044631,-0.038274,0,0
5,G PROTEIN COUPLED RECEPTOR ACTIVITY,0.19695,-0.045111,-0.045928,0,0
5,RESPONSE TO UV,0.29586,-0.04512,-0.053542,0,0
5,REACTOME MITOTIC G1 G1 S PHASES,0.36064,-0.045303,-0.04259,0,0
5,RESPONSE TO ABIOTIC STIMULUS,0.57857,-0.045418,-0.018707,0,0
5,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.37932,-0.04554,-0.055927,0,0
5,RNA DEPENDENT ATPASE ACTIVITY,0.22235,-0.045751,-0.073962,0,0
5,KEGG ACUTE MYELOID LEUKEMIA,0.20309,-0.045936,-0.048716,0,0
5,PID HDAC CLASSI PATHWAY,0.18508,-0.046222,-0.040773,0,0
5,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.70355,-0.046222,-0.020531,0,0
5,BIOCARTA NFAT PATHWAY,0.095625,-0.046234,-0.09647,0,0
5,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.1313,-0.046382,-0.046979,0,0
5,POSITIVE REGULATION OF TRANSCRIPTION,0.19095,-0.046424,-0.052697,0,0
5,MYELOID LEUKOCYTE DIFFERENTIATION,0.4598,-0.046579,-0.20076,0,0
5,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.16828,-0.046579,-0.044964,0,0
5,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.50896,-0.04681,-0.015947,0,0
5,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.38408,-0.046947,-0.027758,0,0
5,BIOCARTA MTOR PATHWAY,0.10654,-0.047095,-0.089891,0,0
5,BIOCARTA CELL2CELL PATHWAY,0.38408,-0.047252,-0.1075,0,0
5,INTERPHASE OF MITOTIC CELL CYCLE,0.12908,-0.047404,-0.065724,0,0
5,REACTOME HIV LIFE CYCLE,0.36991,-0.047451,-0.03725,0,0
5,REACTOME IL 2 SIGNALING,0.83713,-0.04754,-0.0094537,0,0
5,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.35153,-0.047557,-0.051737,0,0
5,KEGG VIBRIO CHOLERAE INFECTION,0.188,-0.047718,-0.068585,0,0
5,CELL SUBSTRATE ADHERENS JUNCTION,0.62732,-0.048034,-0.072223,0,0
5,PID TELOMERASEPATHWAY,0.085627,-0.048556,-0.083292,0,0
5,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.14769,-0.048596,-0.094381,0,0
5,REGULATION OF LYMPHOCYTE ACTIVATION,0.73628,-0.048721,0.032816,0,0
5,CELL PROJECTION BIOGENESIS,0.16294,-0.049487,-0.079784,0,0
5,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.39371,-0.049954,-0.076294,0,0
5,TRANSCRIPTION REPRESSOR ACTIVITY,0.050569,-0.050157,-0.072378,0,0
5,ST G ALPHA S PATHWAY,0.27999,-0.050336,-0.048825,0,0
5,BIOCARTA MCALPAIN PATHWAY,0.28785,-0.050411,-0.082286,0,0
5,PID SMAD2 3NUCLEARPATHWAY,0.11039,-0.05071,-0.080971,0,0
5,PORE COMPLEX,0.52594,-0.050711,-0.046238,0,0
5,BIOCARTA AGR PATHWAY,0.32506,-0.05084,-0.061628,0,0
5,TRANSCRIPTION ACTIVATOR ACTIVITY,0.10654,-0.050955,-0.048574,0,0
5,REGULATION OF TRANSCRIPTION,0.049546,-0.050963,-0.053414,0,0
5,ANATOMICAL STRUCTURE DEVELOPMENT,0.12689,-0.051181,-0.054478,0,0
5,ACTIN FILAMENT BINDING,0.30815,-0.051294,-0.048305,0,0
5,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.36064,-0.051392,-0.065951,0,0
5,ACID AMINO ACID LIGASE ACTIVITY,0.063042,-0.051527,-0.098224,0,0
5,GLUTAMATE RECEPTOR ACTIVITY,0.97557,-0.051604,0.06778,0,0
5,REACTOME SIGNALING BY FGFR IN DISEASE,0.33373,-0.052043,-0.031039,0,0
5,ACTIN FILAMENT BASED PROCESS,0.58456,-0.05262,-0.023547,0,0
5,REACTOME RNA POL III TRANSCRIPTION,0.12049,-0.052827,-0.094349,0,0
5,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.076492,-0.052849,-0.11256,0,0
5,REACTOME G ALPHA I SIGNALLING EVENTS,0.32077,-0.052919,-0.042353,0,0
5,RESPONSE TO NUTRIENT,0.38408,-0.053179,-0.074604,0,0
5,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.56075,-0.05353,-0.029752,0,0
5,REACTOME SYNTHESIS OF DNA,0.50896,-0.053536,-0.036632,0,0
5,PROTEIN C TERMINUS BINDING,0.36526,-0.05395,-0.0367,0,0
5,REACTOME S PHASE,0.12049,-0.054153,-0.087789,0,0
5,POSITIVE REGULATION OF CASPASE ACTIVITY,0.92682,-0.054246,0.0024904,0,0
5,CELL MIGRATION,0.38408,-0.054332,-0.061765,0,0
5,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.10465,-0.05441,-0.078933,0,0
5,REGULATION OF ENDOCYTOSIS,0.54321,-0.054526,-0.069179,0,0
5,KEGG ONE CARBON POOL BY FOLATE,0.059411,-0.054644,-0.22823,0,0
5,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,0.17374,-0.05476,-0.18209,0,0
5,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.15517,-0.05483,-0.058711,0,0
5,POSITIVE REGULATION OF RNA METABOLIC PROCESS,0.15517,-0.05483,-0.058711,0,0
5,NUCLEAR PORE,0.64605,-0.055107,-0.043409,0,0
5,REACTOME SYNTHESIS OF PC,0.097379,-0.055173,-0.13884,0,0
5,CELL JUNCTION,0.21905,-0.055478,-0.084256,0,0
5,BILE ACID METABOLIC PROCESS,0.63354,-0.055491,-0.06979,0,0
5,REACTOME AXON GUIDANCE,0.40843,-0.055601,-0.037537,0,0
5,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.079444,-0.055794,-0.11829,0,0
5,KEGG BUTANOATE METABOLISM,0.16032,-0.0558,-0.10069,0,0
5,BIOCARTA FAS PATHWAY,0.11841,-0.055911,-0.099467,0,0
5,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,0.11235,-0.055911,-0.15633,0,0
5,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.15517,-0.056035,-0.10224,0,0
5,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.69061,-0.056263,-0.035306,0,0
5,HEART DEVELOPMENT,0.7495,-0.0566,-0.0069766,0,0
5,GLUTAMATE SIGNALING PATHWAY,0.70355,-0.056854,-0.047108,0,0
5,BIOCARTA IL2RB PATHWAY,0.26471,-0.056872,-0.079476,0,0
5,GTPASE BINDING,0.087232,-0.0569,-0.092027,0,0
5,REACTOME SIGNALLING BY NGF,0.072231,-0.057143,-0.058468,0,0
5,REACTOME IL 7 SIGNALING,0.34702,-0.057168,-0.086508,0,0
5,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.64605,-0.057277,-0.068672,0,0
5,TUBE DEVELOPMENT,0.88523,-0.057685,0.019461,0,0
5,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.31232,-0.057743,-0.045165,0,0
5,KEGG PROSTATE CANCER,0.19393,-0.057916,-0.075,0,0
5,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,0.8303,-0.058304,0.023235,0,0
5,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.065563,-0.058359,-0.051807,0,0
5,METALLOPEPTIDASE ACTIVITY,0.30815,-0.058612,-0.068642,0,0
5,REACTOME PLC BETA MEDIATED EVENTS,0.20937,-0.058688,-0.06087,0,0
5,GABA RECEPTOR ACTIVITY,1,-0.058749,-0.0037626,0,0
5,REACTOME G1 S TRANSITION,0.11636,-0.059098,-0.079005,0,0
5,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.47049,-0.059098,-0.026597,0,0
5,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.066855,-0.0591,-0.071565,0,0
5,ST GA12 PATHWAY,0.092194,-0.059134,-0.092461,0,0
5,BIOCARTA SPRY PATHWAY,0.63354,-0.05953,-0.058144,0,0
5,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.33812,-0.059587,-0.074666,0,0
5,BIOCARTA STATHMIN PATHWAY,0.60272,-0.059589,0.0069873,0,0
5,PROTEIN RNA COMPLEX ASSEMBLY,0.14769,-0.059706,-0.089979,0,0
5,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.16294,-0.059729,-0.073542,0,0
5,NEURON DIFFERENTIATION,0.70355,-0.060016,0.01724,0,0
5,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.14285,-0.060075,-0.056769,0,0
5,PHOSPHOINOSITIDE METABOLIC PROCESS,0.13583,-0.060211,-0.060789,0,0
5,REACTOME HIV INFECTION,0.14769,-0.060253,-0.053214,0,0
5,ATP DEPENDENT RNA HELICASE ACTIVITY,0.13814,-0.060871,-0.099743,0,0
5,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.26098,-0.061041,-0.065091,0,0
5,KEGG RNA DEGRADATION,0.22235,-0.061293,-0.059631,0,0
5,ST T CELL SIGNAL TRANSDUCTION,0.43883,-0.061438,-0.04706,0,0
5,PID CD8TCRPATHWAY,0.42347,-0.061667,-0.046239,0,0
5,BIOCARTA HCMV PATHWAY,0.20309,-0.061708,-0.084794,0,0
5,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.43883,-0.062012,-0.10797,0,0
5,REGULATION OF HYDROLASE ACTIVITY,0.22235,-0.062048,-0.05114,0,0
5,SYNAPTIC TRANSMISSION,0.26098,-0.062077,-0.042411,0,0
5,REACTOME GAP JUNCTION ASSEMBLY,0.57857,-0.062078,-0.050384,0,0
5,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.61497,-0.062167,-0.051628,0,0
5,KEGG CHRONIC MYELOID LEUKEMIA,0.39371,-0.062245,-0.039658,0,0
5,UBIQUITIN CYCLE,0.099158,-0.062411,-0.091999,0,0
5,KEGG STEROID HORMONE BIOSYNTHESIS,0.25363,-0.062745,-0.147,0,0
5,PID FCER1PATHWAY,0.082489,-0.062805,-0.088486,0,0
5,ATP DEPENDENT HELICASE ACTIVITY,0.20937,-0.063,-0.069891,0,0
5,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.35607,-0.063236,-0.02894,0,0
5,RESPONSE TO NUTRIENT LEVELS,0.56075,-0.063384,-0.029998,0,0
5,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.39858,-0.063546,-0.039391,0,0
5,GTPASE ACTIVITY,0.25729,-0.063546,-0.066922,0,0
5,BIOCARTA IL2 PATHWAY,0.81668,-0.063936,-0.026638,0,0
5,TUBE MORPHOGENESIS,0.65234,-0.063951,0.027531,0,0
5,PHOSPHOLIPASE C ACTIVATION,0.64605,-0.063982,-0.032748,0,0
5,METALLOENDOPEPTIDASE ACTIVITY,0.71006,-0.063989,-0.040573,0,0
5,PID GLYPICAN 1PATHWAY,0.58456,-0.064018,-0.057027,0,0
5,REGULATION OF CELL GROWTH,0.073629,-0.064146,-0.10728,0,0
5,GLYCOLIPID METABOLIC PROCESS,0.71658,-0.0642,-0.06456,0,0
5,PID CONE PATHWAY,0.11039,-0.064221,-0.11715,0,0
5,RESPONSE TO ORGANIC SUBSTANCE,0.4978,-0.064265,-0.024458,0,0
5,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.4978,-0.064337,-0.08075,0,0
5,GATED CHANNEL ACTIVITY,0.35607,-0.0644,-0.03683,0,0
5,PROTEIN DOMAIN SPECIFIC BINDING,0.16828,-0.064419,-0.053826,0,0
5,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.16559,-0.065018,-0.055387,0,0
5,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.30815,-0.065061,-0.038068,0,0
5,BIOCARTA CCR3 PATHWAY,0.33812,-0.065143,-0.046809,0,0
5,HEMOSTASIS,0.2,-0.065179,-0.10348,0,0
5,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.05161,-0.065258,-0.17134,0,0
5,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.1028,-0.065918,-0.08792,0,0
5,SA TRKA RECEPTOR,0.71658,-0.065957,-0.029247,0,0
5,REACTOME DEVELOPMENTAL BIOLOGY,0.17653,-0.066471,-0.049225,0,0
5,PROTEIN UBIQUITINATION,0.19095,-0.066543,-0.066347,0,0
5,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,0.65866,-0.066916,-0.0088014,0,0
5,RESPONSE TO EXTRACELLULAR STIMULUS,0.27611,-0.067014,-0.058709,0,0
5,REACTOME COMPLEMENT CASCADE,0.05161,-0.067138,-0.23455,0,0
5,ENZYME INHIBITOR ACTIVITY,0.093897,-0.067153,-0.095142,0,0
5,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,0.064293,-0.067214,-0.12114,0,0
5,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.30815,-0.067483,-0.049943,0,0
5,REACTOME NUCLEOTIDE EXCISION REPAIR,0.32506,-0.067582,-0.041588,0,0
5,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.34702,-0.067735,-0.12634,0,0
5,BIOCARTA UCALPAIN PATHWAY,0.43367,-0.067739,-0.087405,0,0
5,BIOCARTA LONGEVITY PATHWAY,0.15264,-0.067946,-0.12627,0,0
5,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,0.17374,-0.068136,-0.10073,0,0
5,PID INTEGRIN2 PATHWAY,0.18508,-0.068219,-0.16178,0,0
5,REACTOME MRNA CAPPING,0.14526,-0.068466,-0.073929,0,0
5,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,0.33812,-0.068733,-0.10924,0,0
5,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.18219,-0.069324,-0.11678,0,0
5,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,0.22235,-0.069723,-0.057616,0,0
5,KEGG HEDGEHOG SIGNALING PATHWAY,0.41842,-0.069895,-0.043273,0,0
5,KEGG GLIOMA,0.10096,-0.069932,-0.054934,0,0
5,BIOCARTA IGF1MTOR PATHWAY,0.33373,-0.07032,-0.056984,0,0
5,BIOCARTA FCER1 PATHWAY,0.18219,-0.071367,-0.094452,0,0
5,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.15773,-0.071428,-0.085881,0,0
5,REACTOME ACTIVATION OF GENES BY ATF4,0.095625,-0.071437,-0.11065,0,0
5,PID TCRRASPATHWAY,0.17653,-0.071638,-0.077219,0,0
5,BIOCARTA HER2 PATHWAY,0.54321,-0.071653,-0.049585,0,0
5,LIGAND GATED CHANNEL ACTIVITY,0.49227,-0.071689,-0.051278,0,0
5,BIOCARTA CXCR4 PATHWAY,0.52025,-0.071691,-0.028383,0,0
5,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.10845,-0.071961,-0.10011,0,0
5,CELL CORTEX,0.10654,-0.071989,-0.080561,0,0
5,PROTEIN N TERMINUS BINDING,0.188,-0.07232,-0.059924,0,0
5,NEUROGENESIS,0.80312,-0.072804,-0.026938,0,0
5,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,0.15773,-0.072826,-0.065956,0,0
5,G PROTEIN COUPLED RECEPTOR BINDING,0.2839,-0.073004,-0.097959,0,0
5,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.15773,-0.073154,-0.09916,0,0
5,BIOCARTA TNFR2 PATHWAY,0.063042,-0.073248,-0.15947,0,0
5,GENERATION OF NEURONS,0.92682,-0.073632,-0.011535,0,0
5,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,0.42855,-0.073747,-0.075608,0,0
5,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,0.50896,-0.073778,-0.033352,0,0
5,NEURITE DEVELOPMENT,0.69707,-0.073949,-0.050146,0,0
5,KEGG TYPE II DIABETES MELLITUS,0.48131,-0.074404,-0.038919,0,0
5,NUCLEOTIDE EXCISION REPAIR,0.12689,-0.074468,-0.081293,0,0
5,APOPTOTIC PROGRAM,0.34702,-0.074629,-0.046329,0,0
5,VESICLE COAT,0.26847,-0.074821,-0.10112,0,0
5,NUCLEAR HORMONE RECEPTOR BINDING,0.23245,-0.074893,-0.068661,0,0
5,HORMONE RECEPTOR BINDING,0.23245,-0.074893,-0.068661,0,0
5,BIOCARTA TNFR1 PATHWAY,0.11841,-0.074997,-0.091045,0,0
5,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.27999,-0.075036,-0.061313,0,0
5,REACTOME INSULIN RECEPTOR RECYCLING,0.29586,-0.075466,-0.11219,0,0
5,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.17099,-0.075494,-0.13245,0,0
5,PID IL2 1PATHWAY,0.22905,-0.075782,-0.072361,0,0
5,UBIQUITIN PROTEIN LIGASE ACTIVITY,0.27611,-0.075905,-0.047251,0,0
5,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.18219,-0.076376,-0.053553,0,0
5,COLLAGEN BINDING,0.73628,-0.076725,-0.081357,0,0
5,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,0.092194,-0.076904,-0.13779,0,0
5,BIOCARTA D4GDI PATHWAY,0.17653,-0.077191,-0.16108,0,0
5,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,0.83713,-0.07721,-0.021708,0,0
5,ACTIN CYTOSKELETON,0.053746,-0.077214,-0.086833,0,0
5,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.20937,-0.077651,-0.076719,0,0
5,LIPOPROTEIN BINDING,0.23245,-0.078108,-0.087274,0,0
5,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.066855,-0.078118,-0.14396,0,0
5,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.19393,-0.078527,-0.062706,0,0
5,TRANSMISSION OF NERVE IMPULSE,0.22568,-0.078599,-0.051311,0,0
5,DOUBLE STRANDED DNA BINDING,0.47049,-0.078609,-0.056909,0,0
5,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,0.11434,-0.078632,-0.13828,0,0
5,PID AVB3 INTEGRIN PATHWAY,0.082489,-0.078639,-0.15641,0,0
5,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.20621,-0.078731,-0.082838,0,0
5,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,0.29992,-0.078762,-0.042635,0,0
5,PID KITPATHWAY,0.21579,-0.078794,-0.085612,0,0
5,BIOCARTA ARENRF2 PATHWAY,0.48131,-0.078809,-0.073896,0,0
5,KEGG FC EPSILON RI SIGNALING PATHWAY,0.52594,-0.078966,-0.039662,0,0
5,KEGG HEMATOPOIETIC CELL LINEAGE,0.1313,-0.079316,-0.13401,0,0
5,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.061812,-0.079527,-0.12193,0,0
5,REACTOME NEUROTRANSMITTER RELEASE CYCLE,0.64605,-0.079629,0.016823,0,0
5,INTERCELLULAR JUNCTION,0.084046,-0.079793,-0.13952,0,0
5,BIOCARTA ATM PATHWAY,0.41842,-0.080039,-0.039501,0,0
5,COLLAGEN,0.18508,-0.080059,-0.1807,0,0
5,PEPTIDYL TYROSINE PHOSPHORYLATION,0.24643,-0.080639,-0.09028,0,0
5,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.27611,-0.080669,-0.12461,0,0
5,PEPTIDYL TYROSINE MODIFICATION,0.2839,-0.080825,-0.089468,0,0
5,VOLTAGE GATED CHANNEL ACTIVITY,0.27611,-0.08158,-0.07106,0,0
5,KEGG BASE EXCISION REPAIR,0.044685,-0.081758,-0.098732,0,0
5,AMINOPEPTIDASE ACTIVITY,0.050569,-0.081877,-0.19646,0,0
5,PID FGF PATHWAY,0.076492,-0.082399,-0.090287,0,0
5,PID TRKRPATHWAY,0.23589,-0.08242,-0.03825,0,0
5,MAPKKK CASCADE GO 0000165,0.055956,-0.082428,-0.10175,0,0
5,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.088862,-0.082538,-0.074872,0,0
5,REACTOME CELL CELL JUNCTION ORGANIZATION,0.43367,-0.083119,-0.036185,0,0
5,DIGESTION,0.46512,-0.083925,-0.099582,0,0
5,KEGG GLYCOSAMINOGLYCAN DEGRADATION,0.054842,-0.084155,-0.22435,0,0
5,PID NFKAPPABCANONICALPATHWAY,0.13355,-0.084366,-0.14065,0,0
5,PID HIVNEFPATHWAY,0.21256,-0.084476,-0.088304,0,0
5,INTEGRIN COMPLEX,0.56666,-0.084785,-0.07245,0,0
5,TRANSCRIPTION COREPRESSOR ACTIVITY,0.063042,-0.084795,-0.07574,0,0
5,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.088862,-0.084981,-0.12816,0,0
5,SIG CHEMOTAXIS,0.070855,-0.085065,-0.084013,0,0
5,REGULATION OF NEURON APOPTOSIS,0.54321,-0.085389,-0.037638,0,0
5,BIOCARTA PTEN PATHWAY,0.10654,-0.085561,-0.098576,0,0
5,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.80989,-0.085677,-0.030071,0,0
5,VIRAL GENOME REPLICATION,0.30815,-0.086768,-0.074157,0,0
5,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.54903,-0.08681,-0.059468,0,0
5,PID PRLSIGNALINGEVENTSPATHWAY,0.60883,-0.087216,-0.053373,0,0
5,MUSCLE CELL DIFFERENTIATION,0.13814,-0.087237,-0.1472,0,0
5,PID MAPKTRKPATHWAY,0.16294,-0.087273,-0.076394,0,0
5,REACTOME ION CHANNEL TRANSPORT,0.48131,-0.087498,-0.015237,0,0
5,PID AURORA B PATHWAY,0.19695,-0.087585,-0.085797,0,0
5,PID S1P META PATHWAY,0.1313,-0.088272,-0.11121,0,0
5,COATED VESICLE MEMBRANE,0.14769,-0.088539,-0.12096,0,0
5,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.054842,-0.088546,-0.12135,0,0
5,RAS GTPASE BINDING,0.057089,-0.088687,-0.091187,0,0
5,CORTICAL ACTIN CYTOSKELETON,0.5726,-0.088739,-0.044355,0,0
5,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15264,-0.088866,-0.1271,0,0
5,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.29586,-0.088923,-0.048846,0,0
5,INTERPHASE,0.079444,-0.089216,-0.077457,0,0
5,PID INTEGRIN A4B1 PATHWAY,0.10465,-0.089401,-0.13082,0,0
5,REACTOME L1CAM INTERACTIONS,0.49227,-0.089495,-0.040244,0,0
5,SMALL CONJUGATING PROTEIN BINDING,0.21579,-0.08953,-0.065546,0,0
5,ENDOSOME,0.053746,-0.090044,-0.1018,0,0
5,REACTOME BOTULINUM NEUROTOXICITY,0.20937,-0.090105,-0.083459,0,0
5,PID PTP1BPATHWAY,0.090515,-0.09019,-0.11127,0,0
5,BIOCARTA BARRESTIN SRC PATHWAY,0.65234,-0.090222,0.0082883,0,0
5,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.10096,-0.090333,-0.099296,0,0
5,NEUROPEPTIDE BINDING,0.34702,-0.090932,-0.071114,0,0
5,NEUROPEPTIDE RECEPTOR ACTIVITY,0.34702,-0.090932,-0.071114,0,0
5,AXONOGENESIS,0.62732,-0.09127,-0.04684,0,0
5,PID REG GR PATHWAY,0.11235,-0.091297,-0.11233,0,0
5,SIG PIP3 SIGNALING IN B LYMPHOCYTES,0.13814,-0.091626,-0.10773,0,0
5,KEGG MTOR SIGNALING PATHWAY,0.17934,-0.091802,-0.050468,0,0
5,KEGG VEGF SIGNALING PATHWAY,0.19695,-0.091833,-0.053831,0,0
5,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.055956,-0.09195,-0.087229,0,0
5,REACTOME M G1 TRANSITION,0.14285,-0.092123,-0.081829,0,0
5,BIOCARTA PYK2 PATHWAY,0.24643,-0.092264,-0.055829,0,0
5,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,0.17374,-0.092536,-0.081488,0,0
5,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,0.20937,-0.092687,-0.11497,0,0
5,REACTOME IL 3 5 AND GM CSF SIGNALING,0.56666,-0.092747,-0.053518,0,0
5,REACTOME CELL CELL COMMUNICATION,0.16032,-0.092776,-0.074444,0,0
5,REACTOME NETRIN1 SIGNALING,0.62732,-0.09292,-0.027001,0,0
5,BIOCARTA RAC1 PATHWAY,0.046579,-0.093226,-0.11168,0,0
5,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,0.059411,-0.09341,-0.19673,0,0
5,LEUKOCYTE DIFFERENTIATION,0.36526,-0.093456,-0.076739,0,0
5,BIOCARTA ARF PATHWAY,0.080955,-0.093466,-0.18311,0,0
5,MEMBRANE COAT,0.17653,-0.093536,-0.11837,0,0
5,COATED MEMBRANE,0.17653,-0.093536,-0.11837,0,0
5,BIOCARTA SPPA PATHWAY,0.55487,-0.094013,-0.036828,0,0
5,REACTOME SPRY REGULATION OF FGF SIGNALING,0.04854,-0.094326,-0.14035,0,0
5,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.087232,-0.094348,-0.11564,0,0
5,REACTOME SIGNALING BY PDGF,0.066855,-0.094599,-0.083647,0,0
5,MYOSIN COMPLEX,0.22568,-0.094885,-0.053801,0,0
5,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.13355,-0.09497,-0.15734,0,0
5,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.87833,-0.095303,-0.02249,0,0
5,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.79636,-0.095447,0.0065787,0,0
5,AXON GUIDANCE,0.59059,-0.09553,0.090675,0,0
5,POSITIVE REGULATION OF DNA BINDING,0.12689,-0.095921,-0.083505,0,0
5,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.26471,-0.095971,-0.061616,0,0
5,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.27999,-0.096574,-0.055875,0,0
5,SIG CD40PATHWAYMAP,0.19095,-0.097377,-0.068715,0,0
5,PHOSPHOLIPID TRANSPORTER ACTIVITY,0.15517,-0.097521,-0.12665,0,0
5,VOLTAGE GATED CATION CHANNEL ACTIVITY,0.2839,-0.097546,-0.071295,0,0
5,RNA HELICASE ACTIVITY,0.17099,-0.097736,-0.081469,0,0
5,NUCLEOTIDE KINASE ACTIVITY,0.74288,-0.097983,-0.027671,0,0
5,CARBOHYDRATE BINDING,0.076492,-0.098977,-0.11767,0,0
5,PROTEIN OLIGOMERIZATION,0.070855,-0.099354,-0.11512,0,0
5,ANTIGEN BINDING,0.17374,-0.099395,-0.10146,0,0
5,PID IL4 2PATHWAY,0.21256,-0.099668,-0.093431,0,0
5,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,0.21905,-0.099747,-0.11943,0,0
5,SA CASPASE CASCADE,0.23245,-0.10014,-0.096067,0,0
5,PID NOTCH PATHWAY,0.049546,-0.10074,-0.12291,0,0
5,PID CD8TCRDOWNSTREAMPATHWAY,0.045624,-0.10098,-0.12947,0,0
5,RESPONSE TO BIOTIC STIMULUS,0.044685,-0.1011,-0.091444,0,0
5,POSITIVE REGULATION OF BINDING,0.18219,-0.10112,-0.065244,0,0
5,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.054842,-0.10124,-0.11889,0,0
5,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,0.25001,-0.10142,-0.12745,0,0
5,KEGG TIGHT JUNCTION,0.064293,-0.10148,-0.079886,0,0
5,REACTOME SIGNALING BY NODAL,0.53742,-0.10164,-0.021318,0,0
5,ORGANELLE OUTER MEMBRANE,0.080955,-0.10166,-0.10779,0,0
5,KEGG AXON GUIDANCE,0.32938,-0.10186,-0.064547,0,0
5,PID LYSOPHOSPHOLIPID PATHWAY,0.16559,-0.1021,-0.084125,0,0
5,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.18219,-0.10216,-0.11439,0,0
5,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.87144,-0.10237,-0.045296,0,0
5,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,0.13814,-0.10259,-0.14466,0,0
5,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.29586,-0.10267,-0.056027,0,0
5,NEGATIVE REGULATION OF CELL ADHESION,0.049546,-0.10279,-0.16721,0,0
5,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,0.12259,-0.10301,-0.12023,0,0
5,REACTOME APOPTOTIC EXECUTION PHASE,0.24288,-0.10365,-0.08237,0,0
5,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.31232,-0.1037,-0.06557,0,0
5,REGULATION OF TRANSFERASE ACTIVITY,0.05161,-0.10396,-0.073526,0,0
5,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.11039,-0.10399,-0.093804,0,0
5,EXTRINSIC TO MEMBRANE,0.14769,-0.10465,-0.13075,0,0
5,POSITIVE REGULATION OF CELL CYCLE,0.10845,-0.10493,-0.14475,0,0
5,CYTOKINE BINDING,0.046579,-0.10508,-0.15912,0,0
5,AMINO SUGAR METABOLIC PROCESS,0.061812,-0.10518,-0.15427,0,0
5,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.05161,-0.10532,-0.076984,0,0
5,BIOCARTA CERAMIDE PATHWAY,0.31653,-0.10563,-0.07076,0,0
5,SULFOTRANSFERASE ACTIVITY,0.20309,-0.10568,-0.068473,0,0
5,BIOCARTA NOS1 PATHWAY,0.52594,-0.10578,-0.056894,0,0
5,REACTOME O LINKED GLYCOSYLATION OF MUCINS,0.052669,-0.1058,-0.17652,0,0
5,BIOCARTA EXTRINSIC PATHWAY,0.054842,-0.10585,-0.28153,0,0
5,REACTOME APOPTOSIS,0.05824,-0.1059,-0.091377,0,0
5,KEGG ERBB SIGNALING PATHWAY,0.11636,-0.1061,-0.058535,0,0
5,REACTOME NEURONAL SYSTEM,0.40843,-0.1062,-0.025703,0,0
5,BIOCARTA DEATH PATHWAY,0.21905,-0.10621,-0.14928,0,0
5,PID BETACATENIN NUC PATHWAY,0.10465,-0.10624,-0.097035,0,0
5,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,0.16828,-0.10631,-0.12126,0,0
5,STRIATED MUSCLE DEVELOPMENT,0.072231,-0.10679,-0.11588,0,0
5,PID AVB3 OPN PATHWAY,0.18508,-0.10685,-0.15768,0,0
5,ER NUCLEAR SIGNALING PATHWAY,0.24288,-0.10692,-0.082298,0,0
5,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.11841,-0.10743,-0.1211,0,0
5,MEDIATOR COMPLEX,0.20621,-0.10745,-0.058177,0,0
5,PID S1P S1P2 PATHWAY,0.088862,-0.10768,-0.098186,0,0
5,BIOCARTA IGF1 PATHWAY,0.047551,-0.10784,-0.12741,0,0
5,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.10845,-0.10837,-0.09438,0,0
5,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.29184,-0.10837,-0.067888,0,0
5,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.12049,-0.10847,-0.16466,0,0
5,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.050569,-0.1086,-0.10055,0,0
5,REACTOME POTASSIUM CHANNELS,0.35607,-0.10953,-0.029675,0,0
5,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.19695,-0.10954,-0.09871,0,0
5,INTERMEDIATE FILAMENT CYTOSKELETON,0.27611,-0.10994,-0.16935,0,0
5,INTERMEDIATE FILAMENT,0.27611,-0.10994,-0.16935,0,0
5,INACTIVATION OF MAPK ACTIVITY,0.059411,-0.11019,-0.22726,0,0
5,ST ADRENERGIC,0.047551,-0.11034,-0.11865,0,0
5,BIOCARTA CACAM PATHWAY,0.28785,-0.11076,-0.10727,0,0
5,SA PTEN PATHWAY,0.22905,-0.11079,-0.073265,0,0
5,KEGG P53 SIGNALING PATHWAY,0.088862,-0.11098,-0.10373,0,0
5,BLOOD COAGULATION,0.052669,-0.11104,-0.15875,0,0
5,DNA DEPENDENT DNA REPLICATION,0.1028,-0.11104,-0.08671,0,0
5,ENDOCYTIC VESICLE,0.18219,-0.11176,-0.12377,0,0
5,KEGG PROTEIN EXPORT,0.16032,-0.11176,-0.10611,0,0
5,REGULATION OF DNA METABOLIC PROCESS,0.04854,-0.11178,-0.11643,0,0
5,CELL CELL SIGNALING,0.13355,-0.11218,-0.066371,0,0
5,CELLULAR COMPONENT DISASSEMBLY,0.11434,-0.11225,-0.096413,0,0
5,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0695,-0.11257,-0.083085,0,0
5,REACTOME SIGNALING BY NOTCH2,0.046579,-0.11269,-0.16529,0,0
5,DNA DIRECTED RNA POLYMERASE COMPLEX,0.12259,-0.11336,-0.11146,0,0
5,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.12259,-0.11336,-0.11146,0,0
5,RNA POLYMERASE COMPLEX,0.12259,-0.11336,-0.11146,0,0
5,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.055956,-0.11339,-0.20229,0,0
5,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,0.38408,-0.11357,-0.063221,0,0
5,NEURON PROJECTION,0.27999,-0.11358,-0.11555,0,0
5,DEACETYLASE ACTIVITY,0.27227,-0.11373,-0.062136,0,0
5,REACTOME G ALPHA S SIGNALLING EVENTS,0.12689,-0.11561,-0.071139,0,0
5,ION CHANNEL ACTIVITY,0.14769,-0.11606,-0.081066,0,0
5,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.14285,-0.11614,-0.10861,0,0
5,SKELETAL MUSCLE DEVELOPMENT,0.10845,-0.11673,-0.11274,0,0
5,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.42347,-0.11717,-0.097873,0,0
5,BEHAVIOR,0.044685,-0.11718,-0.083222,0,0
5,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,0.15773,-0.11757,-0.081574,0,0
5,SECRETORY PATHWAY,0.046579,-0.11793,-0.098998,0,0
5,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.073629,-0.11807,-0.12259,0,0
5,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.43883,-0.11821,-0.10399,0,0
5,SKELETAL DEVELOPMENT,0.04854,-0.11844,-0.13564,0,0
5,PROTEOGLYCAN METABOLIC PROCESS,0.15773,-0.1185,-0.13649,0,0
5,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,0.42347,-0.11857,-0.037955,0,0
5,REACTOME SIGNALING BY NOTCH3,0.21905,-0.11899,-0.082216,0,0
5,OUTER MEMBRANE,0.12049,-0.11907,-0.099861,0,0
5,LOCOMOTORY BEHAVIOR,0.05824,-0.11912,-0.12119,0,0
5,REACTOME PHOSPHORYLATION OF THE APC C,0.13583,-0.11962,-0.12418,0,0
5,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.073629,-0.11983,-0.14585,0,0
5,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.04854,-0.12007,-0.16148,0,0
5,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.14048,-0.12089,-0.11485,0,0
5,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.20621,-0.12092,-0.088198,0,0
5,PHOSPHOINOSITIDE BINDING,0.25363,-0.12093,-0.080842,0,0
5,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.066855,-0.1211,-0.13352,0,0
5,REGULATION OF TRANSPORT,0.087232,-0.12118,-0.073346,0,0
5,CELL CELL ADHESION,0.29586,-0.12134,-0.061443,0,0
5,PID DELTANP63PATHWAY,0.25001,-0.12218,-0.1058,0,0
5,ISOPRENOID METABOLIC PROCESS,0.15517,-0.12272,-0.16437,0,0
5,BIOCARTA EGF PATHWAY,0.064293,-0.12274,-0.13984,0,0
5,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.62732,-0.12325,-0.033713,0,0
5,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.059411,-0.12352,-0.14819,0,0
5,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.20309,-0.12439,-0.079298,0,0
5,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,0.14526,-0.1254,-0.11495,0,0
5,N ACETYLTRANSFERASE ACTIVITY,0.19695,-0.12597,-0.16794,0,0
5,N ACYLTRANSFERASE ACTIVITY,0.19695,-0.12597,-0.16794,0,0
5,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.054842,-0.12727,-0.15681,0,0
5,N METHYLTRANSFERASE ACTIVITY,0.053746,-0.12732,-0.12589,0,0
5,PID IL12 STAT4PATHWAY,0.046579,-0.12782,-0.21777,0,0
5,SYNAPSE ORGANIZATION AND BIOGENESIS,0.48678,-0.12822,-0.034363,0,0
5,KEGG PANCREATIC CANCER,0.045624,-0.12838,-0.088292,0,0
5,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.061812,-0.12851,-0.094977,0,0
5,MICROSOME,0.087232,-0.12987,-0.12483,0,0
5,HORMONE METABOLIC PROCESS,0.087232,-0.13033,-0.137,0,0
5,PROTEIN TETRAMERIZATION,0.073629,-0.13041,-0.15257,0,0
5,DEPHOSPHORYLATION,0.054842,-0.13041,-0.091663,0,0
5,PID IL12 2PATHWAY,0.046579,-0.13081,-0.12429,0,0
5,NUCLEAR ORGANIZATION AND BIOGENESIS,0.073629,-0.13088,-0.077811,0,0
5,KEGG BASAL CELL CARCINOMA,0.1028,-0.13116,-0.086929,0,0
5,KEGG PRIMARY IMMUNODEFICIENCY,0.055956,-0.13195,-0.14704,0,0
5,PID TRAIL PATHWAY,0.1313,-0.1322,-0.14483,0,0
5,CATION CHANNEL ACTIVITY,0.22905,-0.13221,-0.082091,0,0
5,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.047551,-0.13243,-0.13014,0,0
5,REACTOME IL RECEPTOR SHC SIGNALING,0.19393,-0.13273,-0.07408,0,0
5,MESODERM DEVELOPMENT,0.27999,-0.13283,-0.094715,0,0
5,REACTOME PYRIMIDINE METABOLISM,0.093897,-0.1335,-0.17269,0,0
5,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.11434,-0.13434,-0.097589,0,0
5,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,0.060602,-0.13445,-0.15941,0,0
5,UDP GLYCOSYLTRANSFERASE ACTIVITY,0.093897,-0.13494,-0.16183,0,0
5,BIOCARTA GH PATHWAY,0.077957,-0.13507,-0.10451,0,0
5,BIOCARTA BARR MAPK PATHWAY,0.15264,-0.13519,-0.093674,0,0
5,EXTRACELLULAR SPACE,0.061812,-0.13527,-0.12234,0,0
5,CYTOPLASMIC VESICLE MEMBRANE,0.059411,-0.1358,-0.11633,0,0
5,CYTOPLASMIC VESICLE PART,0.059411,-0.1358,-0.11633,0,0
5,PID ATF2 PATHWAY,0.25001,-0.13686,-0.096591,0,0
5,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.43367,-0.13719,-0.09879,0,0
5,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,0.44924,-0.13738,-0.086887,0,0
5,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.19095,-0.13954,-0.11637,0,0
5,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.12908,-0.13962,-0.10804,0,0
5,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.079444,-0.13981,-0.099505,0,0
5,POSITIVE REGULATION OF JNK ACTIVITY,0.21579,-0.13988,-0.079807,0,0
5,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.055956,-0.1412,-0.1824,0,0
5,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.11434,-0.14151,-0.11442,0,0
5,ADHERENS JUNCTION,0.4598,-0.14187,-0.070355,0,0
5,REACTOME INTERFERON GAMMA SIGNALING,0.053746,-0.14231,-0.21744,0,0
5,PML BODY,0.070855,-0.14237,-0.17342,0,0
5,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,0.065563,-0.1427,-0.1175,0,0
5,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.050569,-0.1432,-0.15553,0,0
5,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.188,-0.14327,-0.088894,0,0
5,KEGG APOPTOSIS,0.075049,-0.14337,-0.10734,0,0
5,KEGG GLYCEROLIPID METABOLISM,0.12473,-0.14388,-0.09462,0,0
5,G1 PHASE OF MITOTIC CELL CYCLE,0.34702,-0.14437,-0.087552,0,0
5,PID NECTIN PATHWAY,0.19095,-0.14485,-0.11456,0,0
5,BIOCARTA TGFB PATHWAY,0.11841,-0.14528,-0.15977,0,0
5,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.049546,-0.14631,-0.17336,0,0
5,PID RAC1 REG PATHWAY,0.12689,-0.1466,-0.10781,0,0
5,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.36526,-0.14672,-0.066665,0,0
5,CATION TRANSPORT,0.077957,-0.14734,-0.10581,0,0
5,BIOCARTA FIBRINOLYSIS PATHWAY,0.076492,-0.14754,-0.23957,0,0
5,BIOCARTA CCR5 PATHWAY,0.40349,-0.14755,-0.070813,0,0
5,G1 PHASE,0.21579,-0.14773,-0.097785,0,0
5,CYTOKINE SECRETION,0.099158,-0.14836,-0.15716,0,0
5,BIOCARTA HDAC PATHWAY,0.060602,-0.14849,-0.15871,0,0
5,REACTOME INTERFERON ALPHA BETA SIGNALING,0.22905,-0.1486,-0.22714,0,0
5,REACTOME ERK MAPK TARGETS,0.082489,-0.14897,-0.11359,0,0
5,B CELL ACTIVATION,0.045624,-0.14924,-0.1659,0,0
5,REGULATION OF CELL DIFFERENTIATION,0.045624,-0.14971,-0.13111,0,0
5,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.054842,-0.14986,-0.097618,0,0
5,BIOCARTA KERATINOCYTE PATHWAY,0.066855,-0.15032,-0.14361,0,0
5,NEURON DEVELOPMENT,0.47588,-0.15049,-0.063249,0,0
5,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,0.073629,-0.15221,-0.17054,0,0
5,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.072231,-0.15224,-0.10967,0,0
5,PID HNF3APATHWAY,0.12908,-0.15268,-0.13534,0,0
5,BIOCARTA CBL PATHWAY,0.25363,-0.15322,-0.13399,0,0
5,SIG BCR SIGNALING PATHWAY,0.16294,-0.15489,-0.10517,0,0
5,REACTOME INTERFERON SIGNALING,0.054842,-0.15533,-0.18487,0,0
5,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,0.077957,-0.15574,-0.14151,0,0
5,ACTIVATION OF JNK ACTIVITY,0.14285,-0.15577,-0.095287,0,0
5,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.14526,-0.15604,-0.087853,0,0
5,REGULATION OF PROTEIN SECRETION,0.087232,-0.15622,-0.15932,0,0
5,MRNA BINDING,0.12689,-0.15788,-0.1211,0,0
5,BIOCARTA AMI PATHWAY,0.059411,-0.15789,-0.29413,0,0
5,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.10465,-0.15812,-0.17675,0,0
5,RNA POLYMERASE ACTIVITY,0.064293,-0.1591,-0.12707,0,0
5,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.34702,-0.16047,-0.019302,0,0
5,AGING,0.066855,-0.16071,-0.17262,0,0
5,REACTOME ERKS ARE INACTIVATED,0.17099,-0.16119,-0.12285,0,0
5,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.087232,-0.16151,-0.22454,0,0
5,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.16294,-0.16308,-0.12066,0,0
5,KEGG MATURITY ONSET DIABETES OF THE YOUNG,0.18219,-0.16324,-0.16682,0,0
5,PID IL3 PATHWAY,0.04854,-0.16331,-0.13249,0,0
5,MYOBLAST DIFFERENTIATION,0.12689,-0.16377,-0.1729,0,0
5,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,0.10096,-0.16404,-0.1748,0,0
5,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,0.12689,-0.16436,-0.19711,0,0
5,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,0.23937,-0.16609,-0.10171,0,0
5,METAL ION TRANSPORT,0.077957,-0.16624,-0.10884,0,0
5,SODIUM ION TRANSPORT,0.49227,-0.16629,-0.094452,0,0
5,BIOCARTA CASPASE PATHWAY,0.16294,-0.16739,-0.15279,0,0
5,BIOCARTA PROTEASOME PATHWAY,0.054842,-0.16763,-0.1591,0,0
5,BIOCARTA TPO PATHWAY,0.087232,-0.17062,-0.12179,0,0
5,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.04854,-0.17158,-0.11572,0,0
5,PID P38 MKK3 6PATHWAY,0.063042,-0.17168,-0.13244,0,0
5,CELL MATURATION,0.090515,-0.17247,-0.14777,0,0
5,HORMONE ACTIVITY,0.43883,-0.17308,-0.077898,0,0
5,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.12049,-0.17575,-0.17178,0,0
5,AMINE BINDING,0.05824,-0.17663,-0.15008,0,0
5,AXON,0.064293,-0.17724,-0.20761,0,0
5,REGULATION OF CYTOKINE SECRETION,0.19393,-0.17802,-0.12672,0,0
5,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.059411,-0.17809,-0.20373,0,0
5,MONOVALENT INORGANIC CATION TRANSPORT,0.082489,-0.17835,-0.11464,0,0
5,PID EPOPATHWAY,0.26098,-0.18002,-0.08314,0,0
5,REACTOME DARPP 32 EVENTS,0.068167,-0.182,-0.15443,0,0
5,POTASSIUM ION TRANSPORT,0.080955,-0.18409,-0.1133,0,0
5,REACTOME METABOLISM OF NON CODING RNA,0.05824,-0.18417,-0.13018,0,0
5,TIGHT JUNCTION,0.10096,-0.18511,-0.11232,0,0
5,INTERLEUKIN BINDING,0.046579,-0.18662,-0.17582,0,0
5,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.11434,-0.1877,-0.14734,0,0
5,REACTOME TIGHT JUNCTION INTERACTIONS,0.24643,-0.18777,-0.064852,0,0
5,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,0.11235,-0.1896,-0.12872,0,0
5,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.17374,-0.19129,-0.1175,0,0
5,BIOCARTA NKT PATHWAY,0.082489,-0.19146,-0.2076,0,0
5,BIOCARTA BCR PATHWAY,0.052669,-0.19447,-0.13075,0,0
5,INTERLEUKIN RECEPTOR ACTIVITY,0.1028,-0.19534,-0.18058,0,0
5,SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.18219,-0.19656,-0.14364,0,0
5,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.079444,-0.20014,-0.17015,0,0
5,APICAL PART OF CELL,0.12259,-0.20243,-0.17361,0,0
5,REGULATION OF BLOOD PRESSURE,0.046579,-0.20672,-0.24458,0,0
5,RESPONSE TO HYPOXIA,0.23589,-0.20873,-0.10655,0,0
5,REGULATION OF CYTOKINE PRODUCTION,0.088862,-0.2114,-0.20486,0,0
5,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.44924,-0.21192,-0.070015,0,0
5,POTASSIUM CHANNEL ACTIVITY,0.073629,-0.21197,-0.14226,0,0
5,PID HNF3BPATHWAY,0.049546,-0.21295,-0.17916,0,0
5,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,0.052669,-0.21479,-0.27859,0,0
5,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,0.075049,-0.21555,-0.28707,0,0
5,APICAL PLASMA MEMBRANE,0.052669,-0.21667,-0.19654,0,0
5,NEUROTRANSMITTER BINDING,0.04854,-0.21822,-0.13674,0,0
5,REACTOME AMYLOIDS,0.061812,-0.21883,-0.1582,0,0
5,LEUKOCYTE MIGRATION,0.62113,-0.21985,-0.014383,0,0
5,RHO GTPASE ACTIVATOR ACTIVITY,0.2,-0.22013,-0.11784,0,0
5,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.12689,-0.22294,-0.12372,0,0
5,BIOCARTA IL22BP PATHWAY,0.15517,-0.22336,-0.18113,0,0
5,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.17099,-0.22411,-0.1645,0,0
5,NEUROTRANSMITTER RECEPTOR ACTIVITY,0.054842,-0.22562,-0.13413,0,0
5,PID HIF1APATHWAY,0.077957,-0.22629,-0.1252,0,0
5,KEGG CIRCADIAN RHYTHM MAMMAL,0.054842,-0.22646,-0.19176,0,0
5,CARBONATE DEHYDRATASE ACTIVITY,0.17099,-0.22864,-0.16102,0,0
5,POSITIVE REGULATION OF CELL DIFFERENTIATION,0.079444,-0.23136,-0.23127,0,0
5,EARLY ENDOSOME,0.046579,-0.23448,-0.21112,0,0
5,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.061812,-0.2347,-0.19736,0,0
5,APICAL JUNCTION COMPLEX,0.05161,-0.23472,-0.1518,0,0
5,APICOLATERAL PLASMA MEMBRANE,0.05161,-0.23472,-0.1518,0,0
5,BIOCARTA EGFR SMRTE PATHWAY,0.0695,-0.23595,-0.18449,0,0
5,SH3 DOMAIN BINDING,0.15015,-0.24088,-0.13128,0,0
5,CALCIUM INDEPENDENT CELL CELL ADHESION,0.12259,-0.24357,-0.18814,0,0
5,REGULATION OF ACTION POTENTIAL,0.31653,-0.24472,-0.086189,0,0
5,REGULATION OF ACTIN FILAMENT LENGTH,0.10654,-0.24596,-0.19722,0,0
5,BIOCARTA SODD PATHWAY,0.04854,-0.24944,-0.2486,0,0
5,REGULATION OF HOMEOSTATIC PROCESS,0.05161,-0.26235,-0.28484,0,0
5,MORPHOGENESIS OF AN EPITHELIUM,0.17653,-0.26302,-0.19848,0,0
5,REGULATION OF CELLULAR COMPONENT SIZE,0.092194,-0.26365,-0.18303,0,0
5,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,0.04854,-0.26892,-0.23664,0,0
5,REGULATION OF NEUROGENESIS,0.055956,-0.28309,-0.33212,0,0
5,SECRETORY GRANULE,0.188,-0.30644,-0.16709,0,0
5,REGULATION OF MYELOID CELL DIFFERENTIATION,0.04854,-0.33481,-0.25926,0,0
5,REACTOME HS GAG DEGRADATION,0.097379,-0.34483,-0.23419,0,0
5,SODIUM CHANNEL ACTIVITY,0.073629,-0.377,-0.19121,0,0
5,HOMOPHILIC CELL ADHESION,0.059411,-0.42116,-0.2452,0,0
